Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,maintenance of blood-brain barrier (GO:0035633),-0.6136085880241289,-2.0963061072850864,0.0,0.107458979870909,0.095,14/30,9.19%,TJP1;GJB6;OCLN;PECAM1;CDH5;LAMA2;CLDN5;ESAM;JAM2;LSR;F11R;SLC1A1;CLDN1;MFSD2A
prerank,B cell receptor signaling pathway (GO:0050853),-0.6210139062237261,-2.0778223682777717,0.0,0.07030026720526757,0.12,11/32,11.83%,BCL2;TEC;PRKCB;RFTN1;BMX;NFATC2;CD38;VAV3;SYK;PIK3CD;SH2B2
prerank,vasculature development (GO:0001944),-0.7411170964580643,-2.0629575335692336,0.0,0.06025737189022934,0.15,14/16,21.08%,CDH5;ERRFI1;PDGFRB;NOTCH4;PDGFRA;FLT4;BMPR2;SOX18;ACVRL1;APLNR;ACVR2B;STRA6;STK11;FOXF1
prerank,collagen fibril organization (GO:0030199),0.7285664406320519,2.040176175565192,0.0,0.0009989914849276092,0.001,30/88,5.11%,COL12A1;PLOD2;COL6A3;COL6A2;COL6A1;ADAMTS3;ADAMTS2;COL8A2;COL8A1;BMP1;COL11A1;COL3A1;DDR2;COL1A2;COL1A1;COL5A3;COL14A1;P4HB;COL15A1;SERPINH1;COL5A2;COL27A1;COL16A1;LOXL1;CYP1B1;TLL1;TGFB2;PLOD1;P3H1;PLOD3
prerank,high-density lipoprotein particle remodeling (GO:0034375),-0.7186485767261761,-1.9989417010727997,0.003816793893129771,0.11574436850581551,0.335,5/15,11.38%,PLTP;APOE;ABCG1;ABCA5;SCARB1
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),-0.5974632020031625,-1.953457905274262,0.0,0.16892149919894292,0.513,17/35,6.94%,KSR1;PDE7B;RAPGEF3;IRAG1;PDE4D;APOE;ADGRG6;RAPGEF2;RIMS2;CAP2;GUCY1B1;ADCY1;NUDT4;AHR;AKAP6;HTR2C;PDE2A
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.5176938319592126,-1.872793500940092,0.0,0.33576746669944457,0.805,18/46,14.69%,ATP1A2;GRM7;GRM5;NRXN1;SHANK3;GRM3;GRM8;GRM1;CACNG7;OPHN1;CACNG8;CDH2;HOMER1;CACNG3;CACNG4;RELN;DGKZ;TPRG1L
prerank,regulation of bicellular tight junction assembly (GO:2000810),-0.6354905956783637,-1.86517125754647,0.0091324200913242,0.31132975476618496,0.835,6/19,6.25%,TJP1;ROCK2;OCLN;CLDN5;PRKCH;F11R
prerank,bicarbonate transport (GO:0015701),0.7738615160254142,1.8595852367633376,0.0,0.24325442657987284,0.33,7/25,7.46%,SLC4A10;SLC26A7;SLC4A4;SLC26A6;SLC4A8;SLC4A11;SLC4A2
prerank,melanocyte differentiation (GO:0030318),-0.7292728321471502,-1.856436590693289,0.003205128205128205,0.3007847146853948,0.858,4/11,4.80%,LRMDA;KIT;ENPP1;MITF
prerank,negative regulation of leukocyte activation (GO:0002695),-0.6696355524299175,-1.852022883943643,0.0,0.27986201611239847,0.871,12/15,24.26%,IL31RA;NR1H3;LRFN5;CD200;ZC3H12A;CD300A;HAVCR2;CD84;GPER1;CD300LF;MILR1;GRN
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.6595490617790655,1.8428097791252585,0.0,0.2330980131497755,0.43,11/79,2.22%,BMPER;THBS1;SLIT2;HTRA3;FGF2;SKIL;NEDD4;CRIM1;EMILIN1;SMAD9;SMAD6
prerank,positive regulation of blood coagulation (GO:0030194),0.8290272871838485,1.8312753153318533,0.0,0.22502283197994397,0.511,3/17,1.08%,THBS1;ST3GAL4;F3
prerank,positive regulation of leukocyte proliferation (GO:0070665),-0.6967197158126682,-1.8165001876778284,0.013937282229965157,0.35451420462084926,0.942,7/12,21.30%,IL34;LYN;BST2;CSF1;PTK2;MAPK3;CSF1R
prerank,response to ketone (GO:1901654),0.7625545319320981,1.8123317235705516,0.0,0.26173576905103363,0.628,5/24,4.18%,THBS1;SLIT3;SLIT2;TGFB3;TGFB2
prerank,carboxylic acid transmembrane transport (GO:1905039),0.7047109446414285,1.8047515599791846,0.0,0.2529113442675064,0.68,10/40,6.91%,SLC38A2;SLC38A1;SLC23A1;SLC23A2;SLC5A6;SLC16A1;SLC38A6;ABCC1;SLC38A3;SLC7A10
prerank,external encapsulating structure organization (GO:0045229),0.6142618478922702,1.8037144634618798,0.0,0.22206153579248003,0.69,36/205,3.06%,THBS1;COL6A3;COL6A2;COL6A1;SMOC2;ADAMTSL3;SH3PXD2A;ADAMTS3;ADAMTS17;ADAMTS2;SMOC1;COL8A2;COL8A1;MFAP5;ELN;COL11A1;ITGA11;COL3A1;DDR2;COL1A2;FGF2;COL1A1;COL5A3;COL14A1;COL15A1;TGFBI;ADAMTSL1;COL5A2;BGN;COL27A1;VIT;COL16A1;LOXL1;DMP1;COMP;SPARC
prerank,response to glucocorticoid (GO:0051384),0.7510239827250232,1.8003280376913342,0.0,0.20791510280055867,0.707,3/26,1.24%,SLIT3;SLIT2;ADAM9
prerank,extracellular structure organization (GO:0043062),0.6125252775210328,1.7990887168727452,0.0,0.18958638402848405,0.719,36/204,3.06%,THBS1;COL6A3;COL6A2;COL6A1;SMOC2;ADAMTSL3;SH3PXD2A;ADAMTS3;ADAMTS17;ADAMTS2;SMOC1;COL8A2;COL8A1;MFAP5;ELN;COL11A1;ITGA11;COL3A1;DDR2;COL1A2;FGF2;COL1A1;COL5A3;COL14A1;COL15A1;TGFBI;ADAMTSL1;COL5A2;BGN;COL27A1;VIT;COL16A1;LOXL1;DMP1;COMP;SPARC
prerank,extracellular matrix organization (GO:0030198),0.6071333822523225,1.798221672782998,0.0,0.17222613200151982,0.72,58/276,6.96%,COL12A1;PLOD2;THBS1;COL6A3;COL6A2;COL6A1;SMOC2;ADAMTSL3;SH3PXD2A;ADAMTS3;ADAMTS17;ADAMTS2;SMOC1;COL8A2;COL8A1;BMP1;MFAP5;ELN;COL11A1;ITGA11;GAS6;COL3A1;DDR2;COL1A2;FGF2;COL1A1;COL5A3;GSN;COL14A1;P4HB;COL15A1;HTRA1;TGFBI;SERPINH1;TIMP2;ADAMTSL1;COL5A2;BGN;COL27A1;VIT;COL16A1;LOXL1;DMP1;COMP;CYP1B1;SPARC;TLL1;TGFB2;ADAMTS10;PLOD1;P3H1;PLOD3;MMP14;MMP28;ADAM10;P4HA1;LOX;QSOX1
prerank,positive regulation of macrophage activation (GO:0043032),0.791398994619894,1.7898711256746211,0.0026455026455026454,0.18463178989616633,0.773,3/17,1.27%,THBS1;LBP;IL33
prerank,establishment of endothelial barrier (GO:0061028),-0.5450562704972566,-1.7801913462561372,0.0,0.4402440109919483,0.981,11/29,11.65%,TJP1;RAPGEF3;PDE4D;PECAM1;PPP1R16B;RAPGEF2;F11R;PDE2A;ROBO4;SOX18;RAP2B
prerank,negative regulation of heart contraction (GO:0045822),-0.7131980508060174,-1.7768859424056522,0.003389830508474576,0.41694753716267025,0.982,2/11,1.27%,ATP1A2;PDE4D
prerank,protein hydroxylation (GO:0018126),0.8081058397987542,1.774874141128593,0.0013280212483399733,0.22618832204569284,0.852,6/15,7.90%,PLOD2;P3H3;PLOD1;P3H1;PLOD3;P3H2
prerank,cellular response to zinc ion (GO:0071294),-0.6491942731731337,-1.770831895041039,0.011111111111111112,0.40635099505462347,0.987,12/15,18.03%,GLRA2;MT1X;MT1A;MT1H;MT1B;MT1G;MT1M;MT1F;MT1E;GLRA1;ATP13A2;MT3
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.6993639376290197,1.7692537914659452,0.002347417840375587,0.22961435053566895,0.88,11/39,6.49%,SLIT2;LRP6;SIX1;PKD1;VEGFA;FGF2;GLI2;LRP5;PKHD1;SEMA3E;TGFBR2
prerank,positive regulation of coagulation (GO:0050820),0.8784222727010519,1.7669990683514383,0.0,0.20792342772959974,0.89,2/10,0.31%,THBS1;ST3GAL4
prerank,positive regulation of hemostasis (GO:1900048),0.8784222727010519,1.7669990683514383,0.0,0.20792342772959974,0.89,2/10,0.31%,THBS1;ST3GAL4
prerank,cardiac muscle cell contraction (GO:0086003),0.7648192698125539,1.7658218629664255,0.00516795865633075,0.19879930550059424,0.893,5/19,3.50%,KCNJ2;CACNA1G;CACNA1C;GSN;CAMK2D
prerank,negative regulation of interleukin-12 production (GO:0032695),0.8238019897256852,1.7645442213906615,0.0013717421124828531,0.1911011946461521,0.896,3/14,6.84%,THBS1;CMKLR1;IRAK3
prerank,type I interferon signaling pathway (GO:0060337),-0.48989058112830763,-1.7642108152823952,0.0,0.3733948478131211,0.989,25/41,24.31%,IFNAR2;STAT1;SAMHD1;IFITM1;BST2;SP100;IFIT3;IP6K2;IFIT2;RNASEL;IFIT1;EGR1;RSAD2;OAS2;IFITM3;PSMB8;IRF9;IFI27;IRF8;MYD88;ADAR;ISG15;IRF7;OASL;IRF5
prerank,cellular response to type I interferon (GO:0071357),-0.48989058112830763,-1.7642108152823952,0.0,0.3733948478131211,0.989,25/41,24.31%,IFNAR2;STAT1;SAMHD1;IFITM1;BST2;SP100;IFIT3;IP6K2;IFIT2;RNASEL;IFIT1;EGR1;RSAD2;OAS2;IFITM3;PSMB8;IRF9;IFI27;IRF8;MYD88;ADAR;ISG15;IRF7;OASL;IRF5
prerank,Golgi to endosome transport (GO:0006895),0.7804415079694544,1.764029849794716,0.004016064257028112,0.1820384483645866,0.898,6/16,7.31%,VPS13A;VPS13C;DOP1B;AP2A1;GBF1;MON2
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.6565906735604334,1.7634359975639489,0.0,0.17456061736629805,0.9,11/51,8.49%,BMPER;HTRA3;CHRDL1;FSTL1;SKIL;CRIM1;SMAD9;SMAD6;SMAD4;SKI;NOG
prerank,muscle tissue morphogenesis (GO:0060415),-0.6463738852357852,-1.755443925742937,0.023715415019762844,0.3748510676338017,0.991,8/16,15.92%,TGFBR3;MYLK;NOTCH1;TBX1;PROX1;HEY2;EFEMP2;BMP2
prerank,regulation of cell junction assembly (GO:1901888),-0.5339412037994447,-1.744724674207744,0.0053475935828877,0.3844656630015809,0.994,7/27,6.25%,TJP1;ROCK2;OCLN;CLDN5;RAPGEF2;PRKCH;F11R
prerank,Rap protein signal transduction (GO:0032486),-0.7107413047550712,-1.7334994700389041,0.01948051948051948,0.3988703255956015,0.995,4/10,11.71%,RAPGEF3;RAPGEF2;RAP2B;PLK2
prerank,regulation of cellular pH (GO:0030641),0.7075335162704175,1.7314774586573594,0.0036275695284159614,0.2868104553227166,0.972,12/29,14.26%,SLC4A10;SLC4A4;SLC26A6;SLC4A8;TM9SF4;SLC9A8;SLC9A4;SLC9A1;SLC4A2;CHP1;SLC4A5;SLC4A3
prerank,embryonic digestive tract development (GO:0048566),0.7613416994562985,1.7297438668496123,0.002551020408163265,0.2807166072646582,0.973,6/18,4.18%,PKDCC;ID2;PCSK5;RARB;GLI2;TGFB2
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),-0.6727705216918104,-1.7284673233302488,0.01056338028169014,0.3931000655681014,0.995,3/12,2.51%,ROCK2;APOE;PICALM
prerank,positive regulation of leukocyte activation (GO:0002696),0.7627820658492455,1.7283225929567407,0.005194805194805195,0.2750859279859753,0.978,3/18,1.27%,THBS1;LBP;IL33
prerank,regulation of fibrinolysis (GO:0051917),0.8161296756526006,1.7271396502466188,0.001388888888888889,0.2683812341464216,0.978,2/13,2.80%,THBS1;FAP
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),0.7803168692685315,1.7225937814746601,0.006729475100942127,0.2773033863578222,0.979,5/16,6.26%,ESR1;DDX5;DDX17;RBFOX2;SAFB
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.7708103802060264,1.7225441181945074,0.0013175230566534915,0.2663311298817006,0.979,3/18,1.79%,IRS1;KCNB1;CCN3
prerank,ion homeostasis (GO:0050801),0.7033628655574171,1.7222619733046665,0.0,0.2572403073688594,0.981,12/30,14.26%,SLC4A10;SLC4A4;FHL1;HCN4;CAMK2D;SLC4A8;SLC4A11;SLC4A2;AP3D1;SLC4A5;WNK1;SLC4A3
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.7518864308515473,1.7216954754573912,0.006329113924050633,0.2500068690242909,0.982,5/20,8.49%,THBS1;SMOC2;FGF2;SULF1;NOG
prerank,regulation of intracellular pH (GO:0051453),0.6832852614236323,1.720528287369658,0.0035629453681710215,0.24589461836146725,0.983,13/34,14.26%,SLC4A10;SLC4A4;SLC26A6;SLC4A8;TM9SF4;SLC9A8;SLC9A4;SLC9A1;SLC4A2;TMEM165;CHP1;SLC4A5;SLC4A3
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.6803208315492083,1.719971053184004,0.0011668611435239206,0.23968906041814844,0.984,11/35,11.48%,ESR1;PMEPA1;NEDD4;DDX5;DDX17;ZMIZ1;RBFOX2;PLPP1;SAFB;UBR5;RNF14
prerank,B cell homeostasis (GO:0001782),-0.6986400372756594,-1.7176904672392996,0.013651877133105802,0.41100549076793924,0.999,3/10,3.12%,LYN;DOCK11;DOCK10
prerank,regulation of acrosome reaction (GO:0060046),-0.7006908966853981,-1.7144875204389463,0.019736842105263157,0.4009984629361691,0.999,1/10,0.16%,PLCB1
prerank,cAMP-mediated signaling (GO:0019933),-0.5521903499755008,-1.710281921487717,0.00510204081632653,0.3956444258883467,0.999,12/24,6.94%,KSR1;PDE7B;RAPGEF3;PDE4D;ADGRG6;RAPGEF2;RIMS2;CAP2;ADCY1;AHR;AKAP6;PDE2A
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.6463622813454181,-1.7084682331888739,0.011278195488721804,0.38346394198550293,0.999,5/12,20.47%,GCNT2;BMP7;CD44;THY1;AGER
prerank,endoderm formation (GO:0001706),0.670867170642902,1.7076923560739445,0.0035671819262782403,0.2820152961950641,0.995,4/35,0.89%,COL12A1;COL6A1;COL8A1;COL11A1
prerank,L-glutamate transmembrane transport (GO:0015813),-0.6764030042063972,-1.7068962828219887,0.026845637583892617,0.37158712665641425,0.999,4/10,8.04%,SLC1A3;SLC25A13;SLC1A1;SLC1A2
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),-0.6833116546226503,-1.7060572363643676,0.02054794520547945,0.35889290697820597,0.999,3/10,7.80%,TGFA;ADRA2A;HBEGF
prerank,motor neuron axon guidance (GO:0008045),0.7904288136450698,1.7047226956669643,0.006747638326585695,0.2860660455387867,0.997,4/15,2.69%,SLIT2;SLIT1;NTN1;TMEFF1
prerank,lipoprotein catabolic process (GO:0042159),-0.6716458247968331,-1.7021838370792766,0.020905923344947737,0.35524810850925587,1.0,4/11,15.46%,APOE;NOTUM;ABHD17C;LYPLA1
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.7009367245154394,-1.7001792037288976,0.013289036544850499,0.3478561369860647,1.0,2/10,2.05%,LYN;KIT
prerank,mesonephros development (GO:0001823),-0.6834385431905095,-1.699329530397862,0.013513513513513514,0.3375488850350883,1.0,4/11,2.42%,ZBTB16;OSR1;BMP7;FGF1
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),0.8144498810902998,1.6941351037505978,0.001402524544179523,0.3252029468278408,0.998,2/11,1.79%,SLIT2;CCN3
prerank,embryonic skeletal system development (GO:0048706),0.6653833467673025,1.6937359417367148,0.008064516129032258,0.3174371124530579,0.998,12/35,8.49%,SIX1;XYLT1;WNT9A;PCSK5;HOXA3;COL1A1;DEAF1;HOXB3;SULF1;KIAA1217;HOXA9;NOG
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.5996070213456419,-1.6912313881735932,0.020491803278688523,0.3455794908578153,1.0,6/15,8.00%,GRM7;GRM5;GRM3;GRM8;GRM1;HOMER1
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.8039437431184602,1.6911289126716813,0.009575923392612859,0.3199710962018137,0.998,2/13,0.98%,CACNA1G;KCNB1
prerank,regulation of mononuclear cell migration (GO:0071675),0.7179946371985033,1.690372061049472,0.0076045627376425855,0.3143112637720809,0.998,3/23,0.49%,THBS1;SLIT2;CMKLR1
prerank,carbohydrate transport (GO:0008643),0.8191002083649974,1.6898314990582717,0.008534850640113799,0.3076893773577037,0.998,3/11,3.08%,SLC23A1;SLC23A2;SLC26A6
prerank,skeletal system development (GO:0001501),0.5796378220725055,1.688364318205593,0.0,0.3059883918563404,0.998,34/148,9.72%,MYOC;GNAS;EXT1;PKD1;CMKLR1;XYLT1;CDH11;PKDCC;GDF10;BMP1;ALPL;PCSK5;COL1A2;COL1A1;PAPSS2;NPR3;DEAF1;GLI2;COMP;TLL1;HES5;TGFB2;P3H1;SULF1;SLC10A7;KIAA1217;MMP14;FGFR1;SOX9;SH3PXD2B;NOG;HAPLN4;EVC;FGFR2
prerank,response to hexose (GO:0009746),0.68889227647446,1.687554447746486,0.009937888198757764,0.3011433542064675,0.998,2/25,1.27%,THBS1;TCF7L2
prerank,digestive tract development (GO:0048565),0.6713695036739051,1.6870622135033937,0.004678362573099415,0.29554778854089114,0.998,12/32,9.72%,PKD1;PKDCC;PCSK5;RARB;GLI2;CLMP;COBL;TGFB2;AGR2;EPHB3;CCDC39;FGFR2
prerank,negative regulation of insulin secretion (GO:0046676),0.7657266231282159,1.6840444549197071,0.005263157894736842,0.30069643696321036,0.998,3/17,1.79%,IRS1;KCNB1;CCN3
prerank,endodermal cell differentiation (GO:0035987),0.6796751340890833,1.6801236699443534,0.007389162561576354,0.3107350831044342,1.0,4/31,0.89%,COL12A1;COL6A1;COL8A1;COL11A1
prerank,response to prostaglandin E (GO:0034695),-0.6692928203352224,-1.6754061773679336,0.010714285714285714,0.37500171106352725,1.0,3/10,13.39%,TGFBR3;GNG2;SFRP1
prerank,regulation of fibroblast migration (GO:0010762),0.729505669831423,1.6752741783107155,0.006459948320413436,0.32538579794784983,1.0,4/20,2.28%,THBS1;DDR2;FGF2;PRKCE
prerank,regulation of BMP signaling pathway (GO:0030510),0.6040477180493172,1.6743136528747848,0.0,0.32174495522703395,1.0,18/73,11.86%,BMPER;HTRA3;FSTL1;ZNF423;FOXD1;SKIL;SFRP4;CRIM1;SMAD9;SMAD6;HES5;SULF1;SMAD4;SKI;NOG;BMP4;BMPR1A;SMAD7
prerank,positive regulation of osteoclast differentiation (GO:0045672),-0.5926042189854345,-1.6720153187569717,0.022641509433962263,0.3722350553864167,1.0,12/14,40.79%,CSF1;TYROBP;POU4F1;ATP6AP1;CCR1;TRAF6;OCSTAMP;IL23A;TNF;TNFSF11;IL12B;IL23R
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.7520074201445046,1.6704978959509251,0.013333333333333334,0.3318013991075473,1.0,7/15,12.65%,SIX1;VEGFA;SIX4;SOX9;NOG;BMP4;SMO
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),-0.6544550226310495,-1.6647796717874257,0.013888888888888888,0.3822890869765019,1.0,2/12,0.51%,IGF1R;INSR
prerank,cardiac muscle tissue morphogenesis (GO:0055008),-0.5015729969291668,-1.66378795811262,0.005319148936170213,0.3733826746066786,1.0,6/29,6.22%,TGFBR3;ENG;NOTCH1;TPM1;PROX1;S1PR1
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.5917883315481962,1.6622146244342355,0.0,0.36372169975675445,1.0,36/80,18.02%,ARFGAP3;ARFGAP1;KDELR3;PLPP3;SCYL1;ARCN1;COPA;COPB1;COPG1;TMEM115;COPE;ARFGAP2;GBF1;COPZ2;KLC2;ARF4;KDELR1;ERGIC1;SCFD1;NSF;KDELR2;ATP9A;RER1;TMED9;ZW10;PICK1;ERGIC2;LMAN2;SEC22B;RINT1;COPB2;KLC1;BNIP1;TMED2;NAPA;GOLPH3
prerank,positive regulation of lipid metabolic process (GO:0045834),-0.549810714960161,-1.6554853562740894,0.0182648401826484,0.3852927249687017,1.0,5/22,9.39%,SORBS1;APOE;PPARA;PPARD;ZBTB20
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),0.7331506551167063,1.6550476410894146,0.007731958762886598,0.39279910843229715,1.0,4/17,5.73%,SLIT2;FSTL1;SFRP4;SULF1
prerank,heart trabecula morphogenesis (GO:0061384),-0.5620277636943394,-1.6549911547596148,0.012711864406779662,0.37551820282258636,1.0,9/18,7.65%,TGFBR3;ENG;TEK;ADGRG6;BMP7;RBP4;NOTCH1;S1PR1;RBPJ
prerank,regulation of muscle cell differentiation (GO:0051147),0.675863289298333,1.6509022802989302,0.0036407766990291263,0.40620694188194767,1.0,11/31,13.80%,BOC;CDON;ID2;HDAC9;FGFR2;ABL1;MAPK12;SRF;PTBP1;MEF2A;RBM4
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.7240993255034739,1.6486650568646808,0.009150326797385621,0.4100651922401809,1.0,8/18,16.57%,ESR1;EGFR;DDX5;NCOR2;BMP4;TERT;IL6;ZC3H10
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),0.7217017792364719,1.6483293062605548,0.007802340702210663,0.403531397166779,1.0,4/20,1.32%,THBS1;SFRP4;PDCD4;GSN
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),0.7286868149947896,1.648196793032211,0.014686248331108143,0.3963398817301797,1.0,8/18,15.54%,NUP93;ENY2;NXF1;ZC3H11A;PABPN1;SARNP;DDX19A;THOC2
prerank,androgen receptor signaling pathway (GO:0030521),0.7869903026761088,1.6470323320676372,0.0111731843575419,0.3942294632480993,1.0,6/11,11.48%,PMEPA1;DDX5;DDX17;ZMIZ1;PLPP1;RNF14
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.5747861824337109,1.6459058783659017,0.0,0.3928726128224925,1.0,32/104,17.19%,BMPER;HTRA3;HTRA4;PMEPA1;SKIL;CRIM1;EMILIN1;SMAD9;CCN3;SMAD6;LDLRAD4;SPRED2;ACVR1;BCL9L;SMAD4;TGFBR2;SKI;NOG;BMPR1A;PDPK1;SMAD7;TGFB1I1;TGFBR1;CIDEA;LRP2;STUB1;NBL1;IL17RD;CD109;RPS27A;UBC;SLC2A10
prerank,transepithelial transport (GO:0070633),0.753526504845466,1.6453838626583295,0.011936339522546418,0.38787258069510083,1.0,5/15,3.92%,SLC23A1;SLC23A2;SLC12A2;SLC26A6;ABCC1
prerank,response to zinc ion (GO:0010043),-0.5092479082583524,-1.6434864981258595,0.010309278350515464,0.3972802005040537,1.0,14/25,18.03%,PAM;GLRA2;CRIP1;MT1X;MT1A;MT1H;MT1B;MT1G;MT1M;MT1F;MT1E;GLRA1;ATP13A2;MT3
prerank,transition metal ion transport (GO:0000041),-0.492009475974304,-1.6421879159816446,0.017241379310344827,0.3898000530250376,1.0,6/35,6.45%,CP;SLC30A10;TRPC3;TFRC;SLC39A8;TRPC6
prerank,peptide cross-linking (GO:0018149),0.687315155362627,1.6421645895968724,0.0037220843672456576,0.3972101143126055,1.0,4/25,2.82%,THBS1;COL3A1;TGM6;TGM5
prerank,negative regulation of protein catabolic process (GO:0042177),0.6347196819478812,1.6394072322982098,0.009237875288683603,0.4039376660600928,1.0,13/40,11.54%,EGFR;TIMP2;PTPN3;TIMP3;RILP;SNRNP70;RIC1;IRAK3;MDM4;CDK5RAP3;CST3;RGP1;NELL1
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.7180580008300411,1.6388547885174858,0.006527415143603133,0.39922197216419586,1.0,4/19,2.01%,SLC26A2;PAPSS2;SULT1C2;SULT1C4
prerank,myoblast differentiation (GO:0045445),0.7571479581615648,1.6371796928103477,0.013605442176870748,0.40075332095359145,1.0,6/14,6.22%,TCF7L2;DDX5;DDX17;SDC1;MBNL1;JAG1
prerank,response to estradiol (GO:0032355),0.6586356431668737,1.6353126266715658,0.008413461538461538,0.4031791841238875,1.0,8/31,10.07%,ESR1;EGFR;CYP19A1;STAT3;NRIP1;SOCS2;ANXA1;FOXA1
prerank,regulation of interleukin-1 production (GO:0032652),0.7507769105084243,1.6323974086177753,0.013623978201634877,0.41165222002644125,1.0,5/15,13.33%,FOXP1;GAS6;HMGB1;ANXA1;F2R
prerank,nucleotide biosynthetic process (GO:0009165),0.7184308788465074,1.6323520842113537,0.014435695538057743,0.40502444770581697,1.0,2/18,0.29%,PRPS2;ME1
prerank,negative regulation of hemostasis (GO:1900047),-0.640592659598861,-1.6323450556152497,0.029605263157894735,0.40544225533684575,1.0,6/12,12.38%,VTN;APOE;TFPI;EDN1;SERPINE1;CD34
prerank,organic anion transport (GO:0015711),0.5871819051488274,1.632109490166106,0.002105263157894737,0.39974398615734447,1.0,10/76,5.77%,SLC4A10;SLC26A7;SLC4A4;SLC23A1;SLCO3A1;SLCO2A1;SLC26A6;SLC4A8;LRRC8D;SLC4A11
prerank,negative regulation of coagulation (GO:0050819),-0.616021851074747,-1.626003529695882,0.017482517482517484,0.4128660015025842,1.0,6/14,12.38%,VTN;APOE;TFPI;EDN1;SERPINE1;CD34
prerank,cell-cell junction organization (GO:0045216),-0.4040177636557323,-1.6259722532556133,0.0,0.4026447804181699,1.0,25/79,9.70%,TJP1;SDK1;CADM1;TLN2;CDH8;CDH13;OCLN;CDH5;CLDN5;CADM2;LIMS2;PKP4;SMAD3;CDH4;ARVCF;GJC1;CXADR;CDH1;CDH6;CDH2;CLDN1;NECTIN2;CDH7;CDH20;CDH19
prerank,dopaminergic neuron differentiation (GO:0071542),0.7007239108350896,1.6247518163193655,0.014416775884665793,0.42942132362589863,1.0,2/19,0.80%,LRP6;VEGFA
prerank,negative regulation of calcium ion transport (GO:0051926),-0.5913214122557554,-1.6244709909509019,0.02962962962962963,0.397355726342805,1.0,5/15,12.04%,ATP1A2;ADRA2A;PACSIN3;NOS1;SLC30A1
prerank,regulation of sprouting angiogenesis (GO:1903670),0.6453623806627735,1.6232049746805115,0.009650180940892641,0.43112032527320376,1.0,5/33,1.13%,BMPER;THBS1;RHOJ;VEGFA;FGF2
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.5515801359806283,1.6231367787007411,0.0,0.4246494273039939,1.0,93/173,24.91%,GAS6;ARFGAP3;ARFGAP1;SEC31A;KDELR3;SEC24D;STX5;ATL2;SEC13;ARCN1;SEC23A;LMAN2L;RAB2A;COPA;DYNC1H1;COPB1;COPG1;GOPC;NRBP2;GOLGB1;TMEM115;ATL3;CNIH2;COPE;ARFGAP2;GBF1;PROZ;COPZ2;ANK2;ARF4;KDELR1;ERGIC1;BET1;DCTN2;SCFD1;NSF;KDELR2;SPAST;HYOU1;TRAPPC12;TRAPPC6A;BCAP31;USO1;NRBP1;TMED9;TRIP11;ZW10;DYNC1LI2;SEC24C;SEC24B;SEC16A;ERGIC2;SEC16B;LMAN2;PREB;SEC22B;COPB2;MIA3;BCAP29;CNIH1;COG6;YIF1A;SPTBN1;SEC24A;DCTN5;TMED2;NAPA;IER3IP1;COG2;CTSZ;ACTR10;TRAPPC3;COG8;TRAPPC11;TRAPPC6B;CAPZA1;DYNC1I2;MIA2;DCTN1;COG5;LMAN1;RAB1A;KLHL12;ACTR1A;COPZ1;RAB1B;TMED7;VAMP4;USE1;PGAP1;DCTN4;TBC1D20;BET1L
prerank,axon extension (GO:0048675),0.6918757506513115,1.6220235161785548,0.008951406649616368,0.4236031278088425,1.0,5/23,1.42%,SLIT3;SLIT2;SLIT1;MAP1B;ULK2
prerank,neuron remodeling (GO:0016322),-0.6402247930581548,-1.62155789887179,0.0472972972972973,0.39535531223533804,1.0,9/10,21.98%,APP;EPHA8;ANKS1A;ADGRB3;CX3CL1;C1QA;SCARF1;C3;RND1
prerank,amino sugar biosynthetic process (GO:0046349),0.7664372395095655,1.6206855499914254,0.010218978102189781,0.42346643596696554,1.0,6/12,8.64%,UAP1L1;PGM3;GFPT1;GFPT2;GNPDA1;NANP
prerank,O-glycan processing (GO:0016266),0.607736395105227,1.6196209878151708,0.0044742729306487695,0.42275232197242546,1.0,10/54,8.47%,ST3GAL4;GXYLT2;GALNT10;GALNT15;GALNT13;MUC1;B3GNT7;MUC13;B4GALT5;ST3GAL2
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.7262761523098206,1.6196055090336512,0.011734028683181226,0.416594140266062,1.0,6/17,15.46%,CACNA1G;KCNB1;SLC4A8;RAB3D;NLGN1;STX1A
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.7236419752443639,1.618970585740973,0.022408963585434174,0.4134811277977911,1.0,3/15,2.89%,PIEZO2;COL11A1;LHFPL5
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.751461366534411,1.6184228889375898,0.006793478260869565,0.4103714307013343,1.0,3/15,1.13%,THBS1;SMOC2;FGF2
prerank,positive regulation of wound healing (GO:0090303),0.6470117202083332,1.6176629317259903,0.009313154831199068,0.40844681430934604,1.0,5/36,2.28%,THBS1;SMOC2;ST3GAL4;PLPP3;PRKCE
prerank,positive regulation of macrophage chemotaxis (GO:0010759),0.7496982010537963,1.6170554745621393,0.015172413793103448,0.4059512898057221,1.0,2/14,0.49%,THBS1;CMKLR1
prerank,apoptotic cell clearance (GO:0043277),0.6589828523503827,1.6157974417478709,0.00620347394540943,0.40645268621691677,1.0,8/30,9.70%,THBS1;RHOBTB1;LRP1;GAS6;HMGB1;RARA;ANXA1;ITGAV
prerank,regulation of macrophage chemotaxis (GO:0010758),0.6910882216178189,1.6152325182522398,0.012853470437017995,0.4033765617518509,1.0,2/21,0.49%,THBS1;CMKLR1
prerank,regulation of cardiac conduction (GO:1903779),-0.423770119405372,-1.6134496434806345,0.010526315789473684,0.40883926160405604,1.0,16/54,12.88%,ATP1A2;ITPR1;ATP1B3;SLC8A1;RYR2;ITPR3;ABCC9;ATP2B1;SLC8A3;ATP1B2;ATP2A3;NPR1;ITPR2;NOS1;ACE2;FXYD1
prerank,actomyosin structure organization (GO:0031032),-0.3996156238199021,-1.6133657078109604,0.0,0.3998670068730787,1.0,19/75,8.08%,TJP1;SORBS1;FRMD5;ROCK2;PHACTR1;FAM171A1;ACTN2;EPB41L3;EPB41;PGM5;TPM1;MYH10;TMOD3;F11R;TMOD1;TNFAIP1;FRMD3;MYH9;LMOD1
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.7194455290235834,1.6116020860747833,0.01844532279314888,0.4163530111448961,1.0,3/16,1.13%,THBS1;VEGFA;FGF2
prerank,positive regulation of positive chemotaxis (GO:0050927),0.7283885125923222,1.608313765742095,0.014608233731739707,0.42730546305298317,1.0,4/15,1.88%,PGF;VEGFA;F3;NTRK3
prerank,membrane repolarization during action potential (GO:0086011),0.7459816308612499,1.608037805195856,0.023778071334214,0.4230534329937595,1.0,4/13,6.92%,KCNJ2;ATP1B1;KCNE5;KCNIP2
prerank,atrioventricular valve morphogenesis (GO:0003181),0.7109933598063792,1.606677457732915,0.010037641154328732,0.42432803701457206,1.0,10/19,12.41%,SLIT3;SMAD6;TGFB2;ACVR1;SMAD4;TGFBR2;HEYL;MDM4;BMPR1A;HEY1
prerank,cell differentiation in spinal cord (GO:0021515),-0.6656763526785003,-1.6047766466535571,0.04482758620689655,0.41503938705281296,1.0,3/10,3.68%,SOX13;MDGA2;SOX6
prerank,cellular response to estradiol stimulus (GO:0071392),0.7051764012087351,1.602697664792866,0.020460358056265986,0.4387216528870693,1.0,2/18,0.30%,ESR1;EGFR
prerank,amino acid transmembrane transport (GO:0003333),0.6224122680169795,1.6021493249167764,0.007909604519774011,0.4358474974803543,1.0,8/45,6.91%,SLC47A1;SLC38A2;SLC38A1;SLC38A6;SLC38A3;SFXN3;LRRC8D;SLC7A10
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.48249665229207733,-1.6007011196890537,0.016666666666666666,0.4174569593887953,1.0,13/30,17.12%,BCL2L1;NOS3;FAS;DDX3X;RFFL;FAIM;ARHGEF2;SERPINE1;FAIM2;GPX1;TNFAIP3;ICAM1;BRCA1
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.6370274485471361,1.6002880320597452,0.015494636471990465,0.43953158691173005,1.0,9/32,9.20%,THBS1;RHOJ;VEGFA;FGF2;HDAC9;MEOX2;FOXC2;RHOA;ANXA1
prerank,neutral amino acid transport (GO:0015804),0.6590099066351864,1.6001780614211134,0.004866180048661801,0.43479276958026153,1.0,8/28,9.35%,SLC38A2;SLC38A1;SLC38A6;SLC1A5;SLC38A3;SLC7A10;SLC43A1;SLC6A7
prerank,cGMP-mediated signaling (GO:0019934),-0.59530835658153,-1.5999187530323775,0.08270676691729323,0.41073305052269093,1.0,6/13,7.83%,IRAG1;APOE;GUCY1B1;HTR2C;PDE2A;KCNC2
prerank,response to glucose (GO:0009749),0.6091270028161282,1.5998339245878437,0.006968641114982578,0.4310708437672569,1.0,7/46,5.49%,THBS1;SLC39A14;KCNB1;GAS6;TCF7L2;UNC13B;ADCY8
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.6743970517331552,1.5974854450577893,0.01597051597051597,0.43771287622334115,1.0,6/23,13.01%,SLC12A7;SLC12A2;SLC9A1;SLC12A4;SLC26A4;SCNN1A
prerank,negative regulation of macroautophagy (GO:0016242),0.6618842381160399,1.597215375663163,0.011435832274459974,0.4338561254835611,1.0,19/26,25.17%,TMEM39A;LZTS1;NRBP2;QSOX1;CLEC16A;SCFD1;SMG1;PHF23;USP36;SEC22B;AKT1;CHMP4B;CHMP4A;LRRK2;TSC2;RUBCN;MTM1;SMCR8;PINK1
prerank,negative regulation of cellular protein localization (GO:1903828),-0.47017726840625573,-1.5961250624283188,0.023809523809523808,0.41177963061514017,1.0,6/34,2.51%,ROCK2;NEDD4L;MFHAS1;ACTN2;RIPOR2;PICALM
prerank,positive regulation of macrophage migration (GO:1905523),0.7039371917271227,1.593137496059431,0.018229166666666668,0.4483729340316371,1.0,2/19,0.49%,THBS1;CMKLR1
prerank,engulfment of apoptotic cell (GO:0043652),0.7300928833860088,1.5929875359319112,0.012465373961218837,0.4437244592190529,1.0,2/15,0.87%,THBS1;RHOBTB1
prerank,regulation of cilium movement (GO:0003352),0.7989511856187959,1.5929734975750194,0.01430615164520744,0.43871619234673165,1.0,5/10,11.76%,CFAP298;CFAP206;ODAD2;CCDC39;CFAP43
prerank,detection of mechanical stimulus (GO:0050982),0.7041304080059951,1.592061142661541,0.019736842105263157,0.4383439940381235,1.0,5/19,11.10%,PIEZO2;PKD1;LHFPL5;JUP;CSRP3
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),0.7383987920534695,1.591994658409602,0.01422475106685633,0.4337288030394037,1.0,5/13,7.85%,UAP1L1;PGM3;GFPT1;GFPT2;GNPDA1
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),0.7420326261425453,1.5918818867334612,0.02309782608695652,0.429511448876843,1.0,2/14,1.32%,THBS1;PDCD4
prerank,bone development (GO:0060348),0.6214103550736553,1.591126819212942,0.009400705052878966,0.4284153265905858,1.0,12/39,11.37%,MYOC;GNAS;LRP6;SFRP4;LRP5;P3H1;SULF1;SLC10A7;SKI;SH3PXD2B;FGFR2;IFITM5
prerank,cellular component maintenance (GO:0043954),-0.602420794624108,-1.5905281108894964,0.0472972972972973,0.41780494081031466,1.0,4/12,8.90%,IGF1R;INSR;ITGA3;CLDN1
prerank,positive regulation of chemotaxis (GO:0050921),0.6123895855697621,1.5879391145460555,0.00805523590333717,0.43954551152422416,1.0,6/43,1.88%,THBS1;SMOC2;VEGFA;F3;FGF2;NTRK3
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.7494313266033414,1.585978063678006,0.02912621359223301,0.44459372106874046,1.0,6/12,12.65%,SIX1;VEGFA;SIX4;SOX9;NOG;SMO
prerank,spliceosomal complex assembly (GO:0000245),0.6085916284353841,1.58514190958765,0.008264462809917356,0.4437099548054787,1.0,20/46,18.04%,SRSF6;KHDC4;LUC7L2;SRSF1;NOL3;SRSF5;CELF4;LUC7L;CELF3;LUC7L3;SF3B1;SF3A1;RBM5;CRNKL1;ZRSR2;SRPK1;YTHDC1;SMN1;NCBP1;SRSF10
prerank,monosaccharide transmembrane transport (GO:0015749),0.7199377989697574,1.58452844203191,0.013550135501355014,0.4421265752095763,1.0,3/16,2.08%,SLC23A1;SLC23A2;SLC5A2
prerank,cellular response to steroid hormone stimulus (GO:0071383),-0.5475950893072279,-1.584023231355609,0.03802281368821293,0.42714442353920573,1.0,3/17,3.60%,ATP1A2;BMP7;TFPI
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.7330252112593678,1.5831701852817208,0.020718232044198894,0.44429373876058825,1.0,3/14,5.73%,THBS1;FGF2;SULF1
prerank,supramolecular fiber organization (GO:0097435),0.5317990056261683,1.5825883323229253,0.0,0.442594002985581,1.0,61/333,9.00%,COL12A1;PLOD2;COL6A3;COL6A2;COL6A1;ADAMTS3;ADAMTS2;COL8A2;COL8A1;BMP1;LTBP2;LTBP3;RHOBTB1;COL11A1;COL3A1;DDR2;MAP7D3;COL1A2;FGF13;COL1A1;COL5A3;GSN;COL14A1;P4HB;COL15A1;TGFBI;SERPINH1;COL5A2;EMILIN1;COL27A1;RND3;STMND1;PPP1R9B;COL16A1;LOXL1;CYP1B1;TLL1;ARHGAP17;TGFB2;PLOD1;CORO6;SNCAIP;DYNC1H1;P3H1;CLIP4;FAT1;PLOD3;TUBGCP3;TLE6;MYO1E;CDC42EP2;ADAM10;GGA2;P4HA1;LOX;IAPP;P3H2;DLG1;ELMO3;RHOA;CST3
prerank,cellular response to fatty acid (GO:0071398),0.744133782035659,1.5814720133581597,0.02051983584131327,0.44313849556157536,1.0,2/12,0.50%,IRS1;PID1
prerank,negative regulation of lymphocyte migration (GO:2000402),-0.6525255380836976,-1.5796749771150296,0.03194888178913738,0.43127343195029827,1.0,5/10,11.47%,LRCH1;RIPOR2;APOD;CD200;PADI2
prerank,acidic amino acid transport (GO:0015800),-0.5571913202621802,-1.579169804201987,0.01809954751131222,0.4243895801012498,1.0,6/17,8.04%,SLC6A13;SLC1A3;SLC6A1;SLC25A13;SLC1A1;SLC1A2
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.7535772196040915,1.5772099204642211,0.01643835616438356,0.45967594187459015,1.0,6/13,14.07%,TMEM30B;TM9SF4;EDEM2;BCAP31;SEC16A;SEC16B
prerank,organic cation transport (GO:0015695),0.69930813096021,1.577142252710198,0.017105263157894738,0.4555302261221886,1.0,1/20,0.01%,SLC47A1
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.6462931171974254,1.5766986815437534,0.00980392156862745,0.45334625347381546,1.0,16/29,22.74%,GOLGA5;COPA;COPB1;TRAPPC10;COPG1;COPE;COPZ2;NSF;COPB2;COG6;NAPA;COG2;TRAPPC3;COG8;COG5;COPZ1
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.7379140573331813,1.576646098081829,0.01510989010989011,0.4492164040379335,1.0,6/14,15.07%,ME1;AK5;AK3;NMNAT3;AK1;NMNAT2
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.7233668973809355,1.576125775002671,0.019498607242339833,0.44723119756485147,1.0,12/14,26.52%,SEC31A;SEC24D;SEC13;SEC23A;SEC24C;SEC24B;MIA3;SEC24A;SEC23B;RAB1A;TBC1D20;SAR1A
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.757851608024881,1.5759838693044739,0.014492753623188406,0.4435141624893851,1.0,5/11,7.85%,UAP1L1;PGM3;GFPT1;GFPT2;GNPDA1
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.5951813810789094,1.5744201608256048,0.0033259423503325942,0.4465963160024964,1.0,19/56,14.57%,BMPER;GDF10;PMEPA1;EMILIN1;SMAD6;INHBC;TGFB3;LDLRAD4;TGFB2;ACVR1;SMAD4;NOG;BMP4;BMPR1A;SMAD7;TGFBR1;INHBA;BMP5;DAB2
prerank,regulation of sensory perception of pain (GO:0051930),0.7739831631601909,1.5720105061389082,0.013927576601671309,0.45385023433472904,1.0,7/11,17.22%,MGLL;TMEM100;CCN3;SCN11A;VIP;F2R;ACP3
prerank,regulation of protein acetylation (GO:1901983),-0.6042598471882233,-1.5718402968411196,0.060498220640569395,0.43643012244520824,1.0,5/12,13.74%,RAPGEF3;DDX3X;FAM161A;TERF2IP;SIRT1
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.6511416415625223,1.5687152159747528,0.015815085158150853,0.46596477827063254,1.0,9/27,15.41%,EGFR;DDX5;STAT3;PUM1;BMP4;AGO2;EIF4G1;LIMD1;IL6
prerank,regulation of granulocyte chemotaxis (GO:0071622),0.6778089092539827,1.5676256820714956,0.024327784891165175,0.46716141256633115,1.0,2/19,0.49%,THBS1;CMKLR1
prerank,mRNA export from nucleus (GO:0006406),0.5509602108412519,1.5674801627619317,0.0031380753138075313,0.4636410298956755,1.0,43/102,22.68%,SRSF6;NUP93;SRSF1;SRSF5;SEC13;RAE1;SRSF2;CASC3;SEH1L;HNRNPA2B1;SMG6;SRSF11;SYMPK;ENY2;SMG1;NXF1;ZC3H11A;U2AF1;SRRM1;NUP37;CHTOP;PABPN1;RANBP2;U2AF2;NUP88;CPSF4;YTHDC1;SARNP;DDX19A;FYTTD1;THOC2;SRSF3;NCBP1;NCBP2;SRSF7;NUP210;POM121;GLE1;NUP62;SRSF4;NDC1;NUP35;UPF1
prerank,endothelial cell development (GO:0001885),-0.498616281438383,-1.5650485535570038,0.021052631578947368,0.4469088415192009,1.0,9/25,7.29%,COL22A1;RAPGEF3;PDE4D;PECAM1;COL18A1;PPP1R16B;RAPGEF2;PDE2A;ROBO4
prerank,mRNA splice site selection (GO:0006376),0.6356812457752151,1.5649785120490551,0.01346389228886169,0.47209097605295264,1.0,12/30,9.65%,SRSF6;KHDC4;LUC7L2;SRSF1;NOL3;SRSF5;CELF4;LUC7L;CELF3;LUC7L3;PSIP1;SF3A1
prerank,anterior/posterior pattern specification (GO:0009952),0.5993573132657385,1.564709214083753,0.010112359550561797,0.4692851696115741,1.0,17/53,14.17%,HOXA5;PCSK5;HOXA3;HOXB6;LRP5;HOXC6;HOXB3;HES5;BHLHE40;HEYL;SKI;HOXA6;HOXA9;TGFBR1;HEY1;HOXB4;HOXA4
prerank,negative regulation of protein processing (GO:0010955),0.7346433184273862,1.563594227341083,0.03519061583577713,0.47079904901181335,1.0,2/12,3.32%,THBS1;GAS1
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.5508117128932275,1.5629281395271755,0.0020964360587002098,0.4700955983240491,1.0,46/96,26.98%,SRSF6;NUP93;SRSF1;SRSF5;SEC13;RAE1;SRSF2;CASC3;SEH1L;HNRNPA2B1;SMG6;SRSF11;SYMPK;SMG1;NXF1;ZC3H11A;U2AF1;SRRM1;NUP37;CHTOP;RANBP2;U2AF2;NUP88;CPSF4;YTHDC1;SARNP;FYTTD1;THOC2;SRSF3;NCBP1;NCBP2;SRSF7;NUP210;POM121;GLE1;NUP62;SRSF4;NDC1;NUP35;UPF1;UPF3B;DDX39B;NUP85;TPR;NUP160;EIF4E
prerank,mesonephric tubule development (GO:0072164),0.7206258368488366,1.560984535067203,0.030585106382978722,0.47548519929563143,1.0,3/15,0.48%,SLIT2;SIX1;PKD1
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.5910398321467825,1.560947906175123,0.015819209039548022,0.4715498168725107,1.0,5/51,1.02%,THBS1;PGF;CMKLR1;VEGFA;GAS6
prerank,sprouting angiogenesis (GO:0002040),0.5859633474062477,1.560736815719261,0.006795016987542469,0.46849285287600845,1.0,9/51,4.87%,BMPER;THBS1;SLIT2;PGF;VEGFA;FGF2;RSPO3;SEMA3E;RAMP2
prerank,atrioventricular valve development (GO:0003171),0.727405007798597,1.560444484553591,0.02457956015523933,0.46603799374826294,1.0,7/14,11.22%,SLIT3;TGFB2;ACVR1;TGFBR2;HEYL;MDM4;BMPR1A
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.6580313009255411,1.5597595855839395,0.02278481012658228,0.4653201598155668,1.0,9/23,12.65%,SIX1;VEGFA;FGF2;SIX4;LBX2;SOX9;NOG;BMP4;SMO
prerank,positive regulation of interleukin-17 production (GO:0032740),-0.5085995785102668,-1.557911716049774,0.03431372549019608,0.4563309033056732,1.0,13/22,28.18%,SLC7A5;RFTN1;SPHK1;PRKCQ;ZBTB7B;NOD2;NR1H4;MYD88;TGFB1;LY9;SLAMF6;IL18;IL15
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.6515945397937085,1.557770428871476,0.020752269779507133,0.4712659080855586,1.0,5/25,6.70%,THBS1;EGFR;GLMN;ILK;FZD7
prerank,response to acidic pH (GO:0010447),0.714559374518247,1.5572298036325896,0.02702702702702703,0.4701286952581228,1.0,6/13,15.82%,SLC9A1;IMPACT;RAB11FIP5;CHP1;RAB11B;PKD2L1
prerank,response to progesterone (GO:0032570),0.6829390910857459,1.5571970159415949,0.026420079260237782,0.4664471389132486,1.0,4/18,9.31%,THBS1;TGFB3;TGFB2;CATSPER3
prerank,actin filament-based transport (GO:0099515),-0.4957607826813035,-1.5571253386871198,0.041474654377880185,0.4504417886210983,1.0,7/21,14.53%,MYO1B;SYNE2;MYO6;ACTN4;MYO1D;SUN2;MYO5C
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.535232048147178,1.5568397964933436,0.0,0.4645960155472686,1.0,45/136,20.15%,ESR1;PKD1;CMKLR1;ID2;GAS6;TCF7L2;SFRP4;PTGIS;CYP1B1;GLIS2;HDAC4;PKHD1;ANXA4;TAX1BP1;BHLHE40;IRAK3;HEYL;DAP;CDK5RAP3;WWP2;ITCH;CHUK;IRAK1;COMMD7;RNF2;SMAD7;CHP1;TRAF3;USP7;MAP3K10;ARRB1;ID1;MDFI;OTULIN;SUMO1;RWDD3;SUFU;UFL1;MEN1;ACOD1;ERBIN;LRRC14;NFKBIA;EIF2AK4;ZNF431
prerank,regulation of interleukin-12 production (GO:0032655),0.5949173815534143,1.5567769518310879,0.01694915254237288,0.46121181071883693,1.0,5/47,6.84%,THBS1;FOXP1;CMKLR1;HMGB1;IRAK3
prerank,retinoic acid metabolic process (GO:0042573),-0.5858061482877038,-1.555319427703229,0.057692307692307696,0.44731408115472,1.0,6/14,20.56%,ALDH1A2;CYP26B1;ADH1A;ALDH1A3;CYP2S1;BCO2
prerank,regulation of lipid biosynthetic process (GO:0046890),-0.4684635621880171,-1.5551501874885054,0.017857142857142856,0.44008659883967505,1.0,14/32,15.90%,SORBS1;APOE;PPARA;PRKAA2;PRKAG2;ADIPOR1;ZBTB20;MID1IP1;ASXL3;CEACAM1;CREBL2;GPER1;AVIL;STAR
prerank,sulfate transport (GO:0008272),0.7166317992497262,1.5540580233662027,0.03765690376569038,0.47081269894856315,1.0,3/14,3.08%,SLC26A7;SLC26A2;SLC26A6
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.586067709496216,1.5537327396855327,0.012359550561797753,0.46860629146953503,1.0,8/46,6.12%,THBS1;FOXP1;ID2;IGFBP5;ELN;TCF7L2;HES5;PRKDC
prerank,RNA export from nucleus (GO:0006405),0.5446512327427763,1.553524783156614,0.0010384215991692627,0.465899737486436,1.0,47/100,26.98%,SRSF6;NUP93;SRSF1;SRSF5;SEC13;RAE1;SRSF2;CASC3;SEH1L;HNRNPA2B1;SMG6;SRSF11;SYMPK;SMG1;NXF1;ZC3H11A;U2AF1;SRRM1;NUP37;CHTOP;RANBP2;U2AF2;NUP88;CPSF4;YTHDC1;SARNP;FYTTD1;THOC2;SRSF3;NCBP1;NCBP2;SRSF7;NUP210;POM121;GLE1;NUP62;SRSF4;NDC1;HNRNPA1;NUP35;UPF1;UPF3B;DDX39B;NUP85;TPR;NUP160;EIF4E
prerank,cardiac right ventricle morphogenesis (GO:0003215),0.7518006549477738,1.551983730183416,0.026499302649930265,0.4694089286013363,1.0,5/11,11.22%,ZFPM2;TGFB2;JAG1;BMP4;BMPR1A
prerank,thymus development (GO:0048538),0.71345171582958,1.5519323999423489,0.029288702928870293,0.4660179115386724,1.0,5/13,12.22%,SIX1;EPHB3;RIPK3;SOD1;TGFBR1
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.6768449073780646,1.5518253138885485,0.03087248322147651,0.4594827018423148,1.0,5/17,8.68%,IRS1;STAT5A;STAT3;BRWD1;SOCS2
prerank,cellular response to interleukin-7 (GO:0098761),0.6768449073780646,1.5518253138885485,0.03087248322147651,0.4594827018423148,1.0,5/17,8.68%,IRS1;STAT5A;STAT3;BRWD1;SOCS2
prerank,response to alcohol (GO:0097305),0.648221336850398,1.5512844772155847,0.022332506203473945,0.45858250028563297,1.0,7/27,12.22%,SLIT3;SLIT2;GRIN3A;TGFBR2;CHRNB2;SOD1;TGFBR1
prerank,"phagocytosis, engulfment (GO:0006911)",0.6160834219905369,1.551237874271711,0.014475271411338963,0.4553898928435421,1.0,3/36,1.32%,THBS1;RHOBTB1;GSN
prerank,RNA 3'-end processing (GO:0031123),0.5667535200586521,1.5510648365511828,0.006550218340611353,0.45283389392528295,1.0,31/69,22.15%,SRSF6;SRSF1;SRSF5;SRSF2;CASC3;TENT4B;SRSF11;SYMPK;ZC3H11A;U2AF1;SRRM1;CHTOP;PABPN1;SUPV3L1;U2AF2;CLP1;CPSF4;SARNP;THOC2;SRSF3;PCF11;TUT7;RPRD1A;NCBP1;CPSF7;NCBP2;SRSF7;CSTF2;CSTF2T;TENT2;SRSF4
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",0.7097565750447256,1.550059706912501,0.027510316368638238,0.4537863320756724,1.0,9/16,15.78%,SRSF6;DDX5;DDX17;SRSF1;CELF4;SFPQ;HNRNPM;RBM17;SCNM1
prerank,mRNA transport (GO:0051028),0.54160747309664,1.5459832079185374,0.004158004158004158,0.46903384769913703,1.0,48/101,27.38%,SRSF6;NUP93;SRSF1;ARC;SRSF5;SEC13;RAE1;SRSF2;CASC3;SEH1L;HNRNPA2B1;SMG6;SRSF11;SYMPK;SMG1;NXF1;ZC3H11A;U2AF1;SRRM1;NUP37;CHTOP;RANBP2;U2AF2;NUP88;CPSF4;YTHDC1;SARNP;FYTTD1;THOC2;SRSF3;NCBP1;NCBP2;SRSF7;NUP210;POM121;GLE1;NUP62;SRSF4;NDC1;NUP35;UPF1;UPF3B;DDX39B;NUP85;TPR;NUP160;EIF4E;ZFP36L1
prerank,regulation of RNA splicing (GO:0043484),0.5616876195261997,1.5455678332353229,0.004314994606256742,0.46747697158557733,1.0,31/69,20.27%,SLC38A2;CLK1;HNRNPH1;AHNAK;AHNAK2;CLK3;MBNL1;RBM39;FASTK;SNRNP70;FUS;HNRNPH2;HNRNPL;MBNL2;METTL16;KHDRBS1;CLK4;PTBP1;SRPK1;U2AF2;HNRNPK;YTHDC1;SRSF3;SRSF10;RBM22;CLK2;BRDT;AFF2;TRA2B;LARP7;HNRNPH3
prerank,regulation of blood coagulation (GO:0030193),0.6380285584185931,1.5454184746832207,0.03593556381660471,0.46476269069074183,1.0,4/27,2.80%,THBS1;ST3GAL4;FAP;EPHB2
prerank,endoderm development (GO:0007492),-0.5799623604047115,-1.5450743499547148,0.04964539007092199,0.46073058896972807,1.0,9/13,35.15%,SOX17;SOX7;LHX1;DUSP4;TBX20;GATA4;DUSP5;LAMC1;DUSP2
prerank,peptidyl-lysine modification (GO:0018205),0.5422526341496582,1.5435588629943118,0.005285412262156448,0.4697416075889823,1.0,48/99,26.91%,PLOD2;NUP93;LOXL1;P3H3;HDAC9;HDAC4;TOPORS;EEF1AKMT3;RAE1;PLOD1;TRIM28;PLOD3;SEH1L;SIRT5;LOX;TRPM4;NUP37;EEF1AKMT2;SENP5;RANBP2;VIPAS39;PIAS4;GCSH;NUP88;SIRT2;STX1A;HDAC6;LIPT1;SUMO1;USPL1;NUP210;POM121;SAE1;NUP62;SENP1;NDC1;LOXL2;SENP7;SUMO2;NUP35;SENP6;KAT2B;SENP3;P3H4;NUP85;TPR;NUP160;ESCO1
prerank,skeletal system morphogenesis (GO:0048705),0.6121306778445288,1.5434532006237802,0.012528473804100227,0.4668501278670631,1.0,15/42,14.68%,LRP6;SIX1;HOXA3;SFRP4;LRP5;HOXB3;FGFR1;SKI;HOXA9;FGFR2;IFITM5;TGFBR1;HOXB4;HOXA4;FUZ
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.6844884514750961,1.5407552952754178,0.026737967914438502,0.4764126626205837,1.0,5/17,10.16%,TMEM100;FGF2;SFRP4;SOX9;BMP4
prerank,positive regulation of muscle cell differentiation (GO:0051149),0.6479928724437669,1.540268053756459,0.03379224030037547,0.4751892947143335,1.0,2/24,0.24%,BOC;CDON
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.5826104213240991,1.5376116691475339,0.010089686098654708,0.48460867355205123,1.0,16/49,16.15%,PMEPA1;SMAD6;ANKRD27;LDLRAD4;DACT1;HMGB1;PRRT2;PEX5;IAPP;TMC8;RAF1;IMPACT;LCMT1;HSPA5;TFIP11;HDAC6
prerank,cell-cell junction maintenance (GO:0045217),-0.587828435159589,-1.5371908178644882,0.06796116504854369,0.474777876018432,1.0,1/11,0.05%,TJP1
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.6947770317540384,1.5366649900350748,0.040522875816993466,0.4856555479330367,1.0,6/17,14.20%,PLA2G4F;PLA2G4A;LPCAT1;LPCAT4;PLA2G5;PLA2G12A
prerank,response to organic cyclic compound (GO:0014070),0.5786507344959829,1.5354244866560145,0.012471655328798186,0.4881210187285255,1.0,10/52,10.07%,ESR1;ALPL;IGFBP5;CYP19A1;CYP1B1;STAT3;CHRNB2;SOCS2;ANXA1;FOXA1
prerank,actin filament depolymerization (GO:0030042),0.742005763945208,1.5338157183760612,0.041193181818181816,0.49253017169903546,1.0,2/11,1.32%,MICAL2;GSN
prerank,muscle contraction (GO:0006936),-0.3433960772909872,-1.5337954881699933,0.0,0.4766094696312156,1.0,29/126,11.52%,SORBS1;ITGA1;ROCK2;MYLK;SNTB1;SLC8A1;ACTN2;TPM1;UTRN;TMOD3;GJC1;MYOF;SMTN;MYL6;BDKRB2;MYL9;TMOD1;DYSF;LMOD1;KCNJ12;DES;MYH11;TPM3;CHRNB1;VIM;ADRA1A;ACTA2;TPM2;NOS1
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.6244857961132253,1.5329656773535731,0.02063106796116505,0.493114429509063,1.0,2/27,0.11%,SLC47A1;SLC38A1
prerank,response to hydrogen peroxide (GO:0042542),0.586792536607391,1.5328788629146395,0.019585253456221197,0.49024157134329277,1.0,18/45,17.75%,PRKCD;ADAM9;CYP1B1;MAP3K5;FXN;NFE2L2;IMPACT;ANXA1;ABL1;RIPK3;SOD1;STK25;PRDX3;RHOB;IL6;CAT;HDAC6;HMOX1
prerank,hemidesmosome assembly (GO:0031581),-0.6136632243147264,-1.5324380365843646,0.05423728813559322,0.4731013604295506,1.0,4/11,10.95%,ITGA6;DST;ITGB4;LAMC2
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),-0.48407392597484644,-1.53216801285629,0.04326923076923077,0.4663888702096401,1.0,8/23,14.31%,EFNB2;AKAP6;PIEZO1;PROX1;NIBAN2;EDN1;MYOCD;IGF1
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.6072743670677032,1.5310781772494533,0.02546296296296296,0.4956472786225398,1.0,12/31,14.68%,SIX1;HOXA3;TWIST1;HOXB3;TGFBR2;HOXA9;NOG;FGFR2;TGFBR1;HOXB4;HOXA4;FUZ
prerank,positive regulation of endopeptidase activity (GO:0010950),-0.46989490309441045,-1.5303445143608994,0.022935779816513763,0.46379345926760895,1.0,14/26,21.86%,LYN;ROCK2;EPHA4;PICALM;GRIN2B;AIM2;PSME3;PSME1;GRIN1;PYCARD;AGER;PRELID1;APH1B;MBP
prerank,chordate embryonic development (GO:0043009),0.5694294820559328,1.5290356279391002,0.011273957158962795,0.5021064402110821,1.0,19/55,9.74%,PKD1;XYLT1;VEGFA;PCSK5;COL1A1;DEAF1;TGFB3;MBNL1;HES5;SIX4;DACT1;DVL1;SULF1;KIAA1217;ADAM10;FGFR1;NOG;FGFR2;FUT8
prerank,purine nucleotide biosynthetic process (GO:0006164),0.735354034889335,1.5283647205088455,0.030344827586206897,0.5019171390431656,1.0,2/12,5.29%,PRPS2;ADA
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.6903552407388499,1.5280477386003959,0.030707610146862484,0.49992294276985916,1.0,3/16,1.19%,SIX1;FGF2;FOXD1
prerank,purine nucleotide metabolic process (GO:0006163),0.6457754957693717,1.5260981707875185,0.025094102885821833,0.5056529252761363,1.0,3/24,4.52%,PRPS2;FHIT;XDH
prerank,spinal cord development (GO:0021510),0.7300118566771632,1.5258126943192027,0.039030955585464336,0.5037511867112885,1.0,3/12,2.38%,PKD1;VIT;GLI2
prerank,protein trimerization (GO:0070206),0.707759670887195,1.5257250054761147,0.03513513513513514,0.4977346997820412,1.0,4/14,12.04%,SCARA5;SLC1A5;DISP1;CLYBL
prerank,protein homotrimerization (GO:0070207),0.707759670887195,1.5257250054761147,0.03513513513513514,0.4977346997820412,1.0,4/14,12.04%,SCARA5;SLC1A5;DISP1;CLYBL
prerank,positive regulation of dendrite extension (GO:1903861),-0.5307126194609767,-1.5255466698180185,0.05263157894736842,0.4706564262872221,1.0,5/17,15.27%,NEDD4L;RIMS2;RIMS1;SYT3;SYT2
prerank,cellular modified amino acid biosynthetic process (GO:0042398),0.6576213390340696,1.5250782186008929,0.032133676092544985,0.4973577734259978,1.0,2/20,1.59%,PLOD2;GCLC
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),0.7134620315876354,1.5245647089844399,0.035182679296346414,0.4964987680090218,1.0,2/13,5.53%,SLC4A10;RAB3GAP1
prerank,neural tube closure (GO:0001843),0.610195319877042,1.5238995568431846,0.014669926650366748,0.49637939166805556,1.0,12/34,18.96%,LRP6;DEAF1;PRICKLE1;COBL;TGFB2;DVL1;SKI;LMO4;LRP2;FUZ;MTHFD1;MTHFR
prerank,primary neural tube formation (GO:0014020),0.618716004376548,1.5229498821476573,0.02631578947368421,0.4978349191201124,1.0,11/30,18.96%,LRP6;DEAF1;PRICKLE1;COBL;TGFB2;SKI;LMO4;LRP2;FUZ;MTHFD1;MTHFR
prerank,positive regulation of response to wounding (GO:1903036),-0.4768333628319887,-1.521461074385201,0.020942408376963352,0.47484635030467087,1.0,7/24,8.90%,PTN;MYLK;VTN;OCLN;ADRA2A;HBEGF;CLDN1
prerank,positive regulation of fatty acid metabolic process (GO:0045923),-0.5688361643625848,-1.521184078605538,0.029535864978902954,0.46864346570846277,1.0,7/15,10.21%,PPARA;LPGAT1;NR1H3;PPARGC1A;PPARD;SLC45A3;MID1IP1
prerank,regulation of dendrite extension (GO:1903859),-0.5225668682784869,-1.5207524552568747,0.04090909090909091,0.4628593223136734,1.0,5/18,15.27%,NEDD4L;RIMS2;RIMS1;SYT3;SYT2
prerank,peroxisomal membrane transport (GO:0015919),0.6206219332571722,1.520498311723128,0.0323785803237858,0.5057627076798101,1.0,14/27,23.07%,ABCD3;PEX7;PXMP2;PEX5;PEX16;PEX13;PEX1;PEX10;ALDH3A2;PEX6;PEX2;ABCD1;ACBD5;PEX14
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.6712855299093763,1.5203828417943175,0.027237354085603113,0.5031895443123949,1.0,6/19,8.45%,UAP1L1;PGM3;GFPT1;GFPT2;GNPDA1;PMM2
prerank,cell junction organization (GO:0034330),-0.3869721220775173,-1.5203447437785989,0.024691358024691357,0.4572865000114071,1.0,22/71,10.15%,TJP1;SDK1;OCLN;GRM5;PPFIA2;SLC6A1;PPFIBP1;APP;LIMS2;SMAD3;PPFIBP2;CXADR;PAK3;OPHN1;SLC8A3;RAB8B;CDC42;CLDN1;RAB39B;ELFN1;APBB2;FLNC
prerank,tube closure (GO:0060606),0.6143202861280218,1.5200948380160053,0.02493765586034913,0.5013343770986407,1.0,11/31,18.96%,LRP6;DEAF1;PRICKLE1;COBL;TGFB2;SKI;LMO4;LRP2;FUZ;MTHFD1;MTHFR
prerank,lipid phosphorylation (GO:0046834),-0.6354263908051067,-1.5184956576980835,0.0891089108910891,0.45491446378461714,1.0,7/10,14.25%,DGKB;DGKD;DGKG;DGKH;DGKE;DGKZ;DGKA
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.6841008454414321,1.5182653371971113,0.04980340760157274,0.5064216773318698,1.0,3/15,1.13%,SMOC2;VEGFA;FGF2
prerank,negative regulation of vascular permeability (GO:0043116),0.7263308178519126,1.5181448945402027,0.0351123595505618,0.5038852505036381,1.0,5/12,8.54%,SLIT2;VEGFA;PDE3A;RAMP2;DDAH1
prerank,carboxylic acid transport (GO:0046942),0.5777201200751179,1.5178686296341266,0.012195121951219513,0.5022640321208329,1.0,9/55,5.06%,SLC38A2;SLC38A1;SLC23A1;SLC23A2;SLC16A9;SLC16A1;SLC38A6;SLC1A5;SLC38A3
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.6029331952265906,1.5175977745621505,0.03464755077658303,0.500500715933672,1.0,13/33,20.20%,ESR1;DDX5;CARM1;RUNX1;AXIN1;RNF14;DNAAF4;UBA5;HDAC6;UFL1;SAFB2;CBFB;CALR
prerank,regulation of endothelial cell migration (GO:0010594),0.54140163869265,1.5173016697746307,0.006417112299465241,0.498960568454022,1.0,12/85,5.94%,BMPER;THBS1;SLIT2;SMOC2;FOXP1;RHOJ;VEGFA;FGF2;SPARC;PRKCA;BCAS3;FOXC2
prerank,organic acid transport (GO:0015849),0.5433106906770588,1.5155981170031876,0.005230125523012552,0.5039409590121217,1.0,15/94,7.63%,SLC38A2;SLC38A1;SLC26A7;SLC23A1;SLC23A2;SLC5A6;SLC16A1;SLC26A6;SLC1A5;RXRA;SLC38A3;LRRC8D;SLC25A32;SLC7A10;SLC43A1
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.6462623453624927,1.5153260934668447,0.04714640198511166,0.5022694129396036,1.0,2/20,0.48%,EGFR;PKD1
prerank,negative regulation of secretion by cell (GO:1903531),-0.42700008217968155,-1.5145098269493107,0.030534351145038167,0.45958269250831957,1.0,13/38,16.92%,GRM7;APOE;STXBP6;IL1RAPL1;NOTCH1;RHBDF1;TNFRSF1A;SLC30A1;RSAD2;RHBDF2;SNCA;SERGEF;SYT11
prerank,xenobiotic transport (GO:0042908),0.6736993143433126,1.513786730989938,0.04365079365079365,0.5066113660231135,1.0,2/17,3.92%,SLC47A1;ABCC1
prerank,negative regulation of leukocyte migration (GO:0002686),0.7578953370734297,1.5133440164034897,0.04671532846715328,0.505675550254287,1.0,2/10,1.74%,SLIT2;EMILIN1
prerank,positive regulation of sprouting angiogenesis (GO:1903672),0.689453134959021,1.512685916436812,0.043115438108484005,0.5057322210980347,1.0,3/15,1.13%,BMPER;VEGFA;FGF2
prerank,muscle cell differentiation (GO:0042692),-0.43392478009865354,-1.5107760654893478,0.024242424242424242,0.4629216801604008,1.0,10/32,10.57%,NEBL;WNT5B;MRTFB;SGCZ;TBX18;TBX1;TMEM204;GATA6;CHRNB1;MYOCD
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),-0.5881692575036691,-1.5107713411024573,0.07885304659498207,0.4566078020631762,1.0,5/11,15.19%,ADIPOR1;SH2B3;CAV1;PTPRT;SOCS3
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.5746039651558151,1.5106518821221784,0.01744186046511628,0.5127180263131625,1.0,8/47,12.09%,THBS1;PID1;PRKCD;XDH;TGFBR2;AKR1C1;DHRS4;SOD1
prerank,sensory perception of chemical stimulus (GO:0007606),0.6992968388276432,1.5074394165941267,0.039030955585464336,0.5251441352739746,1.0,1/15,0.24%,GNAS
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.551242146294088,-1.505895410255023,0.08032128514056225,0.46341176138823664,1.0,5/14,13.74%,RAPGEF2;PRKAR2B;PRKAR1B;PKIG;SIRT1
prerank,protein localization to nucleus (GO:0034504),0.5294882771129102,1.5058066295155663,0.007352941176470588,0.5297038827068997,1.0,53/102,30.44%,SIX1;COL1A1;NUP93;PRICKLE1;SEC13;TOPORS;IPO5;LMNA;STAT3;SIX4;MORC3;RRS1;DVL1;IPO4;E2F3;HIKESHI;WRN;BMP4;INTS13;CNEP1R1;IPO13;YWHAE;TNPO2;ARL2;NUP88;TNPO1;POM121;AKT1;IPO9;APPL2;CALR;APPL1;NUP62;TBRG1;PPP1R10;PAF1;TSC2;IPO8;HNRNPU;NUTF2;NUP85;XPA;TPR;RPAIN;NOP53;TAF3;TOR1AIP2;TOR1AIP1;RPF2;ZBTB7A;PIKFYVE;NUP188;NUP50
prerank,regulation of mast cell activation (GO:0033003),-0.6143476513306876,-1.505718281669511,0.0625,0.4578489021490493,1.0,7/10,31.46%,LYN;NECTIN2;CD84;CD300LF;MILR1;TSLP;CD226
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.6405569772086843,1.5056290816368494,0.03811944091486658,0.5245154280806995,1.0,12/23,19.27%,THBS1;SMAD4;GIPC1;TGFB1I1;DAB2;CREBBP;FLCN;SLC2A10;CDKN1C;MEN1;CITED2;HIPK2
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.6405569772086843,1.5056290816368494,0.03811944091486658,0.5245154280806995,1.0,12/23,19.27%,THBS1;SMAD4;GIPC1;TGFB1I1;DAB2;CREBBP;FLCN;SLC2A10;CDKN1C;MEN1;CITED2;HIPK2
prerank,positive regulation of potassium ion transport (GO:0043268),0.591127710361571,1.5056030770362367,0.02715466351829988,0.5216967934528662,1.0,8/38,8.74%,KCNJ2;KCNJ15;FHL1;DRD1;KCNN1;KCNE5;ANK2;DLG1
prerank,bone morphogenesis (GO:0060349),0.7157606153278663,1.505133414739303,0.029333333333333333,0.5210073591059126,1.0,6/14,11.37%,LRP6;SFRP4;LRP5;SKI;FGFR2;IFITM5
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.6944980748958414,1.5046189002856059,0.03504043126684636,0.5207174124060513,1.0,4/14,6.07%,EHHADH;ACOXL;ACOX3;ECI2
prerank,Golgi organization (GO:0007030),0.5211884796776056,1.5036339372136485,0.007268951194184839,0.5222694549416323,1.0,59/112,29.12%,STX5;ATL2;CSNK1D;LMAN2L;RAB2A;FBXW8;GOLGA8B;GOLGA5;RAB30;RAB43;BCAS3;GOLGB1;ATL3;GBF1;ATP8B2;TJAP1;ARHGAP21;HUWE1;BET1;PLEKHM2;TRAPPC12;TMED9;TRIP11;ZW10;STK25;SEC16A;PI4K2A;SEC16B;LMAN2;SEC22B;STX16;TMED2;GOLPH3;COG2;NPLOC4;BLZF1;SEC23IP;TRAPPC11;LRRK2;OPTN;ATP8B1;LMAN1;RAB1A;GORASP2;DYNC2H1;TMED7;VAMP4;VPS51;TBC1D20;CUL7;VTI1B;CSNK1A1;GOLGA2;GCC2;SURF4;UBXN2A;ARL1;STX17;PRMT5
prerank,regulation of heart rate by cardiac conduction (GO:0086091),0.591034274195569,1.5034440576489667,0.02211874272409779,0.5203271714609836,1.0,9/38,8.80%,KCNJ2;CACNA1G;CACNA1C;HCN4;CAMK2D;KCNE5;ANK2;JUP;TRPM4
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.6984106711700075,1.501509077513114,0.04576043068640646,0.5266096743971116,1.0,3/14,8.97%,THBS1;MEOX2;RHOA
prerank,positive regulation of transforming growth factor beta production (GO:0071636),0.7209933528562075,1.5007427489424163,0.05603448275862069,0.5273811047782164,1.0,1/11,0.08%,THBS1
prerank,smooth muscle cell differentiation (GO:0051145),-0.5593561990244266,-1.500436756412617,0.07246376811594203,0.4656731985551934,1.0,8/12,14.85%,MRTFB;TBX18;TMEM204;GATA6;EDNRB;MYOCD;HEY2;APLNR
prerank,nucleotide metabolic process (GO:0009117),0.640500207106127,1.499375657558572,0.040100250626566414,0.5309210068633284,1.0,7/23,15.07%,ME1;AK5;FHIT;REXO2;NMNAT3;AK1;NMNAT2
prerank,negative chemotaxis (GO:0050919),0.6035197579391207,1.4985119234266193,0.02364066193853428,0.53233959085597,1.0,8/33,9.70%,SLIT3;SLIT2;SLIT1;NTN1;SEMA3E;SEMA4B;RHOA;ITGAV
prerank,positive regulation of cell cycle (GO:0045787),0.5509109319610109,1.4981755746962062,0.01843817787418655,0.5310330534374502,1.0,12/62,10.07%,SMOC2;EGFR;LRP6;PKD1;TGFB2;PRKCA;USP2;RARA;PKN2;FGFR2;CDC25B;FOXA1
prerank,establishment of protein localization to extracellular region (GO:0035592),0.5892154058024185,1.497086386832266,0.03161592505854801,0.5332605975205112,1.0,17/39,20.57%,LTBP2;NECAB3;ARFGAP3;COPG1;RAB8A;MON1A;ABCA1;RAB3D;PREB;TMEM167A;MIA3;RAB3B;TANGO6;GOLPH3;STEAP3;RCN3;MIA2
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.6587976974240315,1.4958603855091497,0.04859335038363171,0.5363059497584267,1.0,2/17,0.48%,EGFR;PKD1
prerank,regulation of exit from mitosis (GO:0007096),0.5831989078229618,1.4956330688019412,0.03294117647058824,0.5345284386211089,1.0,15/38,18.58%,PPP1R9B;ANAPC5;CDC16;CDC14A;UBE2C;ANAPC4;ZW10;ANAPC2;SIRT2;ANAPC1;RPS27A;UBC;ANAPC10;CDC27;CDC20
prerank,ureteric bud development (GO:0001657),0.6769772981461553,1.495590251534025,0.050397877984084884,0.5319369503206985,1.0,3/17,1.34%,SLIT2;SIX1;GPC3
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),-0.6160387509162095,-1.4946003037554412,0.07507507507507508,0.47462462404446876,1.0,3/10,9.55%,ATP1A2;ADRA2A;SESTD1
prerank,cation transport (GO:0006812),0.50976046041052,1.4940079998832354,0.0,0.5367120573686207,1.0,22/167,9.44%,SLC47A1;PIEZO2;SLC4A4;KCNJ2;SLC23A1;KCNJ15;KCNK5;SLC5A6;ATP1B1;FGF13;SLC12A2;SLC5A2;HCN4;SLC9B2;KCNN1;SLC4A11;SCN11A;KCNIP2;TRPM7;TRPM4;CATSPER3;KCNK6
prerank,ventricular septum morphogenesis (GO:0060412),0.6089277957563223,1.492272319597208,0.03864734299516908,0.5421743065209181,1.0,14/27,12.41%,SLIT3;SLIT2;ZFPM2;TGFB2;ACVR1;SMAD4;TGFBR2;HEYL;NOG;BMP4;BMPR1A;SMAD7;TGFBR1;HEY1
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.6121686877008782,1.4918276737440044,0.039950062421972535,0.5413714162986677,1.0,15/27,23.75%,MORF4L2;MRGBP;TRRAP;ATAT1;SGF29;MORF4L1;KAT6B;TAF6;KAT2A;CREBBP;BRD8;KAT7;KAT8;TAF6L;KAT2B
prerank,circulatory system development (GO:0072359),0.5231018565831745,1.4908741138192938,0.0030864197530864196,0.5430741975461059,1.0,39/118,16.78%,MICAL2;CACNA1C;PKD1;ID2;ZFPM2;PCSK5;PLCE1;COL3A1;NTRK3;ECE1;GLI2;PDLIM7;NXN;HDAC9;TGFB2;RAMP2;ACVR1;FOXC2;TGFBR2;SOX9;SH3PXD2B;FOXL1;ALPK3;POU6F1;TAB2;ZDHHC16;WDR11;TGFBR1;SRF;HEY1;DNAAF4;KAT2A;MEF2A;TCF25;AKAP13;CRB2;NF1;MTHFD1;KDM6B
prerank,microtubule polymerization (GO:0046785),0.607808335071076,1.4908564508585933,0.046019900497512436,0.5403986120954091,1.0,10/28,19.00%,MAP7D3;FGF13;TUBG2;CSNK1D;TUBGCP3;CKAP5;AKAP9;NDEL1;CCDC57;SLAIN2
prerank,positive regulation of embryonic development (GO:0040019),-0.49929447951628003,-1.4904457579830015,0.0625,0.4796641308544025,1.0,5/19,7.84%,PLCB1;WNT4;OSR1;TENM4;NIBAN2
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.5713092194334495,1.4899746424042708,0.021939953810623556,0.5415240205923247,1.0,6/43,4.16%,THBS1;FOXP1;ID2;IGFBP5;FGF2;HES5
prerank,establishment of endothelial intestinal barrier (GO:0090557),-0.5799964038923817,-1.4891719408185264,0.05921052631578947,0.47702481493860033,1.0,4/11,11.65%,TJP1;RAPGEF2;F11R;RAP2B
prerank,import into cell (GO:0098657),0.5770062022163074,1.4878597326300376,0.034722222222222224,0.5487023481686308,1.0,8/41,7.19%,SLC47A1;SLC38A1;SLC5A6;SLC39A14;SLC12A7;LRSAM1;LRRC8D;SLC12A4
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.6960538205233643,1.4869491777910961,0.06732117812061711,0.5503643888763186,1.0,2/12,6.52%,FOXP1;HMGB1
prerank,histone modification (GO:0016570),0.5215475019347099,1.4866392857401933,0.0072992700729927005,0.5490178875176289,1.0,38/109,19.30%,PRMT8;PRKCD;EYA2;PRDM5;HDAC9;HDAC4;BAZ2A;UBE2B;MORF4L2;MIDEAS;MRGBP;TRRAP;EHMT1;SGF29;RPS6KA4;NSD1;HUWE1;CARM1;RCOR3;ENY2;MORF4L1;MIER2;MAP3K12;KAT6B;TAF6;HDAC1;KDM4A;KAT2A;USP36;SIRT2;CREBBP;HDAC6;SIN3B;MTA3;UFL1;BRD8;NTMT1;CDK2
prerank,response to fatty acid (GO:0070542),0.665154792689859,1.4853291517190386,0.05111402359108781,0.5522939260929489,1.0,2/17,0.50%,IRS1;PID1
prerank,embryonic eye morphogenesis (GO:0048048),0.7240501491394156,1.4837579011352058,0.06591865357643759,0.5571419801704155,1.0,2/11,0.74%,LRP6;MFAP5
prerank,peptidyl-proline hydroxylation (GO:0019511),0.7180428631347735,1.483626985630765,0.05726872246696035,0.5551503416118551,1.0,3/11,7.90%,P4HB;P4HA1;P3H2
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.5491354280764573,1.4834612890419605,0.02092511013215859,0.5532268649653257,1.0,30/59,25.05%,PRKCD;CIT;ACVR1B;CAMK2D;CSNK2A1;CSNK2A2;PRKCA;DYRK4;ACVR1;PRKDC;TGFBR2;STK39;CDK10;MAPK8;MAP3K12;PDPK1;TGFBR1;MAP3K10;WNK1;CDC42BPB;CAD;AKT1;HIPK2;CDK5;LRRK2;HIPK4;TAF1;ROCK1;TBK1;LMTK2
prerank,peptidyl-lysine dimethylation (GO:0018027),0.6515407065476414,1.483410510759208,0.05680317040951123,0.5507692229013756,1.0,14/18,26.23%,EHMT1;ASH1L;EEF1AKMT2;KMT2D;SETD4;KMT2B;SUV39H2;SETD1A;SUV39H1;SETD2;KMT2A;SMYD2;SETD7;EHMT2
prerank,osteoclast differentiation (GO:0030316),0.6352462541175021,1.4829955698629658,0.047619047619047616,0.5499810077963057,1.0,5/22,8.25%,FOXP1;GAB2;ANXA2;GLO1;SBNO2
prerank,peptidyl-threonine modification (GO:0018210),0.5438484034033396,1.4828795275223419,0.0208105147864184,0.5478267583908552,1.0,34/66,25.05%,PRKCD;CIT;GALNT13;ACVR1B;CAMK2D;CSNK2A1;CSNK2A2;PRKCA;DYRK4;ACVR1;PRKDC;TGFBR2;STK39;CDK10;MAPK8;MAP3K12;PDPK1;TGFBR1;MAP3K10;WNK1;GALNT3;CDC42BPB;GALNT1;CAD;AKT1;HIPK2;CDK5;LRRK2;HIPK4;GALNT2;TAF1;ROCK1;TBK1;LMTK2
prerank,regulation of smooth muscle cell migration (GO:0014910),0.6348641385258571,1.481500966993166,0.0567741935483871,0.5515819157234035,1.0,3/20,1.00%,SLIT2;IGFBP5;LRP1
prerank,negative regulation of protein localization to cell surface (GO:2000009),-0.5942439693508171,-1.4795807371203515,0.09885931558935361,0.49637010094576417,1.0,3/11,2.51%,NEDD4L;ACTN2;PICALM
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.7260186086727423,1.4793501175466495,0.04219409282700422,0.5589547642262341,1.0,4/11,15.41%,EGFR;DDX5;BMP4;IL6
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.6664081317645562,1.4779377916778744,0.044382801664355064,0.5630098219439178,1.0,6/14,21.19%,GAS6;CARD16;PTPN2;TRAIP;CCDC3;GPS2
prerank,fatty acid transport (GO:0015908),-0.5241719459936981,-1.4776102501992097,0.08189655172413793,0.4955238940257008,1.0,5/17,9.19%,APOE;ACSL1;PPARD;SLC27A4;MFSD2A
prerank,chloride transport (GO:0006821),0.5320004911464252,1.4773713572964855,0.016304347826086956,0.5628987161888093,1.0,9/74,5.11%,SLC4A10;SLC26A7;SLC12A7;SLC12A2;SLC26A6;CLIC3;SLC4A8;CLIC4;GABRA3
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.7203086179744318,1.477224651904383,0.04878048780487805,0.5609079232320775,1.0,6/12,8.83%,NFIB;GLI2;EPHB2;EPHB6;CHRNB2;TSKU
prerank,potassium ion import across plasma membrane (GO:1990573),0.5681676607722563,1.4768161797633275,0.04186046511627907,0.5602848411401006,1.0,6/41,3.02%,KCNJ2;KCNJ15;SLC12A7;ATP1B1;SLC12A2;HCN4
prerank,protein O-linked glycosylation (GO:0006493),0.5232842955011674,1.4767899822197836,0.01049317943336831,0.5577857339913249,1.0,17/96,8.76%,PLOD2;ST3GAL4;GXYLT2;GALNT10;GALNT15;GALNT13;MUC1;PGM3;PLOD1;POGLUT3;PLOD3;B3GNT7;POGLUT1;MUC13;B4GALT5;ST3GAL2;OGT
prerank,peptidyl-serine modification (GO:0018209),0.5084231575387622,1.475659168346186,0.0010204081632653062,0.56060072162521,1.0,77/166,25.17%,PKD1;PRKCD;GAS6;ULK2;GALNT13;MARK1;PRKCE;CSNK1D;CAMK2D;CSNK2A1;CSNK2A2;MORC3;POGLUT3;PRKCA;DYRK4;PRKDC;POGLUT1;TGFBR2;TLK1;STK39;RPS6KA4;AKT2;DGKQ;PKN2;PAK2;MAPK8;SMG1;CHUK;CSNK1G1;ATM;MAP3K12;PDPK1;MAPK12;TGFBR1;UHMK1;CSNK1E;MAP3K10;DMPK;WNK1;GALNT3;NDNF;LATS2;TLK2;PARP1;CAMK4;GALNT1;MKNK2;VRK2;MAST2;IKBKE;AKT1;NTMT1;HIPK2;CDK2;CDK5;MAPK9;LRRK2;SGK3;VRK3;MAST4;PRKACA;EIF2AK3;HIPK4;PRKCI;CSNK1G3;TOP1;STK38;CAMK1;RPS6KB1;GALNT2;TAF1;RPS6KA2;ROCK1;TBK1;NEK6;LMTK2;PINK1
prerank,myotube cell development (GO:0014904),0.7226763226943567,1.4752409627229208,0.062154696132596686,0.560153400553234,1.0,3/10,7.97%,SIX1;SKI;SELENON
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.5954488040918746,1.474625783483902,0.043010752688172046,0.5603654850981782,1.0,6/30,7.74%,KCNJ2;CACNA1G;CACNA1C;KCNE5;ANK2;SNTA1
prerank,protein targeting to peroxisome (GO:0006625),0.5958060754451502,1.4744191789493644,0.04697156983930779,0.558719059581682,1.0,15/29,23.07%,ABCD3;PEX7;PXMP2;PEX5;PEX16;PEX13;PEX1;PEX10;ALDH3A2;HACL1;PEX6;PEX2;ABCD1;ACBD5;PEX14
prerank,response to cholesterol (GO:0070723),0.650689889997128,1.4738986886261163,0.06064690026954178,0.5587949688350303,1.0,7/17,13.79%,LRP6;GRAMD1A;OSBPL7;TGFBR2;TGFBR1;SMO;GRAMD1C
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.6210578011416371,1.4737801388139031,0.04573547589616811,0.5568722081569545,1.0,15/23,27.52%,SEC13;VCP;FAF2;SYVN1;TMED9;TECPR2;SEC16A;PREB;NPLOC4;LMAN1;DERL1;SELENOS;HERPUD1;SEC61B;SURF4
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.6627537046821379,1.4730658969187784,0.057068741893644616,0.557684746480016,1.0,8/17,16.30%,SPRED2;CALM2;DGKQ;SMAD7;EIF4G1;PPEF2;SIRT2;CALM3
prerank,cellular response to hexose stimulus (GO:0071331),0.6160614389918341,1.4729988518633106,0.04193138500635324,0.5555333410510668,1.0,6/23,5.49%,SLC39A14;KCNB1;GAS6;UNC13B;SLC26A6;ADCY8
prerank,iron ion transmembrane transport (GO:0034755),0.7366783006819578,1.472949649443817,0.051893408134642355,0.5532272130459824,1.0,2/10,0.56%,SCARA5;SLC39A14
prerank,water transport (GO:0006833),-0.5534839924670433,-1.472404334533581,0.08561643835616438,0.5034062513829464,1.0,9/12,44.68%,AQP11;CFTR;AQP1;AQP4;AQP9;PDPN;AQP6;AQP7;SLC5A1
prerank,positive regulation of protein acetylation (GO:1901985),-0.5845722948735572,-1.4719589639656678,0.06920415224913495,0.4985269034637227,1.0,6/12,13.02%,RAPGEF3;PRKAA2;DDX3X;PRKAA1;FAM161A;TERF2IP
prerank,chromatin assembly or disassembly (GO:0006333),0.7013530198647119,1.4716006972778428,0.05211267605633803,0.5568422936608045,1.0,7/11,26.55%,CHAF1B;M1AP;CDAN1;SUV39H2;NOC2L;TP53;CHAF1A
prerank,muscle organ development (GO:0007517),0.5457336404681474,1.4700882784313622,0.028026905829596414,0.5614022723151815,1.0,14/54,13.77%,COL6A3;FHL1;ITGA11;SGCD;MKX;MRAS;DMD;MEF2B;EVC;POU6F1;CTF1;MAPK12;MEF2D;MEF2A
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),-0.5258050644200973,-1.4695099453218183,0.04680851063829787,0.4991079855018877,1.0,8/17,7.65%,MAML2;MAML3;STAT1;NOTCH1;PLXND1;NOTCH3;NOTCH4;RBPJ
prerank,positive regulation of locomotion (GO:0040017),0.6103748222551224,1.4694482736263106,0.041666666666666664,0.562018526720926,1.0,3/27,3.02%,THBS1;NTN1;TWIST1
prerank,nuclear export (GO:0051168),0.5278638737005161,1.4691980726353473,0.01611170784103115,0.5606883524572213,1.0,40/80,26.98%,PKD1;SRSF6;XPO1;SRSF1;SRSF5;STRADA;RAE1;SRSF2;CASC3;XPO6;SRSF11;NXF1;ZC3H11A;U2AF1;SRRM1;CHTOP;XPO4;CHP1;WASHC4;U2AF2;SARNP;THOC2;SRSF3;NCBP1;NCBP2;SRSF7;POM121;CALR;NUP62;CCHCR1;RITA1;SRSF4;HNRNPA1;DESI1;UPF3B;DDX39B;NUTF2;XPO7;TPR;EIF4E
prerank,serine family amino acid metabolic process (GO:0009069),0.6689228752607899,1.468676521764895,0.06040268456375839,0.5606479810477139,1.0,9/16,20.54%,GCLC;SRR;GLYAT;MTHFD1;SHMT2;SHMT1;DAO;SARS1;SEPHS2
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.5965890745194192,1.4682709566483167,0.045283018867924525,0.5601301821576716,1.0,12/29,18.89%,ESR1;CARM1;RUNX1;FOXA1;AXIN1;DNAAF4;KMT2D;UBA5;UFL1;VPS11;CNOT9;CBFB
prerank,regulation of interleukin-17 production (GO:0032660),-0.4345083097254866,-1.468126576719921,0.028901734104046242,0.49662708091411956,1.0,24/31,41.95%,SLC7A5;RFTN1;SPHK1;PRKCQ;ZBTB7B;NOD2;NR1H4;MYD88;TGFB1;LY9;NCKAP1L;SLAMF6;IL18;IL15;IL12A;CARD9;IL23A;TLR4;FOXP3;CCL1;IL12B;IL23R;IL2;OSM
prerank,miRNA metabolic process (GO:0010586),0.6368821755502365,1.4668168329750393,0.04774193548387097,0.5644864092841168,1.0,8/20,16.45%,DDX17;TENT4B;PRKRA;DIS3L2;DGCR8;AGO2;SND1;TUT7
prerank,integrated stress response signaling (GO:0140467),0.6666322369208001,1.4663451887938808,0.07723577235772358,0.5641933591062068,1.0,10/14,26.13%,ATF4;NFE2L2;IMPACT;HSPA5;QRICH1;EIF2AK4;EIF2S1;EIF2AK3;HERPUD1;CCL2
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.5892331865649401,1.4661273051774821,0.0421179302045728,0.5628695327587188,1.0,7/33,9.68%,THBS1;FGF2;MEOX2;HMGB1;JUP;RHOA;ANGPT4
prerank,protein localization to cilium (GO:0061512),0.5842000642567267,1.4653654616703908,0.06115107913669065,0.5642124600707175,1.0,9/32,12.18%,ZNF423;EHD1;MAPK15;CSNK1D;BBS9;TMEM107;IFT20;TCTN1;INVS
prerank,ventricular septum development (GO:0003281),0.5743040565891032,1.464942672020105,0.04895104895104895,0.5638180410103564,1.0,15/37,12.41%,SLIT3;SLIT2;ZFPM2;TGFB2;ACVR1;SMAD4;TGFBR2;MATR3;HEYL;MDM4;NOG;BMPR1A;SMAD7;TGFBR1;HEY1
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.5306734113712173,1.4643651360471734,0.019933554817275746,0.5642058392014672,1.0,22/65,17.19%,HTRA3;HTRA4;PMEPA1;SKIL;EMILIN1;SMAD6;LDLRAD4;SPRED2;BCL9L;TGFBR2;SKI;PDPK1;SMAD7;TGFB1I1;TGFBR1;CIDEA;STUB1;IL17RD;CD109;RPS27A;UBC;SLC2A10
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),-0.5641288787584868,-1.4642826726463796,0.07719298245614035,0.5004865202464048,1.0,6/11,19.34%,EFNB2;FRS2;SOX6;MYOCD;BMP2;TGFB1
prerank,PERK-mediated unfolded protein response (GO:0036499),0.7172779879814783,1.4638252088077568,0.06871345029239766,0.564303734365754,1.0,8/10,26.13%,ATF4;NFE2L2;HSPA5;QRICH1;EIF2S1;EIF2AK3;HERPUD1;CCL2
prerank,response to UV (GO:0009411),0.5168289744849954,1.4637366340944102,0.023109243697478993,0.5622894929449687,1.0,40/95,26.78%,EGFR;PRKCD;NEDD4;SCARA3;UBE2B;ATF4;CCAR2;ERCC8;ERCC5;ERCC4;MAPK8;WRN;SDE2;ERCC3;ERCC2;CAT;CREBBP;PARP1;N4BP1;CDC25A;REV1;MEN1;AKT1;USP1;NOC2L;EIF2AK4;EIF2S1;CIRBP;MAP2K7;USP47;TRIAP1;PRIMPOL;TAF1;SDF4;TP53;POLD1;UVSSA;YY1;XPA;ZRANB3
prerank,smooth muscle contraction (GO:0006939),-0.5280166349623525,-1.4623570176990974,0.08239700374531835,0.499905315532236,1.0,9/14,12.31%,ROCK2;MYLK;SLC8A1;SMTN;BDKRB2;MYH11;ADRA1A;ACTA2;PIK3C2A
prerank,positive regulation of DNA metabolic process (GO:0051054),0.5411626863642663,1.4614695620454248,0.02813852813852814,0.5706038727633381,1.0,9/61,6.52%,SMOC2;EGFR;FGF2;EYA2;GNL3;PARP3;TRIM28;ERCC8;HMGB1
prerank,aortic valve morphogenesis (GO:0003180),0.5921423296841328,1.4610739606536651,0.05562130177514793,0.570111953054625,1.0,11/30,10.16%,SLIT3;SLIT2;ELN;EMILIN1;SMAD6;TWIST1;JAG1;HEYL;SOX9;NFATC1;BMP4
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.564134519718102,1.4610431433118134,0.034636871508379886,0.5678872798489524,1.0,18/46,18.13%,PRKCD;GAS6;TCF7L2;NEDD4;IPO5;BAG3;TRIM28;MAVS;JUP;ZIC1;UBR5;ANP32B;XPO4;KHDRBS1;YWHAE;NCBP2;CPSF6;RBM22
prerank,action potential (GO:0001508),0.5612472011809059,1.4603744501856466,0.03968253968253968,0.5685995336112765,1.0,6/44,6.76%,KCNJ2;CACNA1G;KCNB1;DMD;KCNE5;SCN11A
prerank,protein deacetylation (GO:0006476),0.5643801077995735,1.458764596815246,0.04265402843601896,0.5734128901963083,1.0,15/41,16.76%,PRDM5;HDAC9;HDAC4;BAZ2A;MORF4L2;MIDEAS;SIRT5;RCOR3;MORF4L1;MIER2;HDAC1;SIRT2;HDAC6;SIN3B;MTA3
prerank,cardiac muscle cell membrane repolarization (GO:0099622),0.7004246554503918,1.4584002455566072,0.06048387096774194,0.5726391149155741,1.0,3/11,6.92%,KCNJ2;ATP1B1;KCNIP2
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.545408155735095,1.4583939702923872,0.02101769911504425,0.5703140449545095,1.0,14/55,16.36%,THBS1;PID1;COQ7;CYP1B1;XDH;TGFBR2;SIRT5;ARF4;AKR1C1;FOXM1;DHRS4;SIRT2;EIF6;AATF
prerank,positive regulation of protein maturation (GO:1903319),-0.5781278079069431,-1.4576266810573468,0.07868852459016394,0.5066412438815987,1.0,9/11,39.57%,CCBE1;SOX4;BAG2;NKD2;NLRC4;RHBDD1;TFR2;ADAM8;ANGPTL8
prerank,aortic valve development (GO:0003176),0.5817576433224667,1.4574740695083337,0.05057471264367816,0.5722475004007076,1.0,12/34,10.16%,SLIT3;SLIT2;ELN;EMILIN1;SMAD6;TWIST1;TNFRSF1B;JAG1;HEYL;SOX9;NFATC1;BMP4
prerank,negative regulation of actin filament polymerization (GO:0030837),0.620309705449342,1.4571461643655366,0.048507462686567165,0.5712492158812164,1.0,4/22,6.32%,SLIT2;PRKCD;GSN;PFN2
prerank,regulation of actin polymerization or depolymerization (GO:0008064),-0.44497136213262756,-1.4562494341372978,0.03125,0.5044918693760999,1.0,6/28,6.04%,ARHGAP28;ARHGAP18;ESAM;CXCL12;PLEKHG2;PAK3
prerank,histone methylation (GO:0016571),0.6020873514867495,1.455644379935217,0.06311881188118812,0.5758017735080938,1.0,15/26,29.54%,PRMT8;EHMT1;NSD1;CARM1;CREBBP;SUV39H2;NTMT1;SUV39H1;FBL;PRMT1;SMYD2;EHMT2;TRMT112;PRMT5;NSD3
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.5351218182631402,1.455629970375997,0.02869757174392936,0.5689953014670154,1.0,36/61,25.54%,SEC31A;SEC24D;STX5;SEC13;CSNK1D;SEC23A;TRAPPC10;CNIH2;PPP6R1;BET1;PPP6R3;SCFD1;NSF;TRAPPC6A;USO1;SEC24C;SEC24B;SEC16A;SEC16B;PREB;SEC22B;CNIH1;SEC24A;TMED2;NAPA;SEC23IP;CTSZ;TRAPPC3;TRAPPC6B;LMAN1;RAB1A;KLHL12;RAB1B;ANKRD28;TBC1D20;TFG
prerank,COPII vesicle coating (GO:0048208),0.5351218182631402,1.455629970375997,0.02869757174392936,0.5689953014670154,1.0,36/61,25.54%,SEC31A;SEC24D;STX5;SEC13;CSNK1D;SEC23A;TRAPPC10;CNIH2;PPP6R1;BET1;PPP6R3;SCFD1;NSF;TRAPPC6A;USO1;SEC24C;SEC24B;SEC16A;SEC16B;PREB;SEC22B;CNIH1;SEC24A;TMED2;NAPA;SEC23IP;CTSZ;TRAPPC3;TRAPPC6B;LMAN1;RAB1A;KLHL12;RAB1B;ANKRD28;TBC1D20;TFG
prerank,vesicle coating (GO:0006901),0.5351218182631402,1.455629970375997,0.02869757174392936,0.5689953014670154,1.0,36/61,25.54%,SEC31A;SEC24D;STX5;SEC13;CSNK1D;SEC23A;TRAPPC10;CNIH2;PPP6R1;BET1;PPP6R3;SCFD1;NSF;TRAPPC6A;USO1;SEC24C;SEC24B;SEC16A;SEC16B;PREB;SEC22B;CNIH1;SEC24A;TMED2;NAPA;SEC23IP;CTSZ;TRAPPC3;TRAPPC6B;LMAN1;RAB1A;KLHL12;RAB1B;ANKRD28;TBC1D20;TFG
prerank,eye development (GO:0001654),0.5523544589948547,1.4554123905389815,0.021566401816118047,0.5677601606005246,1.0,17/54,14.44%,SMOC1;CACNA1C;CHRDL1;PBX3;COL5A2;HES5;TGFB2;RAB3GAP1;PBX1;MEIS3;SKI;SH3PXD2B;TSKU;CPAMD8;ZDHHC16;BLOC1S3;SIPA1L3
prerank,myelination in peripheral nervous system (GO:0022011),0.6939089551034051,1.4548096449524597,0.07334273624823695,0.5681102682882594,1.0,7/13,16.28%,MYOC;LGI4;SKI;SOD1;NCMAP;SIRT2;NF1
prerank,COPII-coated vesicle budding (GO:0090114),0.5308252876084004,1.4542866115163964,0.026172300981461286,0.5681351101604842,1.0,40/68,26.92%,SEC31A;SEC24D;STX5;SEC13;CSNK1D;SEC23A;TRAPPC10;CNIH2;PPP6R1;BET1;PPP6R3;SCFD1;NSF;TRAPPC6A;USO1;SEC24C;SEC24B;SEC16A;SEC16B;PREB;SEC22B;MIA3;CNIH1;SEC24A;TMED2;NAPA;SEC23B;SEC23IP;CTSZ;TRAPPC3;TRAPPC6B;LMAN1;RAB1A;KLHL12;RAB1B;ANKRD28;TBC1D20;TFG;SAR1A;GOLGA2
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.5098664115433722,1.4539483584970547,0.015789473684210527,0.5674467515072139,1.0,33/95,18.10%,THBS1;HTRA3;HTRA4;PMEPA1;SKIL;EMILIN1;SMAD6;DKK3;LDLRAD4;SPRED2;BCL9L;SMAD4;TGFBR2;SKI;GIPC1;PDPK1;SMAD7;TGFB1I1;TGFBR1;CIDEA;DAB2;STUB1;LATS2;CREBBP;IL17RD;CD109;RPS27A;UBC;FLCN;SLC2A10;CDKN1C;MEN1;CITED2
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.6126093348000591,1.4521932391296806,0.0605296343001261,0.5731440483037998,1.0,7/23,14.20%,PLA2G4F;PLA2G4A;MBOAT2;LPCAT4;PLA2G5;LPCAT3;PLA2G12A
prerank,mRNA 3'-end processing (GO:0031124),0.5277778563738562,1.4518955781309129,0.018458197611292075,0.5722782971867018,1.0,33/78,22.15%,SRSF6;CPSF4L;SRSF1;PABPC1;SRSF5;SRSF2;CASC3;TENT4B;SRSF11;SYMPK;ZC3H11A;U2AF1;SRRM1;CHTOP;PABPN1;U2AF2;CLP1;CPSF4;SARNP;THOC2;SRSF3;PCF11;RPRD1A;NCBP1;CPSF7;NCBP2;CPSF6;SRSF7;CSTF2;CSTF2T;TENT2;PAF1;SRSF4
prerank,potassium ion export across plasma membrane (GO:0097623),0.6978384879548389,1.4518060871188037,0.043835616438356165,0.5704551143738177,1.0,3/13,6.92%,KCNK5;KCNE5;KCNIP2
prerank,extracellular matrix assembly (GO:0085029),0.6083420251110366,1.4517587390222098,0.05667506297229219,0.5684300120337901,1.0,6/23,6.96%,LTBP3;GAS6;EMILIN1;NTN4;RAMP2;QSOX1
prerank,negative regulation of endothelial cell migration (GO:0010596),0.5757215083426649,1.4517145945731376,0.04700352526439483,0.5664204874040704,1.0,6/36,9.68%,THBS1;SLIT2;FGF2;HMGB1;JUP;ANGPT4
prerank,regulation of response to stress (GO:0080134),0.7085780894156202,1.4514693386258475,0.06302521008403361,0.5653449742902207,1.0,2/10,5.49%,SLC38A2;ADCY8
prerank,fatty acid beta-oxidation (GO:0006635),0.5439224418294908,1.4514608471753538,0.02937853107344633,0.5632252984908278,1.0,30/51,33.25%,ABCD3;EHHADH;ACOXL;ECHDC2;ACOX3;ECI2;ETFDH;ETFB;ETFA;AUH;ACAT1;BDH2;CRAT;SLC27A2;PEX2;ECHDC1;ABCD1;MCAT;HADHA;GCDH;ACOT8;MTLN;ACAT2;SCP2;CPT2;ECI1;ABCD4;MECR;CROT;DECR2
prerank,response to estrogen (GO:0043627),0.5783493255529036,1.4511865822522325,0.07142857142857142,0.5622308883385742,1.0,9/31,18.10%,ESR1;BCAS3;RARA;SRA1;SFR1;SERPINB9;KMT2D;CYP27B1;CITED2
prerank,nucleosome assembly (GO:0006334),0.5775377307425328,1.4508437455475804,0.054878048780487805,0.5615580884649324,1.0,16/31,28.44%,CHAF1B;IPO4;NAA60;SOX9;ANP32B;SPTY2D1;CABIN1;KAT6B;BRD2;NAP1L3;NAP1L2;UBN1;H3-3A;DAXX;CHAF1A;HIRA
prerank,endomembrane system organization (GO:0010256),0.4920420223382096,1.4507560757289368,0.0060790273556231,0.5597820512447945,1.0,66/178,21.72%,NUP93;SEC31A;MAPK15;ATL2;SEC61A1;CSNK1D;LMAN2L;RAB2A;FBXW8;GOLGA8B;GOLGA5;RAB30;TLCD2;RAB43;DOP1B;DNAJC13;BCAS3;SMPD4;GOLGB1;ATL3;LAMTOR1;USP50;GBF1;ATP8B2;TJAP1;ARHGAP21;HUWE1;LAPTM4B;PLEKHM2;TRAPPC12;AP3D1;TMED9;TRIP11;ZW10;WASHC4;SEC16A;DMPK;SQSTM1;PI4K2A;REEP3;SEC16B;LMAN2;MIA3;TLCD1;SPTBN1;BNIP1;TMED2;VPS11;GOLPH3;TMEM170A;COG2;NPLOC4;BLZF1;SEC23IP;PHETA2;TRAPPC11;ARFGEF2;REEP5;LRRK2;OPTN;ATP8B1;LMAN1;ATL1;RAB1A;GORASP2;EIF2AK3
prerank,ribosomal subunit export from nucleus (GO:0000054),0.6818668921143592,1.4500977426146158,0.06162464985994398,0.560535624435716,1.0,6/13,16.13%,XPO1;LTV1;RRS1;ABCE1;NUP88;EIF6
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.57363214802403,1.449082818268074,0.045346062052505964,0.5628998986570004,1.0,7/34,11.54%,MYOC;P4HB;ILK;S100A10;DOCK5;ABL1;NRP1
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.5843455770789202,1.449029856301401,0.05773955773955774,0.5610604565125524,1.0,4/31,5.53%,CACNA1G;KCNB1;SYT8;RAB3GAP1
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.6795902848108585,1.4485137466447187,0.08016877637130802,0.5612252460417478,1.0,6/12,11.90%,KDELR3;GPAA1;KDELR1;KDELR2;HSPA5;RER1
prerank,adherens junction organization (GO:0034332),-0.3851537053698453,-1.4464974989726713,0.020689655172413793,0.5268502882269053,1.0,15/48,9.70%,TJP1;CADM1;CDH8;CDH13;CDH5;CADM2;CDH4;PIP5K1C;CDH1;CDH6;CDH2;NECTIN2;CDH7;CDH20;CDH19
prerank,ceramide transport (GO:0035627),-0.5571872725589642,-1.4463805991386396,0.07746478873239436,0.5213697367835558,1.0,3/12,9.38%,PLTP;CERT1;GLTP
prerank,positive regulation of epithelial cell migration (GO:0010634),0.5091955600278311,1.4463267093475711,0.014583333333333334,0.5686703528423476,1.0,21/92,12.61%,THBS1;SMOC2;FOXP1;VEGFA;FGF2;ADAM9;PRKCE;SPARC;TGFB2;PRKCA;BCAS3;FOXC2;DOCK5;GFUS;SOX9;ANGPT4;BMP4;ABL1;NRP1;IQSEC1;PIK3CB
prerank,negative regulation of smooth muscle cell migration (GO:0014912),0.673625804386585,1.4450755041314887,0.07180851063829788,0.5719134093324499,1.0,3/14,1.00%,SLIT2;IGFBP5;LRP1
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.6468086448887914,1.4436478568589985,0.07267833109017496,0.5762564852394924,1.0,4/15,11.86%,TGFB3;TGFB2;IRAK3;SMAD7
prerank,mitotic nuclear membrane organization (GO:0101024),0.540844314434678,1.4432709910925126,0.03811659192825112,0.573720080603061,1.0,25/51,27.61%,NUP93;SEC13;LMNA;SEH1L;SPAST;RCC1;NUP37;CHMP3;REEP3;SIRT2;SUMO1;CC2D1B;IST1;POM121;CHMP4B;CHMP4A;NDC1;NUP35;CHMP2A;PPP2CA;NUP85;BANF1;NUP160;PPP2R1A;AHCTF1
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.540844314434678,1.4432709910925126,0.03811659192825112,0.573720080603061,1.0,25/51,27.61%,NUP93;SEC13;LMNA;SEH1L;SPAST;RCC1;NUP37;CHMP3;REEP3;SIRT2;SUMO1;CC2D1B;IST1;POM121;CHMP4B;CHMP4A;NDC1;NUP35;CHMP2A;PPP2CA;NUP85;BANF1;NUP160;PPP2R1A;AHCTF1
prerank,limb morphogenesis (GO:0035108),0.6293806553574256,1.4431360438492509,0.07133917396745933,0.5722441187443875,1.0,5/20,7.48%,LRP6;PCSK5;MBNL1;TGFB2;SKI
prerank,ureteric bud morphogenesis (GO:0060675),0.6507308505970162,1.4416127932321943,0.07529722589167767,0.5772180038980457,1.0,2/16,1.13%,SIX1;FGF2
prerank,protein O-linked glycosylation via serine (GO:0018242),0.700522776862954,1.4406640466661462,0.08262108262108261,0.579083266252189,1.0,5/10,16.08%,GALNT13;POGLUT3;POGLUT1;GALNT3;GALNT1
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.5822297384860429,1.4398095063614436,0.06119951040391677,0.580812930638002,1.0,5/32,6.22%,THBS1;MYOC;SEMA3E;BCAS3;JAG1
prerank,potassium ion homeostasis (GO:0055075),0.6072490153275494,1.4395436617265442,0.07323232323232323,0.5800058626738308,1.0,4/23,1.24%,KCNJ2;SLC12A7;ATP1B1;SLC12A2
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),0.6618241106058458,1.439344027309064,0.0748663101604278,0.5787835559264698,1.0,7/15,6.32%,SFRP4;GPC3;RSPO3;TIAM1;CSNK1D;DACT1;LBX2
prerank,mitochondrion transport along microtubule (GO:0047497),0.6657976622049326,1.4392313218739723,0.0862533692722372,0.577196660238103,1.0,4/13,10.03%,SYBU;RHOT2;RHOT1;SPAST
prerank,cardiac myofibril assembly (GO:0055003),-0.5278404537335475,-1.438632715370569,0.07692307692307693,0.5370874917339082,1.0,4/15,7.28%,NEBL;PDGFRB;PROX1;PDGFRA
prerank,regulation of autophagosome maturation (GO:1901096),0.6769958746602063,1.437606029863997,0.07310344827586207,0.5821640591030623,1.0,8/13,23.91%,TMEM39A;CLEC16A;TBC1D25;PHF23;CLN3;RUBCN;UVRAG;SMCR8
prerank,early endosome to Golgi transport (GO:0034498),0.7049460061833266,1.4375978823378543,0.07122093023255814,0.580149302349409,1.0,5/11,11.96%,STX5;SNX2;TRAPPC10;SNX1;TMED9
prerank,tRNA transport (GO:0051031),0.5654584358264368,1.436801736145996,0.055089820359281436,0.5817401787634259,1.0,18/35,26.60%,NUP93;SEC13;RAE1;SSB;SEH1L;NUP37;RANBP2;NUP88;XPOT;NUP210;POM121;NUP62;NDC1;NUP35;YBX1;NUP85;TPR;NUP160
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.5714726968667776,1.436510802736137,0.0592503022974607,0.5789260444472096,1.0,17/32,26.60%,NUP93;SEC13;RAE1;SSB;SEH1L;NUP37;RANBP2;NUP88;XPOT;NUP210;POM121;NUP62;NDC1;NUP35;NUP85;TPR;NUP160
prerank,tRNA export from nucleus (GO:0006409),0.5714726968667776,1.436510802736137,0.0592503022974607,0.5789260444472096,1.0,17/32,26.60%,NUP93;SEC13;RAE1;SSB;SEH1L;NUP37;RANBP2;NUP88;XPOT;NUP210;POM121;NUP62;NDC1;NUP35;NUP85;TPR;NUP160
prerank,regulation of chromosome segregation (GO:0051983),0.6542091719123166,1.435593036638864,0.0701058201058201,0.5810092706660163,1.0,6/16,8.70%,CSNK2A1;CSNK2A2;HORMAD1;PUM1;RMI2;CDC6
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.6099221678364947,1.43552386590376,0.07561929595827901,0.5792763124406624,1.0,4/20,5.38%,PID1;PKDCC;RHOQ;PPFIA1
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.5456785257122021,1.4348818963249987,0.051341890315052506,0.5801133182820803,1.0,5/44,4.20%,THBS1;VEGFA;GAS6;CSNK2A1;CARD16
prerank,histone deubiquitination (GO:0016578),0.6409503465395224,1.434834669655437,0.075,0.5783368394139363,1.0,12/18,27.18%,TRRAP;ENY2;KAT2A;USP7;USP36;BRCC3;USP49;ATXN7;TAF10;USP16;USP21;USP22
prerank,quinone biosynthetic process (GO:1901663),0.6499206054799654,1.4346064231354223,0.09015256588072122,0.5774857374967441,1.0,8/14,18.62%,COQ7;UBIAD1;COQ10B;FDXR;COQ8B;COQ2;COQ9;COQ6
prerank,regulation of T cell migration (GO:2000404),-0.49332096869916997,-1.4333946281904797,0.06086956521739131,0.5454696001647427,1.0,5/18,3.85%,LRCH1;RIPOR2;APOD;APP;CXCL12
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.5897057822779613,1.4329956513394944,0.07054455445544554,0.5827233652509073,1.0,4/27,1.87%,IRS1;PID1;PRKCD;GRB10
prerank,regulation of phospholipase activity (GO:0010517),0.6948278766706326,1.4328932615699508,0.08333333333333333,0.5811471011021881,1.0,5/10,11.53%,LRP1;FGFR1;PLA2G5;FGFR2;PDPK1
prerank,cell-substrate junction assembly (GO:0007044),-0.4136629099183899,-1.4327903654226526,0.047337278106508875,0.5414082128612361,1.0,9/33,6.65%,SORBS1;ACTN2;ITGA6;DST;PEAK1;THSD1;ITGB4;WHAMM;PTPRK
prerank,heart development (GO:0007507),0.4958027037475283,1.431076290824482,0.005060728744939271,0.5872133111148462,1.0,46/150,16.78%,MICAL2;CACNA1C;PKD1;ID2;ZFPM2;VEGFA;PCSK5;PLCE1;SGCD;COL3A1;GPC3;NTRK3;ECE1;GLI2;PDLIM7;HDAC9;TGFB2;RAMP2;ACVR1;FOXC2;TGFBR2;SOX9;SH3PXD2B;FOXL1;CRELD1;ALPK3;FLRT2;BMP4;POU6F1;TAB2;CSRP3;ZDHHC16;WDR11;TGFBR1;SRF;DNAAF4;KAT2A;MEF2D;MEF2A;BMP5;TCF25;AKAP13;NF1;NIPBL;MTHFD1;KDM6B
prerank,histone deacetylation (GO:0016575),0.5479019847090317,1.4310296099826136,0.04205607476635514,0.5854259422266456,1.0,17/43,17.77%,PRDM5;HDAC9;HDAC4;BAZ2A;MORF4L2;MIDEAS;RCOR3;MORF4L1;MIER2;SFPQ;HDAC1;SIRT2;PER1;HDAC6;SIN3B;MTA3;SMARCAD1
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),0.6616486046028587,1.4309909084758532,0.07093184979137691,0.5836337752990928,1.0,2/14,0.80%,PGF;VEGFA
prerank,ubiquinone metabolic process (GO:0006743),0.6441594159470688,1.4304538551994366,0.08689655172413793,0.5839996585440617,1.0,8/15,18.62%,COQ7;UBIAD1;COQ10B;FDXR;COQ8B;COQ2;COQ9;COQ6
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.5358501443872379,1.4302376444219012,0.049107142857142856,0.5830020441065789,1.0,8/53,6.18%,EGFR;PRKCD;EYA2;DDX5;SPRED2;TRIM28;CCAR2;ERCC8
prerank,positive regulation of lipid catabolic process (GO:0050996),0.6270192397358583,1.4301229899838037,0.08344370860927153,0.5815233008131616,1.0,4/19,8.69%,IRS1;PRKCD;TWIST1;AKT2
prerank,vitamin transport (GO:0051180),0.5792373463529968,1.4300603133414305,0.05896510228640193,0.5798612774546144,1.0,3/29,6.01%,SLC23A1;SLC5A6;SLC25A32
prerank,nucleosome organization (GO:0034728),0.538963655168436,1.4294750936388887,0.04391891891891892,0.5804937065490482,1.0,28/55,28.74%,CHAF1B;NAA60;SOX9;SMARCC2;ANP32B;SPTY2D1;ACTR6;KAT6B;ZNHIT1;BRD2;NFE2;VPS72;NAP1L3;HMGA1;BRDT;NAP1L2;BPTF;PAF1;SETD2;SMARCA4;SRCAP;ANP32E;H3-3A;DAXX;CHAF1A;ARID1A;SMARCD2;SMARCC1
prerank,regulation of cellular metabolic process (GO:0031323),0.5540819176482524,1.4291342138777297,0.04067796610169491,0.579987331214611,1.0,13/45,16.13%,PID1;COQ7;NCOR2;CYP1B1;LAMTOR1;PM20D2;ARF4;RSPO1;FOXM1;ARF1;ACACA;STUB1;EIF6
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.5396380437588245,1.4286245991519515,0.053591790193842644,0.5801931536357128,1.0,12/48,9.68%,THBS1;RHOJ;VEGFA;FGF2;HDAC9;STAT5A;PRKCA;FOXC2;HMGB1;FGFR1;ANXA1;ANGPT4
prerank,negative regulation of microtubule polymerization (GO:0031115),-0.5566003076725872,-1.4281074982860542,0.10820895522388059,0.5491243728887846,1.0,5/12,15.09%,CDH5;MAP2;EML2;SNCA;TUBB4A
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.6816488599161838,1.4280492073049975,0.07637906647807638,0.5807952468621896,1.0,6/12,16.57%,ESR1;NCOR2;STAT3;TERT;IL6;ZC3H10
prerank,peptidyl-threonine dephosphorylation (GO:0035970),-0.45951343495194974,-1.4264722198028812,0.06481481481481481,0.548195625311076,1.0,11/22,25.24%,PPM1E;DUSP16;DUSP10;PPP2CB;PPM1G;DUSP6;PPP5C;DUSP4;PPP1CA;PPM1A;PPM1D
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),-0.4449432287660962,-1.4262187708225949,0.04716981132075472,0.5433827575455166,1.0,10/23,16.79%,DYNC1I1;CCDC88A;TUBA1B;KIF1A;CCDC88C;TUBA1A;KIF5B;KIF1C;HOOK2;MAP6D1
prerank,regulation of autophagosome assembly (GO:2000785),0.5722232103356909,1.426046087315376,0.05826397146254459,0.5879376050081171,1.0,21/33,27.29%,NPRL3;TMEM39A;RAB3GAP1;LRSAM1;IFT20;SCFD1;PIP4K2B;PHF23;SEC22B;IFT88;RAB3GAP2;CHMP4B;CHMP4A;LRRK2;NPRL2;MTM1;RAB1B;SMCR8;PINK1;RAB5A;PIP4K2C
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.6429937456342507,1.4253302874679423,0.0907911802853437,0.589114419760366,1.0,14/16,33.32%,CELF4;THRAP3;CELF3;DAZAP1;NCBP1;TRA2B;RBMXL1;TRA2A;CIRBP;RBM3;PRDX6;SF3B4;SNW1;NCL
prerank,intestinal lipid absorption (GO:0098856),0.6954418813093972,1.4244180271586822,0.08819538670284939,0.5912207326173533,1.0,3/11,9.00%,CEL;LIMA1;AKR1C1
prerank,positive regulation of cytokinesis (GO:0032467),0.5687179465892331,1.423973571876276,0.05812574139976275,0.5911694286001486,1.0,14/32,21.82%,CIT;PRKCE;CDC14A;GIPC1;CDC6;RHOA;PKN2;SPAST;CDC25B;OPN1MW;CSPP1;KIF20B;SVIL;DRD2
prerank,antibacterial humoral response (GO:0019731),0.6420448536544479,1.4232036109741135,0.07346938775510205,0.5925442017767545,1.0,5/16,18.98%,RNASE7;RNASE3;RNASE6;DEFB1;DMBT1
prerank,lymphocyte chemotaxis (GO:0048247),0.5685052679832152,1.4224362770396337,0.05745721271393643,0.5940196722570196,1.0,5/34,7.33%,GAS6;SLC12A2;CCL13;CCL15;CXCL16
prerank,ncRNA export from nucleus (GO:0097064),0.5582730210761154,1.4222297599018185,0.06413301662707839,0.5929672962255683,1.0,18/36,26.60%,NUP93;SEC13;RAE1;SSB;SEH1L;NUP37;RANBP2;NUP88;XPOT;NCBP2;NUP210;POM121;NUP62;NDC1;NUP35;NUP85;TPR;NUP160
prerank,cellular polysaccharide catabolic process (GO:0044247),0.6398608733587939,1.422016180428978,0.0849933598937583,0.5919857041100192,1.0,5/16,7.85%,PYGB;STBD1;GAA;PHKA1;PHKB
prerank,monoacylglycerol metabolic process (GO:0046462),0.6623070044852442,1.4209341183345185,0.07458563535911603,0.5946871834796703,1.0,2/13,1.81%,MGLL;PLA2G4A
prerank,negative regulation of locomotion (GO:0040013),-0.542382402054415,-1.4208662077935403,0.10774410774410774,0.552676925750333,1.0,5/12,11.80%,FRMD5;FBLN1;SPOCK3;DUSP3;SPINT2
prerank,glucan catabolic process (GO:0009251),0.6507903034553684,1.4199985935147477,0.08333333333333333,0.5969928572905772,1.0,5/15,7.85%,PYGB;STBD1;GAA;PHKA1;PHKB
prerank,positive regulation of organelle organization (GO:0010638),0.572453013551113,1.4199814159753519,0.07402912621359223,0.595167412704475,1.0,12/32,13.29%,SORBS3;ANXA2;C2CD5;RAB3GAP1;ATL3;PLA2G5;AKT2;ANXA1;SYNJ1;KATNBL1;TMED9;LIG4
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.5179033229638822,1.4199428685688646,0.020277481323372464,0.5934704920870898,1.0,10/73,8.32%,THBS1;LBP;IL33;SPN;EPHB2;TWIST1;STAT3;MAVS;HMGB1;FZD5
prerank,histone H3-K4 methylation (GO:0051568),0.5859319032864214,1.4199139455812095,0.07090464547677261,0.5917212497395349,1.0,12/26,22.26%,KMT2C;OGT;WDR5;KMT2D;SETD4;KMT2B;MEN1;WDR82;SETD1A;DPY30;TET2;KMT2A
prerank,regulation of tumor necrosis factor production (GO:0032680),0.49599499587301277,1.4194108888343593,0.016563146997929608,0.5921820467760819,1.0,15/112,8.32%,THBS1;FOXP1;LBP;GAS6;IL33;SPN;EPHB2;TWIST1;STAT3;MAVS;HMGB1;IRAK3;TRIM27;RARA;FZD5
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.6464892073140881,1.4194042195809695,0.10540540540540541,0.5903663879752291,1.0,5/15,11.86%,ACVR1B;ACVR1;DACT1;SKI;SMAD7
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.5753209053146416,1.419150466081671,0.060794044665012405,0.5896172617978365,1.0,8/29,14.20%,PLA2G4F;PLA2G4A;LPCAT1;MBOAT2;LPCAT4;PLA2G5;LPCAT3;PLA2G12A
prerank,positive regulation of calcium ion transport (GO:0051928),-0.416826526231461,-1.418686475447643,0.04878048780487805,0.5533939648747123,1.0,9/36,6.74%,MYLK;CACNA1D;CACNB2;TRPC3;CXCL12;PDGFRB;ATP2B1;TRPC6;ORAI1
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.5326940400152603,1.4184512348504448,0.04767309875141884,0.5908458890590698,1.0,17/50,23.43%,THBS1;VEGFA;GAS6;NOL3;CSNK2A1;CARD16;RAF1;PAK2;YWHAE;HGF;AKT1;SH3RF1;BCL2L12;USP47;SFN;TRIAP1;DPEP1
prerank,regulation of vasculature development (GO:1901342),0.5895610114053399,1.4181983064029786,0.07835820895522388,0.5901061316215555,1.0,3/26,1.98%,BMPER;FGF2;PROK2
prerank,calcium ion transmembrane import into cytosol (GO:0097553),-0.39907691845195736,-1.4177140583544747,0.038461538461538464,0.5504310064266149,1.0,12/41,10.18%,ITPR1;SLC8A1;SLC24A2;RYR2;ITPR3;CACNA2D1;GRIN2B;HTR2C;TRPV2;SLC8A3;ITPR2;GRIN2A
prerank,oligosaccharide biosynthetic process (GO:0009312),0.6206884859636417,1.4171801042137784,0.08076923076923077,0.5926772144696839,1.0,6/20,11.02%,ST3GAL4;ST6GALNAC5;B4GALT1;ST3GAL2;FUT8;FUT4
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.5075662589327553,1.4167478813257743,0.029818956336528223,0.5927164478814013,1.0,42/80,30.23%,SGSM2;STX5;RAB7B;SNX2;ERC1;TRAPPC10;RIC1;GBF1;VPS52;TBC1D23;TRIM27;SNX1;RGP1;VPS26A;TMED9;TMEM87B;SNX32;VPS53;CLTC;TBC1D10A;SPAG9;TBC1D17;STX16;GGA1;HEATR5A;PHETA2;EVI5;DCTN1;LMAN1;VPS51;SNX3;BET1L;VTI1B;RNF126;GCC2;SNX5;SURF4;CLN5;ARL1;ARFRP1;PIKFYVE;VTI1A
prerank,regulation of T cell mediated immunity (GO:0002709),0.7095648065002731,1.416546149426385,0.08615819209039548,0.5917656698316723,1.0,4/10,10.71%,TNFRSF1B;HMGB1;TRPM4;RIPK3
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.5354871049876061,1.4153653359867862,0.06150341685649203,0.5948595921906366,1.0,19/49,23.75%,THBS1;RAB7B;KMT2C;RUNX1;AGO1;PITHD1;HDAC1;WDR5;KMT2D;SCIN;KMT2B;EIF6;NFE2;CBFB;SETD1A;DPY30;KMT2A;PRMT1;KAT2B
prerank,membrane lipid catabolic process (GO:0046466),0.695955253314921,1.4148401993789206,0.09195402298850575,0.595298109362413,1.0,2/10,2.95%,CYP1B1;PDXDC1
prerank,intracellular protein transport (GO:0006886),0.4735576512759785,1.4145279469165069,0.002,0.5948537436881903,1.0,117/304,23.91%,PKD1;SGSM2;XPO1;LTBP2;NUP93;ARFGAP3;SEC31A;CTTN;KIF13A;PRICKLE1;EHD1;TBC1D8B;TBC1D2B;STX5;SEC13;ARCN1;IPO5;STRADA;RAB43;STAT3;COPA;C2CD5;BAG3;RAB24;AP2A1;STX11;RAB21;IPO4;RIC1;GGA2;TLK1;E2F3;XPO6;HIKESHI;COPZ2;GIPC1;ARF4;AKT2;SNX1;SCFD1;NSF;STX2;VPS26A;ARFIP2;RAB38;ARF1;SNX9;AP3D1;XPO4;USO1;WDR11;EVI5L;TMED9;IPO13;CHP1;TECPR2;ERP29;TBC1D9B;NLGN1;PICK1;TBC1D25;SEC16A;TNPO2;CLTC;VIPAS39;PREB;RAB23;HPS4;NUP88;TBCK;COPB2;SIL1;STX4;TBC1D10A;STX1A;SCFD2;HDAC6;TBC1D17;STX16;BCS1L;GGA1;SNX13;TMED2;NAPA;RAB5B;TNPO1;POM121;AKT1;SNX15;RAB3GAP2;SEC23IP;IPO9;VPS45;APPL2;COX18;EVI5;CALR;APPL1;TBC1D22B;LAMP2;NUP62;CCHCR1;LMAN1;VPS26C;PPP1R10;RAB1A;IFT27;TSC2;RAB18;COPZ1;DESI1;RABGAP1;CAMSAP3;RAB1B;AP3B1;TMED7;IPO8
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),-0.464494240645184,-1.414095120442019,0.07317073170731707,0.5557996797320559,1.0,6/22,6.74%,LYN;ROCK2;EPHA4;PICALM;ABCG1;GSAP
prerank,regulation of cardiac muscle cell action potential (GO:0098901),0.5861661833255951,1.41402110184067,0.08239700374531835,0.5952288839130376,1.0,9/25,12.19%,CACNA1C;FGF13;HCN4;CAMK2D;ANK2;JUP;DLG1;TRPM4;AKAP9
prerank,regulation of glucose transmembrane transport (GO:0010827),-0.48861666261545034,-1.4136796946271535,0.06938775510204082,0.5514829504809862,1.0,5/18,8.83%,OCLN;SLC2A1;PRKCB;PRKAG2;BRAF
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.5853839458488553,1.4136476173135695,0.08094645080946451,0.5950598733613645,1.0,11/24,17.04%,SEC31A;SEC24D;SEC13;SEC23A;FCER1G;PDIA3;BCAP31;SEC24C;SEC24B;IDE;SEC24A
prerank,carboxylic acid metabolic process (GO:0019752),0.565857766423981,1.4133990934507206,0.06310679611650485,0.5943214629016915,1.0,4/33,1.81%,SLC23A1;SLC23A2;PTGIS;PLA2G4A
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.5206780601942873,1.4133482443745053,0.02267818574514039,0.5927961309371491,1.0,10/69,8.32%,THBS1;LBP;IL33;SPN;EPHB2;TWIST1;STAT3;MAVS;HMGB1;FZD5
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.5583236498810273,1.4132721998387305,0.060570071258907364,0.591294959997693,1.0,7/39,8.97%,THBS1;MYOC;EFNA5;SEMA3E;JAG1;FZD7;RHOA
prerank,embryonic appendage morphogenesis (GO:0035113),0.681870734048841,1.4128455122987655,0.10220994475138122,0.5913132293030494,1.0,4/12,7.48%,LRP6;MBNL1;TGFB2;SKI
prerank,visual system development (GO:0150063),0.5570743642533109,1.412568934013615,0.05667060212514758,0.5908393489557974,1.0,14/37,20.09%,SMOC1;CHRDL1;PBX3;TGFB2;PBX1;MEIS3;SH3PXD2B;CPAMD8;ZDHHC16;BLOC1S3;SIPA1L3;MAB21L2;HIPK2;ATF6
prerank,chemical homeostasis (GO:0048878),0.5248586923564442,1.4125358215213024,0.03479236812570146,0.5892146920149224,1.0,16/61,16.84%,SLC4A10;SLC4A4;ACOXL;SLC4A8;TLCD2;ACOX3;TENT4B;SLC4A11;SLC4A2;NR1D2;SLC4A5;WNK1;SLC4A3;PNPLA3;THADA;TLCD1
prerank,regulation of early endosome to late endosome transport (GO:2000641),0.6223279881854845,1.4123014527102604,0.0815006468305304,0.5884504501187235,1.0,8/18,19.31%,RDX;DNAJC13;RAB21;EZR;CHMP3;DAB2;VPS11;PTPN23
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),0.6607536195521472,1.4115208926746359,0.08798882681564246,0.590111363577401,1.0,8/13,20.74%,CPSF4L;CPSF4;NCBP1;CPSF7;NCBP2;CPSF6;CSTF2;CSTF2T
prerank,positive regulation of axonogenesis (GO:0050772),0.5478544412684246,1.4113977127031414,0.05964912280701754,0.588889272538374,1.0,5/43,2.45%,SLIT2;PLXNA4;NTN1;TIAM1;TIAM2
prerank,protein import into peroxisome matrix (GO:0016558),0.6608508195665465,1.4108717372998514,0.10043041606886657,0.5893961614765401,1.0,9/12,23.07%,PEX7;PEX5;PEX16;PEX13;PEX1;PEX10;PEX6;PEX2;PEX14
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.5064986439790584,1.4099093717350673,0.04287245444801715,0.5917925950522044,1.0,26/76,19.69%,CMKLR1;PTGIS;CYP1B1;PKHD1;ANXA4;TAX1BP1;IRAK3;DAP;CDK5RAP3;ITCH;CHUK;NFKBIB;IRAK1;COMMD7;CHP1;TRAF3;USP7;G3BP2;ARRB1;OTULIN;RWDD3;UFL1;ACOD1;ERBIN;LRRC14;NFKBIA
prerank,stress fiber assembly (GO:0043149),-0.5140805790154516,-1.4098305558867028,0.09448818897637795,0.5515770552881425,1.0,3/15,0.87%,SORBS1;PHACTR1;FAM171A1
prerank,contractile actin filament bundle assembly (GO:0030038),-0.5140805790154516,-1.4098305558867028,0.09448818897637795,0.5515770552881425,1.0,3/15,0.87%,SORBS1;PHACTR1;FAM171A1
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.5771815109007401,1.409604337756005,0.07881773399014778,0.5913591436611391,1.0,4/28,1.87%,IRS1;PID1;PRKCD;GRB10
prerank,catecholamine metabolic process (GO:0006584),0.6540609179784809,1.408594504843605,0.08187919463087248,0.5938319937664439,1.0,3/14,4.59%,DRD1;LRTOMT;SNCAIP
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.6572329673534434,1.408369613319562,0.09078212290502793,0.5930785930504099,1.0,10/14,25.34%,SRSF6;PCBP4;PTBP1;U2AF2;SRSF10;SRSF7;SAP18;SFSWAP;SRSF4;C1QBP
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),0.6681549506486462,1.407559997275679,0.08250355618776671,0.5947821563609433,1.0,5/12,14.57%,FOXP1;NCOR2;HEYL;HDAC1;DAB2
prerank,positive regulation of integrin activation (GO:0033625),-0.5485228693104834,-1.4070826071577212,0.10238907849829351,0.5540713168617611,1.0,3/11,11.33%,RASIP1;PIEZO1;PLEK
prerank,negative regulation of protein phosphorylation (GO:0001933),0.4841696337751758,1.4069740891863518,0.008138351983723296,0.5955808223103535,1.0,36/150,13.19%,SLIT2;RASSF2;LRP6;PID1;PRKCD;PMEPA1;EMILIN1;UBASH3B;NTRK3;SMAD6;PLPP3;EPHB2;TWIST1;LDLRAD4;SPRED2;WWTR1;XDH;CALM2;DVL1;DMD;PRKDC;TRIM27;NOG;CDK5RAP3;IMPACT;AKT1S1;DGKQ;PAK2;PAQR3;NIBAN1;PDPK1;SMAD7;DEPTOR;CHP1;EIF4G1;PPEF2
prerank,ubiquinone biosynthetic process (GO:0006744),0.6322578511390405,1.4065486187033887,0.0997229916897507,0.5957789448324472,1.0,8/15,18.62%,COQ7;UBIAD1;COQ10B;FDXR;COQ8B;COQ2;COQ9;COQ6
prerank,cellular sodium ion homeostasis (GO:0006883),-0.4944732759844649,-1.4061017708212877,0.10276679841897234,0.5516770834000431,1.0,4/15,1.30%,ATP1A2;ATP1B3;NEDD4L;SLC8A1
prerank,regulation of fatty acid metabolic process (GO:0019217),-0.5029320083372654,-1.405965103454444,0.09205020920502092,0.5469811310976472,1.0,6/17,9.77%,PPARA;PRKAA2;PRKAG2;PPARD;ADIPOR1;CAV1
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),-0.4844698213788832,-1.4058900493247593,0.08,0.5421024705377623,1.0,4/18,1.91%,ROCK2;TEK;CDH5;RIPOR2
prerank,nuclear membrane reassembly (GO:0031468),0.5244745032314828,1.4056534821184807,0.05251396648044693,0.5978562144165621,1.0,26/54,27.80%,NUP93;SEC13;LMNA;SEH1L;SPAST;RCC1;NUP37;CHMP3;REEP3;SIRT2;SUMO1;CC2D1B;IST1;POM121;CHMP4B;CHMP4A;NDC1;NUP35;CHMP2A;PPP2CA;NUP85;BANF1;NUP160;PPP2R1A;AHCTF1;UBXN2A
prerank,protein import (GO:0017038),0.4990030242037098,1.4049205929461084,0.03208556149732621,0.5994063407157052,1.0,43/84,31.10%,ABCD3;NUP93;PRICKLE1;PXMP2;SEC13;IPO5;STAT3;IPO4;E2F3;HIKESHI;PEX5;PEX16;PEX13;IPO13;ALDH3A2;TNPO2;NUP88;TNPO1;POM121;AKT1;IPO9;APPL2;APPL1;CLU;LAMP2;NUP62;PPP1R10;PEX2;TSC2;ABCD1;ACBD5;PEX14;IPO8;NUTF2;NUP85;TPR;RPAIN;FIS1;NUP188;NUP50;ATAD1;HSP90AA1;FAM53C
prerank,cell junction assembly (GO:0034329),-0.34147654293835467,-1.4045691162361382,0.0,0.540703955562402,1.0,35/100,13.92%,TJP1;SDK1;TLN2;ADGRL3;CDH8;GPM6A;CDH5;ITGA6;NRXN1;SHANK3;CLDN5;DNM3;SPOCK2;LIMS2;PKP4;ARVCF;PLXND1;GJC1;CDH1;OPHN1;CDH6;CDH2;DNER;CDC42;CDH7;CDH20;CDH19;FLNC;FN1;SLITRK1;CTNND1;PKP2;FBLIM1;SDK2;CDH9
prerank,cellular response to organic substance (GO:0071310),0.49423169195814265,1.4032670573358217,0.017708333333333333,0.6048665100325833,1.0,25/116,13.42%,SLIT3;SLIT2;PID1;IGFBP5;GHR;DPYSL3;ACVR1B;CYP1B1;SHC1;NFAT5;STAT3;RAMP2;ACVR1;TGFBR2;SOCS2;RHOA;PTPN18;MAPK8;RAMP1;URI1;BMPR1A;TGFBR1;CASP1;PTPN2;LRP2
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.6338601648129444,1.4024354235934628,0.08718626155878467,0.606769212715675,1.0,3/15,6.92%,KCNJ2;ATP1B1;KCNIP2
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.6711283010497249,1.4015123942944236,0.0958904109589041,0.6089051763713168,1.0,6/12,18.03%,SEH1L;MAD1L1;CENPC;MIS12;RMDN1;CDT1
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.6300807872923287,1.401151041970738,0.09492847854356307,0.6087423948509448,1.0,7/15,16.67%,SIX1;TWIST1;TGFBR2;FGFR2;TGFBR1;NIPBL;MTHFD1
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.5055657337603122,1.4007582604819726,0.030687830687830688,0.6087667856499119,1.0,29/86,18.10%,THBS1;GDF10;ZNF423;FOXD1;NUP93;INHBC;ACVR1B;TGFB3;HES5;TGFB2;ACVR1;SULF1;SMAD4;GIPC1;BMP4;BMPR1A;SH2B1;TGFB1I1;TGFBR1;INHBA;BMP5;DAB2;CREBBP;CRB2;FLCN;SLC2A10;CDKN1C;MEN1;CITED2
prerank,peptidyl-serine phosphorylation (GO:0018105),0.48271427063659433,1.4001103343489447,0.012195121951219513,0.6097703320972081,1.0,68/153,25.17%,PKD1;PRKCD;GAS6;ULK2;MARK1;PRKCE;CSNK1D;CAMK2D;CSNK2A1;CSNK2A2;MORC3;PRKCA;DYRK4;PRKDC;TGFBR2;TLK1;STK39;RPS6KA4;AKT2;DGKQ;PKN2;PAK2;MAPK8;SMG1;CHUK;CSNK1G1;ATM;MAP3K12;PDPK1;MAPK12;TGFBR1;UHMK1;CSNK1E;MAP3K10;DMPK;WNK1;LATS2;TLK2;CAMK4;MKNK2;VRK2;MAST2;IKBKE;AKT1;HIPK2;CDK2;CDK5;MAPK9;LRRK2;SGK3;VRK3;MAST4;PRKACA;EIF2AK3;HIPK4;PRKCI;CSNK1G3;TOP1;STK38;CAMK1;RPS6KB1;TAF1;RPS6KA2;ROCK1;TBK1;NEK6;LMTK2;PINK1
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.5479935254836241,1.3998089934677718,0.06939704209328783,0.6094577658581116,1.0,16/40,16.22%,COL1A1;TCF7L2;TIAM1;TGFB3;TWIST1;WWTR1;TGFB2;JAG1;BCL9L;SMAD4;TGFBR2;TGFB1I1;TGFBR1;DAB2;IL6;CRB2
prerank,cellular senescence (GO:0090398),0.5782267956770644,1.3997589532119965,0.07664233576642336,0.60794928022666,1.0,3/27,0.93%,ID2;PRKCD;ECRG4
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.5982788971213979,1.399695798098016,0.0938722294654498,0.6065552600915496,1.0,7/22,17.29%,ESR1;MED13;SRF;PSMC5;PSMC4;MED14;MED12
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),-0.3619813902603159,-1.3995162832221137,0.043010752688172046,0.5494102830664138,1.0,23/59,14.13%,ROBO1;SDK1;CADM1;CDH13;PECAM1;BSG;ROBO2;CDH4;CDH1;CNTN6;TENM3;CNTN4;DSCAML1;CDH2;ROBO4;NECTIN2;NEXN;PLXNB2;CD84;CEACAM1;PTPRT;SDK2;IGSF21
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.6217840413784198,1.3990086257894931,0.0847457627118644,0.6078042287489087,1.0,6/19,11.54%,MYOC;VEGFA;COL16A1;S100A10;ABL1;NRP1
prerank,extracellular matrix disassembly (GO:0022617),0.5208712814187688,1.3981111079797635,0.0691609977324263,0.6098704266665704,1.0,11/53,12.96%,BMP1;GSN;HTRA1;TIMP2;TLL1;MMP14;ADAM10;SH3PXD2B;CAPN2;SCUBE3;MMP16
prerank,cellular component disassembly (GO:0022411),0.5214441426058213,1.397984052164695,0.0659090909090909,0.6086791470006989,1.0,11/53,12.96%,BMP1;GSN;HTRA1;TIMP2;TLL1;MMP14;ADAM10;SH3PXD2B;CAPN2;SCUBE3;MMP16
prerank,chromatin assembly (GO:0031497),0.545851961679416,1.3979291190001908,0.0711743772241993,0.607232282716771,1.0,18/38,26.55%,CHAF1B;M1AP;NAA60;EZH1;SOX9;CDAN1;ANP32B;SPTY2D1;KAT6B;BRD2;NAP1L3;NAP1L2;NOC2L;PAF1;TP53;H3-3A;DAXX;CHAF1A
prerank,cardiac muscle cell action potential (GO:0086001),0.564879593773646,1.3977201886245536,0.08333333333333333,0.6064511283321975,1.0,8/30,7.17%,KCNJ2;CACNA1G;CACNA1C;ATP1B1;HCN4;DMD;KCNIP2;ANK2
prerank,cellular response to hydrogen peroxide (GO:0070301),0.5556682650192815,1.3977111640011626,0.07729468599033816,0.6048289655174355,1.0,12/33,16.15%,PRKCD;CYP1B1;MAP3K5;FXN;NFE2L2;IMPACT;ANXA1;ABL1;RIPK3;RHOB;IL6;HDAC6
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),-0.437942308013071,-1.3976460836732298,0.09895833333333333,0.549608755682263,1.0,5/25,8.20%,KIT;B2M;WNT5A;SLC7A5;LACC1
prerank,calcium ion import into cytosol (GO:1902656),-0.5165642040348098,-1.3974094396521488,0.1076923076923077,0.5452574806400395,1.0,5/15,7.17%,SLC8A1;SLC24A2;CACNA2D1;TRPV2;SLC8A3
prerank,skin development (GO:0043588),0.5175229576161949,1.3972350389682988,0.051648351648351645,0.6050932478651115,1.0,10/65,6.85%,PKD1;COL3A1;COL1A2;COL1A1;COL5A3;ADAM9;COL5A2;CLIC4;JAG1;BCR
prerank,RNA transport (GO:0050658),0.505090830837223,1.3971873650826185,0.04756756756756757,0.6036255926003846,1.0,37/71,27.86%,SRSF6;SRSF1;ARC;SIDT2;SRSF5;RAE1;SRSF2;CASC3;TGFBR2;HNRNPA2B1;SRSF11;NXF1;ZC3H11A;U2AF1;CKAP5;SRRM1;CHTOP;U2AF2;SARNP;THOC2;SRSF3;NCBP1;NCBP2;SRSF7;POM121;RTRAF;ATXN2;NUP62;SRSF4;HNRNPA1;YBX1;UPF3B;DDX39B;TPR;EIF4E;ZFP36L1;XPO5
prerank,negative regulation of lipid biosynthetic process (GO:0051055),-0.4597917262004756,-1.3968633387557479,0.09049773755656108,0.5418897461491244,1.0,10/20,23.47%,WNT4;ASXL3;CEACAM1;GPER1;BMP2;BRCA1;ERLIN2;TRIB3;SIK1;APOC1
prerank,eye photoreceptor cell development (GO:0042462),0.6360993258671696,1.3957240638249533,0.10949868073878628,0.6082061591764857,1.0,5/15,18.79%,VEGFA;TOPORS;RPGRIP1L;CRB2;MYO7A
prerank,establishment of protein localization to organelle (GO:0072594),0.49814813080724485,1.3954352927882256,0.04220779220779221,0.6077152955796719,1.0,32/72,27.46%,NUP93;TSPAN10;PRICKLE1;SEC13;IPO5;STAT3;LRSAM1;IPO4;E2F3;HIKESHI;IPO13;TNPO2;NUP88;TNPO1;POM121;AKT1;IPO9;APPL2;NEURL1B;APPL1;LAMP2;NUP62;PPP1R10;LAMP1;TSC2;IPO8;PINK1;NUTF2;NUP85;TPR;RALA;RPAIN
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.5268358645524394,1.3952813464212646,0.06509539842873176,0.6066802191027449,1.0,9/47,12.40%,MYOC;EFNA5;P4HB;ILK;S100A10;DOCK5;ABL1;NRP1;RCC2
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.42943721143903824,-1.3952139127339271,0.055248618784530384,0.5410389612044495,1.0,9/26,13.49%,TGFA;ERRFI1;APP;CBLB;ADRA2A;HBEGF;SNX6;SOCS5;GPRC5A
prerank,cytoplasmic sequestering of protein (GO:0051220),0.6431895422699649,1.3950319955520918,0.09279778393351801,0.6061610332842103,1.0,7/13,26.06%,PKD1;GOPC;MDFI;SUFU;NFKBIA;YWHAB;GET4
prerank,ERBB2 signaling pathway (GO:0038128),0.5660880297640909,1.3949470445491143,0.08302354399008674,0.6048879977739573,1.0,4/31,4.72%,MYOC;EGFR;SHC1;PRKCA
prerank,chondroitin sulfate catabolic process (GO:0030207),0.6554623533923291,1.3941386517264833,0.09005376344086022,0.6067879650372261,1.0,5/13,15.42%,BGN;ARSB;CSPG4;HEXA;VCAN
prerank,regulation of Wnt signaling pathway (GO:0030111),0.4937404008010382,1.3938605603864167,0.023735810113519093,0.6063262313399238,1.0,27/108,11.30%,ESR1;TRABD2B;CTNND2;LRP1;SFRP4;GPC3;RSPO3;TIAM1;GRB10;ATP6V1C2;MDFIC;NXN;CSNK2A1;TCF7L1;DACT1;SULF1;FZD7;SKI;RSPO1;DACT3;TSKU;FOXL1;NFATC1;RUNX1;FGFR2;TERT;AXIN1
prerank,embryonic limb morphogenesis (GO:0030326),0.5643384138399333,1.3936504500782825,0.07242990654205607,0.6055811590824809,1.0,9/34,8.49%,LRP6;CACNA1C;AFF3;ECE1;TWIST1;MBNL1;TGFB2;SKI;NOG
prerank,nitric oxide mediated signal transduction (GO:0007263),-0.509595040674685,-1.39271194737186,0.09302325581395349,0.5431721763519543,1.0,6/16,12.10%,APOE;NOS3;GUCY1B1;KCNC2;NOS1;DDAH2
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.5790113586197719,1.3925845344684114,0.08701134930643127,0.6085296690947436,1.0,10/25,25.41%,LDB1;TCEA2;CCAR2;HMGN1;CCNT2;SETD5;ZMYND11;KAT7;EAF1;DDX39B
prerank,glutamine family amino acid catabolic process (GO:0009065),-0.5264095060614338,-1.3921186430154189,0.09608540925266904,0.5400653532345555,1.0,7/13,15.26%,NOS3;ALDH4A1;GLUL;PRODH;GLS;NOS1;GAD1
prerank,negative regulation of macrophage activation (GO:0043031),-0.49117167562180386,-1.3912488106867784,0.08870967741935484,0.5373893197378488,1.0,7/16,16.92%,IL31RA;NR1H3;LRFN5;CD200;ZC3H12A;CX3CL1;SYT11
prerank,ion transport (GO:0006811),0.4856215480656735,1.3910621199358721,0.029106029106029108,0.6132346426719589,1.0,15/111,7.46%,PIEZO2;SLC26A7;SLC26A2;SLC12A7;SLC12A2;SLC24A3;HCN4;SLC26A6;KCNN1;SLC9A8;SLC9A4;SLC9A1;CHRNB2;SLC12A4;SLC4A2
prerank,modulation of excitatory postsynaptic potential (GO:0098815),-0.4435799312934189,-1.3910246677767741,0.065,0.5334479597931913,1.0,10/26,14.50%,NRXN1;SHANK3;APP;RIMS2;RIMS1;SLC8A3;CUX2;RELN;PRKCZ;GRIN1
prerank,vesicle cytoskeletal trafficking (GO:0099518),-0.3970697857396046,-1.3906805460027372,0.06206896551724138,0.5298682204661134,1.0,12/39,14.53%,MYO1B;PPFIA2;DYNC1I1;MYO6;ACTN4;BICDL1;TRAK2;MYO1D;KIF1A;TRAK1;KIF5B;MYO5C
prerank,nucleotide-sugar metabolic process (GO:0009225),0.6561486825542169,1.3901456974383748,0.11404728789986092,0.6154900481964867,1.0,5/12,9.74%,GFPT1;GMDS;GFPT2;GFUS;FUT8
prerank,protein import into peroxisome membrane (GO:0045046),0.5904049117176876,1.3894159664114007,0.09407216494845361,0.6169010274543447,1.0,10/22,23.07%,ABCD3;PXMP2;PEX5;PEX16;PEX13;ALDH3A2;PEX2;ABCD1;ACBD5;PEX14
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),-0.3995978356991597,-1.3892101282522338,0.06790123456790123,0.5294447028499567,1.0,11/35,9.28%,TJP1;TEK;RAPGEF3;ESAM;F11R;ARHGDIA;BAIAP2;IQGAP2;PDGFRA;CDC42;ABI3
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),-0.3576187968757811,-1.3886128389855497,0.030303030303030304,0.526463512258574,1.0,10/57,8.41%,ADCY5;LPAR1;GRM7;GRM8;ADCY1;ADRA2A;PDE2A;HTR4;ADCY4;OPRM1
prerank,negative regulation of protein autophosphorylation (GO:0031953),-0.5686921644421628,-1.3879661705509325,0.1288135593220339,0.5238357732561126,1.0,4/10,9.77%,ENG;ERRFI1;ENPP1;CAV1
prerank,positive regulation of protein sumoylation (GO:0033235),0.6932382921894885,1.3871906788898083,0.1111111111111111,0.6247756007411774,1.0,6/10,21.56%,GNL3;HDAC4;PIAS4;RWDD3;SAE1;MUL1
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.645376125248226,1.3867983729113253,0.11690140845070422,0.6249086076966247,1.0,2/12,2.65%,ESR1;NCOR2
prerank,protein O-linked mannosylation (GO:0035269),-0.4750080208647076,-1.3858602629870629,0.09170305676855896,0.5255536932870449,1.0,3/18,2.18%,TMTC2;TMTC4;CRPPA
prerank,positive regulation of catabolic process (GO:0009896),0.5106235772737019,1.3858465202215091,0.051627384960718295,0.6275423282024918,1.0,15/65,11.30%,WWP1;GPC3;NEDD4;STX5;CSNK2A1;ACTN3;VCP;RILP;DACT1;HUWE1;WWP2;NSF;ITCH;VIP;AXIN1
prerank,energy reserve metabolic process (GO:0006112),0.5967062428727378,1.385633524768739,0.1010230179028133,0.6268880780797172,1.0,6/19,7.85%,PID1;PPP1R3C;GFPT1;PHKA1;GFPT2;PHKB
prerank,negative regulation of bone mineralization (GO:0030502),-0.5222687367172877,-1.385326472155907,0.11152416356877323,0.5227488993659896,1.0,5/13,13.10%,ENPP1;SRGN;BCOR;RFLNA;RFLNB
prerank,glycogen metabolic process (GO:0005977),0.5693781606480528,1.3850342972843823,0.08899876390605686,0.6276170524889851,1.0,6/27,7.85%,PYGB;PPP1R3C;STBD1;GAA;PHKA1;PHKB
prerank,protein localization to Golgi apparatus (GO:0034067),0.5719152593185108,1.385011902681872,0.08508014796547472,0.6260736869928484,1.0,6/27,10.50%,VPS13A;VPS13C;CSNK1D;IFT20;GBF1;PAQR3
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),-0.4393355726757452,-1.3843711049064473,0.07960199004975124,0.520760276507866,1.0,8/22,23.81%,GCNT2;BMP7;CD44;THY1;AGER;MAPK7;MBP;MYADM
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.5980909183801306,1.3842966163233477,0.10880829015544041,0.6275223395192027,1.0,6/18,9.20%,RHOJ;VEGFA;FGF2;HDAC9;FOXC2;ANXA1
prerank,regulation of protein polymerization (GO:0032271),-0.3937351580598489,-1.3836667074900892,0.06547619047619048,0.5184923675702788,1.0,7/35,6.82%,ARHGAP28;ARHGAP18;MAP2;ESAM;PLEKHG2;PAK3;CAMSAP1
prerank,positive regulation of immune system process (GO:0002684),0.6167863919843787,1.3833310360314608,0.09746328437917223,0.6301488179394535,1.0,5/16,14.90%,VEGFA;TGFB2;ANXA1;PIK3CB;MIA3
prerank,positive regulation of mRNA processing (GO:0050685),0.5937355088147399,1.3832672651623599,0.09217171717171717,0.628788989248221,1.0,16/21,33.32%,CELF4;THRAP3;CELF3;DAZAP1;NCBP1;NCBP2;TRA2B;RBMXL1;TRA2A;CIRBP;PAF1;RBM3;PRDX6;SF3B4;SNW1;NCL
prerank,muscle cell migration (GO:0014812),0.6751720559966913,1.3826358261694105,0.11739130434782609,0.6297431193917247,1.0,2/10,1.79%,SIX1;CCN3
prerank,ether lipid biosynthetic process (GO:0008611),0.6740257453014594,1.382606421315392,0.1006993006993007,0.6282680561623267,1.0,4/10,18.32%,PLA2G4A;PEX7;FAR1;AGPS
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.6010573240790541,1.3820504530143811,0.09743589743589744,0.6290803071586837,1.0,4/21,8.78%,SLIT2;EPHB2;TGFB2;LZTR1
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.6776058604224995,1.38152880835158,0.1168091168091168,0.6297887597665369,1.0,1/10,0.33%,LRP6
prerank,regulation of myotube differentiation (GO:0010830),0.5751199056221065,1.3813118072150627,0.10062893081761007,0.629079209365843,1.0,8/24,13.84%,CCN3;HDAC9;HDAC4;MMP14;TMEM119;FBXO22;HDAC1;DMPK
prerank,regulation of cardiac muscle cell contraction (GO:0086004),0.5730113892128247,1.3813066527897164,0.0880503144654088,0.6275064605031672,1.0,9/27,12.19%,CACNA1C;FGF13;HCN4;CAMK2D;ANK2;JUP;DLG1;TRPM4;AKAP9
prerank,regulation of B cell differentiation (GO:0045577),0.6166279439878121,1.3812972790757212,0.1095360824742268,0.6259721212738527,1.0,5/17,12.95%,ID2;MMP14;IKZF3;CD27;INHBA
prerank,negative regulation of transmembrane transport (GO:0034763),0.675237216555498,1.3812865253161242,0.11561561561561562,0.6244506090354968,1.0,1/10,0.08%,THBS1
prerank,regulation of calcium ion transport (GO:0051924),-0.37041558635814736,-1.3812589574993306,0.0425531914893617,0.5204592110665793,1.0,15/54,11.52%,MYLK;BCL2;EPB41;CACNA1D;CACNB2;CACNA2D1;ATP2B1;TRPC6;ADRA2A;ORAI1;PLPP4;HOMER1;PACSIN3;CD84;NOS1
prerank,calcium ion import across plasma membrane (GO:0098703),-0.5190665566680924,-1.3799229589313335,0.11397058823529412,0.5198532147566309,1.0,5/14,7.17%,SLC8A1;SLC24A2;CACNA2D1;TRPV2;SLC8A3
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.5895485032486882,1.3797550104631569,0.09693877551020408,0.6293419311524637,1.0,17/23,34.78%,GPS1;CUL4A;PARP1;RPS27A;UBC;COPS4;COPS7A;COPS3;XPA;DDB1;RBX1;COPS5;RAD23B;CUL4B;COPS2;COPS7B;CETN2
prerank,global genome nucleotide-excision repair (GO:0070911),0.5785704389387252,1.3792644084545906,0.1,0.6298377095577097,1.0,18/26,34.78%,CHD1L;ERCC4;CUL4A;USP45;ERCC3;ERCC2;PARP1;RPS27A;UBC;RNF111;GTF2H4;XPA;DDB1;RBX1;RAD23B;ERCC1;CUL4B;CETN2
prerank,glycogen catabolic process (GO:0005980),0.6299783301723201,1.378984206906956,0.1136986301369863,0.6295001770626503,1.0,5/15,7.85%,PYGB;STBD1;GAA;PHKA1;PHKB
prerank,endothelial cell proliferation (GO:0001935),0.6180390676214607,1.3786052950267613,0.0992063492063492,0.6295999868817952,1.0,5/17,10.16%,BMPER;PROK2;DLG1;ANGPT4;BMP4
prerank,icosanoid biosynthetic process (GO:0046456),0.6847878647112208,1.3785644369803853,0.09272467902995721,0.6281933179883162,1.0,3/10,10.43%,PLA2G4A;PLA2G5;FADS1
prerank,negative regulation of lipid metabolic process (GO:0045833),-0.44073782204862594,-1.3778837916910807,0.07725321888412018,0.5210783482373166,1.0,9/22,19.98%,APOD;ADRA2A;PRKAA1;ASXL3;CEACAM1;BSCL2;GPER1;PPP2R5A;ALK
prerank,fluid transport (GO:0042044),0.6310516757452305,1.3777898519172604,0.12876712328767123,0.6298280081133628,1.0,2/12,5.77%,SLC26A6;SLC4A11
prerank,sodium ion homeostasis (GO:0055078),-0.45804204351012023,-1.3771911131355181,0.0825242718446602,0.5188005213666976,1.0,4/21,1.30%,ATP1A2;ATP1B3;NEDD4L;SLC8A1
prerank,positive regulation of cytoplasmic transport (GO:1903651),0.6820001862959288,1.3759280356654928,0.09928057553956834,0.6364023068608987,1.0,6/11,19.31%,RDX;RAB21;EZR;DAB2;VPS11;PTPN23
prerank,regulation of focal adhesion assembly (GO:0051893),0.5142449503261188,1.3756787878962384,0.06215316315205328,0.6359212917764373,1.0,13/54,12.40%,THBS1;MYOC;VEGFA;EFNA5;LDB1;COL16A1;BCAS3;S100A10;SLC9A1;RHOA;ABL1;NRP1;RCC2
prerank,protein alkylation (GO:0008213),0.5901929270720172,1.3753797434332518,0.0982367758186398,0.6356454235531962,1.0,10/22,23.43%,PRMT8;FAM98A;GSPT1;FAM98B;LCMT1;EEF1AKMT2;ETF1;PCMT1;SNRPB;PRMT1
prerank,regulation of histone H3-K9 methylation (GO:0051570),-0.5325119839523125,-1.3737771568179,0.1162079510703364,0.5239018168237268,1.0,6/10,22.29%,RIF1;SIRT1;JARID2;BRCA1;KDM1A;DNMT3B
prerank,protein import into nucleus (GO:0006606),0.4986475110626704,1.3727477959056247,0.05378704720087816,0.645294233059116,1.0,32/66,28.05%,NUP93;PRICKLE1;SEC13;IPO5;STAT3;IPO4;E2F3;HIKESHI;RGPD1;KPNA2;IPO13;TNPO2;RANBP2;NUP88;KPNA3;TNPO1;POM121;AKT1;IPO9;KPNA4;APPL2;APPL1;NUP62;PPP1R10;TSC2;NUP35;IPO8;NUTF2;NUP85;TPR;RPAIN;KPNA6
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.3346243981979486,-1.3716543404193053,0.0,0.5256162294237997,1.0,47/87,25.48%,RPS14;RPS15;RPL8;RPS25;RPS8;RPS20;RPL4;RPS27;RPS10;RPL24;RPS29;RPS7;RPL26;RPS16;RPL35;RPS24;RPL36;RPL18A;RPS12;RPL11;RPS11;RPL12;UBA52;RPL18;RPS15A;RPS28;RPL21;RPL7;RPL10;RPL15;RPS18;RPS19;RPS3;RPL38;SRP68;RPS5;RPL28;RPL35A;RPS4X;RPL17;RPL23;RPL9;RPL31;RPL37;RPL14;RPS17;RPL34
prerank,regulation of smoothened signaling pathway (GO:0008589),0.5143752248000022,1.3714871997471247,0.07995495495495496,0.6491525407304721,1.0,21/50,23.22%,GPC3;GLIS2;GAS1;RAB34;VCP;ARMC9;RORA;ZIC1;TEDC1;EVC;FGFR2;WDR11;PDCL;SMO;FUZ;CREBBP;SUFU;UCHL5;GLI3;DLG5;TXNDC15
prerank,intracellular protein transmembrane transport (GO:0065002),0.5248019792370492,1.3709629894413873,0.08449074074074074,0.6498820060756711,1.0,18/42,23.07%,PEX7;SEC61A1;C2CD5;TOMM40;PEX5;AKT2;PEX16;PEX1;PEX10;AIFM1;HSPA5;HSPD1;TOMM70;GRPEL1;PEX6;ZFAND2B;PEX2;PEX14
prerank,regulation of interleukin-4 production (GO:0032673),-0.4470388530167181,-1.3709329114734312,0.0958904109589041,0.5234840305340901,1.0,7/21,14.34%,LEF1;SLC7A5;SYK;HAVCR2;PRKCQ;LGALS9;PRKCZ
prerank,ncRNA metabolic process (GO:0034660),0.5380904236223875,1.370875730005579,0.08264462809917356,0.6486295007088312,1.0,15/37,29.80%,DDX17;TENT4B;PRKRA;MAEL;DTD1;DGCR8;AGO2;TDRD12;TUT7;ZCCHC8;TDRKH;NIFK;XPO5;KHSRP;MEPCE
prerank,positive regulation of biomineral tissue development (GO:0070169),-0.3815324783728331,-1.3706862219440645,0.05223880597014925,0.5204168394668837,1.0,13/40,9.22%,PTN;WNT4;SLC8A1;BMP6;ADGRV1;OSR1;WNT6;BMP7;KL;ATP2B1;FBN2;ANO6;BMPR2
prerank,positive regulation of lipid biosynthetic process (GO:0046889),-0.4165395068520229,-1.3702587457857147,0.056818181818181816,0.5175736286284958,1.0,10/29,11.38%,SORBS1;APOE;PPARA;LPGAT1;NR1H3;SLC45A3;MFSD2A;ZBTB20;MID1IP1;SCARB1
prerank,negative regulation of B cell proliferation (GO:0030889),-0.535979314802434,-1.3696256790221129,0.11328125,0.5154220641169396,1.0,4/11,14.96%,LYN;TNFRSF21;CD300A;TYROBP
prerank,mature B cell differentiation involved in immune response (GO:0002313),-0.5164178871812319,-1.3693217769747688,0.12403100775193798,0.5123049503553002,1.0,5/12,19.56%,DOCK11;DOCK10;LFNG;MFNG;DLL1
prerank,regulation of plasminogen activation (GO:0010755),0.6581483623132961,1.368894700126415,0.11487481590574374,0.6558269185061193,1.0,3/12,11.94%,THBS1;RUNX1;SERPINE2
prerank,positive regulation of glucose metabolic process (GO:0010907),0.6168423605099933,1.3679777892860518,0.12704918032786885,0.658269601323165,1.0,7/14,18.60%,IRS1;ACTN3;AKT2;NNMT;PTPN2;ARPP19;AKT1
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.6214039597948785,1.3678954482100922,0.12092391304347826,0.6570106918293734,1.0,6/16,15.41%,ST3GAL4;NFAT5;RHOA;IRAK1;FUT4;IL6
prerank,relaxation of cardiac muscle (GO:0055119),0.635800091540339,1.3678734949312001,0.11657303370786516,0.6555129951487128,1.0,4/13,3.50%,KCNJ2;ATP1B1;GSN;CAMK2D
prerank,protein methylation (GO:0006479),0.5387062037231146,1.3676502096703775,0.07364787111622555,0.6548618975930668,1.0,20/40,29.59%,PRMT8;EEF1AKMT3;FAM98A;EHMT1;NSD1;GSPT1;CARM1;FAM98B;LCMT1;EEF1AKMT2;ETF1;PCMT1;NTMT1;SNRPB;PRMT1;EHMT2;TRMT112;PRMT5;NSD3;PRMT3
prerank,positive regulation of endothelial cell migration (GO:0010595),0.48441218452530416,1.367545831216461,0.049893842887473464,0.6537506450374334,1.0,19/84,11.54%,THBS1;SMOC2;FOXP1;VEGFA;FGF2;PLPP3;SPARC;STAT5A;PRKCA;BCAS3;FOXC2;HMGB1;FGFR1;GFUS;ANGPT4;BMP4;ABL1;PDPK1;NRP1
prerank,regulation of mitochondrial depolarization (GO:0051900),0.6781615750686149,1.3673158731581596,0.10195530726256984,0.6532417355983624,1.0,1/10,0.08%,MYOC
prerank,in utero embryonic development (GO:0001701),0.5697856558853955,1.3671165945810526,0.10493046776232617,0.6524903278117323,1.0,9/25,13.29%,PKD1;VEGFA;TGFB3;MBNL1;ADAM10;FGFR2;FUT8;TGFBR1;LIG4
prerank,cellular response to reactive oxygen species (GO:0034614),0.5015532785626985,1.3669286197725776,0.06755260243632337,0.6516658626823101,1.0,16/59,16.15%,EGFR;PRKCD;CYP1B1;MAP3K5;FXN;NFE2L2;IMPACT;ANXA1;MAPK8;CHUK;ABL1;RIPK3;PRDX3;RHOB;IL6;HDAC6
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.6202871779478283,1.366115274647351,0.12016021361815754,0.653543575344137,1.0,6/15,15.41%,LRP1;DDR2;FAP;CST3;DDR1;IL6
prerank,regulation of protein metabolic process (GO:0051246),-0.3732742806685823,-1.3660391212146377,0.05405405405405406,0.5165614147512522,1.0,10/44,12.05%,ROCK2;NEDD4L;APOE;APP;FAF1;GSAP;KLF2;ACE;MTPN;SPOP
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),0.6594730096048733,1.3658322492931616,0.11898016997167139,0.6531687667347452,1.0,1/11,0.33%,LRP6
prerank,response to light stimulus (GO:0009416),0.5071593707139931,1.3657843284826523,0.07536557930258718,0.6518038870967915,1.0,26/55,27.37%,UBE2B;CCAR2;ERCC8;ERCC5;ERCC4;MAPK8;ERCC3;OPN1MW;OPN1MW3;ERCC2;FECH;REV1;MEN1;USP1;CIRBP;MAP2K7;DRD2;CRY2;OPN3;PRIMPOL;POLD1;COPS3;UVSSA;ZRANB3;RRH;GPR52
prerank,DNA duplex unwinding (GO:0032508),0.5214776625545271,1.3654860762896597,0.07349665924276169,0.6513875332991994,1.0,33/50,35.55%,CHD1L;MCMDC2;MCM2;ANXA1;CUL4A;WRN;RAD50;ERCC3;ERCC2;SUPV3L1;PARP1;MCM4;RPS27A;UBC;HMGA1;RAD51;TWNK;MCM7;RECQL5;GTF2H4;XPA;RTEL1;DDB1;DDX11;RBX1;SSBP1;RAD23B;BLM;CUL4B;PURA;CETN2;DHX9;MRE11
prerank,relaxation of muscle (GO:0090075),0.635562952798654,1.3648603214426989,0.11357340720221606,0.6525426583217546,1.0,4/13,3.50%,KCNJ2;ATP1B1;GSN;CAMK2D
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.6180190999329,1.3639100828465867,0.12681638044914134,0.6550006935868743,1.0,6/16,15.94%,HNRNPA2B1;SMG6;ERCC4;ATM;TNKS2;PARP1
prerank,odontogenesis (GO:0042476),0.5396003972850759,1.3635275183623283,0.09036144578313253,0.6551263640331638,1.0,9/35,12.95%,LRP6;COL1A2;GLI2;TGFB3;TGFB2;FGFR2;BMP4;HDAC1;INHBA
prerank,cellular response to light stimulus (GO:0071482),0.49681235817128155,1.3625770296123856,0.05077262693156733,0.6576866317441414,1.0,28/66,28.77%,PRKCD;NEDD4;ATF4;PDE6A;ERCC4;SDE2;OPN1MW;OPN1MW3;CREBBP;PARP1;N4BP1;CDC25A;SAG;NOC2L;EIF2AK4;EIF2S1;GNB1;USP47;TRIAP1;OPN3;TAF1;TP53;POLD1;YY1;RRH;GPR52;ATR;PDE6G
prerank,mitotic chromosome condensation (GO:0007076),0.5609018905666814,1.3624725185073012,0.1100123609394314,0.6566422621538727,1.0,6/26,11.05%,SMC4;CSNK2A1;CSNK2A2;KMT5A;MCPH1;PHF8
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.5541920668631626,-1.3622659109935942,0.14893617021276595,0.5226496124454928,1.0,2/11,1.07%,LYN;MFHAS1
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.6631382819179923,1.3618397040262704,0.12296296296296297,0.6578277043700361,1.0,3/10,8.69%,IRS1;PRKCE;AKT2
prerank,dermatan sulfate metabolic process (GO:0030205),0.6321558484927974,1.361389241543836,0.11281337047353761,0.6582350226003508,1.0,3/13,4.44%,DSE;BGN;CSPG4
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.5788525642781172,1.3609955319248788,0.11757105943152454,0.6585030514738558,1.0,4/22,5.76%,RASSF2;VEGFA;CALM2;TOM1L1
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.5804236022624362,1.3608897187151954,0.11443433029908973,0.6573828618025961,1.0,6/20,7.30%,VEGFA;SMAD9;ATF4;NFE2L2;SMAD4;RUNX2
prerank,DNA packaging (GO:0006323),0.6028141489389401,1.3603116335419512,0.11866666666666667,0.6582774424254773,1.0,8/16,26.55%,CHAF1B;M1AP;CDAN1;AIFM1;NOC2L;TP53;BANF1;CHAF1A
prerank,regulation of cell morphogenesis (GO:0022604),0.5451095913415454,1.3602136894832881,0.11057108140947752,0.6572115231467509,1.0,10/30,19.53%,EFNA5;FMNL2;SPARC;ARC;BCL9L;MYO9A;PHIP;SH3D19;ZMYM3;ZRANB1
prerank,negative regulation of protein modification process (GO:0031400),0.48701530797520654,1.3601728057499336,0.05938494167550371,0.655855213402636,1.0,18/79,10.91%,SLIT2;LRP6;PID1;NTRK3;PLPP3;EPHB2;WWTR1;XDH;P3H1;DMD;PRKDC;PPP1R8;SNTA1;BEX4;CDK5RAP3;IMPACT;PAQR3;NIBAN1
prerank,carbohydrate biosynthetic process (GO:0016051),0.5874263788117046,1.3600175325117612,0.11683417085427136,0.6550667989161489,1.0,6/21,11.02%,ST3GAL4;ST6GALNAC5;B4GALT1;ST3GAL2;FUT8;FUT4
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.5560875025119248,1.359419248454109,0.09344660194174757,0.6563006610830511,1.0,11/31,8.80%,GDF10;TWIST2;CRIM1;SMAD6;LRP5;TWIST1;NBR1;SKI;SOX9;NOG;TRPM4
prerank,gastrulation (GO:0007369),0.6277258893472744,1.3591138840686592,0.11885245901639344,0.6561655607319127,1.0,2/15,2.63%,GPC3;LRP5
prerank,vesicle transport along actin filament (GO:0030050),-0.4408579618887005,-1.3590603754665265,0.10267857142857142,0.5265203073808397,1.0,4/19,8.78%,MYO1B;MYO6;ACTN4;MYO1D
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.43313585096596613,-1.3589962537608202,0.10952380952380952,0.5229428184610684,1.0,5/23,5.46%,TGFBR3;ENG;NREP;SMAD3;ITGA3
prerank,inorganic anion transport (GO:0015698),0.5031596601099007,1.3588497943381606,0.06787330316742081,0.6557201797371865,1.0,6/53,5.77%,SLC4A10;SLC26A7;SLC26A6;CLIC3;CLIC4;SLC4A11
prerank,protein secretion (GO:0009306),0.5124791805219544,1.3587187729953494,0.07744107744107744,0.6548024255304158,1.0,21/56,20.57%,PCSK5;LTBP2;NECAB3;ARFGAP3;COPG1;RAB8A;MON1A;NAGPA;ANXA1;VIP;ABCA1;RAB3D;PREB;TMEM167A;MIA3;RAB3B;TANGO6;GOLPH3;STEAP3;RCN3;MIA2
prerank,regulation of metal ion transport (GO:0010959),-0.47154084496235726,-1.3586288281331784,0.10762331838565023,0.5202573396264273,1.0,5/16,6.74%,BCL2;EPB41;SLC30A10;CACNA2D1;ORAI1
prerank,tRNA methylation (GO:0030488),0.5449203096979784,1.3583070549605891,0.08520710059171598,0.6551176802308761,1.0,19/34,33.77%,TRMT61B;TARBP1;TRMT1;DALRD3;TYW3;THADA;THUMPD3;TRMT44;ALKBH8;METTL1;TRMT61A;NSUN6;MTO1;TRMT112;TRMT1L;METTL6;PRORP;METTL2B;METTL2A
prerank,protein localization to cell-cell junction (GO:0150105),-0.4889062259273922,-1.3582529447636595,0.10526315789473684,0.5175532359065922,1.0,5/15,6.25%,TJP1;CDH5;CGNL1;LSR;F11R
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.5496445922448175,1.3571318581915806,0.1159062885326757,0.6586782242814402,1.0,15/26,29.82%,FOXP1;NCOR2;HEYL;HDAC1;DAB2;PER1;VPS11;CNOT9;CALR;CRY2;SMARCA4;NCOR1;KANK2;VPS18;ZBTB7A
prerank,positive regulation of ossification (GO:0045778),-0.37809070163244485,-1.356465315945576,0.04861111111111111,0.5182133982559723,1.0,14/39,9.22%,PTN;WNT4;SLC8A1;BMP6;ADGRV1;ZBTB16;OSR1;WNT5A;BMP7;KL;ATP2B1;FBN2;ANO6;BMPR2
prerank,regulation of vacuole organization (GO:0044088),0.5875899655985815,1.3563953107824853,0.11012658227848102,0.6603809425602416,1.0,12/20,26.05%,NPRL3;ANXA2;IFT20;LAPTM4B;IFT88;ENO2;NPRL2;MTM1;RAB1B;SCARB2;ENO4;RAB5A
prerank,cellular response to pH (GO:0071467),0.6069623472799504,1.356171407590546,0.1227154046997389,0.6598067538539185,1.0,7/17,17.69%,SLC9A1;IMPACT;RAB11FIP5;CHP1;RAB11B;PKD2L1;HVCN1
prerank,retinoic acid receptor signaling pathway (GO:0048384),0.668770397599195,1.3553520783826487,0.1119186046511628,0.6618126907563653,1.0,4/10,8.14%,RARB;RXRA;RXRB;RARA
prerank,negative regulation of mRNA processing (GO:0050686),0.6246970353596814,1.3546034508184388,0.12379642365887207,0.6633978454165899,1.0,10/15,25.34%,SRSF6;PCBP4;PTBP1;U2AF2;SRSF10;SRSF7;SAP18;SFSWAP;SRSF4;C1QBP
prerank,camera-type eye morphogenesis (GO:0048593),0.6703732757196723,1.3543190968936283,0.11657303370786516,0.6631417723183732,1.0,3/10,7.48%,LRP6;VEGFA;SKI
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.5743891985606318,1.354247593303721,0.10723192019950124,0.6619326538695226,1.0,7/24,11.61%,MYOC;VEGFA;COL16A1;S100A10;ABL1;NRP1;IQSEC1
prerank,phosphatidylglycerol metabolic process (GO:0046471),0.5764298444352959,1.3540887814109246,0.11346633416458853,0.6611558074799984,1.0,8/24,16.77%,PLA2G4F;PLA2G4A;LPCAT1;LPCAT4;PLA2G5;PGS1;PLA2G12A;PLA2G15
prerank,regulation of actin nucleation (GO:0051125),0.6504174069238586,1.354038602787422,0.12534435261707988,0.6598851633039567,1.0,5/12,15.17%,GSN;ARFIP2;ARF1;PICK1;SCIN
prerank,positive regulation of DNA replication (GO:0045740),0.6132317329811284,1.3539213770702225,0.12483745123537061,0.6589049694584781,1.0,3/16,8.58%,EGFR;GLI2;BRPF3
prerank,histone lysine demethylation (GO:0070076),0.5711360434007504,1.3539157611334292,0.11706102117061021,0.6574540560794806,1.0,9/25,16.78%,JMJD1C;RIOX2;KDM2A;PHF8;KDM5B;KDM4A;HR;KDM5C;KDM6B
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.6072426804970197,1.3530017948801776,0.12402088772845953,0.6598549188525724,1.0,2/16,4.72%,SLC39A14;PRKCA
prerank,regulation of macrophage activation (GO:0043030),0.5484534388647522,1.3525739008202027,0.11003627569528417,0.6602781175833374,1.0,4/30,4.78%,THBS1;LBP;IL33;SHPK
prerank,blood vessel morphogenesis (GO:0048514),-0.3492373032648522,-1.3516599952879562,0.0390625,0.5265247598960039,1.0,18/54,11.33%,FLT1;TGFBR3;EFNB2;ENG;LAMA1;CCBE1;KDR;RASIP1;TBX1;PROX1;SOX17;SLC1A1;CDH2;RBPJ;FLT4;CAV1;SYK;SOX18
prerank,regulation of cholesterol esterification (GO:0010872),-0.573722533624828,-1.3516536897909222,0.12012987012987013,0.5229253046195348,1.0,4/10,8.02%,APOE;ABCG1;STARD4;AGTR1
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),-0.4177366069400089,-1.3512279338722464,0.07906976744186046,0.520413270563076,1.0,14/26,26.73%,PPARA;SLC30A10;SLC25A33;SLC5A3;TRAP1;ADGRB1;GRIN1;SNCA;ABCD2;ABCB7;SLC18A2;TLR6;ALOX5;CD36
prerank,cartilage development (GO:0051216),0.5151495695123077,1.3512167486040925,0.07840909090909091,0.6646226396126115,1.0,11/49,10.16%,PKD1;SLC39A14;FGF2;NFIB;CCN3;HES5;SULF1;RUNX2;SOX9;RUNX1;BMP4
prerank,protein polymerization (GO:0051258),0.5031630504773839,1.3506579840896853,0.08734602463605823,0.6656385884317763,1.0,16/55,20.24%,PSTPIP1;MAP7D3;FGF13;GSN;COBL;CKAP5;UBE2C;SPIRE2;TTC17;CHMP3;MICALL2;WASHC3;TRIM6;CHMP4B;CHMP4A;CORO7
prerank,sulfation (GO:0051923),0.6496698484991856,1.3504065169427983,0.11961057023643949,0.6653502848185994,1.0,2/11,2.01%,SULT1C2;SULT1C4
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),0.6406199528022106,1.3501743515554119,0.15268225584594222,0.664868267093729,1.0,4/13,14.07%,TMEM30B;TM9SF4;SEC16A;SEC16B
prerank,inorganic cation import across plasma membrane (GO:0098659),0.4865516449295832,1.3501429069383317,0.06580366774541532,0.6635423857600681,1.0,12/75,7.19%,KCNJ2;KCNJ15;SLC39A14;SLC12A7;ATP1B1;SLC12A2;SLC5A2;HCN4;TRPV3;SLC9A4;SLC9A1;SLC12A4
prerank,modulation by symbiont of entry into host (GO:0052372),-0.48028963196184804,-1.3497068996270856,0.11666666666666667,0.5206901933843432,1.0,7/16,11.08%,TRIM14;FUCA2;NECTIN2;CAV1;TRIM21;EXOC2;TRIM68
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.5792370774036973,1.3493991574403887,0.1036745406824147,0.6650971213255381,1.0,5/21,13.35%,IGFBP5;FGF2;BMPR1A;P2RY6;MEF2D
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.5111706107373991,1.349087640032759,0.08156424581005586,0.6649322146910758,1.0,15/52,17.12%,ARFGAP1;SEC31A;KDELR3;SHC1;GFPT1;LMNA;ERN2;SYVN1;HYOU1;ATP6V0D1;HSPA5;ADD1;PREB;YIF1A;SSR1
prerank,protein modification process (GO:0036211),0.48685919072050615,1.3489354434985863,0.0367170626349892,0.6641186805767775,1.0,31/76,23.96%,PLOD2;ST8SIA2;TGM5;GGCX;PRKDC;LOX;NAGPA;AKT2;WWP2;ABL1;RIPK3;LCMT1;FBXO22;ATG3;UBE2L6;PARP1;LIPT1;NTAQ1;ARAF;GNMT;FBXW2;LOXL2;CSNK1G3;STK38;UBA3;CDKL3;B4GALT7;MAN2B1;PHKA2;FBXO11;PHEX
prerank,positive regulation of neuron differentiation (GO:0045666),-0.3752242339638336,-1.3488919954129244,0.05228758169934641,0.5192042073910801,1.0,9/40,10.49%,TCF4;ZEB1;BRINP3;BRINP1;PROX1;GPRC5B;BRINP2;ARHGEF2;MMD
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.58100373917793,1.3487377844666537,0.11197916666666667,0.6635448799550732,1.0,4/20,7.92%,ADAM9;HM13;ADAM10;MBTPS1
prerank,electron transport chain (GO:0022900),0.6030733869768402,1.3479279971053169,0.14611260053619302,0.6654213086887399,1.0,5/15,10.64%,ETFRF1;ENOX2;ETFDH;ETFB;ETFA
prerank,actin filament bundle organization (GO:0061572),-0.3988111626465898,-1.3478670551453442,0.07317073170731707,0.5182267887830591,1.0,12/33,13.10%,MYO1B;PAWR;SHROOM2;EPS8;PLS3;NEDD9;BAIAP2;SHROOM1;AIF1L;RFLNA;LCP1;RFLNB
prerank,regulation of osteoblast differentiation (GO:0045667),0.4897588283871029,1.3478224897570772,0.05813953488372093,0.6644134857876857,1.0,27/82,15.41%,SMOC1;GDF10;DDR2;TWIST2;CRIM1;DDX5;SMAD6;LRP5;TWIST1;WWTR1;ATF4;ACVR1;NBR1;RUNX2;SKI;SOX9;NOG;TRPM4;TMEM119;FGFR2;BMP4;BMPR1A;NELL1;LIMD1;CCN4;IL6;HGF
prerank,sulfur compound biosynthetic process (GO:0044272),0.47710779417861904,1.3476000972537172,0.047866805411030174,0.6639224206866633,1.0,26/104,16.47%,SLC26A2;ST3GAL4;DSE;GCLC;GSTT1;BGN;PAPSS2;CHST11;CHPF2;CSPG4;GSTM5;MPST;SLC10A7;B3GNT7;B4GALT1;LIAS;B4GALT5;ST3GAL2;METTL16;MAT2B;GSTO2;SLC35B3;VCAN;AKR1A1;GSTZ1;B4GAT1
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.6339424924226602,1.3473895145798622,0.12150837988826815,0.6634033905306155,1.0,3/12,4.44%,DSE;BGN;CSPG4
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.47634046852497297,1.3468082716743888,0.04979253112033195,0.6643464875452709,1.0,18/95,9.87%,ST3GAL4;EXT1;XYLT1;GPC6;GPC3;DSE;BGN;CHST11;SDC1;CHPF2;CSPG4;SLC10A7;B3GNT7;B4GALT1;B4GALT5;ST3GAL2;ABCC5;HS6ST2
prerank,histone lysine methylation (GO:0034968),0.5349134290812695,1.3467618231133796,0.11957796014067995,0.6631335425302338,1.0,15/33,26.49%,PRDM5;WDR5;SETDB1;KMT2D;KMT2B;MEN1;WDR82;SUV39H2;DPY30;SUV39H1;KMT2A;SETDB2;SMYD2;EHMT2;TRMT112
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.5239440484929315,1.346572700429166,0.0941860465116279,0.662482910907496,1.0,18/42,25.72%,VARS1;VARS2;WARS2;HARS2;PPA2;YARS1;DARS2;YARS2;NARS2;PPA1;EPRS1;SARS2;SARS1;DARS1;CARS2;TARS2;CARS1;QARS1
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.5798513113905308,1.3463462311182315,0.12321660181582361,0.6620650987807449,1.0,4/22,4.76%,NTRK3;NTRK1;EHD1;KIDINS220
prerank,B cell proliferation (GO:0042100),-0.4584917611242078,-1.3457414339041134,0.09448818897637795,0.5199758931291413,1.0,5/17,14.92%,BCL2;CD180;CD40;CTPS1;CR2
prerank,phagolysosome assembly (GO:0001845),0.6378309096603263,1.3456127695457984,0.1337126600284495,0.6637490722100831,1.0,3/12,8.09%,RAB7B;RAB34;PLA2G5
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.5696520804849683,1.345426371418291,0.10434782608695652,0.663179754918833,1.0,7/25,13.59%,SLIT2;PRKCD;LIMK2;PFN2;CDK10;EVI5L;ARHGAP44
prerank,triglyceride metabolic process (GO:0006641),-0.3694153815851567,-1.345310836121501,0.07547169811320754,0.5176319674745754,1.0,19/48,26.72%,APOE;PLAAT3;LPGAT1;GK;MOGAT3;CAV1;LPIN2;LPL;SIRT1;GK5;DGAT2;DGAT1;FABP7;FABP5;FABP3;APOC1;LIPH;LIPC;LPIN1
prerank,cytosolic transport (GO:0016482),0.46917575638546544,1.3451603677890767,0.03684210526315789,0.6629091610226516,1.0,44/108,27.10%,VPS13A;ANKRD27;VPS13C;STX5;SNX2;DOP1B;ERC1;AP2A1;RILP;RIC1;GBF1;MON2;VPS52;TBC1D23;TRIM27;EEA1;SNX1;RGP1;VPS26A;TMEM87B;SNX32;VPS53;CLTC;TBC1D10A;SPAG9;TBC1D17;STX16;GGA1;CLN3;HEATR5A;PHETA2;PTPN23;EVI5;CORO7;DCTN1;LAMP1;VPS51;BET1L;LMTK2;VTI1B;RAB5A;RNF126;GCC2;SNX5
prerank,negative regulation of cell growth (GO:0030308),0.46846343337849866,1.345114160274431,0.03329864724245578,0.6617378733077139,1.0,28/121,17.17%,SLIT3;SLIT2;FHL1;FGF13;OSGIN2;ULK2;CCN3;PPP1R9B;ACVR1B;PRDM11;PTPRS;TGFB2;CCAR2;SMAD4;DACT3;SERTAD2;NDRG3;DCBLD2;INHBA;CGRRF1;SESN2;RBBP7;CYP27B1;SERTAD3;MINAR1;APBB1;FLCN;DIP2B
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.5860525523215316,1.3450110668711202,0.12156862745098039,0.6608012536250272,1.0,7/20,16.69%,ZC3H7A;PUM1;PRKRA;TERT;AGO1;AGO2;TSN
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.6260610984688728,1.344935991438094,0.14027777777777778,0.6597634206057489,1.0,7/13,22.04%,RHOQ;AK3;RAB23;EFL1;ENTPD7;LRRK2;MFN1
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),0.6186367247944359,1.3445889047426849,0.13991769547325103,0.6598548630107558,1.0,8/14,20.74%,CPSF4L;CPSF4;NCBP1;CPSF7;NCBP2;CPSF6;CSTF2;CSTF2T
prerank,regulation of RNA metabolic process (GO:0051252),0.4956180949334555,1.3444263258615599,0.0787139689578714,0.6591500797363445,1.0,24/59,20.27%,CLK1;HNRNPH1;AHNAK;AHNAK2;CLK3;MBNL1;FASTK;TNFRSF1B;SNRNP70;FUS;HNRNPH2;HNRNPL;MBNL2;PCBP4;PCBP2;CLK4;PTBP1;USP36;RC3H2;CLK2;BRDT;AFF2;TRA2B;HNRNPH3
prerank,positive regulation of angiogenesis (GO:0045766),0.47232651997733033,1.3435167631578429,0.04806687565308255,0.6614682091445048,1.0,20/108,10.39%,BMPER;THBS1;SMOC2;PGF;VEGFA;F3;FGF2;PTGIS;CYP1B1;TWIST1;PRKCA;RAMP2;FOXC2;ANGPTL4;JUP;PAK4;STIM1;RUNX1;ANGPT4;AGGF1
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.4960895021674189,1.34289654452962,0.07104413347685684,0.6626900737876052,1.0,36/69,29.43%,UBXN8;VCP;DNAJB14;EDEM2;FAF2;SYVN1;HSPA5;UBQLN1;RNF103-CHMP3;STUB1;USP19;FBXO17;RNF121;TRIM13;YOD1;UBE4A;NPLOC4;DNAJC18;UBXN4;UBE2G2;ECPAS;DERL1;SGTB;SELENOS;HERPUD1;TMEM67;AMFR;DNAJB12;JKAMP;SEC61B;TMUB2;SEL1L2;FAM8A1;UBE4B;STT3B;TMUB1
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),-0.4480470104017559,-1.3419723565814592,0.10377358490566038,0.5227162911880745,1.0,11/20,20.72%,SEMA6A;SEMA3D;SEMA7A;SEMA5A;SEMA4D;SEMA3G;SEMA4A;SEMA5B;SEMA4G;SEMA6D;SEMA3B
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.46736877776363883,1.3419296542835795,0.017329255861365953,0.665378278536034,1.0,12/150,2.33%,THBS1;MYOC;ESR1;EGFR;IRS1;TNFAIP8L3;GAS6;F3;FGF2;TCF7L2;FGF17;GAB2
prerank,regulation of ion transmembrane transport (GO:0034765),0.535317215783235,1.3419209641783532,0.10287081339712918,0.6640261092922459,1.0,8/33,13.93%,KCNJ2;KCNJ15;NEDD4;KCNE5;WWP2;AKAP9;YWHAE;WNK1
prerank,neutrophil activation (GO:0042119),0.6398689720452579,1.3414995876900155,0.13556851311953352,0.6643604264234865,1.0,2/12,8.83%,PRKCD;FCER1G
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.5787338942618296,1.3413627976504838,0.1423076923076923,0.6635888841609096,1.0,5/21,9.87%,EXT1;XYLT1;HS3ST4;SULF1;HS6ST2
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.540134169135975,1.3413439474965738,0.11505507955936352,0.6622921378991256,1.0,9/30,18.67%,FOXP1;DDX5;NCOR2;HEYL;RNF14;HDAC1;DAB2;HDAC6;SAFB2
prerank,photoreceptor cell development (GO:0042461),0.615906184376328,1.3411989354938605,0.13892709766162312,0.6615177428852598,1.0,2/14,3.69%,VEGFA;TOPORS
prerank,hematopoietic stem cell proliferation (GO:0071425),-0.5365081847045795,-1.341010553407063,0.14376996805111822,0.5217675397798007,1.0,7/11,21.94%,MECOM;WNT5A;CD34;ETV6;YJEFN3;WNT10B;WNT2B
prerank,cell projection assembly (GO:0030031),0.5763291092233344,1.3408471436235119,0.1329923273657289,0.6615379168255603,1.0,6/22,15.17%,RHOJ;GSN;RHOQ;CYFIP1;PARVA;SCIN
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.5072505328635228,1.3403801932182384,0.09703196347031963,0.6621528899090815,1.0,10/48,11.54%,MYOC;P4HB;CUX1;FBXW8;ILK;S100A10;PRKDC;DOCK5;ABL1;NRP1
prerank,metanephros development (GO:0001656),0.5613477152864502,1.3402199644999306,0.1214017521902378,0.6614388129344057,1.0,4/26,4.30%,SIX1;PKD1;FOXD1;SIX4
prerank,lamellipodium assembly (GO:0030032),-0.4204095040688514,-1.339744010269756,0.07211538461538461,0.5215437519281849,1.0,11/26,8.81%,ABLIM1;CDH13;KIT;CCDC88A;PARVB;PTPRO;S1PR1;WHAMM;SPATA13;ARHGEF6;SPEF1
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),-0.2994974951870884,-1.3396035152126387,0.0,0.5184709083922554,1.0,33/138,9.43%,FLT1;IGF1R;PTPRG;MTSS1;INSR;LYN;PTN;TEK;KIT;EPHA4;EPHA7;TIE1;IL31RA;KDR;FRS2;NEDD9;PTPRD;PDGFRB;MPZL1;EPHA8;BDKRB2;EPHA6;ERBB4;ROR2;PDGFRA;MERTK;FGFR4;CSF1;FLT4;NPR1;BMPR2;LIFR;ANGPTL1
prerank,cellular response to copper ion (GO:0071280),-0.48498988817487454,-1.339579084837155,0.12452830188679245,0.5152389101531106,1.0,10/16,18.03%,MT1X;MT1A;MT1H;MT1B;MT1G;MT1M;MT1F;MT1E;SNCA;MT3
prerank,positive regulation of protein import into nucleus (GO:0042307),0.5540546931923531,1.3387279015660087,0.11179361179361179,0.6663497926478078,1.0,8/28,10.20%,PRKCD;IPO5;BAG3;TRIM28;MAVS;JUP;ZIC1;UBR5
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),0.573410767820114,1.3378900141495587,0.12692307692307692,0.6683721948536182,1.0,13/24,26.12%,FLVCR1;FXN;RSAD1;SUCLA2;NFE2L1;HMBS;ABCB6;FECH;UROS;SLC25A38;ABCB10;ABCG2;COX15
prerank,brain morphogenesis (GO:0048854),-0.5397512903174757,-1.3378748365868036,0.13448275862068965,0.5157217432157856,1.0,2/12,4.03%,SHANK3;CTNNA2
prerank,regulation of heart contraction (GO:0008016),-0.3219160443764585,-1.3377089010164858,0.0,0.5128698199940086,1.0,21/90,11.79%,ATP1A2;ITPR1;ATP1B3;CELF2;PDE4D;SLC8A1;RYR2;TPM1;ITPR3;ABCC9;ATP2B1;SLC8A3;ATP1B2;KCNJ12;ATP2A3;DES;NPR1;ITPR2;TBX2;NOS1;ACE2
prerank,cellular response to hormone stimulus (GO:0032870),0.4882137545117278,1.3375811972746936,0.06659267480577137,0.6682947843284364,1.0,14/69,10.84%,SLIT3;SLIT2;GHR;RDX;STAT3;RAMP2;BCAS3;RARA;SRA1;SOCS2;AKR1C1;SFR1;RAMP1;URI1
prerank,regulation of cell differentiation (GO:0045595),0.4664967076987718,1.3374166901893731,0.027663934426229508,0.6676917966212507,1.0,30/148,13.64%,SIX1;SMOC1;ID2;ZFHX3;DDX5;TIAM1;DDX17;PHLDB1;HES5;ATF4;TCFL5;MBOAT2;FGFR1;RUNX2;EDN3;RAF1;PA2G4;CDK5RAP3;RUNX1;FGFR2;ANP32B;FADS1;NR1D2;SMAD7;TGFBR1;SRF;HEY1;PDCD2;NLGN1;PTBP1
prerank,embryonic organ morphogenesis (GO:0048562),0.5205475506942749,1.3374081902467791,0.09142212189616253,0.6663840582998146,1.0,12/42,16.35%,SIX1;ID2;MFAP5;HOXA3;HOXB3;ACVR1;HOXA9;FGFR2;HOXB4;HOXA4;FUZ;NIPBL
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.5046984417271613,1.3369840561317239,0.09644087256027555,0.6654070373818124,1.0,30/50,30.44%,NUP93;SEC13;RAE1;PUM1;SEH1L;AGO1;NUP37;AGO2;EIF4G1;RANBP2;NUP88;POLR2F;NUP210;POM121;NUP62;POLR2B;NDC1;NUP35;IPO8;H3-3A;NUP85;POLR2H;TPR;NUP160;TNRC6A;POLR2I;PUM2;POLR2L;NUP188;NUP50
prerank,regulation of gene silencing by RNA (GO:0060966),0.5046984417271613,1.3369840561317239,0.09644087256027555,0.6654070373818124,1.0,30/50,30.44%,NUP93;SEC13;RAE1;PUM1;SEH1L;AGO1;NUP37;AGO2;EIF4G1;RANBP2;NUP88;POLR2F;NUP210;POM121;NUP62;POLR2B;NDC1;NUP35;IPO8;H3-3A;NUP85;POLR2H;TPR;NUP160;TNRC6A;POLR2I;PUM2;POLR2L;NUP188;NUP50
prerank,endoplasmic reticulum organization (GO:0007029),0.4841415543811582,1.3368714533286234,0.07883369330453564,0.6645267188589628,1.0,30/72,22.65%,SEC31A;MAPK15;STX5;ATL2;SEC61A1;LMAN2L;DOP1B;SMPD4;TLE6;ATL3;TRAM2;LPCAT3;ALDH3A2;SEC16A;REEP3;SEC16B;LMAN2;MIA3;STX1A;BNIP1;HMOX1;TMEM170A;TMEM33;REEP5;LRRK2;LMAN1;ATL1;EIF2AK3;SHTN1;RAB18
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.585267711475621,1.336574165512099,0.1291139240506329,0.664415769335717,1.0,5/22,5.54%,ADAM9;TIMP2;PTPN3;TIMP3;TNFRSF1B
prerank,cellular response to sterol (GO:0036315),0.6319296210244696,1.33619522592771,0.11549295774647887,0.6647305388764294,1.0,6/13,13.79%,LRP6;GRAMD1A;OSBPL7;RORA;SMO;GRAMD1C
prerank,protein K11-linked ubiquitination (GO:0070979),0.5473413762872762,1.3360299556989483,0.11895910780669144,0.6640750851350048,1.0,16/27,31.63%,ANAPC5;CDC16;UBE2B;UBE2C;ANAPC4;ANAPC2;ANAPC1;ANAPC10;CDC27;RNF4;UBE2W;ANAPC11;UBE2S;UBE2H;PRKN;UBE2A
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.5031184525743424,1.335862765518658,0.09578107183580388,0.663450224970124,1.0,5/48,6.84%,SLIT3;SLIT2;GAS6;CARD16;IRAK3
prerank,ERAD pathway (GO:0036503),0.4824371002454769,1.3349829359812613,0.06878306878306878,0.6658148637368821,1.0,42/83,29.43%,UBXN8;VCP;DNAJB14;FAF2;SYVN1;UGGT2;UGGT1;HSPA5;UBQLN1;RNF103-CHMP3;STUB1;USP13;USP19;FBXO17;RNF121;TRIM13;YOD1;UBE4A;NPLOC4;DNAJC18;ERLEC1;UBXN4;RCN3;UBE2G2;ECPAS;DERL1;SGTB;SELENOS;HERPUD1;TMEM67;AMFR;DNAJB12;GET4;JKAMP;SEC61B;TMUB2;SEL1L2;CCDC47;FAM8A1;UBE4B;STT3B;TMUB1
prerank,protein homooligomerization (GO:0051260),0.46644538908151084,1.3345342821142263,0.04639175257731959,0.6663213503780804,1.0,32/114,20.73%,SCARA5;KCNJ2;PRMT8;MPP2;EHD1;TRMT61B;ATL2;ARC;SLC1A5;ADCY8;ATL3;FUS;CRYZ;DISP1;TRPM4;C9;SPAST;CBR4;CLYBL;ACACA;LETM1;G3BP2;MICU1;PKD2L1;ACOT13;SHMT2;GNMT;SHMT1;TK1;APPL2;PDCD6IP;IKZF4
prerank,import into nucleus (GO:0051170),0.48001084159352986,1.3343316454504974,0.07667386609071274,0.6657295144090152,1.0,31/73,26.43%,NUP93;PRICKLE1;SEC13;IPO5;STAT3;IPO4;E2F3;HIKESHI;IPO13;SNUPN;GEMIN7;TNPO2;NUP88;SMN1;TNPO1;POM121;AKT1;IPO9;APPL2;APPL1;NUP62;PPP1R10;GEMIN2;SNRPB;HNRNPA1;TSC2;IPO8;DDX20;NUTF2;NUP85;TPR
prerank,sensory organ development (GO:0007423),0.49946937836560334,1.3338199392303558,0.09786276715410573,0.6664680513900285,1.0,17/51,20.09%,SMOC1;CHRDL1;PBX3;ECE1;TGFB2;SIX4;PBX1;MEIS3;SH3PXD2B;CPAMD8;ZDHHC16;BLOC1S3;SIPA1L3;MAB21L2;MYO7A;HIPK2;ATF6
prerank,negative regulation of lipid storage (GO:0010888),-0.44071433889698375,-1.3337045703363788,0.10126582278481013,0.5193055631214827,1.0,6/19,6.89%,OSBPL8;PPARA;ABCG1;NR1H3;ABHD5;PPARD
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.4222335356342003,-1.3336338946244644,0.07653061224489796,0.5162921487174432,1.0,7/23,9.55%,UACA;BMP7;DDX3X;C1QTNF3;TMSB4X;ADIPOR1;ZC3H12A
prerank,cellular potassium ion homeostasis (GO:0030007),0.6169373731412295,1.3332455006712536,0.13440860215053763,0.6674726988027017,1.0,3/13,1.24%,KCNJ2;ATP1B1;SLC12A2
prerank,RNA splicing (GO:0008380),0.47086058250221613,1.3331741789969216,0.05795574288724974,0.6664260350203248,1.0,40/95,25.41%,PPP1R9B;NOL3;MBNL1;SRSF2;CCAR2;SNRNP48;FUS;YJU2;SRSF11;CELF3;LUC7L3;CDK12;SF3B2;SF3B1;U2AF1;SRRM1;SNRNP25;SFPQ;ZRSR2;PTBP1;HNRNPC;SRPK1;SCNM1;NCBP1;WDR83;NCBP2;SYNCRIP;SRSF10;SRSF7;TRA2B;HNRNPH3;DHX8;GEMIN2;SNRPB;SRSF4;DHX16;PPIG;SNRNP35;PPP2CA;DDX39B
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.6432010232548299,1.3325960721183912,0.13598901098901098,0.6673992166356713,1.0,2/13,1.74%,NEDD4;EMILIN1
prerank,negative regulation of signal transduction (GO:0009968),0.4506394117099693,1.3322115779996035,0.009027081243731194,0.6677569795206176,1.0,37/249,9.83%,THBS1;EGFR;IRS1;PID1;TRABD2B;IGFBP5;NTN1;PRKCD;LRP1;FGF2;SFRP4;GPC3;NEDD4;EMILIN1;UBASH3B;GRB10;NXN;GLIS2;DKK3;LRPAP1;CSNK2A1;CSNK2A2;CARD16;XDH;VCP;ACVR1;DACT1;SULF1;MMP14;IRAK3;DACT3;NOG;TSKU;NFATC1;PTPN18;WWP2;PIP4K2B
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.6273240408182891,1.3318017077669988,0.14500683994528044,0.6680348304504227,1.0,4/14,11.98%,CARD14;TNFSF15;IRAK1;TNFRSF10B
prerank,sodium ion transport (GO:0006814),0.481179184046839,1.3312962017589458,0.06421052631578947,0.6687719113745383,1.0,14/85,6.76%,SLC4A4;SLC23A1;SLC5A6;ATP1B1;FGF13;SLC12A2;SLC24A3;SLC5A2;HCN4;SLC9B2;SLC4A8;SLC6A2;SLC4A11;SCN11A
prerank,negative regulation of cellular component movement (GO:0051271),-0.49189258301638217,-1.330212828227526,0.16115702479338842,0.5215052361647904,1.0,4/15,3.22%,TGFBR3;FRMD5;FBLN1;SPOCK3
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.5879169753111383,1.3301681764591657,0.14104193138500634,0.6719361395665927,1.0,9/17,26.66%,HM13;VCP;FAF2;SYVN1;NPLOC4;DERL1;SELENOS;HERPUD1;SEC61B
prerank,protein transport (GO:0015031),0.4497798217425793,1.3300831212034172,0.006,0.6709866791693855,1.0,124/332,23.69%,SGSM2;LTBP2;LRP1;NECAB3;ARFGAP3;SEC31A;CTTN;ATP6V1C2;KIF13A;EHD1;TBC1D8B;TBC1D2B;STX5;SEC13;ARCN1;LMAN2L;RAB34;RAB43;TCIRG1;COPA;RAB24;RAMP2;AP2A1;STX11;COPG1;RILP;LRSAM1;DNM2;RAB21;SLC10A7;ATP6V0A1;RIC1;GGA2;RAB8A;TLK1;HIKESHI;COPZ2;ARF4;GOLGA4;MON1A;SNX1;SCFD1;NSF;STX2;VPS26A;ARFIP2;RAB38;RAMP1;ABCA1;ARF1;ATP6V0D1;SNX9;AP3D1;RAB3D;USO1;WDR11;EVI5L;TMED9;ERP29;TBC1D9B;PICK1;LRP2;TBC1D25;TOM1;ATP6V1B2;CHMP3;RAB11B;CLTC;VIPAS39;PREB;RAB23;TMEM167A;ATP6V1E1;TBCK;COPB2;MIA3;SIL1;STX4;TBC1D10A;RAB3B;STX1A;SCFD2;HDAC6;TBC1D17;STX16;SCAMP2;SPTBN1;GGA1;TANGO6;SNX13;TMED2;NAPA;GOLPH3;RAB5B;BLZF1;SNX15;RAB3GAP2;SEC23IP;STEAP3;VPS45;ATP6V1C1;NEURL1B;RCN3;EVI5;MIA2;SCAMP3;TBC1D22B;CLU;LAMP2;OPTN;VPS26C;RAB1A;IFT27;ZG16;NDC1;RAB18;COPZ1;SNX4;RABGAP1;RAB1B;AP3B1;SCAMP1;TMED7;VAMP4
prerank,respiratory tube development (GO:0030323),0.5511316065331591,1.329422574491692,0.10960591133004927,0.6723952687255349,1.0,7/28,10.16%,VEGFA;PCSK5;FGF2;GLI2;CCDC39;FGFR2;BMP4
prerank,regulation of lipid kinase activity (GO:0043550),-0.5365020620759638,-1.3293905190700257,0.14121037463976946,0.5203390417428976,1.0,3/11,4.55%,PIK3R1;WDR91;RB1
prerank,regulation of protein kinase activity (GO:0045859),0.46464564197940317,1.3290299561607037,0.04672897196261682,0.672641957284322,1.0,29/106,20.13%,RASSF2;LRP6;PLCE1;GAS6;DDR2;UBASH3B;CAMKK1;WWTR1;DVL1;TRIM27;AKT1S1;PAK2;TAB2;SNX9;PDPK1;SOD1;DEPTOR;CHP1;MAPRE3;GSKIP;CAMK2N1;IQGAP1;NF1;PRKAG1;AKT1;XRCC6;RTRAF;DUSP19;MAP2K3
prerank,metal ion export (GO:0070839),0.5422959964726803,1.3288836120596952,0.09843937575030012,0.6719003350801076,1.0,6/31,6.92%,SLC4A4;KCNK5;ATP1B1;KCNE5;SLC9A1;KCNIP2
prerank,regulation of protein import into nucleus (GO:0042306),0.5245682565938158,1.3285360067724845,0.12232779097387174,0.6719960163146766,1.0,14/36,18.13%,PRKCD;MDFIC;IPO5;BAG3;TRIM28;MAVS;JUP;ZIC1;BMP4;UBR5;CHP1;RAB23;SUFU;RBM22
prerank,reverse cholesterol transport (GO:0043691),-0.49809013440675376,-1.3279618685359689,0.15807560137457044,0.5206935035014544,1.0,4/13,11.38%,APOE;ABCG1;ABCA5;SCARB1
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.6501922463084588,1.327692985535112,0.17011834319526628,0.6741569403634015,1.0,4/10,16.70%,ESR1;HMGB1;PSMC5;PSMC4
prerank,camera-type eye development (GO:0043010),0.5532728623773359,1.3274785393579513,0.11945812807881774,0.6737291144991328,1.0,7/25,8.83%,CACNA1C;VEGFA;CYP1B1;HES5;RAB3GAP1;SKI;TSKU
prerank,polyol metabolic process (GO:0019751),-0.36859321676248274,-1.327154339336879,0.056451612903225805,0.5194672385195468,1.0,11/46,8.88%,PLCB1;INPP4B;ITPKB;INPP5D;ISYNA1;NUDT4;PLCB4;PLCH1;SLC5A3;IP6K2;PLCD1
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),0.5386020448220535,1.3265300297639409,0.12939698492462312,0.6762055946290824,1.0,6/29,8.68%,PKD1;GHR;STAT5A;STAT3;SOCS6;SOCS2
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.47645343624916126,1.3259665024750786,0.06468716861081654,0.6772316967321944,1.0,43/84,25.34%,SRSF6;DDX5;DDX17;RBFOX2;MBNL1;RBM39;CELF4;THRAP3;CELF3;HNRNPL;MBNL2;RBM25;PCBP4;DAZAP1;RBM5;METTL16;KHDRBS1;PTBP1;RBM4;SRPK1;U2AF2;HNRNPK;YTHDC1;SRSF3;ZC3H10;NCBP1;SRSF10;SRSF7;TRA2B;RBMXL1;LARP7;TRA2A;CIRBP;SAP18;SFSWAP;FXR2;SRSF4;HNRNPA1;SF1;HNRNPU;RBM3;RBM24;C1QBP
prerank,regulation of monocyte chemotaxis (GO:0090025),0.5588198511171781,1.325764749930399,0.1415929203539823,0.6767889280124831,1.0,3/24,6.52%,SLIT2;CCN3;HMGB1
prerank,regulation of protein sumoylation (GO:0033233),0.6021077283385443,1.3253641970379941,0.1461836998706339,0.6772492445932324,1.0,7/17,21.56%,ZMIZ1;GNL3;HDAC4;PIAS4;RWDD3;SAE1;MUL1
prerank,regulation of membrane depolarization (GO:0003254),0.5891950523376556,1.324867150182285,0.13766233766233765,0.6780611726301002,1.0,4/18,3.50%,FHL1;PTPN3;HCN4;CAMK2D
prerank,amino acid transport (GO:0006865),0.5037534131265474,1.323460366853484,0.09263392857142858,0.6824675149341145,1.0,7/49,7.63%,SLC38A2;SLC38A1;SLC38A6;SLC1A5;SLC38A3;SLC7A10;SLC43A1
prerank,response to lipid (GO:0033993),0.4641540039817914,1.3233900899997082,0.05399792315680166,0.6814929626083783,1.0,23/105,15.34%,ESR1;FOXP1;ALPL;LBP;SMAD6;CYP19A1;RXRA;STAT3;RXRB;IRAK3;LIAS;SOX9;RARA;SOCS2;ANXA1;FOXA1;TAB2;IRAK1;F2R;SRR;PRDX3;CYP27B1;FOXO3
prerank,response to UV-A (GO:0070141),0.6215745185852858,1.3232967882230664,0.14603616133518776,0.6805999839623637,1.0,1/14,0.30%,EGFR
prerank,positive regulation of intracellular protein transport (GO:0090316),0.459844208216083,1.3229779849178316,0.030425963488843813,0.6806316653143885,1.0,44/144,18.56%,PRKCD;KCNB1;GAS6;TMEM30B;TCF7L2;ABLIM3;IPO5;CSNK2A2;TM9SF4;C2CD5;BAG3;TRIM28;BCAS3;MAVS;MIEF2;JUP;HUWE1;FZD5;AKT2;ZIC1;PPP3CC;MAPK8;UBR5;ANP32B;XPO4;TENM1;CHP1;YWHAE;SEC16A;USP36;SEC16B;HPS4;TFDP1;PCM1;MICALL2;YWHAQ;ERBB2;E2F1;VPS11;RBM22;NPEPPS;KIF20B;SAE1;BID
prerank,regulation of cell projection organization (GO:0031344),-0.5074731866749137,-1.3226857849385425,0.1482889733840304,0.5272036045440125,1.0,5/13,12.55%,NTNG1;MACF1;MFSD2A;SEMA4D;ERMN
prerank,negative regulation of protein localization to membrane (GO:1905476),0.5434308935344262,1.321937323716552,0.14536340852130325,0.6835731677670092,1.0,7/24,17.25%,PID1;RHOQ;GDI1;PPFIA1;CLTC;DAB2;LZTFL1
prerank,natural killer cell mediated immunity (GO:0002228),0.6024324515906923,1.3205107269311744,0.13877551020408163,0.6879708769850053,1.0,3/15,8.96%,KLRK1;RAET1E;PLEKHM2
prerank,cytoplasmic translational initiation (GO:0002183),0.5927916439192484,1.3204470584845944,0.14172185430463577,0.6869385881593255,1.0,13/17,32.58%,EIF4A2;EIF4A1;DHX29;EIF4G1;RBM4;EIF2S2;EIF3D;EIF3A;EIF4B;EIF4H;EIF3M;EIF3I;EIF2D
prerank,negative regulation of cellular biosynthetic process (GO:0031327),-0.3569963163082063,-1.3200646426015976,0.056910569105691054,0.5305956266713397,1.0,18/47,21.85%,ROCK2;WNT4;RAPGEF2;PROX1;C1QTNF3;ZC3H12A;CAV1;PLEK;CEACAM1;CD34;SIRPA;BRCA1;C1QTNF12;GLA;ERLIN2;TRIB3;SIK1;EP300
prerank,smooth muscle tissue development (GO:0048745),-0.5447086316740025,-1.3199206854802312,0.13712374581939799,0.5277481708913807,1.0,4/10,5.78%,ENG;MYLK;PTCH1;PROX1
prerank,secondary palate development (GO:0062009),-0.49421213862459634,-1.319874293144216,0.13076923076923078,0.5246788835238786,1.0,4/14,2.15%,TGFBR3;LEF1;CHD7;WNT5A
prerank,negative regulation of autophagosome assembly (GO:1902902),0.6281481266580551,1.3194897232955518,0.15142857142857144,0.6895599868259452,1.0,10/13,25.17%,TMEM39A;SCFD1;PHF23;SEC22B;CHMP4B;CHMP4A;LRRK2;MTM1;SMCR8;PINK1
prerank,positive regulation of cell division (GO:0051781),0.5154742697948554,1.3191059479993859,0.1068075117370892,0.6899162885551,1.0,13/38,14.97%,CIT;PRKCE;CDC14A;GIPC1;CDC6;RHOA;PKN2;FGFR2;SPAST;CDC25B;OPN1MW;CSPP1;SIRT2
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.6412761228285454,1.318014638617979,0.13623595505617977,0.693093919689213,1.0,4/11,13.27%,ZMIZ1;ELOF1;SERTAD2;ZMIZ2
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.48992010824996446,-1.317755009202632,0.1039426523297491,0.526507648269098,1.0,7/16,13.52%,PDGFD;PLAT;PDGFRB;PDGFRA;PDGFC;PIK3C2A;PTPN1
prerank,regulation of macroautophagy (GO:0016241),0.4719481794398155,1.3169566942030744,0.055150884495317375,0.6962615203536942,1.0,53/105,27.36%,NEDD4;ATP6V1C2;EXOC4;SESN3;LZTS1;NRBP2;ATP6V0A1;LAMTOR1;QSOX1;CLEC16A;MAPK8;SMG1;VPS26A;ATP6V0D1;SESN2;SNX32;PAFAH1B2;TBC1D25;UBQLN1;ATP6V1B2;USP36;ATP6V1E1;HDAC6;TRIM13;PRKAG1;CLN3;RB1CC1;AKT1;ATP6V1C1;PRKAB1;CDK5;RHEB;UCHL1;LRRK2;PRKACA;IL4;CAPNS1;RUFY4;RPTOR;TSC2;SMCR8;ATP6V0E1;TBK1;PINK1;ATP6V0B;EXOC7;GPSM1;ATG13;LAMTOR2;CAPN1;SNX5;LAMTOR3;ERN1
prerank,presynaptic endocytosis (GO:0140238),0.5436052799896789,1.3168859833000117,0.1482889733840304,0.6952364534740971,1.0,10/24,20.44%,STON2;SYT8;CEL;FCHO2;STON1;SYNJ1;NLGN1;STX1A;CDK5;SYNJ2
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.6478261583024342,1.316688003814979,0.16228070175438597,0.6947668933357273,1.0,2/10,1.87%,PID1;GRB10
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",0.5564915729093691,1.3165102787367573,0.14713216957605985,0.6942172279737818,1.0,8/22,17.09%,EDEM3;EDEM2;SYVN1;UGGT2;UGGT1;RPS27A;UBC;TRIM13
prerank,ribonucleoprotein complex assembly (GO:0022618),0.44946926965484296,1.3156579515363187,0.043209876543209874,0.6964623256677008,1.0,37/132,18.04%,SRSF6;RPSA;KHDC4;LUC7L2;SRSF1;NOL3;SRSF5;CELF4;RRS1;PRKDC;RRP7A;LUC7L;CELF3;LUC7L3;NLE1;SF3B1;RBM5;CRNKL1;DHX29;XAB2;SNUPN;ZRSR2;GEMIN7;SRPK1;CLP1;EIF2S2;YTHDC1;PPAN;ISY1;EIF6;EIF3A;SMN1;NCBP1;BOP1;CPSF7;CPSF6;SRSF10
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.5890672059048755,1.315441833355694,0.14419225634178906,0.6960728015999681,1.0,3/17,1.13%,SLIT2;VEGFA;FGF2
prerank,positive regulation of RNA metabolic process (GO:0051254),0.5052387812214373,1.315301968549217,0.11757990867579908,0.6953998226423401,1.0,3/45,1.59%,SLC38A2;EGFR;DDX5
prerank,receptor signaling pathway via STAT (GO:0097696),0.551149101815102,1.3146961756315958,0.13682864450127877,0.6966442191519676,1.0,6/25,8.68%,PKD1;GHR;STAT5A;STAT3;SOCS6;SOCS2
prerank,positive regulation of protein export from nucleus (GO:0046827),0.6092943662757777,1.3143958966801177,0.15424164524421594,0.6966233039112082,1.0,10/15,26.43%,GAS6;TCF7L2;BAG3;ANP32B;XPO4;YWHAE;RBM22;CAMK1;TP53;TPR
prerank,fatty acid oxidation (GO:0019395),0.48637664775209166,1.3138803891069633,0.09444444444444444,0.6973880446456708,1.0,18/57,22.89%,ABCD3;EHHADH;ECHDC2;ECI2;ADIPOR2;PEX13;AUH;ACAT1;ALDH3A2;BDH2;HACL1;SLC27A2;PHYH;PEX2;ECHDC1;ABCD1;MCAT;HADHA
prerank,regulation of chromatin organization (GO:1902275),0.6133791593198562,1.313799529256539,0.1510989010989011,0.6964127570231291,1.0,10/14,27.86%,TLK1;SETD5;TLK2;MLLT3;SSRP1;SETD1A;HNRNPU;PARG;IGF2;CDK9
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.5040369644962942,1.3134792184099569,0.1267605633802817,0.6963960476370868,1.0,22/41,30.44%,NUP93;SEC13;RAE1;SEH1L;OGT;NUP37;RANBP2;NUP88;EIF6;PRKAG1;NUP210;POM121;NUP62;NDC1;NUP35;SCARB2;NUP85;TPR;NUP160;ZBTB7A;NUP188;NUP50
prerank,regulation of epithelial cell differentiation (GO:0030856),-0.45842496636694297,-1.31321197106784,0.12556053811659193,0.5344699679823033,1.0,9/17,19.56%,OSR1;AJAP1;APOLD1;CAV1;CEACAM1;PRKX;MAFF;DSPP;DLL1
prerank,negative regulation of double-strand break repair (GO:2000780),0.534290044414314,1.3130304167825806,0.1354292623941959,0.696983185519906,1.0,18/30,33.29%,HELB;TWIST1;RMI2;OTUB1;OGG1;UBR5;OTUB2;TFIP11;MAD2L2;FBH1;CGAS;SHLD3;SHLD1;HSF1;TRIP12;PARPBP;ERCC6;POLQ
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.6322224076121573,1.3130165140261454,0.16073968705547653,0.6957637825199571,1.0,4/12,14.83%,P4HB;SOAT1;LPCAT3;ACSL3
prerank,peptidyl-lysine monomethylation (GO:0018026),0.6492633381949896,1.312728382086078,0.1476608187134503,0.6956663148963959,1.0,7/10,25.99%,KMT5A;EHMT1;EEF1AKMT2;SETD4;SETD2;SMYD2;SETD7
prerank,regulation of protein localization to membrane (GO:1905475),0.5414384426913342,1.3125692711576487,0.12640801001251564,0.6950960916246853,1.0,12/28,25.77%,GPC6;GSN;GPC3;MMP14;SPTBN1;CLN3;CDK5;APPL1;CRIPT;GPC1;GPC4;VTI1B
prerank,regulation of peptide hormone secretion (GO:0090276),-0.3322480362751352,-1.3124397439322002,0.03529411764705882,0.5330383466309038,1.0,12/67,7.83%,ITPR1;RAPGEF4;CHD7;RAPGEF3;SLC2A1;DPP4;CACNA1D;CACNA1E;ITPR3;ADRA2A;HTR2C;KCNC2
prerank,proteolysis (GO:0006508),0.4421952336641078,1.312252900626506,0.018090452261306532,0.6951200713904836,1.0,69/252,23.96%,ADAMTS3;CAPN5;HTRA3;BMP1;TRABD2B;PCSK5;F3;HTRA4;HTRA1;ECE1;PRSS38;FAP;CPZ;HM13;CPQ;MMP14;SPG7;ADAM10;PM20D2;BACE2;TASP1;CLPP;XPNPEP1;MBTPS1;CAPN10;CAPN2;OGT;DDI2;BACE1;SDE2;FBXO3;PSMA6;CASP1;LONP1;MMP16;NLN;CPXM2;LNPEP;PSEN2;LAP3;CAPN15;HGF;DPP8;IDE;PSMC4;SUFU;PCSK7;CLN3;NAPSA;NPEPPS;CTSZ;LVRN;FBXW2;MMP2;CPB2;CTSB;CTSK;RNPEPL1;SENP1;UBA3;SENP6;CTSO;CAPN6;DESI2;DESI1;AFG3L2;SPPL2A;ADAMTS9;PHEX
prerank,positive regulation of neutrophil migration (GO:1902624),-0.447696594438853,-1.31222361463676,0.13135593220338984,0.5304158063208337,1.0,4/18,4.65%,RIPOR2;CAMK1D;DNM1L;DAPK2
prerank,regulation of mRNA metabolic process (GO:1903311),0.6409732630283639,1.3116190821343447,0.15826330532212884,0.6965436400253062,1.0,5/11,18.67%,SAFB;SLTM;SRPK1;NCBP1;SAFB2
prerank,regulation of cell-matrix adhesion (GO:0001952),0.4832321833617932,1.3115658043496305,0.11074918566775244,0.6955242944074709,1.0,11/64,8.97%,THBS1;MYOC;EFNA5;LDB1;PKHD1;CD3E;SEMA3E;JAG1;SLC9A1;JUP;RHOA
prerank,acute inflammatory response (GO:0002526),0.5548051767562872,1.311480756667741,0.1357409713574097,0.6946260575378383,1.0,2/23,1.08%,LBP;F3
prerank,phagosome-lysosome fusion (GO:0090385),0.6517026723506981,1.3113914018945036,0.1619190404797601,0.6937220472319505,1.0,4/10,17.93%,RAB7B;RAB34;PLA2G5;CLN3
prerank,positive regulation of tissue remodeling (GO:0034105),-0.5259746422244291,-1.3113071625581447,0.15862068965517243,0.5294625953645985,1.0,1/10,0.70%,ROCK2
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.4856687465264221,1.311228602586608,0.10485651214128035,0.6931632917057887,1.0,22/63,21.35%,THBS1;TCF7L2;NOL3;ACVR1;FGFR1;TMC8;PAK2;ITGAV;LTBR;BMP4;MADD;PHIP;TNFRSF10B;DEPTOR;TGFBR1;STX4;BIRC6;BID;ZMYND11;SH3RF1;BCL2L12;IL4
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.5004501345764798,1.311111904059008,0.12009237875288684,0.6924286681113617,1.0,13/43,15.34%,FGF2;NFIB;DDX5;GNL3;STAT3;KLF5;TGFB2;SOX9;BMP4;TERT;SRF;NFATC3;FOXO3
prerank,positive regulation of RNA splicing (GO:0033120),0.5348741319916148,1.3109811220837246,0.12066905615292713,0.69170206286818,1.0,12/29,20.85%,SLC38A2;CELF4;THRAP3;CELF3;DAZAP1;U2AF2;NCBP1;RBM22;TRA2B;RBMXL1;TRA2A;CIRBP
prerank,inositol phosphate-mediated signaling (GO:0048016),0.5761616495546616,1.3103767606456531,0.15072083879423329,0.6929026423145747,1.0,8/19,19.95%,PLCE1;NFAT5;EDN3;NFATC1;PPP3CC;NFATC3;NMUR1;NFATC4
prerank,regulation of spindle organization (GO:0090224),0.5845782693477022,1.310043769767445,0.15057915057915058,0.6930284506368825,1.0,8/18,22.70%,PARP3;RAE1;DYNC1H1;CLTC;DCTN1;NUP62;RNF4;SENP6
prerank,response to purine-containing compound (GO:0014074),-0.4533245910838948,-1.3098590211796508,0.1308016877637131,0.5298000300508651,1.0,4/17,3.91%,STAT1;RYR2;TRPC3;ABCC9
prerank,negative regulation of phosphorylation (GO:0042326),0.4610191958095646,1.30860617666501,0.08130939809926083,0.6976813817665147,1.0,19/85,12.95%,SLIT2;LRP6;PID1;NTRK3;PLPP3;EPHB2;HDAC4;WWTR1;XDH;ACTN3;PRKDC;CDK5RAP3;IMPACT;BMP4;PAQR3;NIBAN1;GIT1;CHP1;INHBA
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.4631410315994549,1.3084987388719398,0.07061266874350987,0.6968579960422303,1.0,40/100,25.47%,RNF144A;XPO1;PRICKLE1;GLMN;FHIT;CSNK1D;COP1;VCP;DVL1;CCAR2;GIPC1;OGT;FBXO22;RNF14;SMAD7;CSNK1E;USP7;DAB2;SIRT2;STUB1;DDA1;TLK2;N4BP1;SUMO1;ARAF;UFL1;RYBP;HECTD1;UCHL5;LRRK2;CLU;USP5;SUMO2;DESI1;DET1;TAF1;HERPUD1;BBS7;CAMLG;RCHY1
prerank,sodium ion import across plasma membrane (GO:0098719),0.5757169021415809,1.3084226051902648,0.15953307392996108,0.6959166661017064,1.0,6/17,8.80%,SLC12A2;SLC5A2;HCN4;SLC9A4;SLC9A1;TRPM4
prerank,histone H4 deacetylation (GO:0070933),0.6518636720199672,1.3078108312255494,0.16546762589928057,0.6971718479467094,1.0,5/10,17.77%,HDAC9;HDAC4;HDAC1;SIRT2;SMARCAD1
prerank,gland development (GO:0048732),0.48198202655824895,1.3074973700654888,0.10869565217391304,0.6971933233125815,1.0,16/59,12.87%,SIX1;IGSF3;GLI2;TGFB3;DKK3;COBL;EPHB3;PRKCSH;SOX9;CDK5RAP3;ANXA1;FGFR2;RIPK3;SOD1;TGFBR1;EZR
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.4414222913663125,1.3065498925895354,0.011,0.6998280136589692,1.0,105/264,25.78%,SRSF6;DDX5;DDX17;HNRNPH1;SRSF1;PABPC1;SRSF5;CELF4;SRSF2;CASC3;SNRNP48;SNRNP70;FUS;PRPF40B;HNRNPA2B1;SRSF11;CHERP;SYMPK;RAVER2;HNRNPH2;HNRNPL;SF3B2;SF3B1;SF3A1;RBM10;PNN;PPIL3;GTF2F1;U2AF1;SRRM1;RBM6;SNRNP25;RBM5;PABPN1;CRNKL1;SFPQ;XAB2;SNUPN;CWF19L1;HNRNPM;PCBP2;LSM2;ZRSR2;PTBP1;GEMIN7;RBM4;RALY;HNRNPC;RBM17;SRPK1;U2AF2;HNRNPK;CLP1;CPSF4;YTHDC1;POLR2F;TFIP11;SRSF3;SCNM1;PCF11;ISY1;SMN1;IK;NCBP1;WDR83;SNRPA;CPSF7;NCBP2;SYNCRIP;SRSF10;SRSF7;RBM22;CWC25;AQR;U2SURP;MTREX;TRA2B;CSTF2;HNRNPH3;ZCCHC8;TRA2A;CSTF2T;DHX8;SNRPB2;GEMIN2;SNRPB;POLR2B;SRSF4;HNRNPA3;HNRNPA1;DHX16;WDR77;YBX1;SF3B6;RBM19;CDK13;SF1;HNRNPU;SNRNP35;USP49;SUGP1;UPF3B;DDX39B;METTL14;DDX20
prerank,negative regulation of proteolysis (GO:0045861),0.5261532305960349,1.3063852401809446,0.13407134071340712,0.6992287343522553,1.0,15/34,24.46%,TIMP2;PTPN3;TIMP3;GAS1;CST3;SERPINE2;CAMK2N1;HDAC6;EFNA1;CLN3;AKT1;CDK5;LRRK2;DNAJC1;ROCK1
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.491339154648865,1.306378869735502,0.12087912087912088,0.6980219550540572,1.0,10/54,9.29%,KCNJ2;KCNJ15;FHL1;NEDD4;KCNN1;KCNE5;STK39;KCNIP2;DLG1;WWP2
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.3705112676478716,-1.3060653873218129,0.10126582278481013,0.5360851869643244,1.0,10/37,6.67%,ALCAM;CADM1;IL1RAPL1;GRID2;VCAM1;PTPRD;TENM4;CXADR;TENM3;TENM2
prerank,negative regulation of cell junction assembly (GO:1901889),0.5406670560053418,1.3059296492791905,0.15625,0.6986485643173398,1.0,3/25,5.16%,THBS1;SLIT1;BCAS3
prerank,regulation of T cell differentiation in thymus (GO:0033081),0.6115102857861514,1.3058111461210868,0.15796703296703296,0.6979228402406649,1.0,5/13,15.99%,GLI2;BMP4;CLPTM1;SOD1;CAMK4
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.5722105615450892,1.3052619520863356,0.15203145478374835,0.6989978472371287,1.0,3/19,11.00%,LBP;PRKCE;IRAK1
prerank,T cell differentiation (GO:0030217),-0.37223504595111684,-1.3051491891084113,0.08695652173913043,0.535354407717402,1.0,7/40,7.44%,LEPR;CHD7;SOX13;KIT;TCF7;JAG2;RHOH
prerank,cellular response to decreased oxygen levels (GO:0036294),0.4797081179111837,1.3047971972939763,0.09299781181619256,0.6996072084086996,1.0,22/65,19.27%,VEGFA;P4HB;PTGIS;TWIST1;LMNA;CARD16;RORA;MDM4;NDRG1;ANGPT4;HYOU1;TERT;PICK1;UBQLN1;NDNF;SIRT2;STUB1;PGK1;HMOX1;NPEPPS;SUV39H2;HIPK2
prerank,zinc ion transport (GO:0006829),0.5533063835175621,1.3038846183187334,0.15414012738853503,0.7020884212253478,1.0,8/21,16.99%,SLC39A14;SLC39A11;SLC39A7;SLC30A5;SLC39A13;SLC39A3;SLC30A6;SLC30A9
prerank,histone H3 deacetylation (GO:0070932),0.5942792660419054,1.3028702880365117,0.1589041095890411,0.7050212419414507,1.0,12/15,32.76%,HDAC9;HDAC4;SFPQ;HDAC1;SIRT2;PER1;SMARCAD1;HDAC2;PER2;ELK4;HDAC3;SIRT7
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.47442763044907993,1.3027670183575515,0.1171960569550931,0.7042228615491783,1.0,23/63,24.86%,PLAGL1;MUC1;CRADD;PRKDC;MDM4;CARM1;PCBP4;ATM;CHEK2;SDE2;TFDP1;CNOT8;CNOT10;RBL2;E2F1;CNOT9;TNKS1BP1;CDK2;SFN;TRIAP1;PRMT1;RPS27L;TP53
prerank,regulation of leukocyte activation (GO:0002694),-0.47614138694181063,-1.3026128487500759,0.15867158671586715,0.5384289566345015,1.0,5/14,15.22%,LYN;MFHAS1;CD200;CD74;GPER1
prerank,positive regulation of lipid transport (GO:0032370),0.620372262503514,1.3019420500576593,0.1763085399449036,0.7064294447164529,1.0,2/12,2.72%,LRP1;CYP19A1
prerank,neural crest cell migration (GO:0001755),-0.3789758186505731,-1.301735975432454,0.0880503144654088,0.5376203116049763,1.0,15/36,18.87%,SEMA6A;SEMA3D;SEMA7A;SEMA5A;TBX1;ERBB4;CORO1C;SEMA4D;SEMA3G;FN1;SEMA4A;HTR2B;SEMA5B;SEMA4G;SEMA6D
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.5379933761920723,1.3012166847380726,0.1484771573604061,0.7081878386415292,1.0,10/24,20.49%,VEGFA;MUC1;GCN1;ATF4;NFE2L2;HSPA5;SESN2;CHD6;ATF6;CREB3L1
prerank,synaptic vesicle membrane organization (GO:0048499),0.5860852361017095,1.301201117087564,0.1449468085106383,0.7070401190049004,1.0,7/17,15.46%,STX11;PRRT2;STX2;AP3D1;SNAP23;STX4;STX1A
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.5941636395813743,1.3001183844040738,0.17486338797814208,0.7103157846039688,1.0,6/13,21.32%,UPP2;DCTPP1;OGG1;TDG;SMUG1;NT5C
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.6365714065609085,1.2999807941619608,0.18023255813953487,0.7096721634248698,1.0,3/10,4.38%,PDE11A;PDE3A;UBE2B
prerank,regulation of lipase activity (GO:0060191),0.6080764127291319,1.2999146104495645,0.16119828815977175,0.7087310641836686,1.0,3/13,8.97%,PCSK5;LMF1;RHOA
prerank,DNA modification (GO:0006304),0.5497909867143496,1.2990961780923267,0.15889029003783103,0.7108348842803662,1.0,7/22,15.94%,PARP3;MPG;OGG1;TDG;SMUG1;EXOSC4;PARP1
prerank,microtubule polymerization or depolymerization (GO:0031109),0.5419500674138801,1.2989375867167745,0.15326633165829145,0.7102726469022422,1.0,3/24,2.03%,MAP7D3;FGF13;STMND1
prerank,epithelial tube morphogenesis (GO:0060562),0.5223637669215363,1.2988098755709832,0.1423570595099183,0.7095495523777857,1.0,5/32,5.52%,SLIT2;PKD1;GLI2;PKHD1;ACVR1
prerank,positive regulation of protein import (GO:1904591),0.5303413350278248,1.2987883121666741,0.15012106537530268,0.7084252321660107,1.0,8/30,10.20%,PRKCD;IPO5;BAG3;TRIM28;MAVS;JUP;ZIC1;UBR5
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.5672844701432203,1.2984843084033093,0.14754098360655737,0.7072109617291965,1.0,14/21,33.35%,CHD1L;ERCC5;ERCC4;CUL4A;ERCC3;ERCC2;PARP1;GTF2H4;XPA;DDB1;RBX1;ERCC1;CUL4B;RPA3
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.5672844701432203,1.2984843084033093,0.14754098360655737,0.7072109617291965,1.0,14/21,33.35%,CHD1L;ERCC5;ERCC4;CUL4A;ERCC3;ERCC2;PARP1;GTF2H4;XPA;DDB1;RBX1;ERCC1;CUL4B;RPA3
prerank,mRNA catabolic process (GO:0006402),0.5001617069149822,1.2984663987530138,0.11019929660023446,0.7060861604311768,1.0,13/44,16.64%,DDX5;THRAP3;ZC3H12D;AGO1;DIS3L2;METTL16;LSM2;SUPV3L1;XRN1;EXOSC4;MRTO4;TUT7;CNOT10
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.5738203113057596,1.2980241470346192,0.16042780748663102,0.7066692469936645,1.0,6/17,8.80%,KCNJ2;CACNA1G;CACNA1C;HCN4;ANK2;TRPM4
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),-0.4549116029587389,-1.2979729852517932,0.14049586776859505,0.5441408063276293,1.0,4/17,4.65%,RIPOR2;CAMK1D;DNM1L;DAPK2
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.5580685142868492,1.2979455289850281,0.14427860696517414,0.7057968125447635,1.0,14/22,34.78%,CHD1L;CUL4A;ERCC3;ERCC2;PARP1;RPS27A;UBC;GTF2H4;XPA;DDB1;RBX1;RAD23B;CUL4B;CETN2
prerank,peptidyl-arginine modification (GO:0018195),0.5987557714163467,1.297568931227966,0.1639784946236559,0.7060194533105679,1.0,1/15,0.46%,PRMT8
prerank,protein maturation (GO:0051604),0.45640321207077056,1.2969602045543502,0.09609292502639916,0.7072978037152017,1.0,26/95,17.93%,ADAMTS3;PCSK5;F3;ECE1;CPZ;MMP14;ADAM10;NAA60;NAA40;TASP1;LMF1;OGT;DDI2;BACE1;SDE2;NAA16;HSPD1;MMP16;MMS19;CPXM2;GCSH;STUB1;PSEN2;LIPT1;PCSK7;CLN3
prerank,carnitine shuttle (GO:0006853),-0.5173592334537319,-1.2966288379914392,0.18269230769230768,0.5442416976608587,1.0,5/11,14.25%,PRKAA2;PRKAG2;CPT1A;MID1IP1;ACACB
prerank,response to iron ion (GO:0010039),-0.49818236592026977,-1.2965672490029385,0.1625441696113074,0.5414058647444919,1.0,3/12,2.12%,BCL2;BMP6;B2M
prerank,aminoglycan biosynthetic process (GO:0006023),0.49800401777005376,1.2955574178953349,0.11891279728199321,0.7117156210718807,1.0,17/49,22.98%,EXT1;XYLT1;GPC6;GPC3;SDC1;B3GNT7;HS6ST2;B3GNT9;HEXA;B4GAT1;B3GNT6;XYLT2;EXT2;HSPG2;B3GNT2;GPC1;B4GALT7
prerank,glycerolipid catabolic process (GO:0046503),0.5671114759747415,1.2954730790860103,0.14871794871794872,0.7108439308838352,1.0,7/19,15.80%,MGLL;PLA2G4F;PLA2G4A;SMPD4;ABHD6;ENPP6;GDPD3
prerank,membrane depolarization during action potential (GO:0086010),0.5380270748024248,1.2953420238911437,0.15506715506715507,0.7101433560642557,1.0,4/26,3.02%,KCNJ2;CACNA1G;CACNA1C;HCN4
prerank,chromatin organization (GO:0006325),0.45022000161937636,1.2952673653911948,0.05804480651731161,0.7092302270254636,1.0,51/132,26.64%,ESR1;HDAC4;BAZ2A;CHD1L;TCF7L1;PHF1;SAFB;TADA2A;EZH1;BRWD1;EHMT1;SOX9;HMGN1;SMARCC2;CDAN1;FOXA1;SETD5;KDM5B;PBRM1;HDAC1;KDM4A;BAZ2B;KAT2A;SETDB1;HMGN2;SUPV3L1;GATAD1;KDM5C;KDM6B;HMG20A;SMARCAD1;SUV39H2;HCFC1;BRDT;MPND;BPTF;SUV39H1;FAM50A;SETD2;LOXL2;TOP1;SETDB2;TAF6L;KAT2B;SMARCA4;HDAC2;DAXX;CHD1;SETD7;MYSM1;ARID1A
prerank,regulation of lymphocyte differentiation (GO:0045619),0.5622495662083333,1.2947176298389522,0.16248348745046234,0.7101941092924209,1.0,5/18,10.41%,PRKDC;TBX21;IKZF3;CRTAM;ABL1
prerank,regulation of protein binding (GO:0043393),0.4526881933733822,1.2942213482910112,0.06871794871794872,0.7109790604530944,1.0,42/114,25.07%,PRMT8;PKD1;PRKCD;LRP1;TCF7L2;TIAM1;HDAC4;LRPAP1;CARD16;DACT1;DVL1;TMC8;SYMPK;EFHB;MAPK8;BMP4;GTF2F1;TERT;NVL;CSNK1E;USP33;ADD1;DAB2;MITD1;TFIP11;STYX;IDE;MEN1;AKT1;CTSZ;HIPK2;SNAPIN;CRK;LRRK2;PRKACA;CAMK1;PEX14;DERL1;TAF1;ROCK1;AMFR;PPP2CA
prerank,positive regulation of protein catabolic process (GO:0045732),0.4650807255161577,1.2939239128482791,0.10599571734475374,0.7110514007719361,1.0,24/84,18.51%,WWP1;ADAM9;GPC3;NEDD4;RDX;STX5;CSNK2A1;VCP;RILP;DACT1;TNFRSF1B;HUWE1;WWP2;NSF;ITCH;VIP;SNX9;AXIN1;EZR;SEC22B;IDE;VPS11;SH3D19;ASB5
prerank,histone H2A acetylation (GO:0043968),0.5803984459055302,1.2936505572265473,0.16869095816464239,0.710958390777513,1.0,5/16,8.89%,MORF4L2;NAA40;TRRAP;ING3;MORF4L1
prerank,negative regulation of myotube differentiation (GO:0010832),0.6168044639662917,1.2933567254236775,0.16457461645746166,0.7109539350642399,1.0,4/12,12.17%,CCN3;HDAC4;TMEM119;HDAC1
prerank,response to interleukin-6 (GO:0070741),0.6448698279871952,1.2931491699188766,0.17595307917888564,0.7106536198286864,1.0,3/10,8.25%,PID1;PTGIS;SBNO2
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.441129504117369,1.2924712397673712,0.04321608040201005,0.7122361234874501,1.0,67/184,24.78%,PKD1;ID2;PPP1R9B;ANAPC5;PSMD7;CSNK1D;CDC16;DYNC1H1;SFI1;PSMA8;ODF2;CDC14A;ALMS1;CDC6;DCTN2;PSMA4;CKAP5;UBE2C;PSMD12;ANAPC4;CUL1;AKAP9;SDCCAG8;ZW10;ERCC3;PSMA6;CEP164;CSNK1E;YWHAE;ERCC2;CEP41;PCM1;ANAPC2;SIRT2;PSMD11;PSMC5;CEP63;PSMD1;HAUS5;ANAPC1;PSMD14;PSMC4;RPS27A;UBC;E2F1;ANAPC10;CDC27;CDC20;CDK2;APPL2;DYNC1I2;APPL1;DCTN1;PSMA3;PSMD4;PRKACA;PSMB1;ACTR1A;CDK5RAP2;NEDD1;PSMA5;CNTRL;PSMA7;PLK4;CCP110;NEK6;RIOK2
prerank,autophagy of nucleus (GO:0044804),0.5878523622776771,1.2923137259808113,0.17771883289124668,0.7116778891173761,1.0,8/16,28.42%,ULK2;WIPI2;ATG3;RB1CC1;ATG9A;ATG13;ATG2B;ULK1
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.5695937380230616,1.2922427515951083,0.170439414114514,0.7107625940130484,1.0,4/17,8.71%,PCSK5;HDAC9;ANGPTL4;LMF1
prerank,neuron differentiation (GO:0030182),0.44628155729082103,1.2921414703209848,0.049796747967479675,0.7099972837556088,1.0,31/165,15.54%,LRP6;ID2;WNT9A;VEGFA;PBX3;VSX1;GLI2;LDB1;LHX9;TGFB2;NRBP2;FZD7;PBX1;RUNX2;FZD5;RUNX1;MYEF2;FOXA1;CTF1;NEUROD2;TGFBR1;SRF;TENM1;ERCC3;INHBA;ERCC2;MANF;WNK1;ACSL3;EN2;THOC2
prerank,protein mannosylation (GO:0035268),-0.4144683690950175,-1.2917778803152211,0.1187214611872146,0.550487861287524,1.0,3/22,2.18%,TMTC2;TMTC4;CRPPA
prerank,regulation of organelle assembly (GO:1902115),0.47262353923667555,1.2915608277787363,0.12404787812840043,0.7111451117020403,1.0,32/72,26.05%,GSN;NPRL3;RDX;TBC1D2B;MAPK15;DYNLT2B;ATXN2L;ALMS1;IFT20;TBC1D24;TRAPPC12;ATG3;SDCCAG8;EZR;TBC1D9B;TBC1D10A;IFT88;TBC1D17;VPS11;EVI5;ATXN2;PDCD6IP;TBC1D22B;RNF4;SENP6;NPRL2;RABGAP1;RAB1B;CYLD;TBC1D20;SPICE1;RAB5A
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.5136064916565344,1.2914778059864676,0.1608643457382953,0.7102845915685135,1.0,14/31,25.37%,PEX7;TOMM40;PEX5;PEX16;PEX1;PEX10;AIFM1;HSPD1;TOMM70;GRPEL1;PEX6;PEX2;PEX14;TIMM17B
prerank,cellular response to purine-containing compound (GO:0071415),-0.5097366415529743,-1.2914031916714932,0.1694915254237288,0.5484512461066852,1.0,2/10,3.24%,SLC8A1;RYR2
prerank,negative regulation of organelle assembly (GO:1902116),0.5149137562012819,1.2913251718033356,0.1453900709219858,0.7097193699951582,1.0,21/35,30.16%,TMEM39A;LIMK2;SMAD4;CDK10;SCFD1;EVI5L;KAT2A;PHF23;SEC22B;CHMP4B;CHMP4A;LRRK2;CDK5RAP2;MTM1;KAT2B;SMCR8;CCP110;PINK1;TESK1;YAP1;TCHP
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.4604709471460109,1.2904666374485985,0.0925531914893617,0.712015187176114,1.0,26/86,21.26%,VEGFA;MUC1;PSMD7;GCN1;ATF4;BAG3;PSMA8;NFE2L2;IMPACT;PSMA4;PSMD12;PSMA6;LIMD1;PSMD11;PSMC5;PSMD1;CREBBP;PSMD14;PSMC4;RPS27A;UBC;HIGD1A;HMOX1;PSMA3;PSMD4;PSMB1
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.43764886650587137,1.2904193415800997,0.026,0.7110264574788697,1.0,95/241,25.59%,SRSF6;DDX5;HNRNPH1;SRSF1;PABPC1;SRSF5;SRSF2;CASC3;SNRNP48;SNRNP70;FUS;PRPF40B;HNRNPA2B1;SRSF11;CHERP;SYMPK;RAVER2;HNRNPH2;HNRNPL;SF3B2;SF3B1;SF3A1;RBM10;PNN;PPIL3;GTF2F1;U2AF1;SRRM1;RBM6;SNRNP25;RBM5;PABPN1;CRNKL1;SFPQ;XAB2;CWF19L1;HNRNPM;PCBP2;LSM2;ZRSR2;PTBP1;GEMIN7;RBM4;RALY;HNRNPC;RBM17;U2AF2;HNRNPK;CLP1;CPSF4;YTHDC1;POLR2F;TFIP11;SRSF3;PCF11;ISY1;IK;NCBP1;WDR83;SNRPA;CPSF7;NCBP2;SYNCRIP;SRSF10;SRSF7;RBM22;CWC25;AQR;U2SURP;MTREX;TRA2B;CSTF2;HNRNPH3;ZCCHC8;TRA2A;CSTF2T;DHX8;SNRPB2;SNRPB;POLR2B;SRSF4;HNRNPA3;HNRNPA1;DHX16;YBX1;SF3B6;RBM19;SF1;HNRNPU;SNRNP35;USP49;SUGP1;UPF3B;DDX39B;METTL14
prerank,protein targeting to lysosome (GO:0006622),0.5489852121473658,1.2901563229195576,0.15612903225806452,0.7109271399653002,1.0,11/20,35.08%,NEDD4;NAGPA;ZFYVE16;CLU;LAMP2;SCARB2;GCC2;GGA3;GNPTAB;M6PR;SNX16
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.625405123564695,1.2901404787977713,0.15983026874115983,0.7098307878728685,1.0,8/12,26.07%,STX11;PRRT2;STX2;SNAP23;STX4;STX1A;STX1B;STX19
prerank,actin filament bundle assembly (GO:0051017),-0.38473438059480786,-1.2899567593043935,0.10778443113772455,0.5488849434073052,1.0,10/33,12.21%,MYO1B;PAWR;SHROOM2;EPS8;PLS3;NEDD9;BAIAP2;SHROOM1;AIF1L;LCP1
prerank,negative regulation of sprouting angiogenesis (GO:1903671),0.6277650218080644,1.2899352654377645,0.1853932584269663,0.7095023309037908,1.0,1/11,0.08%,THBS1
prerank,positive regulation of cell adhesion (GO:0045785),0.46639998591944126,1.2898642813816898,0.12269272529858849,0.708681956172506,1.0,19/74,18.10%,ZFHX3;VEGFA;ADAM9;P4HB;VIT;TGFB2;PRKCA;AGR2;FOXC2;TFE3;ITGAV;ATM;SMAD7;ARL2;NDNF;STX4;ERBB2;FLCN;CITED2
prerank,regulation of DNA biosynthetic process (GO:2000278),0.5345110090553119,1.2895821897087618,0.16365824308062576,0.7086065893405297,1.0,5/27,10.85%,SMOC2;FGF2;TOM1L1;SMG6;ATM
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.5266370642437843,1.2895632403891828,0.15055079559363524,0.7075259887634378,1.0,5/29,7.71%,SLC4A10;EPHB2;ARC;RAB3GAP1;DLG4
prerank,negative regulation of endocytosis (GO:0045806),-0.4130581554570985,-1.2895153427844748,0.11214953271028037,0.5470192297106653,1.0,7/24,12.89%,MCTP1;PICALM;NR1H3;PACSIN3;CD300A;CAV1;PRKD1
prerank,regulation of protein catabolic process (GO:0042176),0.4562050299757263,1.289135794654591,0.09548793284365163,0.7081262899360041,1.0,18/99,11.37%,EGFR;WWP1;GPC3;NEDD4;STX5;CSNK2A1;VCP;RILP;DACT1;IRAK3;MDM4;HUWE1;WWP2;NSF;ITCH;VIP;AXIN1;CHEK2
prerank,histone mRNA catabolic process (GO:0071044),0.5898408096241219,1.2888390832145027,0.17297297297297298,0.7081540270365242,1.0,8/15,22.68%,TENT4B;SSB;ATM;XRN1;EXOSC4;TUT7;TENT2;UPF1
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.51505624937945,1.2887977463345657,0.13028169014084506,0.7071487915610271,1.0,16/38,26.46%,ABLIM3;CSNK2A2;HUWE1;FZD5;SREBF1;USP36;HPS4;MICALL2;VPS11;NPEPPS;SAE1;LRRK2;LMAN1;PINK1;ATG13;HTRA2
prerank,regulation of nervous system process (GO:0031644),-0.43966941565485695,-1.2887943218490638,0.13716814159292035,0.5457266349933738,1.0,5/18,7.17%,ROCK2;APP;NOS3;HTR2C;SLC8A3
prerank,positive regulation of bone mineralization (GO:0030501),-0.3707224436358627,-1.2885585476799573,0.09655172413793103,0.5434167919242437,1.0,12/35,9.22%,PTN;WNT4;SLC8A1;BMP6;ADGRV1;OSR1;BMP7;KL;ATP2B1;FBN2;ANO6;BMPR2
prerank,regulation of SMAD protein signal transduction (GO:0060390),0.5522526941074969,1.2882890257971378,0.1681643132220796,0.7079578736661906,1.0,11/21,17.19%,NUP93;CCN3;TGFB3;WWTR1;SMAD4;BMP4;BMPR1A;SH2B1;TGFBR1;DAB2;SLC2A10
prerank,dendritic spine morphogenesis (GO:0060997),0.5868530146084242,1.2882023478186497,0.1760752688172043,0.7071733635929263,1.0,6/15,11.74%,CTNND2;EPHB2;ARC;EPHB3;DLG4;SHANK1
prerank,glutamate receptor signaling pathway (GO:0007215),-0.3650963095639296,-1.2881405596585183,0.11971830985915492,0.5413970767001585,1.0,12/37,8.00%,PLCB1;GRM7;GRM5;GRM3;APP;GRID2;GRM8;GRM1;GRIK2;GRIN2B;GRIA4;HOMER1
prerank,cellular response to alkaloid (GO:0071312),-0.459206682318205,-1.2879880346371935,0.15294117647058825,0.538949334214338,1.0,3/17,3.24%,SLC8A1;TGM2;RYR2
prerank,glycosaminoglycan metabolic process (GO:0030203),0.4864028825855177,1.2879162941861007,0.14046822742474915,0.707151059295413,1.0,5/54,3.13%,EXT1;XYLT1;GPC6;GPC3;SDC1
prerank,positive regulation of vacuole organization (GO:0044090),0.63436110807111,1.2877127324011917,0.17969821673525377,0.7067952949332613,1.0,4/10,9.83%,ANXA2;RAB3GAP1;LRSAM1;PIP4K2B
prerank,actin polymerization or depolymerization (GO:0008154),0.4882445062423766,1.287433329979633,0.13559322033898305,0.7067080291395504,1.0,15/50,21.29%,PSTPIP1;MICAL2;GSN;VILL;COBL;ABI1;SPIRE2;TTC17;MICALL2;SCIN;WASHC3;WDR1;CORO7;ABI2;SVIL
prerank,negative regulation of mononuclear cell migration (GO:0071676),0.624564386963129,1.2873726242166057,0.1747159090909091,0.7058394316585721,1.0,6/12,18.60%,SLIT2;CCN3;BMP5;MIA3;NBL1;AKT1
prerank,microglial cell activation (GO:0001774),-0.4201274277749253,-1.287051564141968,0.14468085106382977,0.5382571244030538,1.0,10/21,24.51%,APP;CX3CR1;CX3CL1;C1QA;TYROBP;SNCA;ITGAM;AGER;GRN;TREM2
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.48014965119870917,-1.2863192537445287,0.15151515151515152,0.5370909030434582,1.0,6/14,13.74%,KIT;WNT5A;SEMA7A;GPRC5B;CD74;SIRT1
prerank,protein depolymerization (GO:0051261),0.5281306551487485,1.2861401084637625,0.16829268292682928,0.7094451334359471,1.0,3/27,2.03%,MICAL2;GSN;STMND1
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.4919427433336684,1.2858537432424657,0.1344632768361582,0.7094385032205132,1.0,7/44,7.17%,KCNJ2;KCNJ15;ATP1B1;KCNN1;KCNE5;KCNIP2;ANK2
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),0.5729611212504179,1.2852184221306189,0.167989417989418,0.7106647259688529,1.0,4/17,14.20%,PLA2G4F;PLA2G4A;PLA2G5;PLA2G12A
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.5167315849837076,-1.2840349219131144,0.19205298013245034,0.5400163678777392,1.0,2/10,4.84%,LYN;FAS
prerank,embryonic organ development (GO:0048568),0.47331514154418697,1.2834137322714592,0.13429522752497225,0.7167835374334645,1.0,15/61,12.53%,PKDCC;PCSK5;PBX3;RARB;GLI2;COBL;TGFB2;ATF4;TGFBR2;PBX1;TBC1D23;FGFR2;BMPR1A;HEY1;ERCC3
prerank,estrogen metabolic process (GO:0008210),0.5935135483814318,1.2833493266989344,0.17032967032967034,0.7158979122091312,1.0,2/15,2.76%,CYP19A1;CYP1B1
prerank,regulation of cell cycle (GO:0051726),0.4340556452344264,1.2832979940952571,0.023046092184368736,0.7149580992779695,1.0,72/271,21.36%,THBS1;PLAGL1;LRP6;PKD1;ID2;TCF7L2;TTC28;PDCD4;GADD45G;PPP1R9B;FAP;PRDM11;STAT3;CSNK2A1;CSNK2A2;TGFB2;EIF4G2;CDC14A;NEK7;PUM1;ADAM10;GBF1;CDK10;SOX9;RARA;SRA1;CDK5RAP3;AKT2;TBRG4;FGFR2;CDC123;BMP4;FOXM1;ABL1;MADD;ATM;INTS13;FBXL12;MAPK12;TAF6;TGFBR1;MED25;UHMK1;INHBA;SND1;SIRT2;RHOB;ING4;CAMK2N1;IQGAP1;CDC25A;APBB1;E4F1;BOP1;CKS1B;MEN1;DAPK3;CITED2;KIF20B;HCFC1;BIRC5;UHRF2;HIPK2;CDK5;MLXIPL;GMNC;CALR;DLGAP5;BIRC3;PRKACA;TBRG1;WDR12
prerank,lung development (GO:0030324),0.5168634913350967,1.2826037045627616,0.1523809523809524,0.7165519334879968,1.0,7/33,10.16%,PKD1;VEGFA;FGF2;GLI2;CCDC39;FGFR2;BMP4
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.5220532335573232,1.281287693884336,0.17204301075268819,0.7207810363960712,1.0,2/33,0.59%,PKD1;ID2
prerank,calcium ion transmembrane transport (GO:0070588),0.4517637046689037,1.281213838003505,0.09830866807610994,0.7199388130069315,1.0,18/86,14.50%,CACNA1G;CACNA1C;PKD1;SLC35G1;GAS6;SLC24A3;TRPV3;MCU;SPG7;TRPC4AP;TRPM7;TRPM4;ITGAV;TMEM165;TRPM6;MICU2;LETM1;MICU1
prerank,regulation of MAPK cascade (GO:0043408),-0.28360558379017325,-1.2811580057888392,0.0,0.5445061123307554,1.0,28/157,6.72%,FLT1;IGF1R;TGFBR3;KSR1;INSR;LYN;ROCK2;TEK;LPAR1;PHLPP1;MAP4K4;PELI2;KIT;TNIK;LBH;JCAD;EPHA7;KDR;DAG1;CAV2;FAS;TBX1;EPHA8;PAK3;ADRA2A;PAK5;DUSP3;ROR2
prerank,regulation of angiogenesis (GO:0045765),0.43693765415366614,1.2809056636796745,0.04819277108433735,0.7199676569350489,1.0,31/192,10.71%,BMPER;THBS1;SMOC2;PGF;RHOJ;HOXA5;VEGFA;F3;FGF2;PTGIS;EMILIN1;PROK2;CYP1B1;ISM1;TWIST1;SPARC;TGFB2;SERPINF1;SEMA3E;PRKCA;RAMP2;THBS2;SULF1;ANGPTL4;JUP;PAK4;STIM1;RUNX1;ANGPT4;AGGF1;AGO1
prerank,protein modification by small protein removal (GO:0070646),0.4335046298314781,1.2808723551760164,0.03625377643504532,0.7189769990367916,1.0,109/252,27.74%,ESR1;IL33;PSMD7;USP24;VCP;USP2;PSMA8;SMAD4;USP50;OTUB1;TRRAP;MDM4;GPS1;MBD6;FOXK1;OGT;RHOA;RHOT1;INO80E;USP40;PSMA4;UCHL3;INO80B;WDR48;USP48;USP45;PSMD12;SMAD7;TGFBR1;USP34;OTUB2;PSMA6;KAT2A;USP11;TRAF3;STAM2;SENP5;USP7;USP33;USP36;USP13;PSMD11;PSMC5;PSMD1;USP19;USP35;PSMD14;CDC25A;OTUD5;PSMC4;RPS27A;UBC;USPL1;POLB;YOD1;USP32;USP10;HCFC1;CDC20;SENP8;ACTR8;USP1;USP46;TAF9B;ZRANB1;NFKBIA;UCHL5;UCHL1;OTUD6B;SMURF2;PSMA3;PSMD4;BRCC3;BIRC3;PSMB1;USP5;SENP1;USP47;COPS4;SENP7;SENP6;COPS7A;DESI2;DESI1;PSMA5;ASXL2;USP14;USP4;CYLD;KAT2B;PSMA7;CCP110;SNX3;USP49;TP53;SENP3;COPS3;RIPK1;YY1;SUDS3;MYSM1;PSMC1;ATXN7;TAF10;USP16;USP21;USP22;PSMA1;USP37
prerank,negative regulation of DNA replication (GO:0008156),0.5898584116772841,1.2806921097907675,0.19696969696969696,0.7185508941485824,1.0,9/13,30.65%,CDC6;CDAN1;GMNC;PDS5A;GTPBP4;S100A11;ATR;WAPL;RAD17
prerank,negative regulation of cyclase activity (GO:0031280),-0.46664455088378576,-1.2800944907911873,0.15849056603773584,0.5442373726287355,1.0,3/14,9.97%,GRM3;ADGRV1;EDNRB
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.5584661008715133,1.279793742494686,0.17519181585677748,0.7209633860949585,1.0,7/18,17.09%,EDEM2;SYVN1;UGGT2;UGGT1;RPS27A;UBC;TRIM13
prerank,cellular defense response (GO:0006968),0.4991241675012531,1.279684689251759,0.13488372093023257,0.7202822408345427,1.0,4/40,4.22%,LSP1;LBP;SPN;TCIRG1
prerank,regulation of gene silencing by miRNA (GO:0060964),0.4711785102296131,1.2796612075333291,0.11160714285714286,0.7192442115881698,1.0,33/62,30.44%,NUP93;SEC13;STAT3;RAE1;PUM1;SEH1L;AGO1;NUP37;AGO2;EIF4G1;RANBP2;LIMD1;NUP88;POLR2F;NUP210;POM121;NUP62;POLR2B;NDC1;NUP35;IPO8;H3-3A;NUP85;POLR2H;TPR;NUP160;TNRC6A;FXR1;POLR2I;PUM2;POLR2L;NUP188;NUP50
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.45266355801196073,1.2794206988980679,0.06960081883316274,0.7190447712566395,1.0,32/128,15.49%,TMEM100;GDF10;LTBP2;COL3A1;COL1A2;ADAM9;PDCD4;DDX5;SMAD9;SMAD6;ZMIZ1;ACVR1B;TGFB3;TGFB2;ACVR1;SMAD4;TGFBR2;RUNX2;SKI;CBL;RHOA;BMP4;BMPR1A;SMAD7;TGFB1I1;TGFBR1;RGMA;INHBA;ZMIZ2;BMP5;STUB1;ID1
prerank,visual perception (GO:0007601),0.4553965842308264,1.2794052949896089,0.1,0.7179761138543745,1.0,7/84,7.06%,SLC4A10;COL11A1;COL1A1;PDE6C;PITPNA;CRYZ;CHRNB2
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.5917643845845114,1.2792795829427084,0.18579234972677597,0.7173240490645441,1.0,8/14,23.50%,TSEN54;FAM98B;CLP1;CPSF4;RTCB;RTRAF;CSTF2;TSEN34
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.5949833834014023,1.2791828866569017,0.18503401360544217,0.7166445359693813,1.0,4/13,11.03%,BLOC1S2;RHOT2;RHOT1;VDAC2
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.6059057715066329,1.278920722652092,0.15966386554621848,0.7165882083186315,1.0,4/13,13.27%,ZMIZ1;ELOF1;SERTAD2;ZMIZ2
prerank,regulation of cellular response to stress (GO:0080135),0.4477750128351098,1.2788800945492809,0.09071949947862357,0.7156041991885393,1.0,49/115,28.20%,SLC38A2;NUP93;SEC13;CAMK2D;RAE1;ATF4;BAG3;ADCY8;CCAR2;SEH1L;HIKESHI;AKT1S1;SMG1;ABL1;ATM;NUP37;DNAJC7;CHORDC1;EIF4G1;YWHAE;MANF;RANBP2;NUP88;USP19;CREBBP;CLN3;NUP210;POM121;ARMT1;NEK4;NUP62;NDC1;RPTOR;ABCD1;NUP35;DNAJC2;FKBP4;AMFR;NEK6;PINK1;VASH1;NUP85;TPR;NUP160;HSPB8;ATR;BAG1;HSF1;DNAJB1
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),-0.45109542293093574,-1.278265191017202,0.13983050847457626,0.5458672278555954,1.0,8/18,14.50%,NRXN1;SHANK3;RIMS2;RIMS1;CUX2;RELN;PRKCZ;GRIN1
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.5442057210025373,1.2781531305977787,0.17228464419475656,0.7172403733431651,1.0,6/20,13.49%,ZMIZ1;DCUN1D5;ITCH;TGFBR1;DCUN1D2;UBQLN1
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.4999683336363779,1.2770605439435012,0.14087759815242495,0.7205549832280868,1.0,5/41,7.17%,KCNJ2;KCNJ15;KCNN1;KCNE5;ANK2
prerank,non-motile cilium assembly (GO:1905515),0.5129485442743092,1.2769933177337556,0.15421686746987953,0.7197002491807368,1.0,9/30,15.49%,GORAB;CSNK1D;TMEM107;TMEM216;RPGRIP1L;TMEM80;FUZ;PCM1;IFT88
prerank,sulfur compound transport (GO:0072348),0.5289988713536017,1.2764700363300514,0.17493796526054592,0.7206294237474266,1.0,4/27,5.65%,SLC26A7;SLC5A6;SLC26A6;LRRC8D
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.47266262264721387,1.2760206634352311,0.14221218961625282,0.7214022887939532,1.0,18/54,23.43%,PLAGL1;MUC1;CRADD;MDM4;CARM1;PCBP4;ATM;CHEK2;TFDP1;CNOT8;CNOT10;RBL2;E2F1;CNOT9;TNKS1BP1;SFN;TRIAP1;PRMT1
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.6177566467194773,1.275874489069549,0.1900709219858156,0.7197802492114483,1.0,1/10,0.76%,PRKCD
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),0.6177566467194773,1.275874489069549,0.1900709219858156,0.7197802492114483,1.0,1/10,0.76%,PRKCD
prerank,positive regulation of heart contraction (GO:0045823),-0.42730221590244316,-1.2758391128394038,0.1623931623931624,0.5489997154171479,1.0,4/19,10.69%,ATP1A2;RYR2;EDN1;ADRA1A
prerank,neurogenesis (GO:0022008),0.48692782715338756,1.275344419401888,0.15052508751458576,0.7206715407208278,1.0,10/43,15.54%,SIX1;CIT;TGFB2;SIX4;WDR62;DAGLA;ANXA1;DCHS1;CXCR4;THOC2
prerank,negative regulation of adenylate cyclase activity (GO:0007194),-0.47448638106694957,-1.2751343510090498,0.19330855018587362,0.547834867265984,1.0,3/13,9.97%,GRM3;ADGRV1;EDNRB
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.5404668785205977,1.2750785305726153,0.17167919799498746,0.720658730626221,1.0,7/22,16.30%,ATP1B1;CALM2;SLC9A1;ANK2;P2RY6;STAC3;CALM3
prerank,phagosome maturation (GO:0090382),0.510560457069602,1.2749543418677751,0.15473441108545036,0.7201236210512164,1.0,9/35,14.82%,ATP6V1C2;RAB34;RAB43;TCIRG1;ATP6V0A1;RAB38;ATP6V0D1;ATP6V1B2;ATP6V1E1
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),0.5896262569640551,1.2746761881480757,0.1829436038514443,0.7201557794389868,1.0,6/14,19.69%,PKD1;NFKBIB;G3BP2;MDFI;SUFU;NFKBIA
prerank,cation transmembrane transport (GO:0098655),-0.3636955504614537,-1.2745810296509141,0.09523809523809523,0.5464394854403989,1.0,7/44,7.97%,ATP1A2;TRPM3;SLC7A5;ABCC9;SLC6A9;SLC38A5;SLC7A1
prerank,organic substance transport (GO:0071702),0.4520322979903897,1.2734059902319688,0.0849740932642487,0.7239955462270958,1.0,24/121,14.90%,SLC47A1;SLC23A1;ABCD3;SLCO2A1;LMAN2L;FLVCR1;RAMP2;SLC6A2;RILP;HIKESHI;DISP1;ATP8A1;RAB38;RAMP1;ABCA1;PCTP;PICK1;LRP2;SLC22A18;TOM1;CHMP3;SLC50A1;ABCB6;MIA3
prerank,response to molecule of bacterial origin (GO:0002237),0.46671363701535706,1.273301496725842,0.1180931744312026,0.7233107649359852,1.0,18/69,18.37%,FOXP1;LBP;SMAD6;IRAK3;LIAS;FZD5;TAB2;IRAK1;F2R;SRR;PRDX3;SIRT2;CYP27B1;IL6;OTUD5;TRIM6;ACOD1;ERBIN
prerank,chondroitin sulfate metabolic process (GO:0030204),0.5178667078588144,1.2729833212842574,0.17249698431845598,0.7234862832426567,1.0,6/30,4.44%,DSE;BGN;CHST11;ARSB;CHPF2;CSPG4
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.46044853610088815,1.272856763743481,0.10785340314136126,0.722848173023603,1.0,28/93,22.78%,RASSF2;EGFR;VEGFA;GAS6;NTRK3;DOCK7;DMD;PFN2;RAF1;NSD1;PAQR3;AXIN1;SMAD7;AKAP9;TENM1;EIF4G1;IL6;HDAC6;ARAF;TRIM6;CNOT9;AKT1;TNKS1BP1;MLXIPL;MAD2L2;ATP2B4;RPTOR;CAMK1
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.44551356083475646,1.2724020543544607,0.08686659772492245,0.723625971024814,1.0,10/122,4.18%,THBS1;SMOC2;EGFR;IRS1;FGF2;IL33;GLI2;LDB1;SAMD4A;TGFB2
prerank,gas transport (GO:0015669),0.6289590697935169,1.2720796032241664,0.19263456090651557,0.7237956993835766,1.0,1/10,1.37%,CYGB
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.6197383848050942,1.2712761558118055,0.1863905325443787,0.7258620976305564,1.0,2/10,1.48%,XYLT1;DSE
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.5246587301813499,1.271180100693801,0.1654320987654321,0.7251401274165138,1.0,8/27,15.46%,ID2;PPP1CC;USP2;BHLHE40;PER3;FBXL12;RBM4;PER1
prerank,protein processing (GO:0016485),0.4447200557318449,1.2710814642228043,0.09483667017913593,0.7244578249615571,1.0,20/102,15.10%,ADAMTS3;PCSK5;F3;ECE1;PRSS12;CPZ;HM13;FXN;MMP14;SPG7;ADAM10;OGT;DDI2;BACE1;SDE2;CASP1;MMP16;SPCS2;CPXM2;PSEN2
prerank,positive regulation of vasculature development (GO:1904018),0.4526192072018733,1.270820502076305,0.11534391534391535,0.7243706727808752,1.0,18/94,10.39%,THBS1;SMOC2;PGF;VEGFA;F3;FGF2;PTGIS;CYP1B1;TWIST1;PRKCA;RAMP2;ANGPTL4;JUP;PAK4;STIM1;RUNX1;ANGPT4;AGGF1
prerank,renal system development (GO:0072001),0.48407142837707196,1.270807032629405,0.13707865168539327,0.723329654936986,1.0,9/52,10.16%,SIX1;PKD1;VEGFA;PCSK5;GLI2;TGFB2;SULF1;PYGO1;BMP4
prerank,cellular response to mechanical stimulus (GO:0071260),0.48502818837814377,1.2706300047694064,0.1590909090909091,0.7229786492287537,1.0,8/46,12.63%,PIEZO2;CRADD;SLC9A1;SOX9;MAPK8;LTBR;TNFRSF10B;CASP1
prerank,synaptic vesicle recycling (GO:0036465),0.503761301822528,1.2706032773932119,0.16707021791767554,0.7219815833816526,1.0,11/31,20.44%,STON2;SYT8;CEL;FCHO2;TBC1D24;STON1;SYNJ1;NLGN1;STX1A;CDK5;SYNJ2
prerank,positive regulation of phospholipase C activity (GO:0010863),0.4929854921046606,1.270251730627096,0.1488862837045721,0.7222887093222131,1.0,5/40,3.12%,ESR1;EGFR;FGF2;NTRK3;EDNRA
prerank,protein sumoylation (GO:0016925),0.4771047419974712,1.2700229519202535,0.1373439273552781,0.7220835326992376,1.0,23/49,27.85%,NUP93;TOPORS;RAE1;TRIM28;SEH1L;TRPM4;NUP37;RANBP2;PIAS4;NUP88;STX1A;SUMO1;NUP210;POM121;SAE1;NUP62;NDC1;SUMO2;NUP35;NUP85;TPR;NUP160;NSMCE2
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.494874278500694,1.2697840756959846,0.14566473988439307,0.7219531850918525,1.0,9/39,6.99%,FGF13;FXYD5;NEDD4;PTPN3;PRKCE;CAMK2D;DMD;STK39;SLMAP
prerank,beta-catenin destruction complex disassembly (GO:1904886),0.5484661050255893,1.269290229179902,0.17167919799498746,0.7228370375896679,1.0,4/21,11.30%,LRP6;DVL1;FZD5;AXIN1
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.543326483199153,1.2690894012705038,0.18030690537084398,0.7225165215085844,1.0,7/20,7.17%,CACNA1C;ATP1B1;CAMK2D;CALM2;DMD;SLC9A1;ANK2
prerank,negative regulation of secretion (GO:0051048),-0.5114414732461927,-1.269040863545041,0.20521172638436483,0.557270218136156,1.0,5/10,23.19%,NR1H3;CD74;ERBB3;PTGER3;NRG1
prerank,pulmonary valve development (GO:0003177),0.5670369790875079,1.2677073641549343,0.2002534854245881,0.7266835485937767,1.0,9/18,12.41%,SLIT2;SMAD6;TGFB2;TNFRSF1B;JAG1;HEYL;NFATC1;BMP4;HEY1
prerank,hepaticobiliary system development (GO:0061008),-0.42837845456713175,-1.2674858239191362,0.17475728155339806,0.5583000396055006,1.0,5/20,5.78%,TGFBR3;WNT4;ARID5B;LSR;PROX1
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.5692827281258765,1.2668336642782743,0.178335535006605,0.7291221249387306,1.0,4/17,5.94%,ADAM9;TGFB2;CD3E;FOXC2
prerank,purine-containing compound biosynthetic process (GO:0072522),0.5302415453713026,1.2659376136249765,0.16645962732919253,0.7316861173322889,1.0,7/25,18.76%,PRPS2;ADA;AMPD3;DGUOK;MTHFD1;SHMT2;SHMT1
prerank,regulation of trophoblast cell migration (GO:1901163),0.5848508143663671,1.265683245978049,0.20781032078103207,0.7316545957247061,1.0,8/14,28.54%,VEGFA;ACVR1B;AGO2;CALR;SMURF2;C1QBP;ARHGDIB;TIMP1
prerank,regulation of phosphatase activity (GO:0010921),0.5298053090330811,1.2651245507733966,0.1820388349514563,0.7328278330301464,1.0,11/24,20.46%,PPP6R1;CDK5RAP3;TIPRL;PPP6R3;ZCCHC9;RIPK3;URI1;CHP1;PPP6R2;PPP1R35;PPP1R36
prerank,tRNA processing (GO:0008033),0.46295553280758184,1.265062601934254,0.12985571587125416,0.7319688358300571,1.0,24/61,24.14%,TSEN54;SSB;ANKRD16;ELP5;FAM98B;TRMT1;PUS3;TRUB1;CTU2;CLP1;CPSF4;RTCB;RPP40;ELAC2;ADAT1;TRMT6;SARS1;RTRAF;CSTF2;METTL1;TRMT61A;NSUN6;TSEN34;RPP21
prerank,regulation of cell growth (GO:0001558),0.4289922105641124,1.265037840069327,0.05953582240161453,0.7309849203531518,1.0,47/204,17.05%,SLIT3;SLIT2;EGFR;FHL1;PLCE1;OSGIN2;CCN3;PPP1R9B;ACVR1B;PRDM11;CAMK2D;CSNK2A1;TGFB2;EIF4G2;FXN;DCUN1D5;CCAR2;MMP14;LAMTOR1;SMAD4;ADAM10;CXCL16;TMC8;PAK4;DACT3;SOCS2;SERTAD2;NDRG3;DCBLD2;ITCH;URI1;TGFBR1;EIF4G1;INHBA;CGRRF1;SESN2;RBBP7;SUPV3L1;EXOSC4;CYP27B1;SERTAD3;KLHL22;ERBB2;NCBP1;MINAR1;APBB1;FLCN
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.44071229677405893,1.2649215094480644,0.10240334378265413,0.7303871009231057,1.0,20/118,9.72%,BMPER;PID1;EFNA5;FGF2;FMNL2;NEDD4;SRCIN1;PROK2;PHLDB1;SPARC;ARC;SIPA1L1;LZTS1;EPHB3;BCL9L;POGLUT1;CHRNB2;PAK2;TANC2;FGFR2
prerank,vascular transport (GO:0010232),0.46465224697221297,1.2648734660138068,0.12579281183932348,0.7295135318683865,1.0,14/81,5.06%,SLC38A2;SLC38A1;SLC4A4;SLC5A6;SLCO3A1;LRP1;SLC2A13;SLC12A2;SLC24A3;SLC16A1;SLC4A8;SLC1A5;ABCC1;SLC38A3
prerank,peptidyl-lysine trimethylation (GO:0018023),0.5227289059457948,1.2643129239916338,0.18395061728395062,0.7306288292962675,1.0,12/26,22.26%,KMT5C;OGT;SETD5;KMT2D;SETD4;WDR82;SUV39H2;SETD1A;TET2;SUV39H1;SETD2;KMT2A
prerank,lysosome organization (GO:0007040),0.4988035709617099,1.2639068729131582,0.17964071856287425,0.7311787603859009,1.0,15/36,22.52%,ARSB;GAA;LAMTOR1;MBTPS1;NAGPA;TMEM106B;ABCA1;TMEM165;HPS4;ACP3;CLN3;MYO7A;SNAPIN;LRRK2;ZKSCAN3
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.5355748872810978,1.2628890355024902,0.18102372034956304,0.7342223880198667,1.0,10/24,25.72%,TENT4B;ERCC4;TEN1;HNRNPC;TNKS2;XRN1;PARP1;HNRNPA1;HNRNPU;SLX4
prerank,protein localization to endoplasmic reticulum (GO:0070972),0.5727805234173109,1.2626747275648889,0.20445609436435125,0.7340177056856039,1.0,8/16,14.95%,GBF1;ANK2;BCAP31;HSPA5;SEC16A;SEC16B;MIA3;BCAP29
prerank,renal absorption (GO:0070293),0.6142814935864032,1.262369235629427,0.2237960339943343,0.7341267991501985,1.0,2/10,5.22%,GSN;MAGED2
prerank,regulation of cytoplasmic transport (GO:1903649),0.6136097317636808,1.2621249184375183,0.2141863699582754,0.7339329833288817,1.0,5/11,20.63%,DNAJC13;ATP9A;USP7;CHMP3;LRRK2
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.5036406445308536,1.261671811385685,0.18083832335329342,0.7345551137147163,1.0,6/32,13.85%,CCL13;RNASE7;RNASE3;RNASE6;DEFB1;HMGN2
prerank,gliogenesis (GO:0042063),0.5761177155112929,1.2616616750201652,0.18758434547908232,0.7335239341012318,1.0,4/15,9.20%,NFIB;TGFB2;CD9;ANXA1
prerank,regulation of ATP metabolic process (GO:1903578),0.46674718626731226,1.2616177736649392,0.1537598204264871,0.7326557420982149,1.0,28/54,31.36%,NUP93;SEC13;RAE1;SEH1L;OGT;NUP37;RANBP2;NUP88;EIF6;SHMT2;PRKAG1;NUP210;POM121;NUP62;NDC1;COX7A2L;ABCD1;NUP35;PINK1;NUP85;TPR;NUP160;SPHK2;FIS1;ZBTB7A;NUP188;NUP50;ATP7A
prerank,pulmonary valve morphogenesis (GO:0003184),0.5638795324430801,1.2612218917350717,0.19505851755526657,0.733154668699978,1.0,8/17,12.41%,SLIT2;SMAD6;TGFB2;JAG1;HEYL;NFATC1;BMP4;HEY1
prerank,regulation of amyloid-beta formation (GO:1902003),-0.36235927850886474,-1.2611944152514871,0.10975609756097561,0.5713214218971794,1.0,6/34,6.74%,ROCK2;APOE;EPHA4;PICALM;ABCG1;GSAP
prerank,positive regulation of Ras protein signal transduction (GO:0046579),-0.3389808854126948,-1.2610726247249773,0.1,0.5687939705224505,1.0,11/61,7.94%,ROBO1;AUTS2;LYN;LPAR1;MAP4K4;ARHGEF3;NOTCH1;NET1;F11R;RASGEF1A;PRAG1
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.5973406447016488,1.2610484609914687,0.21763869132290184,0.7327983452366325,1.0,7/11,24.86%,MUC1;FOXM1;ING4;HIPK2;MAD2L2;RPS27L;TP53
prerank,endocrine system development (GO:0035270),0.5428683612505144,1.260954758620399,0.18631178707224336,0.7320956952037095,1.0,3/21,3.09%,SIX1;GLI2;DKK3
prerank,cellular response to amino acid starvation (GO:0034198),0.4664605893576679,1.2606253486677181,0.13010752688172042,0.732323822476811,1.0,28/71,22.82%,NPRL3;ATP6V1C2;SEC13;GCN1;MAP3K5;SESN3;TCIRG1;ATF4;LAMTOR1;SEH1L;DAP;CASTOR2;IMPACT;MAPK8;ATP6V0D1;SESN2;ATP6V1B2;ATP6V1E1;FLCN;ATF2;KPTN;ATP6V1C1;RHEB;EIF2AK4;EIF2S1;EIF2AK3;RPTOR;NPRL2
prerank,photoperiodism (GO:0009648),0.5169917726019105,1.2605948380703422,0.17560975609756097,0.7313977328567924,1.0,8/28,15.46%,ID2;PPP1CC;USP2;BHLHE40;PER3;FBXL12;RBM4;PER1
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),-0.41206665326409353,-1.2605641793760987,0.1615720524017467,0.5673103565779705,1.0,8/21,18.03%,EPHA7;GRIN2B;AIM2;SOX2;GRIN1;DELE1;PYCARD;MT3
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.613608089612879,1.2603888082150028,0.20614035087719298,0.7311988833828371,1.0,1/10,0.97%,LBP
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.5717181910956837,1.260250493987306,0.19843342036553524,0.7306809247750592,1.0,8/15,26.66%,VCP;FAF2;SYVN1;NPLOC4;DERL1;SELENOS;HERPUD1;SEC61B
prerank,protein localization to organelle (GO:0033365),0.4386693134892299,1.259332186678534,0.08530318602261049,0.7332340982296915,1.0,24/133,13.34%,SIX1;ZNF423;COL1A1;CNTLN;TSPAN10;EHD1;STX5;CSNK1D;TOPORS;LMNA;SIX4;DVL1;BBS9;SSB;IFT20;GBF1;ANK2;TRAM2;BMP4;PAQR3;CSRP3;CNEP1R1;ALDH3A2;YWHAE
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.4621855189084473,1.2590840848582512,0.12513484358144553,0.7331259818462909,1.0,22/74,17.55%,COL1A1;TIAM1;PHLDB1;TGFB3;TWIST1;LDLRAD4;SPRED2;WWTR1;TGFB2;BCL9L;SMAD4;TGFBR2;FOXA1;SMAD7;TGFB1I1;TGFBR1;BMP5;DAB2;IL6;IL17RD;CRB2;EFNA1
prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.49191656750867707,1.2587018128175913,0.20047169811320756,0.7335837471752201,1.0,9/36,13.30%,EGFR;CYGB;NPR3;DNM2;DDAH1;TERT;NOSIP;PIK3CB;S100A1
prerank,positive regulation of Rho protein signal transduction (GO:0035025),-0.3731475834229822,-1.2580088456866456,0.1282051282051282,0.5707744830535553,1.0,6/30,7.94%,ROBO1;LPAR1;ARHGEF3;NET1;F11R;PRAG1
prerank,positive regulation of axon extension (GO:0045773),0.536003212853054,1.2573982663167282,0.19872611464968154,0.7374572169999558,1.0,4/22,11.54%,NTN1;VEGFA;GOLGA4;NRP1
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.6144329746522575,1.2572237594165954,0.22005988023952097,0.7370573345887885,1.0,2/11,2.34%,GSN;PRR7
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.45129539261009094,1.2571427532783668,0.13859275053304904,0.7363232294905029,1.0,22/78,20.27%,EGFR;PID1;LRP1;RHOQ;PRKCE;EPHB2;PLS1;PPFIA1;AGR2;MMP14;DLG1;PDPK1;CLTC;SQSTM1;DAB2;STAC3;STX4;SPTBN1;CLN3;AKT1;CDK5;APPL1
prerank,regulation of cell killing (GO:0031341),0.5758351636618461,1.2569352007698178,0.2020997375328084,0.7360447742887638,1.0,4/16,9.79%,CFH;TGFB2;FZD7;MAPK8
prerank,BMP signaling pathway (GO:0030509),0.46778901576248727,1.2567823221234768,0.15059588299024917,0.7355822640388298,1.0,15/62,12.32%,TMEM100;PDCD4;DDX5;SMAD9;SMAD6;TGFB3;TGFB2;ACVR1;SMAD4;RUNX2;NOG;BMP4;BMPR1A;SMAD7;RGMA
prerank,mRNA processing (GO:0006397),0.4240681012310741,1.256648523915884,0.02702702702702703,0.7350801970433906,1.0,116/287,27.61%,SRSF6;DDX5;HNRNPH1;SRSF1;PABPC1;SRSF5;SRSF2;CASC3;SNRNP48;SNRNP70;FUS;PRPF40B;HNRNPA2B1;SRSF11;CHERP;SYMPK;RAVER2;HNRNPH2;HNRNPL;SF3B2;SF3B1;SF3A1;TBRG4;RBM10;PNN;PPIL3;ZC3H11A;GTF2F1;U2AF1;SRRM1;RBM6;SNRNP25;CHTOP;RBM5;PABPN1;CRNKL1;SFPQ;ERCC3;XAB2;CWF19L1;HNRNPM;PCBP2;ERCC2;LSM2;ZRSR2;PTBP1;GEMIN7;RBM4;RALY;HNRNPC;RBM17;U2AF2;HNRNPK;CLP1;CPSF4;YTHDC1;SARNP;POLR2F;THOC2;TFIP11;SRSF3;PCF11;ISY1;RPRD1A;IK;NCBP1;WDR83;SNRPA;CPSF7;NCBP2;CPSF6;SYNCRIP;SRSF10;SRSF7;RBM22;CWC25;AQR;U2SURP;RAMAC;MTREX;TRA2B;CSTF2;HNRNPH3;ZCCHC8;TRA2A;CSTF2T;DHX8;SNRPB2;PRKACA;GEMIN2;SNRPB;POLR2B;SRSF4;HNRNPA3;HNRNPA1;DHX16;YBX1;PRMT9;SF3B6;RBM19;SF1;HNRNPU;SNRNP35;USP49;SUGP1;UPF3B;DDX39B;METTL14;GTF2H4;RNMT;POLR2H;DDX41;SON;ERN1;SRRT;GPATCH1
prerank,negative regulation of signaling receptor activity (GO:2000272),-0.39180457122606316,-1.2566180365086785,0.13592233009708737,0.5714651193851774,1.0,9/25,13.49%,PPARA;ERRFI1;CBLB;SLC6A9;CNRIP1;SNX6;ACE2;SOCS5;GPRC5A
prerank,negative regulation of cation transmembrane transport (GO:1904063),-0.43512558732565787,-1.2566170345231913,0.14049586776859505,0.5687092699655945,1.0,2/18,1.06%,ATP1A2;NEDD4L
prerank,central nervous system neuron axonogenesis (GO:0021955),0.5974866733446648,1.2560778775691244,0.1864864864864865,0.7363622516611826,1.0,4/12,8.24%,EPHB2;EPHB6;CHRNB2;B4GALT5
prerank,cortical cytoskeleton organization (GO:0030865),0.49435578095166766,1.2559156876333706,0.17146282973621102,0.7359433979484148,1.0,10/41,15.14%,RHOBTB1;FMNL2;RHOQ;RND3;LLGL1;DLG1;RHOA;EZR;NLGN1;RHOB
prerank,transport across blood-brain barrier (GO:0150104),0.46209505514848265,1.255576533682903,0.12539515279241306,0.7361500904690996,1.0,14/83,5.06%,SLC38A2;SLC38A1;SLC4A4;SLC5A6;SLCO3A1;LRP1;SLC2A13;SLC12A2;SLC24A3;SLC16A1;SLC4A8;SLC1A5;ABCC1;SLC38A3
prerank,regulation of sequestering of triglyceride (GO:0010889),-0.441207856323374,-1.2554636120075553,0.1885245901639344,0.5689155346517494,1.0,4/15,12.22%,OSBPL8;PPARA;ABHD5;LPL
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),0.628142154949694,1.2553635580406284,0.20501474926253688,0.7359162546429279,1.0,8/10,33.08%,OGT;DGKQ;USP7;GNMT;SELENOS;ZNF692;SIRT7;SDHAF3
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.521992503910494,1.25501676328469,0.1834975369458128,0.7361545866067745,1.0,6/26,10.07%,SMOC2;PRKCA;USP2;PKN2;CDC25B;FOXA1
prerank,regulation of cellular response to heat (GO:1900034),0.45081569707467695,1.2549629880231907,0.13841201716738197,0.7352968542515848,1.0,37/77,30.61%,NUP93;SEC13;CAMK2D;RAE1;BAG3;CCAR2;SEH1L;HIKESHI;AKT1S1;ATM;NUP37;DNAJC7;CHORDC1;YWHAE;RANBP2;NUP88;CREBBP;NUP210;POM121;NUP62;NDC1;RPTOR;NUP35;DNAJC2;FKBP4;NUP85;TPR;NUP160;HSPB8;ATR;BAG1;HSF1;DNAJB1;NUP188;HSPH1;NUP50;HSP90AA1
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.5575559555769404,1.2544840054814324,0.19845360824742267,0.7361353385547923,1.0,5/19,12.13%,GAS6;ZMIZ1;MMP14;PRKDC;CD27
prerank,cellular response to heat (GO:0034605),0.499460873293119,1.2542449294792306,0.18072289156626506,0.7360268309536939,1.0,9/35,17.75%,THBS1;BAG3;VCP;HIKESHI;YWHAE;RBBP7;STUB1;SUMO1;HMOX1
prerank,epithelial cell differentiation (GO:0030855),0.4422938861637285,1.2541744436212345,0.12930135557872785,0.735249384788462,1.0,24/88,20.81%,SIX1;VEGFA;FSTL1;ANXA7;ANXA4;JAG1;FZD7;AKT2;AKR1C1;ANXA1;FGFR2;BMP4;EHF;HDAC1;DHRS9;BDH2;DAB2;KDM6B;PGK1;CNN3;AKT1;DMBT1;HNRNPH3;CTSB
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.36283769339212935,-1.2539005822517737,0.12318840579710146,0.569975153439509,1.0,11/39,8.43%,ROBO1;TSPAN5;MAML2;NOS3;ROBO2;MAML3;NOTCH1;JAG2;NOTCH4;RBPJ;EPN2
prerank,regulation of protein kinase B signaling (GO:0051896),0.43087386309605225,1.2535850437679499,0.04149797570850203,0.7365554492445818,1.0,17/193,4.52%,THBS1;MYOC;ESR1;EGFR;IRS1;TNFAIP8L3;GAS6;F3;FGF2;TCF7L2;NTRK3;NTRK1;FGF17;GAB2;PHLPP2;PKHD1;XDH
prerank,iron ion transport (GO:0006826),0.47713102771200555,1.253085782077542,0.16629955947136563,0.7375332135112778,1.0,12/47,15.18%,SCARA5;SLC39A14;ATP6V1C2;TCIRG1;DNM2;ATP6V0A1;ATP6V0D1;ATP6V1B2;RAB11B;CLTC;ATP6V1E1;IREB2
prerank,protein localization to centrosome (GO:0071539),0.5636712012831541,1.2529523197941275,0.20974289580514208,0.7369758319931424,1.0,5/17,14.88%,CSNK1D;GOLGB1;DCTN2;PCM1;NUDCD3
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),0.5250412635018314,1.2517765571707353,0.1828358208955224,0.7404560861046056,1.0,9/26,13.34%,FHL1;ATP1B1;NEDD4;STK39;ANK2;DLG1;WWP2;AKAP9;YWHAE
prerank,positive regulation of amyloid-beta formation (GO:1902004),-0.41977475311511914,-1.251764918604495,0.17316017316017315,0.5726219792079675,1.0,5/18,6.74%,ROCK2;EPHA4;PICALM;ABCG1;GSAP
prerank,cellular response to estrogen stimulus (GO:0071391),0.5694959126335338,1.251701658340118,0.22644163150492264,0.739719342180346,1.0,5/14,12.88%,BCAS3;RARA;SRA1;SFR1;SERPINB9
prerank,positive regulation of actin filament polymerization (GO:0030838),0.4859446277208461,1.2513717454673374,0.17162471395881007,0.7400291590874934,1.0,10/44,15.17%,GSN;CTTN;PRKCE;CDC42EP2;PFN2;SNX9;SPIRE2;TENM1;CDC42EP5;SCIN
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),-0.5091994827664911,-1.2513600892781422,0.1918238993710692,0.5708600641704926,1.0,5/11,13.74%,LYN;RAPGEF2;PIK3CD;LGALS9;SIRT1
prerank,negative regulation of RNA splicing (GO:0033119),0.5515099892828789,1.2510803135443302,0.20502645502645503,0.7401038750480864,1.0,10/19,25.34%,SRSF6;PCBP4;PTBP1;U2AF2;SRSF10;SRSF7;SAP18;SFSWAP;SRSF4;C1QBP
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.5497361599497355,1.2510626905416509,0.19078947368421054,0.7391518732680773,1.0,2/19,0.50%,EXT1;XYLT1
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.4791392563210658,1.2507257842228228,0.16898148148148148,0.7393595067478607,1.0,21/41,30.44%,NUP93;SEC13;RAE1;SEH1L;OGT;NUP37;RANBP2;NUP88;EIF6;PRKAG1;NUP210;POM121;NUP62;NDC1;NUP35;NUP85;TPR;NUP160;ZBTB7A;NUP188;NUP50
prerank,regulation of axonogenesis (GO:0050770),0.471394755230936,1.250300734435084,0.18485523385300667,0.7399741253980613,1.0,9/51,9.58%,SLIT2;PLXNA4;TIAM1;TIAM2;GDI1;SIPA1L1;EPHB3;RHOA;PAK2
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.43425155547922156,-1.2502348691407525,0.196,0.5710286057405766,1.0,6/16,15.19%,PARP14;ADIPOR1;INPP5F;SH2B3;CAV1;SOCS3
prerank,aminoglycan catabolic process (GO:0006026),0.5139198608198332,1.2501919538745652,0.2078239608801956,0.7394003272262487,1.0,3/28,3.13%,GPC6;GPC3;SDC1
prerank,icosanoid metabolic process (GO:0006690),0.4819843006788109,1.25019183030086,0.18931475029036005,0.7383874500656649,1.0,7/40,10.43%,MGLL;PTGIS;PLA2G4A;CYP1B1;ABCC1;DAGLA;FADS1
prerank,peroxisome organization (GO:0007031),0.5158216882856936,1.250149193412218,0.19900497512437812,0.737559103167484,1.0,14/25,26.21%,ABCD3;PEX7;PEX11A;PEX16;PEX1;PEX10;SEC16B;TMEM135;PEX6;PEX2;ABCD1;PEX14;ACOT8;LONP2
prerank,potassium ion transmembrane transport (GO:0071805),0.43173118911907327,1.25002771512572,0.083248730964467,0.7369759436710972,1.0,17/135,7.72%,KCNJ2;KCNJ15;KCNK5;SLC12A7;KCNB1;ATP1B1;SLC12A2;SLC24A3;HCN4;KCNN1;SLC9A8;SLC9A4;KCNE5;SLC9A1;KCNIP2;SLC12A4;KCND1
prerank,protein deubiquitination (GO:0016579),0.4241206107554411,1.2500135848276932,0.06445115810674723,0.7360182202854239,1.0,115/242,31.24%,ESR1;IL33;PSMD7;USP24;VCP;USP2;PSMA8;SMAD4;USP50;OTUB1;TRRAP;MDM4;MBD6;FOXK1;ENY2;OGT;RHOA;RHOT1;INO80E;USP40;PSMA4;UCHL3;INO80B;WDR48;USP48;USP45;PSMD12;SMAD7;TGFBR1;USP34;OTUB2;PSMA6;KAT2A;USP11;TRAF3;STAM2;USP7;USP33;USP36;USP13;PSMD11;PSMC5;PSMD1;USP19;USP35;PSMD14;CDC25A;OTULIN;OTUD5;PSMC4;RPS27A;UBC;POLB;SHMT2;YOD1;USP32;USP10;HCFC1;CDC20;SENP8;ACTR8;USP1;USP46;TAF9B;ZRANB1;NFKBIA;UCHL5;UCHL1;OTUD6B;SMURF2;PSMA3;PSMD4;BRCC3;BIRC3;PSMB1;USP5;USP47;DESI2;PSMA5;ASXL2;USP14;USP4;CYLD;KAT2B;PSMA7;CCP110;SNX3;USP49;TP53;RIPK1;YY1;SUDS3;MYSM1;PSMC1;ATXN7;TAF10;USP16;USP21;USP22;PSMA1;USP37;TADA3;TNIP1;USP30;OTUD3;NLRP3;PSMD2;FOXO4;ADRM1;KEAP1;USP26;PRKN;SPATA2;USP9X;COPS5
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.47608945907119304,1.2496491682569395,0.17752808988764046,0.7364050759881836,1.0,12/48,15.08%,SLC26A2;AK5;PAPSS2;ADCY2;ADCY8;ADCY9;DCAKD;PANK4;ACAT1;AMPD3;GUCY2D;SLC35B3
prerank,cellular glucose homeostasis (GO:0001678),0.4799485538454671,1.249438480419311,0.16570771001150747,0.7362404143265879,1.0,7/41,8.69%,SLC39A14;KCNB1;GAS6;UNC13B;ADCY8;LRRC8D;FOXK1
prerank,glycosaminoglycan catabolic process (GO:0006027),0.4612931966717731,1.2494356779924394,0.17105263157894737,0.735253660930559,1.0,8/55,6.52%,GPC6;FGF2;GPC3;BGN;SDC1;ARSB;CSPG4;SLC9A1
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.415772851268152,1.249213567473859,0.012,0.7351520051783292,1.0,136/417,23.17%,FOXP2;WWP1;FOXP1;ID2;ZFPM2;GAS6;ZNF423;FOXD1;TCF7L2;PDCD4;TWIST2;GCLC;DEAF1;PHC2;MDFIC;LDB1;PRICKLE1;PRDM5;NCOR2;GLIS2;TWIST1;DKK3;SHC1;PRDM11;LHX9;TLE2;RBFOX2;HDAC9;HDAC4;EIF4A2;SIX4;KMT5A;TRIM28;ERN2;CCAR2;MIDEAS;BHLHE40;SMAD4;HEYL;RUNX2;EHMT1;DAP;TBX21;SOX9;MAEL;RARA;MBTD1;BTAF1;SBNO2;PA2G4;ILF3;RCOR3;FOXK1;SMARCC2;WWP2;SPINDOC;EID2B;TSC22D4;PHC3;SCMH1;BMP4;FOXM1;COMMD7;KAT6B;ID4;NR1D2;KHDRBS1;SFPQ;HDAC1;KDM4A;HEY1;NACC1;NPAS1;MAP3K10;LIMD1;PIAS4;HEXIM1;ZNF148;MBD1;RING1;SIRT2;VDR;ING4;YWHAQ;PER1;ID1;L3MBTL2;FOXN3;HDAC6;NKX6-2;NIPBL;KDM5C;MTA3;CBX5;L3MBTL3;SUMO1;E2F1;DPF3;CALCA;NR3C1;THAP7;CDKN1C;MEN1;HMGA1;KLF10;CITED2;CHD8;SUV39H2;ZMYND11;CBFA2T2;BIRC5;CDK5;MLXIPL;XRCC6;CALR;SCML2;CREB3L1;SMURF2;KAT7;IKZF4;MPHOSPH8;SAP18;SUV39H1;YEATS2;ATP8B1;IL4;SAMD11;USP47;CRY2;LOXL2;ZKSCAN3;GLI3;KAT8;PEX14;BCLAF1;SETDB2
prerank,negative regulation of growth (GO:0045926),0.4334278950264866,1.2490662433068869,0.11099585062240663,0.7346864938733337,1.0,26/121,17.05%,SLIT3;SLIT2;FHL1;OSGIN2;CCN3;PPP1R9B;ACVR1B;PRDM11;TGFB2;CCAR2;SMAD4;DACT3;SERTAD2;NDRG3;DCBLD2;ING5;INHBA;CGRRF1;SESN2;RBBP7;CYP27B1;SERTAD3;ING4;MINAR1;APBB1;FLCN
prerank,regulation of mRNA processing (GO:0050684),0.5072141886891036,1.2489591765718073,0.18181818181818182,0.7340681354686469,1.0,15/32,19.98%,RBM39;SAFB;SLTM;METTL16;PABPN1;KHDRBS1;SRPK1;HNRNPK;CPSF4;YTHDC1;SRSF3;NCBP1;SRSF10;SAFB2;LARP7
prerank,lysosome localization (GO:0032418),0.48874328772421866,1.2477942408608054,0.19244391971664698,0.7375905130228757,1.0,15/37,19.72%,RAB34;BLOC1S2;LAMTOR1;FAM98A;KLC2;PLEKHM2;TMEM106B;NDEL1;PLEKHM1;SPAG9;HDAC6;FLCN;SYTL4;SNAPIN;BORCS6
prerank,acylglycerol catabolic process (GO:0046464),0.5022954932847713,1.2476330616033828,0.18727050183598531,0.7371856112109667,1.0,4/30,15.02%,MGLL;DAGLA;ABHD6;PNPLA3
prerank,regulation of receptor recycling (GO:0001919),0.5658758760841296,1.2474717666872375,0.21052631578947367,0.7368033423739669,1.0,6/16,20.96%,ECE1;ANXA2;LAMTOR1;NSF;TRAT1;OPTN
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.5806763876053547,1.2473854816652254,0.23182441700960219,0.7361276487758296,1.0,4/12,8.80%,CACNA1C;JUP;DLG1;TRPM4
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.6064006008102371,1.2470358238202297,0.21888412017167383,0.7363923401711879,1.0,5/11,14.85%,PRKCD;CYP1B1;MAP3K5;STK25;GSKIP
prerank,mRNA metabolic process (GO:0016071),0.4388868489936899,1.2467944701474194,0.1323529411764706,0.7362848838831695,1.0,40/90,30.02%,DDX5;SRSF1;SRSF5;SRSF2;SSB;HNRNPA2B1;SRSF11;ZC3H12D;SF3B2;SF3A1;TBRG4;U2AF1;DIS3L2;METTL16;SFPQ;PCBP2;LSM2;PTBP1;U2AF2;PCF11;CNOT10;NCBP1;NCBP2;CPSF6;SRSF7;PRKACA;GEMIN2;SNRPB;SRSF4;PRMT9;TP53;SON;ERN1;RIDA;HSF1;LSM5;DXO;PRPF18;SNRPF;SF3B4
prerank,GTP metabolic process (GO:0046039),0.5692371282087517,1.246461938436071,0.1983695652173913,0.7366008809755975,1.0,7/15,22.04%,RHOQ;AK3;RAB23;EFL1;ENTPD7;LRRK2;MFN1
prerank,ear morphogenesis (GO:0042471),0.5423825886391236,1.2461240259384305,0.1802252816020025,0.7369053333209516,1.0,6/20,9.72%,SIX1;EPHB2;TWIST1;NOG;ZIC1;FGFR2
prerank,canonical Wnt signaling pathway (GO:0060070),0.457515418729719,1.2459844387948384,0.14725274725274726,0.7364156548551593,1.0,11/68,8.32%,LRP6;WNT9A;TCF7L2;SFRP4;PLPP3;LRP5;TCF7L1;DVL1;BCL9L;FZD7;FZD5
prerank,lipoxygenase pathway (GO:0019372),-0.4510940828473684,-1.245945823775238,0.19424460431654678,0.5791261515775586,1.0,4/14,12.82%,PON2;HPGD;ALOX12;GPX1
prerank,response to amino acid starvation (GO:1990928),0.46114141782378965,1.2458454012101716,0.14285714285714285,0.7359579605830715,1.0,28/72,22.82%,NPRL3;ATP6V1C2;SEC13;GCN1;MAP3K5;SESN3;TCIRG1;ATF4;LAMTOR1;SEH1L;DAP;CASTOR2;IMPACT;MAPK8;ATP6V0D1;SESN2;ATP6V1B2;ATP6V1E1;FLCN;ATF2;KPTN;ATP6V1C1;RHEB;EIF2AK4;EIF2S1;EIF2AK3;RPTOR;NPRL2
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.44115322344008523,1.245508891276085,0.1419491525423729,0.736266048312174,1.0,27/84,21.26%,ECRG4;ANAPC5;PSMD7;CDC16;PSMA8;PSMA4;UBE2C;PSMD12;ANAPC4;PSMA6;ANAPC2;PSMD11;PSMC5;PSMD1;ANAPC1;PSMD14;PSMC4;RPS27A;UBC;ANAPC10;CDC20B;CDC27;CDC20;CDK2;PSMA3;PSMD4;PSMB1
prerank,cellular protein localization (GO:0034613),0.42293402660309154,1.2454511022866848,0.03803803803803804,0.7355184550519213,1.0,94/285,23.66%,EGFR;SGSM2;CNTLN;ARFGAP3;SEC31A;CTTN;KIF13A;EHD1;TBC1D8B;TBC1D2B;STX5;SEC13;ARCN1;RAB43;PTPRU;COPA;TM9SF4;RAB24;AP2A1;STX11;RIC3;PACS2;RAB21;DMD;LAMTOR1;RIC1;GGA2;TLK1;COPZ2;ANK2;WIPI2;ARF4;SH3PXD2B;SNX1;SCFD1;NSF;STX2;VPS26A;ARFIP2;RAB38;CSRP3;ARF1;SNX9;AP3D1;USO1;WDR11;EVI5L;TMED9;ERP29;TBC1D9B;PICK1;TBC1D25;CLTC;VIPAS39;RAB23;TBCK;COPB2;SIL1;STX4;TBC1D10A;STX1A;ID1;SCFD2;HDAC6;TBC1D17;NIPBL;STX16;GGA1;SNX13;TMED2;NAPA;RAB5B;SNX15;RAB3GAP2;MYO7A;SEC23IP;VPS45;COX18;EVI5;LRRK2;TBC1D22B;VPS26C;TM9SF1;RAB1A;IFT27;FBLN5;RAB18;COPZ1;RABGAP1;UNC50;RAB1B;AP3B1;USP4;TMED7
prerank,artery morphogenesis (GO:0048844),0.49823020507205174,1.244792593639551,0.19927095990279464,0.7369329034685471,1.0,11/30,13.42%,VEGFA;LRP1;TGFB2;JAG1;NOG;BMP4;BMPR1A;NRP1;SMAD7;TGFBR1;LRP2
prerank,regulation of protein phosphorylation (GO:0001932),0.422184982274137,1.2447884917676526,0.05527638190954774,0.735967507733329,1.0,46/256,13.07%,BMPER;SLIT2;PGF;EGFR;LRP6;PID1;SLCO3A1;VEGFA;EFNA5;PLCE1;GAS6;FGF2;CARD14;NTRK3;NTRK1;FGF17;PLPP3;EPHB2;CSNK1D;WWTR1;LIMK2;ATF4;XDH;MAVS;BRD4;ILK;PRKDC;RSPO1;SOX9;NSD1;CDK5RAP3;AKT2;IMPACT;TMEM119;BMP4;ABL1;MUSK;PAQR3;NIBAN1;AXIN1;ROPN1L;PHIP;SOD1;CHP1;ERP29;SESN2
prerank,chromosome organization (GO:0051276),0.44060931673119647,1.2447631744683103,0.12227979274611399,0.735085492995526,1.0,35/99,26.41%,TCF7L2;LDB1;RAE1;TCF7L1;PHF1;SAFB;EZH1;BRWD1;EHMT1;GPS1;HMGN1;CDAN1;CENPT;CUL4A;ABL1;HDAC1;LIG4;HMGN2;PARP1;GATAD1;RPS27A;UBC;HMG20A;CDT1;MTHFR;SUV39H1;FAM50A;COPS4;COPS7A;SMARCA4;HDAC2;H3-3A;COPS3;SETD7;XPA
prerank,negative regulation of cell projection organization (GO:0031345),-0.3385321573656422,-1.244736047586076,0.11965811965811966,0.5795313749785375,1.0,10/48,7.94%,EFNB2;LPAR1;APOE;EPHA4;RAPGEF2;PTPRO;PTPN9;GRIN2B;DCC;PRAG1
prerank,myofibril assembly (GO:0030239),-0.34311275487410475,-1.2447179412660219,0.09929078014184398,0.5769059469226956,1.0,8/42,8.08%,ACTN2;PGM5;TPM1;PDGFRB;TMOD3;TMOD1;PDGFRA;LMOD1
prerank,epithelial to mesenchymal transition (GO:0001837),-0.3399166789471266,-1.2438800254119302,0.11403508771929824,0.5762994589831818,1.0,12/47,7.65%,TGFBR3;LEF1;ENG;ROCK2;WNT4;WNT5A;BMP7;TBX3;NOTCH1;NOTCH4;AKNA;RBPJ
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),-0.4221891597562523,-1.243360635149839,0.16,0.574902534068831,1.0,4/19,4.65%,RIPOR2;CAMK1D;DNM1L;DAPK2
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.45908535468855616,-1.243304688255568,0.21611721611721613,0.572435819291752,1.0,4/15,7.82%,ALDH4A1;GGT5;GGACT;PRODH
prerank,cellular iron ion homeostasis (GO:0006879),0.4685302073579202,1.2432817335643116,0.15679824561403508,0.7396188930846295,1.0,14/55,15.18%,SCARA5;SLC39A14;FLVCR1;HMOX2;FXN;SMAD4;ACO1;ATP6V0D1;SOD1;CUL1;CYBRD1;FRRS1;ABCB6;IREB2
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.4867578515275371,1.2429474911994507,0.17031070195627157,0.739946121515878,1.0,9/42,11.54%,MYOC;VEGFA;COL16A1;CD3E;S100A10;JUP;GFUS;ABL1;NRP1
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.4689945445172621,1.2426883898779872,0.18232044198895028,0.7399491658379194,1.0,16/52,18.60%,EGFR;LRP1;PRKCE;EPHB2;PLS1;AGR2;DLG1;PDPK1;SQSTM1;STAC3;ACSL3;STX4;SPTBN1;CNST;CLN3;AKT1
prerank,digestive tract morphogenesis (GO:0048546),0.5774289918060778,1.2424060492409454,0.2225201072386059,0.740056318654242,1.0,4/14,9.72%,ID2;AGR2;EPHB3;FGFR2
prerank,cardiac conduction system development (GO:0003161),0.5269660902089712,1.242305656125799,0.2027363184079602,0.7394208555244095,1.0,6/24,12.41%,CACNA1G;HCN4;SMAD4;BMP4;BMPR1A;HEY1
prerank,cell-cell junction assembly (GO:0007043),-0.32178400082952074,-1.2420762114248676,0.08421052631578947,0.5727752103373992,1.0,18/63,9.70%,TJP1;TLN2;GJB6;CDH8;CDH5;CLDN5;EPB41L3;PKP4;GJB2;ARVCF;GJC1;GJD3;PIP5K1C;CDH6;CDH2;CDH7;CDH20;CDH19
prerank,cellular response to retinoic acid (GO:0071300),-0.3510783456697537,-1.2418808202193659,0.13846153846153847,0.5706875262770471,1.0,9/42,6.40%,LYN;WNT5B;PTK7;WNT5A;WNT6;BRINP3;TBX1;BRINP1;BRINP2
prerank,regulation of protein-containing complex assembly (GO:0043254),0.4376023430515065,1.2418700908556999,0.12124352331606218,0.7401343887081433,1.0,30/110,18.81%,TRABD2B;VEGFA;MPP7;GSN;HJURP;MAPK15;VCP;CDC42EP2;ANKRA2;PEX5;IAPP;SLF2;TMC8;RAF1;IMPACT;SPIDR;LCMT1;ABCA1;NCLN;HSPA5;FARP2;PREB;TFIP11;HDAC6;SUMO1;NAPA;CDT1;HCFC1;BID;AIDA
prerank,regulation of filopodium assembly (GO:0051489),0.48019776168334016,1.240943818575299,0.17770034843205576,0.7425998608636194,1.0,12/38,13.59%,PRKCD;ARAP1;RHOQ;DPYSL3;TGFB3;BCAS3;GAP43;NRP1;TENM1;MIEN1;NLGN1;ARHGAP44
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.49091965026268,1.2408585420395035,0.18050541516245489,0.7419412743636246,1.0,14/36,20.07%,EHMT1;RBBP8;PHC3;RNF2;RBBP7;TFDP1;RING1;L3MBTL2;CBX5;E2F1;PCGF2;RYBP;RAD51;MAX
prerank,Golgi ribbon formation (GO:0090161),0.5839832826043022,1.2406900635502296,0.22937062937062938,0.7415894797233782,1.0,9/13,30.23%,TRIP11;STX16;GOLPH3;OPTN;VAMP4;GOLGA2;GCC2;PRMT5;VTI1A
prerank,regulation of histone modification (GO:0031056),0.5816016936628362,1.2406534886331366,0.21389645776566757,0.7407482633323893,1.0,9/13,32.37%,SETD5;NNMT;FLCN;MTHFR;AKAP8;PARG;IGF2;CDK9;UBE2N
prerank,protein stabilization (GO:0050821),0.4257526720732956,1.240585793993644,0.07849133537206932,0.7400855388149261,1.0,51/168,21.57%,RASSF2;PRKCD;ATP1B1;PLPP3;UBE2B;MORC3;BAG3;P3H1;HYPK;USP2;DVL1;RAB21;PFN2;PER3;PRKRA;COA8;ANK2;MDM4;SYVN1;TELO2;CHEK2;NAA16;NCLN;SMAD7;PARVA;CHP1;HSPD1;USP7;SEC16A;USP33;USP36;IFT46;HPS4;USP13;USP19;CREB1;HIP1;SUMO1;EFNA1;PEX6;HCFC1;TAF9B;CCT6A;CCT4;CCT8;CALR;CLU;LAMP2;TBRG1;MUL1;LAMP1
prerank,histone H3-K4 trimethylation (GO:0080182),0.5873788666026631,1.2405077183669047,0.22901849217638692,0.7393854196558011,1.0,6/11,22.26%,OGT;KMT2D;WDR82;SETD1A;TET2;KMT2A
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.5944929165745488,1.2401558341348435,0.19436619718309858,0.7397408211611152,1.0,8/11,26.43%,TRIM28;RESF1;SETDB1;MPHOSPH8;TASOR;SETDB2;DNMT1;TPR
prerank,protein localization to cell junction (GO:1902414),-0.40919447934908365,-1.2394391828568834,0.1917808219178082,0.574076435408807,1.0,4/22,4.73%,TJP1;CGNL1;HEG1;BSN
prerank,cellular biogenic amine catabolic process (GO:0042402),0.6093285709007232,1.239090017392937,0.2180028129395218,0.7428035006203467,1.0,4/10,12.64%,LRTOMT;CHDH;HNMT;SMOX
prerank,heme biosynthetic process (GO:0006783),0.5406952385785205,1.238873086873327,0.21456436931079323,0.7426767710997264,1.0,11/22,26.12%,FLVCR1;FXN;NFE2L1;HMBS;ABCB6;FECH;UROS;SLC25A38;ABCB10;ABCG2;COX15
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.558901214242487,1.2388289917105422,0.22019635343618513,0.7418925932364864,1.0,3/15,8.69%,IRS1;PRKCE;AKT2
prerank,tRNA modification (GO:0006400),0.45692285938017474,1.2382155745410934,0.16740088105726872,0.7432937188853469,1.0,25/62,26.65%,TRMT61B;TARBP1;SSB;ANKRD16;ELP5;TRMT1;PUS3;ALKBH1;TRUB1;TYW3;CTU2;THADA;TPRKB;THUMPD3;TRMT44;TRMT6;ALKBH8;METTL1;TRMT61A;NSUN6;PUS1;MTO1;PUS10;TRMT112;DTWD1
prerank,phosphatidylcholine metabolic process (GO:0046470),0.4539046429990092,1.238200876299122,0.1588683351468988,0.7423800763433028,1.0,16/70,16.77%,PLA2G4F;PLA2G4A;PEMT;CSNK2A1;CSNK2A2;LPCAT1;MBOAT2;LPCAT4;PLA2G5;STARD7;GPAT4;LPCAT3;PCTP;PLA2G12A;CHKB;PLA2G15
prerank,cellular response to misfolded protein (GO:0071218),0.5447866264815318,1.2380573075520775,0.21428571428571427,0.7419986638063096,1.0,10/20,26.33%,VCP;DNAJB14;UGGT2;UGGT1;STUB1;DNAJC18;DERL1;UBE2W;DNAJB12;RNF126
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.4174189464936806,-1.2377940877746925,0.21810699588477367,0.575521235125749,1.0,5/17,16.35%,COX8A;COX6C;COX4I1;COX10;COX5B
prerank,folic acid metabolic process (GO:0046655),0.5408220902532641,1.2377469811290074,0.21778350515463918,0.7421641972941204,1.0,9/18,18.96%,SLC25A32;PM20D2;MTRR;MTHFD2;ALDH1L2;MTHFD1;SHMT2;SHMT1;MTHFR
prerank,histone H4 acetylation (GO:0043967),0.4684035838662846,1.2373027468832163,0.18378995433789955,0.7428255767880236,1.0,23/47,23.40%,KANSL2;MORF4L2;NAA60;NAA40;TRRAP;ING3;OGT;MORF4L1;ING5;WDR5;ING4;PER1;APBB1;ATF2;HCFC1;BRD8;KANSL1;KAT7;MSL1;KMT2A;KAT8;MEAF6;ZZZ3
prerank,protein glycosylation (GO:0006486),0.43311866939478555,1.2371304982109226,0.10816326530612246,0.7425274557358262,1.0,23/125,11.64%,PLOD2;ST3GAL4;ST8SIA2;GALNT10;PGM3;GFPT1;PLOD1;PLOD3;B3GNT7;POGLUT1;GFPT2;B4GALT1;B4GALT5;PMM2;ST3GAL2;OGT;MGAT4B;FUT8;NPC1;DOLPP1;GALNT18;FUT4;TMEM165
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.5088493537466263,1.236979177559499,0.21289537712895376,0.7421581026616836,1.0,6/27,10.85%,DDX5;TWIST1;SPRED2;KMT5A;YJU2;ATM
prerank,positive regulation of phospholipase activity (GO:0010518),0.5223212292480178,1.2365026657672797,0.2092426187419769,0.7429620374177303,1.0,8/22,11.53%,ESR1;FGF2;NTRK3;FGFR1;ARF4;PLA2G5;FGFR2;PDPK1
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),0.5972952595220605,1.2363573427059533,0.23109243697478993,0.7426418060392148,1.0,4/12,7.10%,IGFBP5;DOCK4;DOCK7;DOCK5
prerank,sphingoid metabolic process (GO:0046519),0.5874327837588371,1.236244442283689,0.20949720670391062,0.7421225974698128,1.0,3/12,6.23%,PLPP3;KDSR;PLPP1
prerank,cellular response to hypoxia (GO:0071456),0.4296909746808411,1.2359657959846428,0.1101956745623069,0.7421879964987023,1.0,40/126,21.26%,VEGFA;P4HB;PTGIS;TWIST1;PSMD7;LMNA;CARD16;PSMA8;RORA;MDM4;NDRG1;PSMA4;ANGPT4;HYOU1;TERT;PSMD12;PSMA6;UBQLN1;LIMD1;NDNF;SIRT2;STUB1;PSMD11;PSMC5;PSMD1;CREBBP;PSMD14;PSMC4;RPS27A;UBC;HIGD1A;PGK1;HMOX1;NPEPPS;SUV39H2;HIPK2;PSMA3;PSMD4;SUV39H1;PSMB1
prerank,regulation of transmembrane transport (GO:0034762),0.4936486056504486,1.2357104810020703,0.18446601941747573,0.7422034064406735,1.0,3/31,1.39%,KCNJ2;KCNJ15;NEDD4
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.5104332476722304,1.2356508155883434,0.18922305764411027,0.7414762316264358,1.0,5/27,4.44%,XYLT1;BGN;CHST11;CHPF2;CSPG4
prerank,'de novo' posttranslational protein folding (GO:0051084),0.4931932362015949,1.235495535751153,0.2143727161997564,0.7410924038371841,1.0,12/30,28.20%,HSPA2;DNAJB14;ST13;HSPA14;UGGT1;DNAJC7;HSPA5;DNAJC18;ENTPD5;DNAJB12;BAG1;DNAJB1
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.565114835615162,1.235198910600924,0.2183288409703504,0.7412885872342005,1.0,2/15,2.38%,LRP6;GLI2
prerank,regulation of transferase activity (GO:0051338),0.5560511970572645,1.235065723513639,0.22864651773981604,0.7408754712825221,1.0,5/17,10.85%,LDB2;LDB1;SMG6;PPP1R3F;ATM
prerank,regulation of bone mineralization (GO:0030500),-0.3276641790856366,-1.234837824230045,0.125,0.580150590752708,1.0,18/55,9.22%,PTN;WNT4;SLC8A1;BMP6;ADGRV1;OSR1;BMP7;ENPP1;KL;ANKH;SRGN;BCOR;ATP2B1;NOTUM;S1PR1;FBN2;ANO6;BMPR2
prerank,histone acetylation (GO:0016573),0.44716309969952384,1.233929374859475,0.1643243243243243,0.7442181914735615,1.0,30/69,23.75%,MORF4L2;TADA1;MRGBP;NAA60;NAA40;TADA2A;TRRAP;ING3;SGF29;KAT14;BRPF3;MORF4L1;ING5;KAT6B;TAF6;WDR5;KAT2A;ING4;PER1;CREBBP;APBB1;ATF2;BRD8;KAT7;YEATS2;KAT8;MEAF6;ZZZ3;TAF6L;KAT2B
prerank,regulation of cellular component biogenesis (GO:0044087),-0.3498819681129602,-1.2332481261394903,0.12582781456953643,0.5816271086737851,1.0,6/39,3.18%,TJP1;ROCK2;APOE;RAPGEF2;TIE1;NOTCH1
prerank,negative regulation of angiogenesis (GO:0016525),0.44367811922244244,1.2329182673094625,0.14947368421052631,0.7469641889623314,1.0,11/84,5.73%,THBS1;HOXA5;SLC12A2;EMILIN1;ISM1;SPARC;TGFB2;SERPINF1;SEMA3E;THBS2;SULF1
prerank,arachidonic acid metabolic process (GO:0019369),0.4911043149943418,1.232579458884107,0.20673076923076922,0.7472848813418628,1.0,6/35,8.05%,MGLL;PTGIS;PLA2G4A;CYP1B1;PTGES2;DAGLA
prerank,neural tube development (GO:0021915),0.5602621221200199,1.2317429709108756,0.21550591327201052,0.749520549309883,1.0,4/15,5.66%,PKD1;HES5;DACT1;DVL1
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.56084284266874,1.2316379334006136,0.23221476510067113,0.7489645022947349,1.0,9/15,27.36%,TSEN54;FAM98B;CLP1;CPSF4;RTCB;RTRAF;CSTF2;TSEN34;ERN1
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.5152335246554317,1.2311870741707682,0.20812807881773399,0.7497557229670209,1.0,12/25,26.50%,LDB1;BRD4;CDK12;HEXIM1;ZMYND11;LARP7;NELFB;CDK13;HNRNPU;EAF1;RECQL5;NELFA
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.4147964787901483,1.2309636726748363,0.04904904904904905,0.7496794914432289,1.0,87/327,20.20%,BNC2;ESR1;SIX1;ZFHX3;ZNF423;VSX1;NFIA;PRRX2;ZMIZ1;LDB1;DMTF1;ACVR1B;JMJD1C;APBB3;WWTR1;BAZ2A;SBNO1;STAT3;TCF7L1;ATF4;ERC1;MLF2;CHD3;TCFL5;PHF1;DNM2;DVL1;CCAR2;NFXL1;NFX1;BHLHE40;FZD7;FUS;TRRAP;RORA;RPS6KA4;TBX21;NSD1;SBNO2;CARM1;ESRRB;OGG1;CRABP2;ABL1;FADS1;SPTY2D1;CHEK2;KAT6B;RNF14;NR1D2;SFPQ;TGFBR1;KMT2D;RALY;LIMD1;SERTAD3;USP13;CREBBP;FOXN3;NKX6-2;PRDM2;NFKB2;ZFPL1;HMG20A;APBB1;MAGED1;E2F1;NFYA;SUFU;NR3C1;THAP7;GON4L;HMGA1;SRSF10;DAPK3;RYBP;ATF2;HCFC1;BRDT;ACTR8;GPBP1L1;TCF3;MLXIPL;TEAD2;ZNF431;WWC2;CALR
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.48142650761730776,-1.230863356333078,0.22602739726027396,0.58533118352363,1.0,7/11,27.50%,CYC1;UQCRC2;UQCR11;UQCRB;UQCRC1;UQCRQ;UQCRH
prerank,positive regulation of superoxide anion generation (GO:0032930),0.5757788501817103,1.2307594323426607,0.23374827109266944,0.7495392849790293,1.0,2/13,12.09%,PRKCD;SOD1
prerank,substrate-dependent cell migration (GO:0006929),0.5698976008090938,1.2307360874859883,0.23705722070844687,0.7486881995619484,1.0,2/14,0.90%,NTN1;ITGA11
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.5870496688834603,1.2305131972306396,0.211864406779661,0.7485546107745696,1.0,3/12,8.69%,IRS1;TWIST1;AKT2
prerank,nitrogen compound transport (GO:0071705),0.4312862805631671,1.2304243422461276,0.10692464358452139,0.7479362760309899,1.0,27/141,14.90%,SLC38A2;SLC38A1;SLC23A1;TMEM30B;SLC12A2;LMAN2L;SLC1A5;ABCC1;FLVCR1;RAMP2;SLC38A3;SLC6A2;RILP;LRRC8D;SLC7A10;HIKESHI;SLC43A1;RAB38;RAMP1;SLC25A47;PICK1;LRP2;TOM1;CHMP3;SLC1A4;ABCB6;MIA3
prerank,negative regulation of telomere maintenance (GO:0032205),0.5756957530513805,1.2303569449412994,0.23119015047879618,0.7472481344639091,1.0,6/15,15.94%,SMG6;ERCC4;ATM;RAD50;TNKS2;PARP1
prerank,positive regulation of multicellular organismal process (GO:0051240),0.4179535427174025,1.230350483280444,0.04613841524573721,0.7463466634196402,1.0,59/308,13.33%,GNAS;SIX1;CMKLR1;BMP1;VEGFA;LBP;LRP1;GAS6;FGF2;COL1A1;FOXD1;IL33;TIAM1;GADD45G;GRB10;GHR;PEMT;ACVR1B;GLMN;TGFB3;TWIST1;WWTR1;LRPAP1;TGFB2;SIX4;DYNC1H1;TLE6;ACVR1;ALMS1;BCL9L;SMAD4;TGFBR2;EHMT1;KMT5C;SOX9;B4GALT5;PLAC8;NOG;ESRRB;OGT;TRPM4;TSKU;ADIPOR2;TMEM119;CRTAM;BMP4;VIP;TERT;ABCA1;BMPR1A;TGFB1I1;SOD1;TGFBR1;SMO;KAT2A;AGO2;INHBA;NLGN1;F2R
prerank,endocardial cushion morphogenesis (GO:0003203),0.5434919438814166,1.230246581546861,0.22148541114058357,0.7457896006365697,1.0,10/18,12.41%,TGFB2;ACVR1;TGFBR2;HEYL;MDM4;SOX9;NOG;BMP4;BMPR1A;HEY1
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.49976979679487543,1.2302003192546818,0.2014475271411339,0.7450032004013825,1.0,8/32,11.47%,PEMT;CSNK2A1;CSNK2A2;LPCAT1;STARD7;GPAT4;LPCAT3;PCTP
prerank,autophagy of peroxisome (GO:0030242),0.5882322808218324,1.229314851387656,0.2314165497896213,0.7473838951333667,1.0,6/12,22.58%,NBR1;PEX5;ATM;SQSTM1;RB1CC1;ACBD5
prerank,negative regulation of cellular catabolic process (GO:0031330),0.4616861630421371,1.2290423894309594,0.16794731064763996,0.7474173129486662,1.0,20/63,15.70%,TIMP2;PTPN3;TIMP3;STAT3;EIF4G2;RIC1;EIF4G3;DAP;CDK5RAP3;FOXK1;CST3;RGP1;TAB2;NELL1;KDM4A;EIF4G1;SIRT2;KLHL22;HGF;TLK2
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.5466091270252552,1.2289291206206374,0.22580645161290322,0.7468753577625327,1.0,6/17,15.32%,IGFBP5;DOCK4;DOCK7;DOCK5;NRP1;CCN4
prerank,chromatin remodeling (GO:0006338),0.43309674268347254,1.2287614116181973,0.14526315789473684,0.7465779817582853,1.0,39/100,26.64%,ESR1;HDAC4;BAZ2A;CHD1L;CHD3;TADA2A;EZH1;SOX9;SMARCC2;FOXA1;INO80B;KDM5B;PBRM1;HDAC1;KDM4A;BAZ2B;KAT2A;HNRNPC;GATAD1;KDM5C;KDM6B;SMARCAD1;CHD8;SUV39H2;HCFC1;BRDT;ACTR8;MPND;BPTF;TOP1;TAF6L;KAT2B;SMARCA4;CHD4;SRCAP;HDAC2;DAXX;MYSM1;ARID1A
prerank,positive regulation of neurogenesis (GO:0050769),0.44952571594638446,1.228458489717902,0.15367727771679474,0.7467795999586895,1.0,8/68,4.42%,SLIT2;PLXNA4;VEGFA;TIAM1;TIAM2;CUX1;FBXW8;SERPINF1
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.51524665092303,1.228452767955347,0.21182266009852216,0.7458727911263663,1.0,8/25,16.15%,VCP;CLPP;UGGT2;UGGT1;LONP1;NGLY1;STUB1;HDAC6
prerank,activation of protein kinase B activity (GO:0032148),-0.37797592920835665,-1.2282378912428262,0.18232044198895028,0.589486848679821,1.0,8/29,6.50%,INSR;OSBPL8;WNT5A;FGF1;CCDC88A;RICTOR;PPIA;ADRA2A
prerank,sensory perception of light stimulus (GO:0050953),0.43677627690837734,1.2281790833383295,0.15106382978723404,0.7459944186184919,1.0,7/87,7.06%,SLC4A10;COL11A1;COL1A1;PDE6C;PITPNA;CRYZ;CHRNB2
prerank,regulation of astrocyte differentiation (GO:0048710),0.5961526020700894,1.2280658307752537,0.24828532235939643,0.7455094353886351,1.0,6/12,15.41%,ID2;HES5;NOG;SERPINE2;CLCF1;IL6
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.5279328411970353,1.2273619931843938,0.22564102564102564,0.7470791321450304,1.0,4/21,11.86%,RASSF2;DMD;PAQR3;SMAD7
prerank,negative regulation of cellular component organization (GO:0051129),0.43901211062155215,1.2270661891487469,0.16648531011969533,0.7472936710068779,1.0,15/74,11.81%,VEGFA;TMEFF2;RDX;FAP;HSPA2;LRSAM1;DNM2;IRAK3;PEX5;IAPP;TMC8;RAF1;IMPACT;LCMT1;HSPA5
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.5658912668163639,1.227007157470726,0.2598639455782313,0.7465985007737926,1.0,5/14,13.93%,ATP1B1;DMD;SLC9A1;CHP1;WNK1
prerank,regulation of monooxygenase activity (GO:0032768),0.5169565594655802,1.226982506281181,0.20075757575757575,0.7457821634951645,1.0,8/23,18.60%,EGFR;CYGB;DNM2;DDAH1;NOSIP;VDR;GDNF;AKT1
prerank,neural crest cell development (GO:0014032),-0.3342387746667093,-1.2269321038337853,0.15966386554621848,0.5902390968149248,1.0,16/44,18.87%,SEMA6A;SEMA3D;SEMA7A;SEMA5A;TBX1;ERBB4;CDH2;CORO1C;SEMA4D;SEMA3G;SEMA4A;SOX11;HTR2B;SEMA5B;SEMA4G;SEMA6D
prerank,regulation of DNA replication (GO:0006275),0.4628460657260648,1.2268195408034626,0.1905829596412556,0.7454722367507652,1.0,23/49,30.65%,EGFR;GLI2;SMC3;RBBP6;BRPF3;CDC6;CDAN1;CDT1;GMNC;KAT7;PDS5A;GTPBP4;PPP2CA;S100A11;EHMT2;ESCO1;PPP2R1A;USP37;ATR;WAPL;CTC1;GLI1;RAD17
prerank,lytic vacuole organization (GO:0080171),0.4963195008676541,1.2264896614488754,0.2202970297029703,0.7457404018381325,1.0,14/32,22.52%,ARSB;GAA;LAMTOR1;MBTPS1;NAGPA;TMEM106B;ABCA1;HPS4;ACP3;CLN3;MYO7A;SNAPIN;LRRK2;ZKSCAN3
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.5209226074017288,1.2261546120831743,0.22935779816513763,0.7460642253545833,1.0,6/20,17.25%,PID1;RHOQ;PPFIA1;CLTC;DAB2;LZTFL1
prerank,NIK/NF-kappaB signaling (GO:0038061),0.4453819582961766,1.2257230723205683,0.17070484581497797,0.7467137319548071,1.0,26/72,24.03%,CARD14;PSMD7;PSMA8;TNFSF15;PSMA4;CHUK;IRAK1;PSMD12;TNFRSF10B;CUL1;PSMA6;PSMD11;PSMC5;PSMD1;PSMD14;NFKB2;PSMC4;AKT1;MAP3K14;PSMA3;PSMD4;BIRC3;PSMB1;PSMA5;ZFP91;PSMA7
prerank,regulation of epithelial cell migration (GO:0010632),0.468962268162942,1.2255050178224032,0.16759776536312848,0.7465702734016891,1.0,8/51,7.95%,BMPER;RHOJ;PRKCE;ARSB;TGFB2;PFN2;DOCK5;SOX9
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.4049452138111957,1.2253706279859973,0.0,0.7461466181154491,1.0,459/1646,22.78%,TBX15;FOXP2;PLAGL1;BNC2;ESR1;EGFR;LRP6;SIX1;WWP1;FOXP1;KLF12;ZBTB7C;ID2;PRRX1;ZFHX3;HOXA5;ZFPM2;VEGFA;HIVEP3;PBX3;NFIX;GAS6;FGF2;ZNF423;HOXA3;COL1A1;FOXD1;NFIB;TCF7L2;PDCD4;ELF4;TWIST2;VSX1;DDX5;GCLC;HOXB6;MKX;SMAD9;NFIA;DDX17;DEAF1;ZIM3;ZFHX4;SMAD6;PRRX2;ZMIZ1;PHC2;MDFIC;GLI2;LDB1;PRICKLE1;JDP2;PRDM5;LRP5;NCOR2;TCF20;DMTF1;ACVR1B;TGFB3;GLIS2;TWIST1;JMJD1C;DKK3;APBB3;HOXC6;SP140;SHC1;PRDM11;LHX9;TLE2;CAMK2D;RBFOX2;CUX1;HDAC9;STAT5A;NFAT5;HDAC4;HOXB3;MED13L;ELF1;SIX5;RXRA;MAP3K5;WWTR1;BAZ2A;MEOX2;SBNO1;ONECUT2;ZNF250;STAT3;HES5;KLF5;ZBTB25;TCEA2;ANXA4;SIX4;KMT5A;TCF7L1;CCNL2;ATF4;TARBP1;ERC1;MLF2;TRIM28;MAMSTR;ERN2;ZFP14;NR2F1;CHD3;TCFL5;GMEB1;PHF1;ACVR1;BRD4;DNM2;TADA1;DVL1;ZNF25;CCAR2;ILK;FOXC2;NFXL1;PKNOX2;MIDEAS;NFX1;SAFB;BHLHE40;RXRB;LBX2;NFE2L2;SMAD4;GPATCH3;MRGBP;HMGB1;MEF2B;FZD7;E2F3;ZNF471;RFX7;TADA2A;FUS;TRRAP;BRWD1;PBX1;TSHZ2;HEYL;RUNX2;MEIS3;MED27;TASP1;CREG1;EHMT1;DAP;THRAP3;RORA;CCNL1;RPS6KA4;ZNF691;MDM4;TBX21;MED13;SOX9;FOXJ3;NSD1;HOXA6;HOXA9;PURG;MAEL;RARA;MBTD1;MED31;IKZF3;BTAF1;SBNO2;SRA1;BRD3;PA2G4;ILF3;CARM1;RCOR3;ESRRB;TFE3;FOXK1;CDC6;ENY2;OGT;ZNF76;SMARCC2;SLTM;DGKQ;ZIC1;RBBP8;PSIP1;FOXL1;RFX2;NFATC1;WWP2;SPINDOC;EID2B;RUNX1;TSC22D4;UBP1;PHC3;SCMH1;OGG1;SFR1;ING5;FOXA1;CRABP2;ZIC4;ZFP90;BMP4;FOXM1;SREBF1;ZBTB2;KDM2A;CSRNP1;CHUK;ZNF260;ABL1;FADS1;EHF;SPTY2D1;RFX5;POU6F1;CCNT2;URI1;MAP3K12;SETD5;PHF8;PITHD1;COMMD7;GLIS1;AXIN1;HSF4;NFE2L1;NRF1;CHEK2;MAZ;KAT6B;RNF14;ID4;KDM5B;FOXP4;NAA16;TAF15;NEUROD2;NR1D2;FOXO6;SMAD7;PHIP;TGFB1I1;KHDRBS1;SFPQ;HDAC1;TGFBR1;KDM4A;SRF;HEY1;TENM1;BAZ2B;HSPD1;FBXL19;ZNF112;KAT2A;ZNF740;INHBA;CD80;ARID4B;KMT2D;HOXB4;MAPRE3;CDC45;ZMIZ2;F2R;MEF2D;MYPOP;HR;NACC1;NPAS1;ZBTB9;MAP3K10;MEF2A;TIAL1;NFATC3;NDP;LIMD1;HOXA4;ERF;ZKSCAN1;MMS19;HNRNPK;PIAS4;HEXIM1;ZNF148;TFDP1;MAFG;MBD1;RING1;MED21;SIRT2;EN2;ARRB1;VDR;SERTAD3;BRD2;USP13;ING4;YWHAQ;FOXO3;PSMC5;IL6;PER1;ID1;CREBBP;L3MBTL2;KMT2B;FOXN3;GRHL1;MED26;CAMK4;BRD9;CREB1;HDAC6;NKX6-2;NFE2;PRDM2;NIPBL;AATF;ERBB2;NFKB2;ZFPL1;KDM5C;MLLT3;MTA3;HOXA2;CBX5;L3MBTL3;SUMO1;HMG20A;APBB1;MAGED1;E2F1;MED14;LCOR;MED12;NFYA;DPF3;CC2D1B;SUFU;CALCA;KLF3;E4F1;NR3C1;THAP7;RFXANK;ELP4;CDKN1C;GON4L;MEN1;HMGA1;ZKSCAN7;HDGFL2;CDT1;SRSF10;DAPK3;RYBP;KLF10;CITED2;CHD8;SUV39H2;ATF2;HCFC1;ZSCAN20;AKT1;SAFB2;BRDT;ZMYND11;ACTR8;HOXB2;CBFA2T2;BIRC5;CC2D1A;CBFB;HOXC5;ZBTB32;GPBP1L1;HIPK2;TCF3;QRICH1;IRF3;CRK;CDK5;MLXIPL;XRCC6;FOSL2;TEAD2;NFATC4;VEZF1;MAX;ATF6;MAP2K3;ZNF431;WWC2;CALR;SCML2;CREB3L1;SMURF2;BICRAL;KAT7;BPTF;CEBPD;MRPL12;IKZF4;HOMEZ;ZBTB24;NEK4;KLF9;MPHOSPH8;SAP18;SUV39H1;CHD2;SMAD5;MAD2L2;HOXC8;YEATS2;ZKSCAN5;NR3C2;MAP2K7;ATP8B1;NUP62;IL4;BCL11B;ATP2B4;MED20;RNF4;NFIC;SAMD11;USP47;ZBTB40;NR2C2;NR2F6;ZNF177;ZNF18;KDM3B;ELP3;CRY2;LOXL2;KMT2A;TFCP2;ZKSCAN3;NUP35;TGFBRAP1;GLI3;DNAJC2;SS18L1;MNT;KAT8;CDK5RAP2
prerank,mitochondrial gene expression (GO:0140053),0.47035045356992383,1.2247118068427203,0.19651162790697674,0.7477694921142893,1.0,15/42,23.42%,MRPS2;MRPS28;NOA1;MRPS18B;MRPS14;MRPS17;FOXO3;TFB2M;PTCD3;TWNK;MRPL12;MRPL47;MRPS24;MRPS21;MRPS18A
prerank,lipid translocation (GO:0034204),0.5246001361029029,1.2242878875737522,0.21309370988446727,0.7483894212201658,1.0,6/21,11.40%,TMEM30B;ABCC1;ATP8B2;ATP8A1;ABCA1;ATP9A
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),0.5967027164338561,1.2238935458255336,0.22191400832177532,0.7489628752127163,1.0,7/11,16.65%,RSPO3;PLEKHA4;CSNK1D;LBX2;CSNK1E;DAB2;MLLT3
prerank,eye morphogenesis (GO:0048592),0.5412713935498559,1.2238905118907568,0.2204515272244356,0.7480613321570441,1.0,5/19,7.48%,MFAP5;VEGFA;COL5A2;STAT3;SKI
prerank,negative regulation of epithelial cell proliferation (GO:0050680),-0.31367388879596947,-1.2227532642511754,0.15584415584415584,0.5979354869870586,1.0,13/66,6.65%,ROBO1;TGFBR3;MTSS1;MCC;NR2F2;APOE;CDK6;B2M;STAT1;CAV2;DUSP10;AQP11;PTPRK
prerank,myelination (GO:0042552),0.4656335542514706,1.2224685155891468,0.19182746878547105,0.7524503278675924,1.0,18/46,22.81%,MYOC;LGI4;ACER3;MARVELD1;PMP22;HES5;SKI;B4GALT5;PLP1;SIRT2;CXCR4;NF1;SCN8A;ACSBG1;BCAS1;ARHGEF10;ABCD1;GPC1
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.41056790173687724,1.222258185712757,0.048,0.7523326164569801,1.0,131/314,30.26%,WWP1;ECRG4;NEDD4;ANAPC5;FBXL7;PSMD7;UBXN8;CDC16;TOPORS;COP1;UBE2B;VCP;PSMA8;DNAJB14;ERCC8;NFE2L2;FAF2;TBX21;SYVN1;HUWE1;WWP2;SHARPIN;PSMA4;ITCH;CUL4A;FBXL4;UBE2C;FBXL12;HSPA5;PSMD12;ANAPC4;CUL1;FBXL19;PSMA6;PCBP2;LTN1;UBQLN1;RNF103-CHMP3;FBXL14;KCTD5;ANAPC2;SIRT2;ARRB1;STUB1;KLHL22;PSMD11;FBXL20;PSMC5;PSMD1;USP19;FBXO17;PPP2R5C;ANAPC1;PSMD14;RNF121;PSMC4;RPS27A;UBC;TRIM13;ANAPC10;YOD1;FBXL18;KCTD17;CDC20B;UBE4A;GID4;CDC27;NPLOC4;DNAJC18;CDC20;UBR2;CDK2;ZFAND2B;FBXW4;DCAF12;PCNP;UBXN4;UCHL1;UBE2G2;SMURF2;RMND5B;PSMA3;DCAF11;PSMD4;PSMB1;RNF4;APPBP2;AREL1;KCTD13;ECPAS;PSMA5;DERL1;RNF216;SGTB;PSMA7;TAF1;RNF122;FBXO9;SELENOS;HERPUD1;TMEM67;AMFR;ANKRD9;UBE2W;DNAJB12;FBXO38;UBR3;RNF126;JKAMP;PSMC1;SEC61B;TMUB2;SEL1L2;PSMA1;DDB1;DMAC2;UBXN2A;FAM8A1;UBE4B;ANAPC11;FBXL8;UBR1;BTRC;STT3B;SPOPL;RBX1;TMUB1;UBE2S;ZFAND2A;PSMD2;CTNNB1
prerank,nucleoside salvage (GO:0043174),0.6006319637659238,1.2222221211581177,0.27298850574712646,0.7515572586238746,1.0,6/10,26.20%,UCK2;UPP2;TK1;TK2;DCK;UCKL1
prerank,cilium organization (GO:0044782),0.4198921327827958,1.2221700715762753,0.07730923694779117,0.7508212229814573,1.0,78/209,25.97%,PKD1;GSN;CFAP298;EXOC4;EHD1;ABLIM3;PKHD1;DYNLT2B;ARMC9;RILP;MNS1;ODF2;CDC14A;BBS9;TMEM107;RAB8A;IFT20;GBF1;CC2D2A;EHD2;ATAT1;ARF4;PDE6D;TCTN1;IQCB1;IFT80;RFX2;TMEM216;CCDC66;ATP6V0D1;CFAP43;WDR11;PTPDC1;PARVA;CEP164;TRAPPC14;TTC17;OCRL;BBS5;MARK4;IFT46;RAB23;CEP41;FUZ;PCM1;NUDCD3;IFT88;NPHP3;HDAC6;INPP5E;TTLL3;LZTFL1;DYNC2I1;IFT43;CCDC57;TEKT2;TMEM237;TTC29;PTPN23;KIF24;RAB1A;TMEM231;SPAG16;TXNDC15;DYNC2H1;BBIP1;FAM161B;TMEM138;CEP89;PLK4;TCTN3;CCP110;TMEM67;BBS7;ACTR2;CEP20;EXOC7;FBF1
prerank,RNA processing (GO:0006396),0.41719330073570743,1.2214477866778948,0.09378185524974515,0.7525024011362739,1.0,68/176,25.78%,DDX17;PPP1R9B;HNRNPH1;TSEN54;SRSF1;NOL3;SRSF5;MBNL1;RBM39;DUSP11;M1AP;SRSF2;TENT4B;CCAR2;SNRNP48;FUS;HNRNPA2B1;YJU2;SRSF11;CELF3;LUC7L3;HNRNPL;CDK12;SF3B2;SF3B1;SF3A1;U2AF1;SRRM1;RBM6;SNRNP25;RBM5;PABPN1;SFPQ;ZRSR2;PTBP1;RBM4;HNRNPC;SRPK1;U2AF2;HNRNPK;CLP1;TFIP11;SCNM1;TUT7;NCBP1;NCBP2;CPSF6;SYNCRIP;SRSF7;HNRNPH3;ZCCHC8;DHX8;PRKACA;TENT2;GEMIN2;SNRPB;SRSF4;DHX16;TSEN34;PABPC4;PRMT9;PPIG;HNRNPU;SNRNP35;RBM3;PPP2CA;DDX39B;DDX20
prerank,positive regulation of reproductive process (GO:2000243),0.4924981600349606,1.2206144691369694,0.22426470588235295,0.7546543154657008,1.0,9/31,16.65%,VEGFA;TAC4;ACVR1B;PDE3A;VIP;AGO2;INHBA;SIRT2;LHFPL2
prerank,cellular response to amyloid-beta (GO:1904646),-0.3560408476865685,-1.2197442531319607,0.147239263803681,0.6028236948992179,1.0,13/35,15.05%,IGF1R;GRM5;EPHA4;APP;CACNA2D1;VCAM1;CASP4;GRIN2A;SNX6;ITGA4;IGF1;GRIN1;CACNB1
prerank,chromosome condensation (GO:0030261),0.4803449422496328,1.2197407785974228,0.1966626936829559,0.7570489869243281,1.0,10/36,18.22%,SMC4;CSNK2A1;CSNK2A2;KMT5A;ERN2;MCPH1;PHF8;AIFM1;ACIN1;DFFB
prerank,microtubule nucleation (GO:0007020),0.534801793658017,1.2196354262467812,0.22427440633245382,0.7565647426285699,1.0,7/19,19.00%,TUBG2;CSNK1D;TUBGCP3;AKAP9;NDEL1;CCDC57;SLAIN2
prerank,substantia nigra development (GO:0021762),0.4831834722484405,1.2194080033458714,0.21688159437280188,0.7564899040941903,1.0,14/37,16.30%,NDRG2;CALM2;RHOA;RAD1;HSPA5;S100A1;YWHAE;SEC16A;PLP1;ZNF148;SIRT2;YWHAQ;CKB;CALM3
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.43905407632748816,1.2192817964253762,0.173036093418259,0.7551429339154533,1.0,27/78,20.86%,SEC31A;SEC24D;SEC13;SEC23A;DYNC1H1;AP2A1;RILP;DNM2;KLC2;FCER1G;DCTN2;ARF1;DYNC1LI2;AP2A2;SEC24C;SEC24B;LAG3;CLTC;KLC1;SEC24A;DCTN5;ACTR1B;ACTR10;CAPZA1;DYNC1I2;DCTN1;CLTA
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.43905407632748816,1.2192817964253762,0.173036093418259,0.7551429339154533,1.0,27/78,20.86%,SEC31A;SEC24D;SEC13;SEC23A;DYNC1H1;AP2A1;RILP;DNM2;KLC2;FCER1G;DCTN2;ARF1;DYNC1LI2;AP2A2;SEC24C;SEC24B;LAG3;CLTC;KLC1;SEC24A;DCTN5;ACTR1B;ACTR10;CAPZA1;DYNC1I2;DCTN1;CLTA
prerank,long-chain fatty acid import into cell (GO:0044539),-0.4900080954805296,-1.219061475423341,0.23920265780730898,0.6020235428980782,1.0,3/10,8.49%,ACSL1;SLC2A1;SLC27A4
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.5360507226905947,1.2189979755934848,0.22091503267973855,0.7553009716456334,1.0,3/19,4.52%,SMOC2;ADAMTS3;XDH
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.45698994827245476,1.2188584685895634,0.20932878270762229,0.7548862426333004,1.0,10/54,11.53%,THBS1;VEGFA;FGF2;STAT5A;PRKCA;HMGB1;FGFR1;JUP;ANGPT4;PDPK1
prerank,negative regulation of biomineral tissue development (GO:0070168),-0.3946498131320504,-1.2187925143294376,0.1729957805907173,0.6001434251875287,1.0,6/21,4.60%,ROCK2;NOS3;ENPP1;NOTCH1;SRGN;BCOR
prerank,cellular response to glucose stimulus (GO:0071333),0.49527900014418086,1.2187597986070855,0.21641791044776118,0.7543710538620737,1.0,5/30,5.49%,SLC39A14;KCNB1;GAS6;UNC13B;ADCY8
prerank,organelle organization (GO:0006996),0.4071585030677554,1.2185057311956973,0.038,0.7543434771474019,1.0,128/388,23.66%,MICAL2;PLCE1;ABCD3;FMNL2;SEC31A;MARK1;VPS13C;MAPK15;PEX7;ATL2;ARC;CCL13;SEC61A1;CSNK1D;LMAN2L;RAB2A;FGD6;FBXW8;GOLGA8B;GOLGA5;RAB30;RAB34;RAB43;DOP1B;PEX11A;BCAS3;SMPD4;RAB3GAP1;MNS1;MIEF2;GOLGB1;ODF2;ATL3;SIRT5;GBF1;ATP8B2;BRWD1;RHOT2;PALLD;FAF2;TJAP1;ARHGAP21;HUWE1;PAK4;PLEKHM2;PEX16;RHOT1;CENPT;PEX1;TERT;RAB38;TRAPPC12;PEX10;NRF1;PHIP;TMED9;TRIP11;CIDEA;ZW10;LONP1;TTC17;LIG4;SEC16A;CHMP3;MTFR1;PI4K2A;SEC16B;MARK4;NDP;LIMD1;LMAN2;SIPA1L3;PRDX3;MIA3;TMEM135;PNPLA3;STX4;CDC42BPB;PARP1;BCS1L;POLG2;BNIP1;TMED2;VPS11;GOLPH3;MAST2;PEX6;TFB2M;SH3D19;COG2;NPLOC4;HCFC1;BLZF1;SEC23IP;ZMYM3;ZFYVE16;TTC29;CLUH;ZRANB1;CHMP4B;CHMP4A;TRAPPC11;TWNK;REEP5;FANCG;NIPSNAP2;LRRK2;PDCD6IP;MAST4;OPTN;ABI2;ATP8B1;SNX11;LMAN1;ATL1;RAB1A;PEX2;GORASP2;EIF2AK3;STOML2;PRKCI;ABCD1;RAB18;PEX14;DYNC2H1;VPS13D;FAM161B;TMED7
prerank,synaptic membrane adhesion (GO:0099560),0.5672396489943046,1.2182838892715664,0.21951219512195122,0.7542207107243093,1.0,4/14,5.02%,GPC6;PTPRS;PTPRF;LRFN4
prerank,regulation of developmental growth (GO:0048638),0.4962269962131816,1.2179691426448191,0.21521997621878716,0.7544157731813619,1.0,12/29,16.35%,SIX1;CTTN;GHR;STAT5A;SIX4;AGR2;DNM2;ABL1;MUSK;SOD1;LATS2;NIPBL
prerank,protein heterotetramerization (GO:0051290),0.5675020802308145,1.2178756485037476,0.23529411764705882,0.7538584554542608,1.0,5/13,17.90%,PKD1;CBR4;HSD17B8;CPSF7;CPSF6
prerank,actin filament polymerization (GO:0030041),0.4999610415656559,1.2177418133212936,0.21668742216687423,0.7534851749292178,1.0,7/29,16.04%,PSTPIP1;GSN;COBL;SPIRE2;TTC17;MICALL2;WASHC3
prerank,negative regulation of extracellular matrix organization (GO:1903054),0.6026456987738635,1.2176093024350483,0.23672883787661406,0.7530760436627957,1.0,4/10,9.00%,EMILIN1;FAP;TNFRSF1B;CST3
prerank,positive regulation of heart rate (GO:0010460),-0.4250129778147565,-1.2167823445843515,0.1865079365079365,0.6024957998869181,1.0,7/17,17.90%,PDE4D;RYR2;TPM1;EDN1;ADRA1A;SCN3B;KCNQ1
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.5908193154977305,1.216745787882353,0.25103448275862067,0.7544017200255757,1.0,4/11,20.44%,SYNJ1;INPP5B;OCRL;SYNJ2
prerank,inositol phosphate dephosphorylation (GO:0046855),0.5908193154977305,1.216745787882353,0.25103448275862067,0.7544017200255757,1.0,4/11,20.44%,SYNJ1;INPP5B;OCRL;SYNJ2
prerank,inorganic anion transmembrane transport (GO:0098661),0.44910553353349064,1.2161698351177233,0.1827354260089686,0.7555776448129076,1.0,7/63,7.19%,SLC26A2;SLC5A6;SLC12A7;SLC12A2;SLC4A8;GABRA3;SLC12A4
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.5031482449001317,1.2161453590885625,0.21882951653944022,0.7547716810981341,1.0,6/25,11.81%,HSPA2;DNAJB14;ST13;HSPA14;DNAJC7;HSPA5
prerank,regulation of cytokinesis (GO:0032465),0.4335663010813172,1.2155456419938853,0.1673728813559322,0.7560398187388052,1.0,26/78,24.42%,CIT;PRKCE;KIF13A;CALM2;CDC14A;GIPC1;CDC6;RHOA;PKN2;SPAST;CDC25B;GIT1;OPN1MW;ZFYVE19;CSPP1;CALM3;FLCN;BIRC6;KIF20B;SVIL;DRD2;SETD2;UVRAG;RAB11FIP4;PLK4;CCP110
prerank,skeletal muscle tissue development (GO:0007519),0.4888879472583152,1.2153557007178746,0.22341696535244923,0.7558435468393572,1.0,5/32,11.10%,SIX1;SIX4;SKI;SELENON;CSRP3
prerank,regulation of mRNA stability (GO:0043488),0.4179297322168044,1.2148425798097258,0.12614445574771108,0.7567583802305623,1.0,62/145,29.31%,XPO1;PRKCD;SAMD4A;PABPC1;PSMD7;PRKCA;FTO;PSMA8;PUM1;TENT5A;FUS;THRAP3;PCBP4;PSMA4;TBRG4;VIP;METTL16;TAF15;PSMD12;PSMA6;EIF4G1;XRN1;EXOSC4;PSMD11;PSMC5;PSMD1;PSMD14;RC3H2;PSMC4;RPS27A;UBC;E2F1;DIS3;TNPO1;GDNF;AKT1;FASTKD3;PSMA3;PSMD4;CIRBP;PSMB1;FXR2;SLC11A1;DCP1A;PSMA5;ZC3H14;YBX1;PSMA7;HNRNPU;ROCK1;RBM24;YWHAB;METTL14;PSMC1;ZFP36L1;RIDA;PSMA1;YTHDF1;FXR1;LARP1;KHSRP;PUM2
prerank,positive regulation of neuroblast proliferation (GO:0002052),0.59703472350348,1.2147711440389688,0.24172661870503598,0.7561309028168235,1.0,1/10,0.80%,VEGFA
prerank,inorganic cation transmembrane transport (GO:0098662),0.4092046925829727,1.2147671099983095,0.07,0.7552586680591795,1.0,39/268,12.11%,SCARA5;SLC4A4;KCNJ2;CACNA1G;KCNK5;CACNA1C;PKD1;SLC39A14;KCNB1;GAS6;ATP1B1;SLC12A2;SLC24A3;HCN4;SLC4A8;SLC39A11;TRPV3;KCNN1;SLC9A8;SLC6A2;SLC39A7;SLC4A11;SLC9A4;SLC9A1;SCN11A;KCND1;TRPC4AP;TRPM7;TRPM4;SLC6A7;KCNK6;ITGAV;SLC30A5;SLC39A13;ATP6V0D1;ABCB8;TMEM165;TRPM6;NNT
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.29402833378053633,-1.2147597010132773,0.06451612903225806,0.6051426311803031,1.0,44/91,23.50%,RPS14;RPS15;RPL8;RPS25;RPS8;RPS20;RPL4;RPS27;RPS10;RPL24;RPS29;RPS7;RPL26;RPS16;RPL35;RPS24;RPL36;RPL18A;RPS12;RPL11;RPS11;RPL12;UBA52;RPL18;RPS15A;RPS28;RPL21;RPL7;RPL10;RPL15;RPS18;RPS19;RPS3;RPL38;SRP68;RPS5;RPL28;RPL35A;RPS4X;RPL17;RPL23;RPL9;RPL31;RPL37
prerank,regulation of defense response to virus (GO:0050688),0.5518999983071009,1.2145966169113573,0.24826629680998613,0.7549974767267144,1.0,8/14,27.60%,IFNLR1;ITCH;TRAF3;PCBP2;RNF216;ILRUN;C1QBP;PPM1B
prerank,RNA stabilization (GO:0043489),0.48645919541315985,1.2144301361910406,0.21462264150943397,0.7547380668628086,1.0,17/33,28.88%,PABPC1;TENT5A;FUS;THRAP3;VIP;TAF15;E2F1;GDNF;ZCCHC17;CIRBP;TENT2;SLC11A1;YBX1;HNRNPU;RBM24;DKC1;LARP1
prerank,urogenital system development (GO:0001655),0.594779839181509,1.2144116237407232,0.24583333333333332,0.7539207633029177,1.0,4/11,9.20%,EPHB2;EPHB3;SOX9;ANXA1
prerank,regulation of superoxide anion generation (GO:0032928),0.5604643216310633,1.213953209726585,0.2393397524071527,0.754753238462463,1.0,3/14,16.36%,PRKCD;SOD1;AATF
prerank,blood vessel endothelial cell migration (GO:0043534),0.5137819634905698,1.2138486470136585,0.23439490445859873,0.7542758730194322,1.0,3/22,1.13%,SLIT2;VEGFA;FGF2
prerank,regulation of smooth muscle contraction (GO:0006940),0.5302477923761907,1.2135955726776912,0.24310776942355888,0.7543037733617854,1.0,3/20,1.98%,PLCE1;CTTN;PROK2
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.5515711810042965,1.2133029184085915,0.2393617021276596,0.7544606984470286,1.0,12/16,33.48%,MCMDC2;MCM2;WRN;MCM4;HMGA1;RAD51;TWNK;MCM7;RECQL5;SSBP1;BLM;PURA
prerank,cellular response to peptide (GO:1901653),-0.32312357432760513,-1.212770966704685,0.1368421052631579,0.6075479563681606,1.0,22/56,18.90%,IGF1R;GRM5;EPHA4;APP;CACNA2D1;VCAM1;ARHGEF2;VIM;CAV1;CASP4;GRIN2A;SNX6;ITGA4;IGF1;GRIN1;CACNB1;GPER1;NOD2;PTPN22;ICAM1;CACNA1A;XBP1
prerank,positive regulation of natural killer cell activation (GO:0032816),0.5701690313973782,1.2124379940249428,0.26322930800542743,0.7567592821927787,1.0,1/13,1.02%,GAS6
prerank,stress granule assembly (GO:0034063),0.533158886121289,1.2122224799369976,0.23958333333333334,0.7566739754488735,1.0,7/20,20.85%,DYNC1H1;ATXN2L;UBAP2L;PRRC2C;ATXN2;EIF2S1;CIRBP
prerank,negative regulation of cell differentiation (GO:0045596),0.416784756283721,1.2121806819924597,0.11235955056179775,0.7559711607606776,1.0,52/181,17.88%,EGFR;ID2;GDF10;WNT9A;ZFPM2;PDCD4;TWIST2;CRIM1;COL5A2;SMAD6;LRP5;TWIST1;LDLRAD4;SPRED2;WWTR1;HES5;XDH;JAG1;NBR1;SKI;RORA;SOX9;HOXA9;SRA1;NOG;ESRRB;TRPM4;TSKU;IQCB1;EID2B;ITGAV;FOXA1;BMP4;ANP32B;ABCA1;SMAD7;TGFBR1;HEY1;PTBP1;BMP5;LIMD1;SIRT2;IL6;TRIO;NPHP3;IL17RD;NEPRO;E2F1;ANKRD26;SUFU;EFNA1;MEN1
prerank,protein targeting to ER (GO:0045047),-0.29067204903362237,-1.211783243801309,0.0847457627118644,0.6074883272479503,1.0,47/99,23.50%,RPS14;RPS15;RPL8;RPS25;RPS8;RPS20;RPL4;RPS27;RPS10;RPL24;RPS29;RPS7;RPL26;RPS16;RPL35;RPS24;RPL36;RPL18A;RPS12;RPL11;SPCS3;RPS11;RPL12;UBA52;RPL18;SEC61G;RPS15A;RPS28;RPL21;RPL7;RPL10;RPL15;RPS18;RPS19;RPS3;SGTA;RPL38;SRP68;RPS5;RPL28;RPL35A;RPS4X;RPL17;RPL23;RPL9;RPL31;RPL37
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.46920170594637983,1.2117345012732714,0.2088681446907818,0.7567065315442913,1.0,7/41,10.43%,MGLL;PLA2G4A;CYP1B1;ELOVL5;SCD5;DAGLA;FADS1
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.4495344462617673,1.21167225055655,0.20288248337028825,0.7560550243874992,1.0,22/55,27.54%,FHL1;FBXL7;PSMD7;PSMA8;PSMA4;PSMD12;CUL1;PSMA6;PSMD11;PSMC5;PSMD1;PSMD14;PSMC4;PSMA3;PSMD4;PSMB1;USP47;PSMA5;PSMA7;PSMC1;ATF5;PSMA1
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),0.5986530254678302,1.2114691011918544,0.2616033755274262,0.7559316595791933,1.0,4/10,6.72%,NEDD4;PRKCE;CAMK2D;STK39
prerank,negative regulation of immune effector process (GO:0002698),-0.464217099233854,-1.211458336927312,0.24752475247524752,0.6057397842050004,1.0,7/13,24.26%,ENPP3;CD300A;HAVCR2;CD55;CD47;RPS19;GRN
prerank,mitochondrion disassembly (GO:0061726),0.48073115401944544,1.2114285637158309,0.24970414201183433,0.7551937269511996,1.0,18/34,34.39%,ULK2;WIPI2;ATG3;SQSTM1;RB1CC1;CTSK;ATG9A;PINK1;AMBRA1;ATG2B;FIS1;ULK1;CISD2;USP30;PRKN;MAP1LC3B;WIPI1;GABARAPL2
prerank,monocarboxylic acid transport (GO:0015718),0.4638400927979714,1.2113988010461452,0.1967032967032967,0.7544114070173913,1.0,7/51,3.85%,SLC5A6;SLCO3A1;SLC16A9;SLCO2A1;SLC16A1;SLC26A6;RXRA
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.5157623651614052,1.2113555754283252,0.23869346733668342,0.7536964916394684,1.0,10/22,27.72%,NEDD4;MVB12B;TOM1L1;RNF115;UBAP1;PTPN23;UBAP1L;MVB12A;RNF126;VPS37B
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.4347998322367598,1.2112382042634138,0.19414316702819956,0.7532591226218889,1.0,26/72,24.86%,PLAGL1;MUC1;CRADD;MDM4;NDRG1;CARM1;PCBP4;FOXM1;ATM;CHEK2;SESN2;TFDP1;ING4;CNOT8;CNOT10;RBL2;E2F1;CNOT9;USP10;TNKS1BP1;HIPK2;SFN;TRIAP1;PRMT1;RPS27L;TP53
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.537578735580231,1.2112243537959726,0.23490813648293962,0.7524530173742962,1.0,7/17,12.41%,ACVR1;JAG1;HEYL;NOG;BMP4;BMPR1A;HEY1
prerank,release of cytochrome c from mitochondria (GO:0001836),-0.42350058631261267,-1.2109914200938574,0.2,0.6043407599767116,1.0,5/17,12.29%,BCL2;BCL2L1;DNM1L;BOK;MFF
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.5437360632516739,1.2105118407339572,0.2459016393442623,0.7532155213542436,1.0,2/16,5.16%,THBS1;BCAS3
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.5437360632516739,1.2105118407339572,0.2459016393442623,0.7532155213542436,1.0,2/16,5.16%,THBS1;BCAS3
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),-0.3760027475754356,-1.2101180167765373,0.16853932584269662,0.60390714533908,1.0,8/27,12.22%,PPARA;PRKCH;ABCG1;NR1H3;AGTR1;CSF1;ABCA5;LPL
prerank,negative regulation of protein polymerization (GO:0032272),0.5003408575682221,1.2101112571780361,0.24014336917562723,0.7537751214623888,1.0,2/27,0.76%,SLIT2;PRKCD
prerank,regulation of telomere capping (GO:1904353),0.5101891591118495,1.2099789090614315,0.228287841191067,0.7533950291113329,1.0,7/23,14.06%,MAPK15;NEK7;SMG6;ATM;RAD50;USP7;TNKS2
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.42585637820016925,1.2092505018145976,0.15113871635610765,0.7550868576041178,1.0,28/113,18.56%,ESR1;TRABD2B;VEGFA;MPP7;UNC13B;CHD1L;IL5;VCP;CDC42EP2;USP50;SLF2;ERCC5;ERCC4;CUL4A;SPIDR;ATM;ABCA1;MED25;ERCC3;EIF4G1;ERCC2;STUB1;PSMC5;PARP1;PSMC4;SUMO1;CDT1;BID
prerank,neuron projection regeneration (GO:0031102),-0.4951272803551391,-1.208912460085824,0.253125,0.6044352262765871,1.0,2/10,1.84%,PTN;NREP
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.493691589635873,1.2088592565818461,0.22102747909199522,0.7556560898598027,1.0,13/29,24.73%,PABPC1;TENT5A;FUS;THRAP3;VIP;TAF15;E2F1;GDNF;CIRBP;SLC11A1;YBX1;HNRNPU;RBM24
prerank,response to laminar fluid shear stress (GO:0034616),0.5984718925280083,1.2088246849404083,0.23055162659123055,0.7548981105385584,1.0,4/10,11.86%,SMAD6;NFE2L2;ABCA1;SMAD7
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.5470667611038378,1.2085872016301995,0.2398921832884097,0.7548632252493032,1.0,3/15,4.44%,DSE;BGN;CSPG4
prerank,nucleic acid metabolic process (GO:0090304),0.4427545726705333,1.208322136818551,0.20417124039517015,0.7549773020250128,1.0,30/69,26.63%,HNRNPH1;RBFOX2;DUSP11;HNRNPA2B1;HNRNPH2;HNRNPL;WRN;GTF2F1;KPNA2;RAD50;HNRNPM;PCBP2;PTBP1;HNRNPC;MMS19;HNRNPK;POLR2F;NCBP1;NCBP2;ATXN2;POLR2B;HNRNPA3;HNRNPA1;TOPBP1;HNRNPU;RECQL5;METTL14;POLG;POLR2H;DNASE1L2
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.45728122543552,1.2079995254082374,0.21171171171171171,0.7552761600035538,1.0,17/52,16.57%,SRSF6;DDX5;DDX17;RBFOX2;MBNL1;CELF4;THRAP3;CELF3;HNRNPL;MBNL2;RBM25;RBM5;KHDRBS1;PTBP1;RBM4;YTHDC1;ZC3H10
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.5803006689026574,1.2076697175263895,0.2594670406732118,0.7556094913306486,1.0,7/12,26.20%,UCK2;UPP2;CAD;TK1;TK2;DCK;UCKL1
prerank,regulation of inclusion body assembly (GO:0090083),0.5815426272842832,1.2073115484056294,0.24651810584958217,0.7560417394242053,1.0,2/11,4.59%,HSPA2;SNCAIP
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.584715384952571,1.2072522913490864,0.2616279069767442,0.7553755886088527,1.0,6/10,24.86%,MUC1;FOXM1;ING4;HIPK2;RPS27L;TP53
prerank,nonribosomal peptide biosynthetic process (GO:0019184),0.5626548264447956,1.2070184868714169,0.23109243697478993,0.7553618715004559,1.0,6/12,27.47%,GCLC;BDH2;GCLM;CHAC2;HAGH;OPLAH
prerank,regulation of mitochondrion organization (GO:0010821),0.4624473025535686,1.2070094887919613,0.21878579610538373,0.7545410905756677,1.0,16/47,21.56%,PID1;CSNK2A2;MIEF2;RHOT2;IAPP;FZD5;RHOT1;SREBF1;SQSTM1;USP36;PLSCR3;HDAC6;FLCN;GOLPH3;LRRK2;MUL1
prerank,regulation of receptor internalization (GO:0002090),0.4828461256486569,1.206853073903412,0.21353558926487748,0.7542070002833495,1.0,9/35,15.86%,VEGFA;SFRP4;LRPAP1;RSPO1;DLG4;ARF1;PICK1;ARRB1;WDR54
prerank,positive regulation of biosynthetic process (GO:0009891),-0.3487082864999926,-1.2067692967011567,0.13664596273291926,0.6073650168755095,1.0,12/40,15.14%,SORBS1;WNT4;APOE;PPARA;SLC5A3;ZBTB20;VIM;MTPN;SUCO;ADGRB1;GRIN1;CREBL2
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.4787923170001605,1.2066556387344516,0.20823529411764705,0.7540887787105417,1.0,6/39,8.39%,THBS1;GAS6;PDCD4;RAMP2;NFE2L2;PAK4
prerank,negative regulation of chemokine production (GO:0032682),-0.4335812342121762,-1.2063081060735927,0.21825396825396826,0.6060158066741695,1.0,5/14,16.22%,APOD;C1QTNF3;LGALS9;SIGIRR;SIRPA
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.5218782676927173,1.2061135112497627,0.25161290322580643,0.755202687902533,1.0,6/21,15.10%,ADAM9;HM13;ADAM10;BACE2;BACE1;PSEN2
prerank,regulation of osteoblast proliferation (GO:0033688),0.5450969102522601,1.2060832659059462,0.23910171730515192,0.7544633161113298,1.0,5/17,11.54%,NPR3;RHOA;TMEM119;FGFR2;NELL1
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.44535947385691105,1.2052799793681461,0.1828752642706131,0.7564498219352971,1.0,22/73,22.78%,EGFR;VEGFA;GAS6;NTRK3;DOCK7;PFN2;RAF1;AXIN1;AKAP9;TENM1;EIF4G1;IL6;HDAC6;ARAF;TRIM6;CNOT9;AKT1;TNKS1BP1;MAD2L2;ATP2B4;RPTOR;CAMK1
prerank,regulation of endothelial cell proliferation (GO:0001936),0.42606936808927154,1.2052572607470753,0.16701902748414377,0.7556938920490051,1.0,15/88,12.22%,THBS1;PGF;VEGFA;F3;FGF2;SPARC;STAT5A;XDH;PRKCA;SULF1;BMP4;AGGF1;VIP;NRP1;TGFBR1
prerank,regulation of anoikis (GO:2000209),-0.41581708577769727,-1.2052384256979132,0.1875,0.6062422806620016,1.0,8/19,21.23%,BCL2;NOTCH1;TLE1;CAV1;BRMS1;PTK2;MCL1;SIK1
prerank,protein complex oligomerization (GO:0051259),0.43509604045417094,1.2051042524457865,0.1781115879828326,0.7554133940661847,1.0,26/85,21.92%,PRMT8;MPP2;EHD1;TRMT61B;ATL2;NOL3;ARC;ADCY8;LRRC8D;MCU;ATL3;SLC9A1;FUS;C9;SPAST;LETM1;G3BP2;MICU1;SHMT2;CPSF7;CPSF6;TWNK;PDCD6IP;IKZF4;ATL1;STOML2
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.46534766546827555,1.2050482857119091,0.2218350754936121,0.7547677121868297,1.0,4/43,1.87%,IRS1;PID1;PRKCD;GRB10
prerank,regulation of Ras protein signal transduction (GO:0046578),0.43286522321299514,1.2047458496179322,0.1809421841541756,0.7549704944118747,1.0,27/85,21.28%,PLCE1;ARHGEF28;ARFGAP1;NTRK1;RDX;EPHB2;SHC1;ARHGAP17;TGFB2;EPS8L1;BCR;RAF1;OGT;LZTR1;FOXM1;MADD;SHOC2;ARHGAP44;SQSTM1;AKAP13;LRRC59;FLCN;ERBIN;MAPKAP1;RASGRF1;DENND4B;NUP62
prerank,response to endoplasmic reticulum stress (GO:0034976),0.42218887001848454,1.2047304539648058,0.17908902691511386,0.754172715815752,1.0,42/107,27.95%,THBS1;P4HB;MAP3K5;ATF4;ERN2;VCP;AGR2;SYVN1;MBTPS1;CDK5RAP3;PDIA3;HYOU1;NIBAN1;AIFM1;BCAP31;HSPA5;TNFRSF10B;UBQLN1;SEC16A;UBA5;USP19;UFL1;ERLEC1;TMEM33;QRICH1;RCN3;ATF6;CREB3L1;RASGRF1;EIF2S1;GORASP2;EIF2AK3;DERL1;SELENOS;HERPUD1;TP53;DNAJB12;NCK1;BBC3;ERN1;UFC1;CCDC47
prerank,production of siRNA involved in RNA interference (GO:0030422),0.5918688979842801,1.2047087053433339,0.2569343065693431,0.7534291204305488,1.0,4/10,16.69%,PRKRA;TERT;AGO2;TSN
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.4635361859121138,1.2045531373463363,0.22427745664739884,0.7531181860213069,1.0,12/40,24.20%,XPO1;GLMN;CSNK2A1;CSNK2A2;CDK5RAP3;AXIN1;ARAF;UFL1;HIPK2;CLU;DESI1;TAF1
prerank,regulation of neuron projection development (GO:0010975),-0.2782871638314073,-1.2040330919821967,0.0,0.606743793541336,1.0,37/163,10.50%,EFNB2;LYN;PTN;LPAR1;CSMD3;APOE;ITGA6;SHANK3;IL1RAPL1;PPFIA2;PTK7;EPHA4;WNT5A;LRRC4C;RAPGEF2;CCDC88A;CHN1;CTNNA2;CAMK1D;SERPINI1;PTPRO;NTNG1;PTPN9;TENM3;PAK3;ROR2;CDH2;DCC;PRAG1;ATP1B2;PAK1;MFSD2A;ABI3;PDLIM5;KIF1A;PLXNB2;BAG5
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.5389473565956124,1.203985775748721,0.25733333333333336,0.7542908568662153,1.0,3/16,8.96%,KLRK1;RAET1E;PLEKHM2
prerank,chondrocyte differentiation (GO:0002062),0.4903216008045285,1.2038156139097085,0.20921985815602837,0.7540741097857852,1.0,9/32,10.16%,SLC39A14;NFIB;CCN3;HES5;SULF1;RUNX2;SOX9;RUNX1;BMP4
prerank,cardiolipin metabolic process (GO:0032048),0.5698372928257626,1.203592004833573,0.2612859097127223,0.7540398828138982,1.0,5/13,15.97%,PLA2G4A;TAMM41;PLA2G5;PGS1;PLSCR3
prerank,organophosphate ester transport (GO:0015748),0.5083943278105905,1.2035600793859185,0.22794117647058823,0.7533105401848462,1.0,5/24,4.82%,TNFAIP8L3;PITPNC1;PRELID3B;PITPNA;PITPNM1
prerank,tRNA aminoacylation (GO:0043039),0.4781584921583486,1.2034096566433736,0.21785714285714286,0.7530092135280283,1.0,12/37,20.32%,VARS1;WARS2;HARS2;PPA2;YARS1;DARS2;YARS2;PPA1;EPRS1;SARS2;SARS1;DARS1
prerank,lamellipodium organization (GO:0097581),-0.364541648848307,-1.2033837152453097,0.18324607329842932,0.6059364424565501,1.0,11/29,8.81%,ABLIM1;CDH13;KIT;CCDC88A;PARVB;PTPRO;S1PR1;WHAMM;SPATA13;ARHGEF6;SPEF1
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.5352422084596502,1.2029678397229986,0.2598639455782313,0.7536898449004955,1.0,9/17,30.15%,DHDDS;ALG13;DOLPP1;ALG1;ALG3;ALG14;ALG12;ALG9;SRD5A3
prerank,protein localization to chromatin (GO:0071168),0.5327684220115896,1.2024219196978743,0.2534435261707989,0.7548242630307561,1.0,2/18,7.62%,ESR1;SGF29
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.4403428923177384,1.2023684894978595,0.19383259911894274,0.7541668203507093,1.0,22/65,24.03%,FHL1;FBXL7;PSMD7;PSMA8;INTS3;CDK5RAP3;PSMA4;PSMD12;CUL1;PSMA6;ZFYVE19;PSMD11;PSMC5;PSMD1;PSMD14;PSMC4;PSMA3;PSMD4;PSMB1;USP47;PSMA5;PSMA7
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.5624913443884261,1.201946133478193,0.24896265560165975,0.7548251753918477,1.0,4/13,11.53%,FGF2;HMGB1;FGFR1;PDPK1
prerank,T-helper cell differentiation (GO:0042093),0.5545928024433101,1.201779103495334,0.2546419098143236,0.7545800125319521,1.0,3/14,6.52%,FOXP1;TMEM98;HMGB1
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.4369560644866498,1.2014759754692974,0.18996798292422626,0.7548788938562787,1.0,10/75,5.73%,THBS1;HOXA5;EMILIN1;ISM1;SPARC;TGFB2;SERPINF1;SEMA3E;THBS2;SULF1
prerank,regulation of multicellular organismal development (GO:2000026),-0.38851280988344145,-1.2013746772121972,0.19021739130434784,0.6085338698361976,1.0,7/25,13.59%,INSR;PTN;SOX17;SPAAR;DUSP6;OAS2;RACGAP1
prerank,heart morphogenesis (GO:0003007),-0.3332803279807979,-1.2011978878209242,0.14912280701754385,0.6063663407509399,1.0,10/50,5.83%,TGFBR3;INSR;ENG;CHD7;NOS3;TBX3;NOTCH1;RYR2;TBX1;SOX17
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.45583396075513744,1.201121395662297,0.20717592592592593,0.7554024126852936,1.0,10/46,12.09%,PDCD4;P4HB;ANXA2;PITPNA;IL12RB2;HNRNPA2B1;HNRNPDL;PAK2;ARF1;SOD1
prerank,phagosome acidification (GO:0090383),0.5010954479679662,1.2008306549577636,0.23803827751196172,0.7555767805930118,1.0,10/26,25.47%,ATP6V1C2;TCIRG1;ATP6V0A1;RAB38;ATP6V0D1;ATP6V1B2;ATP6V1E1;ATP6V1C1;ATP6V0E1;ATP6V0B
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.49575284268355396,1.2005329326294025,0.23536439665471923,0.7557968223827841,1.0,17/29,34.78%,CHD1L;ERCC5;CUL4A;ERCC3;ERCC2;PARP1;RPS27A;UBC;GTF2H4;XPA;DDB1;RBX1;RAD23B;CCNH;CUL4B;RPA3;CETN2
prerank,acyl-CoA biosynthetic process (GO:0071616),0.5451776431524606,1.2004023026784871,0.23790322580645162,0.7554161104254954,1.0,8/16,23.67%,SCD5;CBR4;PPT2;ACAT1;ACACA;HSD17B8;GCDH;PPCS
prerank,cellular response to leucine starvation (GO:1990253),0.6000913693353791,1.2003621084111793,0.2711864406779661,0.7547364255843559,1.0,5/10,20.14%,GCN1;SESN3;IMPACT;SESN2;EIF2AK4
prerank,regulation of neurotransmitter transport (GO:0051588),-0.43668240662018865,-1.200271665052422,0.21224489795918366,0.6061761501772422,1.0,4/16,8.17%,MCTP1;RIMS1;MCTP2;SYN1
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.4309706539048394,1.1997107379172347,0.20084566596194503,0.7562136013317937,1.0,27/79,20.86%,SEC31A;SEC24D;SEC13;SEC23A;DYNC1H1;AP2A1;RILP;DNM2;KLC2;FCER1G;DCTN2;ARF1;DYNC1LI2;AP2A2;SEC24C;SEC24B;LAG3;CLTC;KLC1;SEC24A;DCTN5;ACTR1B;ACTR10;CAPZA1;DYNC1I2;DCTN1;CLTA
prerank,water-soluble vitamin metabolic process (GO:0006767),0.43397941489707825,1.1994932651122576,0.19284940411700974,0.7561644956880088,1.0,17/68,19.56%,SLC23A1;SLC23A2;SLC5A6;AOX1;ABCC1;SLC25A32;MTRR;MMAB;NNMT;MTHFD2;GSTO2;ALDH1L2;MTHFD1;SHMT2;SHMT1;MTHFR;RFK
prerank,nerve growth factor signaling pathway (GO:0038180),0.5986972508533479,1.1994401138246233,0.26606875934230195,0.7555462029876246,1.0,2/10,4.76%,NTRK1;KIDINS220
prerank,regulation of postsynapse organization (GO:0099175),-0.37051372616321687,-1.1992412420098433,0.18556701030927836,0.6063479037545577,1.0,11/28,10.30%,SHANK3;IL1RAPL1;PPFIA2;EPHA4;WNT5A;ARHGAP22;HOMER1;ABHD17C;ABI3;PDLIM5;KIF1A
prerank,phospholipid transport (GO:0015914),0.4485047624433328,1.1991499128704122,0.21564245810055865,0.7557419607050778,1.0,12/52,11.47%,TNFAIP8L3;TMEM30B;PITPNC1;PRELID3B;ABCC1;PITPNA;PITPNM1;ATP8B2;ATP8A1;ABCA1;ATP9A;PCTP
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.39727089801474025,1.199034681016904,0.034,0.7553409440770245,1.0,151/497,23.17%,FOXP2;WWP1;FOXP1;ID2;IGFBP5;ZFPM2;GAS6;ZNF423;FOXD1;TCF7L2;PDCD4;TWIST2;GCLC;DEAF1;PHC2;MDFIC;LDB1;PRICKLE1;PRDM5;NCOR2;GLIS2;TWIST1;DKK3;SAMD4A;SHC1;PRDM11;LHX9;TLE2;RBFOX2;HDAC9;HDAC4;SIX4;KMT5A;TRIM28;ERN2;CCAR2;MIDEAS;BHLHE40;SMAD4;HEYL;RUNX2;EHMT1;DAP;TBX21;SOX9;MAEL;RARA;MBTD1;BTAF1;SBNO2;PA2G4;ILF3;RCOR3;FOXK1;CDC6;SMARCC2;WWP2;SPINDOC;EID2B;CDAN1;TSC22D4;PHC3;SCMH1;BMP4;FOXM1;COMMD7;KAT6B;ID4;NR1D2;KHDRBS1;SFPQ;HDAC1;KDM4A;HEY1;NACC1;NPAS1;MAP3K10;RBM4;LIMD1;PIAS4;HEXIM1;ZNF148;MBD1;RING1;SIRT2;VDR;ING4;YWHAQ;PER1;ID1;L3MBTL2;FOXN3;HDAC6;NKX6-2;CNOT8;NIPBL;KDM5C;CNOT10;MTA3;CBX5;L3MBTL3;SUMO1;E2F1;EPRS1;DPF3;CALCA;NR3C1;THAP7;CDKN1C;MEN1;HMGA1;SYNCRIP;DAPK3;KLF10;CITED2;CNOT9;CHD8;SUV39H2;ZMYND11;CBFA2T2;SHMT1;BIRC5;CDK5;MLXIPL;XRCC6;GMNC;CALR;SCML2;CREB3L1;SMURF2;KAT7;IKZF4;MPHOSPH8;SAP18;SUV39H1;YEATS2;ATP8B1;IL4;EIF2AK3;SAMD11;USP47;FXR2;CRY2;LOXL2;PDS5A;ZKSCAN3;GLI3;KAT8;PEX14;BCLAF1;SETDB2
prerank,neurotransmitter biosynthetic process (GO:0042136),-0.4570859799408434,-1.198939949203887,0.23809523809523808,0.6045984311304659,1.0,4/14,11.73%,MOXD1;ALDH9A1;NOS1;SLC22A2
prerank,negative regulation of anoikis (GO:2000811),-0.45513314667310345,-1.1988118050533767,0.200836820083682,0.6025255130047812,1.0,4/14,9.77%,BCL2;NOTCH1;TLE1;CAV1
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.3969553060546718,1.1987889246772878,0.01,0.7553593112954923,1.0,234/807,22.01%,FOXP2;ESR1;WWP1;FOXP1;KLF12;ID2;ZFHX3;ZFPM2;VEGFA;NFIX;GAS6;ZNF423;FOXD1;TCF7L2;IL33;SKIL;RARB;PDCD4;TWIST2;DDX5;GCLC;DEAF1;MUC1;PHC2;MDFIC;GLI2;LDB2;LDB1;PRICKLE1;JDP2;PRDM5;NCOR2;GLIS2;TWIST1;DKK3;SHC1;PRDM11;LHX9;TLE2;RBFOX2;CUX1;HDAC9;HDAC4;RXRA;STAT3;HES5;SIX4;KMT5A;PHF21A;ATF4;TRIM28;ERN2;NR2F1;CHD3;TCFL5;USP2;TLE6;DACT1;ZNF25;CCAR2;FOXC2;MIDEAS;NFX1;PRDM6;BHLHE40;SMAD4;PER3;HMGB1;EZH1;HEYL;RUNX2;EHMT1;NRIP1;DAP;SKI;MDM4;TBX21;TRIM27;SOX9;NSD1;MAEL;RARA;MBTD1;BTAF1;SBNO2;PA2G4;ILF3;NOG;RCOR3;FOXK1;DLG1;IMPACT;SMARCC2;MIER2;WWP2;SPINDOC;EID2B;RUNX1;TSC22D4;MCPH1;FGFR2;PHC3;SCMH1;ZFP90;BMP4;FOXM1;ZBTB2;KDM2A;POU6F1;URI1;ATN1;CBX2;COMMD7;GLIS1;HSF4;MAZ;RNF2;KAT6B;ID4;FOXP4;NR1D2;SMAD7;KHDRBS1;SFPQ;HDAC1;KDM4A;MED25;HEY1;EZR;MYPOP;NACC1;NPAS1;MAP3K10;MEF2A;FRK;LIMD1;ERF;TCF25;PIAS4;HEXIM1;DAB2;ZNF148;MBD1;RING1;SIRT2;VDR;ING4;YWHAQ;FOXO3;PER1;ID1;CREBBP;L3MBTL2;FOXN3;PARP1;CREB1;HDAC6;NKX6-2;PRDM2;NIPBL;MDFI;KDM5C;SIN3B;VPS72;MTA3;CBX5;RPS27A;UBC;L3MBTL3;SUMO1;APBB1;FLCN;E2F1;LCOR;DPF3;SUFU;CALCA;E4F1;NR3C1;THAP7;EFNA1;ORC2;CDKN1C;PCGF2;MEN1;HMGA1;KLF10;CITED2;CHD8;SUV39H2;HCFC1;ZMYND11;CBFA2T2;BIRC5;CBFB;ZBTB32;SARS1;NOC2L;TCF3;TAF9B;CDK5;MLXIPL;XRCC6;LARP7;LEFTY1;MAX;ZNF431;WWC2;CALR;SCML2;CREB3L1;SMURF2;KAT7;BPTF;IKZF4;MPHOSPH8;SAP18;SUV39H1;MAD2L2;YEATS2;GPS2;ATP8B1;IL4;MIER1;PEX2;PAF1;NFIC;RITA1;SAMD11;USP47;CRYM;NR2C2;NR2F6;ZNF177
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.5383930077120332,1.1982957624741188,0.25,0.756321251194357,1.0,3/17,6.22%,STAT3;GNL1;JAG1
prerank,outflow tract septum morphogenesis (GO:0003148),0.5045935717371228,1.198289296395274,0.2335483870967742,0.7555206644267342,1.0,12/24,13.42%,ZFPM2;SMAD6;TGFB2;ACVR1;SMAD4;TGFBR2;FGFR2;BMP4;BMPR1A;NRP1;PARVA;LRP2
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.5092421893849958,1.1981681173635934,0.23654568210262827,0.7551216275847875,1.0,7/21,14.20%,PLA2G4F;PLA2G4A;MBOAT2;LPCAT4;PLA2G5;LPCAT3;PLA2G12A
prerank,regulation of urine volume (GO:0035809),0.5902626833397352,1.1977320448034021,0.26571428571428574,0.7557927983926701,1.0,1/10,1.92%,NPR3
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.4285716013493077,1.1977298270661596,0.18756585879873552,0.7549802466167307,1.0,20/95,15.41%,LBP;ADAM9;PDCD4;CARD16;SHPK;TNFRSF1B;HMGB1;TRIM41;SBNO2;FZD5;RHOA;MAPK8;NFKBIB;IRAK1;GIT1;PABPN1;CASP1;CD80;SIRT2;IL6
prerank,cilium assembly (GO:0060271),0.4061842172004399,1.197387631248958,0.069,0.7553833613625323,1.0,105/296,25.97%,PKD1;GSN;CFAP298;EXOC4;EHD1;GORAB;CSNK1D;ABLIM3;PKHD1;CFAP206;DYNC1H1;DYNLT2B;ARMC9;SFI1;RILP;ODF2;CDC14A;BBS9;DNAAF3;ALMS1;TMEM107;RAB8A;IFT20;GBF1;CC2D2A;EHD2;ATAT1;ARF4;PDE6D;CCDC39;TCTN1;IQCB1;IFT80;RFX2;DCTN2;CKAP5;TMEM216;CCDC66;RPGRIP1L;ATP6V0D1;CFAP43;WDR11;PTPDC1;AKAP9;PARVA;SDCCAG8;TRIP11;CEP164;TRAPPC14;CSNK1E;YWHAE;OCRL;BBS5;TMEM80;MARK4;IFT46;RAB23;CEP41;FUZ;PCM1;NUDCD3;CEP63;IFT88;HAUS5;NPHP3;HDAC6;INPP5E;LRGUK;TTLL3;LZTFL1;DYNC2I1;TNPO1;IFT43;CCDC57;TEKT2;TMEM237;PTPN23;DYNC1I2;DCTN1;KIF24;PRKACA;RAB1A;IFT27;ACTR1A;TMEM231;CDK5RAP2;SPAG16;NEDD1;TXNDC15;CNTRL;DYNC2H1;BBIP1;TMEM138;NPHP4;CEP89;PLK4;TCTN3;CCP110;TMEM67;BBS7;ACTR2;CEP20;TUBB4B;EXOC7;FBF1
prerank,RNA interference (GO:0016246),0.5411593617958359,1.1968291898218189,0.25508819538670285,0.7565785414559908,1.0,6/17,16.69%,PRKRA;TERT;AGO1;AGO2;CLP1;TSN
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.4888396746897725,1.1967216502477434,0.2384428223844282,0.7561298656791885,1.0,13/30,26.46%,ABLIM3;CSNK2A2;HUWE1;FZD5;USP36;HPS4;MICALL2;VPS11;NPEPPS;SAE1;PINK1;ATG13;HTRA2
prerank,T cell migration (GO:0072678),0.5623026588223963,1.196710043546739,0.26975476839237056,0.7553570540436636,1.0,2/13,7.33%,SLC12A2;CXCL16
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.48201651726997263,-1.1965864924254082,0.2620481927710843,0.6053905309747185,1.0,4/10,17.63%,CX3CR1;CEACAM1;LGALS9;ARRB2
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.4675819281631179,1.1964682993662878,0.2273781902552204,0.7554128431349209,1.0,16/40,25.17%,PID1;VCP;SLC4A11;AKT2;PPA2;ABL1;SOD1;PRDX3;AKT1;LRRK2;STOML2;ABCD1;PYCR1;RNF122;BAD;PINK1
prerank,positive regulation of synapse assembly (GO:0051965),-0.376488217529361,-1.1963781891126006,0.21875,0.6035780084337972,1.0,12/27,12.77%,NRXN1;IL1RAPL1;GRID2;PTPRD;SRPX2;SEMA4D;CUX2;CLSTN1;EPHB1;IL1RAP;SYNDIG1;VSTM5
prerank,regulation of gene expression (GO:0010468),0.39734545017567635,1.1963148670124337,0.007,0.7551527020382733,1.0,212/903,18.69%,SLC38A2;BNC2;ESR1;SIX1;FOXP1;PID1;ID2;ZFHX3;HOXA5;VEGFA;C1D;GAS6;ATP1B1;F3;FGF2;ZNF423;FOXD1;IL33;SFRP4;GSN;SLC24A3;VSX1;AFF3;EMILIN1;NFIA;YBX3;NTRK3;COQ7;CLK1;FGF17;DRD1;PRRX2;HNRNPH1;LDB1;PRDM5;DMTF1;ACVR1B;RDX;AHNAK;GLMN;EPHB2;AHNAK2;ANXA7;C1QTNF1;TWIST1;JMJD1C;APBB3;PRDM11;PRDM10;CLK3;HDAC4;MBNL1;WWTR1;BAZ2A;SBNO1;STAT3;TGFB2;TCF7L1;CD3E;ZC3H7A;ATF4;XDH;ERC1;MLF2;FASTK;RAMP2;CHD3;TCFL5;PHF1;AGR2;DNM2;DVL1;CCAR2;NFXL1;SNRNP70;NFX1;PRDM6;PUM1;FAM98A;BHLHE40;NFE2L2;ADAM10;FZD7;ANKRA2;FUS;MATR3;TRRAP;ANK2;HNRNPDL;EDN3;RORA;RPS6KA4;TBX21;TRIM27;SOX9;NSD1;SBNO2;CARM1;NOG;ESRRB;BTNL9;TSKU;DGKQ;HNRNPH2;TMEM119;HNRNPL;MBNL2;WWP2;RUNX1;PCBP4;MAPK8;OGG1;CRABP2;BMP4;UBR5;PRDM4;ABL1;MUSK;FADS1;FAM98B;TERT;SPTY2D1;AGO1;ATM;TDG;FUBP1;BMPR1A;CHEK2;MAZ;KAT6B;RNF14;METTL16;NELL1;PABPN1;NR1D2;SFPQ;HDAC1;TGFBR1;KDM4A;MARF1;HEY1;PIK3CB;SMO;PTRH2;AGO2;ERP29;EZR;SERPINB9;INHBA;TRAF3;SETDB1;KMT2D;VTCN1;PCBP2;CLK4;PTBP1;TRIM26;USP36;SEC16B;LIMD1;HNRNPK;ZNF148;CPSF4;VDR;SERTAD3;YTHDC1;USP13;CAMK2N1;CCN4;AFF4;IL6;PER1;CREBBP;FOXN3;UBAP2;MED26;HDAC6;NKX6-2;PRDM2;NFKB2;ZFPL1;ZC3H10;ZNF462;RBL2;KDM6B;HMG20A;FGF5;APBB1;FLCN;MAGED1;E2F1;SLC2A10;NFYA;SUFU;NR3C1;THAP7;PRKAG1;RFXANK;TRIM6;GON4L;HMGA1;SRSF10;DAPK3;RYBP;CITED2;CLK2;GDNF;ATF2;HCFC1;AKT1;BRDT;ACTR8
prerank,"base-excision repair, AP site formation (GO:0006285)",0.5272188257289157,1.1957095035094072,0.2510176390773406,0.7564382838422585,1.0,5/17,14.43%,MPG;ERCC5;OGG1;TDG;SMUG1
prerank,regulation of cellular protein catabolic process (GO:1903362),0.5244791959344233,1.195161726775609,0.26541554959785524,0.7574927966012894,1.0,7/18,12.87%,RDX;DACT1;RIC1;CDK5RAP3;RGP1;NELL1;EZR
prerank,histone H4-K16 acetylation (GO:0043984),0.517417309251503,1.1950417771280313,0.2585551330798479,0.7571659480976141,1.0,11/19,23.12%,KANSL2;OGT;WDR5;ING4;HCFC1;KANSL1;KAT7;MSL1;KMT2A;KAT8;MEAF6
prerank,regulation of phospholipase C activity (GO:1900274),0.5387235731118457,1.194993323490842,0.2779291553133515,0.7565242721945317,1.0,5/15,10.41%,ESR1;FGF2;NTRK3;FGFR1;ABL1
prerank,protein deneddylation (GO:0000338),0.5909188305420582,1.194097966433129,0.2850678733031674,0.7588670535938278,1.0,7/10,34.59%,GPS1;COPS4;COPS7A;COPS3;COPS5;COPS2;COPS7B
prerank,sensory perception of sound (GO:0007605),-0.29085676207008676,-1.1940403552299124,0.12280701754385964,0.6071624884612594,1.0,14/88,5.32%,USP53;GRM7;COL4A3;EYA1;CEMIP;DCDC2;RIPOR2;ADGRV1;KIT;CACNA1D;CCDC50;CLIC5;WHRN;TBX1
prerank,cellular response to fluid shear stress (GO:0071498),-0.46405303750745086,-1.1939552122214165,0.21568627450980393,0.6049816414404265,1.0,3/12,8.94%,MTSS1;KLF2;ASS1
prerank,positive regulation of phospholipid transport (GO:2001140),-0.47947228387909396,-1.1938201136824986,0.23225806451612904,0.6029675579342557,1.0,1/10,1.41%,APOE
prerank,negative regulation of peptidase activity (GO:0010466),0.4536463251731281,1.1936843834664577,0.22727272727272727,0.7595750640953857,1.0,11/47,18.60%,LRP1;SERPINH1;TIMP2;TIMP3;SERPINF1;CST3;SERPINE2;SERPINB9;CRB2;SERPING1;AKT1
prerank,inositol phosphate catabolic process (GO:0071545),0.5776309046613659,1.193583799038851,0.27800829875518673,0.7591226479532728,1.0,4/12,20.44%,SYNJ1;INPP5B;OCRL;SYNJ2
prerank,regulation of mitotic spindle organization (GO:0060236),0.47480289995255837,1.193415719504275,0.24707259953161592,0.7588948512611803,1.0,14/35,26.95%,PARP3;RAE1;DYNC1H1;EML3;CHMP3;CLTC;CHMP4B;DCTN1;PDCD6IP;NUP62;HNRNPU;CHMP2A;TPR;DRG1
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.5693986047989892,1.193189832546996,0.26495726495726496,0.7589164897137706,1.0,8/12,28.48%,SEC61A1;HSPA5;CHMP4B;CHMP4A;SGTB;GET3;SEC61B;SEC62
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.44944933060603237,1.1930591146322789,0.20809248554913296,0.7585735565107915,1.0,19/48,26.60%,NUP93;SEC13;RAE1;SEH1L;OGT;NOA1;NUP37;RANBP2;NUP88;EIF6;PRKAG1;NUP210;POM121;NUP62;NDC1;NUP35;NUP85;TPR;NUP160
prerank,regulation of G0 to G1 transition (GO:0070316),0.467975723888059,1.1930140769162907,0.23775388291517324,0.7579309115927979,1.0,14/38,20.07%,EHMT1;RBBP8;PHC3;RNF2;RBBP7;TFDP1;RING1;L3MBTL2;CBX5;E2F1;PCGF2;RYBP;RAD51;MAX
prerank,nuclear pore organization (GO:0006999),0.5443578536540685,1.1924866298730554,0.28864569083447333,0.758941890903417,1.0,7/14,27.61%,NUP93;SEH1L;TMEM170A;NDC1;NUP35;TPR;AHCTF1
prerank,cellular response to oxygen-containing compound (GO:1901701),0.40247480460000645,1.192437500727818,0.08542713567839195,0.7583256433884793,1.0,44/291,13.07%,SLIT2;ESR1;EGFR;IRS1;PID1;WNT9A;IGFBP5;PRKCD;LBP;ADAM9;PDCD4;DRD1;HCN4;SLC26A6;IPO5;PDE3A;CARD16;SHPK;VCP;TNFRSF1B;LAMTOR1;HMGB1;FZD7;TRIM41;NRIP1;RORA;SOX9;SBNO2;CAPN2;IMPACT;RHOA;MAPK8;CHUK;ATM;NFKBIB;IRAK1;GIT1;P2RY6;PABPN1;AKAP9;CASP1;EZR;CD80;SESN2
prerank,protein localization to vacuole (GO:0072665),-0.44308711543853435,-1.1923639294344646,0.21686746987951808,0.6042606114747413,1.0,7/13,27.06%,LAMTOR5;SH3BP4;ATP13A2;LAMTOR4;LMBRD1;RTN4;MFSD1
prerank,purine ribonucleotide transport (GO:0015868),-0.4144543287217791,-1.1923599620496725,0.22746781115879827,0.6019094028697812,1.0,2/16,2.40%,ABCC4;LRRC8C
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.46267676658182955,1.1920866163199384,0.232037691401649,0.7587329745488275,1.0,16/37,26.63%,ENTPD2;SIDT2;ENTPD6;PPP1R8;RNASE3;RNASE6;SND1;SUPV3L1;NCBP1;DFFB;ENTPD7;MTREX;PABPC4;ENTPD5;NUDT18;DNASE1L2
prerank,defense response to Gram-positive bacterium (GO:0050830),0.4642500417004296,1.1920851102751004,0.24267291910902697,0.7579374824491933,1.0,8/40,18.98%,LBP;RNASE7;RNASE3;GBP6;RNASE6;DEFB1;IL6;DMBT1
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.5869482904136452,1.1919240306030272,0.26863572433192684,0.7576674562699856,1.0,4/10,28.77%,PDE6A;SAG;GNB1;PDE6G
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.4356312582782962,1.1918581932808816,0.20064724919093851,0.7571142319312348,1.0,8/66,9.20%,EGFR;PKD1;ID2;FHL1;RDX;DACT1;DLG1;ANXA1
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.48305743134145357,1.1914465640045,0.24561403508771928,0.757786676953416,1.0,12/29,17.88%,TCF7L2;TLE2;TCF7L1;BCL9L;TRRAP;PYGO1;TLE3;TERT;HDAC1;KMT2D;CREBBP;MEN1
prerank,neural crest cell differentiation (GO:0014033),0.5238255272338137,1.1913510449172855,0.2536327608982827,0.7573155491081673,1.0,1/18,0.33%,LRP6
prerank,acylglycerol biosynthetic process (GO:0046463),0.507218937912475,1.191320486986082,0.27581863979848864,0.7566319444042346,1.0,6/23,16.77%,PLCE1;PLA2G4A;GPAT4;AGMO;PNPLA3;PLA2G15
prerank,cytoplasmic translation (GO:0002181),-0.2934241679610187,-1.1911341401541158,0.10714285714285714,0.6025737189022933,1.0,49/91,25.48%,RPS14;RPS15;RPL8;RPS25;RPS8;RPS20;RPL4;RPS27;RPS10;RPL24;EIF2B3;RPS29;RPS7;RPL26;RPS16;RPL35;RPS24;RPL36;GSPT2;RPL18A;RPS12;RPL11;RPS11;RPL12;UBA52;RPL18;RPS15A;RPS28;RPL21;RPL7;RPL10;RPL15;RPS18;RPS19;RPS3;RPL38;RPS5;RPL28;RPL35A;RPS4X;RPL17;RPL23;RPL9;RPL31;RPL37;RWDD1;RPL14;RPS17;RPL34
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.5013793263358778,1.1911181075884245,0.24779874213836478,0.7564991701482779,1.0,8/26,18.02%,ST3GAL4;TKT;B4GALT5;ST3GAL2;GAL3ST4;B3GNT6;RRM2B;GOLPH3
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.5952839249381512,1.190908534221965,0.2646638054363376,0.7564128467051875,1.0,6/10,17.55%,ANXA2;RIC1;CDK5RAP3;RGP1;NELL1;EFNA1
prerank,mitotic DNA replication (GO:1902969),0.5822055320814297,1.1908379485221672,0.25441176470588234,0.7558832905745437,1.0,4/10,16.80%,MCMDC2;MCM2;CDC45;MCM4
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.5524746392613058,1.190820354887457,0.2574679943100996,0.7551600726997332,1.0,5/13,13.93%,NFIB;SOX9;BMP4;SRF;NFATC3
prerank,response to nutrient levels (GO:0031667),0.5382698335435843,1.1904138815920497,0.26711409395973157,0.7558244047236437,1.0,4/17,12.78%,KCNB1;ATF4;MEAK7;EIF4G1
prerank,peptide metabolic process (GO:0006518),0.43426009506316315,1.1902293390892535,0.2145922746781116,0.7557360133775639,1.0,23/75,19.85%,PCSK5;GSTT1;CPZ;GSTM5;HM13;CPQ;DMD;BACE2;DNPEP;BACE1;SOD1;SPCS2;NLN;CARNMT1;CPXM2;LNPEP;PSEN2;GSR;GSTZ1;IDE;NPEPPS;LVRN;SEC11A
prerank,cellular response to BMP stimulus (GO:0071773),0.4432463131852111,1.1901696043188963,0.19716775599128541,0.7551446574410525,1.0,15/66,12.32%,TMEM100;PDCD4;DDX5;SMAD9;SMAD6;TGFB3;TGFB2;ACVR1;SMAD4;RUNX2;SOX9;BMP4;BMPR1A;SMAD7;RGMA
prerank,anterior/posterior axis specification (GO:0009948),-0.42992566164395074,-1.189990986682783,0.2608695652173913,0.6030080062672679,1.0,2/15,3.06%,WLS;TBX3
prerank,mitochondrion morphogenesis (GO:0070584),0.5725073289719839,1.1897965149476815,0.26038781163434904,0.7556223516010327,1.0,1/11,0.50%,PID1
prerank,negative regulation of RNA metabolic process (GO:0051253),0.5281979551711504,1.1896531398153232,0.25895316804407714,0.7553011063806434,1.0,5/18,16.57%,ESR1;NCOR2;TERT;PTBP1;ZC3H10
prerank,activin receptor signaling pathway (GO:0032924),0.5394531681180132,1.1893377950676782,0.2648221343873518,0.7555996970185589,1.0,4/15,12.95%,ACVR1B;ACVR1;TGFBR1;INHBA
prerank,Golgi localization (GO:0051645),0.5810051913007412,1.1888044753041123,0.28405797101449276,0.7566513278701025,1.0,4/11,12.93%,ARCN1;COPG1;ARHGAP21;STK25
prerank,phosphate ion homeostasis (GO:0055062),0.5731961895911972,1.1886599059521035,0.27615062761506276,0.7564047834254999,1.0,1/10,1.29%,SFRP4
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.5224780640253518,1.1881633094839197,0.24609375,0.7573994507201107,1.0,3/18,8.83%,CMKLR1;FPR3;FCER1G
prerank,intracellular cholesterol transport (GO:0032367),0.5374199431431333,1.1881061001373894,0.27125506072874495,0.7568282803743221,1.0,4/15,13.32%,LRP6;NPC1;ABCA1;OSBP
prerank,regulation of cell cycle phase transition (GO:1901987),0.41811523116760163,1.1879581106266164,0.19576719576719576,0.7565191703341227,1.0,39/91,30.18%,ANAPC5;PSMD7;CDC16;PSMA8;PSMA4;UBE2C;PSMD12;ANAPC4;CUL1;ERCC3;PSMA6;ERCC2;ANAPC2;PSMD11;PSMC5;PSMD1;ANAPC1;PSMD14;PSMC4;ANAPC10;DBF4;CDC27;CDC20;PSMA3;PSMD4;PSMB1;ATP2B4;PSMA5;PSMA7;TAF1;TP53;PSMC1;PSMA1;DDB1;ANAPC11;BTRC;UBE2S;TRIM39;PSMD2
prerank,inner ear morphogenesis (GO:0042472),0.5135108487879052,1.1879241101395477,0.25154130702836003,0.7558632249741971,1.0,5/22,9.72%,SIX1;EPHB2;SOX9;ZIC1;FGFR2
prerank,skeletal muscle organ development (GO:0060538),0.5010235856015604,1.1875898317786349,0.25339925834363414,0.7562634142542211,1.0,4/26,11.10%,SIX1;SIX4;DISP1;CSRP3
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.4485817205892799,1.1873944944323986,0.229490022172949,0.7561612169224319,1.0,13/52,16.87%,EGFR;LRP1;PRKCE;EPHB2;EPB41L2;PLS1;AGR2;DLG1;PDPK1;SQSTM1;STAC3;STX4;SPTBN1
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),-0.45364455155930694,-1.1871037993634803,0.2785714285714286,0.6077844365099805,1.0,1/12,1.26%,IL1R1
prerank,regulation of leukocyte migration (GO:0002685),0.5398195753203889,1.1869400816156996,0.26052631578947366,0.7569468793049733,1.0,6/16,23.99%,VEGFA;ANXA1;MIA3;HMOX1;TNFSF18;BST1
prerank,myeloid cell activation involved in immune response (GO:0002275),0.5252764863743888,1.1867987348311364,0.2848020434227331,0.7566495392298456,1.0,3/18,8.83%,LBP;SBNO2;FCER1G
prerank,protein-containing complex disassembly (GO:0032984),0.44148267985445794,1.1861682221220005,0.21597300337457817,0.7580359733560482,1.0,19/54,27.20%,LRP6;VCP;DVL1;LIX1L;WIPI2;FZD5;AXIN1;UBQLN1;CHMP3;VIPAS39;CLN3;LAMP2;PYM1;UVRAG;DVL2;VTI1B;CSNK1A1;VPS16;FZD1
prerank,telomere maintenance via recombination (GO:0000722),0.5910146989591081,1.1858281587240904,0.27365356622998543,0.758342452806884,1.0,8/11,27.85%,ERCC4;RAD50;TPRKB;SMC5;RAD51;XRCC3;SMC6;NSMCE2
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),0.5796690697857174,1.185796818976401,0.2797704447632712,0.7576811388993402,1.0,5/10,11.94%,PRKCD;RDX;C1QTNF1;CD9;SERPINE2
prerank,regulation of ossification (GO:0030278),0.471835395085448,1.1856761099050959,0.2400932400932401,0.757280674553913,1.0,9/36,10.16%,LRP6;DDR2;SMAD6;TWIST1;TGFB2;ACVR1;NBR1;SOX9;BMP4
prerank,regulation of cell death (GO:0010941),0.4216137046578549,1.1854115720709375,0.22245762711864406,0.7573964088193674,1.0,16/94,12.78%,SRSF6;LRP1;FGF2;SRGAP2;CCN5;ACER3;CCN3;PRR7;LRPAP1;AGR2;TNFRSF1B;IMPACT;NOA1;BMP4;CHP1;EIF4G1
prerank,cellular response to interleukin-6 (GO:0071354),0.48689566012334123,1.1852362030977839,0.2518610421836228,0.7572273571203334,1.0,6/26,8.25%,PID1;PTGIS;STAT3;SMAD4;CBL;SBNO2
prerank,nucleosome disassembly (GO:0006337),0.5388728100661005,1.1851646250443955,0.25753424657534246,0.755919900347534,1.0,7/14,28.74%,SMARCC2;NFE2;HMGA1;SMARCA4;ARID1A;SMARCD2;SMARCC1
prerank,chromatin disassembly (GO:0031498),0.5388728100661005,1.1851646250443955,0.25753424657534246,0.755919900347534,1.0,7/14,28.74%,SMARCC2;NFE2;HMGA1;SMARCA4;ARID1A;SMARCD2;SMARCC1
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),-0.48254365188731774,-1.1850166907000232,0.2727272727272727,0.6107196228800466,1.0,5/10,20.61%,SHQ1;PIH1D1;RUVBL1;TAF9;ZNHIT6
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.3943949815970324,1.1849207269867932,0.03,0.7559498159826776,1.0,163/572,22.26%,FOXP2;ESR1;FOXP1;KLF12;ID2;ZFHX3;ZFPM2;VEGFA;NFIX;NFIB;TCF7L2;IL33;SKIL;RARB;NEDD4;DDX5;DEAF1;GLI2;LDB2;LDB1;JDP2;PRDM5;NCOR2;GLIS2;TWIST1;CUX1;HDAC9;HDAC4;RXRA;STAT3;HES5;KMT5A;PHF21A;ATF4;BAG3;NR2F1;CHD3;TCFL5;USP2;TLE6;DACT1;ZNF25;FOXC2;NFX1;PRDM6;BHLHE40;SMAD4;PER3;HMGB1;EZH1;NRIP1;SKI;MDM4;TBX21;TRIM27;SOX9;NSD1;RARA;NOG;DLG1;IMPACT;MIER2;WWP2;RUNX1;MCPH1;FGFR2;ZFP90;BMP4;FOXM1;ZBTB2;POU6F1;URI1;ATN1;CBX2;GLIS1;HSF4;MAZ;RNF2;ID4;FOXP4;NR1D2;SMAD7;SFPQ;HDAC1;SRF;MED25;HEY1;EZR;MYPOP;MEF2A;FRK;NFATC3;ERF;TCF25;HEXIM1;DAB2;ZNF148;SIRT2;VDR;FOXO3;PER1;ID1;CREBBP;PARP1;PRDM2;NIPBL;MDFI;SIN3B;VPS72;MTA3;CBX5;RPS27A;UBC;SUMO1;APBB1;FLCN;E2F1;LCOR;SUFU;E4F1;NR3C1;THAP7;EFNA1;ORC2;PCGF2;MEN1;KLF10;CITED2;CHD8;SUV39H2;HCFC1;CC2D1A;CBFB;ZBTB32;SARS1;NOC2L;TCF3;TAF9B;NFATC4;LARP7;LEFTY1;MAX;ZNF431;WWC2;CALR;SMURF2;BPTF;SUV39H1;MAD2L2;YEATS2;GPS2;IL4;MIER1;PEX2;PAF1;NFIC;RITA1;CRYM;NR2C2;NR2F6;ZNF177;CRY2;LOXL2
prerank,glycine transport (GO:0015816),-0.475682690157834,-1.1846715343615664,0.2550335570469799,0.6092702601677025,1.0,3/10,8.39%,SLC6A9;SLC38A5;SLC6A17
prerank,peptidyl-glutamic acid modification (GO:0018200),0.495569830119005,1.1845121733583055,0.2663316582914573,0.756546445326341,1.0,8/24,16.93%,VKORC1L1;TTLL2;GGCX;TPGS1;AGBL5;CEP41;PARP1;TTLL3
prerank,regulation of lamellipodium assembly (GO:0010591),0.4758926535849398,1.1844179509062216,0.25205158264947247,0.756099078197779,1.0,2/34,0.88%,SLIT2;PLCE1
prerank,NAD biosynthetic process (GO:0009435),0.5122864379090232,1.1837945465776722,0.2698612862547289,0.7575224250035897,1.0,6/20,16.25%,PTGIS;QPRT;NNMT;NMNAT3;NMNAT2;NAPRT
prerank,tight junction assembly (GO:0120192),-0.31457434196424056,-1.183635409951601,0.21782178217821782,0.6094815506988349,1.0,10/49,8.90%,PARD6G;OCLN;PECAM1;CDH5;CLDN5;ESAM;LSR;F11R;APC;CLDN1
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.561069003965882,1.1834192311405793,0.27434842249657065,0.7579865676578963,1.0,1/12,1.27%,IL33
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.4281543013238021,1.1830686474591428,0.2243797195253506,0.7584375841098375,1.0,30/78,25.47%,RNF144A;PRICKLE1;CSNK1D;COP1;VCP;DVL1;NFE2L2;FBXO22;RNF14;BCAP31;SMAD7;CSNK1E;UBQLN1;DAB2;SIRT2;STUB1;DDA1;SUMO1;CDC20B;HECTD1;CDC20;LRRK2;CLU;USP5;SUMO2;DET1;TAF1;HERPUD1;BBS7;RCHY1
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.42880547486076914,1.1830086676165277,0.20042643923240938,0.7578430541025102,1.0,12/76,12.87%,RASSF2;EGFR;PDCD4;CCN3;NFAT5;ILK;DLG1;RHOA;IRAK1;C1QTNF4;CD27;EZR
prerank,icosanoid secretion (GO:0032309),-0.45423808410377137,-1.1823715571027904,0.25517241379310346,0.6104102205496338,1.0,4/12,7.66%,ABCC4;BDKRB2;PNPLA8;ACE
prerank,regulation of mitotic cell cycle (GO:0007346),0.402999302939446,1.182318276065374,0.15837563451776648,0.75944933502195,1.0,72/171,29.64%,SMOC2;TTC28;PTPN3;ANAPC5;PSMD7;GAS1;CDC16;PRKCA;USP2;PSMA8;NEK7;GBF1;CDK10;SRA1;CDK5RAP3;PSMA4;PKN2;CDC25B;FOXA1;RCC1;INTS13;UBE2C;PSMD12;ANAPC4;CUL1;ERCC3;PSMA6;ERCC2;ANAPC2;PSMD11;IQGAP1;PSMC5;PSMD1;ANAPC1;PSMD14;PSMC4;ANAPC10;CDKN1C;CKS1B;DAPK3;CDC27;KIF20B;HECA;CDC20;CCDC57;DLGAP5;PSMA3;PSMD4;PSMB1;CUL9;PSMA5;RNF20;RPS6KB1;CYLD;PSMA7;CDK13;HNRNPU;NEK6;CUL7;CCDC8;PSMC1;EIF4E;USP22;PSMA1;DDB1;CDK9;HSF1;ANAPC11;BTRC;PRMT5;UBE2S;BTG3
prerank,response to lipopolysaccharide (GO:0032496),0.4085343372698752,1.182148066398082,0.1612576064908722,0.7592608565795251,1.0,31/138,18.37%,FOXP1;LBP;ADAM9;PDCD4;SMAD6;CARD16;SHPK;TNFRSF1B;HMGB1;IRAK3;TRIM41;LIAS;SBNO2;RHOA;MAPK8;NFKBIB;TAB2;IRAK1;GIT1;PABPN1;CASP1;CD80;F2R;SRR;PRDX3;CYP27B1;IL6;OTUD5;TRIM6;ACOD1;ERBIN
prerank,cardiac atrium morphogenesis (GO:0003209),-0.40674391453051334,-1.1820909900859284,0.2217573221757322,0.6088685298903229,1.0,7/16,18.13%,ENG;NOTCH1;PROX1;BMPR2;HEY2;BMP2;DLL4
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),-0.3822272398906129,-1.182065992352216,0.2146118721461187,0.6043453307724743,1.0,12/22,27.78%,ZDHHC14;ZDHHC18;ZDHHC3;ZDHHC2;ZDHHC23;ZDHHC12;ZDHHC21;ZDHHC7;GOLGA7B;ZDHHC6;ZDHHC24;ZDHHC22
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),-0.3822272398906129,-1.182065992352216,0.2146118721461187,0.6043453307724743,1.0,12/22,27.78%,ZDHHC14;ZDHHC18;ZDHHC3;ZDHHC2;ZDHHC23;ZDHHC12;ZDHHC21;ZDHHC7;GOLGA7B;ZDHHC6;ZDHHC24;ZDHHC22
prerank,glycine metabolic process (GO:0006544),0.562613420315041,1.1819181931072722,0.2761087267525036,0.7592911626691135,1.0,5/12,27.41%,GCSH;GLYAT;SHMT2;SHMT1;RIDA
prerank,endosome organization (GO:0007032),0.4601654895292766,1.1817994458899481,0.2453488372093023,0.758966861454972,1.0,12/41,20.41%,DNAJC13;RILP;LAMTOR1;USP50;EEA1;LAPTM4B;WASHC4;SQSTM1;PI4K2A;VPS11;PHETA2;ARFGEF2
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.4499976570360964,-1.1817183687853414,0.25704225352112675,0.6030046640370805,1.0,4/13,12.53%,NOS3;MTHFD1L;GCH1;SPR
prerank,steroid hormone mediated signaling pathway (GO:0043401),0.5554836133067413,1.1814484673970678,0.2912621359223301,0.7593869090558002,1.0,3/13,10.16%,ESR1;PLPP1;BMP4
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.4297406412728399,1.1811331799986042,0.20210526315789473,0.7597012702695102,1.0,20/87,13.27%,GDF10;LTBP2;COL3A1;COL1A2;ADAM9;SMAD9;SMAD6;ZMIZ1;TGFB3;TGFB2;ACVR1;SMAD4;TGFBR2;SKI;CBL;RHOA;BMPR1A;SMAD7;TGFBR1;ZMIZ2
prerank,negative regulation of interleukin-10 production (GO:0032693),-0.4024388022381031,-1.180913643126365,0.22821576763485477,0.6028238579305861,1.0,5/16,20.47%,TNFRSF21;CD274;TYROBP;DLL1;AGER
prerank,negative regulation of epithelial cell migration (GO:0010633),0.4765859673321631,1.1805033111795478,0.26297169811320753,0.7611177151057689,1.0,2/33,0.13%,THBS1;SLIT2
prerank,regulation of hemopoiesis (GO:1903706),-0.4747868229022383,-1.1800485071653843,0.25925925925925924,0.602659269492014,1.0,4/10,10.33%,PTN;PRKCB;IL17D;MAFB
prerank,C21-steroid hormone metabolic process (GO:0008207),0.5130595190995217,1.1795158137772261,0.27058823529411763,0.7637093725695983,1.0,4/20,13.40%,STARD3NL;AKR1C1;FDXR;DHRS9
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.5646292570176715,1.17920001512418,0.2603129445234708,0.7640676825112825,1.0,4/12,10.34%,MBTPS1;DGKQ;SREBF1;LPCAT3
prerank,response to copper ion (GO:0046688),-0.40099079455000847,-1.179166888892266,0.24596774193548387,0.602662659672611,1.0,11/20,21.25%,MT1X;MT1A;MT1H;MT1B;MT1G;MT1M;MT1F;MT1E;SNCA;MT3;ATP5F1D
prerank,calcium ion import (GO:0070509),0.48151999792485184,1.179104719710218,0.2644526445264453,0.7635939506746721,1.0,3/28,6.03%,CACNA1G;CACNA1C;MCU
prerank,positive regulation of rRNA processing (GO:2000234),0.582912724653054,1.1783307816088928,0.29394812680115273,0.7653869550108775,1.0,9/10,39.88%,RIOK1;BUD23;WDR75;RIOK2;TRMT112;SIRT7;UTP15;DIMT1;WDR43
prerank,negative regulation of transferase activity (GO:0051348),0.4906409986035431,1.178125707107851,0.24908869987849333,0.765292607290577,1.0,10/28,24.86%,EIF4A2;ERCC4;ABL1;SMAD7;PRDX3;CDKN1C;MEN1;NPRL2;HNRNPU;TP53
prerank,regulation of protein transport (GO:0051223),0.47845425907313466,1.1776342377030191,0.2558714462299135,0.7662254679460044,1.0,13/27,26.70%,P3H1;DISP1;LLGL1;WWP2;SCFD1;CHP1;GAPVD1;STXBP5;NDEL1;DNAJA1;DNAJC1;SNX3;NDFIP1
prerank,cell projection organization (GO:0030030),0.4784548410581737,1.1774108835609634,0.2644230769230769,0.7661994691696133,1.0,6/30,15.17%,RHOJ;GSN;RHOQ;CYFIP1;PARVA;SCIN
prerank,organelle assembly (GO:0070925),0.3973398160243088,1.1767955589534407,0.079,0.7674921911508796,1.0,132/384,26.02%,PKD1;GSN;ULK2;CFAP298;EXOC4;EHD1;CSNK1D;ABLIM3;GOLGA8B;PKHD1;RAB43;DYNC1H1;DYNLT2B;ARMC9;TUBGCP3;RILP;PACS2;ATXN2L;CDC14A;BBS9;NEK7;TMEM107;RAB8A;IFT20;GBF1;CC2D2A;EHD2;WIPI2;ATAT1;ARF4;PDE6D;CENPC;SH3PXD2B;TCTN1;UBAP2L;IQCB1;IFT80;RFX2;PRRC2C;CENPT;TMEM216;RAB38;RCC1;CCDC66;TRAPPC6A;ATP6V0D1;ATG3;CFAP43;WDR11;PTPDC1;ATG16L2;MIS12;PATL1;PARVA;DHX29;CEP164;TRAPPC14;STAM2;MAPRE3;OCRL;BBS5;UBQLN1;CHMP3;FARP2;LIMD1;IFT46;ABCB6;RAB23;CEP41;HPS4;FUZ;PCM1;NUDCD3;CEP63;IFT88;HAUS5;NPHP3;HDAC6;INPP5E;TTLL3;LZTFL1;DYNC2I1;CDS1;IST1;IFT43;RB1CC1;CCDC57;TEKT2;TMEM237;PTPN23;VTA1;CHMP4B;CHMP4A;CCDC61;DLGAP5;ATXN2;PDCD6IP;KIF24;EIF2S1;EIF2A;CIRBP;ATG16L1;NUP62;RAB1A;GORASP2;RUFY4;MVB12A;POGZ;TMEM231;SYNPO;SPAG16;TXNDC15;RAB1B;DYNC2H1;BBIP1;TMEM138;CEP89;PLK4;ATG9A;TCTN3;TMEM67;BBS7;NEK6;CHMP2A;NCOR1;FITM2;ACTR2;CEP20;EXOC7;FBF1;AMBRA1;ATG13
prerank,regulation of dendrite development (GO:0050773),-0.3408304129562029,-1.176733032027693,0.22377622377622378,0.6062807287906384,1.0,16/37,15.90%,PTN;NEDD4L;CSMD3;BMP7;TNIK;HECW2;CAMK1D;DCC;VLDLR;MFSD2A;ADGRB3;SEMA4D;SARM1;LRP8;RTN4IP1;CDKL5
prerank,regulation of mitochondrial fusion (GO:0010635),0.5663845257760569,1.1767125827454983,0.2778581765557164,0.7670168797846938,1.0,2/11,8.15%,PID1;HUWE1
prerank,endocytic recycling (GO:0032456),0.44278482600269276,1.1766568902485077,0.24057649667405764,0.7664368354098553,1.0,18/50,25.71%,EHD1;ANKRD27;EHD2;VPS52;VPS26A;VPS53;RAB11B;MICALL2;DENND1B;PTPN23;VPS26C;SNX4;DENND1A;RAB11FIP4;VPS51;SNX3;LMTK2;VPS35L
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.40720203553372286,1.1766297454865948,0.16819571865443425,0.7657712953516279,1.0,49/145,24.42%,FHL1;FBXL7;PSMD7;CSNK1D;DYNC1H1;SFI1;PSMA8;BRD4;ODF2;ALMS1;DCTN2;PSMA4;CDC25B;CKAP5;PSMD12;CUL1;AKAP9;SDCCAG8;RCC2;PSMA6;CEP164;CSNK1E;YWHAE;CEP41;PCM1;PSMD11;PSMC5;CEP63;PSMD1;HAUS5;PSMD14;CDC25A;PSMC4;CDK2;DYNC1I2;DCTN1;PSMA3;PSMD4;PRKACA;PSMB1;USP47;ACTR1A;CDK5RAP2;NEDD1;PSMA5;CNTRL;PSMA7;PLK4;CCP110
prerank,positive regulation of sodium ion transport (GO:0010765),-0.4550687944448202,-1.1763253977503467,0.2616487455197133,0.6051635351300542,1.0,7/12,20.62%,CNKSR3;GPD1L;NOS1;PKP2;ANK3;SCN3B;SCN5A
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.44612590470034924,1.176210047224175,0.23702031602708803,0.7663986059184528,1.0,26/52,27.35%,ABLIM3;CSNK2A2;HUWE1;FZD5;PPP3CC;MAPK8;YWHAE;USP36;HPS4;TFDP1;MICALL2;YWHAQ;E2F1;VPS11;NPEPPS;SAE1;BID;SFN;BAD;TP53;PINK1;YWHAB;NMT1;ATG13;HTRA2;BBC3
prerank,positive regulation of cellular metabolic process (GO:0031325),0.4124032610170549,1.1755860057094598,0.22083333333333333,0.7678069629305558,1.0,16/98,13.54%,THBS1;PID1;VEGFA;SFRP4;ECE1;ANXA2;XDH;TGFBR2;IFNLR1;AKR1C1;NSF;DHRS4;EIF4G1;INHBA;PICK1;ACACA
prerank,positive regulation of actin filament depolymerization (GO:0030836),-0.48249831149876665,-1.1753400817853423,0.262987012987013,0.6053080254369717,1.0,3/10,11.33%,ACTN2;SEMA5A;PLEK
prerank,UV protection (GO:0009650),0.5761858413697213,1.1746724843491816,0.29814550641940085,0.7701986020803415,1.0,6/10,26.41%,SCARA3;ERCC5;ERCC2;CAT;SDF4;XPA
prerank,cellular response to interleukin-12 (GO:0071349),0.44104158787591546,1.1745619476819635,0.2379862700228833,0.769833552394488,1.0,10/48,12.09%,PDCD4;P4HB;ANXA2;PITPNA;IL12RB2;HNRNPA2B1;HNRNPDL;PAK2;ARF1;SOD1
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.45955981694926307,1.1740122723921125,0.24242424242424243,0.7710004193193336,1.0,8/39,9.29%,FHL1;FXYD5;NEDD4;PTPN3;KCNE5;STK39;ANK2;WWP2
prerank,modulation of chemical synaptic transmission (GO:0050804),-0.28045121007140883,-1.1736500177733822,0.08333333333333333,0.6072591860620004,1.0,32/107,14.79%,ATP1A2;GRM7;GRM5;MCTP1;GRM3;LRRC4C;APP;RIMS2;GRID2;GRM8;NRG3;GRM1;GRIK2;RIMS1;EIF4EBP2;OPHN1;CDH2;MCTP2;SLC8A3;HOMER1;SYN1;LGI1;NMU;CX3CR1;CNTNAP4;CLSTN1;RELN;DGKZ;DLGAP1;LRP8;TPRG1L;DLGAP2
prerank,leukocyte cell-cell adhesion (GO:0007159),-0.3761612622255988,-1.1735912822777375,0.16417910447761194,0.605186327176278,1.0,6/24,11.54%,PECAM1;VCAM1;F11R;SYK;SEMA4D;ITGA4
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),-0.3985730134002491,-1.172568296435309,0.242914979757085,0.6053618006702588,1.0,5/19,13.39%,SLCO1C1;APP;KLF2;MTPN;PAX8
prerank,regulation of neurotransmitter secretion (GO:0046928),-0.34497160587189457,-1.1724460187667398,0.20710059171597633,0.6035310452542665,1.0,11/32,16.92%,MCTP1;RIMS2;RIMS1;MCTP2;SYN1;DTNBP1;SLC30A1;PREPL;GPER1;CAMK2A;SYT11
prerank,negative regulation of chemotaxis (GO:0050922),0.4737432697199604,1.1723565224923254,0.26360338573155984,0.7760342089292611,1.0,4/31,7.12%,THBS1;SLIT2;SEMA3E;SEMA4B
prerank,histone H3-K36 demethylation (GO:0070544),0.5869890810986486,1.1722875100887316,0.28763040238450077,0.7754992859406608,1.0,4/10,12.23%,RIOX2;KDM2A;PHF8;KDM4A
prerank,hemopoiesis (GO:0030097),-0.2766712424044169,-1.1713299227771454,0.10526315789473684,0.6039883632961321,1.0,22/87,13.50%,FLT1;TGFBR3;MECOM;TEK;ZBTB16;KIT;WNT5A;SNRK;KDR;MEIS1;NOTCH4;FLT3LG;FLT4;HIPK1;TAL1;SH2B3;PLEK;KITLG;PRKX;CD34;SFRP1;ETV6
prerank,negative regulation of kinase activity (GO:0033673),0.42655088115159856,1.1713287532652499,0.24419889502762432,0.7781254357658841,1.0,23/62,24.26%,LRP6;UBASH3B;WWTR1;DVL1;TRIM27;AKT1S1;PAK2;PDPK1;DEPTOR;CHP1;PRDX3;GSKIP;CAMK2N1;NF1;CDKN1C;AKT1;RTRAF;DUSP19;SFN;TSC2;NPRL2;SMCR8;HNRNPU
prerank,cellular response to topologically incorrect protein (GO:0035967),0.47131198282046466,1.1710822615210277,0.26019184652278177,0.7782005467183022,1.0,15/31,28.16%,HSPA2;BAG3;DNAJB14;HSPA14;HSPA5;STUB1;HDAC6;DNAJC18;OPTN;UBE2W;DNAJB12;DAXX;HSPB8;ERN1;HSF1
prerank,zinc ion transmembrane transport (GO:0071577),0.49822025290614735,1.1710419393275648,0.273972602739726,0.7775792724680909,1.0,7/22,16.53%,SLC39A14;SLC39A11;SLC39A7;SLC30A5;SLC39A13;SLC39A3;SLC30A6
prerank,proteoglycan metabolic process (GO:0006029),0.4920451312574987,1.17088763828921,0.27060270602706027,0.7773267027271284,1.0,6/26,12.12%,XYLT1;CHST11;HS3ST4;SULF1;FOXL1;GAL3ST4
prerank,response to metal ion (GO:0010038),0.4284736472158526,1.170880762673638,0.23411371237458195,0.7765805481724205,1.0,8/67,9.92%,THBS1;ADAM9;NEDD4;SEC31A;CALM2;FXN;NDRG1;SLC30A5
prerank,lung epithelium development (GO:0060428),0.5780644769836912,1.1707117125839226,0.2857142857142857,0.7764051695811796,1.0,2/10,10.16%,PKD1;BMP4
prerank,negative regulation of interleukin-1 production (GO:0032692),0.4879457564489471,1.1705761977405775,0.2645161290322581,0.7761073493198959,1.0,3/23,11.35%,GAS6;CARD16;GIT1
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.4437312759915092,1.1700234573095865,0.24354657687991021,0.7772075246529733,1.0,8/50,12.13%,EGFR;PDCD4;NFAT5;ILK;RHOA;IRAK1;C1QTNF4;CD27
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),-0.3365472940709522,-1.1697219443316722,0.18620689655172415,0.6058304863830273,1.0,10/41,7.80%,IL34;TGFA;GRM5;EPHA4;NEDD9;GPRC5B;DOCK3;ADRA2A;ACE;HBEGF
prerank,negative regulation of blood coagulation (GO:0030195),-0.3431760101350953,-1.16964358768991,0.19047619047619047,0.6038424832570403,1.0,11/38,12.38%,VTN;APOE;NOS3;TFPI;PLAT;F8;PDGFRA;EDN1;A2M;SERPINE1;CD34
prerank,negative regulation of bone remodeling (GO:0046851),0.564825687549206,1.1691268493358808,0.28969359331476324,0.7794898210489812,1.0,4/11,17.39%,UBASH3B;TMEM119;IL6;CALCA
prerank,regulation of cellular protein localization (GO:1903827),0.4477892021712674,1.1685972264744153,0.2534562211981567,0.7805277176286067,1.0,12/45,15.94%,GPC6;GPC3;VCP;DVL1;GBF1;SPIDR;CCDC66;RAB11FIP5;CSNK1E;RAB11B;NDEL1;PARP1
prerank,kidney development (GO:0001822),0.4337257246379848,1.16840537832936,0.23580786026200873,0.7804256505548234,1.0,14/65,16.35%,SIX1;PKD1;VEGFA;PCSK5;GLI2;TGFB2;SULF1;PYGO1;BMP4;TGFBR1;IFT88;NPHP3;NF1;NIPBL
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.40329141629889415,1.1683459103769307,0.17593528816986856,0.7798565445420503,1.0,19/151,11.54%,BMPER;EGFR;TNFAIP8L3;GAS6;FGF2;FSHR;NTRK3;NTRK1;CCL13;SHC1;CCL15;PRKCA;HMGB1;ROR1;PLA2G5;FGFR2;MAP3K12;P2RY6;NRP1
prerank,female gonad development (GO:0008585),0.5222634842520346,1.168316500569976,0.27055702917771884,0.7791840623055608,1.0,5/19,12.95%,VEGFA;FSHR;CYP19A1;SOD1;INHBA
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.5822726774999698,1.1679016487890166,0.296137339055794,0.7798689464055188,1.0,6/10,28.20%,BAG3;IMPACT;SIRT2;CITED2;NCK1;DNAJB1
prerank,response to retinoic acid (GO:0032526),-0.3104272666253395,-1.1670876875606817,0.1559633027522936,0.60796910415133,1.0,11/59,6.40%,LYN;WNT5B;PTK7;WNT5A;WNT6;ACER2;RBP4;BRINP3;TBX1;BRINP1;BRINP2
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.4578805667093273,1.166846085241145,0.24381625441696114,0.7826771784751769,1.0,4/37,2.85%,IGFBP5;FGF2;PDCD4;TGFB3
prerank,negative regulation of autophagy (GO:0010507),0.44279316362022153,1.1667271682845812,0.25111607142857145,0.7823369105667786,1.0,27/54,26.98%,STAT3;LZTS1;EIF4G2;NRBP2;SNRNP70;QSOX1;EIF4G3;DAP;FOXK1;SMG1;TAB2;KDM4A;EIF4G1;USP36;SIRT2;KLHL22;HGF;TLK2;AKT1;LRRK2;ZKSCAN3;RUBCN;SMCR8;PINK1;MET;GOLGA2;EIF4E
prerank,negative regulation of cytoskeleton organization (GO:0051494),0.4713819034041616,1.1659865150722066,0.26895734597156395,0.7841129883404976,1.0,5/29,6.35%,SLIT2;PRKCD;LIMA1;PFN2;SMAD4
prerank,negative regulation of ATP metabolic process (GO:1903579),0.5130468460138352,1.1659610344023834,0.2857142857142857,0.7834454671120759,1.0,7/17,19.59%,PID1;HDAC4;ACTN3;GIT1;PARP1;FLCN;MLXIPL
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.44062988550232013,1.1656870820163507,0.271889400921659,0.7836054257632752,1.0,18/46,17.09%,ZNF423;NPR3;DOCK7;ATF4;ACTN3;ACOT11;FOXC2;PGAM5;TFE3;TLE3;IP6K1;PCTP;ABHD6;CIDEA;LNPEP;ID1;FLCN;ACOT13
prerank,sequestering of extracellular ligand from receptor (GO:0035581),0.5379545989909568,1.1656687000240198,0.2950138504155125,0.7829290246306785,1.0,2/13,0.82%,CHRDL1;FSTL1
prerank,positive regulation of BMP signaling pathway (GO:0030513),0.4800905270560666,1.1656480882307245,0.2827417380660955,0.7822345565461583,1.0,7/25,11.22%,ZNF423;FOXD1;HES5;SULF1;SMAD4;BMP4;BMPR1A
prerank,signal peptide processing (GO:0006465),0.562720784855069,1.165589035771572,0.30638297872340425,0.7816963167307825,1.0,4/11,19.85%,PCSK5;HM13;SPCS2;SEC11A
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.5731630289932784,1.1655022641391268,0.3211781206171108,0.7804577499578358,1.0,2/11,3.55%,SHC1;STAT5A
prerank,cellular response to interleukin-2 (GO:0071352),0.5731630289932784,1.1655022641391268,0.3211781206171108,0.7804577499578358,1.0,2/11,3.55%,SHC1;STAT5A
prerank,negative regulation of defense response to virus (GO:0050687),0.5668569801441274,1.1653489976593103,0.2972972972972973,0.7801930455451791,1.0,6/10,27.60%,ITCH;PCBP2;MUL1;ILRUN;C1QBP;PPM1B
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.4673464077420513,1.1652316804748273,0.2781065088757396,0.7798439957253332,1.0,9/33,15.34%,HOXA5;ACVR1B;RAB7B;STAT3;PRKDC;PITHD1;INHBA;SCIN;FOXO3
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.43094232022393086,1.1649248506219043,0.24833702882483372,0.7801352819186324,1.0,13/67,14.52%,MYOC;P4HB;VIT;CD3E;AGR2;ILK;S100A10;DOCK5;JUP;ABL1;NRP1;ARL2;NDNF
prerank,pyrimidine-containing compound metabolic process (GO:0072527),-0.47654749321079115,-1.1648087983070121,0.2815533980582524,0.6116868479372821,1.0,4/11,13.23%,ENPP3;SLC19A3;ERH;SLC19A2
prerank,glial cell development (GO:0021782),-0.3621000988217035,-1.1645165513476994,0.24630541871921183,0.6102685570028297,1.0,12/25,21.12%,CDK6;APP;EIF2B3;CSPG5;NRROS;EIF2B1;SOX11;MT3;DLL1;SOX4;MXRA8;MDK
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.5364804852624605,1.1640671957149125,0.3103448275862069,0.7822007085028947,1.0,3/14,8.69%,IRS1;TWIST1;AKT2
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.47533705860285735,1.1639822103017063,0.2890528905289053,0.7817353550336845,1.0,12/26,27.60%,CARD16;TRAFD1;IRAK3;ITCH;MAPKBP1;PCBP2;SIRT2;ACOD1;MUL1;ILRUN;C1QBP;PPM1B
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.4802884333177825,1.1639478760944117,0.2871165644171779,0.7811075997899556,1.0,3/27,1.13%,IRS1;TNFAIP8L3;FGF2
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.43281034050206235,1.1639180481245985,0.24259055982436883,0.7804484226442094,1.0,31/66,29.80%,PRKCD;IPO5;WWTR1;LIMK2;BAG3;TRIM28;MAVS;JUP;CDK5RAP3;ZIC1;UBR5;TERT;SESN2;ORMDL3;RBM22;AKT1;CCT6A;CCT4;LARP7;CCT8;KAT7;EIF2AK3;TCP1;EFCAB7;TPR;DKC1;LIF;CCT5;TESK1;YAP1;MEPCE
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.39115520972547624,1.1639109676279944,0.119,0.7797243586864012,1.0,94/366,20.77%,BNC2;ESR1;SIX1;ZFHX3;ZNF423;VSX1;NFIA;PRRX2;LDB1;DMTF1;ACVR1B;JMJD1C;APBB3;WWTR1;BAZ2A;SBNO1;STAT3;TCF7L1;ATF4;ERC1;MLF2;CHD3;TCFL5;PHF1;DNM2;DVL1;TOM1L1;CCAR2;NFXL1;NFX1;BHLHE40;FZD7;FUS;TRRAP;RORA;RPS6KA4;TBX21;NSD1;SBNO2;CYFIP1;SMC3;CARM1;RBBP6;ESRRB;OGG1;CRABP2;ABL1;FADS1;SPTY2D1;CHEK2;KAT6B;RNF14;NR1D2;SFPQ;TGFBR1;KMT2D;NOLC1;LIMD1;SERTAD3;USP13;FOXO3;CREBBP;FOXN3;NKX6-2;PRDM2;NFKB2;ZFPL1;HMG20A;APBB1;MAGED1;E2F1;NFYA;SUFU;NR3C1;THAP7;GON4L;HMGA1;SRSF10;DAPK3;RYBP;ATF2;HCFC1;BRDT;ACTR8;GPBP1L1;TCF3;MLXIPL;TEAD2;ZNF431;WWC2;CALR;ATXN2;KAT7;EIF2A
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.3951179719825191,-1.163304730523199,0.2757009345794392,0.6112000374044736,1.0,4/19,3.80%,GRM5;RYR2;KDR;VCAM1
prerank,endocardial cushion development (GO:0003197),0.503079007727798,1.162973464858548,0.2888318356867779,0.7821854297466323,1.0,10/21,12.41%,TGFB2;ACVR1;HEYL;MDM4;SOX9;NOG;CRELD1;BMP4;BMPR1A;HEY1
prerank,renal filtration (GO:0097205),0.5800354962995444,1.1627736089567111,0.29036827195467424,0.7820993336444373,1.0,3/10,5.73%,TBC1D8B;MYO1E;SULF1
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.4191751555677476,1.1624309155057184,0.21864951768488747,0.782540143284251,1.0,12/80,13.34%,THBS1;VEGFA;GAS6;MAP3K5;CSNK2A1;CARD16;HMGB1;RAF1;BCAP31;CASP1;F2R;YWHAE
prerank,RNA methylation (GO:0001510),0.4310613012304243,1.1620736023707114,0.25331858407079644,0.7829867954872722,1.0,28/60,34.43%,TRMT61B;TARBP1;METTL16;TYW3;THADA;THUMPD3;TRMT44;TRMT6;TFB2M;ALKBH8;FBL;METTL1;TRMT61A;NSUN6;BUD23;METTL8;MTO1;METTL14;TRMT112;NSUN3;MEPCE;METTL6;RBM15;TGS1;PCIF1;METTL2B;METTL2A;MRM2
prerank,aminoglycan metabolic process (GO:0006022),0.5776341580537578,1.1618308325332676,0.3024602026049204,0.7831005514714197,1.0,1/10,0.50%,XYLT1
prerank,morphogenesis of an epithelium (GO:0002009),0.4861699684239993,1.1616748356077846,0.29797979797979796,0.782877598003136,1.0,3/25,9.72%,LRP6;SOX9;FGFR2
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),0.5390253968926872,1.161666316258002,0.3153526970954357,0.7821684302909425,1.0,8/13,14.57%,NUP93;TGFB3;SMAD4;BMP4;BMPR1A;SH2B1;TGFBR1;DAB2
prerank,V(D)J recombination (GO:0033151),0.5605115119511559,1.1616622816759028,0.2874828060522696,0.7814330221809982,1.0,4/11,19.28%,PRKDC;HMGB1;LIG4;TCF3
prerank,membrane protein proteolysis (GO:0033619),0.4520115081145799,1.1613015191277396,0.26697892271662765,0.7819118709226118,1.0,7/37,9.76%,ADAM9;HM13;ADAM10;BACE2;CLPP;MBTPS1;BACE1
prerank,DNA alkylation (GO:0006305),0.5100222992690582,1.1611974579046809,0.29781771501925547,0.7807512169302092,1.0,8/19,26.32%,BAZ2A;EHMT1;MTRR;TEX15;FOS;DNMT1;EHMT2;DNMT3A
prerank,DNA methylation or demethylation (GO:0044728),0.5100222992690582,1.1611974579046809,0.29781771501925547,0.7807512169302092,1.0,8/19,26.32%,BAZ2A;EHMT1;MTRR;TEX15;FOS;DNMT1;EHMT2;DNMT3A
prerank,positive regulation of DNA repair (GO:0045739),0.446681228826916,1.1610715669622669,0.2643020594965675,0.7804701539826376,1.0,11/46,16.98%,EGFR;EYA2;TRIM28;ERCC8;HMGB1;SLF2;FOXM1;SPIDR;SPIRE2;PARP1;FAM168A
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.4425494343865436,-1.1610595112229465,0.24825174825174826,0.6146884003137906,1.0,4/12,9.38%,PPARA;ABCG1;NR1H3;ABCA5
prerank,regulation of vasoconstriction (GO:0019229),-0.3545073131539734,-1.1608693816011648,0.24083769633507854,0.6130540225498681,1.0,10/27,11.79%,ATP2B1;BDKRB2;ACE;AGTR1;BMPR2;TBXA2R;CAV1;ADRA1A;CHRM3;ACE2
prerank,positive regulation of lipid kinase activity (GO:0090218),0.4735176155503569,1.1606314632801287,0.2769607843137255,0.7812321732633131,1.0,3/29,1.13%,IRS1;TNFAIP8L3;FGF2
prerank,insulin receptor signaling pathway (GO:0008286),0.4271515742222164,1.1598146339241648,0.2592190889370933,0.7833086557229402,1.0,19/69,16.29%,IRS1;SLC39A14;GRB10;RHOQ;ATP6V1C2;SHC1;TCIRG1;C2CD5;FOXC2;ATP6V0A1;AKT2;ZNF106;ATP6V0D1;PHIP;PTPN2;ATP6V1B2;ATP6V1E1;SOS1;IDE
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),0.5014193192426859,1.1594515649288186,0.2928759894459103,0.7838170361272461,1.0,7/19,22.25%,DLG2;CLIC4;CRB1;DLG1;CRB2;ERBIN;PRKCI
prerank,sphingosine metabolic process (GO:0006670),0.5201402712705239,1.1593840300453893,0.3050397877984085,0.7833065794979409,1.0,3/17,6.23%,ACER3;PLPP3;PLPP1
prerank,regulation of glucose metabolic process (GO:0010906),0.46689482476004857,1.1592176581146887,0.2697841726618705,0.7831178207138991,1.0,10/34,18.60%,IRS1;RORA;AKT2;FOXK1;OGT;DGKQ;USP7;GNMT;BCKDK;AKT1
prerank,negative regulation of protein secretion (GO:0050709),0.4571468774458243,1.1591756395021422,0.29976851851851855,0.7825119150333905,1.0,3/38,1.79%,IRS1;KCNB1;CCN3
prerank,regulation of ERBB signaling pathway (GO:1901184),0.5253841836988363,1.1590685091138007,0.2930800542740841,0.7821293588362033,1.0,5/15,16.37%,EGFR;MVB12B;PTPN18;WDR54;ERBB2
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.41041172010176963,1.158750744069689,0.24555903866248693,0.7824464408553018,1.0,38/94,25.97%,CSNK1D;DYNC1H1;SFI1;ODF2;ALMS1;CC2D2A;TCTN1;IQCB1;DCTN2;CKAP5;TMEM216;RPGRIP1L;AKAP9;SDCCAG8;CEP164;CSNK1E;YWHAE;MARK4;CEP41;PCM1;CEP63;HAUS5;DYNC1I2;DCTN1;KIF24;PRKACA;ACTR1A;CDK5RAP2;NEDD1;CNTRL;NPHP4;CEP89;PLK4;TCTN3;CCP110;TMEM67;TUBB4B;FBF1
prerank,coenzyme A metabolic process (GO:0015936),0.5281801711804622,1.1586596138677396,0.3053735255570118,0.7820063993472085,1.0,10/14,32.67%,DCAKD;PANK4;ACAT1;PANK3;PPCS;PANK2;ACLY;PPCDC;CROT;COASY
prerank,regulation of synapse assembly (GO:0051963),0.4394829448500409,1.1585182147786734,0.2790960451977401,0.7817681099639187,1.0,11/46,13.27%,SLIT1;GPC6;EPHB2;CLSTN2;LRFN4;EPHB3;CHRNB2;MUSK;SETD5;EIF4G1;NLGN1
prerank,response to organophosphorus (GO:0046683),-0.40592055114460424,-1.1584894553971543,0.23790322580645162,0.6166058754119162,1.0,6/16,13.42%,STAT1;TRPC3;ABCC9;TRIM16;RFC3;TYMS
prerank,glycolipid biosynthetic process (GO:0009247),0.45293853174638016,1.1580862533608833,0.2810304449648712,0.782476730427632,1.0,7/38,14.41%,ST3GAL4;PIGW;ST6GALNAC5;ST3GAL2;PIGF;PIGL;PGAP2
prerank,positive regulation of ATP metabolic process (GO:1903580),0.46697503233321475,1.158009877058613,0.26153846153846155,0.782008847548919,1.0,4/32,5.17%,SLC4A4;PID1;ACTN3;VCP
prerank,regulation of B cell proliferation (GO:0030888),-0.31878446363069723,-1.1575923478224346,0.2288135593220339,0.6166372473936289,1.0,12/44,14.96%,LYN;BCL2;TFRC;AHR;TNFRSF21;NFATC2;CD38;VAV3;CD300A;CD74;CD40;TYROBP
prerank,telomere capping (GO:0016233),0.5187764750253837,1.15735711442493,0.2986666666666667,0.7835491872657468,1.0,5/16,15.59%,PRKDC;TEN1;RAD50;DCLRE1B;TFIP11
prerank,nucleotide-excision repair (GO:0006289),0.40981670283508226,1.1573564779302286,0.22384937238493724,0.7828183331339013,1.0,56/101,35.01%,CHD1L;ERCC8;GPS1;ERCC5;HMGN1;ERCC4;OGG1;CUL4A;USP45;ERCC3;XAB2;LIG4;ERCC2;USP7;MMS19;POLR2F;PARP1;ISY1;RPS27A;UBC;SLC30A9;HUS1;POLB;AQR;POLR2B;COPS4;COPS7A;TP53;RNF111;POLD1;SLX4;COPS3;UVSSA;GTF2H4;POLR2H;XPA;PNKP;DDB1;POLR2I;RBX1;POLR2L;COPS5;XRCC1;POLR2K;RAD23B;ERCC1;CCNH;ERCC6;CUL4B;POLK;RPA3;COPS2;COPS7B;FAN1;CETN2;RFC4
prerank,mRNA modification (GO:0016556),0.4917723906241316,1.1572061341936464,0.2803129074315515,0.7825925474011576,1.0,10/22,27.34%,TRMT61B;METTL16;PUS3;TRUB1;TRMT6;TRMT61A;PUS1;METTL8;METTL14;DKC1
prerank,myeloid dendritic cell activation (GO:0001773),0.555974530144312,1.1568062037216478,0.30800542740841247,0.7832205278260672,1.0,4/12,21.35%,TGFBR2;HMGB1;CAMK4;IL4
prerank,positive regulation of double-strand break repair (GO:2000781),0.45006121016979206,1.1565019976329693,0.2665094339622642,0.7834938175566377,1.0,20/39,29.56%,PARP3;PRKDC;FUS;SLF2;KMT5C;FOXM1;SPIDR;WDR48;SPIRE2;MMS19;PARP1;MAD2L2;SLF1;ACTR2;SHLD3;WAS;PNKP;SHLD1;DDX11;TIMELESS
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.41424478578577506,1.1559727302691605,0.22722400857449088,0.784563367679141,1.0,23/77,21.35%,THBS1;TCF7L2;NOL3;CSNK2A1;CSNK2A2;FXN;ACVR1;ITGAV;BMP4;BCL2L2;URI1;MAZ;PHIP;TGFBR1;HGF;SLC35F6;BIRC6;AKT1;ZMYND11;NOC2L;CLU;SH3RF1;IL4
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.48982180461496627,1.155946063529844,0.2862362971985384,0.7839122492262283,1.0,7/26,17.12%,EGFR;SOX9;SYAP1;PDPK1;IQGAP1;ERBB2;GAREM1
prerank,positive regulation of filopodium assembly (GO:0051491),0.48213444812208656,1.15582903018327,0.2757352941176471,0.7835618546979453,1.0,9/24,13.27%,ARAP1;RHOQ;DPYSL3;TGFB3;BCAS3;NRP1;TENM1;MIEN1;NLGN1
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.38859923484386694,-1.1554402524496874,0.2548076923076923,0.6197747744298089,1.0,5/20,9.20%,BCL2;BCL2L1;FAS;DCC;BOK
prerank,lymphocyte migration (GO:0072676),0.45969359237086094,1.15542985867277,0.28258221680876977,0.7841627802423486,1.0,4/32,9.97%,CCL13;CCL15;TBX21;CRTAM
prerank,glutathione biosynthetic process (GO:0006750),0.5444770984490489,1.1554200457299897,0.3034965034965035,0.7834637142082179,1.0,6/11,31.84%,GCLC;GCLM;CHAC2;HAGH;OPLAH;GSS
prerank,peptidyl-lysine methylation (GO:0018022),0.4843210176081701,1.15527045900677,0.28465346534653463,0.7832436442249748,1.0,12/26,26.49%,EEF1AKMT3;KMT5A;EHMT1;EEF1AKMT2;SETD4;SUV39H2;SUV39H1;SETD2;SMYD2;SETD7;EHMT2;TRMT112
prerank,neuromuscular synaptic transmission (GO:0007274),0.5179164604831369,1.155235091520759,0.3156498673740053,0.7826449588638384,1.0,6/18,20.22%,ERC1;CHRNB2;TBC1D24;STAC3;ERC2;KIF1B
prerank,DNA metabolic process (GO:0006259),0.3898700648050743,1.154994201327262,0.14814814814814814,0.7827380668469823,1.0,119/270,33.48%,TCF7L2;HELB;PARP3;CHD1L;MPG;UBE2B;TRIM28;POLE2;VCP;PRKDC;HMGB1;INTS3;RMI2;TRRAP;KMT5C;MCM2;ERCC5;CDC6;DCTPP1;RBBP8;ERCC4;RAD1;OGG1;WRN;TERT;ATM;KPNA2;TDG;USP45;TDP1;RAD50;ERCC3;LONP1;ALKBH1;CSNK1E;CDC45;LIG4;USP7;SUPV3L1;MMS19;SMUG1;DCLRE1B;ATRIP;PARP1;UBE2V2;TSN;MCM4;RPS27A;UBC;SUMO1;HUS1;POLB;ORC2;SMARCAD1;MEN1;TOP3B;CDT1;DBF4;DFFB;RAD51;UHRF2;CDK2;XRCC3;XRCC6;FANCG;ENDOV;PDS5A;TOP1;TOPBP1;UPF1;SMC1A;UVRAG;TOP1MT;ALKBH3;PRIMPOL;TOP3A;MCM7;RECQL5;DNMT1;PARG;PRIM1;POLD1;SLX4;GTF2H4;POLG;XPA;PARP4;DNASE1L2;ZRANB3;PNKP;RPAIN;RTEL1;DDB1;NOP53;ADPRS;ATR;RAD52;IGHMBP2;PDS5B;TIMELESS;SMARCAL1;MBD4;CTC1;HINFP;RAD17;UBE2A;XRCC1;BLM;MSH2;UBE2N;CNBP;ERCC1;GLRX2;SIRT7;CHRNA4;POLK;POLQ;RPA3;PURA
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.4904593888036272,1.1549215271155762,0.29156327543424315,0.7822732321621838,1.0,3/24,1.87%,NEDD4;EMILIN1;GRB10
prerank,histone H3 acetylation (GO:0043966),0.44279301763617956,1.1548048758396585,0.2754285714285714,0.7819395607232174,1.0,22/40,28.97%,LDB1;TADA1;NAA60;TADA2A;SGF29;KAT14;BRPF3;ING5;KAT6B;WDR5;KAT2A;ING4;PER1;KAT7;YEATS2;MEAF6;TAF6L;KAT2B;BRD1;TAF10;TAF5L;TADA3
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.4467604846899026,-1.154711150800482,0.26618705035971224,0.6194568267652374,1.0,4/12,13.34%,CYP26B1;KLF2;CNOT1;TRIM16
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.38342462573650765,1.154264260976651,0.042,0.7829683474941826,1.0,197/834,20.09%,PLAGL1;ESR1;EGFR;LRP6;SIX1;MICAL2;PKD1;PID1;ZFHX3;HOXA5;ZFPM2;VEGFA;NFIX;FGF2;NFIB;TCF7L2;IL33;RARB;ELF4;SMAD9;NFIA;GALR1;DDX17;RHOQ;MUC1;ZMIZ1;GLI2;LDB2;LDB1;GNL3;LRP5;TCF20;TGFB3;GLIS2;TWIST1;PRDM10;NFAT5;HDAC4;HOXB3;ELF1;GCN1;RXRA;WWTR1;MEOX2;ONECUT2;STAT3;KLF5;TGFB2;DCAF6;ATF4;NR2F1;BCAS3;MAVS;ACVR1;BRD4;KMT2C;DVL1;FOXC2;PRKDC;JAG1;RXRB;BCL9L;NFE2L2;SMAD4;SLC9A1;HMGB1;MEF2B;E2F3;PBX1;HEYL;RUNX2;MEIS3;NRIP1;THRAP3;SKI;RORA;JUP;ARF4;RPS6KA4;MED13;SOX9;FOXJ3;RARA;SBNO2;FZD5;PLAC8;ESRRB;TFE3;OGT;ZNF76;NFATC1;CDK12;RUNX1;UBP1;FGFR2;FOXA1;BMP4;FOXM1;PRDM4;SREBF1;GTF2F1;CSRNP1;CHUK;ABL1;EHF;TERT;RFX5;AGO1;CCNT2;ATM;CSRP3;BMPR1A;GLIS1;NRF1;KAT6B;PAXBP1;NR1D2;TAF6;SMAD7;PHIP;SFPQ;HDAC1;SRF;MED25;RGMA;PTOV1;HEY1;KAT2A;AGO2;SSBP3;INHBA;KMT2D;HOXB4;ZMIZ2;MEF2D;MEF2A;SQSTM1;NFATC3;BMP5;DAB2;TFDP1;MED21;SIRT2;ARRB1;VDR;FOXO3;IL6;HGF;PER1;CREBBP;GRHL1;CRTC2;PARP1;CREB1;PRDM2;AATF;NFKB2;ZNF462;KDM6B;RPS27A;UBC;SLC30A9;APBB1;FLCN;E2F1;MED14;MED12;DPF3;E4F1;NR3C1;RFXANK;ATAD2B;MEN1;HMGA1;KLF10;CITED2;CHD8;GDNF;ATF2;HCFC1;HOXB2;BRD8;MPND;CCDC62;HIPK2;TCF3;IRF3;MLXIPL;XRCC6;FOSL2;NFKBIA;RTRAF;TET2;LARP7;VEZF1;MAX;ATF6
prerank,fatty acid catabolic process (GO:0009062),0.41968714863707063,1.1541896972670262,0.25938189845474613,0.7824732251943516,1.0,30/67,29.94%,ABCD3;EHHADH;CEL;ECHDC2;ECI2;PEX13;AUH;ACAT1;ALDH3A2;BDH2;HACL1;MCEE;PLA2G15;SLC27A2;PHYH;PCCB;PEX2;ECHDC1;ABCD1;ACBD5;MCAT;HADHA;ACOT8;FAAH;MTLN;ACAT2;ABHD3;SCP2;CPT2;ECI1
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.4163671785589856,1.1538001014254455,0.259825327510917,0.7830323810420039,1.0,24/71,22.80%,FAP;HM13;VCP;PSMA8;CLPP;SOCS6;CAPN2;DDI2;PSMA6;LONP1;NGLY1;ATE1;STUB1;HDAC6;IDE;RPS27A;UBC;CTSZ;ZRANB1;CHMP4B;PDCD6IP;CTSB;CTSK;CTSO
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.397161005952248,1.1537064901813874,0.2223360655737705,0.7826403133651025,1.0,17/140,8.80%,ESR1;CACNA1C;CMKLR1;PLCE1;PROK2;TAC4;DRD1;C1QTNF1;EDNRA;ADCY8;HMGB1;IAPP;DLG4;FPR3;GPR20;ACKR4;TRPM4
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.4531145331447719,1.153383910230827,0.2669082125603865,0.7830363864307904,1.0,12/37,19.92%,FHIT;CSNK2A1;CSNK2A2;CCAR2;GIPC1;OGT;USP7;TLK2;N4BP1;RYBP;HIPK2;UCHL5
prerank,response to interferon-beta (GO:0035456),-0.37839932064860626,-1.1532174764263365,0.23786407766990292,0.6209845471972933,1.0,7/22,13.20%,IFNAR2;STAT1;IFITM1;BST2;AIM2;IFITM3;NDUFA13
prerank,negative regulation of axonogenesis (GO:0050771),0.4825028510269085,1.1529547265263944,0.3103448275862069,0.7837497170012194,1.0,5/27,8.97%,FGF13;ULK2;GDI1;PTPRS;RHOA
prerank,nucleoside triphosphate metabolic process (GO:0009141),0.5340523678778061,1.1525741746155795,0.31275720164609055,0.7842973801663701,1.0,5/14,14.60%,AK5;AK3;DCTPP1;SMPDL3A;AK1
prerank,focal adhesion assembly (GO:0048041),-0.3731805460719262,-1.1525720955310526,0.23963133640552994,0.6205652402362988,1.0,6/21,6.65%,SORBS1;ACTN2;PEAK1;THSD1;WHAMM;PTPRK
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.39540572521958145,1.1518974059127594,0.2089704383282365,0.7858760535190441,1.0,56/152,24.37%,EGFR;COL1A1;SFRP4;GPC3;RSPO3;PLEKHA4;ATP6V1C2;PSMD7;CSNK1D;CSNK2A1;UBE2B;VCP;PSMA8;DACT1;SULF1;CCAR2;ILK;LBX2;SKI;JUP;RSPO1;TRPM4;PSMA4;FGFR2;UBR5;CSNK1G1;TERT;AXIN1;PSMD12;USP34;PSMA6;CSNK1E;WNK1;TNKS2;GSKIP;PSMD11;PSMC5;PSMD1;PSMD14;PSMC4;DAPK3;ZRANB1;SULF2;SMURF2;PSMA3;LRRK2;PSMD4;DEPDC1B;PSMB1;USP47;CSNK1G3;PSMA5;RNF146;PSMA7;SMARCA4;LGR6
prerank,atrial cardiac muscle cell action potential (GO:0086014),0.5433415168527884,1.1518877647560213,0.301521438450899,0.7851935595638587,1.0,3/13,7.17%,CACNA1C;KCNE5;ANK2
prerank,homotypic cell-cell adhesion (GO:0034109),0.4474696826993328,1.1518560278119974,0.2848699763593381,0.7845690880284496,1.0,4/39,5.90%,GNAS;UBASH3B;PLPP3;ILK
prerank,regulation of intracellular transport (GO:0032386),0.44561709047751263,1.151803326878597,0.27909738717339666,0.7840317539863133,1.0,14/38,21.57%,GAS1;DYNC1H1;DYNLT2B;CAPN10;SCFD1;ATP9A;RAB11B;RBM4;NDEL1;RINT1;GRIPAP1;REEP5;LRRK2;LAMP1
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.5167660217641785,1.1517018516068303,0.31283422459893045,0.7836580934596403,1.0,9/16,31.42%,PIGW;PIGF;PIGL;PIGX;PIGV;PIGQ;PIGB;PIGN;PIGC
prerank,negative regulation of catabolic process (GO:0009895),0.4347711821222265,1.1515896205089395,0.2773302646720368,0.7833097712246918,1.0,11/47,17.01%,EGFR;HDAC4;ACTN3;RILP;IRAK3;MDM4;CST3;GIT1;CIDEA;SIRT2;AZIN1
prerank,mitotic sister chromatid segregation (GO:0000070),0.4057058630719184,1.1515056507155865,0.23804463336875664,0.7828726777376399,1.0,27/98,23.27%,TUBG2;SMC4;CSNK2A1;CSNK2A2;KMT5A;RRS1;SEH1L;DCTN2;MCPH1;EML3;DIS3L2;PHF8;MIS12;ZW10;CHMP3;KLHL22;NIPBL;HASPIN;CHMP4B;CHMP4A;DLGAP5;PDCD6IP;NUP62;POGZ;PDS5A;SMC1A;WRAP73
prerank,apical protein localization (GO:0045176),-0.4704529190063278,-1.151165271801813,0.31690140845070425,0.6219831512764591,1.0,6/10,19.07%,SHROOM2;MAL;INSC;VANGL2;SHROOM3;ACTB
prerank,cellular response to UV (GO:0034644),0.4128646759060142,1.1505064848238362,0.23850267379679144,0.7855071868962953,1.0,27/76,28.54%,PRKCD;NEDD4;CARD16;ATF4;IMPACT;ERCC4;SDE2;CREBBP;PARP1;N4BP1;CDC25A;NOC2L;MMP2;EIF2AK4;EIF2S1;USP47;TRIAP1;OPN3;TAF1;TP53;PPID;POLD1;YY1;XPA;DDB1;ATR;TIMP1
prerank,sodium-independent organic anion transport (GO:0043252),0.5684746554389191,1.1504801707600298,0.3174825174825175,0.7848776490696516,1.0,2/10,1.22%,SLCO3A1;SLCO2A1
prerank,purine ribonucleotide metabolic process (GO:0009150),0.415620964238532,1.1503957477469204,0.2636165577342048,0.784452149655387,1.0,18/68,22.04%,RHOQ;SULT1C2;SULT1C4;ACSF2;ACOT11;AK3;GPAT4;ACAT1;BPNT1;AMPD3;RAB23;GLYAT;ACOT13;EFL1;ACSL6;ENTPD7;LRRK2;MFN1
prerank,positive regulation of fat cell differentiation (GO:0045600),0.4381458616232397,1.1503676601489157,0.29318181818181815,0.7838183544788795,1.0,8/47,9.94%,SIX1;CMKLR1;ID2;LRP5;CARM1;TFE3;TRPM4;SYAP1
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.41471774418858803,1.1503264081635096,0.2473002159827214,0.7832392939277936,1.0,24/74,24.03%,VEGFA;PSMD7;PSMA8;NFE2L2;PSMA4;PSMD12;PSMA6;LIMD1;SIRT2;PSMD11;PSMC5;PSMD1;CREBBP;PSMD14;PSMC4;RPS27A;UBC;HIGD1A;CITED2;PSMA3;PSMD4;PSMB1;PSMA5;PSMA7
prerank,negative regulation of viral release from host cell (GO:1902187),0.5397158902593311,1.1493791721882474,0.2925824175824176,0.7856736846492433,1.0,6/13,21.42%,TRIM28;MID2;CHMP3;TRIM26;TRIM13;TRIM8
prerank,cellular response to lipopolysaccharide (GO:0071222),0.40686926482536584,1.149093714496258,0.24087591240875914,0.7859325278318142,1.0,18/101,13.03%,LBP;ADAM9;PDCD4;PRKCE;CARD16;SHPK;TNFRSF1B;HMGB1;TRIM41;SBNO2;RHOA;MAPK8;NFKBIB;IRAK1;GIT1;PABPN1;CASP1;CD80
prerank,neuron fate commitment (GO:0048663),0.5383946100554111,1.1489347204416023,0.30547945205479454,0.7857326154588652,1.0,1/14,0.59%,ID2
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),-0.43759429951771794,-1.1487922153923038,0.297029702970297,0.6258970666322348,1.0,6/12,23.47%,CEACAM1;SIRT1;BRCA1;ERLIN2;TRIB3;APOC1
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.41725745862871133,1.1487308795337459,0.2582781456953642,0.7856923247581019,1.0,24/72,22.27%,FGF2;FGF17;HNRNPH1;SPRED2;RBFOX2;FGFR1;CBL;NOG;FGFR2;FLRT2;GTF2F1;SHOC2;HNRNPM;PTBP1;TIAL1;GALNT3;POLR2F;FGF5;NCBP1;NCBP2;FGF18;FGFR3;POLR2B;HNRNPA1
prerank,P-body assembly (GO:0033962),0.5554286423676267,1.1485005843105989,0.32208157524613223,0.7857407053215238,1.0,4/12,20.52%,DYNC1H1;PATL1;LIMD1;ATXN2
prerank,regulation of actin filament-based process (GO:0032970),0.41751725524190214,1.1479308806039525,0.26200873362445415,0.7869108315116664,1.0,14/70,15.37%,PRKCD;EFNA5;RHOBTB1;LRP1;RHOQ;RND3;ARHGAP17;CDK10;RHOA;ABL1;EZR;ARHGAP44;RHOB;IQGAP1
prerank,amyloid fibril formation (GO:1990000),0.4318991928645387,1.1478258868819229,0.27784156142365096,0.7865401982310033,1.0,15/51,17.39%,GSN;TGFBI;SNCAIP;ADAM10;GGA2;IAPP;CST3;BACE1;RIPK3;UBE2L6;SERF1A;GGA1;RPS27A;UBC;CALCA
prerank,Golgi inheritance (GO:0048313),0.561587705278626,1.1476659178555262,0.3164005805515239,0.7863460492518947,1.0,3/11,12.93%,STX5;GBF1;STK25
prerank,regulation of spindle assembly (GO:0090169),0.4769428617637907,1.1476194546316871,0.3006060606060606,0.785785623233645,1.0,11/25,26.95%,DYNC1H1;EML3;CHMP3;CHMP4B;PDCD6IP;RNF4;SENP6;HNRNPU;CHMP2A;TPR;DRG1
prerank,mitotic metaphase plate congression (GO:0007080),0.4294537384711442,1.1474679869701185,0.27752808988764044,0.7856357035015924,1.0,15/51,21.28%,RRS1;SEH1L;MAD1L1;CENPC;DCTN2;EML3;MIS12;ZW10;CHMP3;RMDN1;CDT1;CHMP4B;CHMP4A;PDCD6IP;NUP62
prerank,DNA-dependent DNA replication (GO:0006261),0.3969954339467106,1.1474608538875726,0.2528263103802672,0.7849537377572866,1.0,47/128,27.54%,HELB;REV3L;PSMD7;MCMDC2;POLE2;PSMA8;MCM2;CDC6;PSMA4;WRN;PSMD12;PSMA6;CDC45;GINS4;PSMD11;PSMC5;PSMD1;PSMD14;PSMC4;MCM4;RPS27A;UBC;POLG2;POLB;ORC2;HMGA1;CDT1;DBF4;RAD51;CDK2;TWNK;PSMA3;PSMD4;PSMB1;TOPBP1;PSMA5;PSMA7;PRIMPOL;MCM7;RECQL5;PRIM1;POLD1;POLG;PSMC1;PNKP;RPAIN;PSMA1
prerank,Rho protein signal transduction (GO:0007266),-0.3085945643843727,-1.1470778934537733,0.15730337078651685,0.628077922984436,1.0,15/53,9.27%,ARHGAP29;ROCK2;ARHGAP6;CDH13;ARHGEF3;EPS8;ADRA2A;CDC42EP4;ARHGDIA;GNA13;CDC42EP3;AGTR1;CDC42;EPS8L2;RHOU
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.46623124055947324,1.1468729793447738,0.300357568533969,0.7862395384626168,1.0,6/33,5.94%,ADAM9;MUC1;CYP1B1;TGFB2;ADA;FOXC2
prerank,autophagy of mitochondrion (GO:0000422),0.4501153805715681,1.1467930642895596,0.30186480186480186,0.7858059839908788,1.0,19/38,34.39%,ULK2;WIPI2;ATG3;SQSTM1;RB1CC1;CTSK;ATG9A;PINK1;AMBRA1;ATG13;ATG2B;FIS1;ULK1;CISD2;USP30;PRKN;MAP1LC3B;WIPI1;GABARAPL2
prerank,dicarboxylic acid transport (GO:0006835),0.46977304254696245,1.1466366134932044,0.3018633540372671,0.7856251976665445,1.0,4/28,7.53%,SLC26A7;SLC26A6;SLC25A32;GIPC1
prerank,platelet aggregation (GO:0070527),0.4545403907905895,1.146532595759788,0.2909090909090909,0.7852512090210483,1.0,3/33,5.90%,GNAS;UBASH3B;ILK
prerank,protein kinase A signaling (GO:0010737),0.544173588108512,1.14635882833257,0.31741573033707865,0.7851052596358233,1.0,3/12,12.87%,TCP11;RDX;EZR
prerank,limb development (GO:0060173),0.47127855136134916,1.1454365056024731,0.30566037735849055,0.7874405047698101,1.0,3/28,2.73%,SMOC1;PCSK5;COMP
prerank,regulation of integrin activation (GO:0033623),-0.42227129511325656,-1.1454044494435325,0.29914529914529914,0.630115598478383,1.0,7/15,27.68%,RASIP1;PIEZO1;PLEK;FBLIM1;KIF14;SELP;SRC
prerank,protein dephosphorylation (GO:0006470),-0.259463767567925,-1.145240665441748,0.13793103448275862,0.6284628201808583,1.0,27/135,10.22%,PTPRG;PTPRB;PPP2R2B;PTPN13;EYA1;PPM1E;PTPN14;PPP1CB;DUSP16;PTPRD;PTPRO;PTPN9;PPP4R1;DUSP10;EYA4;PPP2R2C;CTTNBP2NL;PTPN4;DUSP3;MTMR3;PTPRK;SSH2;PPP2R3A;CTDSP1;PPP2CB;PPM1G;DUSP22
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.46886293095103515,-1.1452008027247966,0.2857142857142857,0.6264717791586468,1.0,4/10,3.10%,ATP1A2;NEDD4L;OSR1;HECW2
prerank,regulation of receptor binding (GO:1900120),-0.4723818029100313,-1.1450409488097553,0.29,0.6247618222849844,1.0,3/10,8.61%,B2M;GREM2;ATP2A3
prerank,myeloid cell development (GO:0061515),0.5141031782435453,1.144628094792837,0.3180026281208936,0.7894802743095622,1.0,2/18,3.98%,FOXP1;ANXA2
prerank,oligosaccharide metabolic process (GO:0009311),0.4360635694857743,1.1440834394221344,0.30067567567567566,0.7905709718907641,1.0,9/46,12.12%,ST3GAL4;ST8SIA2;ST6GALNAC5;B4GALT1;ST3GAL2;FUT8;MAN2C1;FUT4;GAL3ST4
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.3838785399712123,1.14399800781093,0.128,0.7901425034799797,1.0,59/348,13.31%,SLC38A2;PID1;ID2;HOXA5;VEGFA;GAS6;F3;FGF2;FOXD1;IL33;SFRP4;GSN;SLC24A3;EMILIN1;NTRK3;ECE1;FGF17;DRD1;RDX;EPHB2;C1QTNF1;TWIST1;ANXA2;STAT3;CD3E;ATF4;TRIM28;RAMP2;AGR2;FAM98A;NFE2L2;ANK2;SOX9;NOG;DGKQ;TMEM119;NSF;ITCH;MAPK8;BMP4;UBR5;MUSK;RESF1;FAM98B;AGO1;ATM;FUBP1;MAZ;TGFBR1;HEY1;PIK3CB;SMO;AGO2;ERP29;EZR;SERPINB9;INHBA;SETDB1;PICK1
prerank,regulation of phosphorylation (GO:0042325),0.39445223573612603,1.1438400165013762,0.23991726990692863,0.789975909682849,1.0,29/120,18.47%,THBS1;EGFR;NUP93;LDB2;LDB1;GLMN;SEC13;RAE1;ILK;SEH1L;FZD7;OGT;BMP4;NUP37;NRP1;ROPN1L;PHIP;INHBA;SESN2;RANBP2;KCTD20;NUP88;SIRT2;EIF6;FLCN;PRKAG1;CDKN1C;NUP210;POM121
prerank,establishment of epithelial cell polarity (GO:0090162),0.5014463077301227,1.1438256557488955,0.32558139534883723,0.7893181304025758,1.0,10/19,27.24%,CYTH3;RHOA;SYNE4;MYO9A;EZR;SIPA1L3;GOLPH3;CAMSAP3;FBF1;PARD3
prerank,neuronal action potential (GO:0019228),0.49078502367624394,1.1431873950848204,0.3128991060025543,0.7907102112722123,1.0,2/22,6.76%,CACNA1G;SCN11A
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.46197953548813475,1.143028270996234,0.2912621359223301,0.7905142272211638,1.0,6/29,12.75%,TOPORS;DCUN1D5;ABL1;AXIN1;SMAD7;DCUN1D2
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.4781685928606406,1.1429421144754852,0.30164765525982257,0.7900806096146855,1.0,4/24,4.38%,PDE11A;TCP11;PDE3A;UBE2B
prerank,adenine nucleotide transport (GO:0051503),-0.39131886708438524,-1.1423336686125514,0.27802690582959644,0.6294526440378242,1.0,2/17,2.40%,ABCC4;LRRC8C
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.37774716763172717,1.142011961514526,0.009,0.7924344693522308,1.0,430/1668,22.26%,TBX15;FOXP2;PLAGL1;ESR1;EGFR;LRP6;SIX1;FOXP1;PKD1;PID1;KLF12;ZBTB7C;ID2;PRRX1;ZFHX3;HOXA5;ZFPM2;VEGFA;HIVEP3;PBX3;NFIX;FGF2;HOXA3;FOXD1;NFIB;TCF7L2;IL33;SKIL;RARB;ELF4;TWIST2;DDX5;HOXB6;MKX;SMAD9;NFIA;GALR1;DDX17;RHOQ;DEAF1;ZIM3;ZFHX4;MUC1;SMAD6;PRRX2;ZMIZ1;GLI2;LDB2;LDB1;JDP2;PRDM5;LRP5;NCOR2;TCF20;DMTF1;TGFB3;GLIS2;TWIST1;JMJD1C;HOXC6;SP140;PRDM10;LHX9;CAMK2D;CUX1;HDAC9;STAT5A;NFAT5;HDAC4;HOXB3;MED13L;ELF1;SIX5;RXRA;WWTR1;MEOX2;ONECUT2;ZNF250;STAT3;HES5;KLF5;ZBTB25;ANXA4;DCAF6;SIX4;KMT5A;TCF7L1;PHF21A;CCNL2;ATF4;TARBP1;TRIM28;MAMSTR;ZFP14;NR2F1;BCAS3;CHD3;TCFL5;MAVS;USP2;GMEB1;TLE6;ACVR1;DACT1;BRD4;KMT2C;TADA1;DVL1;ZNF25;FOXC2;PRKDC;PKNOX2;MIDEAS;NFX1;PRDM6;JAG1;SAFB;BHLHE40;RXRB;BCL9L;LBX2;NFE2L2;SMAD4;PER3;MRGBP;SLC9A1;HMGB1;MEF2B;E2F3;ZNF471;RFX7;TADA2A;FUS;EZH1;BRWD1;PBX1;TSHZ2;HEYL;RUNX2;MEIS3;MED27;CREG1;NRIP1;THRAP3;SKI;RORA;JUP;ARF4;CCNL1;RPS6KA4;ZNF691;MDM4;TBX21;MED13;TRIM27;SOX9;FOXJ3;NSD1;HOXA6;HOXA9;PURG;RARA;MED31;IKZF3;SBNO2;SRA1;FZD5;BRD3;PLAC8;NOG;RCOR3;ESRRB;TFE3;FOXK1;ENY2;DLG1;OGT;IMPACT;ZNF76;SMARCC2;SLTM;DGKQ;MIER2;ZIC1;RBBP8;PSIP1;FOXL1;RFX2;NFATC1;CDK12;WWP2;RUNX1;MCPH1;UBP1;FGFR2;FOXA1;ZIC4;ZFP90;BMP4;FOXM1;PRDM4;SREBF1;ZBTB2;GTF2F1;KDM2A;CSRNP1;CHUK;ZNF260;ABL1;EHF;RFX5;POU6F1;AGO1;CCNT2;URI1;ATM;ATN1;PHF8;CBX2;CSRP3;BMPR1A;GLIS1;HSF4;NFE2L1;NRF1;MAZ;RNF2;KAT6B;RNF14;ID4;KDM5B;PAXBP1;FOXP4;NEUROD2;NR1D2;TAF6;FOXO6;SMAD7;PHIP;SFPQ;HDAC1;SRF;MED25;RGMA;PTOV1;HEY1;BAZ2B;HSPD1;FBXL19;ZNF112;KAT2A;AGO2;SSBP3;EZR;ZNF740;INHBA;ARID4B;KMT2D;HOXB4;ZMIZ2;MEF2D;MYPOP;HR;NACC1;NPAS1;ZBTB9;MEF2A;FRK;SQSTM1;TIAL1;NFATC3;BMP5;HOXA4;ERF;ZKSCAN1;TCF25;HNRNPK;PIAS4;HEXIM1;DAB2;ZNF148;TFDP1;MAFG;MED21;SIRT2;EN2;ARRB1;VDR;BRD2;FOXO3;PSMC5;IL6;HGF;PER1;ID1;CREBBP;GRHL1;CRTC2;MED26;PARP1;BRD9;CREB1;NKX6-2;NFE2;PRDM2;NIPBL;AATF;ERBB2;MDFI;NFKB2;SIN3B;VPS72;ZNF462;RPRD1A;MTA3;KDM6B;HOXA2;CBX5;RPS27A;UBC;SUMO1;SLC30A9;APBB1;FLCN;E2F1;MED14;LCOR;MED12;NFYA;DPF3;CC2D1B;SUFU;KLF3;E4F1;NR3C1;THAP7;EFNA1;RFXANK;ELP4;ORC2;PCGF2;ATAD2B;MEN1;HMGA1;ZKSCAN7;HDGFL2;KLF10;CITED2;CHD8;SUV39H2;GDNF;ATF2;HCFC1;ZSCAN20;SAFB2;HOXB2;CC2D1A;CBFB;HOXC5;BRD8;ZBTB32;SARS1;MPND;NOC2L;CCDC62;HIPK2;TCF3;TAF9B;IRF3;CRK;MLXIPL;XRCC6;FOSL2;NFKBIA;TEAD2;RTRAF;NFATC4;TET2;LARP7;LEFTY1;VEZF1;MAX;ATF6;ZNF431;WWC2;CALR;CREB3L1;SMURF2;KAT7;BPTF;CEBPD;IKZF4;HOMEZ;ZBTB24;KLF9;SAP18;SUV39H1;CHD2;SMAD5;MAD2L2;HOXC8;YEATS2;ZKSCAN5;NR3C2;GPS2;BCL2L12;IL4;BCL11B;MIER1;ATP2B4;IER2;MED20;RNF4;PEX2;PAF1;SENP1;NFIC;RITA1;ZBTB40;POGZ;CRYM;NR2C2;NR2F6;ZNF177;ZNF18;KDM3B;ELP3;CRY2;LOXL2;KMT2A
prerank,positive regulation of translation (GO:0045727),0.4027474454418377,1.1419090690513403,0.2602308499475341,0.7920539888120013,1.0,29/94,25.59%,THBS1;YBX3;RCC1L;SAMD4A;MPV17L2;PRKDC;RMND1;CDC123;NIBAN1;KHDRBS1;AGO2;UHMK1;IL6;EIF6;ERBB2;EIF3D;FASTKD3;CIRBP;PYM1;FXR2;UPF3A;RPS6KB1;RPS9;EIF5A2;RBM3;RPS27L;UPF3B;C1QBP;METTL14
prerank,positive regulation of cell junction assembly (GO:1901890),0.4253932624200179,1.14039642095465,0.2748091603053435,0.7963627120681259,1.0,7/56,6.03%,MYOC;VEGFA;COL16A1;EPHB2;CLSTN2;EPHB3;S100A10
prerank,activation of protein kinase activity (GO:0032147),0.4007729342550708,1.1399161934856528,0.24896265560165975,0.7971199930358115,1.0,23/106,11.98%,PRKCD;VEGFA;GAS6;CARD14;NTRK3;GHR;PRRC1;STRADA;TGFB2;ADCY2;ADCY8;TOM1L1;TNFSF15;TGFBR2;ADCY9;PAK4;PAK2;ABL1;RIPK3;IRAK1;AXIN1;PDPK1;TNFRSF10B
prerank,dicarboxylic acid metabolic process (GO:0043648),0.42840755481977477,1.1398695731605324,0.29714285714285715,0.7965604475508357,1.0,26/52,33.34%,ME1;GCLC;SLC25A32;MTRR;MTHFD2;MDH1B;ALDH1L2;MTHFD1;SHMT2;SHMT1;MTHFR;GCLM;PHYH;ACOT8;L2HGDH;HOGA1;FPGS;MDH2;ACLY;NIT2;DGLUCY;ALDH18A1;IDH2;SDHAF3;SDHA;IDH1
prerank,negative regulation of axon extension (GO:0030517),-0.3514174462061944,-1.1393410350595343,0.23170731707317074,0.6348406769293846,1.0,14/30,18.88%,SEMA6A;MAP2;SEMA3D;SEMA7A;SEMA5A;SEMA4D;SEMA3G;SEMA4A;MAG;SEMA5B;SEMA4G;MT3;SEMA6D;RTN4R
prerank,DNA strand elongation (GO:0022616),0.49495178084859903,1.139193011859846,0.3156498673740053,0.798104985015977,1.0,6/18,16.80%,MCMDC2;TERT;RAD50;DCLRE1B;GINS4;MCM4
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),0.49342160923300715,1.1389760297686622,0.31863979848866497,0.7981068288272942,1.0,3/20,1.24%,KCNJ2;ATP1B1;SLC12A2
prerank,protein-DNA complex assembly (GO:0065004),0.39986207137152624,1.1388897779602147,0.25906735751295334,0.7976704533485569,1.0,47/116,27.73%,CHAF1B;PSMD7;CHD1L;PSMA8;NAA60;MCM2;SOX9;ERCC5;CDC6;PSMA4;CUL4A;ANP32B;SPTY2D1;KAT6B;PSMD12;ERCC3;PSMA6;ERCC2;BRD2;PSMD11;PSMC5;PSMD1;PARP1;PSMD14;PSMC4;MCM4;RPS27A;UBC;NAP1L3;ORC2;CDT1;RAD51;NAP1L2;PSMA3;PSMD4;PSMB1;PSMA5;PSMA7;MCM7;H3-3A;DAXX;GTF2H4;PSMC1;XPA;CHAF1A;PSMA1;DDB1
prerank,smoothened signaling pathway (GO:0007224),0.45672820622447263,1.1387854110860607,0.3080568720379147,0.7972982755222644,1.0,16/32,31.43%,GLI2;HES5;CC2D2A;SMO;EVC2;MAP3K10;PKD2L1;HIPK2;IFT27;TMEM231;GLI3;TCTN3;TTBK2;STIL;GLI1;ULK3
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.44952861149540985,1.1386838706128666,0.30870083432657924,0.7969267535159301,1.0,9/33,17.50%,FGF2;GNL3;STAT3;KLF5;TGFB2;TERT;SRF;FOXO3;NR3C1
prerank,membrane repolarization (GO:0086009),0.5143142837046532,1.1382692025898566,0.3224115334207077,0.7976217110199346,1.0,4/15,6.92%,KCNJ2;ATP1B1;KCNE5;KCNIP2
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.42423443185829846,1.1382209095054194,0.2763596004439512,0.7970634119003419,1.0,29/59,31.26%,TCF7L2;TWIST1;TRIM28;RUNX2;MED27;MED13;SOX9;MED31;AGO1;MED25;IL6;MED26;MED14;MED12;CBFB;MED20;BCLAF1;TP53;CCNC;MED24;MED23;SETX;TNRC6A;MED8;MECP2;MED15;CTNNB1;MOV10;NFKB1
prerank,proteoglycan biosynthetic process (GO:0030166),0.45979588737036275,1.1381022659495872,0.2917675544794189,0.796761547860146,1.0,3/31,2.92%,EXT1;XYLT1;CHST11
prerank,regulation of extracellular matrix organization (GO:1903053),0.5234513936126721,1.13807814762137,0.3280212483399734,0.7961558679137254,1.0,6/15,11.32%,LRP1;DDR2;FAP;RIC1;RUNX1;DDR1
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.563261045524994,1.137901399198164,0.33240997229916897,0.7960218281316022,1.0,7/11,31.72%,TENT4B;EXOSC4;LARP7;FBL;DKC1;EXOSC2;EXOSC3
prerank,sphingolipid catabolic process (GO:0030149),0.5225979804326624,1.1377967880173612,0.30707610146862485,0.7956384943147377,1.0,4/15,9.86%,ACER3;PDXDC1;SMPD4;SMPDL3A
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.3810169574584433,1.1377923493770186,0.1432865731462926,0.7949557844806256,1.0,118/341,26.38%,WWP1;RNF144A;NEDD4;FBXO10;ANAPC5;FBXL7;PSMD7;CDC16;TOPORS;MVB12B;COP1;UBE2B;UBR4;VCP;PSMA8;TOM1L1;UBE2R2;ERCC8;NFE2L2;UBE3C;RNF115;TBX21;SYVN1;TRPC4AP;NTAN1;CBL;HUWE1;RBBP6;WWP2;SHARPIN;PSMA4;ITCH;CUL4A;RNF114;FBXL4;UBE2C;FBXO22;MYLIP;RNF14;PSMD12;TGFB1I1;ANAPC4;FBXL19;PSMA6;PCBP2;UBQLN1;USP33;SQSTM1;RNF11;FBXL14;KCTD5;ANAPC2;ATE1;UBAP1;SIRT2;ARRB1;UBE2L6;STUB1;KLHL22;PSMD11;PSMC5;PSMD1;PPP2R5C;ANAPC1;PSMD14;RC3H2;PSMC4;TRIM13;UBL7;BIRC6;ANAPC10;KCTD17;UBE4A;GID4;CDC27;NPLOC4;CDC20;RNF7;PTPN23;ZFAND2B;FBXW4;ZRANB1;PCNP;UCHL1;UBE2G2;SMURF2;RMND5B;PSMA3;DCAF11;PSMD4;UBAP1L;PSMB1;RNF4;APPBP2;AREL1;MVB12A;KCTD13;TTC3;PSMA5;RNF20;RNF216;RNF146;FBXO11;PSMA7;TAF1;RNF122;HERPUD1;AMFR;ANKRD9;UBE2W;RNF111;PINK1;RCHY1;UBR3;COPS3;RNF126;RNF166;PSMC1
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.5382526943881006,1.1377018878195115,0.32336182336182334,0.7945522038782505,1.0,7/11,33.73%,ATF4;HSPA5;ATF6;CREB3L1;TP53;ATF6B;CEBPB
prerank,double-strand break repair via break-induced replication (GO:0000727),0.5404311834258265,1.1376584244579708,0.33426573426573425,0.7939799194411976,1.0,5/12,16.80%,MCMDC2;MCM2;CDC45;GINS4;MCM4
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.41682272297567663,1.137409657127865,0.2897914379802415,0.7940760830869777,1.0,20/60,28.32%,SMOC2;FGF2;MAPK15;NEK7;ATM;NVL;TNKS2;HGF;POLG2;CCT6A;CCT4;CCT8;MAP2K7;HNRNPA1;TCP1;PNKP;DKC1;ATR;PRKD2;CCT5
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.5320468217617754,1.1373909205769797,0.32514450867052025,0.7934485510435945,1.0,2/13,2.01%,SULT1C2;SULT1C4
prerank,positive regulation of synaptic transmission (GO:0050806),-0.2799323016075901,-1.1369035191292087,0.16923076923076924,0.6390363893183777,1.0,26/72,15.22%,NRXN1;SHANK3;APP;RIMS2;SLC24A2;CACNG7;ADCY1;GRIK2;RIMS1;GRIN2B;CACNG8;SLC8A3;LGI1;ZDHHC3;NMU;GRIN2A;CACNG3;ADRA1A;CACNG4;CLSTN1;PLK2;DTNBP1;RELN;PRKCZ;ZDHHC2;GPER1
prerank,gene silencing by miRNA (GO:0035195),0.45319559772171325,1.1368975161532788,0.30365853658536585,0.794378519303308,1.0,9/32,16.25%,ZC3H7A;PUM1;PRKRA;AGO1;AGO2;RBM4;LIMD1;EIF6;CNOT8
prerank,peptidyl-methionine modification (GO:0018206),0.5418854284162091,1.136516674350585,0.3337969401947149,0.7949631377606997,1.0,8/12,33.42%,NAA60;NAA16;METAP1D;METAP2;NAA15;NAA25;METAP1;NAA20
prerank,activation of adenylate cyclase activity (GO:0007190),0.44992670212734137,1.136282708951329,0.30238095238095236,0.7950111609251146,1.0,9/35,13.17%,FSHR;DRD1;EDNRA;ADCY2;ADCY8;RAF1;ADCY9;CAP1;GLP1R
prerank,pharyngeal system development (GO:0060037),0.5105372063615262,1.1360090641967935,0.3254281949934124,0.7952328382205351,1.0,7/15,14.05%,TGFB2;SIX4;NOG;BMP4;BMPR1A;TGFBR1;BMP5
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.5442479777511364,1.1355833873567094,0.31690140845070425,0.7959358334304164,1.0,7/12,25.23%,TRIM28;RESF1;SETDB1;MPHOSPH8;TASOR;SETDB2;DNMT1
prerank,sodium ion export across plasma membrane (GO:0036376),0.5312381323055937,1.1355143670325085,0.32060027285129605,0.7954781883575129,1.0,3/13,6.52%,SLC4A4;ATP1B1;SLC9A1
prerank,cellular response to lipid (GO:0071396),0.38761449416163146,1.1354881961137042,0.224469160768453,0.7948896400620914,1.0,28/191,11.58%,ESR1;EGFR;IRS1;PID1;WNT9A;LBP;ADAM9;PDCD4;CARD16;SHPK;ADCY2;ADCY8;TNFRSF1B;HMGB1;FZD7;TRIM41;NRIP1;RORA;SOX9;SBNO2;RHOA;MAPK8;URI1;ATM;NFKBIB;IRAK1;GIT1;PABPN1
prerank,positive regulation of receptor internalization (GO:0002092),0.4829997885623164,1.1352389935335254,0.32709113607990015,0.7950015789559354,1.0,2/22,1.29%,VEGFA;SFRP4
prerank,RNA catabolic process (GO:0006401),0.43078994882175586,1.134808652200014,0.30514285714285716,0.7958113206641074,1.0,18/46,28.65%,SIDT2;PPP1R8;RNASE3;ZC3H12D;RNASE6;DIS3L2;METTL16;LSM2;SND1;SUPV3L1;CNOT10;NCBP1;MTREX;PABPC4;ERN1;RIDA;LSM5;DXO
prerank,amino acid import across plasma membrane (GO:0089718),0.4755691386665286,1.1345979388033085,0.31857318573185733,0.7958600476675496,1.0,2/24,3.76%,SLC47A1;SLC1A5
prerank,receptor clustering (GO:0043113),0.4690808158920823,1.1342743435884752,0.3161209068010076,0.7962514731718641,1.0,8/27,13.31%,DLG2;DVL1;DLG4;DLG1;NRXN2;MUSK;NLGN1;PICK1
prerank,positive regulation of telomere maintenance (GO:0032206),0.4548042226206961,1.1342005971072402,0.29820359281437125,0.7958226700391408,1.0,12/31,27.63%,GNL3;MAPK15;NEK7;HNRNPA2B1;ATM;RAD50;TNKS2;MAP2K7;PPP1R10;SLX4;PNKP;RTEL1
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.43420946656966536,1.1341534461933425,0.3103850641773629,0.7953161700825494,1.0,5/41,8.14%,LBP;GAS6;IRAK3;TRIM27;RARA
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.40433956921452197,1.1340706415349437,0.2553191489361702,0.7948871901622271,1.0,10/88,7.54%,TRABD2B;VEGFA;MPP7;EMILIN1;SDC1;PRKCA;VCP;CDC42EP2;PFN2;SLF2
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.42539131898152227,1.134031114973179,0.2876404494382023,0.7943247178114067,1.0,21/51,30.26%,MAPK15;TENT4B;NEK7;SMG6;ATM;TEN1;HNRNPC;TNKS2;XRN1;CCT6A;CCT4;CCT8;MAP2K7;HNRNPA1;TCP1;HNRNPU;PNKP;ATR;CCT5;CTC1;CTNNB1
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.39585831079968514,1.1339618720420566,0.23397761953204477,0.7938680990800894,1.0,31/151,16.48%,ST3GAL4;PCSK5;GSTT1;ACER3;PLA2G4A;PEMT;PLPP3;CSNK2A1;CSNK2A2;GSTM5;LPCAT1;KDSR;ELOVL5;DMD;PLPP1;B4GALT5;NFS1;ST3GAL2;NANP;STARD7;GPAT4;LPCAT3;PCTP;GAL3ST4;INHBA;ALDH3A2;GSTO2;CHKB;AKR1A1;GSTZ1;B3GNT6
prerank,negative regulation of myoblast differentiation (GO:0045662),0.5439627374833474,1.1333444452833301,0.33975240715268223,0.7951525551432056,1.0,5/13,10.16%,PRICKLE1;SOX9;SRA1;EID2B;BMP4
prerank,calcium-mediated signaling (GO:0019722),0.4044216650127609,1.1333242180422385,0.2710084033613445,0.7945355188796286,1.0,17/93,13.84%,EGFR;CACNA1C;PLCE1;ATP1B1;PPP1R9B;MCU;SLC9A1;ANK2;ACKR4;TRPM4;PPP3CC;RCAN1;PDPK1;BCAP31;DEFB1;STIMATE;DMPK
prerank,regulation of cation transmembrane transport (GO:1904062),-0.3401351267674463,-1.1333055423565452,0.2345679012345679,0.6456458469014607,1.0,9/29,8.60%,DPP10;CACNA1D;KCNIP3;KCNIP4;KCNIP1;FGF12;KCNN2;HOMER1;DPP6
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.5553003482459502,1.1330515917429769,0.3264705882352941,0.7947478902100148,1.0,3/10,4.11%,GHR;STAT5A;STAT3
prerank,positive regulation of vasculogenesis (GO:2001214),0.5560939507531404,1.1328822526103735,0.33432835820895523,0.7945966276362241,1.0,1/10,0.56%,TMEM100
prerank,filopodium assembly (GO:0046847),0.5161151351367883,1.1327874060214704,0.33707865168539325,0.7942247675663207,1.0,3/16,3.57%,SRGAP2;PPP1R9B;FGD6
prerank,phospholipid metabolic process (GO:0006644),0.41290620297781105,1.1327199818961826,0.28202368137782563,0.7937765671595133,1.0,15/71,17.61%,TNFAIP8L3;PLA2G4F;PLA2G4A;PLPP3;LPCAT1;PLPP1;LPCAT4;PLA2G5;LGALS13;PIP4K2B;FADS1;PNPLA3;PIP5K1A;PLA2G15;AGPAT5
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.5212910995489956,1.132625678063807,0.32737276478679506,0.7934282635987839,1.0,3/15,5.50%,AK5;ENTPD2;ENTPD6
prerank,regulation of neuron death (GO:1901214),-0.266088227460143,-1.1325154002247353,0.16176470588235295,0.6455507253455324,1.0,20/82,15.04%,EFNB2;WNT5A;PICALM;RRAS2;GRID2;GRIN2B;PPARGC1A;DCC;LANCL1;CD200;CSF1;EGR1;EPHB1;FAIM2;CD34;BTBD10;SARM1;C1QA;TYROBP;SNCA
prerank,metanephric mesenchyme development (GO:0072075),0.5660912265668789,1.1321805459566157,0.33088235294117646,0.794160661606905,1.0,2/10,4.30%,SIX1;SIX4
prerank,regulation of protein targeting to membrane (GO:0090313),0.4662397903114832,1.1319858903380153,0.2986198243412798,0.7941402190563264,1.0,7/28,16.37%,KCNB1;GDI1;C2CD5;MIEF2;AKT2;CHP1;ERBB2
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.3965024069500258,1.1316333357165238,0.26288659793814434,0.7946397642966239,1.0,18/113,12.22%,PGF;EGFR;SRSF6;VEGFA;F3;FGF2;TCF7L2;STAT5A;PKHD1;PRKCA;FZD7;SOX9;FGFR2;BMP4;AGGF1;VIP;NRP1;TGFBR1
prerank,neuron migration (GO:0001764),0.4303737296123562,1.1316237387744095,0.296,0.7939878716966674,1.0,11/48,12.51%,VEGFA;FGF13;MAP1B;MARK1;LRP12;NAV1;FGFR1;PEX13;NRP1;SDCCAG8;DNAAF4
prerank,respiratory system development (GO:0060541),0.45960321333986337,1.1316052049522416,0.3237753882915173,0.7933770833428708,1.0,7/32,10.16%,VEGFA;FGF2;GLI2;DISP1;CCDC39;FGFR2;BMP4
prerank,protein localization to plasma membrane (GO:0072659),0.3925611272435537,1.1312191461310386,0.25025641025641027,0.7939210635182269,1.0,23/129,8.74%,LRP6;KCNB1;GAS6;ATP1B1;FGF13;TTC7A;EHD1;RDX;RAB34;PIGW;C2CD5;NECTIN3;RAMP2;PACS2;PRAM1;S100A10;RAB8A;SLMAP;ANK2;EHD2;JUP;FCHO2;DLG1
prerank,bicellular tight junction assembly (GO:0070830),-0.3041491173686807,-1.1310942904946297,0.23076923076923078,0.6469954797157059,1.0,9/46,8.90%,PARD6G;OCLN;PECAM1;CDH5;CLDN5;ESAM;F11R;APC;CLDN1
prerank,peptidyl-serine dephosphorylation (GO:0070262),-0.4162825180472448,-1.1310597595241874,0.27692307692307694,0.6449861416252479,1.0,6/14,21.94%,PPP2R2B;PPP2R2C;PPP2CB;PPP5C;PPP1R15B;PPP1CA
prerank,regulation of ion transport (GO:0043269),0.4087038742591635,1.130447460246351,0.2939914163090129,0.7957502351458191,1.0,5/76,2.14%,KCNJ2;KCNJ15;NEDD4;SYT8;DRD1
prerank,regulation of fatty acid biosynthetic process (GO:0042304),-0.3495671954553236,-1.1302861999329556,0.2789473684210526,0.644832135552584,1.0,8/26,12.09%,PRKAA2;PRKAG2;LPGAT1;NR1H3;ADIPOR1;SLC45A3;MID1IP1;CEACAM1
prerank,protein localization to microtubule organizing center (GO:1905508),0.5161722716547565,1.1302035945813016,0.3314993122420908,0.7958236074874039,1.0,7/15,32.84%,CSNK1D;DCTN2;PCM1;NEDD1;STIL;C2CD3;PIBF1
prerank,lymphocyte mediated immunity (GO:0002449),0.5353798613133405,1.129601776333007,0.3346938775510204,0.7970535822404979,1.0,2/12,6.22%,GNL1;JAG1
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.5423416138412414,1.1293085487013215,0.33841886269070737,0.7959441394292956,1.0,8/11,32.67%,DCAKD;PANK4;ACAT1;PANK3;PPCS;PANK2;PPCDC;COASY
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.5423416138412414,1.1293085487013215,0.33841886269070737,0.7959441394292956,1.0,8/11,32.67%,DCAKD;PANK4;ACAT1;PANK3;PPCS;PANK2;PPCDC;COASY
prerank,coenzyme A biosynthetic process (GO:0015937),0.5423416138412414,1.1293085487013215,0.33841886269070737,0.7959441394292956,1.0,8/11,32.67%,DCAKD;PANK4;ACAT1;PANK3;PPCS;PANK2;PPCDC;COASY
prerank,morphogenesis of an epithelial sheet (GO:0002011),0.5598908210650501,1.1292280490695787,0.34402332361516036,0.795547967743701,1.0,1/10,0.33%,LRP6
prerank,natural killer cell activation (GO:0030101),0.48601480342920544,1.1291609400154246,0.315,0.7951051762949746,1.0,3/23,7.19%,ELF4;KLRK1;PBX1
prerank,neurotransmitter secretion (GO:0007269),-0.3232470083916987,-1.1290554439347573,0.224,0.6460831815503246,1.0,17/44,22.17%,NRXN1;LIN7A;RIMS2;RIMS1;PIP5K1C;SYN2;SYN1;STXBP3;SYT10;SNCA;GAD1;SNAP25;SLC32A1;PTPRN2;GRM4;CPLX2;PDZD11
prerank,negative regulation of binding (GO:0051100),0.40551271499506186,1.1290534825831586,0.28525980911983034,0.7947829442835429,1.0,30/81,24.74%,PRKCD;LRPAP1;CARD16;DACT1;DVL1;TMC8;BTAF1;SYMPK;EFHB;MAPK8;GTF2F1;SMO;CSNK1E;USP33;DAB2;MITD1;TFIP11;STYX;MDFI;SUMO1;E2F1;AKT1;CTSZ;NFKBIA;LRRK2;CAMK1;PEX14;ILRUN;ROCK1;GTPBP4
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.4567256239911838,1.1289030479285893,0.3217286914765906,0.7946214319735115,1.0,19/32,32.89%,ERCC3;ERCC2;POLR2F;POLR1G;CAVIN1;TBP;POLR1C;TAF1C;TAF1;GTF2H4;POLR2H;UBTF;TAF1D;POLR2L;TAF1B;POLR2K;RRN3;TAF1A;CCNH
prerank,kinetochore organization (GO:0051383),0.5234320164962193,1.1284345333879082,0.319672131147541,0.7954052750350727,1.0,6/13,21.94%,CENPC;CENPT;MIS12;CDT1;DLGAP5;POGZ
prerank,macrophage activation involved in immune response (GO:0002281),0.5294983596790205,1.1280160307755005,0.34328358208955223,0.7960918538039592,1.0,2/13,8.25%,LBP;SBNO2
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.5396301234973196,1.127835161295389,0.35019973368841545,0.7960070105545531,1.0,3/12,8.14%,F3;IFT20;CBL
prerank,endothelial cell migration (GO:0043542),0.4373197893161967,1.1276257243834305,0.30941176470588233,0.7959786030629175,1.0,10/37,11.54%,VEGFA;FSTL1;CCN3;CYP1B1;FAP;GIPC1;RHOA;LGALS8;ABL1;NRP1
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),-0.4502021295754383,-1.1275389196601688,0.3041958041958042,0.6479578867953161,1.0,6/11,20.61%,PPARA;SLC30A10;TRAP1;ABCD2;ABCB7;SLC18A2
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.4897366922027556,1.1271361173301566,0.3227040816326531,0.7968778782652552,1.0,2/20,2.28%,LBP;PRKCE
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),-0.425902478296478,-1.1270843339775227,0.30916030534351147,0.6471015271013487,1.0,5/14,13.78%,LIMS2;LOXL3;EMP2;PRKD1;CD63
prerank,oxoacid metabolic process (GO:0043436),0.45764877027923756,1.1270490255874623,0.3238213399503722,0.796500692000343,1.0,9/27,18.87%,SULT1C2;SULT1C4;LIAS;PPA2;BPNT1;LIPT1;PPA1;GNMT;DAO
prerank,regulation of interleukin-13 production (GO:0032656),-0.41510175230273383,-1.126453614320589,0.3159722222222222,0.6466401409737271,1.0,4/13,14.34%,LEF1;TNFRSF21;LGALS9;PRKCZ
prerank,regulation of protein export from nucleus (GO:0046825),0.4819093356777608,1.1263878149837487,0.3341404358353511,0.7979335535445654,1.0,7/23,13.34%,GAS6;TCF7L2;BAG3;ANP32B;XPO4;UHMK1;YWHAE
prerank,endodermal cell fate commitment (GO:0001711),-0.4587729470269091,-1.1262095046682288,0.3174061433447099,0.6451581619122575,1.0,4/10,15.98%,SOX17;LEO1;SOX2;CTR9
prerank,muscle filament sliding (GO:0030049),-0.31664668010160646,-1.126203155190021,0.2702702702702703,0.6410842371595463,1.0,8/38,11.37%,ACTN2;TPM1;MYL6;TMOD1;DES;TPM3;VIM;TPM2
prerank,actin-myosin filament sliding (GO:0033275),-0.31664668010160646,-1.126203155190021,0.2702702702702703,0.6410842371595463,1.0,8/38,11.37%,ACTN2;TPM1;MYL6;TMOD1;DES;TPM3;VIM;TPM2
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.44084622205168106,1.1258338886916075,0.29638273045507585,0.7990659065458519,1.0,18/36,29.49%,KIF13A;RAB34;NECTIN3;GGA2;GOLGA4;NSF;SPTBN1;GGA1;GOLPH3;BLZF1;OPTN;GORASP2;VAMP4;AFDN;VAMP2;GCC2;GGA3;ARFRP1
prerank,positive regulation of cell differentiation (GO:0045597),0.3836298528862287,1.125825522509622,0.2094188376753507,0.7984226090831106,1.0,53/237,16.22%,BOC;CDON;CMKLR1;TMEM100;PKDCC;ID2;HOXA5;DDR2;COL1A1;TIAM1;LRP5;TGFB3;TWIST1;WWTR1;TGFB2;ACVR1;BCL9L;SMAD4;TGFBR2;FGFR1;HEYL;RUNX2;EDN3;SOX9;PLA2G5;PA2G4;CARM1;IMPACT;TRPM4;RHOA;TMEM119;SYAP1;BMP4;ABL1;BMPR1A;NELL1;NEUROD2;MAPK12;TGFB1I1;TGFBR1;SRF;HOXB4;MEF2A;RBM4;WDFY2;DAB2;NBL1;CCN4;IL6;HGF;SPAG9;CREB1;CRB2
prerank,selective autophagy (GO:0061912),0.4226597084610697,1.1255882369031773,0.3132664437012263,0.7985202271509856,1.0,33/56,33.79%,ULK2;DYNC1H1;STBD1;NBR1;PEX5;LGALS8;ATM;DYNC1LI2;UBQLN1;UBA5;SQSTM1;IFT88;HDAC6;RPS27A;UBC;UFL1;RB1CC1;TEX264;DYNC1I2;ACBD5;AMBRA1;ATG13;ATG2B;UFC1;UBE2V1;ULK1;USP30;PRKN;UBE2N;MAP1LC3B;DYNLL2;UFM1;AUP1
prerank,regulation of TOR signaling (GO:0032006),0.41577956075719,1.1254632225348196,0.3007438894792774,0.7982359603152254,1.0,24/67,24.87%,GAS6;NPRL3;SEC13;PKHD1;LAMTOR1;SEH1L;AKT1S1;DGKQ;TELO2;DEPTOR;TMEM127;TBCK;MINAR1;FLCN;ARAF;GOLPH3;UBR2;RHEB;RPTOR;TSC2;NPRL2;SMCR8;FBXO9;FAM83D
prerank,vasodilation (GO:0042311),-0.41160334870949755,-1.1254049526370664,0.3151750972762646,0.6410227529280315,1.0,5/13,17.41%,NOS3;KLF2;NOS1;GPER1;SOD2
prerank,negative regulation of hippo signaling (GO:0035331),0.544505323680377,1.125404293717219,0.32667617689015693,0.797744358186169,1.0,5/12,23.05%,CIT;LIMD1;MAP2K3;WWC2;DLG5
prerank,GPI anchor biosynthetic process (GO:0006506),0.4561211818610524,1.125246345277768,0.32558139534883723,0.7975762893700719,1.0,15/30,32.83%,PIGW;GPAA1;PIGF;PIGL;PGAP2;PIGT;DPM3;PIGX;PIGV;PGAP1;PIGQ;PIGB;PIGN;PIGC;PIGO
prerank,response to X-ray (GO:0010165),0.5184851904422288,1.125136000301449,0.33992094861660077,0.7972618599503758,1.0,6/14,20.87%,ANXA1;ATM;LIG4;NIPBL;XRCC6;BRCC3
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.494536908987426,1.1250650021362631,0.32778489116517284,0.7968222481511925,1.0,5/18,12.17%,CCN3;HDAC4;FZD7;TMEM119;HDAC1
prerank,regulation of long-term synaptic potentiation (GO:1900271),-0.35448741403675066,-1.124880274300672,0.27586206896551724,0.6403407078772368,1.0,6/28,4.10%,PTN;APOE;SHANK3;EPHA4;APP;ADCY1
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.44646555670801924,1.124877142692907,0.3132387706855792,0.7967377151165201,1.0,2/35,0.53%,PCDHB16;CDH11
prerank,iron ion homeostasis (GO:0055072),0.4209339594407347,1.1245684581116346,0.32201533406352684,0.7970389567200138,1.0,15/58,15.18%,SCARA5;NEO1;FLVCR1;HMOX2;FXN;SMAD4;ACO1;ATP6V0D1;SOD1;CUL1;CYBRD1;BDH2;FRRS1;ABCB6;IREB2
prerank,autophagosome assembly (GO:0000045),0.4213772384517158,1.1245572517440219,0.30190796857463525,0.7964146131219978,1.0,21/52,29.93%,ULK2;RAB43;PACS2;WIPI2;ATG3;ATG16L2;UBQLN1;RAB23;RB1CC1;ATG16L1;RAB1A;RUFY4;RAB1B;ATG9A;AMBRA1;ATG13;ATG2B;UBXN2A;ULK1;STX17;IRGM
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.5494273912116818,1.1244086004072387,0.3463768115942029,0.7962277431188887,1.0,8/11,35.45%,ATL2;LPCAT3;BNIP1;ATL1;VCPIP1;ARL6IP1;STX18;MOSPD3
prerank,cell part morphogenesis (GO:0032990),0.5237478115964019,1.12417103443601,0.34153005464480873,0.7962857496535884,1.0,1/13,0.50%,PID1
prerank,regulation of hippo signaling (GO:0035330),0.5049038297974924,1.1241433196845338,0.328042328042328,0.795704172905176,1.0,7/17,23.41%,CIT;MOB3B;LIMD1;MAP2K3;WWC2;DLG5;NEK8
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),-0.44801280197205146,-1.1241393508448265,0.31561461794019935,0.640266157765495,1.0,2/11,2.93%,NOVA1;NOVA2
prerank,inflammatory response (GO:0006954),0.3827145976333981,1.1240925754082185,0.23891129032258066,0.7952088093104043,1.0,27/195,16.10%,THBS1;MGLL;CMKLR1;PROK2;TAC4;CCL13;HDAC9;HDAC4;CCL15;STAT3;ADCY8;NOX4;NFX1;HMGB1;ABCF1;FPR3;LIAS;ANXA1;ITCH;CHUK;AOC3;F2R;NFATC3;PTGDR;CXCR4;IL6;TRAF3IP2
prerank,regulation of protein modification process (GO:0031399),-0.3072392045109327,-1.1240468618744426,0.22033898305084745,0.6385140615093393,1.0,14/50,16.55%,LYN;CDH5;GRM5;PPP1R16B;CCDC88A;CORO1C;HSPB1;PLXNB2;SPRED1;FN1;CCDC88C;CADM4;PML;PTK2
prerank,regulation of amyloid-beta clearance (GO:1900221),0.5045883841692987,1.1239745243220634,0.335978835978836,0.7949491280905572,1.0,8/16,26.22%,LRP1;LRPAP1;HDAC1;SRF;CLU;IL4;ROCK1;HMGCR
prerank,positive regulation of transport (GO:0051050),0.4023610791787976,1.1235400378791351,0.2916666666666667,0.7956855627530737,1.0,21/85,20.20%,LRP1;GAS6;GPC3;RXRA;ANXA2;C2CD5;DYNC1H1;CAPN10;PLA2G5;AKT2;FCER1G;ANXA1;CHP1;LMAN2;DAB2;ACSL3;SCIN;CD151;BID;TUB;CALR
prerank,ribosomal small subunit assembly (GO:0000028),0.5041193768786885,1.1228789933478567,0.345679012345679,0.7971208998204606,1.0,3/16,6.42%,RPSA;PRKDC;RRP7A
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),0.5548925988008396,1.1224483365935911,0.3553956834532374,0.7971935564714321,1.0,5/10,20.86%,AP2A1;MYLIP;AP2A2;CLTC;CLTA
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),0.5548925988008396,1.1224483365935911,0.3553956834532374,0.7971935564714321,1.0,5/10,20.86%,AP2A1;MYLIP;AP2A2;CLTC;CLTA
prerank,transferrin transport (GO:0033572),0.4519579385950457,1.1222471233478228,0.3309776207302709,0.7971317900139968,1.0,14/33,25.47%,ATP6V1C2;TCIRG1;DNM2;ATP6V0A1;ATP6V0D1;ATP6V1B2;RAB11B;CLTC;ATP6V1E1;STEAP3;ATP6V1C1;ATP6V0E1;LMTK2;ATP6V0B
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.4503730677416925,1.122056218902686,0.32800982800982803,0.7971112699380783,1.0,12/30,25.00%,FHIT;CCAR2;GIPC1;OGT;USP7;TLK2;N4BP1;STYX;RYBP;UCHL5;USP14;CAMLG
prerank,regulation of T cell differentiation (GO:0045580),0.44743309827008937,1.1220005498819496,0.3236994219653179,0.7966665205896738,1.0,11/33,21.35%,ZMIZ1;TBX21;RUNX1;CRTAM;ABL1;CLPTM1;SOD1;KAT2A;CAMK4;CBFB;IL4
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.5548025997792003,1.1219314815530046,0.33709449929478136,0.7962422196741104,1.0,5/10,26.03%,HMGB1;RUNX1;CBFB;SH3RF1;SOCS1
prerank,keratinocyte differentiation (GO:0030216),0.4600697754768342,1.121892119960403,0.3309265944645006,0.7957160080487814,1.0,5/29,9.20%,ADAM9;CLIC4;JAG1;BCR;ANXA1
prerank,response to peptide (GO:1901652),0.44259070431373665,1.1214243325085294,0.319377990430622,0.7964996838070281,1.0,4/33,9.20%,IRS1;STAT5A;STAT3;ANXA1
prerank,intracellular pH reduction (GO:0051452),0.45494122274927773,1.121273386122854,0.3125,0.7963338923794029,1.0,15/33,31.80%,ATP6V1C2;TCIRG1;ATP6V0A1;RAB38;ATP6V0D1;ATP6V1B2;ATP6V1E1;ATP6V1C1;SLC11A1;ATP6V0E1;ATP6V0B;GPR89A;GPR89B;ATP6V1H;ATP6V1G1
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.4727097105770011,1.121196317126264,0.3299874529485571,0.7959251756336071,1.0,10/20,25.37%,MCU;SPG7;MICU2;LETM1;MICU1;PMPCA;STOML2;AFG3L2;SLC8B1;PMPCB
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.49924230143016446,1.1210856049254594,0.32526881720430106,0.7956414909428484,1.0,5/15,17.89%,ZC3H12D;ZC3H12C;LACTB2;RPP40;KHNYN
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.40641333013800907,1.1207569540849767,0.3016216216216216,0.7960580550904528,1.0,26/76,25.47%,RNF144A;PRICKLE1;CSNK1D;COP1;VCP;DVL1;CDK5RAP3;FBXO22;AXIN1;RNF14;SMAD7;CSNK1E;DAB2;SIRT2;STUB1;DDA1;SUMO1;HECTD1;LRRK2;CLU;USP5;SUMO2;DET1;TAF1;BBS7;RCHY1
prerank,regulation of oligodendrocyte differentiation (GO:0048713),-0.38622647612137073,-1.1206617101846161,0.2714285714285714,0.6449767059652564,1.0,6/18,8.46%,IL34;PTN;NOTCH1;TNFRSF21;TENM4;SLC45A3
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.46894809903914864,1.12054840740075,0.345088161209068,0.7960557175466606,1.0,9/25,24.90%,VCP;RILP;LAPTM4B;CHMP3;VTA1;CHMP4B;CHMP4A;MVB12A;CHMP2A
prerank,positive regulation of myoblast differentiation (GO:0045663),0.5148153837155109,1.120238145400559,0.33240997229916897,0.7963635282376397,1.0,1/16,0.03%,BOC
prerank,epidermal cell differentiation (GO:0009913),0.4395181604263417,1.1200996538008896,0.31949250288350634,0.7961619623506784,1.0,14/41,26.47%,ADAM9;CLIC4;JAG1;BCR;ANXA1;HDAC1;ERCC3;ERCC2;PIP5K1A;ASAH1;OPN3;HDAC2;KRT10;CERS3
prerank,positive regulation of intracellular transport (GO:0032388),0.44491263780266976,1.1200201930261722,0.3054892601431981,0.7957488673819006,1.0,14/38,26.43%,NEDD4;EHD1;DYNC1H1;BCAS3;EHD2;CAPN10;TENM1;PCM1;KIF20B;ICE1;PGAP1;TBC1D20;VAMP2;TPR
prerank,response to tumor necrosis factor (GO:0034612),0.39708916439511976,1.1199934437654604,0.30325288562434416,0.7951776818266326,1.0,10/91,7.33%,PID1;ADAM9;AFF3;YBX3;CCL13;CCL15;SMPD4;NFE2L2;ADAM10;CXCL16
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.5532979466789875,1.1196061178325107,0.3516642547033285,0.7957495959586195,1.0,4/10,9.72%,LRP5;TGFBR2;SOX9;FGFR2
prerank,histone H4-K5 acetylation (GO:0043981),0.5133193007425088,1.11794942929668,0.3342140026420079,0.7996642570975817,1.0,9/15,23.12%,KANSL2;OGT;WDR5;ING4;HCFC1;KANSL1;KAT7;KAT8;MEAF6
prerank,histone H4-K8 acetylation (GO:0043982),0.5133193007425088,1.11794942929668,0.3342140026420079,0.7996642570975817,1.0,9/15,23.12%,KANSL2;OGT;WDR5;ING4;HCFC1;KANSL1;KAT7;KAT8;MEAF6
prerank,regulation of protein localization to cell periphery (GO:1904375),0.48918768898994697,1.1171896801136827,0.3453333333333333,0.8013802570337851,1.0,7/18,25.77%,MISP;MMP14;SPTBN1;CLN3;CDK5;APPL1;VTI1B
prerank,innate immune response in mucosa (GO:0002227),0.554019625096057,1.11711329256864,0.3448773448773449,0.8009495317378287,1.0,3/10,21.35%,RNASE3;DEFB1;IL4
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),-0.4261839619768482,-1.116887020115421,0.30097087378640774,0.6524596895559645,1.0,9/12,42.26%,SLC5A3;ADGRB1;GRIN1;TLR6;CD36;ZNF205;TLR4;RAB27A;DUOXA1
prerank,bile acid and bile salt transport (GO:0015721),-0.3542185387804489,-1.1168211942095119,0.26666666666666666,0.6506080762771081,1.0,3/24,2.21%,ABCC4;SLCO2B1;SLCO1C1
prerank,regulation of cholesterol transport (GO:0032374),0.47773410996067955,1.116800663511908,0.3413333333333333,0.8012973086933907,1.0,2/20,6.20%,LRP1;LAMTOR1
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.5360499492804631,1.116325305967004,0.36123348017621143,0.8021124450690315,1.0,6/11,33.58%,IPO4;CABIN1;UBN1;H3-3A;HIRA;HAT1
prerank,termination of RNA polymerase I transcription (GO:0006363),0.4576285625894937,1.1160526624445812,0.3402187120291616,0.8023001727952104,1.0,17/30,32.89%,ERCC3;ERCC2;POLR2F;POLR1G;CAVIN1;TBP;POLR1C;TAF1C;GTF2H4;POLR2H;UBTF;TAF1D;POLR2L;TAF1B;POLR2K;TAF1A;CCNH
prerank,AMP metabolic process (GO:0046033),0.519791490957702,1.1159193571899841,0.340080971659919,0.8020559936375676,1.0,3/13,12.67%,XDH;AK3;AMPD3
prerank,aorta development (GO:0035904),-0.4161527785439243,-1.1153291069950926,0.315018315018315,0.6522534035288199,1.0,8/14,14.85%,ROBO1;ROBO2;PDGFRB;TBX1;PDE2A;TBX2;EFEMP2;APLNR
prerank,DNA replication (GO:0006260),0.39428078275804135,1.1153090703708706,0.2920997920997921,0.8033611710089519,1.0,39/105,27.98%,HELB;REV3L;POLE2;RMI2;MCM2;CDC6;RBBP8;RAD1;ING5;WRN;ATM;RAD50;CDC45;ING4;ATRIP;MCM4;HUS1;POLG2;POLB;REV1;ORC2;DBF4;CDK2;KAT7;TBRG1;TOP1;TOPBP1;UPF1;PTMS;TOP1MT;DONSON;TOP3A;MCM7;RECQL5;POLD1;POLG;PNKP;RPAIN;ATR
prerank,neuron development (GO:0048666),0.38695636633866776,1.1148525357999302,0.28249744114636643,0.8040816293117897,1.0,31/141,15.54%,MYOC;PBX3;NEDD4;VSX1;LGI4;STMND1;PPP1R9B;GLI2;EHD1;LRP12;DOCK7;TGFB2;BLOC1S2;HMGB1;GPRIN1;PBX1;TBC1D23;TBC1D24;B4GALT5;RUNX1;SRF;TENM1;UHMK1;NLGN1;BLOC1S3;MANF;WNK1;PLP1;MICALL2;IL6;THOC2
prerank,protein-containing complex assembly (GO:0065003),0.37792093426445433,1.1145889282902997,0.23293172690763053,0.8042558736029917,1.0,105/259,27.45%,TCF7L2;TIAM1;SEC31A;SEC24D;COL16A1;STX5;FBXL7;NOL3;SEC13;CSNK1D;SEC23A;TLE2;HES5;TCF7L1;CD3E;TRAPPC10;DNAJB14;ADCY8;MCU;DMD;CNIH2;BCL9L;GPAA1;SPG7;SLC9A1;ADAM10;TRRAP;LLGL1;DLG4;MDM4;SOX9;SH3PXD2B;PPP6R1;PYGO1;BET1;PPP6R3;TLE3;SCFD1;ST13;NSF;WIPF1;CDC123;TERT;TRAPPC6A;SNX9;AXIN1;USO1;SHANK1;CUL1;HDAC1;ZW10;KMT2D;SEC24C;SEC24B;SEC16A;FARP2;SEC16B;PREB;SEC22B;CREBBP;KPNA3;CNIH1;SEC24A;EPRS1;MEN1;TMED2;NAPA;SEC23IP;CTSZ;TRAPPC3;TEAD2;TRAPPC6B;CAPZA1;DARS1;LRRK2;LMAN1;RAB1A;KLHL12;STOML2;KMT2A;REPS2;AFG3L2;PEX14;NIFK;RAB1B;DET1;SMARCA4;ANKRD28;TBC1D20;BAD;TP53;DNAJB12;PPID;AFDN;TFG;TRADD;VAMP2;RIPK1;CAND1;CSNK1A1;GOLGA2;WAS;PPP2R1A;PARD3;WDCP
prerank,RNA metabolic process (GO:0016070),0.3867257143894063,1.1145604920448944,0.286302780638517,0.8036934834540274,1.0,51/127,25.78%,DDX17;HNRNPH1;SIDT2;RBFOX2;RBM39;DUSP11;FTO;M1AP;HNRNPA2B1;PPP1R8;RNASE3;HNRNPH2;HNRNPL;RNASE6;TBRG4;GTF2F1;RBM6;AGO1;RBM5;PABPN1;AGO2;ALKBH1;HNRNPM;PCBP2;PTBP1;RBM4;HNRNPC;SND1;SUPV3L1;HNRNPK;CLP1;POLR2F;TFIP11;TP53RK;NCBP1;NCBP2;SYNCRIP;MTREX;HNRNPH3;ATXN2;DHX8;TENT2;POLR2B;HNRNPA3;HNRNPA1;PABPC4;HNRNPU;RBM3;DDX39B;METTL14;DDX20
prerank,nuclear envelope organization (GO:0006998),0.4809614537494932,1.1139482350652006,0.3381014304291287,0.8050180891386516,1.0,5/20,18.18%,NUP93;TMEM43;DMPK;REEP3;TMEM170A
prerank,dopamine metabolic process (GO:0042417),0.4869748192315488,1.113789871058852,0.33163913595933925,0.8048525310080703,1.0,4/18,4.59%,DRD1;LRTOMT;TGFB2;SNCAIP
prerank,body fluid secretion (GO:0007589),0.5110533173620212,1.1135411498144803,0.3333333333333333,0.8049339732814582,1.0,3/15,10.56%,VEGFA;GPAT4;VIP
prerank,Wnt signaling pathway (GO:0016055),0.39894235931805305,1.1133944302325725,0.3025210084033613,0.8047285965478801,1.0,18/92,13.14%,LRP6;WNT9A;TCF7L2;SFRP4;PLPP3;LRP5;NXN;TCF7L1;DVL1;BCL9L;FZD7;FZD5;VPS26A;CSNK1G1;AXIN1;CUL1;USP34;CSNK1E
prerank,N-terminal protein amino acid modification (GO:0031365),0.518837179810814,1.1133711572258975,0.3518776077885953,0.8041568516575591,1.0,7/14,26.15%,NAA60;NAA40;NAA16;NTMT1;METAP1D;METAP2;NAA15
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.4355180645878148,1.1133223506732857,0.3400713436385256,0.8036694074126739,1.0,16/35,30.26%,MAPK15;NEK7;HNRNPA2B1;ATM;TNKS2;CCT6A;CCT4;CCT8;MAP2K7;HNRNPA1;TCP1;PNKP;RTEL1;ATR;CCT5;CTNNB1
prerank,nucleus organization (GO:0006997),0.4208131981300581,1.113182924053155,0.33712984054669703,0.8034358975685322,1.0,15/47,26.80%,NUP93;SEH1L;CHMP3;DMPK;USP36;REEP3;TMEM170A;CHMP4B;CHMP4A;PDCD6IP;NDC1;NUP35;CHMP2A;TPR;ATXN7
prerank,generation of neurons (GO:0048699),0.3812845762544923,1.1131356519896796,0.25884732052578363,0.8029314012711034,1.0,30/190,12.51%,SIX1;WNT9A;CIT;FGF13;MAP1B;MARK1;LDB1;LRP12;NAV1;DOCK7;LHX9;HES5;TGFB2;SIX4;NRBP2;BHLHE40;FZD7;FGFR1;HEYL;RUNX2;FZD5;PEX13;RUNX1;MYEF2;CTF1;NRP1;NEUROD2;SDCCAG8;HEY1;DNAAF4
prerank,response to sterol (GO:0036314),0.5441672953707595,1.1128437623210012,0.3586800573888092,0.8031995517115049,1.0,3/11,12.22%,TGFBR2;RORA;TGFBR1
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.4016529232250776,1.11277277792383,0.3075313807531381,0.802759987139873,1.0,12/90,8.87%,GNAS;CMKLR1;VEGFA;GADD45G;GRB10;PEMT;DYNC1H1;ALMS1;EHMT1;PLAC8;OGT;ADIPOR2
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.4980269890848487,1.112717033178581,0.3522267206477733,0.8023067513311624,1.0,6/17,13.49%,P4HB;NOL3;NFE2L2;SOD1;SFPQ;UBQLN1
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.4220688250319611,1.112709010371351,0.344097995545657,0.8016842833222343,1.0,6/51,5.60%,DCLK1;SRGAP2;CTTN;ANKRD27;SNX2;DNM2
prerank,telomere maintenance (GO:0000723),0.42143888347799396,1.112581755287584,0.3246606334841629,0.8014239765891964,1.0,21/50,27.98%,PARP3;PRKDC;ERCC4;WRN;TERT;ATM;TEN1;RAD50;DCLRE1B;PARP1;TPRKB;SMC5;HUS1;RAD51;XRCC3;XRCC6;POLD1;SMC6;RTEL1;NSMCE2;ATR
prerank,glutathione derivative metabolic process (GO:1901685),0.485210845436663,1.1125618071583334,0.35382685069008785,0.8001993435093769,1.0,5/20,16.08%,GSTT1;GSTM5;GSTO2;AKR1A1;GSTZ1
prerank,glutathione derivative biosynthetic process (GO:1901687),0.485210845436663,1.1125618071583334,0.35382685069008785,0.8001993435093769,1.0,5/20,16.08%,GSTT1;GSTM5;GSTO2;AKR1A1;GSTZ1
prerank,autophagosome organization (GO:1905037),0.4194098251309261,1.1124032929889862,0.32471910112359553,0.8000203783436198,1.0,19/50,28.42%,ULK2;RAB43;PACS2;WIPI2;ATG3;ATG16L2;UBQLN1;RAB23;RB1CC1;ATG16L1;RAB1A;RUFY4;RAB1B;ATG9A;AMBRA1;ATG13;ATG2B;UBXN2A;ULK1
prerank,regulation of B cell apoptotic process (GO:0002902),0.5265905278666486,1.1123397625338065,0.360056258790436,0.7995794328598876,1.0,1/12,0.44%,FOXP1
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.44977268883632454,1.1120801420690494,0.330498177399757,0.7997546243330602,1.0,4/29,12.95%,THBS1;PAK2;LTBR;INHBA
prerank,negative regulation of protein binding (GO:0032091),0.40724548109019637,1.11179197037181,0.3125,0.8000636356457932,1.0,19/71,19.03%,PRKCD;PTPRF;LRPAP1;CARD16;DACT1;DVL1;TMC8;SYMPK;EFHB;MAPK8;GTF2F1;CSNK1E;USP33;DAB2;MITD1;TFIP11;STYX;AKT1;CTSZ
prerank,vitamin D metabolic process (GO:0042359),0.5228496661144634,1.111573730070331,0.355463347164592,0.8001192371916075,1.0,4/13,15.00%,LRP2;PIAS4;VDR;CYP27B1
prerank,negative regulation of metabolic process (GO:0009892),0.4138782887853249,1.1109352057926631,0.3378995433789954,0.801464487376891,1.0,18/54,17.09%,ZNF423;NPR3;DOCK7;ATF4;ACTN3;ACOT11;FOXC2;PGAM5;TFE3;TLE3;IP6K1;PCTP;ABHD6;CIDEA;LNPEP;ID1;FLCN;ACOT13
prerank,protein localization to chromosome (GO:0034502),0.4371676993301956,1.1107805121323637,0.32784958871915393,0.8013320746237629,1.0,3/34,7.54%,ESR1;PARP3;SLF2
prerank,mucosal immune response (GO:0002385),0.5011470212883196,1.1101103686957339,0.34346103038309117,0.8028055348238485,1.0,4/15,21.35%,IFNLR1;RNASE3;DEFB1;IL4
prerank,leukotriene metabolic process (GO:0006691),0.48757748576419885,1.1098541335486138,0.3472041612483745,0.8029781327374341,1.0,3/19,8.09%,PLA2G4A;ABCC1;PLA2G5
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.3954022266920551,1.109641987927622,0.30620985010706636,0.8029759304028015,1.0,14/75,12.22%,PGF;VEGFA;F3;FGF2;STAT5A;PRKCA;HMGB1;FGFR1;BMP4;AGGF1;VIP;PDPK1;NRP1;TGFBR1
prerank,positive regulation of histone deacetylation (GO:0031065),0.5270175750382878,1.1093848011681418,0.3788300835654596,0.803144175592192,1.0,5/12,28.08%,VEGFA;NIPBL;AKAP8;SAP30BP;PRKD2
prerank,regulation of telomere maintenance (GO:0032204),0.45599957724182133,1.1091855337648817,0.32575757575757575,0.8031418456820381,1.0,6/26,13.51%,GNL3;SMG6;ERCC4;SMG1;RAD50;USP7
prerank,polyamine metabolic process (GO:0006595),0.5176352158212673,1.1087962320602525,0.3528591352859135,0.8037272541847991,1.0,5/13,18.87%,SAT2;SMOX;SRM;HDAC6;AOC1
prerank,axonal transport (GO:0098930),0.4353701616393401,1.1087767031256062,0.3479289940828402,0.8031545158791683,1.0,13/36,23.53%,DYNC1H1;RAB21;BLOC1S2;SYBU;SPAST;AP3D1;SOD1;BLOC1S3;SNAPIN;KIF1B;DCTN1;NEFL;AP3B1
prerank,folic acid-containing compound metabolic process (GO:0006760),0.4759860047645742,1.1073889962528995,0.35058214747736094,0.8068594643295712,1.0,8/19,18.96%,SLC25A32;MTRR;MTHFD2;ALDH1L2;MTHFD1;SHMT2;SHMT1;MTHFR
prerank,mesoderm formation (GO:0001707),-0.3974507582248131,-1.1072593204876868,0.3179916317991632,0.6712311668121997,1.0,4/17,9.22%,ITGB4;ITGA3;ITGA8;BMPR2
prerank,cAMP metabolic process (GO:0046058),-0.41224427339609493,-1.1071727573965071,0.34397163120567376,0.66939759926774,1.0,4/13,7.39%,ADCY5;PDE4D;ADCY1;ADCY4
prerank,protein polyubiquitination (GO:0000209),0.371054707000132,1.1068158419867193,0.22822822822822822,0.8080481352821302,1.0,118/297,30.27%,WWP1;RNF144A;NEDD4;FBXO10;ANAPC5;FBXL7;PSMD7;CDC16;FBXW8;TOPORS;UBE2B;PSMA8;LRSAM1;UBE2R2;ERCC8;UBE3C;RNF115;SYVN1;TRIM27;HUWE1;RBBP6;WWP2;SHARPIN;PSMA4;ITCH;UBR5;RNF114;FBXL4;UBE2C;FBXO22;MYLIP;FBXL12;RNF14;PSMD12;ANAPC4;CUL1;FBXL19;PSMA6;TRAF3;TNKS2;FBXL14;LNPEP;ANAPC2;UBE2L6;STUB1;PSMD11;FBXL20;PSMC5;PSMD1;DDA1;FBXO17;ANAPC1;TRAF3IP2;PSMD14;UBE2V2;RC3H2;PSMC4;RPS27A;UBC;ANAPC10;FBXL18;TPP2;TRIM6;NPEPPS;UBE4A;CDC27;HECTD1;UBR2;CBFB;FBXW2;FBXW4;RUSC1;UBE2G2;SMURF2;PSMA3;PSMD4;PSMB1;MUL1;RNF4;UBOX5;AREL1;TTC3;PSMA5;RNF20;RNF216;ZFP91;RNF146;FBXO11;PSMA7;TAF1;FBXO9;AMFR;UBE2W;FBXO38;FBXW10;SHPRH;RNF126;RNF166;PSMC1;RNF167;PSMA1;UBE2V1;UBE4B;RNF135;ANAPC11;FBXL8;BTRC;FBXO41;RBX1;UBE2Q2;DCAF15;TRAF5;UBE2S;TRIP12;PSMD2;BLMH;CTNNB1;UBE2H
prerank,positive regulation of nervous system development (GO:0051962),-0.3132853499437821,-1.1067418781912028,0.28,0.6684132154277526,1.0,14/42,11.90%,NRXN1;IL1RAPL1;TGM2;GRID2;PTPRD;OPRM1;FAIM;SRPX2;CX3CR1;CUX2;CLSTN1;EPHB1;IL1RAP;SYNDIG1
prerank,receptor-mediated endocytosis (GO:0006898),0.38310462836609993,1.106732437533519,0.28061224489795916,0.8076641959267015,1.0,29/132,16.21%,LRP6;LRP1;NEDD4;CTTN;COLEC11;IGF2R;PDLIM7;SPARC;DNAJC13;RAMP2;AP2A1;DNM2;CD9;CXCL16;FCHO2;SNX1;FCER1G;HYOU1;RAMP1;RABEPK;SNX9;AP2A2;LRP2;SNAP91;CLTC;COLEC12;DAB2;GPR107;PI4KB
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.41147296231123975,1.1066728411494187,0.3219026548672566,0.8072204337388859,1.0,30/60,33.73%,TCF7L2;TRIM28;RUNX2;MED27;MED13;SOX9;MED31;AGO1;SRF;MED25;IL6;MED26;MED14;MED12;CBFB;MED20;TP53;CCNC;MED24;MED23;TNRC6A;MED8;MECP2;MED15;CTNNB1;MOV10;NFKB1;RELA;MED1;CEBPB
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.4886424007231532,1.1063124387721182,0.34748010610079577,0.8076963776301211,1.0,9/17,26.43%,EMC2;EMC1;EMC9;EMC8;CAMLG;MMGT1;EMC4;GET4;GET3
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.4181799217551514,1.105732727263011,0.3559127439724455,0.8088367857432553,1.0,5/43,8.14%,LBP;GAS6;IRAK3;TRIM27;RARA
prerank,atrial septum development (GO:0003283),0.530646970796916,1.1057242819163577,0.36412315930388217,0.808228737101609,1.0,4/13,15.71%,TGFB2;ANK2;MDM4;NPHP3
prerank,modification-dependent protein catabolic process (GO:0019941),0.37863051762117567,1.1056877624051686,0.2786220871327254,0.8076983057370232,1.0,79/193,30.43%,RNF144A;NEDD4;FBXO10;ANAPC5;FBXL7;CDC16;TOPORS;UBE2B;UBR4;UBE2R2;UBE3C;SYVN1;TRPC4AP;NTAN1;CBL;RBBP6;ITCH;RNF114;FBXL4;UBE2C;FBXO22;MYLIP;RNF14;ANAPC4;LONP1;UBQLN1;USP33;SQSTM1;RNF11;FBXL14;ANAPC2;ARRB1;UBE2L6;STUB1;PSMD11;ANAPC1;PSMD14;RC3H2;RPS27A;UBC;UBL7;BIRC6;ANAPC10;UBE4A;CDC27;NPLOC4;CDC20;RNF7;PCYOX1L;FBXW4;UBE2G2;SMURF2;AREL1;TTC3;RNF20;RNF146;FBXO11;TAF1;HERPUD1;AMFR;RNF111;PINK1;RCHY1;UBR3;COPS3;RNF126;RNF166;NDFIP1;RNF167;DDB1;UBE4B;ANAPC11;BTRC;RBX1;UBE2S;TRIP12;UBE2H;ADRM1;KEAP1
prerank,inhibitory synapse assembly (GO:1904862),0.5343476172713494,1.1056069253911074,0.3602941176470588,0.8073211327466863,1.0,2/11,4.75%,FGF13;LGI2
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.3791765775501349,1.10520575270841,0.27715736040609135,0.8079365113840574,1.0,47/166,24.97%,THBS1;SMOC2;EGFR;IRS1;FGF2;AGXT2;GLI2;LDB1;SAMD4A;ELOVL5;PRKDC;GIPC1;DDAH1;BRPF3;AKT2;SREBF1;NIBAN1;NNMT;CNEP1R1;CHP1;PTPN2;ARPP19;IL6;HGF;EIF6;ERBB2;EIF3D;CDT1;AKT1;EPM2AIP1;MLXIPL;APPL1;KAT7;CLU;CIRBP;PYM1;FXR2;SLC25A37;LDLR;UPF3A;OPN3;RPS6KB1;PRMT1;ABCB10;RBM3;RPS27L;UPF3B
prerank,axon guidance (GO:0007411),0.377857820727237,1.1051440821255827,0.24044265593561368,0.8074801344944009,1.0,24/201,7.27%,SLIT3;SLIT2;SLIT1;PLXNA4;EMB;NTN1;VEGFA;EFNA5;NFIB;GRB10;GAB2;GLI2;TMEFF1;PDLIM7;EPHB2;SHC1;SEMA3E;NTN4;PRKCA;EPHB3;EPHB6;GAP43;SEMA4B;PALLD
prerank,regulation of nervous system development (GO:0051960),0.43858387345673866,1.1048723433941434,0.33409350057012543,0.8076982629886296,1.0,10/37,16.17%,LGI4;DOCK7;HES5;TNFRSF1B;BHLHE40;HEYL;HEY1;SIRT2;NPHP3;NKX6-2
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.4003941495430803,-1.1044666625106312,0.3170731707317073,0.6721430353170474,1.0,5/13,13.49%,ERRFI1;CBLB;SNX6;SOCS5;GPRC5A
prerank,plasma membrane invagination (GO:0099024),0.4587939572956796,1.1044300117078574,0.36260978670012545,0.8084311318218197,1.0,5/29,12.38%,GSN;SNX18;RHOA;SNX9;SPIRE2
prerank,negative regulation of epithelial cell differentiation (GO:0030857),-0.4139967366673161,-1.1037771928260667,0.3157894736842105,0.671885005867696,1.0,6/14,13.01%,ZEB1;OSR1;NOTCH4;CAV1;SPRED1;SPRY1
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.4738919827009442,1.103689457787562,0.36904761904761907,0.8101844301877912,1.0,7/19,12.22%,ZFPM2;FGF2;NOG;RUNX1;FGFR2;BMPR1A;TGFBR1
prerank,piRNA metabolic process (GO:0034587),0.4791454077592973,1.10345141760975,0.34509803921568627,0.8102700117512107,1.0,4/19,20.82%,TEX15;MAEL;TDRD12;TDRKH
prerank,protein heterooligomerization (GO:0051291),0.4868406713044948,1.1031926587958372,0.33771353482260186,0.8104324252164831,1.0,5/17,17.90%,PKD1;CBR4;HSD17B8;CPSF7;CPSF6
prerank,"DNA-templated transcription, termination (GO:0006353)",0.40473243367618755,1.1027839651401885,0.3383947939262473,0.8110746613184232,1.0,36/68,33.38%,SYMPK;MAZ;PABPN1;ERCC3;ERCC2;CLP1;CPSF4;POLR2F;PCF11;SMN1;NCBP1;CPSF7;NCBP2;POLR1G;POLR3K;CAVIN1;CSTF2;CSTF2T;SNRPB;TBP;POLR1C;TAF1C;GTF2H4;POLR2H;UBTF;SETX;TAF1D;PRMT5;POLR2L;TTF2;SNRPF;TAF1B;POLR2K;TAF1A;CCNH;CPSF3
prerank,mRNA stabilization (GO:0048255),0.43105172529920804,1.102057579559636,0.35206422018348627,0.8126659891883101,1.0,16/40,24.73%,YBX3;PABPC1;TENT5A;FUS;THRAP3;VIP;TAF15;HNRNPC;E2F1;SYNCRIP;GDNF;CIRBP;SLC11A1;YBX1;HNRNPU;RBM24
prerank,regulation of platelet activation (GO:0010543),-0.3528133110989906,-1.1018735264379755,0.2777777777777778,0.6748825651705687,1.0,8/21,11.33%,LYN;APOE;TEC;NOS3;PDGFRA;SYK;PRKCQ;PLEK
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.4542118700461727,1.1018152594527375,0.36039360393603936,0.8128129786838023,1.0,8/26,13.64%,ACTN3;SLC9A1;CHERP;EFHB;RCAN1;STIMATE;CHP1;PTBP1
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.42880616380412867,1.1014370338193675,0.35406698564593303,0.813370496889939,1.0,13/39,16.21%,TTC7A;PIK3C2B;SOCS4;SOCS7;SOCS6;SOCS2;PIP4K2B;SMG1;IP6K1;PIK3CB;PI4K2A;TTC7B;PI4KB
prerank,positive regulation of macrophage differentiation (GO:0045651),0.5278851092127349,1.101217807790295,0.3698060941828255,0.8134090690962085,1.0,2/11,4.72%,ID2;PRKCA
prerank,negative regulation of cellular process (GO:0048523),0.3689757195455786,1.1007382066559968,0.193,0.8142732391103827,1.0,98/521,15.41%,SLIT3;SLIT2;PLXNA4;ZBTB7C;SRSF6;FHL1;WNT9A;FGF2;SRGAP2;OSGIN2;SFRP4;PDCD4;CCN5;TGFBI;EMILIN1;CCN3;NTRK1;SPN;PPP1R9B;SMAD6;ACVR1B;CYP1B1;GLMN;EPHB2;VPS13C;TGFB3;P3H3;PRDM11;SLURP1;PKHD1;LRPAP1;LMNA;PTPRU;TGFB2;P3H1;CLMN;AGR2;TNFRSF1B;TMEM98;CCAR2;NOX4;TMEM115;CD9;PLPP1;SMAD4;ADAM10;ABI1;PRKRA;IFNLR1;CDK10;SKI;TEX15;RAF1;MDM4;P3H2;TES;CHERP;DACT3;DDAH1;CDC6;IMPACT;SERTAD2;NDRG3;DCBLD2;ING5;BMP4;FOXM1;ANP32B;LPCAT3;DIS3L2;RBM5;TAF6;TGFB1I1;PBRM1;TENM1;PTPN2;INHBA;CGRRF1;SESN2;PIP4P2;F2R;RBBP7;GSDME;FRK;BMP5;TMEM127;FUZ;MIA3;SIRT2;VDR;CYP27B1;SERTAD3;RHOB;SCIN;ING4;CAMK2N1;CCN4;IL6
prerank,acyl-CoA metabolic process (GO:0006637),0.4387401611870527,1.1007037554653636,0.3475177304964539,0.8137667107810314,1.0,11/35,25.09%,ACSF2;ACOT11;SUCLA2;GPAT4;ACACA;GLYAT;MCEE;ACOT13;ACSL6;HMGCS2;ACOT8
prerank,calcineurin-NFAT signaling cascade (GO:0033173),0.5442694347596712,1.1006233358330648,0.3691860465116279,0.8127482826038794,1.0,5/10,19.95%,NFAT5;NFATC1;PPP3CC;NFATC3;NFATC4
prerank,calcineurin-mediated signaling (GO:0097720),0.5442694347596712,1.1006233358330648,0.3691860465116279,0.8127482826038794,1.0,5/10,19.95%,NFAT5;NFATC1;PPP3CC;NFATC3;NFATC4
prerank,cortical actin cytoskeleton organization (GO:0030866),0.48274882940082187,1.1000946748762497,0.34880636604774534,0.8137614923381168,1.0,4/20,8.74%,FMNL2;RHOQ;LLGL1;DLG1
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.43069518595411477,1.1000716107505657,0.34834123222748814,0.8132037351874919,1.0,15/40,28.01%,PRKCD;KMT5A;SMG1;ABL1;UBE2V2;USP1;ARMT1;NEK4;FXR2;BCLAF1;SMYD2;PARG;UBE2V1;CDK9;FXR1
prerank,semaphorin-plexin signaling pathway (GO:0071526),-0.3111015261274437,-1.0996437697723906,0.28859060402684567,0.6786593024693451,1.0,17/35,19.11%,SEMA6A;PLXNA2;SEMA3D;SEMA7A;SEMA5A;PLXND1;NRP2;ARHGDIA;PLXNB2;SEMA4D;SEMA3G;SEMA4A;PLXNB1;SEMA5B;SEMA4G;SEMA6D;PLXNA3
prerank,protein export from nucleus (GO:0006611),0.449071782526862,1.0996138578854011,0.35175879396984927,0.813980110476891,1.0,14/27,27.86%,PKD1;XPO1;STRADA;XPO6;XPO4;CHP1;STYX;CALR;CCHCR1;DESI1;NUTF2;XPO7;TPR;XPO5
prerank,inositol phosphate metabolic process (GO:0043647),-0.30417478504722484,-1.0993178392691925,0.26956521739130435,0.6774858292733791,1.0,10/46,8.88%,PLCB1;INPP4B;ITPKB;INPP5D;ISYNA1;NUDT4;PLCB4;PLCH1;IP6K2;PLCD1
prerank,cell differentiation in hindbrain (GO:0021533),-0.4471198308966196,-1.0992452898060259,0.3515358361774744,0.6756509071615383,1.0,7/11,24.15%,GRID2;PROX1;OPHN1;FAIM2;LHX1;CBLN1;CEND1
prerank,regulation of trans-synaptic signaling (GO:0099177),0.4464011356553053,1.0990209907512432,0.35167464114832536,0.8151585803637655,1.0,8/33,15.39%,GRIK4;CEL;ARC;SLC4A8;BCR;IQSEC2;NLGN1;PSMC5
prerank,melanosome organization (GO:0032438),0.4540828846542698,1.0988371913533872,0.35572139303482586,0.8151178351156023,1.0,8/26,14.67%,KIF13A;BLOC1S2;RAB38;TRAPPC6A;AP3D1;BLOC1S3;ABCB6;HPS4
prerank,monocyte chemotaxis (GO:0002548),-0.3336011049603559,-1.0983286952725275,0.29473684210526313,0.6760828871932067,1.0,3/32,4.40%,FLT1;IL6R;PTPRO
prerank,response to peptide hormone (GO:0043434),0.4218755782264524,1.098257240658619,0.3445086705202312,0.8162213820301728,1.0,7/43,9.20%,IRS1;IGFBP5;STAT5A;STAT3;MEAK7;OGT;ANXA1
prerank,vasculogenesis (GO:0001570),-0.3229107128644848,-1.09822489248209,0.2978723404255319,0.6743052490326981,1.0,10/32,11.33%,TGFBR3;ENG;NOTCH1;KDR;RASIP1;PDGFRB;SOX17;CAV1;SPRED1;SOX18
prerank,positive regulation of apoptotic process (GO:0043065),0.36838760186449304,1.0980516027805465,0.23316582914572864,0.8162397759247106,1.0,65/293,18.07%,SLIT2;RASSF2;HOXA5;SFRP4;PTGIS;TIAM1;GADD45G;PRR7;TIAM2;VAV2;UNC13B;CYP1B1;FAP;TGFB3;PRDM11;MAP3K5;TGFB2;CRADD;ATF4;DNM2;CCAR2;HMGB1;IAPP;ING3;KALRN;BACE1;MAPK8;ING5;FOXA1;BMP4;ABL1;ATM;RBM5;AIFM1;TNFRSF10B;SOD1;TGFBR1;ERCC3;HSPD1;PTRH2;PDCD2;MAP3K10;SQSTM1;SOS2;ARHGEF1;AKAP13;SIRT2;PSEN2;RHOB;SCIN;ING4;LATS2;FOXO3;SOS1;IL6;TRIO;NF1;RPS27A;UBC;APBB1;FLCN;E2F1;NGEF;DAPK3;RYBP
prerank,transcription by RNA polymerase I (GO:0006360),0.43972046407787624,1.0980034850934797,0.35083532219570407,0.8157571112728226,1.0,20/34,34.24%,ERCC3;ERCC2;POLR2F;POLR1G;CAVIN1;TBP;POLR1C;TAF1C;TAF1;GTF2H4;POLR2H;UBTF;TAF1D;POLR2L;TAF1B;POLR2K;RRN3;TAF1A;CCNH;TCOF1
prerank,positive regulation of ERAD pathway (GO:1904294),0.5174342785858567,1.0980026795754751,0.36022253129346316,0.8151325839295356,1.0,6/13,25.30%,NFE2L2;BCAP31;UBQLN1;USP13;HERPUD1;RNFT1
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.49834153447169977,1.0979515682438774,0.3743169398907104,0.8146645322964686,1.0,9/16,33.29%,HELB;RMI2;MAD2L2;FBH1;CGAS;SHLD3;SHLD1;PARPBP;POLQ
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.3916690002251771,1.09781838972512,0.32460732984293195,0.8144521130524798,1.0,16/93,13.74%,RASSF2;SH3RF3;VEGFA;GADD45G;MAP3K5;TGFB2;MID1;XDH;HMGB1;FZD7;LTBR;AXIN1;CD27;STK25;TRAF3;MAP3K10
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.4303739043414784,1.0976195539064628,0.3494809688581315,0.8144006532650934,1.0,21/39,35.01%,CHD1L;ERCC5;ERCC4;OGG1;CUL4A;ERCC3;ERCC2;PARP1;RPS27A;UBC;POLD1;GTF2H4;XPA;DDB1;RBX1;ERCC1;CUL4B;POLK;RPA3;FAN1;RFC4
prerank,positive regulation of phosphorylation (GO:0042327),0.37238446776859563,1.097146580755945,0.280561122244489,0.8152496639358703,1.0,38/240,11.54%,THBS1;SLC4A4;PGF;EGFR;SLCO3A1;VEGFA;EFNA5;GAS6;DDR2;FGF2;CARD14;NTRK3;NTRK1;FGF17;GLMN;EPHB2;CSNK1D;LIMK2;MAVS;EPHB3;ILK;EPHB6;FZD7;FGFR1;ROR1;RSPO1;SOX9;AKT2;TMEM119;FGFR2;BMP4;ABL1;MUSK;NIBAN1;LMO4;AXIN1;DDR1;NRP1
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.5227226000770552,1.0971136198214246,0.3587257617728532,0.8147218537460232,1.0,5/11,21.35%,TBX21;ANXA1;SMAD7;RC3H2;IL4
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.4725608155565063,1.0970017448656428,0.35927367055771725,0.8144123538644911,1.0,4/21,4.44%,BGN;CHST11;CHPF2;CSPG4
prerank,eye photoreceptor cell differentiation (GO:0001754),0.5214319203450601,1.0966869278292695,0.36901408450704226,0.8147606781507226,1.0,2/12,4.11%,VEGFA;STAT3
prerank,protein autoubiquitination (GO:0051865),0.405361739832815,1.0966317260265608,0.3239130434782609,0.8142976953518778,1.0,19/61,25.30%,SH3RF3;UBE2B;LRSAM1;NFX1;ERCC8;RNF115;WWP2;ITCH;RNF11;STUB1;TRIM13;UHRF2;RNF141;SH3RF1;RNF4;RNF146;RNF122;AMFR;RNFT1
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.5443876495203176,1.0965300164692893,0.3599419448476052,0.8139968407240711,1.0,4/10,12.87%,RHOA;SYNE4;MYO9A;EZR
prerank,myeloid cell differentiation (GO:0030099),-0.3046044724514128,-1.096461916920871,0.2833333333333333,0.6768791527167821,1.0,6/47,3.78%,LYN;MFHAS1;ZBTB16;KIT;SNRK;RPS14
prerank,response to amyloid-beta (GO:1904645),-0.3115514070927522,-1.0961597810172101,0.2692307692307692,0.6756238264914405,1.0,13/44,15.05%,IGF1R;GRM5;EPHA4;APP;CACNA2D1;VCAM1;CASP4;GRIN2A;SNX6;ITGA4;IGF1;GRIN1;CACNB1
prerank,positive regulation of interleukin-8 production (GO:0032757),0.41572490720783406,1.0960135717376642,0.3511111111111111,0.8149373850461292,1.0,5/49,6.52%,LBP;F3;STAT3;MAVS;HMGB1
prerank,regulation of glycolytic process (GO:0006110),0.39712762203297836,1.0960118623450312,0.3507057546145494,0.8143240315745298,1.0,27/68,26.60%,SLC4A4;NUP93;SEC13;HDAC4;RAE1;ACTN3;SEH1L;OGT;NUP37;GIT1;RANBP2;NUP88;EIF6;PRKAG1;NUP210;POM121;MLXIPL;NUP62;NDC1;NUP35;PFKFB4;ENTPD5;NCOR1;PFKFB1;NUP85;TPR;NUP160
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.3790651897860983,1.0959424115473344,0.3158974358974359,0.8139129286355912,1.0,33/129,16.70%,EGFR;COL1A1;SFRP4;GPC3;PLEKHA4;PSMD7;CSNK1D;UBE2B;VCP;PSMA8;DACT1;CCAR2;ILK;JUP;RSPO1;TRPM4;PSMA4;FGFR2;UBR5;CSNK1G1;AXIN1;PSMD12;USP34;PSMA6;CSNK1E;WNK1;TNKS2;GSKIP;PSMD11;PSMC5;PSMD1;PSMD14;PSMC4
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.5112072409951081,1.0958542325629417,0.3623789764868603,0.8135882301371347,1.0,6/13,24.17%,TSR1;RRS1;RPP40;ABT1;KRI1;TBL3
prerank,striated muscle cell development (GO:0055002),-0.3986981782877193,-1.0956439182135114,0.31970260223048325,0.675076270866556,1.0,4/14,8.08%,PGM5;TMOD3;TMOD1;LMOD1
prerank,cellular response to organonitrogen compound (GO:0071417),0.38630289171173376,1.0954230818941209,0.3161764705882353,0.8142994259241173,1.0,15/99,13.07%,SLIT2;IGFBP5;HCN4;SLC26A6;IPO5;PDE3A;LAMTOR1;JUP;SOX9;CAPN2;IMPACT;P2RY6;AKAP9;EZR;SESN2
prerank,positive regulation of cellular component movement (GO:0051272),0.46789840068904626,1.0951462257196762,0.36295369211514394,0.8144948875609938,1.0,6/24,12.22%,NTN1;VEGFA;TWIST1;AKT2;CCDC25;TGFBR1
prerank,regulation of mitochondrial translation (GO:0070129),0.4699505631388119,1.0949481618711996,0.36246786632390743,0.8145007064423694,1.0,6/21,19.25%,RCC1L;MPV17L2;RMND1;ALKBH1;SHMT2;FASTKD3
prerank,positive regulation of mitochondrial translation (GO:0070131),0.5066195066557058,1.0947985911515945,0.3672627235213205,0.8143513701024019,1.0,3/14,8.52%,RCC1L;MPV17L2;RMND1
prerank,mRNA methylation (GO:0080009),0.49797893682340755,1.0947017754052504,0.3676056338028169,0.8139995878538192,1.0,6/15,25.59%,TRMT61B;METTL16;TRMT6;TRMT61A;METTL8;METTL14
prerank,protein localization to cell periphery (GO:1990778),0.3785752609538214,1.0945606434700956,0.2978505629477994,0.8138501008329013,1.0,22/133,8.74%,LRP6;KCNB1;GAS6;ATP1B1;FGF13;TTC7A;EHD1;RDX;RAB34;PIGW;C2CD5;RAMP2;PACS2;PRAM1;S100A10;RAB8A;SLMAP;ANK2;EHD2;JUP;FCHO2;DLG1
prerank,regulation of membrane repolarization (GO:0060306),0.5197926448448418,1.094529753558161,0.36941813261163736,0.8133376388080465,1.0,4/13,13.34%,KCNJ2;KCNE5;AKAP9;YWHAE
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.5361644382935321,1.0945106875049617,0.3911806543385491,0.8127814339028587,1.0,6/11,29.31%,STAT3;PUM1;LIMD1;XPO5;FXR1;PUM2
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.3657127822326803,1.0940877957050827,0.205,0.8134723575519319,1.0,124/476,21.35%,ESR1;EGFR;LRP6;SIX1;ID2;ZFHX3;HIVEP3;FGF2;ZNF423;COL1A1;NFIB;ELF4;DEAF1;ZMIZ1;MDFIC;GLI2;LRP5;TGFB3;GLIS2;SHC1;PRDM11;HDAC4;ELF1;RXRA;MAP3K5;STAT3;HES5;SIX4;ATF4;TRIM28;ACVR1;BRD4;DNM2;ILK;FOXC2;RXRB;SMAD4;GPATCH3;FZD7;RUNX2;TASP1;THRAP3;RORA;TBX21;MED13;SOX9;NSD1;RARA;ILF3;ESRRB;TFE3;FOXK1;ENY2;SMARCC2;ZIC1;NFATC1;RUNX1;SFR1;ING5;ZFP90;BMP4;FOXM1;CHUK;EHF;MAP3K12;PHF8;PITHD1;AXIN1;CHEK2;MAZ;KAT6B;RNF14;NAA16;TAF15;NR1D2;PHIP;TGFB1I1;HDAC1;TGFBR1;HEY1;KAT2A;INHBA;CD80;MAPRE3;F2R;NDP;MMS19;SERTAD3;FOXO3;PSMC5;IL6;CREBBP;KMT2B;CAMK4;CREB1;NFE2;MLLT3;APBB1;E2F1;MED14;MED12;NFYA;CDKN1C;HMGA1;RYBP;CITED2;CHD8;HCFC1;AKT1;HIPK2;TCF3;QRICH1;MLXIPL;XRCC6;TEAD2;MAP2K3;BICRAL;MRPL12;NEK4;SMAD5;MAD2L2;MAP2K7;NUP62;IL4
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.4440593097075966,1.0940229365706133,0.35731414868105515,0.8130675674190306,1.0,16/30,29.49%,KIF13A;RAB34;GGA2;GOLGA4;NSF;SEC16A;SPTBN1;GGA1;GOLPH3;BLZF1;OPTN;VAMP4;VAMP2;GCC2;GGA3;ARFRP1
prerank,proteasomal protein catabolic process (GO:0010498),0.36919418625227535,1.0940216008292807,0.2821285140562249,0.8124631373805342,1.0,76/201,30.26%,WWP1;NEDD4;PSMD7;TOPORS;COP1;UBE2B;VCP;PSMA8;ERCC8;NFE2L2;TBX21;SYVN1;SOCS6;HUWE1;DDI2;WWP2;SHARPIN;PSMA4;ITCH;CUL4A;PSMD12;FBXL19;PSMA6;PCBP2;KCTD5;ATE1;SIRT2;ARRB1;STUB1;KLHL22;PSMD11;PSMC5;PSMD1;PPP2R5C;PSMD14;PSMC4;TRIM13;KCTD17;GID4;ERLEC1;ZFAND2B;PCNP;RCN3;UCHL1;SMURF2;RMND5B;PSMA3;DCAF11;PSMD4;PSMB1;RNF4;APPBP2;AREL1;KCTD13;PSMA5;DERL1;RNF216;PSMA7;RNF122;ANKRD9;UBE2W;DNAJB12;RNF126;PSMC1;PSMA1;DDB1;UBXN2A;CCDC47;NR1D1;UBE4B;BTRC;SPOPL;RBX1;ZFAND2A;PSMD2;CTNNB1
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.38332947988750904,-1.093921835982052,0.319634703196347,0.6774170591657542,1.0,7/18,13.53%,NRXN1;SHANK3;CACNG7;CACNG8;CACNG3;CACNG4;RELN
prerank,nuclear migration (GO:0007097),0.5121975073279322,1.0935225331699148,0.3902777777777778,0.813390451718472,1.0,5/13,14.74%,DOCK7;DYNC1H1;CLMN;TMEM201;PCM1
prerank,triglyceride homeostasis (GO:0070328),-0.3424871315265653,-1.0932452990763124,0.2914572864321608,0.677178507314862,1.0,10/26,18.90%,APOE;NR1H3;PNPLA8;C1QTNF3;SCARB1;LPL;SIRT1;DGAT2;NR1H4;XBP1
prerank,positive regulation of neuron projection development (GO:0010976),-0.267499299692899,-1.0931883441684989,0.19607843137254902,0.6753551720089234,1.0,23/85,13.93%,LYN;PTN;APOE;ITGA6;PTK7;WNT5A;BMP7;RAPGEF2;CAMK1D;SERPINI1;TENM3;ROR2;ATP1B2;VLDLR;PLXNB2;CUX2;STYXL1;PRKD1;CX3CL1;RELN;RIT2;LRP8;SCARF1
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.40176896065336054,1.0928039369892155,0.3365591397849462,0.8149688345140782,1.0,27/76,27.69%,PRICKLE1;GNL3;HDAC4;DCUN1D5;HUWE1;CDK5RAP3;WDR48;AXIN1;SMAD7;DCUN1D2;TANK;PHF23;UBQLN1;PIAS4;STUB1;RWDD3;SAE1;MYCBP2;LRRK2;BIRC3;MUL1;DERL1;XIAP;PINK1;RCHY1;NDFIP1;RIPK2
prerank,negative regulation of response to stimulus (GO:0048585),0.4002491043406503,1.09264418576685,0.35384615384615387,0.814839798184589,1.0,9/60,10.58%,SLIT2;COL3A1;UBASH3B;VPS13C;TWIST1;ACVR1;DDAH1;LPCAT3;TERT
prerank,platelet degranulation (GO:0002576),0.3795524232938013,1.0926370077866625,0.33264248704663213,0.8142441092397984,1.0,14/118,7.16%,THBS1;VEGFA;GAS6;CHID1;TIMP3;TGFB3;SPARC;PCDH7;TOR4A;TGFB2;MAGED2;CD9;QSOX1;FAM3C
prerank,regulation of neutrophil chemotaxis (GO:0090022),0.4596034171986385,1.0922882414615656,0.351010101010101,0.8146363063100637,1.0,2/23,6.03%,SLIT2;MCU
prerank,cellular response to glucagon stimulus (GO:0071377),-0.3812362016370118,-1.0921218293213022,0.344,0.676122465149346,1.0,6/17,7.39%,ADCY5;ADCY1;PRKAR2B;PRKACB;PRKAR1B;ADCY4
prerank,tRNA metabolic process (GO:0006399),0.48570144046500874,1.092018480561392,0.35058214747736094,0.8148488009354391,1.0,8/17,27.42%,SSB;DTD1;DARS2;YARS2;ADAT1;SARS1;RPP21;POP5
prerank,regulation of coagulation (GO:0050818),0.5247847467054443,1.0918240752084503,0.3863013698630137,0.8148340696168985,1.0,2/11,13.33%,EPHB2;F2R
prerank,inner dynein arm assembly (GO:0036159),0.5412244032942773,1.0913163155847996,0.3902097902097902,0.8157794398247994,1.0,4/10,24.38%,CCDC39;DNAAF4;CFAP73;DNAAF5
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.4865826990029591,1.0909719999992533,0.3745072273324573,0.8162111873473774,1.0,1/18,0.08%,MYOC
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.3973678878459287,1.0908176715053262,0.3459051724137931,0.8160751726918664,1.0,11/72,8.14%,MYOC;FGF2;NEDD4;FSHR;NTRK3;NTRK1;TGFB2;FGFR1;ROR1;SOX9;CBL
prerank,response to steroid hormone (GO:0048545),0.43319485987767037,1.0903149656674802,0.3859223300970874,0.8169965900034467,1.0,5/31,10.84%,THBS1;TGFB3;TGFB2;CATSPER3;URI1
prerank,defense response to symbiont (GO:0140546),-0.2662127652490302,-1.0901434396442309,0.24561403508771928,0.6791963117254782,1.0,20/92,13.51%,SERINC3;BCL2;BCL2L1;IFNAR2;STAT1;AGBL4;ABCC9;SAMHD1;IFITM1;BST2;NLRC5;IFIT3;IFIT2;RNASEL;IFIT1;PQBP1;RSAD2;OAS2;IFITM3;CD40
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.39267445232943277,1.090136609790842,0.350210970464135,0.8169437521014584,1.0,16/86,15.41%,EGFR;PRKCD;VEGFA;EFNA5;GHR;CSPG4;IL5;ACVR1;DGKQ;PAK2;ANGPT4;ABL1;NRP1;CD80;IL6;HGF
prerank,regulation of cholesterol storage (GO:0010885),-0.4015535182662987,-1.089872581725098,0.3614457831325301,0.677924713343258,1.0,8/15,17.19%,PPARA;ABCG1;NR1H3;PPARD;SCARB1;LPL;MSR1;TTC39B
prerank,negative regulation of cell migration (GO:0030336),0.37821097550389177,1.0894842987590558,0.3131416837782341,0.8183425127792894,1.0,18/137,6.32%,SLIT2;IGFBP5;LRP1;COL3A1;FGF2;SRGAP2;SRGAP3;TMEFF2;DPYSL3;CYP1B1;MAPK15;LDLRAD4;SLURP1;CLIC4;PTPRU;SULF1;JAG1;PFN2
prerank,regulation of collagen biosynthetic process (GO:0032965),0.4790611297817873,1.0894003163857913,0.37667560321715815,0.8179892760526083,1.0,6/19,15.41%,EMILIN1;TGFB3;RUNX1;BMP4;F2R;IL6
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.5171004949103402,1.089396818454332,0.4067796610169492,0.8167815376525217,1.0,5/12,21.50%,ACTN3;RCAN1;CHP1;HOMER2;ATP2B4
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.5171004949103402,1.089396818454332,0.4067796610169492,0.8167815376525217,1.0,5/12,21.50%,ACTN3;RCAN1;CHP1;HOMER2;ATP2B4
prerank,rRNA modification (GO:0000154),0.46874045456187186,1.089239316685813,0.37051282051282053,0.8166257380135213,1.0,14/21,40.59%,TFB2M;TSR3;FBL;BUD23;TRMT112;DKC1;NSUN3;NOP10;THUMPD1;MRM2;ZCCHC4;DIMT1;NSUN4;MTERF4
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.4735528877174384,1.0890921171700598,0.3706111833550065,0.816488738661808,1.0,5/20,6.72%,NEDD4;PRKCE;CAMK2D;GOPC;STK39
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),0.518838319403916,1.0889517230932337,0.37965616045845274,0.8163037003444061,1.0,5/12,25.29%,TMEFF2;AP2A1;CLTC;SELENOS;HDAC2
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.4455878439197308,1.0884944418494626,0.3627450980392157,0.8164539525381177,1.0,7/29,18.85%,ACSF2;ACOT11;GPAT4;ACAT1;GLYAT;ACOT13;ACSL6
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.4455878439197308,1.0884944418494626,0.3627450980392157,0.8164539525381177,1.0,7/29,18.85%,ACSF2;ACOT11;GPAT4;ACAT1;GLYAT;ACOT13;ACSL6
prerank,calcium ion transport (GO:0006816),0.38161502728630053,1.0883615986084845,0.33367875647668394,0.8162582433747573,1.0,19/113,12.06%,CACNA1G;CACNA1C;PKD1;GAS6;SLC24A3;GRIN3A;CRACR2A;TRPV3;RAMP2;CHRNB2;ANK2;TRPC4AP;TRPM7;TRPM4;STIM1;ITGAV;RAMP1;TMEM165;TRPM6
prerank,regulation of nucleocytoplasmic transport (GO:0046822),0.5172948709561476,1.0883151509485067,0.37393767705382436,0.8157882864909664,1.0,5/12,13.80%,NEDD4;BMP4;KHDRBS1;UHMK1;RBM4
prerank,positive regulation of programmed cell death (GO:0043068),0.3660903599065962,1.0879131898426482,0.2686116700201207,0.8163845669451089,1.0,60/272,18.07%,SLIT2;RASSF2;HOXA5;SFRP4;TIAM1;GADD45G;NTRK1;PRR7;TIAM2;VAV2;UNC13B;CYP1B1;TGFB3;MAP3K5;CRADD;ATF4;DNM2;CCAR2;HMGB1;IAPP;ING3;KALRN;MAPK8;ING5;FOXA1;BMP4;ABL1;ATM;RBM5;AIFM1;TNFRSF10B;SOD1;ERCC3;HSPD1;PDCD2;MAP3K10;SQSTM1;MARK4;SOS2;ARHGEF1;AKAP13;PSEN2;RHOB;SCIN;ING4;LATS2;FOXO3;SOS1;IL6;TRIO;HDAC6;NF1;RPS27A;UBC;APBB1;FLCN;E2F1;NGEF;DAPK3;RYBP
prerank,DNA geometric change (GO:0032392),0.4574695881280902,1.0875503672990436,0.35785536159601,0.8168521357958485,1.0,13/24,35.55%,HMGB1;HNRNPA2B1;ANXA1;WRN;RAD50;SUPV3L1;RECQL5;ZRANB3;RTEL1;DDX11;BLM;DHX9;MRE11
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),-0.3952694532444603,-1.0873808351813472,0.35546875,0.6822892004654093,1.0,8/15,26.73%,DDX3X;GBP5;DHX33;MYD88;TREM2;CPTP;TLR6;CD36
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.46199851166496314,1.0870925722001998,0.3786163522012579,0.817644627120462,1.0,3/22,4.52%,VEGFA;GADD45G;XDH
prerank,regulation of translation (GO:0006417),0.3690033512122706,1.087081979192101,0.3185035389282103,0.81707543064533,1.0,60/173,28.88%,THBS1;IGFBP5;SAMD4A;EIF4A2;EIF4G2;PRKDC;EIF4G3;CYFIP1;ILF3;GSPT1;IMPACT;NIBAN1;EIF4G1;ALKBH1;LTN1;NOLC1;RBM4;ETF1;FOXO3;IL6;EIF6;CNOT8;ERBB2;CNOT10;EIF3D;NCBP1;EPRS1;SHMT2;NCBP2;SYNCRIP;DAPK3;CNOT9;SHMT1;GLE1;EIF2AK4;CALR;ATXN2;EIF2A;CIRBP;SHFL;PYM1;EIF2AK3;FXR2;UPF1;EIF4B;UPF3A;RPS6KB1;YBX1;RBM3;RPS27L;UPF3B;METTL14;MRPL13;EIF4E;RIDA;YTHDF1;FXR1;NSUN3;EIF4H;LARP1
prerank,positive regulation of gene expression (GO:0010628),0.36290295360451386,1.0869350565368456,0.23,0.8169184671159838,1.0,63/442,12.95%,THBS1;SLC38A2;EGFR;PID1;ID2;HOXA5;VEGFA;GAS6;F3;FGF2;FOXD1;IL33;SFRP4;GSN;SLC24A3;DDX5;EMILIN1;NTRK3;FGF17;DRD1;RDX;GLMN;EPHB2;C1QTNF1;TWIST1;SAMD4A;STAT3;CD3E;ATF4;RAMP2;AGR2;TENT4B;PRKDC;FAM98A;NFE2L2;ANK2;SOX9;NOG;DGKQ;TMEM119;SF3B1;MAPK8;CRTAM;BMP4;UBR5;MUSK;FAM98B;AGO1;ATM;NIBAN1;FUBP1;MAZ;SOD1;TGFBR1;HEY1;PIK3CB;SMO;KAT2A;AGO2;ERP29;EZR;SERPINB9;INHBA
prerank,regulation of actin filament depolymerization (GO:0030834),-0.41062836396131985,-1.0869086700968604,0.34576271186440677,0.6815487188724345,1.0,4/12,11.33%,PLEKHH2;SEMA5A;MTPN;PLEK
prerank,ovarian follicle development (GO:0001541),0.5204011036838083,1.0867725901409226,0.35833333333333334,0.8168250929633061,1.0,3/13,12.95%,VEGFA;SOD1;INHBA
prerank,regulation of protein autophosphorylation (GO:0031952),0.43225465896533,1.0865552149304805,0.3690621193666261,0.8168673129016614,1.0,9/36,16.30%,RASSF2;VEGFA;CALM2;TOM1L1;IMPACT;RAD50;CHP1;PPP2R5C;CALM3
prerank,regulation of DNA metabolic process (GO:0051052),0.4175230079030267,1.086465025431664,0.3653179190751445,0.8165431247403331,1.0,20/44,32.76%,HELB;TOM1L1;SMG6;SMG1;KPNA2;UBE2V2;SMARCAD1;CDT1;WDR70;USP1;KAT7;MPHOSPH8;UPF1;PARG;UBE2V1;CDK9;MPV17;IL7R;UBE2N;SIRT7
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.4508573619360913,1.086376216300789,0.35441527446300713,0.8162025065364509,1.0,6/27,8.74%,FXYD5;PTPN3;CAMK2D;SLMAP;SNTA1;DLG1
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.3275604467214898,-1.0863363358709868,0.27624309392265195,0.6810127949120023,1.0,12/32,15.09%,CDH5;MAP2;NAV3;CAMSAP1;APC;EML2;SPEF1;ARHGEF2;MID1IP1;CLASP2;SNCA;TUBB4A
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.5092320387124154,1.0862120872250813,0.36899862825788754,0.8160930387463002,1.0,3/13,10.85%,DDX5;SPRED2;ATM
prerank,regulation of glycogen metabolic process (GO:0070873),0.5190331279549635,1.0861805461754979,0.3852573018080668,0.815598375075175,1.0,4/12,23.21%,PPP1R3C;PPP1R3F;AKT1;PPP1R3B
prerank,triglyceride catabolic process (GO:0019433),-0.3637713505479837,-1.0858518555452008,0.3607305936073059,0.6804191815214816,1.0,9/19,35.75%,LPL;FABP7;FABP5;FABP3;LIPH;LIPC;FABP4;FABP12;PNPLA2
prerank,amino acid import (GO:0043090),0.4739898621779676,1.085833677567309,0.361323155216285,0.8160286149270678,1.0,2/21,5.31%,SLC47A1;SFXN3
prerank,regulation of cilium assembly (GO:1902017),0.4078907454727064,1.084865546540786,0.35978260869565215,0.8183616577185451,1.0,30/62,30.16%,TBC1D2B;MAPK15;LIMK2;DYNLT2B;IFT20;CDK10;TBC1D24;ATG3;EVI5L;SDCCAG8;TBC1D9B;MARK4;FUZ;TBC1D10A;IFT88;TBC1D17;KCTD17;EVI5;TBC1D22B;RABGAP1;CYLD;CCP110;ARHGAP35;TBC1D20;TAPT1;IFT140;TESK1;YAP1;TBC1D19;TCHP
prerank,mitochondrion localization (GO:0051646),0.4713064491062331,1.0845670853627951,0.3658210947930574,0.8186661979136822,1.0,7/19,22.96%,MARK1;TLE6;MEF2A;LRRK2;MUL1;MFN1;MTM1
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.40472281951573047,1.0843020598377309,0.36083608360836084,0.818876613573683,1.0,15/56,18.60%,EGFR;RDX;ANAPC5;CDC16;BRD4;ANXA1;CDC25B;UBE2C;ANAPC4;RCC2;EIF4G1;TFDP1;CDC25A;CDC27;AKT1
prerank,regulation of mRNA catabolic process (GO:0061013),0.3763077589322697,1.08413653774381,0.3374358974358974,0.8187941907085807,1.0,43/121,28.01%,XPO1;PRKCD;SAMD4A;PABPC1;PSMD7;PRKCA;PSMA8;PUM1;PCBP4;PSMA4;PSMD12;PSMA6;EIF4G1;XRN1;EXOSC4;PSMD11;PSMC5;PSMD1;PSMD14;CNOT8;RC3H2;PSMC4;RPS27A;UBC;DIS3;TNPO1;AKT1;PSMA3;PSMD4;PSMB1;FXR2;UPF1;DCP1A;PSMA5;ZC3H14;PSMA7;RBM24;YWHAB;PSMC1;ZFP36L1;PSMA1;YTHDF1;FXR1
prerank,negative regulation of DNA metabolic process (GO:0051053),-0.3450756065988059,-1.0840613761651043,0.33014354066985646,0.6831131219057666,1.0,6/24,13.02%,DACH1;NIBAN2;BMPR2;H1-0;ACVRL1;TERF2IP
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.5144040587552742,1.0837972531434483,0.3963068181818182,0.8180448650944759,1.0,7/12,28.97%,ANAPC5;CDC16;ANAPC4;CDC27;DLGAP5;NSMCE2;ANAPC11
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.5144040587552742,1.0837972531434483,0.3963068181818182,0.8180448650944759,1.0,7/12,28.97%,ANAPC5;CDC16;ANAPC4;CDC27;DLGAP5;NSMCE2;ANAPC11
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.5144040587552742,1.0837972531434483,0.3963068181818182,0.8180448650944759,1.0,7/12,28.97%,ANAPC5;CDC16;ANAPC4;CDC27;DLGAP5;NSMCE2;ANAPC11
prerank,base conversion or substitution editing (GO:0016553),-0.42647971820219766,-1.0836199033527947,0.3741935483870968,0.6822291301388472,1.0,6/11,41.29%,ADARB2;ADAR;METTL3;APOBEC2;ADAD1;A1CF
prerank,mesenchyme morphogenesis (GO:0072132),0.4917208582054805,1.0834664846218252,0.3787465940054496,0.8184802863189744,1.0,8/17,12.41%,TGFB2;ACVR1;HEYL;MDM4;SOX9;NOG;BMPR1A;HEY1
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.423188006606814,1.0834415683335936,0.3694412770809578,0.8179481418666327,1.0,12/45,14.57%,GDF10;INHBC;TGFB3;TGFB2;ACVR1;SMAD4;BMP4;BMPR1A;TGFBR1;INHBA;BMP5;DAB2
prerank,sulfur amino acid catabolic process (GO:0000098),0.5217863057437606,1.0830680137285664,0.3896296296296296,0.8184965868173905,1.0,2/10,7.58%,MPST;MTRR
prerank,regulation of stem cell differentiation (GO:2000736),0.3849103870420173,1.0830439608243434,0.35149572649572647,0.8179797576003764,1.0,34/89,24.73%,LDB1;PSMD7;HES5;PSMA8;SLC4A11;PRKDC;JAG1;ESRRB;RUNX1;PSMA4;ITCH;ABL1;BMPR1A;PSMD12;PSMA6;HOXB4;PSMD11;PSMC5;PSMD1;PSMD14;PSMC4;GDNF;CBFB;TCF3;SETD1A;PSMA3;PSMD4;PSMB1;KMT2A;PSMA5;NELFB;PSMA7;HNRNPU;RBM24
prerank,mammary gland development (GO:0030879),0.4670827936453596,1.0829882735720773,0.37296620775969963,0.8175843739764717,1.0,3/21,2.85%,VEGFA;GLI2;TGFB3
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.3393659417773801,-1.0829545750635807,0.32978723404255317,0.6820130208442458,1.0,1/26,0.01%,ATP1A2
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.43004864350197003,1.082695562513752,0.3702801461632156,0.8178732389013411,1.0,3/34,1.13%,IRS1;TNFAIP8L3;FGF2
prerank,regulation of viral release from host cell (GO:1902186),0.45815157948691526,1.0826444600711533,0.37218045112781956,0.8174472888908773,1.0,9/21,27.73%,TRIM28;MID2;CHMP3;TRIM26;TRIM13;TRIM8;CHMP2A;VPS37B;DDB1
prerank,neuromuscular junction development (GO:0007528),-0.3376189817673404,-1.0825025799714052,0.3212669683257919,0.681168673719611,1.0,6/24,4.36%,UNC13C;PPFIBP1;CACNB2;PDZRN3;CACNB4;PPFIBP2
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.5259977479130978,1.0822917960366465,0.3930635838150289,0.8178947148109791,1.0,6/10,25.95%,EMC2;EMC1;EMC9;EMC8;MMGT1;EMC4
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.46968138855623903,1.0821559468241466,0.37305699481865284,0.8176999039270163,1.0,8/21,27.54%,TWIST1;MED13;SRF;MED14;MED12;BCLAF1;MED24;SETX
prerank,atrial septum morphogenesis (GO:0060413),0.5389267184733155,1.0819965234422368,0.40625,0.8175531880827728,1.0,2/10,5.52%,TGFB2;ACVR1
prerank,regulation of fat cell differentiation (GO:0045598),0.3925447775241614,1.0819800052433097,0.34824281150159747,0.816997677486866,1.0,19/74,18.60%,CMKLR1;ID2;ZFPM2;LRP5;WWTR1;FTO;RORA;CARM1;TRPM4;SYAP1;WDFY2;SIRT2;IL6;TRIO;CREB1;E2F1;ANKRD26;CDS1;AKT1
prerank,ncRNA 3'-end processing (GO:0043628),0.5047536963434893,1.0819430861912678,0.3902097902097902,0.8165087992199384,1.0,8/14,33.40%,INTS14;SSB;ELAC2;TOE1;ERI1;INTS7;INTS6;TRNT1
prerank,pre-replicative complex assembly (GO:0036388),0.39601908664000507,1.0817788816885427,0.36482084690553745,0.8164341039384755,1.0,25/64,27.54%,PSMD7;PSMA8;MCM2;CDC6;PSMA4;PSMD12;PSMA6;PSMD11;PSMC5;PSMD1;PSMD14;PSMC4;MCM4;RPS27A;UBC;ORC2;CDT1;PSMA3;PSMD4;PSMB1;PSMA5;PSMA7;MCM7;PSMC1;PSMA1
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.45077201364076613,1.0817045982292866,0.38213399503722084,0.8160785277480656,1.0,7/26,14.71%,EGFR;RDX;CDK10;CDC6;ANXA1;EIF4G1;TFDP1
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.5318116993342538,1.0816180680599519,0.37640449438202245,0.8157119163615731,1.0,1/10,1.27%,IL33
prerank,dorsal/ventral pattern formation (GO:0009953),0.47209501568275,1.081550009106119,0.3638676844783715,0.8153169826381681,1.0,7/20,18.81%,GLI2;ACVR1;NOG;BMPR1A;NBL1;MDFI;AIDA
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.458792031875938,1.0813460461377047,0.390745501285347,0.8153493164663675,1.0,9/21,23.22%,RAB34;ARMC9;TEDC1;EVC;PDCL;SMO;UCHL5;DLG5;TXNDC15
prerank,barbed-end actin filament capping (GO:0051016),0.4760022259489478,1.0812349799182366,0.38633377135348224,0.8144803487056771,1.0,7/18,21.29%,GSN;VILL;ADD1;SCIN;CAPZA1;ADD3;SVIL
prerank,actin filament capping (GO:0051693),0.4760022259489478,1.0812349799182366,0.38633377135348224,0.8144803487056771,1.0,7/18,21.29%,GSN;VILL;ADD1;SCIN;CAPZA1;ADD3;SVIL
prerank,histone mRNA metabolic process (GO:0008334),0.44857774182142446,1.0808546878004937,0.39631901840490796,0.8150116319446056,1.0,11/27,22.68%,TENT4B;SSB;ATM;XRN1;EXOSC4;TUT7;NCBP1;NCBP2;TENT2;SNRPB;UPF1
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.4533897353699282,1.0807151602949163,0.3825,0.8148299201273894,1.0,4/24,9.25%,PID1;GFPT1;GFPT2;COQ10B
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.38177621201006146,1.080471436156736,0.35161290322580646,0.8149975061428903,1.0,27/88,23.65%,IGFBP5;SAMD4A;RIC1;ILF3;CDK5RAP3;CST3;RGP1;NELL1;SERPINE2;RBM4;CAMK2N1;HDAC6;CNOT8;CNOT10;EPRS1;SYNCRIP;CLN3;DAPK3;CNOT9;AKT1;SHMT1;CDK5;CALR;EIF2AK3;FXR2;YBX1;DNAJC1
prerank,positive regulation of protein localization to membrane (GO:1905477),0.3838462827632923,1.0802877359743286,0.35294117647058826,0.8149466808197066,1.0,26/98,18.60%,EGFR;KCNB1;LRP1;PRKCE;EPHB2;PLS1;C2CD5;AGR2;MIEF2;AKT2;DLG1;PPP3CC;MAPK8;PDPK1;CHP1;YWHAE;SQSTM1;STAC3;TFDP1;STX4;YWHAQ;ERBB2;SPTBN1;E2F1;BID;AKT1
prerank,ER-associated misfolded protein catabolic process (GO:0071712),0.5343040871539924,1.0802644769923535,0.37727910238429174,0.8144355174615786,1.0,3/11,10.59%,VCP;UGGT2;UGGT1
prerank,regulation of actin filament polymerization (GO:0030833),0.39685214497714066,1.0801540227269395,0.33974358974358976,0.8141608609364905,1.0,6/69,6.32%,SLIT2;PRKCD;CTTN;PRKCE;CDC42EP2;PFN2
prerank,response to calcium ion (GO:0051592),0.38065327948704886,1.0801197522344657,0.3368091762252346,0.8136688968140061,1.0,15/102,13.77%,THBS1;ADAM9;NEDD4;SEC31A;SYT8;CAMK2D;CLIC4;CALM2;ADCY8;KCNIP2;STIM1;NEUROD2;NLGN1;ADD1;MEF2A
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.38198306444759605,1.079972063159513,0.359504132231405,0.8135261395549922,1.0,33/101,25.59%,THBS1;RDX;SAMD4A;DACT1;PRKDC;OGT;NIBAN1;EIF4G1;EZR;INHBA;STUB1;TBC1D10A;IL6;EIF6;ERBB2;EIF3D;PERP;VPS11;IST1;AKT1;NFKBIA;CIRBP;PYM1;FXR2;UPF3A;RPS6KB1;CYFIP2;RBM3;BAD;RPS27L;UPF3B;HDAC2;METTL14
prerank,lipoprotein transport (GO:0042953),0.5423940836112817,1.0798503889839384,0.40252454417952316,0.8133192278799972,1.0,1/10,1.00%,LRP1
prerank,regulation of vesicle-mediated transport (GO:0060627),0.38469863173830726,1.0792843286490006,0.361317747077577,0.8143988673467902,1.0,41/91,29.71%,STON2;ARFGAP1;GAS1;DNAJC13;RAB21;RAB8A;MBTPS1;SCFD1;STON1;NSF;ITGAV;ABL1;ATP9A;NRP1;RAB3D;STXBP5;USP7;CHMP3;RAB11B;RINT1;STX4;RAB3B;RAB4B;HIP1;RAB5B;RUFY2;ZFYVE16;LRRK2;RAB4A;TSC2;BET1L;VAMP2;RAB5A;RALA;LGI3;FES;ABL2;RAB3A;RUFY1;RAB5C;PACSIN2
prerank,fructose 6-phosphate metabolic process (GO:0006002),0.5409668112274024,1.0790382447921498,0.40746268656716417,0.8145372401423194,1.0,2/10,7.56%,GFPT1;GFPT2
prerank,organonitrogen compound catabolic process (GO:1901565),0.39580815074782355,1.0789946983556906,0.3723756906077348,0.8140631761952348,1.0,15/57,19.05%,PLA2G4A;PDXDC1;LRSAM1;CPQ;MPST;GNPDA1;PLA2G5;UCHL3;LNPEP;IDE;RENBP;PLA2G15;NPEPPS;BCKDK;LVRN
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),-0.3672068605816412,-1.078884840286558,0.3677685950413223,0.68844903313165,1.0,3/18,2.82%,FLT1;COL4A3;AKT3
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.35738554021359253,1.0786680215513547,0.142,0.8144247775991457,1.0,280/1082,22.78%,PLAGL1;ESR1;EGFR;LRP6;SIX1;PKD1;PID1;ID2;ZFHX3;HOXA5;ZFPM2;VEGFA;HIVEP3;NFIX;FGF2;ZNF423;COL1A1;NFIB;TCF7L2;IL33;RARB;ELF4;NFIA;GALR1;DDX17;RHOQ;DEAF1;ZMIZ1;MDFIC;GLI2;LDB2;LDB1;LRP5;TCF20;TGFB3;GLIS2;TWIST1;SHC1;PRDM11;PRDM10;NFAT5;HDAC4;HOXB3;ELOF1;ELF1;RXRA;MAP3K5;WWTR1;MEOX2;ONECUT2;STAT3;HES5;KLF5;DCAF6;SIX4;ATF4;TRIM28;NR2F1;BCAS3;MAVS;ACVR1;BRD4;KMT2C;DNM2;DVL1;ILK;FOXC2;PRKDC;JAG1;RXRB;BCL9L;NFE2L2;SMAD4;GPATCH3;SLC9A1;HMGB1;MEF2B;FZD7;E2F3;PBX1;HEYL;RUNX2;MEIS3;TASP1;NRIP1;THRAP3;SKI;RORA;JUP;ARF4;RPS6KA4;TBX21;MED13;SOX9;FOXJ3;NSD1;RARA;SBNO2;FZD5;PLAC8;ILF3;ESRRB;TFE3;FOXK1;ENY2;OGT;HMGN1;SERTAD2;ZNF76;SMARCC2;ZIC1;NFATC1;RUNX1;UBP1;FGFR2;SFR1;ING5;FOXA1;ZFP90;BMP4;FOXM1;PRDM4;SREBF1;GTF2F1;CSRNP1;CHUK;ABL1;EHF;RFX5;AGO1;CCNT2;ATM;MAP3K12;PHF8;PITHD1;CSRP3;BMPR1A;GLIS1;AXIN1;NRF1;CHEK2;MAZ;KAT6B;RNF14;PAXBP1;NAA16;TAF15;NR1D2;TAF6;SMAD7;PHIP;TGFB1I1;SFPQ;HDAC1;TGFBR1;SRF;MED25;RGMA;PTOV1;HEY1;KAT2A;AGO2;SSBP3;INHBA;CD80;KMT2D;HOXB4;MAPRE3;ZMIZ2;F2R;MEF2D;MEF2A;SQSTM1;NFATC3;BMP5;NDP;MMS19;DAB2;TFDP1;MED21;SIRT2;ARRB1;VDR;SERTAD3;FOXO3;PSMC5;IL6;HGF;PER1;CREBBP;KMT2B;GRHL1;CRTC2;PARP1;CAMK4;CREB1;NFE2;PRDM2;AATF;ERBB2;NFKB2;ZNF462;MLLT3;KDM6B;RPS27A;UBC;SLC30A9;APBB1;FLCN;E2F1;MED14;MED12;NFYA;DPF3;E4F1;NR3C1;RFXANK;CDKN1C;ATAD2B;MEN1;HMGA1;RYBP;KLF10;CITED2;CHD8;GDNF;ATF2;HCFC1;AKT1;HOXB2;BRD8;MPND;CCDC62;HIPK2;TCF3;QRICH1;IRF3;MLXIPL;XRCC6;FOSL2;NFKBIA;TEAD2;RTRAF;TET2;VEZF1;MAX;ATF6;MAP2K3;BICRAL;KAT7;BPTF;MRPL12;NEK4;SMAD5;MAD2L2;MAP2K7;GPS2;BCL2L12;NUP62;IL4;BCL11B;IER2;RNF4;SENP1;NFIC;EIF2AK3;POGZ;NR2C2;KMT2A;TFCP2;RPTOR;ZKSCAN3;ICE1;GLI3;DNAJC2;SS18L1;TRIAP1;KAT8;CAMK1;CDK5RAP2
prerank,protein modification by small protein conjugation (GO:0032446),0.36268465700442015,1.0785902290805183,0.273,0.8140711781027782,1.0,143/361,30.49%,WWP1;RNF144A;NEDD4;NUP93;FBXO10;FBXL7;CDC16;FBXW8;TOPORS;RAE1;UBE2B;TRIM28;VCP;RNF182;DTX3;DCUN1D5;UBE2R2;PRKDC;NFX1;NFE2L2;SEH1L;KLHL7;PEX5;TRIM41;SYVN1;TRPC4AP;TRIM27;CBL;HUWE1;CDK5RAP3;LZTR1;TRPM4;PEX13;WWP2;ITCH;FBXO25;CUL4A;UCHL3;NUP37;RNF25;PEX10;UBE2C;MYLIP;ATG3;RNF14;SDE2;NEUROD2;CUL1;DTX2;DCUN1D2;RNF38;USP7;UBA5;RNF103-CHMP3;TRIM26;RANBP2;PIAS4;NUP88;ARRB1;STUB1;STX1A;UBE2V2;OTULIN;RPS27A;UBC;SUMO1;TRIM13;BIRC6;UFL1;TRIM6;VPS11;NUP210;CDC27;POM121;SAE1;ASB5;UBR2;UHRF2;RNF7;MYCBP2;PCNP;TRAIP;UBE2G2;SMURF2;TRIM47;NUP62;TRIM43;USP5;MUL1;PEX2;PAF1;AREL1;CUL9;NDC1;UBA3;SUMO2;KCTD13;NUP35;PEX14;DERL1;RNF20;FBXO11;UBE2Z;DET1;FBXO9;SELENOS;RNF138;AMFR;ANKRD9;UBE2W;RNF111;PINK1;RTF1;RCHY1;CUL7;UBR3;UVSSA;FBH1;NUP85;SHPRH;TPR;NUP160;CAND1;UFC1;DDB1;NSMCE2;TRIM7;RNF135;ANAPC11;UBR1;BTRC;RBX1;UBE2Q2;DCAF15;UBE2S;KLHL9;VPS18;TRIM39;NUP188;UBE2H;KEAP1;NUP50;PJA2
prerank,glycoprotein biosynthetic process (GO:0009101),0.3919865500680334,1.0782294647462551,0.3659574468085106,0.8145518809783586,1.0,13/79,13.25%,ST3GAL4;XYLT1;ST8SIA2;CHST11;B3GNT7;B4GALT5;PMM2;ST3GAL2;FOXL1;NPC1;FUT4;GAL3ST4;B3GNT9
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.44402384285670704,1.0782029933813984,0.38154613466334164,0.8140428690606338,1.0,13/26,28.97%,ANAPC5;CDC16;CDC6;LCMT1;UBE2C;ANAPC4;CDC27;DLGAP5;CDK5RAP2;NEK6;RIOK2;NSMCE2;ANAPC11
prerank,regulation of vasculogenesis (GO:2001212),0.49175213928407424,1.0777986187963227,0.4164305949008499,0.8146117860564328,1.0,2/14,4.52%,TMEM100;XDH
prerank,positive regulation of protein kinase activity (GO:0045860),0.37212529976412123,1.0777395895915116,0.32793522267206476,0.8142249545531318,1.0,23/148,11.30%,RASSF2;PRKCD;VEGFA;GAS6;DDR2;SRCIN1;CAMKK1;STRADA;TGFB2;CALM2;TOM1L1;NOX4;TGFBR2;DLG4;PAK4;RHOA;PAK2;SYAP1;RIPK3;TAB2;TELO2;SNX9;AXIN1
prerank,organelle disassembly (GO:1903008),0.43220915160878953,1.077580493327437,0.3678571428571429,0.8140992485210286,1.0,13/33,28.42%,ULK2;STX5;VCP;GBF1;UBA5;KLC1;UFL1;RB1CC1;TEX264;GOLGA2;ATG2B;UFC1;ULK1
prerank,T cell activation (GO:0042110),-0.2684072847717617,-1.077387515387253,0.2641509433962264,0.6903878851328797,1.0,19/69,21.79%,LEPR;CHD7;KIT;DPP4;CXADR;JAG2;RHOH;CD74;PIK3CD;LCP1;LFNG;CTPS1;CD44;PTPN22;DLL4;SOX4;NHEJ1;MDK;CD276
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.5280957056974999,1.0770861194639645,0.4109985528219971,0.8149280133406951,1.0,4/11,12.77%,NECAB3;SOAT1;BACE2;AGO2
prerank,angiogenesis involved in wound healing (GO:0060055),0.5319159056447104,1.0770027017051043,0.4088235294117647,0.8145743953757422,1.0,4/11,14.52%,VEGFA;ADIPOR2;SRF;NDNF
prerank,negative regulation of T cell proliferation (GO:0042130),0.43693644057788467,1.0769311081375463,0.37681159420289856,0.8142049833907726,1.0,5/28,13.14%,SPN;GLMN;CRTAM;CD80;VTCN1
prerank,pentose-phosphate shunt (GO:0006098),0.5237563177952145,1.0766871164157241,0.4037089871611983,0.8143387767766526,1.0,4/11,16.49%,SHPK;TKT;DERA;PGD
prerank,positive regulation of vascular permeability (GO:0043117),-0.41436818306803624,-1.0765280253015224,0.37623762376237624,0.6906476412343164,1.0,5/12,9.83%,TJP1;OCLN;BMP6;PDE2A;ANGPT1
prerank,hippo signaling (GO:0035329),-0.3302561756612965,-1.0764732028522714,0.29906542056074764,0.6888379461815781,1.0,3/26,4.41%,TJP1;TEAD4;AMOTL2
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.37090990954209774,1.076277272876155,0.3693877551020408,0.8149754139012093,1.0,24/142,15.51%,ESR1;CACNA1C;CMKLR1;SLC35G1;PLCE1;PROK2;TAC4;C1QTNF1;EDNRA;ADCY8;HMGB1;IAPP;DLG4;FPR3;ACKR4;TRPM4;ABL1;BCAP31;GLP1R;F2R;YWHAE;PTGDR;CXCR4;CALB2
prerank,cellular glucan metabolic process (GO:0006073),0.5253044975362403,1.076188874948823,0.38596491228070173,0.8146524574462821,1.0,3/11,7.85%,PPP1R3C;PHKA1;PHKB
prerank,ncRNA catabolic process (GO:0034661),0.44090192841610426,1.0759823507992328,0.39027431421446385,0.8146895664642955,1.0,9/28,20.29%,ERN2;TENT4B;DIS3L2;SND1;XRN1;EXOSC4;DIS3;MTREX;ZCCHC8
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.4375930020748925,1.0759629889465603,0.37254901960784315,0.8141695882034085,1.0,8/29,16.45%,ZC3H7A;PUM1;PRKRA;HNRNPA2B1;AGO1;DGCR8;AGO2;TUT7
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.4153721355637324,1.0755213626007252,0.357981220657277,0.8149040222484808,1.0,21/42,33.29%,HELB;RMI2;FUS;SPIDR;WDR48;MMS19;PARP1;RAD51;MAD2L2;SETD2;ACTR2;FBH1;CGAS;SHLD3;WAS;RTEL1;SHLD1;TIMELESS;PARPBP;ERCC6;POLQ
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.4294055716115963,-1.0754906736337557,0.3310810810810811,0.6893291008189705,1.0,2/10,2.33%,SHANK3;APP
prerank,negative regulation of protein metabolic process (GO:0051248),0.40689839300545655,1.0753512334453361,0.358294930875576,0.8148583896323425,1.0,15/48,24.46%,EGFR;RILP;IRAK3;IAPP;MDM4;ITGAV;SIRT2;VBP1;AZIN1;CLU;MAD2L2;PFDN4;LDLR;SNX3;ROCK1
prerank,negative regulation of stress fiber assembly (GO:0051497),0.4522292667717552,1.0751515245899654,0.380716934487021,0.8148910216988977,1.0,4/24,5.38%,MYOC;ARAP1;TMEFF2;PPFIA1
prerank,regulation of glucose import (GO:0046324),0.43765901465766266,1.0750249188823071,0.3837772397094431,0.814682132029397,1.0,4/30,1.96%,IRS1;PID1;GRB10;RHOQ
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.37437654561501954,-1.074909470129354,0.32270916334661354,0.6890073207383015,1.0,9/18,28.36%,PLCB1;OPRM1;CHRM3;RGS8;CHRM2;CHRM1;GNAQ;GNA15;AGRN
prerank,actin cytoskeleton reorganization (GO:0031532),-0.2829673592191985,-1.0748508453844827,0.27,0.6872622570770668,1.0,20/63,13.52%,AUTS2;PHACTR1;PTK7;KIT;TNIK;NEDD9;PARVB;RICTOR;CXADR;S1PR1;WHAMM;MYH9;GAB1;SYDE1;PAK1;CDC42BPG;PLEK;DTNBP1;THSD7A;PTPN1
prerank,negative regulation of cytokine production (GO:0001818),0.36695230953394015,1.0739029345831084,0.34444444444444444,0.8173677978164675,1.0,37/163,20.34%,THBS1;CMKLR1;GAS6;PDCD4;CHID1;HDAC9;ANXA4;TAX1BP1;MAVS;GPATCH3;HMGB1;IRAK3;RPS6KA4;TBX21;TRIM27;RARA;ANXA1;ITCH;MAPKBP1;CIDEA;EZR;INHBA;PCBP2;ARRB1;UBE2L6;IL6;N4BP1;OTUD5;ADCY7;SLC2A10;ACOD1;IKBKE;NPLOC4;SARS1;IRF3;APPL2;HOMER2
prerank,apoptotic DNA fragmentation (GO:0006309),-0.378144202354755,-1.0733111811151232,0.3409090909090909,0.6891216562996896,1.0,4/16,11.29%,CECR2;KPNA1;H1-0;KPNB1
prerank,central nervous system development (GO:0007417),0.3611186457546154,1.0732642008681073,0.3149448345035105,0.8185965412031726,1.0,43/250,16.48%,DCLK1;SLC23A1;WWP1;PKD1;ZFHX3;PBX3;ECRG4;NFIB;GSN;VIT;ADGRL2;GLIS2;STAT3;HES5;PITPNM1;RAB3GAP1;AMIGO3;TGFBR2;PBX1;MEIS3;TBC1D23;SOX9;S100B;CDK5RAP3;HAPLN4;ZIC1;SYNJ1;ZIC4;POU6F1;ATN1;PHF8;SMO;ALDH3A2;LIG4;PAFAH1B2;NPAS1;ABCB6;SCIN;CXCR4;VCAN;NF1;NIPBL;PHGDH
prerank,negative regulation of nervous system development (GO:0051961),0.4814201458821395,1.0730943193050118,0.4066225165562914,0.8185372319206259,1.0,1/17,0.26%,SLIT1
prerank,aorta morphogenesis (GO:0035909),-0.37756406389457114,-1.073066848992919,0.3426294820717131,0.6878602176721124,1.0,10/17,14.18%,ENG;MYLK;PDGFRB;TBX1;PROX1;RBPJ;TBX2;ACVRL1;HEY2;EFEMP2
prerank,positive regulation of secretion by cell (GO:1903532),0.39163747501297796,1.072985303792613,0.3774403470715835,0.8182723106306873,1.0,16/70,18.14%,KCNB1;ADAM9;SLC12A2;UNC13B;TGFB3;APBB3;TGFB2;RAB2B;EDN3;EZR;STXBP5;STX1A;APBB1;SYTL4;GOLPH3;IER3IP1
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),-0.3192933855190273,-1.072310068466547,0.2883435582822086,0.687899381563661,1.0,11/34,13.52%,PTPRB;PTPN13;DUSP16;PTPRO;PTPN9;DUSP10;DUSP3;DUSP22;DUSP6;PTPRT;PTPN1
prerank,regulation of cytoskeleton organization (GO:0051493),0.3731632729355953,1.0718806379007435,0.3724066390041494,0.8209205512002987,1.0,16/108,10.43%,PRKCD;EFNA5;RHOBTB1;LRP1;RHOQ;RND3;PHLDB1;SORBS3;CLIC4;ARHGAP17;CDK10;CAPN2;RHOA;PAK2;ABL1;KATNBL1
prerank,regulation of cell population proliferation (GO:0042127),0.35782520723534444,1.071745533090649,0.239,0.8207377537770315,1.0,131/691,15.41%,THBS1;PGF;EGFR;SIX1;IRS1;ZBTB7C;ID2;WNT9A;ELN;VEGFA;ECRG4;FGF2;TCF7L2;SFRP4;TIAM1;ACER3;NTRK3;NPR3;PROK2;NTRK1;PPP1R9B;FGF17;BRICD5;SMAD6;GAB2;GNL3;LRP5;CYP1B1;GLMN;TGFB3;MAPK15;P3H3;SHC1;SLURP1;RBFOX2;STAT5A;HDAC4;WWTR1;PKHD1;LMNA;STAT3;PTPRU;CSNK2A1;HES5;TGFB2;TCIRG1;SIX4;P3H1;CLMN;DNAJA2;MEAK7;TCFL5;FXN;NOX4;TMEM115;PRKDC;JAG1;PLPP1;FAM98A;TGFBR2;IL12RB2;ADAM10;ABI1;PRKRA;FGFR1;IFNLR1;CDK10;MEIS3;EDN3;SKI;JUP;RAF1;MDM4;P3H2;SOX9;TES;RARA;CHERP;BEX4;S100B;DDAH1;AKT2;CDC6;TRPM4;RHOA;RUNX1;TBRG4;ITGAV;FGFR2;ING5;CDC25B;CDC123;BMP4;FOXM1;FAM98B;VIP;DIS3L2;CTF1;CHTOP;BMPR1A;RBM5;MAZ;PHIP;TGFB1I1;PBRM1;HDAC1;TGFBR1;TENM1;PTPN2;TRAPPC14;INHBA;CGRRF1;KMT2D;F2R;NACC1;GSDME;FRK;SETD4;BMP5;TMEM127;FUZ;PRDX3;CLCF1;SIRT2;VDR;CYP27B1;SCIN;STX4;ING4;CAMK2N1;IL6
prerank,ethanol metabolic process (GO:0006067),-0.41488222056163343,-1.0715064358513873,0.34285714285714286,0.688215757127495,1.0,5/12,15.39%,ALDH1A1;ACSS2;ALDH2;SULT1A1;ADH1A
prerank,RNA biosynthetic process (GO:0032774),0.4278316690843712,1.071277568245963,0.3765133171912833,0.8215212781297541,1.0,12/31,29.92%,HELB;TCEA2;TERT;TAF6;TAF13;SMN1;TBP;PRIM1;TAF10;SETX;PRMT5;TTF2
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.395759794580885,1.0712100189984397,0.38633818589025753,0.8211303968921165,1.0,33/64,32.89%,ELOF1;TCEA2;CDK12;GTF2F1;CCNT2;ERCC3;ERCC2;POLR2F;AFF4;MLLT3;NCBP1;SSRP1;ELP4;NCBP2;PAF1;POLR2B;SETD2;NELFB;CDK13;EAF1;CTDP1;RTF1;GTF2H4;POLR2H;NELFA;CDK9;POLR2I;MLLT1;POLR2L;ADRM1;POLR2K;ELP2;CCNH
prerank,regulation of hydrolase activity (GO:0051336),0.39587862527018863,1.0708291373352503,0.39154616240266965,0.8217061746202774,1.0,15/71,13.59%,PLXNA4;EFNA5;VAV2;RDX;SIPA1L1;FGD6;EPHB3;RAB3GAP1;CDK5RAP3;ADAP1;WRN;TDG;SOD1;OCRL;ARHGAP44
prerank,positive regulation of cartilage development (GO:0061036),0.4792672660287406,1.0708046582355621,0.39895697522816165,0.8212024594046318,1.0,4/17,10.16%,PKDCC;BMP1;SOX9;BMP4
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.47054148907778565,1.0706062683570132,0.3970976253298153,0.8212171079097991,1.0,6/19,24.26%,TENT4B;TEN1;HNRNPC;XRN1;HNRNPA1;HNRNPU
prerank,phosphatidylserine metabolic process (GO:0006658),0.43067791040435743,1.0703175486109593,0.3929824561403509,0.8214984129140803,1.0,9/32,17.28%,PLA2G4F;PLA2G4A;MBOAT2;LPCAT4;PLA2G5;LPCAT3;PLA2G12A;PLA2G15;PTDSS1
prerank,positive regulation of cell communication (GO:0010647),-0.33001670400017363,-1.0703027066480688,0.31797235023041476,0.6894046471288705,1.0,9/28,11.31%,WLS;RIMS2;GRIK2;RIMS1;HOMER1;LGI1;EDN1;NMU;CLSTN1
prerank,positive regulation of macroautophagy (GO:0016239),0.4140787371132146,1.070287425231872,0.3820861678004535,0.821016826645293,1.0,24/48,29.93%,SESN3;BAG3;RAB3GAP1;LRSAM1;PIP4K2B;SESN2;PAFAH1B2;TRIM13;RAB3GAP2;OPTN;IL4;RUFY4;TSC2;UVRAG;VPS13D;SMCR8;TBK1;PINK1;GPSM1;HSPB8;PIP4K2C;SLC25A5;LARP1;IRGM
prerank,negative regulation of type I interferon production (GO:0032480),0.41867147688467915,1.070196845436914,0.3885647607934656,0.8207220470052656,1.0,19/40,28.92%,PTPRS;TAX1BP1;MAVS;GPATCH3;ITCH;PCBP2;UBE2L6;OTUD5;ACOD1;IKBKE;NPLOC4;IRF3;RNF216;CYLD;ILRUN;TBK1;YY1;PPM1B;RNF135
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.37791427370113967,1.0699545268529922,0.37591623036649213,0.8208735324347178,1.0,18/94,12.09%,PRKCD;DDX5;CYP1B1;FHIT;TOPORS;MAP3K5;ATF4;ERN2;TNFRSF1B;PRKDC;CUL4A;ABL1;BCL2L2;ATM;CHEK2;AIFM1;TNFRSF10B;CUL1
prerank,macrophage activation (GO:0042116),0.42644868356810334,1.069696231753274,0.39311163895486934,0.8210456915740579,1.0,2/34,0.97%,FOXP1;LBP
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.4294958767037307,1.0696428257157584,0.3795180722891566,0.8206297642767387,1.0,3/37,2.75%,EFNA5;STMND1;PHLDB1
prerank,regulation of establishment of endothelial barrier (GO:1903140),-0.3704326213747311,-1.0693533021634816,0.3617021276595745,0.6900876190390235,1.0,6/17,11.44%,ROCK2;CDH5;CLDN5;F11R;S1PR3;TNFRSF1A
prerank,snRNA metabolic process (GO:0016073),0.4834284407000726,1.0692754812610505,0.40671140939597317,0.8210799304055362,1.0,11/17,37.69%,INTS3;INTS4;MTREX;ZCCHC8;INTS9;INTS7;MEPCE;INTS6;INTS10;RBM7;INTS8
prerank,positive regulation of protein modification process (GO:0031401),0.36610158398204645,1.0692239558499912,0.3447927199191102,0.8206666419053089,1.0,48/203,18.66%,PGF;EGFR;TRABD2B;PRKCD;SLCO3A1;VEGFA;EFNA5;GAS6;FGF2;CARD14;NTRK3;NTRK1;FGF17;CSNK1D;LIMK2;CALM2;MAVS;RAB3GAP1;ILK;RSPO1;SOX9;SYMPK;AKT2;TMEM119;BMP4;ABL1;MUSK;RAMP1;NIBAN1;NNMT;AXIN1;CNEP1R1;CHP1;ERP29;PTBP1;WDFY2;DAB2;ARRB1;HGF;NSMF;CALM3;ERBB2;FGF5;FLCN;EFNA1;RB1CC1;AKT1;RAB3GAP2
prerank,I-kappaB phosphorylation (GO:0007252),0.5339751069647525,1.0692183855879238,0.42,0.8201143883519403,1.0,2/10,10.33%,ERC1;CHUK
prerank,megakaryocyte differentiation (GO:0030219),-0.42642568956628446,-1.0691496847906792,0.3894736842105263,0.688810547659534,1.0,3/11,9.72%,KIT;TAL1;SH2B3
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.4505979385363234,1.068897347954399,0.39308578745198464,0.820467544106525,1.0,12/22,34.75%,PSMA8;NFE2L2;PSMA4;PSMA6;PSMA3;PSMB1;PSMA5;PSMA7;PSMA1;PSMB2;PSMB4;PSMB10
prerank,renal water homeostasis (GO:0003091),-0.34443618994469183,-1.0687145213932647,0.350253807106599,0.6880233918546445,1.0,6/23,7.39%,ADCY5;ADCY1;PRKAR2B;PRKACB;PRKAR1B;ADCY4
prerank,establishment of apical/basal cell polarity (GO:0035089),0.49198783874469687,1.068470488324519,0.40135135135135136,0.8211190059114182,1.0,4/14,12.87%,RHOA;SYNE4;MYO9A;EZR
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.43250468056616,1.0684211254151377,0.37731196054254007,0.8206853605058247,1.0,7/28,21.66%,EGFR;MMP14;WWP2;HEY1;ARRB1;AKT1;RITA1
prerank,cardiac muscle cell development (GO:0055013),-0.36326877643482064,-1.0683925439063866,0.34913793103448276,0.6870270799956747,1.0,7/20,9.49%,SORBS2;SLC8A1;PDGFRB;CXADR;PDGFRA;MYH11;PDLIM5
prerank,positive regulation of lyase activity (GO:0051349),0.5035323010512578,1.068306355082069,0.3975409836065574,0.8204600066707716,1.0,3/14,9.42%,CACNA1C;FXN;STIM1
prerank,regulation of axon extension (GO:0030516),0.4197464291798086,1.068213707467809,0.38173302107728335,0.8201512544548277,1.0,6/37,10.41%,NTN1;CTTN;PTPRS;DNM2;GOLGA4;ABL1
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.371479563150985,-1.0681741337217316,0.36964980544747084,0.6857305295393937,1.0,8/17,16.28%,BMP6;SASH1;LY86;CD180;CACTIN;CX3CL1;SIGIRR;CD55
prerank,regulation of axon regeneration (GO:0048679),-0.4184555330375881,-1.0680881724662037,0.3741258741258741,0.6840926350204573,1.0,7/12,24.26%,PTN;EPHA4;INPP5F;SCARF1;RTN4R;RTN4RL1;GRN
prerank,regulation of myeloid cell differentiation (GO:0045637),0.3919434267160934,1.0678724747850104,0.3787375415282392,0.8205985681194774,1.0,20/62,23.75%,THBS1;HOXA5;KMT2C;HOXA9;RUNX1;AGO1;HDAC1;WDR5;KMT2D;CREBBP;KMT2B;EIF6;NFE2;CBFB;SETD1A;DPY30;PAF1;KMT2A;PRMT1;KAT2B
prerank,regulation of establishment of planar polarity (GO:0090175),0.37594126119599985,1.067831223977665,0.3764458464773922,0.8201457562373049,1.0,34/88,27.54%,TIAM1;PRICKLE1;PSMD7;PKHD1;AP2A1;PSMA8;DACT1;DVL1;FZD7;FZD5;RHOA;PSMA4;PSMD12;PSMA6;AP2A2;CLTC;PSMD11;PSMC5;PSMD1;NPHP3;PSMD14;PSMC4;SMURF2;PSMA3;PSMD4;PSMB1;PSMA5;PSMA7;DVL2;PSMC1;WNT11;CELSR3;FZD1;PSMA1
prerank,glucose transmembrane transport (GO:1904659),-0.3706885009865657,-1.0678158939717093,0.35833333333333334,0.6828924527583193,1.0,4/18,6.89%,SLC2A1;SORT1;SLC5A3;PPARD
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.38675860300916703,1.0675154127290811,0.37044967880085655,0.8205427474997248,1.0,15/78,18.60%,EGFR;PKD1;IPO5;CDK5RAP3;CDC6;CCNT2;CCNE2;MAPRE3;CCNG2;HEXIM1;LATS2;CDC25A;CDKN1C;MEN1;AKT1
prerank,maintenance of protein localization in organelle (GO:0072595),0.47115196965092737,1.0672379933238663,0.4020618556701031,0.8207480850163921,1.0,9/19,28.28%,TOPORS;MORC3;HSPA5;ARL2;AKT1;HNRNPU;PINK1;TAPT1;TAF3
prerank,positive regulation of stem cell proliferation (GO:2000648),0.4885853164799353,1.0669688243275517,0.417910447761194,0.8209876108693003,1.0,3/17,12.84%,LTBP3;TERT;PDCD2
prerank,embryonic hemopoiesis (GO:0035162),-0.4141211618918065,-1.066932064409536,0.36551724137931035,0.6833391702822073,1.0,6/12,11.58%,KIT;KDR;FLT3LG;TAL1;SH2B3;KITLG
prerank,regulation of cellular protein metabolic process (GO:0032268),-0.2836417992452993,-1.066782255557039,0.2833333333333333,0.6819017930789286,1.0,10/47,10.27%,GRM5;APOE;APP;WDR91;NR1H3;AGTR1;CSF1;EDNRB;EDN1;MTPN
prerank,response to growth factor (GO:0070848),0.4136929168704267,1.0666472280091714,0.391156462585034,0.8213074146201608,1.0,11/41,18.60%,ACVR1B;SHC1;ACVR1;TGFBR2;URI1;BMPR1A;TGFBR1;LRP2;HDAC6;ERBB2;AKT1
prerank,synaptic vesicle endocytosis (GO:0048488),0.4232440578874671,1.0666120282097922,0.38694074969770254,0.8208446588021863,1.0,10/33,15.46%,STON2;SYT8;CEL;DNM2;FCHO2;STON1;SYNJ1;NLGN1;SNAP91;STX1A
prerank,sulfur amino acid metabolic process (GO:0000096),0.44343085574590396,1.066594800305551,0.4072632944228275,0.820339195717053,1.0,4/24,7.58%,GCLC;MPST;NOX4;MTRR
prerank,keratan sulfate biosynthetic process (GO:0018146),0.4441116677618513,1.066556282565117,0.38972431077694236,0.8198908064295345,1.0,5/26,8.47%,ST3GAL4;B3GNT7;B4GALT1;B4GALT5;ST3GAL2
prerank,negative regulation of interferon-gamma production (GO:0032689),0.44487956473065515,1.0665452812679002,0.3969658659924147,0.8193578379359941,1.0,4/23,12.95%,GAS6;HMGB1;RARA;INHBA
prerank,neuron projection development (GO:0031175),0.3666060683646537,1.0664483846802415,0.358948432760364,0.8190748349723616,1.0,22/168,7.91%,MYOC;DCLK1;CTNND2;SRGAP2;NEDD4;CTTN;STMND1;PPP1R9B;EHD1;ANKRD27;LRP12;EPHB2;ARC;DOCK7;EPHB3;DNM2;BLOC1S2;HMGB1;GPRIN1;TBC1D23;DLG4;TBC1D24
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),-0.36497083017103416,-1.0663763769513697,0.3722943722943723,0.6811290845086084,1.0,2/19,2.51%,APOE;PICALM
prerank,positive regulation of monooxygenase activity (GO:0032770),0.43689415012940175,1.0657654026532757,0.39748427672955977,0.8204752743977773,1.0,8/26,18.60%,NPR3;TERT;PIK3CB;S100A1;VDR;CYP27B1;GDNF;AKT1
prerank,regulation of neuron differentiation (GO:0045664),0.38650367099375343,1.0656656002977163,0.40324324324324323,0.8202131481022973,1.0,13/76,13.27%,SIX1;ID2;ZFHX3;TIAM1;HES5;FGFR1;HEYL;CDK5RAP3;IMPACT;RHOA;NEUROD2;HEY1;NLGN1
prerank,histone H3-K9 demethylation (GO:0033169),0.5213527482189824,1.0655745761518693,0.4183381088825215,0.819919863126628,1.0,4/11,13.57%,JMJD1C;PHF8;KDM4A;HR
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.5139473480149229,1.0654189554323497,0.4173669467787115,0.8197940493588228,1.0,5/11,12.22%,TGFB2;ACVR1;TGFBR2;SMAD7;TGFBR1
prerank,response to interleukin-4 (GO:0070670),-0.44966542881855676,-1.0648655523740174,0.40202702702702703,0.683233742825587,1.0,2/10,3.79%,LEF1;TCF7
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),0.48861125074570355,1.064486223033656,0.4078762306610408,0.8218545571128528,1.0,4/13,11.22%,ZFPM2;FGF2;FGFR2;BMPR1A
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.43185578650250334,1.064110976654121,0.37259615384615385,0.8223922181273193,1.0,9/32,19.58%,ID2;BRD4;ESRRB;CDC6;CDC45;TFDP1;E2F1;CDT1;CDK5
prerank,artery development (GO:0060840),-0.3359417657521214,-1.0640723459190025,0.36036036036036034,0.6835596267227617,1.0,10/23,16.08%,ROBO1;ENG;ROBO2;TBX1;PDE2A;BMPR2;ACVRL1;EFEMP2;APLNR;ACVR2B
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.3620410522861292,1.0640481273479476,0.34734734734734735,0.8220223982782239,1.0,69/259,19.31%,PKD1;NTN1;SRGAP2;FXYD5;GSN;CFAP298;PPP1R9B;EXOC4;EHD1;PMP22;FGD6;ABLIM3;PKHD1;DYNLT2B;ARMC9;RILP;CDC14A;BBS9;TMEM107;RAB8A;IFT20;GBF1;CC2D2A;EHD2;ATAT1;ARF4;PDE6D;CYFIP1;TCTN1;IQCB1;IFT80;RFX2;ABLIM2;ARFIP2;TMEM216;CCDC66;ATP6V0D1;NRP1;CFAP43;WDR11;PTPDC1;PARVA;CEP164;TRAPPC14;EZR;OCRL;BBS5;EMP3;IFT46;RAB23;CEP41;FUZ;PCM1;NUDCD3;EMP1;IFT88;PIP5K1A;NPHP3;HDAC6;INPP5E;TTLL3;LZTFL1;GOLPH3;DYNC2I1;IFT43;CCDC57;TEKT2;TMEM237;PTPN23
prerank,protein localization to membrane (GO:0072657),0.3645445339159079,1.0639991566453386,0.343087790110999,0.821601871168929,1.0,38/187,13.72%,LRP6;KCNB1;GAS6;ATP1B1;FGF13;DLG2;TTC7A;EHD1;RDX;RAB34;PIGW;TM9SF4;C2CD5;RAMP2;PACS2;DVL1;PRAM1;S100A10;RAB8A;SLMAP;ANK2;EHD2;JUP;DLG4;FCHO2;SH3PXD2B;DLG1;NPC1;NRXN2;RAB38;RAMP1;AP3D1;RAB3D;EZR;NLGN1;PICK1;SEC16A;RAB11B
prerank,regulation of cell aging (GO:0090342),0.5180040110442327,1.0633960899526689,0.4185714285714286,0.8227684316666529,1.0,5/11,25.21%,LMNA;FOXM1;NEK4;NEK6;VASH1
prerank,regulation of signal transduction (GO:0009966),0.36333653891359285,1.063294521934895,0.35454545454545455,0.8225034438606986,1.0,50/190,20.76%,ESR1;MGLL;IGFBP5;PLCE1;RSPO3;UBASH3B;MDFIC;GAS1;ELF1;WWTR1;TCF7L1;CD3E;ACVR1;SULF1;ILK;LLGL1;RORA;CASTOR2;SOCS2;OGT;DGKQ;ZIC1;FOXL1;RUNX1;SHARPIN;FGFR2;IRAK1;AXIN1;GIT1;NCLN;WDR11;GRK6;PTPN2;CD80;SRMS;USP33;FUZ;GSKIP;CREBBP;SIK2;GDNF;DHRS3;IGFBP6;CBFB;TMEM237;ZFAND2B;CRK;LRRK2;GRK4;CLU
prerank,sodium ion transmembrane transport (GO:0035725),0.3818768111945826,1.0625594687186,0.378803777544596,0.824069847661574,1.0,13/84,9.35%,SLC4A4;ATP1B1;SLC12A2;SLC24A3;SLC5A2;HCN4;SLC4A8;SLC6A2;SLC9A4;SLC9A1;SCN11A;TRPM4;SLC6A7
prerank,regulation of microtubule polymerization (GO:0031113),-0.299299599949581,-1.062164906937646,0.3356643356643357,0.6865974957162488,1.0,11/40,15.09%,OCLN;CDH5;MAP2;NAV3;CAMSAP1;EML2;PAK1;CLIP1;PRUNE1;SNCA;TUBB4A
prerank,defense response to bacterium (GO:0042742),0.37542781637335254,1.062034536557053,0.38696109358569925,0.8249919557720005,1.0,10/105,9.62%,PRKCD;LBP;SPN;SHC1;RNASE7;MAVS;RNASE3;GBP6;FCER1G;RNASE6
prerank,regulation of cell size (GO:0008361),0.4495332297067013,1.0618215413234355,0.389873417721519,0.8250342667276162,1.0,6/23,12.87%,VAV2;RDX;AKT1S1;RHOA;DEPTOR;EZR
prerank,DNA biosynthetic process (GO:0071897),-0.37885319941799755,-1.0616495057766995,0.3800738007380074,0.6860709366090728,1.0,10/16,22.46%,PPIA;RFC3;TYMS;SIRT1;POLD2;WRNIP1;POLE;POLD4;CDKN2D;POLL
prerank,regulation of apoptotic process (GO:0042981),0.35353967060047314,1.0615679307104775,0.232,0.8252098096159305,1.0,161/676,19.85%,THBS1;SLIT2;RASSF2;EGFR;HOXA5;VEGFA;FSTL1;GAS6;SFRP4;GCLC;TIAM1;GADD45G;CARD14;PROK2;NTRK1;SMAD6;PRR7;TIAM2;FBXO10;VAV2;UNC13B;COMP;CYP1B1;TGFB3;NOL3;GAS1;SHC1;TOPORS;MAP3K5;PKHD1;ANXA4;CRADD;SIX4;CD3E;ATF4;ERC1;BAG3;ACTN3;TAX1BP1;VCP;HYPK;FXN;DNM2;CCAR2;GLO1;PRKDC;HMGB1;ADAM10;ANGPTL4;IAPP;ING3;ARF4;RAF1;SOX9;CBL;IKZF3;NDRG1;SRA1;PA2G4;ERCC5;SOCS2;KALRN;AKT2;AKT1S1;ANXA1;RBM25;PAK2;ANGPT4;ITCH;MAPK8;ING5;WRN;FOXA1;BMP4;ANP32B;ABL1;VIP;MADD;RIPK3;BCL2L2;LCMT1;ATM;IRAK1;RBM5;AIFM1;NAA16;HSPA5;PHIP;TNFRSF10B;SOD1;CD27;HDAC1;CIDEA;ERCC3;HSPD1;CASP1;PDCD2;SERPINB9;MIEN1;VTCN1;LRP2;MAP3K10;SQSTM1;USP36;SOS2;SUPV3L1;ARHGEF1;HNRNPK;DAB2;PRDX3;AKAP13;PSEN2;RHOB;SCIN;ING4;LATS2;FOXO3;SOS1;IL6;HGF;CAT;CREBBP;TRIO;TOMM70;PLSCR3;NSMF;NF1;AATF;HIP1;RPS27A;UBC;HIGD1A;APBB1;FLCN;MAGED1;E2F1;BIRC6;ARAF;PRLR;PERP;NGEF;BNIP1;CLN3;GOLPH3;DAPK3;RYBP;CITED2;IER3IP1;GDNF;BID;AKT1;BIRC5;STEAP3;TAF9B;DNAJA1;QRICH1;IRF3;CDK5;NFKBIA;PRDX2;RTKN
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.4478647871015315,1.0615019077509111,0.39245283018867927,0.8248292122862535,1.0,3/23,5.17%,GPC3;GLIS2;VCP
prerank,phospholipid dephosphorylation (GO:0046839),0.41056055937275504,1.0611030567827542,0.3948896631823461,0.825418242450561,1.0,9/37,13.45%,PLPP3;PLPP5;PLPP1;MTMR11;SYNJ1;INPP5B;MTMR10;PIP4P2;OCRL
prerank,maturation of 5.8S rRNA (GO:0000460),0.4720639039433367,1.0608055669851608,0.4144736842105263,0.825691572812331,1.0,9/17,26.81%,C1D;PRKDC;LAS1L;EXOSC4;EIF6;MTREX;WDR12;MAK16;RRP15
prerank,positive regulation of keratinocyte migration (GO:0051549),0.5156946617166417,1.0600261191587945,0.4194008559201141,0.8273663755017465,1.0,2/10,11.61%,ADAM9;IQSEC1
prerank,establishment of vesicle localization (GO:0051650),0.46296452514949493,1.0597379420918145,0.4066225165562914,0.8276312359119398,1.0,6/18,19.58%,LIMK2;DNM2;SYNJ1;CCDC186;SNAPIN;CDK5
prerank,DNA repair (GO:0006281),0.3592509359931364,1.059701310965229,0.32965931863727455,0.827177817884951,1.0,121/284,33.35%,PARP3;CHD1L;MPG;UBE2B;TRIM28;FTO;POLE2;VCP;PRKDC;ERCC8;INTS3;RMI2;TRRAP;KMT5C;HUWE1;ERCC5;RBBP8;FAAP20;ERCC4;RAD1;MAPK8;OGG1;WRN;ABL1;ATM;KPNA2;TDG;WDR48;CHEK2;USP45;TDP1;PMS2;KDM4A;RAD50;ERCC3;ALKBH1;CSNK1E;LIG4;ERCC2;MMS19;SMUG1;PIAS4;DCLRE1B;FANCE;ATRIP;PARP1;UBE2V2;FAAP24;RPS27A;UBC;SUMO1;SLC30A9;APBB1;HUS1;POLB;MEN1;ACTR8;RAD51;USP1;TNKS1BP1;XRCC3;TEX264;TRAIP;FANCG;ENDOV;BRCC3;MAD2L2;APEX2;USP47;SETD2;PDS5A;TOPBP1;UPF1;SMC1A;UVRAG;ALKBH3;PRIMPOL;TP53;RECQL5;POLD1;SLX4;FBH1;GTF2H4;XPA;PARP4;ZRANB3;PNKP;RPAIN;SETX;DDB1;UBE2V1;NOP53;ADPRS;ATR;RAD52;IGHMBP2;PDS5B;TIMELESS;SMARCAL1;MBD4;TDP2;HINFP;RAD17;RHNO1;UBE2A;XRCC1;RAD23B;BLM;MTA1;MSH2;HERC2;UBE2N;VCPIP1;ERCC1;ALKBH5;CHRNA4;ERCC6;CUL4B;POLK;POLQ;RPA3
prerank,DNA integrity checkpoint signaling (GO:0031570),0.42345815563039085,1.0596467817032864,0.39809296781883197,0.8267622395379928,1.0,18/36,30.78%,CDC6;TIPRL;RAD1;ATM;CHEK2;CDC45;CEP63;ATRIP;HUS1;E2F1;CDT1;DONSON;ATR;INTS7;TIMELESS;HINFP;RAD17;RHNO1
prerank,mitotic spindle organization (GO:0007052),0.3638616937927458,1.058774960065446,0.3742393509127789,0.8287070623065431,1.0,28/153,14.04%,XPO1;TUBG2;PPP1CC;TBCE;SEC13;DYNC1H1;MISP;VCP;WDR62;SEH1L;MAD1L1;CENPC;SMC3;RHOA;DCTN2;CENPT;SPAST;CKAP5;RCC1;INTS13;NUP37;CHEK2;MIS12;RCC2;ZW10;DYNC1LI2;NDEL1;RANBP2
prerank,response to muscle stretch (GO:0035994),0.4847605022870963,1.058726138805557,0.3962516733601071,0.8282984466244065,1.0,4/15,11.10%,GSN;DMD;SLC9A1;CSRP3
prerank,regulation of organelle organization (GO:0033043),0.3775051407688616,1.058643312585457,0.39574468085106385,0.8279876483900008,1.0,35/80,28.26%,RDX;MAPK15;STX5;CLIC4;MAVS;MIEF2;RHOT2;CLEC16A;CAPN2;RHOT1;PAK2;TMED9;AKAP9;EZR;TBC1D25;SQSTM1;PREB;CLN3;VPS11;GOLPH3;CDT1;ARMH3;TMEM33;LMAN1;MUL1;CAPN6;CAMSAP3;MTM1;TAOK1;SCARB2;PINK1;SAR1A;MYO5A;SURF4;FIS1
prerank,regulation of necroptotic process (GO:0060544),0.44420670962842174,1.0583650705174337,0.4099616858237548,0.8282516902570425,1.0,10/23,31.13%,YBX3;OGT;RIPK3;STUB1;PDCD6IP;BIRC3;CYLD;RIPK1;HSP90AA1;SPATA2
prerank,regulation of tube diameter (GO:0035296),-0.4011036999595868,-1.0582517864215566,0.37777777777777777,0.6909114500678419,1.0,6/13,11.79%,ROCK2;NOS3;ACE;AGTR1;NPR1;ACE2
prerank,vascular process in circulatory system (GO:0003018),-0.4011036999595868,-1.0582517864215566,0.37777777777777777,0.6909114500678419,1.0,6/13,11.79%,ROCK2;NOS3;ACE;AGTR1;NPR1;ACE2
prerank,regulation of macrophage differentiation (GO:0045649),0.4842409848544087,1.0582484742109048,0.4105263157894737,0.8280000281549965,1.0,4/15,12.95%,ID2;PRKCA;PTPN2;INHBA
prerank,nuclear transport (GO:0051169),0.47308113222294446,1.0579153758738324,0.41312741312741313,0.8284221149177595,1.0,2/16,9.13%,XPO1;PSIP1
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.4063231642088096,1.057612631250378,0.4123006833712984,0.8287479771596962,1.0,23/48,33.08%,ZMIZ1;ELOF1;SERTAD2;SF3B1;KAT2A;ZMIZ2;POLR2F;ATAD2B;HMGA1;POLR1G;TBP;POLR1C;TAF1C;KAT2B;POLR2H;ARID1A;SPHK2;TAF1D;POLR2L;TAF1B;POLR2K;TAF1A;ERCC6
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.4643570006185139,1.0572802539576795,0.40843214756258234,0.829185147260133,1.0,7/18,24.86%,MORC3;SKI;MED25;NF1;PEX2;B4GALT7;TP53
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.3798495808560383,1.0564913218129162,0.3959445037353255,0.8309241174781584,1.0,28/85,25.47%,RNF144A;PRICKLE1;CSNK1D;COP1;OSBPL7;VCP;DVL1;FBXO22;RNF14;SMAD7;CSNK1E;DAB2;SIRT2;STUB1;USP13;PSMC5;DDA1;SUMO1;HECTD1;LRRK2;CLU;USP5;SUMO2;DET1;TAF1;BBS7;RNFT1;RCHY1
prerank,regulation of T cell cytokine production (GO:0002724),0.4825180210621329,1.056461815938641,0.414535666218035,0.8304590667987585,1.0,4/15,11.86%,TNFRSF1B;FZD5;TRPM4;SMAD7
prerank,axonemal dynein complex assembly (GO:0070286),0.44441929179538464,1.055624823853963,0.42143727161997563,0.8322915830247563,1.0,9/27,25.83%,DNAH8;DNAAF3;ODAD2;CCDC39;DNAAF4;CFAP73;TTC12;DNAAF5;DNAL1
prerank,positive regulation of ruffle assembly (GO:1900029),0.4937016203736179,1.0555247039277342,0.4041958041958042,0.8320028074773107,1.0,5/13,14.82%,EPS8L1;FAM98A;NLGN1;NDEL1;PLEKHM1
prerank,glucose metabolic process (GO:0006006),0.3897420214073815,1.0549208088844526,0.41209406494960804,0.8331166308248239,1.0,13/58,18.80%,SLC39A14;LRP5;ATF4;SORD;GAA;ADPGK;CRTC2;AKR1A1;HECTD4;PGK1;SLC37A4;ENO2;GDPGP1
prerank,negative regulation of cell cycle process (GO:0010948),0.3889368602561333,1.0544229454058585,0.4053452115812918,0.8339822283245866,1.0,27/61,32.22%,TOM1L1;EHMT1;RBBP8;PHC3;BMP4;RNF2;ZFYVE19;RBBP7;TFDP1;RING1;L3MBTL2;CBX5;E2F1;PCGF2;RYBP;RAD51;MAX;PPP1R10;CCP110;CHMP2A;EHMT2;E2F8;WAPL;FOXO4;SUZ12;CHMP4C;MGA
prerank,cellular response to DNA damage stimulus (GO:0006974),0.35527430682928823,1.054390162818567,0.33633633633633636,0.8335113260091511,1.0,132/336,29.86%,FOXP1;HELB;MAPK15;PARP3;TOPORS;CHD1L;UBE2B;TRIM28;POLE2;VCP;CBX1;PHF1;GNL1;TNFRSF1B;DCUN1D5;PRKDC;ERCC8;INTS3;RMI2;OTUB1;TRRAP;SLF2;KMT5C;RBBP6;RBBP8;FAAP20;ERCC4;RAD1;OGG1;CUL4A;WRN;UBR5;ABL1;SPIDR;BCL2L2;ATM;WDR48;CHEK2;USP45;MAPK12;TDP1;ZDHHC16;RAD50;ERCC3;TANK;ALKBH1;CSNK1E;MMS19;CEP63;TLK2;ATRIP;PARP1;NIPBL;AATF;SMC5;CBX5;SUMO1;APBB1;HUS1;E2F1;POLB;UFL1;MEN1;IKBKE;USP10;ALKBH8;ATF2;BID;RAD51;IRF3;XRCC3;MTREX;TRAIP;FANCG;ENDOV;NEK4;SUV39H1;USP47;ZBTB40;SLF1;SFN;PDS5A;TOPBP1;UPF1;SMC1A;UVRAG;TAOK3;TAOK1;ALKBH3;BOD1L1;TAF1;RBM24;TP53;MCM7;XIAP;RECQL5;TAOK2;POLD1;SLX4;FBH1;GTF2H4;CGAS;SETD7;SMC6;YY1;SHPRH;XPA;PARP4;HTRA2;ZRANB3;PNKP;USP16;BCL6;RPAIN;SETX;RTEL1;DDB1;NOP53;ADPRS;ATR;RAD52;GRB2;HMCES;IGHMBP2;DDX11;PDS5B;TIMELESS;SMARCAL1;YAP1;MBD4;CASP2;TRIP12
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.5144991200697335,1.0541405060199691,0.4115107913669065,0.8337092811378101,1.0,2/10,12.71%,LRP1;PTPN2
prerank,regulation of macrophage migration (GO:1905521),0.5212015474629028,1.0540899892096922,0.4166666666666667,0.8332953982708353,1.0,2/10,10.73%,EMILIN1;MTUS1
prerank,response to glucagon (GO:0033762),-0.3522722463722593,-1.0539852073974658,0.36693548387096775,0.7000003749269168,1.0,6/19,7.39%,ADCY5;ADCY1;PRKAR2B;PRKACB;PRKAR1B;ADCY4
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.4279677117111023,1.0538721335761685,0.4134969325153374,0.8333334210384388,1.0,11/29,25.07%,LDLRAD4;SPRED2;FOXA1;SMAD7;BMP5;FUZ;IL17RD;EFNA1;MAD2L2;ZNF750;PPP2CA
prerank,regulation of insulin secretion (GO:0050796),0.3743653291719936,1.0533672631950302,0.38790406673618355,0.8341899645575481,1.0,11/101,7.98%,IRS1;CACNA1C;EFNA5;KCNB1;TCF7L2;CCN3;LRP5;PRKCA;MCU;AACS;CAPN10
prerank,regulation of epithelial cell proliferation (GO:0050678),0.38180787909430913,1.0530022690538436,0.39721627408993576,0.8346714089332097,1.0,13/85,10.16%,EGFR;SRSF6;VEGFA;FGF2;TCF7L2;DEAF1;PKHD1;TGFB2;SIX4;PRKDC;SOX9;FGFR2;BMP4
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.38216435408248833,1.0527698862640653,0.41278439869989164,0.8347771712091515,1.0,36/73,33.08%,GLMN;HDAC4;PHF1;TRIM27;SF3B1;TDG;KAT2A;RBBP7;POLR2F;HDAC6;POLR1G;MPHOSPH8;TBP;TASOR;POLR1C;TAF1C;KAT2B;DNMT1;H3-3A;DNMT3A;POLR2H;IGF2;SPHK2;TAF1D;MECP2;POLR2L;SUZ12;CTCF;TAF1B;SPI1;MTF2;POLR2K;MTA1;CREBZF;TAF1A;ERCC6
prerank,autophagosome maturation (GO:0097352),0.4171384871282122,1.0525498221244398,0.4075425790754258,0.8348494481053882,1.0,17/32,36.12%,VCP;LIX1L;WIPI2;UBQLN1;CHMP3;VIPAS39;CLN3;LAMP2;UVRAG;VTI1B;VPS16;STX17;MAP1LC3B;GABARAPL2;EPG5;TSG101;ATG14
prerank,defense response to virus (GO:0051607),-0.2512261692260991,-1.0525395047861832,0.34,0.7019008530916031,1.0,26/100,18.23%,SERINC3;BCL2;BCL2L1;IFNAR2;STAT1;AGBL4;ABCC9;SAMHD1;IFITM1;BST2;NLRC5;IFIT3;IFIT2;RNASEL;IFIT1;PQBP1;RSAD2;OAS2;IFITM3;CD40;IFI27;SERINC5;MLKL;PHB2;PYCARD;MYD88
prerank,regulation of execution phase of apoptosis (GO:1900117),0.4992688855871231,1.0522115653551782,0.4314574314574315,0.8352588465076828,1.0,4/11,14.97%,PTGIS;FAP;CIDEA;SIRT2
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),-0.4136425131578427,-1.0520651871361721,0.33807829181494664,0.7012885443706324,1.0,2/11,1.32%,NEDD4L;ACTN2
prerank,negative regulation of cartilage development (GO:0061037),0.49847916401759124,1.0518917579022735,0.43859649122807015,0.835607093562022,1.0,3/13,12.22%,WNT9A;SOX9;TGFBR1
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.35299880030452446,1.0517879860563213,0.356,0.8353545499344737,1.0,77/390,15.41%,PGF;EGFR;IRS1;SLC39A14;VEGFA;EFNA5;DDR2;FGF2;COL1A1;ARHGEF28;TIAM1;UBASH3B;GRB10;NTRK3;GHR;RHOQ;ATP6V1C2;NTRK1;FGF17;HNRNPH1;VAV2;EPHB2;SIPA1L1;SPRED2;SHC1;RBFOX2;TNK1;STAT3;TCIRG1;ARPC1B;CD3E;CLNK;AP2A1;EPHB3;SULF1;FOXC2;EPHB6;ATP6V0A1;GIGYF1;ABI1;FGFR1;ROR1;CBL;CYFIP1;SOCS2;KALRN;AKT2;RHOA;PAK2;ZNF106;ITGAV;FGFR2;FLRT2;GTF2F1;MUSK;ATP6V0D1;DDR1;GIT1;SHOC2;NRP1;PHIP;PIK3CB;PTPN2;AP2A2;HNRNPM;SRMS;PTBP1;ATP6V1B2;FRK;TIAL1;GALNT3;ATP6V1E1;SIRT2;PSEN2;POLR2F;SOS1;HGF
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.36775655540509566,1.0517379126623743,0.38848920863309355,0.834942051672696,1.0,27/124,15.41%,MYOC;NEDD4;CTTN;STMND1;PPP1R9B;EHD1;LRP12;LIMA1;DOCK7;MNS1;ODF2;BLOC1S2;HMGB1;GPRIN1;TBC1D23;TBC1D24;CYFIP1;ARFIP2;UHMK1;TTC17;NLGN1;BLOC1S3;MANF;MARK4;PLP1;MICALL2;IL6
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.36436715129821157,1.0514403047667216,0.39897435897435896,0.8352153719188916,1.0,22/125,14.04%,XPO1;TUBG2;PPP1CC;TBCE;SEC13;DYNC1H1;WDR62;SEH1L;MAD1L1;CENPC;DCTN2;CENPT;CKAP5;RCC1;INTS13;NUP37;MIS12;RCC2;ZW10;DYNC1LI2;NDEL1;RANBP2
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.35747275074300533,1.0514172302290299,0.3614457831325301,0.8347304501938141,1.0,30/214,13.33%,BMPER;EGFR;TNFAIP8L3;GAS6;FGF2;FSHR;EMILIN1;NTRK3;NTRK1;TIMP3;EPHB2;CCL13;SPRED2;SHC1;PKHD1;CCL15;PRKCA;SMAD4;HMGB1;ROR1;PLA2G5;DLG1;FGFR2;MAP3K12;P2RY6;NRP1;ARHGAP8;PTPN2;EZR;F2R
prerank,maturation of SSU-rRNA (GO:0030490),0.4194206333183337,1.051356575026775,0.4152941176470588,0.8343649898104324,1.0,12/34,24.78%,HELB;TSR1;SRFBP1;WDR3;RIOK1;DCAF13;TSR2;NOB1;TSR3;NGDN;WDR46;RIOK2
prerank,clathrin coat assembly (GO:0048268),-0.3811528766874034,-1.0513447275427263,0.35361216730038025,0.7012877755680711,1.0,5/15,12.31%,SGIP1;PICALM;HIP1R;NSG1;PIK3C2A
prerank,secretion (GO:0046903),-0.3898740305715265,-1.0512011635196052,0.40076335877862596,0.6998250372069018,1.0,5/14,13.07%,SLC22A6;RIMS1;NPR1;SLC22A2;SLC22A4
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.41563513190429197,1.0511325495158306,0.389082462253194,0.834432513071765,1.0,18/37,33.35%,CHD1L;ERCC5;ERCC4;CUL4A;ERCC3;ERCC2;PARP1;RPS27A;UBC;POLD1;GTF2H4;XPA;DDB1;RBX1;ERCC1;CUL4B;POLK;RPA3
prerank,regulation of cell motility (GO:2000145),0.3674570727068824,1.0511286946136367,0.3987603305785124,0.8338907408976819,1.0,21/121,12.40%,EGFR;PLXNA4;NTN1;FGF2;SRCIN1;FGF17;LDB2;LDB1;TWIST1;LMNA;MEAK7;RAF1;BEX4;AKT2;RHOA;PKN2;ABL1;LMO4;SERPINE2;CCDC25;RCC2
prerank,regulation of cellular localization (GO:0060341),0.39824705078746325,1.0510082951621915,0.40656851642129105,0.8336868800035566,1.0,7/46,8.02%,EFNA5;GSN;LRP5;CAMK2D;DYNC1H1;DVL1;MAD1L1
prerank,inositol lipid-mediated signaling (GO:0048017),0.39437262613573226,1.0509891247662662,0.40757749712973596,0.8331840552728517,1.0,9/50,8.97%,IRS1;PLCE1;TNFAIP8L3;NTRK1;GAB2;PIK3C2B;FGFR1;OGT;RHOA
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),0.4883559993681965,1.050687953729143,0.41120218579234974,0.8334877055607579,1.0,5/13,17.19%,IL33;SOAT1;RAMP1;CHP1;SLC2A10
prerank,cellular response to alcohol (GO:0097306),0.4023440258618651,1.050362242743503,0.4048723897911833,0.8338438456026142,1.0,14/42,20.84%,LRP6;GRAMD1A;ADCY2;OSBPL7;ADCY8;JUP;SPIDR;SMO;GRAMD1C;ADCY7;GOLPH3;RAD51;GNB1;KLF9
prerank,myeloid leukocyte differentiation (GO:0002573),0.3852131249932471,1.05025693952316,0.4100327153762268,0.8336167695268847,1.0,14/65,17.11%,FOXP1;VEGFA;GAB2;RXRA;GLO1;TGFBR2;RARA;SBNO2;RUNX1;BMP4;FARP2;PARP1;CAMK4;E2F1
prerank,protein ubiquitination (GO:0016567),0.3511381845608633,1.0501756546850982,0.336,0.8332922733668074,1.0,182/471,30.59%,WWP1;RNF144A;SH3RF3;NEDD4;FBXO10;FBXL7;PSMD7;CDC16;FBXW8;TOPORS;UBE2B;VCP;RNF182;DTX3;PSMA8;LRSAM1;UBE2R2;PRKDC;NFX1;ERCC8;NFE2L2;KLHL7;UBE3C;RNF115;PEX5;TRIM41;SYVN1;TRPC4AP;TRIM27;CBL;HUWE1;RBBP6;LZTR1;PEX13;WWP2;PSMA4;ITCH;FBXO25;CUL4A;UBR5;UCHL3;RNF114;FBXL4;RNF25;PEX10;UBE2C;FBXO22;MYLIP;ATG3;FBXL12;RNF14;SDE2;NEUROD2;PSMD12;CUL1;DTX2;FBXL19;PSMA6;RNF38;USP7;RNF103-CHMP3;TRIM26;TNKS2;RNF11;FBXL14;LNPEP;ARRB1;UBE2L6;STUB1;KLHL22;PSMD11;FBXL20;PSMC5;PSMD1;DDA1;FBXO17;PSMD14;UBE2V2;RC3H2;OTULIN;PSMC4;RPS27A;UBC;TRIM13;BIRC6;FBXL18;TPP2;TRIM6;VPS11;NPEPPS;UBE4A;CDC27;ASB5;UBR2;CBFB;UHRF2;RNF7;MYCBP2;FBXW2;RNF141;FBXW4;RUSC1;PCNP;TRAIP;UBE2G2;SMURF2;PSMA3;PSMD4;SH3RF1;TRIM47;PSMB1;TRIM43;USP5;MUL1;RNF4;PEX2;PAF1;UBOX5;KLHL12;AREL1;CUL9;KCTD13;PEX14;PSMA5;DERL1;RNF20;RNF146;FBXO11;UBE2Z;DET1;PSMA7;TAF1;RNF122;FBXO9;SELENOS;RNF138;AMFR;ANKRD9;UBE2W;RNF111;PINK1;RNFT1;RTF1;RCHY1;CUL7;UBR3;FBXW10;UVSSA;FBH1;SHPRH;RNF126;RNF166;PSMC1;CAND1;USP22;RNF167;PSMA1;DDB1;UBE2V1;TRIM7;UBE4B;RNF135;ANAPC11;FBXL8;UBR1;BTRC;FBXO41;RBX1;UBE2Q2;DCAF15;UBE2S;KLHL9;VPS18;TRIM39;TRIP12;PSMD2;BLMH;CTNNB1;UBE2H;KEAP1;PJA2;HECTD2
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.5067102239603587,1.049842916648283,0.44666666666666666,0.8336636728589324,1.0,8/13,32.12%,NFE2L2;HGF;LRRK2;PYCR1;MET;GPR37;GPR37L1;NR4A3
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),0.526120165412252,1.049597436567671,0.4310099573257468,0.8338242333525911,1.0,2/10,2.76%,MUC1;CYP1B1
prerank,lipid transport (GO:0006869),0.37462249501443223,1.0492988786866788,0.40392561983471076,0.8341374619884107,1.0,10/97,4.82%,SLCO3A1;TNFAIP8L3;ABCD3;LBP;SLCO2A1;PITPNC1;RXRA;PRELID3B;PITPNA;PITPNM1
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.3727388135624176,1.0486797278130462,0.4025157232704403,0.8353847331158855,1.0,13/100,8.14%,MYOC;EGFR;FGF2;NEDD4;FSHR;NTRK3;NTRK1;TWIST1;TGFB2;FGFR1;ROR1;SOX9;CBL
prerank,ribosome assembly (GO:0042255),0.39374459116725624,1.048645856981321,0.42160278745644597,0.8349298378801796,1.0,15/47,25.34%,RPSA;MRPS2;RRS1;MPV17L2;RRP7A;NLE1;DHX29;PPAN;EIF6;EFL1;BOP1;EIF2A;SBDS;RPS27L;C1QBP
prerank,positive regulation of calcium ion import (GO:0090280),-0.40091264980297703,-1.048373089801349,0.375,0.7053894900301457,1.0,2/12,4.83%,CXCL12;PDGFRB
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.4078490695101143,1.048363935830943,0.4144893111638955,0.835162142710791,1.0,18/40,33.71%,TONSL;WRN;RAD51;TRAIP;DONSON;PRIMPOL;BOD1L1;POLD1;FBH1;ZRANB3;RTEL1;CDK9;ATR;DDX11;TIMELESS;SMARCAL1;BLM;MMS22L
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.44995434438248544,1.0480690803594843,0.4036458333333333,0.8353921701834315,1.0,7/22,25.41%,BRD4;HMGN1;CDK12;CCNT2;KAT7;CDK13;DDX39B
prerank,synaptic vesicle localization (GO:0097479),0.489454186331439,1.0480476742850964,0.4140302613480055,0.8349099249245748,1.0,5/13,19.58%,DNM2;SYNJ1;NLGN1;SNAPIN;CDK5
prerank,response to organonitrogen compound (GO:0010243),0.4108668087765063,1.0472345356417685,0.43287037037037035,0.8366376467017131,1.0,12/38,25.10%,VCP;MEAK7;IRAK3;SYVN1;IL6;ERLEC1;GLRB;RCN3;KAT7;DRD2;DERL1;DNAJB12
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.37867616163465084,1.0470601553341137,0.41353383458646614,0.8365802638829303,1.0,8/72,7.43%,SLIT2;PRKCD;FGF13;EMILIN1;LIMA1;PFN2;SMAD4;IAPP
prerank,heart process (GO:0003015),0.4792926766961011,1.046849203279317,0.42141863699582754,0.8365930955356207,1.0,3/14,12.09%,SGCD;NOX4;SOD1
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.4714719254871613,1.0466931300051947,0.4270833333333333,0.8364748950832023,1.0,4/17,12.19%,KCNE5;ANK2;SNTA1;AKAP9
prerank,regulation of axon guidance (GO:1902667),0.5156287771982984,1.0464585996281996,0.43447293447293445,0.836618053741787,1.0,3/10,19.04%,VEGFA;NRP1;MYCBP2
prerank,positive regulation of cell population proliferation (GO:0008284),0.3500920340025905,1.0462033860598072,0.357,0.8368035490927117,1.0,84/423,17.75%,THBS1;PGF;EGFR;IRS1;FOXP1;PID1;ID2;ZFPM2;VEGFA;GAS6;DDR2;FGF2;TCF7L2;TIAM1;ACER3;NTRK3;PROK2;FGF17;GAB2;LRP5;TGFB3;MAPK15;SHC1;HDAC4;WWTR1;PKHD1;CSNK2A1;HES5;TGFB2;TCIRG1;DNAJA2;FXN;FAM98A;TGFBR2;IL12RB2;ADAM10;FGFR1;MEIS3;EDN3;SOX9;RARA;S100B;AKT2;TRPM4;TMEM119;TBRG4;ITGAV;FGFR2;CDC25B;CDC123;BMP4;FOXM1;FAM98B;VIP;TERT;CTF1;CHTOP;BMPR1A;MAZ;PHIP;HDAC1;TGFBR1;KMT2D;LIG4;F2R;NACC1;BMP5;PRDX3;CLCF1;STX4;MAP3K3;CCN4;IL6;SLC35F6;CNOT8;ERBB2;OSMR;FGF5;E2F1;GAREM1;SSR1;PRLR;UFL1;HMOX1
prerank,regulation of wound healing (GO:0061041),0.40770377932866797,1.0462015360160257,0.41839080459770117,0.8362611331128601,1.0,4/42,2.80%,SRSF6;FGF2;PRKCE;EPHB2
prerank,tRNA wobble uridine modification (GO:0002098),0.4786921698359746,1.0461318096462149,0.428958051420839,0.8359337295849483,1.0,7/14,24.84%,TRMU;ELP1;CTU2;ELP4;ALKBH8;ELP3;MTO1
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.3577445513736069,1.0460858457266744,0.4186284544524053,0.8355316664402319,1.0,32/140,15.67%,SLIT2;RHOJ;PLCE1;SRGAP2;SRGAP3;TIAM1;ARAP1;RHOQ;TIAM2;VAV2;ARHGAP17;BCR;RHOT2;ARHGAP21;KALRN;RHOA;RHOT1;ITGAV;FOXM1;INPP5B;MYO9A;ARHGAP20;ARHGAP8;OCRL;ARHGAP44;SQSTM1;SOS2;ARHGEF1;AKAP13;RHOB;SOS1;TRIO
prerank,synaptic vesicle transport (GO:0048489),0.4998198005976548,1.0460434611081129,0.43820224719101125,0.8350877154312238,1.0,4/11,19.58%,DNM2;SYNJ1;SNAPIN;CDK5
prerank,double-strand break repair via homologous recombination (GO:0000724),0.3698368801450981,1.0459030988103726,0.40932642487046633,0.8349227835254023,1.0,34/95,28.35%,REV3L;MCMDC2;TONSL;MCM2;ERCC5;MORF4L1;RBBP8;ERCC4;SFR1;WRN;SWI5;SPIDR;SFPQ;RAD50;CDC45;GINS4;PARP1;PSMD14;NIPBL;SMC5;MCM4;HUS1;RAD51;XRCC3;RNF138;MCM7;RECQL5;SLX4;FBH1;SMC6;YY1;SWSAP1;NSMCE2;RAD52
prerank,regulation of mitotic sister chromatid separation (GO:0010965),0.4796487935533943,1.0456887179836005,0.4370860927152318,0.8349626873600107,1.0,8/15,26.43%,CDC16;CDC6;UBE2C;ANAPC1;CDC27;NEK6;RIOK2;TPR
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.32775851410384865,-1.0455275286571886,0.37073170731707317,0.7105816756932731,1.0,4/23,3.65%,CEMIP;BMP7;APP;PRKAG2
prerank,superoxide metabolic process (GO:0006801),0.4273865570663673,1.045154689548551,0.4175,0.8359539906416922,1.0,4/29,12.09%,SH3PXD2A;NOX4;SH3PXD2B;SOD1
prerank,positive regulation by host of viral transcription (GO:0043923),-0.36637082962161127,-1.04498000109248,0.3914590747330961,0.7101313111819806,1.0,1/15,0.48%,LEF1
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.48395376739688295,1.0442600609053845,0.4242837653478854,0.8379599148363434,1.0,6/13,28.87%,TGFBR2;RUNX1;CBFB;GLI3;SOCS1;NKAP
prerank,methylguanosine-cap decapping (GO:0110156),0.5171943869473895,1.0442138483698769,0.43564356435643564,0.837548347343543,1.0,6/10,36.17%,PNRC2;PATL1;DCP1A;EDC4;DCPS;DCP1B
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.46094340190759236,1.044202232534266,0.41827541827541825,0.8370346214124651,1.0,9/19,30.77%,CSNK2A2;FZD5;SREBF1;USP36;HDAC6;PINK1;HTRA2;SREBF2;PRKN
prerank,positive regulation of protein transport (GO:0051222),0.3813730317990384,1.0441568666432879,0.42717391304347824,0.8366215925818687,1.0,18/67,18.42%,ADAM9;UNC13B;TGFB3;APBB3;TGFB2;BCAS3;TENM1;CHP1;EZR;PCM1;ACSL3;APBB1;CNST;SYTL4;CLN3;GOLPH3;IER3IP1;KIF20B
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.37942591500962,1.044122576357677,0.4228694714131607,0.8361649605262471,1.0,40/72,35.01%,ERCC8;GPS1;ERCC5;HMGN1;ERCC4;CUL4A;ERCC3;XAB2;ERCC2;USP7;POLR2F;ISY1;RPS27A;UBC;AQR;POLR2B;COPS4;COPS7A;POLD1;COPS3;UVSSA;GTF2H4;POLR2H;XPA;DDB1;POLR2I;RBX1;POLR2L;COPS5;XRCC1;POLR2K;ERCC1;CCNH;ERCC6;CUL4B;POLK;RPA3;COPS2;COPS7B;RFC4
prerank,regulation of interleukin-8 production (GO:0032677),0.38197753096305037,1.044109154505506,0.4002157497303128,0.8356589719250228,1.0,11/69,15.41%,LBP;F3;STAT3;ANXA4;MAVS;HMGB1;ANXA1;MAPKBP1;F2R;ARRB1;IL6
prerank,cellular macromolecule catabolic process (GO:0044265),0.39468144463397636,1.0440307328284775,0.41714285714285715,0.835333212148281,1.0,22/49,29.17%,SIDT2;PPP1R8;RNASE3;RNASE6;CHEK2;SND1;SUPV3L1;NGLY1;FBXO17;IDE;NCBP1;DFFB;MTREX;UBE2G2;PABPC4;ADAMTS9;OGA;RIPK1;HTRA2;DNASE1L2;MANBA;STT3B
prerank,central nervous system myelination (GO:0022010),0.5096723423050865,1.0439336332693714,0.44017094017094016,0.8350506332778677,1.0,4/11,20.76%,HES5;B4GALT5;PLP1;CLU
prerank,keratan sulfate metabolic process (GO:0042339),0.421929433830674,1.0437250246548235,0.42073170731707316,0.8350824264281484,1.0,9/31,18.30%,ST3GAL4;B3GNT7;B4GALT1;B4GALT5;ST3GAL2;HEXA;B4GAT1;CHST5;GLB1
prerank,acute-phase response (GO:0006953),0.49364492915021563,1.0435931600194248,0.4297752808988764,0.8349284850301942,1.0,1/12,0.97%,LBP
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.3998567102013051,1.0435540321752157,0.41898148148148145,0.8344902404797658,1.0,21/42,28.74%,CHD3;SMARCC2;SPTY2D1;INO80B;ACTR6;PBRM1;HDAC1;ZNHIT1;HNRNPC;VPS72;SMARCAD1;CHD8;ACTR8;SMARCA4;CHD4;SRCAP;HDAC2;ANP32E;ARID1A;SMARCD2;SMARCC1
prerank,serine family amino acid catabolic process (GO:0009071),0.5199720000011211,1.0435533666579602,0.4515669515669516,0.8339517590712859,1.0,4/10,18.87%,GCSH;SHMT2;SHMT1;DAO
prerank,protein phosphorylation (GO:0006468),0.3497888599165964,1.0435068381250605,0.37,0.83353602255839,1.0,136/478,21.22%,DCLK1;EGFR;PKD1;PKDCC;PRKCD;GAS6;CIT;DDR2;ULK2;MARK1;NTRK1;PRKCE;ACVR1B;EPHB2;MAPK15;CSNK1D;CLK3;CAMK2D;MAP3K5;STRADA;TNK1;CSNK2A1;CSNK2A2;TGFB2;MORC3;LIMK2;ERC1;PRKCA;FASTK;ERN2;DYRK4;EPHB3;ACVR1;NRBP2;ILK;PRKDC;NEK7;TGFBR2;ADAM10;ABI1;TLK1;STK39;IRAK3;BCR;FGFR1;CDK10;RPS6KA4;RARA;PAK4;ILF3;AKT2;DGKQ;CDK12;GMFB;PKN2;PAK2;FGFR2;MAPK8;SMG1;CDC25B;BMP4;CHUK;CSNK1G1;ABL1;MUSK;MAP4K5;TNNI3K;RIPK3;ATM;MAP3K12;IRAK1;BMPR1A;DDR1;CHEK2;PDPK1;MAPK12;SMAD7;NRBP1;GRK6;TGFBR1;UHMK1;STK25;CSNK1E;PICK1;SRMS;MAP3K10;DMPK;FRK;WNK1;MARK4;SRPK1;TBCK;COQ8B;BRD2;MAP3K3;EEF2K;LATS2;TLK2;CDC42BPB;CAMK4;CREB1;TP53RK;ERBB2;HASPIN;STK16;BIRC6;MKNK2;PRKAG1;SIK2;VRK2;DAPK3;MAST2;CAD;IKBKE;CLK2;BCKDK;AKT1;BIRC5;CDKL2;CDK20;HIPK2;CDK2;PRKAB1;CDK5;EIF2AK4;MAPK9;JAK1;LRRK2;GRK4;SGK3;FGFR3;NEK4;VRK3;MAST4;ABI2;PRKACA
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.38983003083776485,1.0434343476276222,0.4271186440677966,0.8331885842231058,1.0,17/54,26.09%,GAS6;CARD16;TAX1BP1;SHARPIN;CHUK;MADD;CASP1;PTPN2;OTULIN;TRAIP;CCDC3;BIRC3;GPS2;CYLD;SPPL2A;TRADD;RIPK1
prerank,regulation of lymphocyte migration (GO:2000401),0.5151548062587973,1.0432859485606454,0.4496551724137931,0.8330679637625024,1.0,4/10,23.86%,SPN;MIA3;AKT1;SLC8B1
prerank,response to histamine (GO:0034776),-0.42504960205156506,-1.043244546145574,0.4088050314465409,0.7128255554858123,1.0,3/10,8.64%,GABRB1;GABRB2;GABRB3
prerank,N-glycan processing (GO:0006491),0.4589082226804761,1.0428328840863201,0.4391891891891892,0.8337653829375725,1.0,4/18,9.74%,ST8SIA2;PRKCSH;MGAT4B;FUT8
prerank,response to unfolded protein (GO:0006986),0.3904532405590103,1.0427351380542782,0.4306651634723788,0.833487386925637,1.0,19/48,30.77%,SERPINH1;HSPA2;BAG3;HSPA14;HSPA5;HSPD1;DNAJA1;OPTN;DERL1;HERPUD1;DAXX;HSPB8;ERN1;HSF1;DNAJB1;STT3B;HSPH1;HSP90AA1;PRKN
prerank,hyaluronan metabolic process (GO:0030212),0.44219208557606215,1.0425338681961651,0.42802056555269924,0.8335174282344616,1.0,5/23,13.46%,FGF2;SLC9A1;ABCC5;CHP1;HEXA
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.37258217664107884,1.042278836492412,0.4033970276008493,0.8337121068501269,1.0,25/73,24.03%,LDB1;PSMD7;PSMA8;PRKDC;RUNX1;PSMA4;ITCH;ABL1;PSMD12;PSMA6;PDCD2;PSMD11;PSMC5;PSMD1;PSMD14;PSMC4;CBFB;TCF3;SETD1A;PSMA3;PSMD4;PSMB1;KMT2A;PSMA5;PSMA7
prerank,polarized epithelial cell differentiation (GO:0030859),0.493740068314789,1.042268646297761,0.4309623430962343,0.8332013266394106,1.0,4/13,12.87%,RHOA;SYNE4;MYO9A;EZR
prerank,pre-miRNA processing (GO:0031054),0.47136075974116637,1.0417929366891239,0.42609853528628494,0.8339837891477271,1.0,4/14,16.45%,PRKRA;AGO1;AGO2;TUT7
prerank,heterotypic cell-cell adhesion (GO:0034113),-0.3322589155954273,-1.041667422727906,0.3778801843317972,0.7150334926614361,1.0,9/25,17.09%,VCAM1;CTNNA3;CXADR;CD200;ITGA7;ITGA4;PKP2;DSP;NINJ1
prerank,positive regulation of cyclase activity (GO:0031281),0.4851116110382031,1.0416186912821253,0.41970310391363025,0.8339209825508401,1.0,3/14,9.79%,CACNA1C;STIM1;MAPK8
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.5212224028385302,1.0415555807973327,0.438953488372093,0.8335566985071183,1.0,3/10,12.19%,DLGAP3;DLGAP4;AKAP9
prerank,positive regulation of kinase activity (GO:0033674),0.36858108614400437,1.0408612688408765,0.42723492723492723,0.8349613150304807,1.0,20/107,13.20%,RASSF2;EGFR;GAS6;DDR2;NTRK3;NTRK1;EPHB2;CAMKK1;EPHB3;EPHB6;FGFR1;ROR1;FGFR2;MUSK;TAB2;LMO4;SNX9;DDR1;RAD50;MAPRE3
prerank,protein-DNA complex disassembly (GO:0032986),0.46328599274839566,1.0406959637087283,0.4368279569892473,0.8348653219859842,1.0,7/16,28.74%,SMARCC2;NFE2;HMGA1;SMARCA4;ARID1A;SMARCD2;SMARCC1
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),0.5107931253212157,1.0405755673305432,0.4519368723098996,0.8346913257523388,1.0,5/10,24.23%,TBX21;SMAD7;RC3H2;IL4;NFKBID
prerank,metal ion homeostasis (GO:0055065),0.4069503721461644,1.0403222164717354,0.4258600237247924,0.8348528961622356,1.0,8/40,15.00%,SLC12A7;SLC12A2;CNNM2;SLC12A4;SELENON;SCNN1A;LETM1;CYP27B1
prerank,regulation of steroid biosynthetic process (GO:0050810),-0.4194259797038744,-1.0400966657379866,0.3745819397993311,0.7174412653940653,1.0,7/11,17.11%,WNT4;FGFR4;EGR1;SIRT1;STAR;BMP2;NR1H4
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.4361199653034645,1.0400152183917772,0.4544319600499376,0.8351466484521326,1.0,6/27,16.51%,AK5;AK6;DTYMK;AK1;GSR;RRM2B
prerank,positive regulation of interleukin-4 production (GO:0032753),-0.36703709781427174,-1.0399588169390295,0.36585365853658536,0.7159402842526366,1.0,6/17,14.34%,SLC7A5;SYK;HAVCR2;PRKCQ;LGALS9;PRKCZ
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.43933249888734405,1.0398864441703575,0.432258064516129,0.8349843108934478,1.0,6/21,19.06%,SAMD4A;CNOT8;TUT7;CNOT10;CNOT9;TNKS1BP1
prerank,receptor internalization (GO:0031623),0.3963854488595444,1.0398217169914439,0.41857798165137616,0.8346388621576166,1.0,10/44,14.98%,LRP1;NEDD4;RAMP2;DNM2;CD9;SNX1;FCER1G;RAMP1;CLTC;ARRB1
prerank,cytosolic calcium ion transport (GO:0060401),0.4181484060097735,1.0397872962849848,0.40875912408759124,0.8342019349065409,1.0,3/28,6.03%,CACNA1C;SLC35G1;MCU
prerank,positive regulation of mRNA metabolic process (GO:1903313),-0.38447478890785564,-1.0396094219884786,0.38305084745762713,0.7150592703569026,1.0,5/13,15.86%,CNOT1;PRR5L;ZC3H12A;ZC3HAV1;GTPBP1
prerank,negative regulation of cell motility (GO:2000146),0.36496569738397133,1.0394567861280821,0.4200626959247649,0.8345457486775397,1.0,14/108,6.22%,SLIT2;IGFBP5;SRGAP2;SRGAP3;TMEFF2;DPYSL3;CYP1B1;MAPK15;LDLRAD4;SLURP1;CLIC4;PTPRU;SULF1;JAG1
prerank,neurotransmitter transport (GO:0006836),0.3792530279545369,1.0392078598599583,0.42473118279569894,0.8346997806370735,1.0,7/73,6.27%,SLC38A2;SLC38A1;UNC13B;SLC6A2;PPFIA1;DVL1;SLC28A2
prerank,connective tissue development (GO:0061448),0.41449000714959416,1.0391281556472727,0.43024618991793667,0.8343827904210458,1.0,8/35,12.46%,PKD1;LRP5;HES5;SULF1;SOX9;SH3PXD2B;SLC39A13;TRIP11
prerank,DNA methylation (GO:0006306),0.44185852204726445,1.0390717117616926,0.43090452261306533,0.8339910729808055,1.0,9/23,26.32%,BAZ2A;EHMT1;MTRR;TEX15;PICK1;FOS;DNMT1;EHMT2;DNMT3A
prerank,regulation of protein dephosphorylation (GO:0035304),0.40888079625992474,1.0390089637069806,0.4226190476190476,0.8336259428563374,1.0,13/37,18.20%,PRKCD;CALM2;PPP1R8;SYMPK;PPP6R1;TIPRL;PPP6R3;CNEP1R1;PTBP1;ARPP19;NSMF;CALM3;PPP6R2
prerank,cellular response to starvation (GO:0009267),0.36200877955727107,1.0387699284317145,0.41742654508611954,0.8337388349250138,1.0,51/147,26.23%,NPRL3;ATP6V1C2;SEC13;GCN1;MAP3K5;SESN3;TCIRG1;ATF4;LAMTOR1;SEH1L;WIPI2;DAP;CLEC16A;CASTOR2;IMPACT;MAPK8;WRN;SREBF1;FADS1;ATP6V0D1;HSPA5;SESN2;PICK1;ATP6V1B2;USP33;ATP6V1E1;VPS41;FOXO3;FLCN;PRKAG1;SIK2;KLF10;ATF2;KPTN;AOC1;ATP6V1C1;RHEB;EIF2AK4;LRRK2;EIF2S1;LAMP2;EIF2AK3;HNRNPA1;RPTOR;NPRL2;ATP6V0E1;TP53;ATP6V0B;STK24;LAMTOR2;EHMT2
prerank,cardiac muscle contraction (GO:0060048),0.4090535087522382,1.038438426314908,0.4145758661887694,0.8341407316638584,1.0,6/34,6.33%,ATP1B1;GSN;CAMK2D;GAA;DMD;KCNE5
prerank,phosphatidylcholine catabolic process (GO:0034638),0.5141952902827929,1.03842784356909,0.430835734870317,0.8336377538521533,1.0,3/10,16.77%,PLA2G4A;PLA2G5;PLA2G15
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.35199994304099175,1.038132723164237,0.4202607823470411,0.8338932269862088,1.0,49/234,19.69%,ESR1;LRP6;SLCO3A1;VEGFA;DDR2;CARD14;NTRK1;PLPP3;RAB7B;HDAC4;STAT3;CARD16;ERC1;MAVS;ADCY8;IRAK3;TRIM41;ROR1;JUP;RPS6KA4;TRIM27;FOXA1;CHUK;RIPK3;NFKBIB;TAB2;RNF25;IRAK1;NEUROD2;MID2;SRF;PSMA6;SMO;TRIM26;TFDP1;PRDX3;IL6;CRTC2;NFKB2;RPS27A;UBC;TRIM13;TRIM6;IKBKE;ATF2;AKT1;HIPK2;TCF3;NFKBIA
prerank,lipid biosynthetic process (GO:0008610),0.3764418802151411,1.03810481391397,0.4434876210979548,0.8334443245681769,1.0,20/77,18.85%,ABCD3;CYP19A1;ACSF3;LPCAT1;SCD5;GPAT4;DOLPP1;SREBF1;FADS1;OLAH;CBR4;FDXR;ACACA;PIP5K1A;HSD17B8;LSS;PRLR;AGPAT5;AGPS;ACSL6
prerank,positive regulation of interleukin-6 production (GO:0032755),0.3820215074509915,1.0380515160976873,0.41081081081081083,0.8330726910426018,1.0,12/68,15.41%,LBP;IL33;TWIST1;RAB7B;STAT3;MAVS;HMGB1;C1QTNF4;HSPD1;F2R;SETD4;IL6
prerank,response to reactive oxygen species (GO:0000302),0.3888594091721439,1.0379058675368753,0.438496583143508,0.8329454170533289,1.0,13/54,20.37%,EGFR;ADAM9;COA8;MAPK8;CHUK;SOD1;STK25;PRDX3;TXNRD2;CAT;HMOX1;AKT1;MAPK9
prerank,protein localization to cell surface (GO:0034394),0.4305366308749182,1.0378541594142423,0.4206060606060606,0.8325530461792613,1.0,13/26,31.90%,PTPRU;RIC3;GGA2;ANK2;GGA1;FBLN5;UNC50;USP4;PRRT1;WNT11;GGA3;CTNNB1;SMURF1
prerank,liver development (GO:0001889),-0.30398856847169403,-1.0376555988251837,0.3743016759776536,0.7181104575749417,1.0,5/32,5.78%,TGFBR3;WNT4;ARID5B;LSR;PROX1
prerank,protein insertion into membrane (GO:0051205),0.41592832600037855,1.0374388516218942,0.4471445929526124,0.833143081591676,1.0,11/32,27.95%,EGFR;STX5;TRAM2;ALDH3A2;STX1A;HMOX1;COX18;VAMP2;GET4;SEC61B;CCDC47
prerank,epiboly involved in wound healing (GO:0090505),0.47492743529039255,1.0374376517432282,0.42585034013605444,0.8326176726631084,1.0,4/16,17.02%,TMEFF2;RHOA;DDR1;CD151
prerank,regulation of neuroinflammatory response (GO:0150077),0.46318214529322144,1.0374024906945083,0.4280155642023346,0.8321946599691583,1.0,3/19,8.05%,IL33;TNFRSF1B;DAGLA
prerank,negative regulation of hydrolase activity (GO:0051346),0.39383772638355286,1.0371476087738265,0.41363636363636364,0.8323632414947281,1.0,15/49,20.63%,SLC39A14;RDX;KLRK1;BCAS3;CST3;ZCCHC9;URI1;RCC2;CHP1;ARL2;WNK1;TMED2;PPP1R35;PPP1R36;LRRK2
prerank,negative regulation of endothelial cell proliferation (GO:0001937),0.4109221635012797,1.0370975222088716,0.44922341696535245,0.8319724777147405,1.0,4/35,5.73%,THBS1;SPARC;XDH;SULF1
prerank,positive regulation of cell motility (GO:2000147),0.35434775990329875,1.036884208971015,0.4264112903225806,0.8320274648917725,1.0,24/205,7.92%,THBS1;MYOC;EGFR;NTN1;VEGFA;F3;COL1A1;ADAM9;TWIST2;TIAM1;NTRK3;DRD1;RDX;EPHB2;TWIST1;STAT3;SEMA3E;PRKCA;ACVR1;MMP14;ADAM10;SEMA4B;CXCL16;ELP5
prerank,potassium ion transport (GO:0006813),0.3592802464094862,1.0367995938362864,0.4278403275332651,0.8317369900447702,1.0,12/120,7.72%,KCNJ2;KCNJ15;KCNK5;KCNB1;SLC24A3;HCN4;KCNN1;SLC9A8;SLC9A4;SLC9A1;KCNIP2;KCND1
prerank,positive regulation of signal transduction (GO:0009967),0.35089675277455257,1.0367924308985423,0.3933601609657948,0.8312283127415409,1.0,43/238,13.27%,SMOC2;ADAMTS3;IRS1;SLC39A14;GAS6;F3;RSPO3;PTGIS;CCN3;GRB10;NTRK3;ATP6V1C2;ZMIZ1;RAB34;STAT3;CSNK2A1;TGFB2;CRADD;PRKCA;ARMC9;DACT1;SULF1;ILK;JAG1;POGLUT1;SKI;RSPO1;DLG4;TEDC1;EVC;ITGAV;FGFR2;ING5;TERT;P2RY6;NRP1;SHANK1;PHIP;TGFBR1;PDCL;SMO;CD80;NLGN1
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),-0.26411613366111575,-1.0360312604098116,0.4090909090909091,0.7203636263650425,1.0,19/55,19.32%,BCL2;BCL2L1;WWOX;TPD52L1;DNM1L;FAS;TNFSF12;NUPR1;BOK;CAV1;BCL2L11;STYXL1;TRAF7;GPER1;HYAL2;PML;PYCARD;RACK1;RPS3
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.4650302843531484,1.035965262705278,0.43355704697986575,0.8329266187459852,1.0,1/15,0.76%,PRKCD
prerank,high-density lipoprotein particle assembly (GO:0034380),0.5151965399552825,1.0358630763250014,0.4444444444444444,0.8327072133627634,1.0,2/10,11.15%,BMP1;ABCA1
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.4910035784335192,1.0358321306755613,0.43283582089552236,0.8322686706494766,1.0,5/13,20.07%,EDEM2;BCAP31;YOD1;ERLEC1;UBE2G2
prerank,protein localization to phagophore assembly site (GO:0034497),0.49956588645884326,1.0357043491069104,0.4525862068965517,0.8320889094366501,1.0,6/11,33.43%,PACS2;WIPI2;ATG9A;ATG13;STX17;WIPI1
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.4628637509902188,1.0350430255393896,0.44550408719346046,0.833402524260017,1.0,5/16,21.43%,SRSF1;PSIP1;NCBP2;RBM22;SFSWAP
prerank,DNA conformation change (GO:0071103),0.46056140876127977,1.035003001192444,0.4654255319148936,0.8329857064385205,1.0,7/17,24.88%,HMGB1;ABL1;ERCC3;TOP3B;TOP1;TOP1MT;TOP3A
prerank,alanine transport (GO:0032328),0.5126906188738058,1.0348506076124424,0.44192634560906513,0.8329049175436276,1.0,3/10,13.81%,SLC38A3;SLC7A10;SLC1A4
prerank,diterpenoid metabolic process (GO:0016101),0.385832663173503,1.034721314777968,0.42316258351893093,0.8327440098706411,1.0,8/55,13.42%,GPC6;LRP1;GPC3;SDC1;AKR1C1;OPN1MW;ALDH3A2;LRP2
prerank,cell-matrix adhesion (GO:0007160),0.3680989265990266,1.0339863499315705,0.4497907949790795,0.8342073697435877,1.0,12/95,6.85%,PKD1;ITGA11;COL3A1;ADAM9;TIAM1;CTTN;EMILIN1;ACTN3;PPFIA1;THBS3;ILK;BCR
prerank,striated muscle tissue development (GO:0014706),0.4230381048468275,1.0339289990501495,0.45018007202881155,0.8338380373777128,1.0,3/29,4.30%,SIX1;SGCD;SIX4
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),-0.30183568219712253,-1.0334792192875528,0.391304347826087,0.7249927990348947,1.0,11/38,12.38%,INSR;ROCK2;SMAD3;KLF2;ASS1;ZC3H12A;CAV1;EDN1;CX3CR1;DDAH2;CD34
prerank,regulation of keratinocyte migration (GO:0051547),0.4874274802502393,1.0334037638290907,0.42715700141442714,0.8347215037704835,1.0,2/12,11.61%,ADAM9;IQSEC1
prerank,positive regulation of pseudopodium assembly (GO:0031274),-0.410754618516771,-1.0333977482701278,0.3987341772151899,0.7215478774820321,1.0,4/10,8.87%,CDC42EP4;APC;CDC42EP3;CDC42
prerank,regulation of pseudopodium assembly (GO:0031272),-0.410754618516771,-1.0333977482701278,0.3987341772151899,0.7215478774820321,1.0,4/10,8.87%,CDC42EP4;APC;CDC42EP3;CDC42
prerank,negative regulation of programmed cell death (GO:0043069),0.3481695715103729,1.033165564074687,0.398,0.8348199249474312,1.0,83/355,19.74%,THBS1;EGFR;VEGFA;FSTL1;GAS6;GCLC;CARD14;PROK2;NTRK1;SMAD6;COMP;NOL3;SHC1;TOPORS;PKHD1;ANXA4;SIX4;ERC1;BAG3;TAX1BP1;HYPK;FXN;GLO1;PRKDC;ADAM10;ANGPTL4;ARF4;RAF1;SOX9;CBL;PA2G4;ERCC5;SOCS2;AKT2;ANXA1;PAK2;ANGPT4;ITCH;MAPK8;BMP4;VIP;RIPK3;BCL2L2;IRAK1;NAA16;HSPA5;PHIP;CD27;HDAC1;HSPD1;SERPINB9;MIEN1;VTCN1;LRP2;SQSTM1;SUPV3L1;HNRNPK;DAB2;PRDX3;PSEN2;PSMC5;IL6;HGF;CAT;AATF;RPS27A;UBC;HIGD1A;BIRC6;ARAF;PRLR;BNIP1;CLN3;GOLPH3;CITED2;GDNF;BID;AKT1;BIRC5;TAF9B;DNAJA1;NFKBIA;PRDX2
prerank,striated muscle contraction (GO:0006941),-0.2753271296797935,-1.0330890451116082,0.3557692307692308,0.7204868985948616,1.0,4/53,3.27%,ATP1A2;SLC8A1;RYR2;TPM1
prerank,regulation of cellular respiration (GO:0043457),0.45507147300055917,1.033071233052913,0.4426877470355731,0.8345739801765686,1.0,7/17,21.35%,ACTN3;VCP;IFNLR1;NOA1;IDE;SHMT2;IL4
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.37219254675202296,1.0329589271704196,0.4265809217577706,0.8343420789695873,1.0,24/70,24.03%,LDB1;PSMD7;PSMA8;PRKDC;RUNX1;PSMA4;ITCH;ABL1;PSMD12;PSMA6;PSMD11;PSMC5;PSMD1;PSMD14;PSMC4;CBFB;TCF3;SETD1A;PSMA3;PSMD4;PSMB1;KMT2A;PSMA5;PSMA7
prerank,branching involved in blood vessel morphogenesis (GO:0001569),0.4994180250507949,1.0329233657446264,0.45098039215686275,0.8339139138554615,1.0,4/13,11.54%,VEGFA;SEMA3E;TGFBR2;NRP1
prerank,regulation of programmed cell death (GO:0043067),0.3565214078728858,1.0327833102792723,0.44081632653061226,0.8337731347671128,1.0,65/161,27.88%,ACER3;NTRK1;FBXO10;GAS1;CRADD;CD3E;ACTN3;VCP;RAF1;SOX9;IKZF3;NDRG1;SRA1;AKT1S1;RBM25;WRN;ANP32B;ABL1;MADD;RIPK3;LCMT1;ATM;TNFRSF10B;CIDEA;CASP1;USP36;MARK4;PSMC5;CREBBP;TOMM70;PLSCR3;HIP1;MAGED1;PERP;DAPK3;BID;AKT1;BIRC5;STEAP3;IRF3;CDK5;PRDX2;ASAH1;RTKN;CALR;LRRK2;CLU;CTSB;BIRC3;NUP62;HS1BP3;TRIAP1;FBXO11;TP53;PINK1;ANP32E;FANK1;DAXX;RIPK1;RABGGTB;SGK1;BCL6;OSGIN1;KANK2;NOP53
prerank,establishment of spindle localization (GO:0051293),0.4733524846037015,1.0323371383742048,0.4392655367231638,0.834460765686029,1.0,3/14,7.26%,DYNC1H1;TLE6;LLGL1
prerank,positive regulation of protein phosphorylation (GO:0001934),0.35003788441005684,1.0322997772594902,0.417,0.8340520117646549,1.0,77/348,18.60%,RASSF2;PGF;EGFR;GDF10;SLCO3A1;VEGFA;EFNA5;GAS6;DDR2;FGF2;CARD14;NTRK3;GHR;NTRK1;FGF17;INHBC;TGFB3;CAMKK1;DOCK7;CSNK1D;TGFB2;CSPG4;LIMK2;IL5;CALM2;MAVS;ACVR1;TOM1L1;ILK;PFN2;SMAD4;RSPO1;RAF1;RPS6KA4;SOX9;AKT2;DGKQ;TMEM119;PAK2;ANGPT4;BMP4;ABL1;MUSK;NIBAN1;TAB2;BMPR1A;SNX9;AXIN1;NRP1;AKAP9;TGFBR1;TENM1;RAD50;EIF4G1;ERP29;INHBA;CD80;MAPRE3;WDFY2;BMP5;DAB2;ARRB1;IQGAP1;IL6;HGF;HDAC6;CALM3;ERBB2;FGF5;FLCN;ARAF;EFNA1;PRKAG1;TRIM6;CNOT9;RB1CC1;AKT1
prerank,positive regulation of neuron migration (GO:2001224),-0.4131214138227973,-1.0322393884036156,0.410958904109589,0.720868454244691,1.0,3/11,9.41%,SEMA6A;RAPGEF2;ARHGEF2
prerank,regulation of proteolysis (GO:0030162),0.3983114545793702,1.032108688020835,0.4513172966781214,0.8340539450061532,1.0,21/48,29.22%,OGT;CST3;ITCH;SERPINE2;TRAF3;STUB1;TBC1D10A;CAMK2N1;HDAC6;PERP;CLN3;IST1;AKT1;CDK5;CYFIP2;DNAJC1;BAD;HDAC2;PLAUR;BTRC;SPOPL
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.29263391622457907,-1.0317763334664873,0.40764331210191085,0.7202212160703086,1.0,13/37,19.45%,BCL2;BCL2L1;DNM1L;NUPR1;BOK;CAV1;RPS7;BCL2L11;STYXL1;EIF5A;RACK1;RPS3;MSX1
prerank,intermediate filament organization (GO:0045109),-0.35703016696496803,-1.0315949359533305,0.3975409836065574,0.7189010010950355,1.0,6/17,16.59%,DES;VIM;PKP2;KLHL24;GFAP;DSP
prerank,anion transmembrane transport (GO:0098656),0.3796642575592817,1.031574264595847,0.4540540540540541,0.8350169230656652,1.0,6/67,5.65%,SLC23A1;SLC23A2;SLC5A6;ABCC1;SFXN3;LRRC8D
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.37573656171695285,1.031525833088739,0.44337606837606836,0.8346197758344673,1.0,14/76,12.51%,CTTN;NTRK3;PRKCE;SORBS3;DYNC1H1;BCAS3;CDC42EP2;PFN2;ABL1;KATNBL1;SNX9;NRP1;TENM1;CDC42EP5
prerank,recombinational repair (GO:0000725),0.3725534466851544,1.0312167482215655,0.44220572640509015,0.8349531070169836,1.0,40/77,35.91%,REV3L;TONSL;ERCC5;MORF4L1;RBBP8;ERCC4;SFR1;WRN;SWI5;SPIDR;SFPQ;RAD50;PARP1;PSMD14;SMC5;HUS1;RAD51;XRCC3;RNF138;RECQL5;SLX4;FBH1;SMC6;YY1;SWSAP1;NSMCE2;RAD52;RHNO1;AP5Z1;ZFYVE26;XRCC1;BLM;UBE2N;POLQ;RPA3;MMS22L;FAN1;SEM1;MRE11;NSMCE1
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.5221747053373482,1.030962752976253,0.4568081991215227,0.8351450847318532,1.0,6/10,31.88%,NFE2L2;LRRK2;PYCR1;RIPK1;GPR37;GPR37L1
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),0.4902391405903121,1.0307553040150796,0.4527777777777778,0.8352245149844858,1.0,1/12,0.40%,IRS1
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.4066669405609762,1.0305899958134104,0.4423305588585018,0.8351792052315467,1.0,14/32,30.26%,MAPK15;NEK7;ATM;TNKS2;CCT6A;CCT4;CCT8;MAP2K7;HNRNPA1;TCP1;PNKP;ATR;CCT5;CTNNB1
prerank,dendritic cell chemotaxis (GO:0002407),0.47576224928477895,1.0305459814428224,0.4456824512534819,0.8347726539052783,1.0,3/14,15.21%,HMGB1;TRPM4;CXCR4
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.4210674559925574,1.030377730862375,0.43546441495778043,0.8347022876301466,1.0,11/29,24.17%,HELB;TSR1;RRS1;DCAF13;RPP40;TSR2;ABT1;NGDN;WDR46;KRI1;TBL3
prerank,positive regulation of cell projection organization (GO:0031346),0.36327469635293896,1.0303645249339963,0.4537037037037037,0.8342228800669189,1.0,15/115,7.71%,SLIT2;PLXNA4;TIAM1;NTRK3;NTRK1;TIAM2;DPYSL3;ARSB;CUX1;FBXW8;P3H1;KIDINS220;DVL1;ROR1;DLG4
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.3316445598092148,-1.030338242926223,0.40540540540540543,0.720470314849379,1.0,4/23,7.05%,PARP14;STAT1;NR1H3;NLRC5
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.38211616236585916,1.0303295551726182,0.44419391206313413,0.8338114903903683,1.0,32/62,32.89%,ELOF1;CDK12;GTF2F1;CCNT2;ERCC3;ERCC2;POLR2F;AFF4;MLLT3;NCBP1;SSRP1;ELP4;NCBP2;PAF1;POLR2B;SETD2;NELFB;CDK13;EAF1;CTDP1;RTF1;GTF2H4;POLR2H;NELFA;CDK9;POLR2I;MLLT1;POLR2L;ADRM1;POLR2K;ELP2;CCNH
prerank,calcium ion transport into cytosol (GO:0060402),-0.3441319433513554,-1.0303217742166422,0.3799126637554585,0.718732387990274,1.0,10/21,14.50%,SLC8A1;RYR2;ITPR3;CACNA2D1;GRIN2B;GRIN2A;ADRA1A;JPH1;JPH2;GRIN1
prerank,apoptotic mitochondrial changes (GO:0008637),-0.3145631659635612,-1.030240870265925,0.39880952380952384,0.7171646459659856,1.0,12/32,19.26%,BCL2;BCL2L1;DNM1L;ERBB4;HK2;IFIT2;BOK;MFF;CAMK2A;SOD2;NDUFS1;BIK
prerank,cholesterol homeostasis (GO:0042632),0.38352161545603597,1.030043129663206,0.43201754385964913,0.8341059621393471,1.0,11/64,11.15%,EHD1;LRP5;LIMA1;SOAT1;HDAC9;LAMTOR1;RORA;TSKU;AKR1C1;NPC1;ABCA1
prerank,positive regulation of cellular protein catabolic process (GO:1903364),-0.36301721254321007,-1.0298176876151939,0.4016393442622951,0.7164775098654947,1.0,4/18,5.19%,APOE;CTSC;VGLL4;FAF1
prerank,immunoglobulin mediated immune response (GO:0016064),0.5122909750138662,1.0297869061909697,0.45779685264663805,0.8342524141552425,1.0,2/10,12.13%,FCER1G;CD27
prerank,hematopoietic progenitor cell differentiation (GO:0002244),-0.3198933196064394,-1.0296402425788171,0.41916167664670656,0.7151555648316861,1.0,7/30,13.39%,FLT1;KIT;KDR;ACE;FLT4;PLEK;SFRP1
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.36610578566415647,1.029559066895042,0.44766839378238343,0.8343511435207231,1.0,18/112,8.97%,GDF10;LTBP2;COL3A1;COL1A2;ADAM9;SMAD9;SMAD6;ZMIZ1;TGFB3;PDE3A;TGFB2;ACVR1;SMAD4;TGFBR2;SKI;SOX9;CBL;RHOA
prerank,cellular response to acid chemical (GO:0071229),0.4227764190833893,1.0291760579701792,0.47116564417177914,0.8348835316602454,1.0,6/27,16.23%,VEGFA;IPO5;LAMTOR1;CAPN2;SESN2;NSMF
prerank,microtubule anchoring at centrosome (GO:0034454),0.5062807299404655,1.0290755936778686,0.45058139534883723,0.8346401191375249,1.0,3/10,20.59%,NIN;PCM1;DCTN1
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.45165114409858365,1.02894542296732,0.465359477124183,0.8334309589572528,1.0,7/20,21.03%,MAD1L1;ATM;ZW10;KLHL22;IK;CDC20;MAD2L2
prerank,spindle assembly checkpoint signaling (GO:0071173),0.45165114409858365,1.02894542296732,0.465359477124183,0.8334309589572528,1.0,7/20,21.03%,MAD1L1;ATM;ZW10;KLHL22;IK;CDC20;MAD2L2
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.45165114409858365,1.02894542296732,0.465359477124183,0.8334309589572528,1.0,7/20,21.03%,MAD1L1;ATM;ZW10;KLHL22;IK;CDC20;MAD2L2
prerank,regulation of chemokine production (GO:0032642),0.40546574841405136,1.0281176995320176,0.45558086560364464,0.8351507299740815,1.0,2/36,1.27%,FOXP1;IL33
prerank,regulation of cholesterol biosynthetic process (GO:0045540),-0.3531017187580111,-1.0281174580120684,0.3673469387755102,0.7174772725239321,1.0,5/17,11.29%,APOE;FGF1;ABCG1;PRKAA1;KPNB1
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.36535806146368993,-1.0280360082028246,0.43190661478599224,0.7159033618433901,1.0,7/17,20.80%,ITGA1;PDGFRB;CD300A;PPP1R12A;PTPA;PPP1R15B;PPP1R15A
prerank,activation of phospholipase C activity (GO:0007202),0.4211582076329416,1.0277013165854605,0.4517704517704518,0.8357599648743822,1.0,2/29,3.12%,EGFR;EDNRA
prerank,positive regulation of dendrite development (GO:1900006),-0.42385203373636193,-1.0276215931964294,0.40636042402826855,0.715144999028926,1.0,4/10,13.83%,PTN;BMP7;VLDLR;LRP8
prerank,ganglioside biosynthetic process (GO:0001574),0.4709775265775452,1.0272408761911547,0.44429347826086957,0.836492556361494,1.0,4/15,8.47%,ST8SIA2;ST6GALNAC5;B4GALT5;ST3GAL2
prerank,regulation of catecholamine secretion (GO:0050433),0.4191708759288798,1.0269268935665776,0.4421182266009852,0.8367938274958654,1.0,3/29,7.06%,KCNB1;SYT8;CHRNB2
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),0.48211987777559745,1.0268591375382448,0.4645776566757493,0.8364682111312322,1.0,1/13,0.40%,IRS1
prerank,regulation of feeding behavior (GO:0060259),-0.41924793447869024,-1.026828630381382,0.42424242424242425,0.7153333879102128,1.0,2/11,2.43%,LEPR;SGIP1
prerank,positive regulation of protein metabolic process (GO:0051247),0.3622611220135731,1.026638452563617,0.4643605870020964,0.83651585324147,1.0,32/110,23.84%,WWP1;GPC3;NEDD4;LDB1;STX5;CSNK2A1;VCP;RILP;DACT1;HUWE1;WWP2;NSF;ITCH;MAPK8;VIP;AXIN1;EIF4G1;INHBA;CD80;SEC22B;IDE;ASB5;AKT1;NFKBIA;SMURF2;CLU;RAB1A;AREL1;SLC25A37;PRMT1;RAB1B;ABCB10
prerank,cellular amide metabolic process (GO:0043603),0.36180364148166533,1.0264118494496441,0.44824016563146996,0.836632692133043,1.0,25/102,18.96%,SLC5A6;PLPP3;CPZ;ATF4;ACSF2;ACOT11;SLC25A32;PLPP1;DNPEP;MTRR;GPAT4;NNMT;MTHFD2;NLN;CPXM2;GLYAT;ALDH1L2;MTHFD1;PLA2G15;ORMDL3;ACOT13;SHMT2;SHMT1;ACSL6;MTHFR
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.3684520937881951,1.0262474869113232,0.4481283422459893,0.8365441994334244,1.0,30/82,27.22%,CSNK1D;DYNC1H1;SFI1;ODF2;ALMS1;DCTN2;CKAP5;AKAP9;SDCCAG8;CEP164;CSNK1E;YWHAE;CEP41;PCM1;CEP63;HAUS5;CDK2;DYNC1I2;DCTN1;PRKACA;ACTR1A;CDK5RAP2;NEDD1;CNTRL;PLK4;CCP110;TP53;TUBB4B;ATF5;PPP2R1A
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.3705701051374296,1.0260562155598005,0.4418356456776948,0.8365617131751608,1.0,17/74,18.68%,THBS1;TCF7L2;EYA2;NOL3;ACVR1;ITGAV;BMP4;TERT;PHIP;TNFRSF10B;TGFBR1;BMP5;BIRC6;HMOX1;GDNF;AKT1;ZMYND11
prerank,regulation of translational initiation (GO:0006446),0.38047591022668314,1.0259501914219207,0.45334796926454446,0.8363302222862486,1.0,24/63,28.88%,EIF4A2;ATF4;EIF4G2;EIF4G3;IMPACT;CDC123;KHDRBS1;AGO2;EIF4G1;UHMK1;ALKBH1;RBM4;NCBP1;NCBP2;GLE1;EIF2AK4;EIF2AK3;EIF4B;RPS6KB1;NCK1;TPR;YTHDF1;EIF4H;LARP1
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.37121289916980177,1.0255578961879726,0.45098039215686275,0.8368259430603457,1.0,24/70,24.03%,PSMD7;PSMA8;FCER1G;PDIA3;PSMA4;ITGAV;CHUK;PSMD12;PSMA6;SEC22B;LNPEP;SNAP23;PSMD11;PSMC5;PSMD1;PSMD14;PSMC4;CALR;PSMA3;PSMD4;PSMB1;ITGB5;PSMA5;PSMA7
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.3837221598371613,1.0248129792812184,0.4666666666666667,0.8382839996990896,1.0,28/58,33.29%,PRKDC;ERCC8;HMGB1;ERCC4;KDM2A;ATM;RAD50;LIG4;PIAS4;DCLRE1B;PSMD14;UBE2V2;SMC5;SUMO1;POLB;XRCC6;BRCC3;UVRAG;IFFO1;NSMCE2;ATP23;SMARCAL1;ZBTB7A;HERC2;UBE2N;ERCC1;ERCC6;POLQ
prerank,DNA dealkylation (GO:0035510),0.5185726866616661,1.0245226324780574,0.4785714285714286,0.8380244812697775,1.0,3/10,13.10%,MPG;FTO;ALKBH1
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.5185726866616661,1.0245226324780574,0.4785714285714286,0.8380244812697775,1.0,3/10,13.10%,MPG;FTO;ALKBH1
prerank,regulation of cell migration (GO:0030334),0.3442362572303514,1.0245058154973365,0.442,0.837556778525971,1.0,50/382,9.20%,THBS1;MYOC;SLIT2;EGFR;PLXNA4;IGFBP5;VEGFA;F3;FGF2;COL1A1;SRGAP2;SRGAP3;ADAM9;TWIST2;SRCIN1;TIAM1;NTRK3;FGF17;DRD1;TMEFF2;LDB2;LDB1;DPYSL3;RDX;CYP1B1;EPHB2;MAPK15;LDLRAD4;SLURP1;ARSB;LMNA;CLIC4;STAT3;PTPRU;SEMA3E;PRKCA;MEAK7;ACVR1;SULF1;MMP14;JAG1;ADAM10;SEMA4B;CXCL16;ELP5;BEX4;NOG;AKT2;RHOA;ANXA1
prerank,positive regulation of cardiocyte differentiation (GO:1905209),-0.40674632388036247,-1.0243933637893015,0.4036363636363636,0.7196821862668973,1.0,4/11,19.34%,EFNB2;MYOCD;GPER1;TGFB1
prerank,signal release from synapse (GO:0099643),-0.29444960625065514,-1.0238590244401922,0.40476190476190477,0.7191809963744982,1.0,16/43,22.17%,NRXN1;LIN7A;RIMS1;PIP5K1C;SYN2;SYN1;STXBP3;SYT10;SNCA;GAD1;SNAP25;SLC32A1;PTPRN2;GRM4;CPLX2;PDZD11
prerank,cellular response to lectin (GO:1990858),0.35881507436751325,1.0237119779213584,0.44813278008298757,0.838627158527306,1.0,29/104,24.33%,PRKCD;MUC1;PSMD7;PSMA8;RAF1;MUC13;FCER1G;PSMA4;PAK2;CHUK;TAB2;PDPK1;PSMD12;CUL1;PSMA6;PSMD11;PSMC5;PSMD1;CREBBP;PSMD14;PSMC4;PSMA3;PSMD4;PRKACA;PSMB1;PSMA5;PSMA7;NRAS;KRAS
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.35881507436751325,1.0237119779213584,0.44813278008298757,0.838627158527306,1.0,29/104,24.33%,PRKCD;MUC1;PSMD7;PSMA8;RAF1;MUC13;FCER1G;PSMA4;PAK2;CHUK;TAB2;PDPK1;PSMD12;CUL1;PSMA6;PSMD11;PSMC5;PSMD1;CREBBP;PSMD14;PSMC4;PSMA3;PSMD4;PRKACA;PSMB1;PSMA5;PSMA7;NRAS;KRAS
prerank,carbohydrate homeostasis (GO:0033500),0.3749559426113421,1.023675521640992,0.45723684210526316,0.8382196030086653,1.0,9/67,8.87%,IRS1;KCNB1;TCF7L2;STAT3;ADCY8;TENT4B;MCU;BACE2;ADIPOR2
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.5000132638306597,1.0235448139804306,0.44298245614035087,0.8380552951840093,1.0,3/11,15.99%,MAVS;STX4;CAMK4
prerank,regulation of protein neddylation (GO:2000434),0.4986195357438432,1.0233205139077726,0.4519940915805022,0.8381556799409682,1.0,2/10,12.75%,DCUN1D5;DCUN1D2
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.3524710864565672,1.0231910083203315,0.4448979591836735,0.8379995104545248,1.0,59/148,28.28%,CSNK2A1;CSNK2A2;KMT5A;RRS1;CHD3;USP2;RMI2;EHMT1;MDM4;CDK5RAP3;RBBP8;RAD1;PIP4K2B;ING5;WRN;ATM;CHEK2;PDPK1;TAF15;TAF6;HDAC1;RAD50;TAF13;RBBP7;USP7;HEXIM1;ATRIP;PPP2R5C;TP53RK;TTC5;HUS1;SSRP1;BOP1;PRKAG1;AKT1;NOC2L;HIPK2;CDK2;TAF9B;PRKAB1;MAPKAP1;CDK5;PAK1IP1;TBP;TOPBP1;MEAF6;TAF1;SMYD2;CHD4;TP53;TOP3A;HDAC2;DAXX;EHMT2;SGK1;TAF10;NOP53;ATR;TAF3
prerank,regulation of immune response (GO:0050776),0.35427490025440034,1.0231146455996223,0.4463917525773196,0.8376825990808272,1.0,25/135,21.60%,FOXP1;COL3A1;COL1A2;COL1A1;SPN;TGFB2;CD3E;KLRK1;NPDC1;RAET1E;CRTAM;RIPK3;TRAF3;LAG3;COLEC12;N4BP1;ADCY7;DENND1B;CLEC2D;APPL2;APPL1;LAIR1;BIRC3;IL4;CD300LB
prerank,phospholipid biosynthetic process (GO:0008654),0.40688562594839195,1.0229508704180876,0.46261682242990654,0.83761430334509,1.0,16/36,31.18%,DHDDS;LPCAT1;DOLPP1;FADS1;FAR1;PIP5K1A;HDHD5;AGPAT5;CLN3;MBOAT1;FITM2;PCYT2;SPHK2;AGPAT3;SRD5A3;SGMS2
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.42709450897202755,1.0228300766150298,0.4493116395494368,0.8374375176977982,1.0,14/23,33.80%,MTMR11;SYNJ1;INPP5B;MTMR10;PIP4P2;OCRL;SYNJ2;MTMR1;MTM1;SACM1L;MTMR2;MTMR9;MTMR12;MTMR4
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.4731439435455445,1.0227328851064261,0.46122448979591835,0.837194872523466,1.0,4/14,12.19%,ATP1B1;KCNIP2;ANK2;AKAP9
prerank,metal ion transport (GO:0030001),-0.2533479292051716,-1.0226295932897154,0.49019607843137253,0.7205546377630742,1.0,22/86,14.50%,ITPR1;SLC8A1;CALCRL;CACNA1D;RYR2;TRPC3;CACNA1E;CACNA2D1;CACNG7;SLC39A8;TUSC3;SLC41A1;CACNG8;SLC8A3;ATP2A3;CAV1;CACNG3;NDFIP2;SLC30A1;TRPC4;TPT1;NIPAL4
prerank,positive regulation of lamellipodium organization (GO:1902745),-0.3076166961428165,-1.0224876183155458,0.4057971014492754,0.719168337361713,1.0,7/32,11.17%,AUTS2;OCLN;PIK3R1;ENPP2;CORO1C;CDC42;WASF2
prerank,mitotic cytokinetic process (GO:1902410),0.44368721415683765,1.0221706121502765,0.44357976653696496,0.8381217475773077,1.0,7/20,24.90%,RHOA;CHMP3;MITD1;CHMP4B;CHMP4A;PDCD6IP;CHMP2A
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.4858924540720258,1.0221139857834356,0.4495798319327731,0.8377475993170603,1.0,4/12,18.54%,ADCY8;TRPM4;STX4;C2CD2L
prerank,negative regulation of inclusion body assembly (GO:0090084),0.5020151688261616,1.022096502380092,0.4520743919885551,0.8372922181349808,1.0,1/10,3.41%,HSPA2
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),-0.3749879970796252,-1.0220025349770578,0.38095238095238093,0.7187591278107995,1.0,6/14,11.79%,NOS3;ENPEP;ACE;AGTR1;EDN1;ACE2
prerank,positive regulation of epidermal cell differentiation (GO:0045606),0.4695061794245795,1.021803940600488,0.4684065934065934,0.8375158800572915,1.0,4/15,15.00%,SFRP4;BMP4;VDR;CYP27B1
prerank,lymphocyte differentiation (GO:0030098),-0.2563746788051971,-1.0217785660521275,0.42105263157894735,0.7176252241976723,1.0,20/68,20.05%,LEPR;CHD7;KIT;VCAM1;KLF6;JAG2;RHOH;IKZF1;HHEX;PIK3CD;ITGA4;LFNG;AXL;CR2;PTPN22;DLL4;TOX;ADGRG3;SOX4;NHEJ1
prerank,regulation of macromolecule metabolic process (GO:0060255),0.353014125464143,1.0217689209283742,0.4571140262361251,0.8370992641173018,1.0,37/170,19.33%,FOXP1;C1D;ATP1B1;AFF3;YBX3;COQ7;PRDM5;PRDM11;PRDM10;PRDM6;LAMTOR1;ANKRA2;HNRNPDL;EDN3;RSPO1;TRIM27;TSKU;PCBP4;PRDM4;FUBP1;ARF1;NELL1;MARF1;PCBP2;TRIM26;HNRNPK;AFF4;UBAP2;PRDM2;ZNF462;KDM6B;HMG20A;RFXANK;TRIM6;GDNF;CDK2;AFF2
prerank,pyruvate metabolic process (GO:0006090),0.38534717041716615,1.021190575413655,0.4497175141242938,0.8380982892178594,1.0,4/52,6.06%,ME1;SLC16A1;LDHC;GLO1
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.35763123308690875,1.0211739210506812,0.4538860103626943,0.837636553314939,1.0,29/105,24.33%,PRKCD;MUC1;PSMD7;PSMA8;RAF1;MUC13;FCER1G;PSMA4;PAK2;CHUK;TAB2;PDPK1;PSMD12;CUL1;PSMA6;PSMD11;PSMC5;PSMD1;CREBBP;PSMD14;PSMC4;PSMA3;PSMD4;PRKACA;PSMB1;PSMA5;PSMA7;NRAS;KRAS
prerank,regulation of leukocyte chemotaxis (GO:0002688),0.4539840450509733,1.0208672390978737,0.4536082474226804,0.8379354772808681,1.0,3/18,10.73%,SLIT2;EDN3;MTUS1
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.5095808927518624,1.0208308078683137,0.4664764621968616,0.8375153935835712,1.0,2/11,13.49%,P4HB;UBQLN1
prerank,regulation of actin filament-based movement (GO:1903115),-0.40910085440501137,-1.0205283159260612,0.3929712460063898,0.7191146551839959,1.0,5/10,22.74%,PDE4D;PDE4B;SCN5A;STC1;SRI
prerank,protein K48-linked deubiquitination (GO:0071108),0.43430091763374007,1.0204817247511448,0.46335078534031415,0.8379206775040428,1.0,8/23,21.50%,USP50;OTUB1;USP34;OTUB2;USP33;OTUD5;YOD1;USP5
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.5072206701296467,1.0204018416091398,0.46742209631728043,0.8376365962487471,1.0,4/10,16.92%,DIS3L2;TUT7;RPS27A;UBC
prerank,regulation of Rac protein signal transduction (GO:0035020),-0.3541732322663083,-1.02036305553416,0.4180327868852459,0.7178099361260202,1.0,2/16,0.80%,AUTS2;ARHGAP24
prerank,protein insertion into ER membrane (GO:0045048),0.39791865951264566,1.020194541058389,0.4448315911730546,0.8376573691222972,1.0,17/37,27.95%,STX5;TRAM2;EMC2;ALDH3A2;EMC1;STX1A;EMC9;HMOX1;EMC8;CAMLG;MMGT1;VAMP2;EMC4;GET4;GET3;SEC61B;CCDC47
prerank,negative regulation of apoptotic process (GO:0043066),0.3426220069611919,1.020175660768935,0.443,0.8372005737930899,1.0,101/444,19.95%,THBS1;EGFR;SIX1;PRKCD;VEGFA;FSTL1;GAS6;GCLC;CARD14;PROK2;NTRK1;SMAD6;COMP;TGFB3;NOL3;SHC1;TOPORS;PKHD1;CSNK2A1;CSNK2A2;CARD16;ANXA4;SIX4;ERC1;BAG3;PRKCA;TAX1BP1;HYPK;FXN;NRBP2;GLO1;PRKDC;ADAM10;ANGPTL4;ARF4;RAF1;TRIM27;SOX9;CBL;PA2G4;ERCC5;SOCS2;AKT2;ANXA1;PAK2;ANGPT4;ITCH;MAPK8;BMP4;VIP;BCL2L2;IRAK1;MAZ;NAA16;HSPA5;PHIP;SOD1;CD27;SFPQ;HDAC1;CIDEA;HSPD1;PTRH2;SERPINB9;MIEN1;VTCN1;LIG4;F2R;YWHAE;LRP2;SQSTM1;SUPV3L1;HNRNPK;NDNF;DAB2;PRDX3;CLCF1;PSEN2;IL6;HGF;CAT;AATF;RPS27A;UBC;HIGD1A;BIRC6;ARAF;PRLR;BNIP1;CLN3;GOLPH3;CITED2;GDNF;BID;AKT1;BIRC5;TAF9B;DNAJA1;NFKBIA;PRDX2;NFATC4
prerank,nuclear pore complex assembly (GO:0051292),0.49723731364323837,1.0201060121671253,0.447178002894356,0.8368765652974223,1.0,5/10,27.61%,NUP93;TMEM170A;NDC1;TPR;AHCTF1
prerank,cellular protein catabolic process (GO:0044257),0.3735120532111979,1.0200609437326618,0.44269662921348313,0.8364934755389666,1.0,21/59,27.14%,FAP;TCIRG1;AP2A1;CLPP;CAPN2;MYLIP;CHEK2;PSMA6;LONP1;AP2A2;CLTC;IDE;CTSZ;UBE2G2;CTSB;CLTA;CTSK;CTSO;RIPK1;HTRA2;AFG1L
prerank,positive regulation of insulin secretion (GO:0032024),0.40833681731305665,1.0199719172165236,0.4681107099879663,0.8362051020321036,1.0,6/36,8.80%,TCF7L2;ADCY8;MCU;AACS;CAPN10;TRPM4
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.3138648218233232,-1.0198493941235167,0.4540229885057471,0.7173143970947026,1.0,8/29,13.52%,IFNAR2;WNT5A;SAMHD1;USP18;NLRC5;RNASEL;CACTIN;PTPN1
prerank,lipoprotein localization (GO:0044872),0.5015106904184425,1.0192181324281138,0.46875,0.837739259388147,1.0,1/11,1.00%,LRP1
prerank,positive regulation of cell cycle process (GO:0090068),0.3654659442956371,1.0191978674523532,0.45811240721102864,0.837289182552184,1.0,24/91,21.82%,CIT;PRKCE;LRP5;DYNC1H1;CDC14A;EDN3;GIPC1;CDC6;RHOA;PKN2;SPAST;CDC25B;PHIP;RCC2;OPN1MW;CSPP1;SIRT2;USP19;DBF4;KIF20B;XRCC3;NUP62;SVIL;DRD2
prerank,positive regulation of binding (GO:0051099),0.36636604494828795,1.0184442831137746,0.4568421052631579,0.8386698316602167,1.0,19/84,18.03%,PKD1;LRP1;TCF7L2;TIAM1;DACT1;HMGB1;SKI;RARA;BMP4;TERT;NVL;MED25;USP33;ADD1;SIRT2;IDE;NCBP1;MEN1;CDT1
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.45160454469079087,1.0178921690707456,0.47247119078104993,0.8395936493373373,1.0,5/18,18.14%,DDR2;EMILIN1;RUNX1;IL6;IER3IP1
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),-0.4073680926695163,-1.0178359091587088,0.422360248447205,0.7207833790913957,1.0,3/10,9.74%,CACNB2;CACNA2D1;PDE4B
prerank,glycoprotein metabolic process (GO:0009100),0.38564015210844704,1.0177920159735672,0.4590909090909091,0.8393545610182934,1.0,13/53,19.47%,ST3GAL4;ST8SIA2;PRKCSH;B4GALT5;ST3GAL2;MGAT4B;FUT8;GAL3ST4;NGLY1;FBXO17;B3GNT6;GOLPH3;GANAB
prerank,reticulophagy (GO:0061709),0.48964631279406484,1.0177884348397703,0.4410112359550562,0.8388591318786532,1.0,8/12,28.42%,ULK2;UBA5;UFL1;RB1CC1;TEX264;ATG2B;UFC1;ULK1
prerank,positive regulation of bone resorption (GO:0045780),0.4891583611226543,1.0176738018386258,0.46518105849582175,0.8386757706156894,1.0,3/11,14.82%,PRKCA;MC4R;PLEKHM1
prerank,ceramide biosynthetic process (GO:0046513),-0.287363655501631,-1.0176651549434097,0.42857142857142855,0.7194863790899474,1.0,6/40,5.34%,ST6GALNAC3;CERS4;SGMS1;ST8SIA4;DEGS2;ST8SIA6
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.4569034649832578,1.0176012778259558,0.4697173620457604,0.8383785094417838,1.0,5/16,7.17%,CACNA1C;CAMK2D;CALM2;DMD;ANK2
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.41120082870220137,1.0174727095094924,0.43911439114391143,0.8382338707131886,1.0,13/31,22.95%,DLG2;CRB1;DLG1;RHOA;SYNE4;MYO9A;EZR;CRB2;WDR1;ERBIN;PDCD6IP;PRKCI;CAMSAP3
prerank,mammary gland epithelium development (GO:0061180),0.4729972354626498,1.01707173664028,0.4626865671641791,0.8387619635741812,1.0,2/14,8.69%,ID2;AKT2
prerank,negative regulation of neurogenesis (GO:0050768),-0.2961197842017027,-1.0169769101583555,0.3836477987421384,0.7194568375048496,1.0,5/34,6.86%,PTN;B2M;RAPGEF2;NOTCH1;ARHGDIA
prerank,regulation of transcription by RNA polymerase I (GO:0006356),0.44318466229688597,1.0168138294127333,0.4585561497326203,0.8389142822084628,1.0,11/18,36.10%,ATF4;PHF8;ERBB2;EIF2AK3;WDR75;UBTF;POLR2L;POLR2K;SIRT7;LYAR;UTP15
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.34429719690410854,1.016586902408225,0.4542713567839196,0.8389817789882525,1.0,58/248,16.70%,EGFR;LRP6;CTNND2;COL1A1;TCF7L2;SFRP4;GPC3;PLEKHA4;PRICKLE1;DKK3;PSMD7;CSNK1D;TLE2;WWTR1;PTPRU;UBE2B;VCP;PSMA8;TLE6;DACT1;DVL1;CCAR2;ILK;FZD7;JUP;RSPO1;SOX9;DACT3;NOG;TRPM4;TLE3;PSMA4;FGFR2;UBR5;CSNK1G1;TPBG;AXIN1;PSMD12;HDAC1;INVS;USP34;PSMA6;CSNK1E;WNK1;TNKS2;LIMD1;DAB2;FUZ;GSKIP;PSMD11;LATS2;PSMC5;PSMD1;NPHP3;PSMD14;OTULIN;MLLT3;PSMC4
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.4144507218308832,-1.016480466697002,0.42295081967213116,0.7190404398666432,1.0,3/11,12.53%,NOS3;GCH1;SPR
prerank,glutathione metabolic process (GO:0006749),0.39881761917675895,1.0163842312753908,0.4671280276816609,0.8389884337137653,1.0,10/38,23.78%,GCLC;GSTT1;GSTM5;SOD1;GSR;GSTZ1;GCLM;CHAC2;DPEP1;HAGH
prerank,response to leucine (GO:0043201),0.5049038577785265,1.0162536439079843,0.47520661157024796,0.8383127187050537,1.0,5/10,22.41%,SESN3;SESN2;KLHL22;UBR2;RPTOR
prerank,cellular response to leucine (GO:0071233),0.5049038577785265,1.0162536439079843,0.47520661157024796,0.8383127187050537,1.0,5/10,22.41%,SESN3;SESN2;KLHL22;UBR2;RPTOR
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.3815628682558208,1.016133479150889,0.4624145785876993,0.8381074741067496,1.0,14/53,23.56%,PKD1;XPO1;GLMN;OSBPL7;DNAAF4;PSMC5;USP19;PSMD14;ARAF;UFL1;UCHL5;PRKACA;DESI1;USP14
prerank,nitric oxide metabolic process (GO:0046209),-0.38141030650270713,-1.01585795864714,0.43018867924528303,0.7189315567209851,1.0,6/14,12.53%,NOS3;CYB5B;GCH1;NOS1;DDAH2;SPR
prerank,ameboidal-type cell migration (GO:0001667),0.37998265500056044,1.0158058103776915,0.47098214285714285,0.8383963237459063,1.0,8/51,9.58%,SRGAP2;GPC3;CCN3;PDXDC1;SEMA3E;FAT2;SEMA4B;PKN2
prerank,negative regulation of small molecule metabolic process (GO:0062014),-0.3515166333689252,-1.0154970737655111,0.4149377593360996,0.7181473581877532,1.0,2/20,6.11%,WNT4;C1QTNF3
prerank,ncRNA transcription (GO:0098781),0.4767110853927674,1.015151962561914,0.4643835616438356,0.8395662231260583,1.0,10/13,35.50%,USPL1;POLR1G;CAVIN1;GTF3C1;GTF3A;NIFK;RPAP2;SIRT7;SNAPC3;BRF1
prerank,cGMP metabolic process (GO:0046068),-0.3860604471899833,-1.0150037791466755,0.40069686411149824,0.7176332373872125,1.0,5/12,20.76%,GUCY1B1;PDE2A;NPR1;PDE9A;NPPC
prerank,regulation of microtubule-based movement (GO:0060632),0.4959074769046518,1.014985849032268,0.47198879551820727,0.8394810958782083,1.0,2/11,4.95%,CFAP298;DYNLT2B
prerank,regulation of neuron apoptotic process (GO:0043523),0.3606665014835489,1.0147840231539729,0.46764091858037576,0.8394903925618307,1.0,22/96,19.95%,SIX1;KCNB1;NTRK1;TGFB3;TGFB2;SIX4;ATF4;NRBP2;AKT1S1;BACE1;SOD1;LIG4;F2R;NDNF;CLCF1;FOXO3;NSMF;NF1;CLN3;GDNF;CDK5;NFATC4
prerank,regulation of centrosome cycle (GO:0046605),0.4397094935053934,1.0144889680223286,0.4721141374837873,0.8397350489048885,1.0,8/21,26.77%,PKHD1;CHMP3;MARK4;XRCC3;CHMP4B;PDCD6IP;CHMP2A;ATF5
prerank,copper ion transport (GO:0006825),0.4865180534721864,1.014416689719376,0.4731638418079096,0.8394402203345593,1.0,4/11,31.36%,STEAP2;STEAP3;SLC31A2;ATP7A
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.3669385025921324,1.0142971853599498,0.48893572181243417,0.8392547006500438,1.0,19/80,14.82%,PLCE1;ARAP1;RHOQ;DPYSL3;TGFB3;BCAS3;EPS8L1;CDC42EP2;FAM98A;CYFIP1;NRP1;TENM1;CDC42EP5;MIEN1;NLGN1;NDEL1;MARK4;FUZ;PLEKHM1
prerank,positive regulation of protein localization to Cajal body (GO:1904871),0.49343606119362937,1.0138682099745457,0.47863247863247865,0.839387660613032,1.0,8/11,29.80%,CCT6A;CCT4;LARP7;CCT8;TCP1;DKC1;CCT5;MEPCE
prerank,regulation of protein localization to Cajal body (GO:1904869),0.49343606119362937,1.0138682099745457,0.47863247863247865,0.839387660613032,1.0,8/11,29.80%,CCT6A;CCT4;LARP7;CCT8;TCP1;DKC1;CCT5;MEPCE
prerank,regulation of endocytic recycling (GO:2001135),0.49814323711156394,1.0137951416286273,0.4730878186968839,0.8390635883366923,1.0,4/11,13.72%,EHD1;EHD2;ATP9A;RAB11B
prerank,protein localization to kinetochore (GO:0034501),0.4695320037082442,1.01375765219779,0.4638472032742155,0.8386695977622132,1.0,5/14,16.87%,CENPT;MIS12;RCC2;ZW10;IK
prerank,snRNA processing (GO:0016180),0.4645104230884929,1.0131464602963098,0.46831955922865015,0.8397828260120155,1.0,7/16,30.32%,INTS14;INTS3;INTS4;TOE1;INTS9;INTS7;INTS6
prerank,cellular response to oxidative stress (GO:0034599),0.35517127755800204,1.0128253304233257,0.4765380604796663,0.8400857507873137,1.0,39/118,25.17%,EGFR;PRKCD;VKORC1L1;ATF4;SLC4A11;NOX4;NFE2L2;MAPK8;STX2;CHUK;ABL1;SOD1;LONP1;SESN2;SRXN1;PRDX3;SIRT2;STX4;FOXO3;TXNRD2;CAT;GSR;PARP1;HMOX1;VRK2;AKT1;PRDX2;MAPK9;LRRK2;EIF2S1;PYCR1;PRDX1;GPX7;FOS;PYROXD1;SELENOS;PXN;TP53;PINK1
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.3588642097878743,1.0127473357731105,0.4740740740740741,0.8397926972572239,1.0,34/88,30.18%,FBXL7;PSMD7;PSMA8;PSMA4;CUL4A;FBXL4;FBXL12;PSMD12;CUL1;PSMA6;FBXL14;PSMD11;FBXL20;PSMC5;PSMD1;FBXO17;PSMD14;PSMC4;FBXL18;FBXW4;PSMA3;PSMD4;PSMB1;PSMA5;PSMA7;FBXO9;FBXO38;PSMC1;PSMA1;DMAC2;FBXL8;BTRC;RBX1;PSMD2
prerank,proton transmembrane transport (GO:1902600),-0.29307270569143257,-1.012738799165092,0.4528301886792453,0.7217501939627856,1.0,1/36,0.01%,ATP1A2
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.48294850259985667,1.0125936632530685,0.46296296296296297,0.8397227734547817,1.0,3/12,20.59%,NIN;PCM1;DCTN1
prerank,cellular transition metal ion homeostasis (GO:0046916),0.3621454447726486,1.0125337787342652,0.45549738219895286,0.8393778560344997,1.0,18/91,15.18%,SCARA5;SLC39A14;FLVCR1;HMOX2;FXN;SLC39A7;SMAD4;ACO1;SLC30A5;SLC39A13;ARF1;ATP6V0D1;SOD1;CUL1;CYBRD1;FRRS1;ABCB6;IREB2
prerank,regulation of secretion by cell (GO:1903530),0.3814481852746088,1.0125120929069364,0.46945701357466063,0.8389373901303034,1.0,13/54,15.43%,SNCAIP;P3H1;RAB21;RIC1;RAB8A;DISP1;LLGL1;ANXA1;NSF;RAB3D;STXBP5;STX4;RAB3B
prerank,L-amino acid transport (GO:0015807),0.41987577758732625,1.0124739561107976,0.466030989272944,0.8385421564314445,1.0,2/28,5.06%,SLC38A2;SLC38A3
prerank,negative regulation of lyase activity (GO:0051350),-0.3605758319800893,-1.0124232174090204,0.4625,0.7208569688872845,1.0,2/16,1.95%,GRM3;ADGRV1
prerank,mononuclear cell differentiation (GO:1903131),0.4202556148422893,1.0117096662482479,0.46886446886446886,0.8400342412390778,1.0,2/24,1.02%,VEGFA;GAS6
prerank,regulation of synapse organization (GO:0050807),-0.31274544413155353,-1.0115631854161786,0.3902439024390244,0.721388895783284,1.0,8/26,10.83%,IL1RAPL1;EPHA4;WNT5A;ARHGAP22;CTNNA2;ABHD17C;PDLIM5;YWHAZ
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.44212776879247195,1.0115619931442035,0.46511627906976744,0.839907379731337,1.0,9/20,25.24%,SCD5;CBR4;FAR1;PPT2;ACACA;ACSL3;HSD17B8;GCDH;FITM2
prerank,long-term memory (GO:0007616),0.44481669893326153,1.0114600143782762,0.4762532981530343,0.8396696683308063,1.0,11/19,31.83%,ARC;SHANK1;KAT2A;CAMK4;NFATC4;EIF2AK4;RASGRF1;LDLR;SGK1;PJA2;PRNP
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",-0.4024611196729673,-1.0110426463496132,0.4370860927152318,0.7209327435255939,1.0,5/10,27.37%,ANO6;CD300A;C3;TREM2;NCKAP1L
prerank,negative regulation of viral entry into host cell (GO:0046597),0.4805599304572816,1.0107758493644032,0.48299319727891155,0.8409360060531812,1.0,3/12,13.81%,GSN;MID2;TRIM26
prerank,negative regulation of intracellular protein transport (GO:0090317),0.432205161498313,1.010720795650227,0.4532828282828283,0.8405876877221236,1.0,7/22,21.36%,MDFIC;GDI1;CHP1;RAB23;SUFU;LRRK2;LMAN1
prerank,receptor catabolic process (GO:0032801),0.4235620183010138,1.0106290490812224,0.4711168164313222,0.8403417879092817,1.0,9/24,23.01%,NEDD4;AP2A1;MYLIP;AP2A2;CLTC;GPRASP1;CLTA;MVB12A;UVRAG
prerank,regulation of establishment of cell polarity (GO:2000114),-0.35773212720507147,-1.0105954162575759,0.43243243243243246,0.7204623970168477,1.0,3/16,1.91%,ROCK2;CDH5;RIPOR2
prerank,histone exchange (GO:0043486),0.3971625548499129,1.0105410635871115,0.4524940617577197,0.8400721538728289,1.0,8/37,16.59%,HJURP;CENPC;CENPT;SPTY2D1;ACTR6;ZNHIT1;RBBP7;VPS72
prerank,negative regulation of protein ubiquitination (GO:0031397),0.37965553628729987,1.010380221246503,0.4644870349492672,0.8400060305710437,1.0,22/50,29.59%,PRR7;NXN;OGT;ABL1;SMAD7;CHP1;SQSTM1;U2AF2;ARRB1;N4BP1;MINAR1;UFL1;AKT1;DNAJA1;USP4;TAF1;GTPBP4;CAMLG;SVBP;PER2;SPOPL;PRMT3
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.49698167324463216,1.010006032956242,0.4893917963224894,0.8404415287977803,1.0,1/11,1.02%,GAS6
prerank,hyaluronan catabolic process (GO:0030214),0.44070807414166785,1.0097626454419406,0.470976253298153,0.8405442997646265,1.0,4/18,13.46%,FGF2;SLC9A1;CHP1;HEXA
prerank,mitotic recombination (GO:0006312),0.4609774215436112,1.0097480464697528,0.4701086956521739,0.8400963068223241,1.0,8/15,28.35%,RAD50;TPRKB;SMC5;RAD51;XRCC3;SMC6;NSMCE2;RAD52
prerank,macrophage differentiation (GO:0030225),0.47285161795973407,1.0097460803218763,0.4930167597765363,0.8396126171044771,1.0,3/13,15.94%,VEGFA;BMP4;PARP1
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.4153739668355515,1.0095784845176634,0.4777777777777778,0.8395422846977229,1.0,8/31,22.75%,CYP19A1;LIAS;NFS1;FDXR;LSS;PRLR;NOXRED1;PYCR1
prerank,sterol homeostasis (GO:0055092),0.3761039791671474,1.0093078380087002,0.46871569703622395,0.839737537448945,1.0,11/65,11.15%,EHD1;LRP5;LIMA1;SOAT1;HDAC9;LAMTOR1;RORA;TSKU;AKR1C1;NPC1;ABCA1
prerank,cellular response to interleukin-4 (GO:0071353),-0.423682528159152,-1.0092957412398629,0.43729903536977494,0.7220539514755316,1.0,2/10,3.79%,LEF1;TCF7
prerank,regulation of sister chromatid cohesion (GO:0007063),-0.39575229354580155,-1.0092678736559604,0.45751633986928103,0.7204466941460711,1.0,2/12,4.70%,RB1;AXIN2
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.3827636420994616,1.0092193728797336,0.47219069239500566,0.8394613508392074,1.0,9/48,13.33%,UBASH3B;DRD1;CAMK2D;CALM2;DMD;ANK2;SELENON;PDPK1;F2R
prerank,keratan sulfate catabolic process (GO:0042340),-0.3942294243594717,-1.0089503169142269,0.4290657439446367,0.719582705447203,1.0,3/11,8.86%,FMOD;LUM;OGN
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.4926150588076773,1.0087438372400501,0.469187675070028,0.8402031289353642,1.0,3/10,10.64%,ETFDH;ETFB;ETFA
prerank,regulation of ATP biosynthetic process (GO:2001169),0.4545748623935489,1.0087291872187907,0.4521276595744681,0.8397528247324719,1.0,8/16,27.90%,PID1;VCP;PARP1;FLCN;IL4;PINK1;DNAJC30;SPHK2
prerank,pseudouridine synthesis (GO:0001522),0.47482245474886114,1.0087042915415707,0.4728789986091794,0.839318181594273,1.0,8/13,33.67%,PUS3;TRUB1;PUS1;PUS10;DKC1;NOP10;PUS7L;PUS7
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.3640773355366838,1.0085748640784116,0.48996832101372756,0.839155756458251,1.0,24/83,20.94%,ACVR1B;ACVR1;BRD4;E2F3;GSPT1;CDC6;CUL4A;RCC1;PHF8;KHDRBS1;CUL1;CCNE2;INHBA;CDC45;TFDP1;LATS2;CDC25A;E2F1;CDT1;DBF4;CDK2;CDK5;MAX;BCAT1
prerank,regulation of calcium ion transmembrane transport (GO:1903169),-0.3261434084483147,-1.008537739123957,0.4896907216494845,0.7189974257866032,1.0,2/23,3.61%,ATP1A2;CACNA2D1
prerank,regulation of establishment of protein localization (GO:0070201),0.47501496118874065,1.0085142277834587,0.47050938337801607,0.8388277971412438,1.0,5/13,24.58%,SCFD1;SPIDR;GAPVD1;DNAJA1;PTP4A3
prerank,inner ear receptor cell stereocilium organization (GO:0060122),0.5012983705855891,1.0084948476732343,0.48759124087591244,0.8383909637808787,1.0,4/10,15.49%,PLS1;TSKU;SOD1;IFT88
prerank,detection of calcium ion (GO:0005513),0.47761862268617566,1.0077743198737399,0.4884353741496599,0.8397731513542516,1.0,4/13,16.30%,CALM2;KCNIP2;STIM1;CALM3
prerank,nervous system development (GO:0007399),0.3367804820600001,1.0075098437638963,0.5,0.8399672488809427,1.0,72/429,15.44%,DCLK1;PCDHB16;NAV2;WWP1;PKD1;ST8SIA2;VEGFA;EFNA5;ECRG4;FGF2;FGF13;GSN;CRIM1;FARP1;FGF17;DRD1;LDB2;LDB1;CNTFR;ACVR1B;EPHB2;GLIS2;NAV1;PMP22;RBFOX2;HDAC4;MBNL1;WWTR1;STAT3;HES5;PCDHB12;DACT1;DVL1;WDR62;JAG1;SPG7;SCD5;DLG4;DAGLA;CHERP;FZD5;S100B;NOG;KALRN;HAPLN4;RBM45;ZIC1;GMFB;ZIC4;NRXN2;ATN1;MYLIP;NELL1;NEUROD2;TGFBR1;BPNT1;TENM1;SMO;DCHS1;RAPGEFL1;INHBA;ALDH3A2;NLGN1;LIG4;NPAS1;MARK4;NDP;NBL1;SCIN;CXCR4;VCAN;SERF1A
prerank,regulation of dendritic cell apoptotic process (GO:2000668),-0.41182495399281904,-1.0072035948536375,0.446875,0.7206076832666292,1.0,3/10,3.85%,LYN;RAPGEF2;CXCL12
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.47804690548829515,1.0065839682419888,0.4834710743801653,0.8418759983439829,1.0,3/13,16.25%,PTGIS;NNMT;NAPRT
prerank,cellular response to calcium ion (GO:0071277),-0.2624064441115649,-1.0065684881069263,0.49411764705882355,0.7205949749443502,1.0,25/67,20.95%,ADGRV1;WNT5A;ITPKB;CPNE4;PRKAA2;ADCY1;KCNH1;RASGRP2;BRAF;PRKAA1;MCOLN1;SYT13;SYT3;SLC25A24;SYT10;SYT2;CPNE7;SYT11;SYT12;HPCA;ECT2;SYT7;SYT15;SCN5A;PPIF
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.34548126532196116,1.0064710109915427,0.4903943377148635,0.8416622119049298,1.0,43/186,16.70%,LRP6;TRABD2B;LRP1;TCF7L2;SFRP4;GRB10;PRICKLE1;NXN;DKK3;PSMD7;TLE2;WWTR1;PTPRU;PSMA8;TLE6;DACT1;DVL1;SOX9;DACT3;NOG;TSKU;NFATC1;TLE3;PSMA4;TPBG;AXIN1;PSMD12;HDAC1;INVS;PSMA6;LIMD1;DAB2;WIF1;FUZ;PSMD11;LATS2;PSMC5;PSMD1;NPHP3;PSMD14;MDFI;MLLT3;PSMC4
prerank,cellular response to tumor necrosis factor (GO:0071356),0.3417918392429,1.006003236658949,0.4903943377148635,0.8423474181375711,1.0,40/175,21.26%,PID1;YBX3;CARD14;CCL13;PSMD7;CCL15;PSMA8;SMPD4;TNFRSF1B;ILK;TNFSF15;NFE2L2;TXNDC17;PSMA4;LTBR;CHUK;COMMD7;PSMD12;CD27;PSMA6;TANK;TRAF3;GSDME;PSMD11;FOXO3;PSMC5;PSMD1;PSMD14;PSMC4;ACOD1;ERBIN;AKT1;MAP3K14;NFKBIA;ASAH1;PSMA3;TNFSF18;PSMD4;BIRC3;PSMB1
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.41219729447601083,1.0057735984720189,0.45875,0.8424411219197244,1.0,10/27,29.39%,ZC3H12D;RNASE6;ZC3H12C;LACTB2;XRN1;PCF11;KHNYN;TOE1;ERN1;RNASE1
prerank,motile cilium assembly (GO:0044458),0.47814001825835584,1.0053840079756076,0.4823695345557123,0.8429445004201657,1.0,3/12,13.47%,DNAAF3;CCDC39;BBS5
prerank,regulation of kinase activity (GO:0043549),0.35960011982813017,1.0052972688908846,0.4916317991631799,0.8426837355986,1.0,18/89,12.45%,EGFR;PLCE1;DDR2;NTRK3;NTRK1;LDB2;LDB1;EPHB2;EPHB3;EPHB6;FGFR1;ROR1;FGFR2;MUSK;LMO4;DDR1;SOD1;RAD50
prerank,regulation of brown fat cell differentiation (GO:0090335),0.45646395614227714,1.0049034055589707,0.48356164383561645,0.843214718967144,1.0,3/16,8.57%,SIX1;FTO;TFE3
prerank,anterograde axonal transport (GO:0008089),0.3907929431923622,1.0047311173601003,0.4803804994054697,0.8431823248498251,1.0,12/37,23.53%,DLG2;RAB21;BLOC1S2;SPAST;AP3D1;SOD1;BLOC1S3;SNAPIN;KIF1B;MAPK8IP3;NEFL;AP3B1
prerank,cardiac cell development (GO:0055006),0.4838991537020579,1.00453645579285,0.4714285714285714,0.8431926996100318,1.0,3/11,9.84%,VEGFA;JAG1;ALPK3
prerank,wound healing (GO:0042060),0.36975374043264153,1.004441850776684,0.4718853362734289,0.8429462448148873,1.0,16/62,17.75%,COL3A1;FGF2;AHNAK2;TGFB2;FZD7;RAF1;NOG;TSKU;DCBLD2;TGFBR1;SRF;MIA3;NF1;ERBB2;SYTL4;HMOX1
prerank,response to insulin (GO:0032868),0.3605628792408301,1.0044218978658155,0.47751605995717344,0.8425056980908571,1.0,13/80,11.53%,IRS1;SLC39A14;RHOQ;HDAC9;C2CD5;MEAK7;PRKDC;RAB8A;CAPN10;AKT2;OGT;SYAP1;PDPK1
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.31993836213229326,-1.004297723895101,0.4258373205741627,0.7244825449547939,1.0,12/25,25.47%,DNM1L;PDCD5;FAM162A;BCL2L11;MFF;GPER1;PYCARD;BIK;PPIF;BNIP3;HRK;PMAIP1
prerank,negative regulation of cell death (GO:0060548),0.3581717922596519,1.0041735974304622,0.4811320754716981,0.8426363473642452,1.0,27/88,26.76%,SRSF6;FGF2;SRGAP2;CCN5;CCN3;LRPAP1;AGR2;TNFRSF1B;IMPACT;BMP4;EIF4G1;CCN4;PSMC5;AKT1;CDK5;CHMP4B;CHMP4A;LRRK2;CLU;NUP62;GPNMB;CHMP2A;PINK1;NCK1;NENF;HTRA2;WNT11
prerank,anion transport (GO:0006820),0.40586613817652095,1.0039001048821894,0.4850657108721625,0.842853263894953,1.0,6/33,11.65%,SLC26A7;LRRC8D;SLC4A2;SLC26A4;VDAC2;SLC17A5
prerank,regulation of cell development (GO:0060284),0.3973703281164206,1.0038344947013975,0.4742990654205608,0.8425390542111568,1.0,7/36,12.41%,DOCK7;HDAC9;HES5;BHLHE40;HEYL;FBXO22;HEY1
prerank,positive regulation of metabolic process (GO:0009893),0.35994342695761433,1.0037240997323746,0.4890738813735692,0.8423408731609079,1.0,12/103,8.87%,GNAS;CMKLR1;VEGFA;GADD45G;GRB10;PEMT;DYNC1H1;ALMS1;EHMT1;PLAC8;OGT;ADIPOR2
prerank,positive regulation of supramolecular fiber organization (GO:1902905),-0.23532286351201762,-1.0036664298110405,0.421875,0.7244770816932825,1.0,20/86,14.18%,OCLN;APOE;APP;EVL;SEMA5A;RB1;NAV3;PROX1;CDC42EP4;SYNPO2;BAIAP2;CDC42EP3;LMOD1;PAK1;CLIP1;EDN1;PLEK;GPX1;CX3CL1;EFEMP2
prerank,protein targeting to membrane (GO:0006612),0.36132202855385376,1.0036593121749475,0.4732905982905983,0.8420129421316759,1.0,33/83,30.52%,ABCD3;PXMP2;SEC61A1;RABGEF1;PEX5;SSR2;PEX16;PEX13;ATG3;ALDH3A2;SIL1;SSR1;ZDHHC4;CHMP4B;CHMP4A;ZDHHC20;PEX2;PRKCI;ABCD1;ACBD5;ZDHHC9;PEX14;SGTB;TAOK2;GET3;PARD3;VPS37B;FIS1;SEC62;SRPRA;PIKFYVE;SRP14;ATAD1
prerank,epithelial structure maintenance (GO:0010669),-0.40329714611127676,-1.0034264815128435,0.423728813559322,0.7234605063046501,1.0,2/11,5.69%,RBP4;CXADR
prerank,aerobic electron transport chain (GO:0019646),-0.24980192094548978,-1.003376335861881,0.4666666666666667,0.7219361486171263,1.0,21/68,24.08%,COX8A;COX6C;NDUFC2;COX4I1;CYC1;UQCRC2;UQCR11;COX10;NDUFA13;NDUFB2;UQCRB;NDUFB7;NDUFAF1;COX5B;UQCRC1;NDUFS1;NDUFA8;NDUFB11;UQCRQ;NDUFS6;NDUFA4
prerank,positive regulation of cell-cell adhesion (GO:0022409),-0.2840231265010358,-1.0032958870123083,0.4155844155844156,0.7204982136648462,1.0,5/41,5.24%,TJP1;PODXL;GCNT2;BMP7;PIEZO1
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.4141367839397728,1.0031890685386118,0.4622754491017964,0.8427021985586555,1.0,8/26,21.72%,CYP1B1;ATF4;SULF1;RORA;IL6;SARS1;SULF2;EIF2AK3
prerank,regulation of chemotaxis (GO:0050920),0.39750197036914947,1.0031378301416605,0.4726114649681529,0.8423462882044664,1.0,1/30,0.08%,THBS1
prerank,positive regulation of cholesterol transport (GO:0032376),-0.3059908117426269,-1.0031239855597014,0.4256410256410256,0.7192957394633256,1.0,7/27,10.35%,PLTP;APOE;PTCH1;NR1H3;ABCA5;CAV1;EEPD1
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.38997248116056105,1.0029588655896164,0.4852941176470588,0.8423478976918481,1.0,12/43,15.41%,DDR2;LRP5;WWTR1;ACVR1;RUNX2;TMEM119;BMP4;BMPR1A;NELL1;CCN4;IL6;HGF
prerank,positive regulation of chromosome organization (GO:2001252),0.4484282100654957,1.0029251775376602,0.4666666666666667,0.8419558762902953,1.0,6/15,29.04%,GNL3;RAD50;LIG4;PPP1R10;RTEL1;DDX11
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.4718442928638993,1.0025156956404835,0.507482993197279,0.842530608444946,1.0,2/13,5.17%,PID1;VCP
prerank,lipid oxidation (GO:0034440),-0.38965740494119777,-1.0022930596616613,0.4204946996466431,0.7198132121385684,1.0,5/12,26.48%,PPARGC1A;ADIPOR1;ALOX12;PLA2G7;ALOX5
prerank,cell cycle G1/S phase transition (GO:0044843),0.3741859738778127,1.0015423713110878,0.486784140969163,0.8445409821354077,1.0,18/61,20.94%,ACVR1B;ACVR1;E2F3;GSPT1;CUL4A;RCC1;PHF8;KHDRBS1;CUL1;CCNE2;INHBA;LATS2;CDC25A;E2F1;DBF4;CDK2;MAX;BCAT1
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.43272508341472127,1.0014757649665549,0.4844559585492228,0.8442251349533167,1.0,6/22,15.00%,VKORC1L1;UBIAD1;LRP2;PIAS4;VDR;CYP27B1
prerank,negative regulation of multicellular organismal process (GO:0051241),0.33964811284009816,1.0013637246845,0.49949545913218973,0.844034452148348,1.0,34/199,12.48%,EGFR;SRSF6;GAS6;ZNF423;NFIB;NPR3;SMAD6;DOCK7;LDLRAD4;PARP3;SPRED2;HDAC9;LRPAP1;TRPV3;ATF4;ACTN3;ACOT11;FOXC2;PFN2;RPS6KA4;SOX9;PGAM5;TFE3;TLE3;FOXA1;BMP4;IP6K1;RAB11FIP5;PCTP;SMAD7;ABHD6;SRF;HEY1;CIDEA
prerank,regulation of acute inflammatory response (GO:0002673),0.44443729654377595,1.0012900037117567,0.4907161803713528,0.8437421432731003,1.0,4/18,21.35%,PTGES;IL6;OSMR;IL4
prerank,steroid catabolic process (GO:0006706),0.4970573817186986,1.0008045893332849,0.492816091954023,0.8444760366541266,1.0,2/10,15.00%,CYP19A1;CYP27B1
prerank,dendrite morphogenesis (GO:0048813),0.40179364423774455,1.000707776743202,0.4537914691943128,0.8442381026211632,1.0,10/35,13.77%,CTNND2;FARP1;EPHB2;ARC;EPHB3;DVL1;DLG4;TMEM106B;SHANK1;MEF2A
prerank,positive regulation of cellular process (GO:0048522),0.3338085056571555,1.000578987004168,0.517,0.8440575585347739,1.0,114/565,18.60%,THBS1;PGF;EGFR;LRP6;IRS1;ZFHX3;PRKCD;VEGFA;LBP;LRP1;GAS6;FGF2;P4HB;TIAM1;ACER3;NTRK3;PROK2;FGF17;GAB2;PRR7;LRP5;TGFB3;MAPK15;SHC1;HDAC4;WWTR1;PKHD1;LMNA;CSNK2A1;HES5;TGFB2;TCIRG1;DYNC1H1;PRKCA;EIF4G2;DNAJA2;FXN;TNFRSF1B;MMP14;FAM98A;TGFBR2;IL12RB2;ADAM10;FZD7;FGFR1;CXCL16;MEIS3;EDN3;SOX9;CAPN10;PLA2G5;RARA;S100B;PA2G4;TFE3;AKT2;CDC6;TRPM4;FCER1G;TBRG4;ITGAV;FGFR2;MAPK8;CDC25B;CDC123;BMP4;FOXM1;FAM98B;VIP;ATM;CTF1;CHTOP;MAZ;PHIP;HDAC1;TGFBR1;SRF;NCMAP;EIF4G1;KMT2D;F2R;ACACA;NACC1;BMP5;SUPV3L1;LMAN2;COLEC12;EXOSC4;PRDX3;CSPP1;CLCF1;SIRT2;KLHL22;STX4;IL6;SLC35F6;CNOT8;ERBB2;SMC5;OSMR;FGF5;NCBP1;FLCN;TRIM13;GAREM1;SSR1;PRLR;UFL1;HDGFL2;CITED2;KIF20B;GDNF;HCFC1;AKT1
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.42350503707277987,1.0001345425103352,0.4807692307692308,0.8446507256199561,1.0,6/24,16.37%,KCNB1;C2CD5;MIEF2;AKT2;CHP1;ERBB2
prerank,DNA recombination (GO:0006310),0.3952483436774531,1.0000768106827085,0.47065868263473054,0.8443195331687203,1.0,18/37,32.63%,HMGB1;WRN;RAD50;LIG4;SUPV3L1;TSN;RAD51;XRCC3;RECQL5;FBH1;RPAIN;RTEL1;RAD52;IGHMBP2;RHNO1;BLM;MSH2;ERCC1
prerank,negative regulation of transport (GO:0051051),-0.2662556127649802,-0.9999611282836867,0.45132743362831856,0.723912205781626,1.0,16/51,19.74%,MCTP1;NR1H3;CTTNBP2NL;BST2;DYSF;PACSIN3;NDFIP2;PRKD1;YRDC;SNCA;CRYAB;SIRPA;ERBB3;SYT11;RACK1;PXK
prerank,regulation of autophagy (GO:0010506),0.3440941919767402,0.9997351339786827,0.5040322580645161,0.844673529734779,1.0,93/216,28.42%,NEDD4;ATP6V1C2;EXOC4;MAPK15;STAT3;CSNK2A2;EIF4G2;OSBPL7;ATP6V0A1;LAMTOR1;HMGB1;RAB8A;EIF4G3;DAP;TRIM27;FZD5;FOXK1;MAPK8;PIP4K2B;SREBF1;VPS26A;ABL1;ATM;TAB2;ATP6V0D1;MID2;KDM4A;PIK3CB;EIF4G1;SNX32;UBQLN1;ATP6V1B2;USP33;USP36;WDR41;TRIM65;ATP6V1E1;SIRT2;KLHL22;USP13;FOXO3;HGF;TLK2;HDAC6;ORMDL3;FLCN;UFL1;PRKAG1;TRIM6;DAPK3;USP10;RB1CC1;AKT1;ATP6V1C1;DCAF12;PRKAB1;CDK5;RHEB;UCHL1;ATF6;LRRK2;OPTN;PRKACA;CAPNS1;TRIM8;RPTOR;ZKSCAN3;RUBCN;KAT8;NPRL2;SMCR8;ATP6V0E1;ROCK1;BAD;PINK1;ATP6V0B;EXOC7;ATG13;LAMTOR2;MET;HTRA2;GOLGA2;CAPN1;EIF4E;SNX5;LAMTOR3;PIP4K2C;ERN1;DRAM1;ABL2;PLEKHF1;TFEB;ULK1
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.416106480051031,0.9996310538929212,0.4794520547945205,0.8444526880749743,1.0,4/26,8.80%,EFNA5;LRP5;ADCY8;TRPM4
prerank,negative regulation of sequestering of calcium ion (GO:0051283),-0.319010436027546,-0.9995473858017636,0.441747572815534,0.7232866184647528,1.0,5/24,10.00%,ITPR1;RYR2;ITPR3;HTR2C;ITPR2
prerank,negative regulation of ossification (GO:0030279),-0.31752233069805286,-0.9992733342113443,0.45410628019323673,0.7223987157338222,1.0,5/23,7.65%,ENPP1;NOTCH1;SRGN;BCOR;RBPJ
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),0.4588400517557119,0.9989635278943921,0.4953764861294584,0.8456776172658341,1.0,9/15,30.12%,SEC61A1;RAB3GAP1;SPCS2;RAB3GAP2;ZFAND2B;SRPRA;SPCS1;ZFAND2A;SRP14
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.47021253091877063,0.998775646787491,0.4856361149110807,0.8456812993851376,1.0,3/14,12.22%,WNT9A;SOX9;TGFBR1
prerank,regulation of myoblast differentiation (GO:0045661),0.4072163696706458,0.9985320054173507,0.4867149758454106,0.8458192381252861,1.0,5/32,10.16%,BOC;SOX9;SRA1;EID2B;BMP4
prerank,peptidyl-proline modification (GO:0018208),0.4184370265048609,0.9984339818502787,0.48055207026348806,0.8455732297226878,1.0,12/25,30.85%,FKBP10;FKBP5;P3H2;PPIL3;NKTR;NTMT1;FKBP1B;FKBP4;PPIG;PPID;PPIC;PPIH
prerank,myotube differentiation (GO:0014902),-0.34392481835669597,-0.9983776842516098,0.4751131221719457,0.7229494761850886,1.0,8/17,15.15%,JAM2;KCNH1;SORT1;ADGRB3;NOS1;ADAMTS15;IGF1;PLD3
prerank,cellular response to ketone (GO:1901655),-0.29440225830189437,-0.9983319870159398,0.5056179775280899,0.7214489432471345,1.0,4/35,4.32%,ADCY5;ROCK2;ADCY1;AHR
prerank,translesion synthesis (GO:0019985),0.38903607491166614,0.9981917132452421,0.4788235294117647,0.8456633396274829,1.0,14/42,25.67%,REV3L;POLE2;VCP;FAAP20;UBE2L6;RPS27A;UBC;REV1;USP10;NPLOC4;MAD2L2;PRIMPOL;RCHY1;POLD1
prerank,double-strand break repair (GO:0006302),0.346206135617344,0.9980302439192887,0.5071138211382114,0.8455500276042427,1.0,42/158,21.03%,REV3L;PARP3;VCP;PRKDC;HMGB1;TONSL;ERCC5;MORF4L1;RBBP8;ERCC4;MAPK8;SFR1;WRN;KDM2A;SWI5;SPIDR;ATM;KPNA2;CHEK2;TDP1;SFPQ;KDM4A;RAD50;LIG4;PIAS4;DCLRE1B;PARP1;PSMD14;UBE2V2;SMC5;SUMO1;APBB1;HUS1;POLB;SMARCAD1;ACTR8;RAD51;TNKS1BP1;XRCC3;XRCC6;BRCC3;MAD2L2
prerank,cellular response to unfolded protein (GO:0034620),0.4165652703718231,0.9976842266669035,0.4866581956797967,0.8459073920384182,1.0,11/26,28.16%,HSPA2;BAG3;HSPA14;HSPA5;HSPD1;OPTN;ABCB10;DAXX;HSPB8;ERN1;HSF1
prerank,midbody abscission (GO:0061952),0.44616795244796925,0.9976307582102931,0.47270306258322237,0.8455660209548117,1.0,6/17,24.90%,CHMP3;MITD1;CHMP4B;CHMP4A;PDCD6IP;CHMP2A
prerank,establishment of mitotic spindle orientation (GO:0000132),0.42171905626531453,0.997536546566225,0.4961734693877551,0.845311782924191,1.0,6/23,22.78%,PKHD1;MISP;ZW10;NDEL1;DCTN1;CDK5RAP2
prerank,regulation of actin filament bundle assembly (GO:0032231),0.4088670459170314,0.9971119009279791,0.47613365155131265,0.8458726658416061,1.0,5/26,6.52%,ASAP3;RDX;ALMS1;PFN2;SLC9A1
prerank,positive regulation of actin nucleation (GO:0051127),0.4909022686487984,0.9969811074957995,0.49647390691114246,0.8457187811692659,1.0,4/11,21.07%,GSN;CYFIP1;SCIN;ABI2
prerank,regulation of cellular amine metabolic process (GO:0033238),0.3751234797311672,0.9966199059614322,0.4753722794959908,0.8461010736672208,1.0,18/50,27.54%,PSMD7;PSMA8;PSMA4;PSMD12;PSMA6;PSMD11;PSMC5;PSMD1;PSMD14;PSMC4;AZIN1;PSMA3;PSMD4;PSMB1;PSMA5;PSMA7;PSMC1;PSMA1
prerank,regulation of interleukin-6 production (GO:0032675),0.3536365857651779,0.9964590966074787,0.5036344755970924,0.8460303889438067,1.0,15/96,15.41%,LBP;GAS6;IL33;TWIST1;RAB7B;STAT3;MAVS;HMGB1;IRAK3;C1QTNF4;HSPD1;F2R;SETD4;ARRB1;IL6
prerank,protein oxidation (GO:0018158),0.4861857529305297,0.9960684196802331,0.49719101123595505,0.8465664157273388,1.0,4/11,22.26%,LOXL1;LOX;PRDX3;LOXL2
prerank,termination of RNA polymerase II transcription (GO:0006369),0.39772245483418306,0.9959868105825439,0.4778972520908005,0.8462864828014152,1.0,12/33,21.70%,SYMPK;MAZ;PABPN1;CLP1;CPSF4;PCF11;NCBP1;CPSF7;NCBP2;CSTF2;CSTF2T;SNRPB
prerank,homocysteine metabolic process (GO:0050667),0.46519857391548475,0.9959665418900816,0.4834054834054834,0.8458560858502662,1.0,3/11,7.58%,MPST;NOX4;MTRR
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.39188603217839824,0.9956829476925191,0.47596717467760846,0.8460831391151388,1.0,7/39,13.19%,EGFR;PTPN3;RNF115;CBL;PTPN18;PTPN2;STAM2
prerank,protein tetramerization (GO:0051262),0.3614289081163317,0.9952931389279964,0.5038335158817087,0.8465564403599003,1.0,16/67,19.77%,KCNJ2;PKD1;CRYZ;TRPM4;CBR4;ACACA;PKD2L1;HSD17B8;ACOT13;SHMT2;GNMT;CPSF7;CPSF6;SHMT1;TK1;APPL2
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.35689395756699366,0.9948437425922083,0.509594882729211,0.8472124310121742,1.0,33/88,25.71%,VPS13A;EXOC4;VPS13C;DOP1B;AP2A1;GOPC;DNM2;GOLGB1;PUM1;GBF1;LLGL1;MON2;SCFD1;STEAP2;ARF1;BLOC1S3;CLTC;SNAP23;ARRB1;STX4;SCAMP2;NAPA;SH3D19;CORO7;ARFGEF2;SCAMP3;CLTA;CLINT1;SCAMP1;ACBD3;CHMP2A;VAMP2;VPS35L
prerank,regulation of oxidoreductase activity (GO:0051341),0.46940813925213687,0.9948010824520963,0.5049365303244006,0.8468500964512031,1.0,3/13,16.15%,ECSIT;ABL1;HDAC6
prerank,secretory granule organization (GO:0033363),0.49111860479006303,0.9947094859680728,0.49644381223328593,0.846611495714539,1.0,4/10,13.78%,BLOC1S2;ABCA1;F2R;BLOC1S3
prerank,nitric oxide biosynthetic process (GO:0006809),-0.38646599824621886,-0.9944938378529291,0.4377224199288256,0.7292614956697289,1.0,6/13,12.53%,NOS3;CYB5B;GCH1;NOS1;DDAH2;SPR
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.4703653542896798,0.9944698507798391,0.5083333333333333,0.8467204188920575,1.0,7/13,22.60%,IPO5;RGPD1;KPNA2;RANBP2;KPNA3;KPNA4;NUP35
prerank,organic hydroxy compound transport (GO:0015850),-0.2836318990466764,-0.9938337870831341,0.4429530201342282,0.7292299937867156,1.0,4/36,2.31%,ABCC4;SLCO2B1;SLCO1C1;RBP4
prerank,regulation of protein kinase C signaling (GO:0090036),-0.3700457821626363,-0.9937598434692897,0.4621212121212121,0.7278543941984063,1.0,8/14,13.51%,ADGRV1;WNT5A;DGKD;DGKG;GPD1L;FLT4;ADRA1A;CD40
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.4336238636219309,0.9937363007242879,0.5038759689922481,0.84809033365902,1.0,7/21,21.03%,MAD1L1;ATM;ZW10;KLHL22;IK;CDC20;MAD2L2
prerank,neutrophil degranulation (GO:0043312),0.3314376453053847,0.9936757142556432,0.5375375375375375,0.8477682353563644,1.0,115/425,27.26%,PRKCD;PYGB;GSN;TIMP2;IGF2R;CRACR2A;PSMD7;ARSB;CEACAM3;ANXA2;TCIRG1;HMOX2;DNAJC13;DYNC1H1;RAB24;UBR4;COPB1;LPCAT1;VCP;STBD1;TNFRSF1B;GAA;ATP6V0A1;LAMTOR1;HMGB1;ADAM10;ARSA;CKAP4;QSOX1;PTGES2;CREG1;FAF2;JUP;RNASE3;B4GALT1;HUWE1;GDI2;CYFIP1;PLAC8;PA2G4;FCER1G;RHOA;CST3;ATP8A1;ITGAV;COMMD9;GLIPR1;GHDC;RAB3D;PSMD12;AMPD3;CAP1;AP2A2;PAFAH1B2;TOM1;FRK;DERA;MLEC;SNAP23;PSMD11;IQGAP1;PSMD1;CAT;RAB4B;PSMD14;NAPRT;STOM;ORMDL3;ACP3;HVCN1;ACTR1B;RAB5B;IST1;GLB1;AOC1;CTSZ;ACTR10;XRCC6;PTAFR;ASAH1;CCT8;SLC27A2;CTSB;DOK3;LAIR1;LAMP2;PSMB1;LAMP1;PYGL;RAB18;SLC11A1;PSMA5;MAGT1;MAN2B1;VNN1;SCAMP1;BST1;CDK13;NRAS;KCMF1;ROCK1;GNS;ACTR2;S100A11;VAMP2;VPS35L;GUSB;TUBB4B;LAMTOR2;NPC2;CAND1;CYSTM1;CAPN1;PLAUR;LAMTOR3
prerank,amyloid precursor protein metabolic process (GO:0042982),-0.34083164010367306,-0.993424034549346,0.4190871369294606,0.7270147248467548,1.0,4/18,7.65%,APOE;ABCG1;TMCC2;NSG1
prerank,positive regulation of lipid localization (GO:1905954),0.4829431217476397,0.9921027589283833,0.4958563535911602,0.8512733447030041,1.0,1/11,1.00%,LRP1
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.4130365227450892,0.9919760641892019,0.4796547472256473,0.8510980676131548,1.0,4/27,5.38%,MYOC;ARAP1;TMEFF2;PPFIA1
prerank,purine ribonucleotide catabolic process (GO:0009154),-0.3368910042376726,-0.9919214371419122,0.48826291079812206,0.7290987152314214,1.0,4/21,6.94%,PDE4D;NT5C2;NUDT4;PDE2A
prerank,negative regulation of TOR signaling (GO:0032007),0.3951447696615121,0.9918757863233687,0.4730195177956372,0.8508747215831234,1.0,14/36,22.82%,NPRL3;SESN3;CASTOR2;AKT1S1;ATM;DEPTOR;SESN2;TMEM127;MINAR1;FLCN;KPTN;UBR2;TSC2;NPRL2
prerank,cellular response to growth factor stimulus (GO:0071363),0.34222797659256426,0.9918006250618601,0.5040650406504065,0.850578146360242,1.0,32/151,15.41%,EGFR;TMEM100;VEGFA;SMAD9;NTRK3;NTRK1;EHD1;ACVR1B;GAS1;SHC1;PDE3A;KIDINS220;RAMP2;ACVR1;SMAD4;TGFBR2;RUNX2;SOX9;ANXA1;SYAP1;BMP4;URI1;BMPR1A;PDPK1;NRP1;SMAD7;TGFBR1;LRP2;NDNF;SIRT2;IQGAP1;HGF
prerank,regulation of cardiac muscle contraction (GO:0055117),0.392900034577347,0.9914074241638242,0.506993006993007,0.8510527307570135,1.0,7/34,11.86%,ATP1B1;HCN4;CALM2;SLC9A1;ANK2;TNNI3K;SMAD7
prerank,cellular protein modification process (GO:0006464),0.330191692986216,0.9912116676423377,0.532,0.851074071021079,1.0,304/982,26.79%,PLOD2;THBS1;DCLK1;ST3GAL4;ST8SIA2;IGFBP5;CHRDL1;PRKCD;FSTL1;GAS6;COL3A1;GPC3;P4HB;MARK1;NTRK1;PTPN3;PRKCE;FBXO10;PPP1CC;LOXL1;DMP1;ACVR1B;CEL;TGM6;TGM5;FBXL7;PARP3;PSMD7;CSNK1D;CLK3;CAMK2D;RAB2A;FBXW8;MAP3K5;PTPRS;PTPRF;STRADA;DUSP11;PTP4A2;TNK1;PTPRU;CSNK2A1;TGFB2;COP1;DCAF6;MORC3;LIMK2;GGCX;P3H1;PRKCA;FASTK;ERN2;PSMA8;ACVR1;NRBP2;B3GNT7;PRKCSH;ILK;PPM1H;PRKDC;ERCC8;NEK7;GPAA1;TGFBR2;ADAM10;RAB8A;SIRT5;TLK1;STK39;IRAK3;BCR;FGFR1;CKAP4;LOX;QSOX1;CDK10;WIPI2;ARF4;RPS6KA4;MBTPS1;GPS1;SOCS6;NAGPA;RARA;B4GALT5;PAK4;ILF3;PMM2;ST3GAL2;SOCS2;AKT2;PPM1M;CST3;DAPP1;ANXA1;PTPN18;CDK12;WWP2;CALU;GMFB;PSMA4;PKN2;PAK2;PPP3CC;MAPK8;CUL4A;NPC1;CDC25B;BMP4;CHUK;ABL1;MAP4K5;TNNI3K;UCHL3;RAB38;RCN1;RIPK3;FBXL4;LCMT1;ATM;MAP3K12;IRAK1;FUT4;FBXO22;BMPR1A;ATG3;CHEK2;FBXL12;PDPK1;PSMD12;NRBP1;GRK6;CUL1;TGFBR1;TULP4;FBXL19;PSMA6;WDR5;STK25;CSNK1E;PPEF2;B3GNT9;PICK1;RBBP7;RAB11B;DMPK;FRK;WNK1;NUCB1;TNKS2;MARK4;FBXL14;SRPK1;DCAF13;NGLY1;TBCK;ATE1;MIA3;SIRT2;UBE2L6;KLHL22;COQ8B;BRD2;PSMD11;LATS2;FBXL20;PSMC5;IL6;VCAN;PSMD1;DDA1;FBXO17;TLK2;CDC42BPB;PPP2R5C;PARP1;ILKAP;CAMK4;CREB1;PSMD14;TP53RK;ERBB2;B3GNT6;STT3A;PSMC4;HASPIN;LIPT1;BIRC6;NTAQ1;ALG1;ARAF;GNMT;MKNK2;UFL1;FBXL18;PRKAG1;CHST5;MEN1;SIK2;VRK2;DAPK3;MAST2;SUMF2;IKBKE;CLK2;BCKDK;ASB5;AKT1;SENP8;BIRC5;CDKL2;CDK20;RNF7;HIPK2;FBXW2;CDK2;ALG3;FBXW4;PRKAB1;CDK5;PPM1J;APLP2;EIF2AK4;MAPK9;PIGT;PSMA3;DCAF11;JAK1;LRRK2;GRK4;SGK3;NEK4;PSMD4;PRKACA;PSMB1;METAP1D;PENK;RAB1A;EIF2AK3;FAM20A;CUL9;PRKCI;LOXL2;B3GNT2;ASB6;CSNK1G3;COPS4;STK38;UBA3;CDKL3;CAMK1;COPS7A;MTM1;B4GALT7;PSMA5;TAOK3;MAN2B1;PHKA2;RAB1B;FBXO11;TAOK1;PHEX;PGAP1;PSMA7;CDK13;VGF;PLK4;TAF1;FBXO9;ROCK1;CSK;PARP8;TBK1;METAP2;NEK6;ANKRD9;LMTK2;PPP2CA;TYK2;PINK1;CTDP1;TAOK2;CUL7;OGA;KRT10;STK24;STK3;COPS3;FBXW10;DCAF5;PRRT1;SDC2;RAB5A;CCL2;CCDC8;PSMC1;RABGGTB;PARP4;DCAF4;SGK1;KCTD7;WNT11;CAND1;CSNK1A1
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),-0.38936449085058883,-0.9905569562694885,0.49230769230769234,0.7307806583251494,1.0,3/12,4.40%,PODXL;PROM1;PTPRO
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.416252284456324,0.9904536114401191,0.5,0.8524107634810898,1.0,9/25,30.02%,SF3B1;SRRM1;WDR83;SRSF10;TRA2B;GEMIN2;SRSF4;KHSRP;SF3B4
prerank,granulocyte chemotaxis (GO:0071621),0.36910035081434617,0.9904098204622768,0.4988738738738739,0.8520440349379719,1.0,7/55,9.20%,CCL13;CCL15;TGFB2;GBF1;EDN3;FCER1G;ANXA1
prerank,regulation of programmed necrotic cell death (GO:0062098),0.42394839106120785,0.9902528562089358,0.4879594423320659,0.8519467623642473,1.0,10/20,31.13%,OGT;RIPK3;STUB1;ASAH1;PDCD6IP;BIRC3;CYLD;RIPK1;HSP90AA1;SPATA2
prerank,regulation of microtubule depolymerization (GO:0031114),0.4138183441525656,0.9902399399522187,0.49936143039591313,0.85150411643152,1.0,2/25,1.30%,FGF13;MAP1B
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),-0.2915333967916646,-0.9899779852966066,0.4556213017751479,0.730510514702857,1.0,7/33,7.80%,TGFA;AFAP1L2;CCDC88A;DGKD;HIP1R;ADRA2A;HBEGF
prerank,regulation of GTPase activity (GO:0043087),0.3372660459371131,0.9899102413588955,0.5025227043390514,0.8518296470044728,1.0,33/177,13.96%,PLXNA4;SGSM2;EFNA5;SRGAP2;ASAP3;ARAP1;NTRK1;VAV2;RDX;CCL13;SIPA1L1;FGD6;CCL15;KLRK1;BCAS3;SNX18;EPHB3;RAB3GAP1;S100A10;RIC1;ADAP1;RGP1;ZC3H15;SNX9;EVI5L;SOD1;RCC2;F2R;OCRL;ARHGAP44;ARL2;WNK1;NDEL1
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.43016588265749106,0.9896837959027288,0.494949494949495,0.851445465466016,1.0,1/20,0.20%,SLC4A4
prerank,positive regulation of glycolytic process (GO:0045821),0.43016588265749106,0.9896837959027288,0.494949494949495,0.851445465466016,1.0,1/20,0.20%,SLC4A4
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.44353275227442407,0.98955282926715,0.50480109739369,0.8513047337102877,1.0,7/16,29.14%,NAA60;NAA40;NAA16;CREBBP;KAT2B;NAA15;NAA25
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.35163205494043565,0.9895007307208247,0.4983991462113127,0.8509729458073391,1.0,31/85,27.54%,TIAM1;PRICKLE1;PSMD7;AP2A1;PSMA8;DVL1;FZD7;FZD5;RHOA;PSMA4;PSMD12;PSMA6;AP2A2;CLTC;PSMD11;PSMC5;PSMD1;PSMD14;PSMC4;SMURF2;PSMA3;PSMD4;PSMB1;PSMA5;PSMA7;DVL2;PSMC1;WNT11;CELSR3;FZD1;PSMA1
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.47769092661133455,0.9894316088715437,0.4964336661911555,0.8506788578515717,1.0,4/11,9.72%,LRP5;TGFBR2;SOX9;FGFR2
prerank,GPI anchor metabolic process (GO:0006505),0.4089314277339774,0.9893184768281936,0.5,0.8505025934070817,1.0,12/26,32.83%,PIGW;PIGF;PIGL;PGAP2;DPM3;PIGV;PGAP1;PIGQ;PIGB;PIGN;PIGC;PIGO
prerank,phosphorylation (GO:0016310),0.33300027007503646,0.9892959082361087,0.537,0.8500899953401931,1.0,147/384,27.90%,DCLK1;PRKCD;GAS6;MARK1;NTRK1;PRKCE;ACVR1B;EPHB2;CSNK1D;CLK3;CAMK2D;NADK;MAP3K5;STRADA;TNK1;STAT3;CSNK2A1;TGFB2;MORC3;LIMK2;PRKCA;SHPK;FASTK;ERN2;ACVR1;NRBP2;ILK;PRKDC;NEK7;TGFBR2;ADAM10;TLK1;STK39;IRAK3;BCR;FGFR1;CDK10;RPS6KA4;RARA;PAK4;ILF3;DGKQ;CDK12;GMFB;PKN2;PAK2;MAPK8;CDC25B;CHUK;ABL1;MAP4K5;TNNI3K;ATM;MAP3K12;IRAK1;BMPR1A;CHEK2;PDPK1;NRBP1;GRK6;TGFBR1;PIK3CB;STK25;CSNK1E;PICK1;DMPK;FRK;WNK1;MARK4;LIMD1;SRPK1;TBCK;COQ8B;BRD2;LATS2;TLK2;CDC42BPB;CAMK4;CREB1;TP53RK;ERBB2;HASPIN;PGK1;BIRC6;MKNK2;PRKAG1;SIK2;VRK2;DAPK3;MAST2;IKBKE;CLK2;BCKDK;AKT1;BIRC5;CDKL2;CDK20;HIPK2;CDK2;PRKAB1;CDK5;EIF2AK4;MAPK9;JAK1;LRRK2;GRK4;SGK3;NEK4;PRKACA;EIF2AK3;FAM20A;PANK3;PRKCI;TOP1;STK38;CDKL3;CAMK1;TAOK3;TAOK1;CDK13;PLK4;TAF1;ROCK1;CSK;TBK1;NEK6;LMTK2;TYK2;PINK1;TAOK2;STK24;STK3;TKFC;PRRT1;CCL2;SGK1;WNT11;CSNK1A1;PI4KA;NIM1K;PNKP;ERN1;PANK2;MAP3K11;MEX3B;CDK9;SPHK2
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.45311056689296886,0.9888567108274573,0.4932249322493225,0.8506863041543219,1.0,9/14,35.94%,FUS;WDR48;MMS19;PARP1;ACTR2;WAS;TIMELESS;ERCC6;ARID2
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.40348429829404553,0.9887014421026946,0.5012315270935961,0.8506020569285541,1.0,6/27,7.97%,AHNAK;CAMK2D;CALM2;DMD;ANK2;SELENON
prerank,glial cell differentiation (GO:0010001),0.40116696471745344,0.9886447760080503,0.4841463414634146,0.8502701001878662,1.0,9/28,23.59%,NFIB;STAT3;HES5;SOX9;PICK1;GPR157;CDK5;GPC1;SOX8
prerank,positive regulation of cell death (GO:0010942),-0.25561975309360147,-0.9884882557564892,0.5185185185185185,0.7326412998675379,1.0,16/59,15.04%,SLC6A13;EFNB2;WNT5A;ACER2;PICALM;AXIN2;FAF1;GRIN2B;APC;PRODH;ZC3H12A;EGR1;SARM1;C1QA;TYROBP;SNCA
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.35883072198740085,0.9883938985572056,0.5032751091703057,0.8503916403705704,1.0,22/67,24.03%,PSMD7;PSMA8;PDIA3;PSMA4;ITGAV;CHUK;PSMD12;PSMA6;SEC22B;SNAP23;PSMD11;PSMC5;PSMD1;PSMD14;PSMC4;CALR;PSMA3;PSMD4;PSMB1;ITGB5;PSMA5;PSMA7
prerank,cellular response to interleukin-15 (GO:0071350),0.45736990254036947,0.9883713712302624,0.4903581267217631,0.8495016447485724,1.0,3/13,4.11%,SHC1;STAT5A;STAT3
prerank,interleukin-15-mediated signaling pathway (GO:0035723),0.45736990254036947,0.9883713712302624,0.4903581267217631,0.8495016447485724,1.0,3/13,4.11%,SHC1;STAT5A;STAT3
prerank,positive regulation of protein binding (GO:0032092),0.37115009099975604,0.9882970376652204,0.4988814317673378,0.849208733324265,1.0,11/56,13.73%,PKD1;LRP1;TCF7L2;TIAM1;DACT1;BMP4;ABL1;TERT;NVL;USP33;ADD1
prerank,protein K63-linked ubiquitination (GO:0070534),0.3804521264215242,0.987928556654289,0.49825378346915017,0.8496386564641252,1.0,21/41,32.79%,NEDD4;UBE2B;RNF115;TRIM27;WWP2;ITCH;TRAF3;STUB1;TRAF3IP2;UBE2V2;HECTD1;RNF4;ZFP91;RNF126;UBE2V1;RNF135;TRAF5;UBE2S;PRKN;UBE2N;ARIH2
prerank,neutrophil activation involved in immune response (GO:0002283),0.3295363645457725,0.9878911552773202,0.5575575575575575,0.8492540688893938,1.0,115/428,27.26%,PRKCD;PYGB;GSN;TIMP2;IGF2R;CRACR2A;PSMD7;ARSB;CEACAM3;ANXA2;TCIRG1;HMOX2;DNAJC13;DYNC1H1;RAB24;UBR4;COPB1;LPCAT1;VCP;STBD1;TNFRSF1B;GAA;ATP6V0A1;LAMTOR1;HMGB1;ADAM10;ARSA;CKAP4;QSOX1;PTGES2;CREG1;FAF2;JUP;RNASE3;B4GALT1;HUWE1;GDI2;CYFIP1;PLAC8;PA2G4;FCER1G;RHOA;CST3;ATP8A1;ITGAV;COMMD9;GLIPR1;GHDC;RAB3D;PSMD12;AMPD3;CAP1;AP2A2;PAFAH1B2;TOM1;FRK;DERA;MLEC;SNAP23;PSMD11;IQGAP1;PSMD1;CAT;RAB4B;PSMD14;NAPRT;STOM;ORMDL3;ACP3;HVCN1;ACTR1B;RAB5B;IST1;GLB1;AOC1;CTSZ;ACTR10;XRCC6;PTAFR;ASAH1;CCT8;SLC27A2;CTSB;DOK3;LAIR1;LAMP2;PSMB1;LAMP1;PYGL;RAB18;SLC11A1;PSMA5;MAGT1;MAN2B1;VNN1;SCAMP1;BST1;CDK13;NRAS;KCMF1;ROCK1;GNS;ACTR2;S100A11;VAMP2;VPS35L;GUSB;TUBB4B;LAMTOR2;NPC2;CAND1;CYSTM1;CAPN1;PLAUR;LAMTOR3
prerank,cardiac muscle tissue development (GO:0048738),0.3753630497894861,0.9878829199493343,0.5181518151815182,0.8488068132514314,1.0,10/50,14.80%,CACNA1G;SGCD;HCN4;SMAD4;BMP4;CSRP3;BMPR1A;HEY1;BMP5;AKAP13
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.39401361204784946,0.9875111052698714,0.5011848341232228,0.8492478609604147,1.0,4/34,4.87%,PGF;VEGFA;GAS1;RAMP2
prerank,neutrophil mediated immunity (GO:0002446),0.3293003903871383,0.9874829142706599,0.5445445445445446,0.8488569411604061,1.0,116/432,27.26%,PRKCD;PYGB;GSN;TIMP2;IGF2R;CRACR2A;PSMD7;ARSB;CEACAM3;ANXA2;TCIRG1;HMOX2;DNAJC13;DYNC1H1;RAB24;UBR4;COPB1;LPCAT1;VCP;STBD1;TNFRSF1B;GAA;ATP6V0A1;LAMTOR1;HMGB1;ADAM10;ARSA;CKAP4;QSOX1;PTGES2;CREG1;FAF2;JUP;RNASE3;B4GALT1;HUWE1;GDI2;CYFIP1;PLAC8;PA2G4;FCER1G;RHOA;CST3;ATP8A1;ITGAV;COMMD9;GLIPR1;GHDC;RAB3D;PSMD12;AMPD3;CAP1;AP2A2;PAFAH1B2;TOM1;FRK;DERA;MLEC;SNAP23;PSMD11;IQGAP1;IL6;PSMD1;CAT;RAB4B;PSMD14;NAPRT;STOM;ORMDL3;ACP3;HVCN1;ACTR1B;RAB5B;IST1;GLB1;AOC1;CTSZ;ACTR10;XRCC6;PTAFR;ASAH1;CCT8;SLC27A2;CTSB;DOK3;LAIR1;LAMP2;PSMB1;LAMP1;PYGL;RAB18;SLC11A1;PSMA5;MAGT1;MAN2B1;VNN1;SCAMP1;BST1;CDK13;NRAS;KCMF1;ROCK1;GNS;ACTR2;S100A11;VAMP2;VPS35L;GUSB;TUBB4B;LAMTOR2;NPC2;CAND1;CYSTM1;CAPN1;PLAUR;LAMTOR3
prerank,growth hormone receptor signaling pathway (GO:0060396),0.4546702912628711,0.987437651881753,0.49442896935933145,0.8484979485474776,1.0,4/14,8.68%,GHR;STAT5A;STAT3;SOCS2
prerank,protein N-linked glycosylation (GO:0006487),0.36209113851744534,0.9870023109984251,0.5229759299781181,0.8490753896284009,1.0,22/66,23.93%,PGM3;GFPT1;GFPT2;B4GALT1;PMM2;UGGT2;MGAT4B;ALG13;FUT8;DOLPP1;UGGT1;TMEM165;STT3A;ALG1;ALG3;LMAN1;DPM3;MGAT5;ALG14;B4GALT7;MAGT1;ENTPD5
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.3540449433840088,0.9869390007678853,0.525,0.8487453733104856,1.0,4/76,2.14%,ESR1;CMKLR1;PLCE1;DRD1
prerank,respiratory electron transport chain (GO:0022904),0.45673842738451015,0.9869372400470974,0.5149934810951761,0.8482827800101121,1.0,4/14,10.64%,ETFRF1;ETFDH;ETFB;ETFA
prerank,sensory perception of mechanical stimulus (GO:0050954),0.35504345245091135,0.9869311299521359,0.5299145299145299,0.8478311723746472,1.0,13/85,13.83%,PIEZO2;COL11A1;COL1A1;LRTOMT;LHFPL5;CDC14A;CHRNB2;ROR1;TIMM9;SLC26A4;SOD1;LRP2;GSDME
prerank,regulation of viral entry into host cell (GO:0046596),0.40306792179795736,0.9869194425074789,0.5,0.8474021035558774,1.0,6/30,17.81%,GSN;P4HB;TRIM27;MID2;TRIM26;TRIM6
prerank,regulation of cellular biosynthetic process (GO:0031326),-0.3056486300498295,-0.9864777436014893,0.4550561797752809,0.7360587084880907,1.0,13/28,19.85%,PRKAA2;PRKAG2;MITF;ADIPOR1;FGFR4;CX3CR1;SIRT1;AVIL;SIRPA;CD47;NR1H4;C3;NOS1AP
prerank,regulation of neuron projection arborization (GO:0150011),-0.3624148962451588,-0.9864137799959954,0.4798387096774194,0.7346235703300029,1.0,5/15,9.19%,WNT5A;GRIP1;NTNG1;MACF1;MFSD2A
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.4034988223708321,0.9863574640745029,0.5012224938875306,0.8483128392734812,1.0,2/27,1.07%,GAS6;DDR2
prerank,cellular response to radiation (GO:0071478),0.38440626983759085,0.986181614998167,0.4901506373117034,0.8483149477568803,1.0,19/40,31.91%,RAD1;SWI5;SPIDR;TANK;OPN1MW;OPN1MW3;LIG4;RHOB;HUS1;RAD51;TNKS1BP1;OPN3;TP53;RRH;GPR52;GRB2;INTS7;RHNO1;BLM
prerank,cellular response to insulin stimulus (GO:0032869),0.34349962470307027,0.9860936392462889,0.5342185903983657,0.8480596045707243,1.0,26/124,16.29%,IRS1;SLC39A14;GRB10;RHOQ;ATP6V1C2;SHC1;HDAC9;TCIRG1;C2CD5;FOXC2;ATP6V0A1;PRKDC;RAB8A;CAPN10;AKT2;ZNF106;SYAP1;ATP6V0D1;PDPK1;PHIP;PTPN2;ATP6V1B2;ATP6V1E1;SOS1;PARP1;IDE
prerank,fat cell differentiation (GO:0045444),0.3663750218149976,0.9860423811477672,0.4834070796460177,0.8477138250011663,1.0,5/57,8.69%,PID1;TCF7L2;SMAD6;BBS9;AKT2
prerank,negative regulation of receptor internalization (GO:0002091),0.46957159156514333,0.9858838226656768,0.5048275862068966,0.8476206464496067,1.0,4/12,20.52%,LRPAP1;DLG4;WDR54;ATXN2
prerank,regulation of histone deacetylation (GO:0031063),0.4606187753243944,0.9853130206175446,0.5123287671232877,0.8485128318788405,1.0,5/13,27.90%,CAMK2D;NIPBL;AKAP8;SAP30BP;SPHK2
prerank,negative regulation of DNA recombination (GO:0045910),0.37642424698810945,0.9841591101564339,0.519298245614035,0.8507576154569608,1.0,21/43,33.29%,HELB;PARP3;RMI2;POLR2F;MAD2L2;POLR2B;DAXX;FBH1;CGAS;POLR2H;SHLD3;ZRANB3;RTEL1;SHLD1;POLR2I;POLR2L;PARPBP;POLR2K;BLM;MSH2;POLQ
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.36654610236665336,0.9839820058748341,0.5028184892897407,0.8507188756075768,1.0,17/53,24.03%,PSMD7;PSMA8;PSMA4;PSMD12;PSMA6;PSMD11;PSMC5;PSMD1;PSMD14;PSMC4;AZIN1;BCKDK;PSMA3;PSMD4;PSMB1;PSMA5;PSMA7
prerank,DNA damage checkpoint signaling (GO:0000077),0.4108192170030588,0.9839555853087725,0.51,0.8503144662517446,1.0,14/28,30.78%,TIPRL;RAD1;ATM;CHEK2;CEP63;ATRIP;HUS1;E2F1;DONSON;ATR;INTS7;HINFP;RAD17;RHNO1
prerank,cellular response to osmotic stress (GO:0071470),0.4274688533555837,0.983936369312903,0.5200517464424321,0.8498913208107448,1.0,4/21,6.72%,YBX3;LRRC8D;SLC4A11;STK39
prerank,regulation of intracellular signal transduction (GO:1902531),0.32899567774234073,0.9836988269122849,0.5505505505505506,0.8500234520501804,1.0,103/420,19.69%,MYOC;RASSF2;EGFR;CMKLR1;RHOJ;VEGFA;SRGAP2;SRGAP3;FSHR;TIAM1;ARAP1;NTRK3;RHOQ;NTRK1;TIAM2;TCP11;VAV2;PRDM11;PKHD1;CSNK2A1;CSNK2A2;ARHGAP17;KMT5A;RRS1;CHD3;USP2;RMI2;MOB3B;BCR;RHOT2;EHMT1;MDM4;ARHGAP21;PAK4;CASTOR2;KALRN;DLG1;RHOA;RBBP8;RHOT1;PAK2;RAD1;ITGAV;PIP4K2B;ING5;WRN;INPP5B;MYO9A;ATM;ARHGAP20;TELO2;CHEK2;ULK4;PDPK1;TAF15;TAF6;HDAC1;ARHGAP8;RAD50;EZR;TRAF3;NLGN1;TAF13;RBBP7;OCRL;USP7;ARHGAP44;SQSTM1;SOS2;ARHGEF1;TMEM127;AKAP13;TBCK;RHOB;SOS1;PIP5K1A;TRIO;ATRIP;WDR54;PPP2R5C;TP53RK;TTC5;TAGAP;FLCN;HUS1;SSRP1;ARAF;UFL1;BOP1;NGEF;PRKAG1;TRIM6;VRK2;AKT1;NOC2L;HIPK2;CDK2;TAF9B;PRKAB1;MAPKAP1;CRK;CDK5;NFKBIA
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.4679156540831472,0.9835090123788013,0.5078909612625538,0.8500070950951532,1.0,7/12,28.32%,GNL3;CCT6A;CCT4;CCT8;TCP1;DKC1;CCT5
prerank,neuron projection morphogenesis (GO:0048812),0.34285839095601606,0.9834825611885133,0.5393258426966292,0.8496099794546935,1.0,27/137,15.67%,DCLK1;CTNND2;SRGAP2;MAP1B;FARP1;CTTN;ANKRD27;EPHB2;ARC;DOCK7;EPHB3;DNM2;DVL1;RAB8A;LLGL1;DLG4;S100B;IMPACT;FGFR2;TMEM106B;SHANK1;NLGN1;LRP2;MEF2A;NBL1;IQGAP1;TRIO
prerank,C4-dicarboxylate transport (GO:0015740),-0.358879930116825,-0.9829802870986545,0.4734982332155477,0.7415477409194147,1.0,6/14,16.20%,SLC25A13;SLC1A1;SLC1A2;SLC25A14;SLC13A5;SLC25A30
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.39155148406597345,0.9827547521534058,0.5151148730350665,0.850890860588749,1.0,14/33,30.89%,PPP6R3;TERT;TELO2;RAD50;DCLRE1B;RAD51;TNKS1BP1;CDK2;ANKRD28;DKC1;RTEL1;CTC1;HSP90AA1;NOP10
prerank,error-prone translesion synthesis (GO:0042276),0.4230825382171265,0.9826402201761488,0.49222797927461137,0.850692073380902,1.0,7/21,24.07%,REV3L;POLE2;RPS27A;UBC;REV1;MAD2L2;PRIMPOL
prerank,regulation of type I interferon production (GO:0032479),0.3503965017427626,0.9824631979882402,0.5117021276595745,0.8506535388135689,1.0,44/84,35.64%,TAX1BP1;MAVS;PRKDC;GPATCH3;POLR3H;ITCH;IRAK1;CRCP;TRAF3;PCBP2;POLR3GL;UBE2L6;POLR2F;CREBBP;NFKB2;OTUD5;ACOD1;IKBKE;NPLOC4;IRF3;POLR3K;XRCC6;POLR1C;RNF216;CYLD;ILRUN;TBK1;CGAS;POLR2H;DDX41;POLR3E;RNF135;POLR2L;CTNNB1;NFKB1;POLR2K;POLR3F;IFIH1;RELA;DHX9;NLRP4;IRF1;MRE11;G3BP1
prerank,regulation of primary metabolic process (GO:0080090),0.33958936173069937,0.9824092139956005,0.5410677618069816,0.8502946048295592,1.0,35/126,24.03%,ID2;TNFAIP8L3;CHD9;NCOR2;PSMD7;RXRA;PSMA8;PLPP1;CARM1;PSMA4;SREBF1;NR1D2;PSMD12;PSMA6;ACACA;PSMD11;PSMC5;PSMD1;CREBBP;PSMD14;SIN3B;PSMC4;AZIN1;LSS;NFYA;PRKAB1;SC5D;PSMA3;PSMD4;GPS2;PSMB1;LDLR;PSMA5;TM6SF2;PSMA7
prerank,negative regulation of cell development (GO:0010721),-0.30886345181375624,-0.9820667543429563,0.4973544973544973,0.7422374973506883,1.0,5/25,14.31%,B2M;NOTCH1;RFLNA;RFLNB;IGF1
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.35002284681047635,0.981919386379401,0.5160599571734475,0.8510207134124552,1.0,32/87,28.63%,FGF2;FGF17;HNRNPH1;SPRED2;RBFOX2;FGFR1;CBL;FGFR2;FLRT2;GTF2F1;SHOC2;HNRNPM;PTBP1;TIAL1;GALNT3;NDNF;POLR2F;FGF5;NCBP1;NCBP2;FGF18;FGFR3;POLR2B;HNRNPA1;PTPN11;DSTYK;CCL2;POLR2H;ZFP36L1;SETX;GRB2;POLR2I
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),0.4604186218960101,0.9818330444724573,0.5145228215767634,0.8507786652751397,1.0,3/13,14.36%,ISCA2;GLRX5;MMS19
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.35206819425866615,-0.9813095002010668,0.49795918367346936,0.7426177638754584,1.0,5/15,16.39%,PRKCH;AGTR1;CSF1;LPL;MSR1
prerank,membrane lipid biosynthetic process (GO:0046467),0.3726859509897863,0.9811919519652342,0.5331088664421998,0.8518830399769108,1.0,7/58,8.47%,ST3GAL4;ACER3;PLPP3;KDSR;ELOVL5;PLPP1;ST3GAL2
prerank,positive regulation of cell migration (GO:0030335),0.3324297139861913,0.9811080542097934,0.5655655655655656,0.8516326150115889,1.0,28/253,7.95%,THBS1;MYOC;EGFR;VEGFA;DDR2;F3;COL1A1;ADAM9;TWIST2;TIAM1;NTRK3;DRD1;PRKCE;ACVR1B;RDX;EPHB2;STAT3;TGFB2;SEMA3E;PRKCA;ACVR1;MMP14;ADAM10;DOCK5;SEMA4B;CXCL16;ELP5;SOX9
prerank,positive regulation of viral life cycle (GO:1903902),0.4197099514682594,0.9810893452397212,0.5188067444876784,0.8512109739875088,1.0,7/22,28.05%,P4HB;KPNA2;CHMP3;CHMP2A;VPS37B;DDB1;KPNA6
prerank,negative regulation of gluconeogenesis (GO:0045721),-0.3985556268336624,-0.9810576940222208,0.4793650793650794,0.7416450435510354,1.0,4/11,21.85%,C1QTNF3;C1QTNF12;SIK1;EP300
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.3499624995615992,0.9809473994778403,0.5263157894736842,0.8510944955525395,1.0,8/87,4.47%,PRKCD;EFNA5;RHOBTB1;LRP1;RHOQ;RND3;ARHGAP17;SEMA3E
prerank,negative regulation of viral transcription (GO:0032897),0.4647922612654184,0.9808711765822131,0.5115961800818554,0.8508220685060814,1.0,6/13,19.98%,TRIM27;UBP1;MID2;HEXIM1;TRIM13;LARP7
prerank,presynapse assembly (GO:0099054),-0.3476147233502457,-0.9803037831616546,0.4796747967479675,0.7419059048958863,1.0,4/16,4.73%,IL1RAPL1;WNT5A;PTPRD;BSN
prerank,post-translational protein modification (GO:0043687),0.3298073763774141,0.9800851665492207,0.57,0.852213655490884,1.0,115/332,29.66%,IGFBP5;CHRDL1;FSTL1;GAS6;GPC3;P4HB;FBXO10;DMP1;FBXL7;PSMD7;RAB2A;FBXW8;PTP4A2;COP1;DCAF6;PSMA8;PRKCSH;ERCC8;ADAM10;RAB8A;CKAP4;QSOX1;MBTPS1;GPS1;SOCS6;SOCS2;CST3;CALU;PSMA4;CUL4A;BMP4;UCHL3;RAB38;RCN1;FBXL4;FBXO22;FBXL12;PSMD12;CUL1;TULP4;FBXL19;PSMA6;WDR5;RBBP7;RAB11B;NUCB1;FBXL14;DCAF13;MIA3;KLHL22;PSMD11;FBXL20;PSMC5;IL6;VCAN;PSMD1;DDA1;FBXO17;PSMD14;STT3A;PSMC4;FBXL18;MEN1;SUMF2;ASB5;SENP8;RNF7;FBXW2;FBXW4;APLP2;PSMA3;DCAF11;PSMD4;PSMB1;PENK;RAB1A;CUL9;ASB6;COPS4;UBA3;COPS7A;PSMA5;RAB1B;FBXO11;PSMA7;VGF;FBXO9;ANKRD9;CUL7;COPS3;FBXW10;DCAF5;SDC2;RAB5A;CCDC8;PSMC1;RABGGTB;DCAF4;KCTD7;CAND1;ESCO1;DCAF17;PSMA1;DDB1;SCG2;TIMP1;RAB3A;WDTC1;FBXL8;BTRC;STT3B;FBXO41;RBX1;ANO8;KLHL9
prerank,cytoskeleton organization (GO:0007010),0.3434149627451093,0.9800472415277648,0.5307612095933264,0.8518382465539985,1.0,13/114,8.97%,MICAL2;RHOBTB1;PLCE1;FMNL2;MARK1;RND3;ARC;CCL13;FGD6;BRWD1;PALLD;PAK4;RHOA
prerank,axoneme assembly (GO:0035082),0.39398590381910964,0.9795929846937274,0.5112692763938316,0.8524899265931302,1.0,8/30,22.93%,CFAP206;DNAAF3;CCDC39;LRGUK;TTLL3;TTC12;SPAG17;SPAG16
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.416534237084312,0.9795091955317233,0.4949874686716792,0.8522195040241765,1.0,1/23,0.20%,SLC4A4
prerank,prostanoid metabolic process (GO:0006692),-0.3727597917115044,-0.979418777505188,0.4674329501915709,0.7423773009749255,1.0,5/13,16.30%,PTGS1;HPGD;GSTM1;PTGR2;CYP2S1
prerank,ventricular cardiac muscle cell action potential (GO:0086005),-0.34495942880644287,-0.9788884911186839,0.4759825327510917,0.7422066009530748,1.0,8/17,20.62%,NEDD4L;RYR2;GPD1L;KCNJ8;PKP2;SCN3B;KCNQ1;SCN5A
prerank,regulation of stress fiber assembly (GO:0051492),0.35574420870025775,0.9787327421940935,0.5005347593582887,0.8535926672556943,1.0,16/74,12.22%,MYOC;ASAP3;ARAP1;TMEFF2;TGFB3;SORBS3;PPFIA1;S100A10;ALMS1;PFN2;SLC9A1;RHOA;PAK2;ABL1;NRP1;TGFBR1
prerank,negative regulation of potassium ion transport (GO:0043267),-0.3608074612232146,-0.9785630975455722,0.5201612903225806,0.7413613709251246,1.0,5/13,15.14%,NEDD4L;ACTN2;CAV1;NOS1;CASQ2
prerank,protein localization to synapse (GO:0035418),0.4699975706475664,0.9785606735020643,0.5006915629322268,0.8535273753852012,1.0,5/12,13.27%,DLG4;MPP4;NRXN2;SHANK1;NLGN1
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.4757321300265104,0.978522758320093,0.5161290322580645,0.8531717750265408,1.0,5/12,24.86%,PRKDC;SDE2;CDK2;RPS27L;TP53
prerank,regulation of cell communication (GO:0010646),0.3873020238209057,0.9779378134755201,0.5351941747572816,0.8541350123191089,1.0,7/35,11.95%,MGLL;CAMK2D;ANK2;SOCS2;ANXA1;NCLN;GRK6
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),0.42944937459565696,0.9777980150221209,0.5061224489795918,0.853980781622516,1.0,4/16,11.22%,ZFPM2;FGF2;FGFR2;BMPR1A
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.41087991121504364,0.977762083496515,0.5104039167686658,0.8536092871925458,1.0,7/24,21.72%,CYP1B1;ATF4;SULF1;RORA;IL6;SULF2;EIF2AK3
prerank,positive regulation of dephosphorylation (GO:0035306),0.39566393955506896,0.977706240730823,0.5024752475247525,0.8532852252561087,1.0,8/27,16.30%,PRKCD;CALM2;SYMPK;RIPK3;CNEP1R1;PTBP1;NSMF;CALM3
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.38987055771600054,0.9775449915958276,0.4846335697399527,0.8532186906699681,1.0,14/31,34.00%,TOPORS;DCUN1D5;UBE2C;AXIN1;DCUN1D2;CDC20;RAB1A;PINK1;GOLGA2;BTRC;UBE2S;GORASP1;UBE2N;ARRDC4
prerank,regulation of viral life cycle (GO:1903900),-0.3199711954421947,-0.9774251018505307,0.4423963133640553,0.7425798340815751,1.0,6/21,14.46%,PPIA;TRIM14;NECTIN2;TRIM21;TRIM68;AXL
prerank,embryonic axis specification (GO:0000578),0.4555441840091915,0.9771217756018291,0.5186206896551724,0.8537829426371072,1.0,3/15,8.32%,SMAD6;COBL;FZD5
prerank,regulation of telomerase activity (GO:0051972),0.3705586631582556,0.977106074269471,0.5188141391106044,0.8533583875200559,1.0,16/45,30.61%,MAPK15;NEK7;SMG6;ERCC4;ATM;NVL;MEN1;CCT4;MAP2K7;TCP1;TP53;PARP4;PNKP;DKC1;CTNNB1;HSP90AA1
prerank,positive regulation of growth (GO:0045927),0.3617956376668094,0.9770575009643443,0.5318918918918919,0.8530071115394513,1.0,22/64,22.41%,EGFR;CSNK2A1;TGFB2;EIF4G2;FXN;AGR2;MMP14;ADAM10;CXCL16;TGFBR1;EIF4G1;SUPV3L1;EXOSC4;KLHL22;ERBB2;NCBP1;HDGFL2;AKT1;TAF9B;DDX49;USP47;RPTOR
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.3927859920874374,0.9764622869617908,0.5170731707317073,0.8539603487558252,1.0,3/35,4.18%,MYOC;EPHB2;TGFB2
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),0.4769284797690894,0.9760984881728564,0.5264586160108549,0.8543936640334623,1.0,5/11,35.32%,ATF4;PINK1;PRKN;NR4A3;NONO
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.3652603883991337,0.9759825822217972,0.5303867403314917,0.8541991131598885,1.0,12/56,22.21%,LBP;HMGB1;ALPK1;TAB2;IRAK1;TRAF3;S100A1;RPS27A;UBC;CTSB;CTSK;TLR1
prerank,peptidyl-amino acid modification (GO:0018193),0.48142149948366014,0.9758653461103443,0.5036284470246735,0.8540419111625038,1.0,6/10,34.61%,FKBP10;METAP1D;METAP2;ATP7A;METAP1;FKBP7
prerank,cell chemotaxis (GO:0060326),0.358356511704966,0.9755861060457905,0.5298013245033113,0.8542512291463961,1.0,11/60,15.63%,PRKCD;VEGFA;CCN3;DOCK4;ABCC1;ACKR4;NRP1;PARVA;CXCR4;HGF;PIP5K1A
prerank,positive regulation of organelle assembly (GO:1902117),0.3774429801480437,0.9753371365269955,0.5172018348623854,0.8543871986491696,1.0,18/44,27.29%,SDC1;IL5;DYNC1H1;RAB3GAP1;LRSAM1;PIP4K2B;MARK4;G3BP2;FUZ;KCTD17;RAB3GAP2;PDCD6IP;NUP62;PLK4;CCP110;ARHGAP35;TAPT1;PIP4K2C
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.4571616276422804,0.9753059176784952,0.5183727034120735,0.8540065986220772,1.0,3/15,7.24%,ADAM9;EHD1;EHD2
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.38225574069299867,0.9747697315131115,0.5006075334143378,0.854790286631486,1.0,9/31,13.42%,ZFPM2;TGFB2;SMAD4;NOG;FGFR2;BMPR1A;SMAD7;TGFBR1;LRP2
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.4567136305847525,0.9747198458515537,0.5339673913043478,0.8544501393037174,1.0,5/15,13.39%,EGFR;NTRK1;ABL1;DDR1;SRMS
prerank,peptidyl-lysine acetylation (GO:0018394),0.4796736591065804,0.9746697148271398,0.5279034690799397,0.8541130399093965,1.0,5/10,26.91%,KAT2A;CREBBP;KAT7;KAT2B;ESCO1
prerank,phospholipid homeostasis (GO:0055091),0.4717546631917642,0.9745894332145836,0.5102880658436214,0.853861026319374,1.0,5/11,26.62%,TLCD2;ABCA1;TLCD1;RCN3;ANGPTL3
prerank,regulation of transport (GO:0051049),-0.2816732924964094,-0.9745031928857739,0.5172413793103449,0.7480864925138301,1.0,4/36,2.89%,LEPR;EPB41;ICA1;MYO6
prerank,negative regulation of B cell activation (GO:0050869),0.42605476528014036,0.9744696515194091,0.527431421446384,0.8536875303173231,1.0,4/21,12.95%,ID2;PARP3;ATM;INHBA
prerank,ribosomal small subunit biogenesis (GO:0042274),0.378117444804992,0.9734141677808789,0.5200471698113207,0.8557800294751908,1.0,7/39,10.83%,RPSA;LTV1;RRP7A;EMG1;SRFBP1;WDR3;RIOK1
prerank,sympathetic nervous system development (GO:0048485),0.440991311493159,0.9731483066198915,0.5054347826086957,0.8559708100977746,1.0,4/15,18.44%,NTRK1;NRP1;NF1;GDNF
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.40924924227903936,0.9731302329614476,0.5088161209068011,0.8555610283168593,1.0,5/22,14.55%,DDX5;SPRED2;CDK5RAP3;ATM;HEXIM1
prerank,interleukin-35-mediated signaling pathway (GO:0070757),0.4662723032703946,0.973019197557407,0.5118694362017804,0.8553463495681041,1.0,2/11,6.51%,STAT3;IL12RB2
prerank,regulation of multicellular organism growth (GO:0040014),0.4519644016802422,0.9728631765632098,0.5327978580990629,0.8552575094263339,1.0,3/15,12.09%,GHR;STAT5A;SOD1
prerank,snRNA transcription (GO:0009301),0.3512800620267446,0.9722222133371861,0.5169769989047097,0.8563584723418995,1.0,35/70,35.36%,INTS14;INTS3;INTS4;GTF2F1;CCNT2;INTS13;TAF6;TAF13;SNAPC4;POLR2F;RPRD1A;NCBP1;USPL1;NCBP2;POLR2B;TBP;ICE1;POLR2H;INTS9;SRRT;CDK9;POLR2I;INTS7;POLR2L;INTS6;GTF2A2;RPAP2;SNAPC1;POLR2K;RPRD2;ZC3H8;INTS10;POU2F1;SNAPC3;GTF2E2
prerank,ERBB signaling pathway (GO:0038127),0.36039605880553444,0.9717707111240003,0.5353982300884956,0.8569681064979809,1.0,15/64,18.60%,EGFR;PLCE1;SHC1;PRKCA;SOX9;CBL;PTPN18;PDPK1;STUB1;IQGAP1;SOS1;ERBB2;GAREM1;ERBIN;AKT1
prerank,cilium movement (GO:0003341),0.3770295129301339,0.9717529432396682,0.5299435028248588,0.8565524826843117,1.0,12/47,24.38%,CFAP251;CFAP206;ODAD2;CCDC39;ROPN1L;DNAAF4;TEKT2;TTC29;CFAP73;SPAG17;CAMSAP3;DNAAF5
prerank,ephrin receptor signaling pathway (GO:0048013),0.3470496814506752,0.971733956515779,0.5340425531914894,0.85614316968429,1.0,12/82,8.97%,EFNA5;ARHGEF28;TIAM1;VAV2;EPHB2;SIPA1L1;ARPC1B;AP2A1;EPHB3;EPHB6;KALRN;RHOA
prerank,regulation of lymphocyte activation (GO:0051249),0.46240061099570584,0.9713522772485159,0.5205479452054794,0.856576026471195,1.0,3/12,12.68%,IKZF3;CRTAM;KAT2A
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.4624796227201674,0.9712545561498506,0.5230769230769231,0.8563323041071949,1.0,1/13,0.51%,PLXNA4
prerank,DNA double-strand break processing (GO:0000729),0.43058464444769484,0.9712485862609468,0.5291777188328912,0.8558907473148019,1.0,10/18,32.37%,RBBP8;ATM;RAD50;UBE2V2;SMARCAD1;RNF138;SLX4;RAD52;BLM;UBE2N
prerank,cellular response to organic cyclic compound (GO:0071407),0.33394630188523206,0.9712390926305494,0.5510835913312694,0.855456047747451,1.0,19/141,12.87%,ESR1;EGFR;IGFBP5;DRD1;CYP1B1;HCN4;SLC26A6;PDE3A;ADCY2;ADCY8;NRIP1;RORA;JUP;IMPACT;SPIDR;URI1;P2RY6;AKAP9;EZR
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),-0.28309077345201916,-0.9712343783760935,0.5222929936305732,0.7543111831813347,1.0,13/32,22.75%,CEMIP;TRPC3;AKAP6;CAV1;CX3CL1;GRIN1;APLNR;SNCA;GPER1;P2RX7;THY1;CASQ1;CXCL10
prerank,regulation of gluconeogenesis (GO:0006111),0.3987351243740701,0.9710899076250199,0.5232120451693852,0.8553537443918835,1.0,8/27,18.35%,OGT;DGKQ;NNMT;PTPN2;USP7;ARPP19;GNMT;CLK2
prerank,positive regulation of JNK cascade (GO:0046330),0.3574585659525984,0.9710091097336062,0.5459459459459459,0.8550745067320215,1.0,11/70,13.74%,RASSF2;SH3RF3;GADD45G;MAP3K5;HMGB1;FZD7;LTBR;AXIN1;CD27;TRAF3;MAP3K10
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.45754954528762737,0.9708836179090208,0.5230125523012552,0.8549029045802845,1.0,4/13,21.57%,GAB2;STX4;IL4;LAMP1
prerank,positive regulation of cellular catabolic process (GO:0031331),0.3364542503334623,0.9707312469071089,0.551829268292683,0.8547899054416497,1.0,36/132,22.82%,SLC4A4;IRS1;PRKCD;ADAM9;RDX;TWIST1;DACT1;TNFRSF1B;HMGB1;TRIM27;AKT2;ITCH;SNX9;MID2;PIK3CB;EZR;SUPV3L1;TRIM65;FOXO3;CNOT8;ORMDL3;FLCN;UFL1;TRIM6;VPS11;SH3D19;MLXIPL;ATF6;LRRK2;OPTN;DAGLB;TRIM8;ABCD1;PFKFB4;UPF1;NPRL2
prerank,regulated exocytosis (GO:0045055),0.3310740629460727,0.9704857198973684,0.5818181818181818,0.8549206699001772,1.0,35/173,19.78%,THBS1;VEGFA;GAS6;SYT8;CHID1;TIMP3;TGFB3;SPARC;PCDH7;TOR4A;ARHGAP17;TGFB2;MAGED2;CD9;QSOX1;FAM3C;BRPF3;STEAP2;RAB11FIP5;SOD1;RAB11B;MANF;SCIN;HGF;STX1A;CD109;SERPING1;LHFPL2;WDR1;SYTL4;PCYOX1L;SNAPIN;CDK5;APLP2;TEX264
prerank,microvillus organization (GO:0032528),-0.37123705362636183,-0.9704437949712098,0.4697986577181208,0.754607375325405,1.0,3/13,2.49%,MAP4K4;TNIK;RAPGEF2
prerank,acylglycerol homeostasis (GO:0055090),-0.3203010784030407,-0.9698980145304854,0.5111111111111111,0.7543363356905172,1.0,5/20,12.22%,APOE;NR1H3;PNPLA8;SCARB1;LPL
prerank,hydrogen peroxide catabolic process (GO:0042744),0.4643433130227394,0.9698023071544345,0.5113314447592068,0.8560555922726989,1.0,6/11,29.98%,PRDX3;CAT;PRDX2;PRDX1;PXDN;PRDX5
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.35017999825942847,0.969749998554914,0.5267094017094017,0.8557120326273044,1.0,11/75,14.21%,MGLL;SLC39A14;PLCE1;PPP1R9B;PDE6A;DGKQ;RPGRIP1L;GIT1;GRK6;USP33;GUCY2D
prerank,regulation of lysosomal lumen pH (GO:0035751),0.46779476485146415,0.9695812984385583,0.5235457063711911,0.8556423014835087,1.0,4/12,27.84%,TMEM165;CLN3;LRRK2;CLN5
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.37928067225558837,0.9692268441650203,0.5474285714285714,0.8560154634169597,1.0,11/45,18.60%,EGFR;PLCE1;SHC1;SOX9;CBL;PDPK1;IQGAP1;SOS1;GAREM1;ERBIN;AKT1
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.38883301424654315,0.969145436591348,0.5463071512309496,0.8557608822483938,1.0,3/33,2.85%,IGFBP5;PDCD4;TGFB3
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.4388273720175748,0.9689237677789692,0.5191040843214756,0.855815051714388,1.0,5/17,13.31%,CYFIP1;GMFB;ARFIP2;ARF1;PICK1
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.3399578659267981,0.9685591151236143,0.5375,0.8561822410957582,1.0,14/102,9.94%,IRS1;SLC39A14;PRKCD;RHOQ;HDAC9;C2CD5;ADCY2;ADCY8;PRKDC;RAB8A;ADCY9;CAPN10;AKT2;SYAP1
prerank,tricarboxylic acid metabolic process (GO:0072350),0.4671673132804136,0.9684128977770188,0.5295735900962861,0.8560590603790911,1.0,8/12,34.94%,ACO1;IREB2;IDH3B;ACLY;IDH2;IDH3G;IDH1;GLUD1
prerank,negative regulation of stem cell differentiation (GO:2000737),0.46624685555810785,0.9682501589374791,0.521497919556172,0.8559877821092543,1.0,3/12,8.52%,HES5;JAG1;ESRRB
prerank,release of sequestered calcium ion into cytosol (GO:0051209),-0.2984822552458689,-0.967731650589951,0.5123152709359606,0.7580963396287035,1.0,5/26,10.00%,ITPR1;RYR2;ITPR3;HTR2C;ITPR2
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.45709385031964334,0.9676540002400381,0.5270457697642164,0.8569520032360785,1.0,2/13,5.33%,GAS6;MAVS
prerank,positive regulation of catalytic activity (GO:0043085),0.38085135012597576,0.9674742307052534,0.525323910482921,0.8569088259455703,1.0,9/37,15.19%,BCAS3;FXN;MAPK8;WRN;ABL1;CHTOP;SOD1;PSEN2;STX4
prerank,nuclear membrane organization (GO:0071763),0.4264908483664883,0.9673707177226359,0.5313315926892951,0.8566900531904895,1.0,8/19,28.80%,SPAST;TMEM43;CHMP4B;DCTN1;NEMP1;CHMP2A;UBXN2A;TOR1AIP1
prerank,lipoprotein biosynthetic process (GO:0042158),-0.3789510567707581,-0.9673306871986128,0.5192307692307693,0.7574779634967574,1.0,1/11,1.41%,APOE
prerank,carboxylic acid catabolic process (GO:0046395),0.4647638043310522,0.9671935970124862,0.5310734463276836,0.8566249184658175,1.0,6/12,31.93%,GNPDA1;RENBP;BCKDK;ACOT8;PON3;NAGK
prerank,regulation of DNA repair (GO:0006282),0.3733210802826866,0.966943719210691,0.5316742081447964,0.8567421578567753,1.0,4/44,6.18%,EGFR;EYA2;TRIM28;ERCC8
prerank,positive regulation of TOR signaling (GO:0032008),0.38428557927257934,0.9668914456413745,0.5390898483080513,0.8564032237607908,1.0,20/40,34.41%,GAS6;SEC13;LAMTOR1;SEH1L;CLEC16A;TELO2;KLHL22;FLCN;GOLPH3;RHEB;RPTOR;SMCR8;LAMTOR2;LAMTOR3;GPR137B;HTR6;HDAC3;PIK3CA;FNIP1;SLC38A9
prerank,translational elongation (GO:0006414),0.342016218323528,0.9667113046516613,0.5413135593220338,0.8563709761307813,1.0,50/101,37.99%,MRPS2;MRPL33;DAP3;MRPL19;MRPS35;MRPS28;MRPS18B;MRPL39;MRPS14;EEF1G;MRPL35;LTN1;MRPS17;EEF2K;EEF1B2;MRPL45;TUFM;EEFSEC;PTCD3;MRPL12;MRPL47;MRPS26;GTPBP2;MRPS24;MRPS21;MRPS18A;MRPL37;MRPL17;MRPL13;MRPL30;MRPL4;MRPL11;MRPL24;MRPL28;MRPS10;CHCHD1;MRPL15;MRPS31;EEF1D;MRPS33;MRPL50;MRPL41;AURKAIP1;MRPL14;MRPL32;MRPL38;NEMF;MRPL57;MRPL46;MRPL2
prerank,positive regulation of histone acetylation (GO:0035066),0.4111062343461439,0.9666865943610611,0.5208070617906684,0.8559820925178748,1.0,4/23,7.72%,MUC1;SMAD4;TADA2A;RPS6KA4
prerank,signal transduction in response to DNA damage (GO:0042770),0.37364936200715226,0.9665939036264704,0.5430539609644087,0.8557366317739821,1.0,24/49,30.78%,MDM4;NDRG1;TIPRL;RAD1;ABL1;ATM;CHEK2;SESN2;CEP63;ATRIP;HUS1;E2F1;USP10;BID;MAD2L2;TRIAP1;DONSON;TP53;ATR;GRB2;INTS7;HINFP;RAD17;RHNO1
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.34494049453295994,0.9661809091232847,0.5555555555555556,0.856223462487213,1.0,22/80,25.59%,THBS1;PRKCD;SLC2A13;SAMD4A;PRKDC;NIBAN1;IL6;EIF6;ERBB2;EIF3D;EFNA1;CLU;CIRBP;PYM1;FXR2;NSMAF;UPF3A;RPS6KB1;RBM3;RPS27L;UPF3B;METTL14
prerank,translational termination (GO:0006415),0.3454211918136442,0.9659080273653875,0.5529411764705883,0.856398843873155,1.0,30/95,28.80%,MRPS2;MRPL33;DAP3;MRPL19;MRPS35;MRPS28;GSPT1;MTRF1L;MRPS18B;ABCE1;MRPL39;MRPS14;MRPL35;ETF1;MRPS17;MRPL45;PTCD3;MRPL12;MRPL47;MRPS26;MRPS24;MRPS21;MRPS18A;MRPL37;MRPL17;MRPL13;TRMT112;MRPL30;MRPL4;MRPL11
prerank,cellular response to oxygen levels (GO:0071453),0.48279338241779496,0.9658368262645577,0.537463976945245,0.8560937060938417,1.0,2/10,13.31%,ATP6V0D1;PICK1
prerank,regulation of biomineral tissue development (GO:0070167),0.3989009087860633,0.9653142806972623,0.5246690734055355,0.8568382496409012,1.0,5/26,7.95%,GAS6;DDR2;TWIST1;NBR1;SOX9
prerank,cellular response to cadmium ion (GO:0071276),0.40501417056510247,0.965218077592159,0.5095298602287166,0.856612911113819,1.0,8/24,25.74%,EGFR;MAPK8;CHUK;SUMO1;AKT1;MAPK9;FOS;DAXX
prerank,cell cycle G2/M phase transition (GO:0044839),0.3366603407795565,0.9650218177689264,0.5590955806783144,0.8566241915986759,1.0,41/129,24.42%,FBXL7;CSNK1D;PPP1R12B;DYNC1H1;SFI1;DNM2;ODF2;ALMS1;DCTN2;CDC25B;FOXM1;CKAP5;LCMT1;CHEK2;FBXL12;KHDRBS1;CUL1;AKAP9;SDCCAG8;CEP164;CSNK1E;YWHAE;CEP41;PCM1;ARPP19;CEP63;HAUS5;CDC25A;CCDC57;CDK2;AKAP8;DYNC1I2;DCTN1;OPTN;PRKACA;ACTR1A;CDK5RAP2;NEDD1;CNTRL;PLK4;CCP110
prerank,polyol biosynthetic process (GO:0046173),0.4353005382874844,0.9643147293166143,0.5179282868525896,0.857750747547844,1.0,2/16,1.78%,FGF2;ACER3
prerank,cellular response to cAMP (GO:0071320),0.3896926321088112,0.9635637564508021,0.5358910891089109,0.8589975932834928,1.0,3/30,3.08%,IGFBP5;HCN4;SLC26A6
prerank,cellular response to drug (GO:0035690),-0.30266686279495864,-0.9635422892621526,0.5309278350515464,0.7648774786620638,1.0,5/25,9.74%,PPM1E;ACER2;TFRC;AIM2;PDE4B
prerank,positive regulation of cell growth (GO:0030307),0.34331645445389813,0.9632720118675244,0.5561385099685204,0.8591959970847195,1.0,24/96,22.41%,EGFR;NTN1;CSNK2A1;TGFB2;EIF4G2;FXN;MMP14;ADAM10;CXCL16;GOLGA4;TGFBR1;EIF4G1;SUPV3L1;EXOSC4;KLHL22;ERBB2;NCBP1;HDGFL2;AKT1;TAF9B;DDX49;USP47;SHTN1;RPTOR
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.39434969372675477,0.9632263831913599,0.513095238095238,0.8588408250751316,1.0,13/29,34.16%,NT5C3B;PATL1;LSM2;EXOSC4;CNOT8;DIS3;DCP1A;EDC4;LSM5;EXOSC2;EXOSC3;DCPS;CNOT6
prerank,tRNA 5'-end processing (GO:0099116),0.438126580542734,0.9631448100571821,0.5191040843214756,0.858601031647806,1.0,6/15,30.67%,SSB;RPP40;RPP14;RPP21;POP5;PRORP
prerank,membrane assembly (GO:0071709),0.3867867122193335,0.9629699126560812,0.531435349940688,0.8585443588306161,1.0,11/34,16.87%,CEL;TLCD2;ANXA2;S100A10;STX2;SPAST;NRXN2;NLGN1;STX4;TLCD1;SPTBN1
prerank,positive regulation of stress fiber assembly (GO:0051496),0.36658165488217803,0.9628518996581032,0.5311438278595696,0.8583629366045065,1.0,9/44,12.22%,MYOC;TGFB3;SORBS3;S100A10;PFN2;RHOA;ABL1;NRP1;TGFBR1
prerank,glucose homeostasis (GO:0042593),0.3444208850939898,0.9624791603588471,0.5618336886993603,0.8587902849718545,1.0,10/83,8.87%,IRS1;KCNB1;TCF7L2;STAT3;ADCY8;LRRC8D;MCU;BACE2;FOXK1;ADIPOR2
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),-0.2881863179853003,-0.9622841044428517,0.5217391304347826,0.7662391549061054,1.0,3/34,1.46%,LYN;MFHAS1;LGR4
prerank,mitotic cell cycle phase transition (GO:0044772),0.32900033357770864,0.9618460772296905,0.5907258064516129,0.8598478819076322,1.0,61/203,23.38%,ACVR1B;FBXL7;CSNK1D;PPP1R12B;CDC16;DYNC1H1;SFI1;ACVR1;DNM2;ODF2;ALMS1;E2F3;GSPT1;DCTN2;CUL4A;SPAST;CDC25B;FOXM1;CKAP5;RCC1;LCMT1;PHF8;UBE2C;CHEK2;FBXL12;KHDRBS1;CUL1;AKAP9;SDCCAG8;CEP164;CCNE2;INHBA;CSNK1E;YWHAE;CCNG2;CEP41;PPP2R2D;PCM1;ARPP19;LATS2;CEP63;HAUS5;ANAPC1;CDC25A;E2F1;DBF4;CDC27;CCDC57;CDK2;CHMP4B;MAX;DYNC1I2;DCTN1;BCAT1;OPTN;PRKACA;ACTR1A;CDK5RAP2;NEDD1;CNTRL;RPS6KB1
prerank,oligodendrocyte development (GO:0014003),0.4376864967864937,0.9618047797672735,0.5287049399198932,0.8594960888670731,1.0,3/15,14.40%,HES5;B4GALT5;PLP1
prerank,regulation of chromatin binding (GO:0035561),0.46545513267178024,0.961733348978493,0.5113960113960114,0.8591993806945363,1.0,7/10,37.05%,BTAF1;MED25;CDT1;WAPL;DDX11;DTX3L;KDM4D
prerank,microvillus assembly (GO:0030033),-0.3599667426559358,-0.9616194754799845,0.47330960854092524,0.7662181713889488,1.0,3/14,2.49%,MAP4K4;TNIK;RAPGEF2
prerank,regulation of platelet aggregation (GO:0090330),0.4304143046186042,0.9615764843063401,0.5268096514745308,0.8591212183241526,1.0,4/17,6.13%,PRKCD;C1QTNF1;PRKCA;CD9
prerank,cytokine-mediated signaling pathway (GO:0019221),0.3203338483332129,0.9615678772325407,0.646,0.8586891435592873,1.0,115/532,21.42%,IRS1;PRKCD;VEGFA;LBP;F3;COL1A2;FGF2;IL33;PDCD4;P4HB;CARD14;GRB10;GHR;MUC1;GAB2;CNTFR;TWIST1;SDC1;CCL13;PSMD7;SHC1;CAMK2D;STAT5A;ANXA2;CCL15;STAT3;MID1;PITPNA;IL5;PSMA8;TNFRSF1B;TXLNA;ILK;TNFSF15;SMAD4;IL12RB2;IRAK3;IFNLR1;BRWD1;HNRNPA2B1;HNRNPDL;RORA;RPS6KA4;SOCS6;CBL;SOCS2;FCER1G;JAGN1;ADIPOR2;ANXA1;TXNDC17;PSMA4;PAK2;LTBR;CHUK;CTF1;TAB2;IRAK1;COMMD7;ARF1;PSMD12;SOD1;CUL1;CD27;IL20RB;PIK3CB;PSMA6;CASP1;TRAF3;CD80;TRIM26;SQSTM1;CLCF1;STX4;MAP3K3;PSMD11;FOXO3;PSMC5;SOS1;IL6;HGF;STX1A;PSMD1;TRAF3IP2;PSMD14;PSMC4;OSMR;RPS27A;UBC;PRLR;IL17RE;HMOX1;AKT1;MAP3K14;BIRC5;PLP2;IRF3;MMP2;CRK;PTAFR;NFKBIA;APPL2;CAPZA1;APPL1;IL17RA;PSMA3;JAK1;TNFSF18;CEBPD;PSMD4;BIRC3;PRKACA;PSMB1;IL4;TRIM8
prerank,peptidyl-tyrosine modification (GO:0018212),0.35314061901860544,0.9611542943921545,0.5498357064622125,0.8591743016829493,1.0,9/56,10.41%,EGFR;PKDCC;DDR2;NTRK1;EPHB2;ABI1;FGFR1;FGFR2;ABL1
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.32858775965552883,0.9611393794575622,0.6004056795131846,0.8587634506169742,1.0,28/182,13.08%,ESR1;FOXP1;ID2;VEGFA;FGF2;SLC24A3;EMILIN1;ANXA7;LRPAP1;TGFB2;CD3E;XDH;ADAM10;DLG4;DGKQ;WWP2;RUNX1;BMP4;TERT;AGO1;BMPR1A;HDAC1;KDM4A;SMO;PTRH2;AGO2;ERP29;SETDB1
prerank,mitotic nuclear division (GO:0140014),0.3482989184193148,0.9609663977787457,0.550755939524838,0.8587412927567082,1.0,23/71,25.54%,TUBG2;SMC4;MISP;SMC3;RHOA;SPAST;UBE2C;CHEK2;MIS12;ZW10;NDEL1;PPP2R2D;KLHL22;STAG1;CHMP4B;CCDC61;NUP62;ARHGEF10;SMC1A;WRAP73;CHMP2A;CTDP1;SPICE1
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.3948401795545668,-0.960927978682912,0.4921135646687697,0.7663779637436406,1.0,3/10,5.24%,PODXL;DPP4;PIEZO1
prerank,phospholipid translocation (GO:0045332),0.3959415200477231,0.9605525160604512,0.5493300852618758,0.8592563171695239,1.0,6/28,11.40%,TMEM30B;ABCC1;ATP8B2;ATP8A1;ABCA1;ATP9A
prerank,phospholipid catabolic process (GO:0009395),0.40005758111798145,0.9601975681573569,0.535264483627204,0.859624384385055,1.0,6/24,15.80%,PLA2G4F;PLA2G4A;SMPD4;SMPDL3A;ENPP6;GDPD3
prerank,amide transport (GO:0042886),0.3975343035392103,0.9601852028526184,0.5233532934131736,0.8592042930506892,1.0,3/26,7.21%,SLC5A6;SLC25A32;DISP1
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.4451953758377397,0.9601387693394583,0.5195681511470985,0.8588567354645448,1.0,1/13,1.27%,IL33
prerank,regulation of cell cycle process (GO:0010564),0.3394308272644279,0.9599222333033259,0.5648535564853556,0.8589201256579722,1.0,32/104,26.77%,KIF13A;CSNK2A1;CSNK2A2;DYNC1H1;CALM2;HORMAD1;RMI2;SOX9;MAD1L1;RCC1;GIT1;MARK4;SND1;USP19;CALM3;FLCN;BIRC6;E4F1;DAPK3;DBF4;KIF20B;CUL9;SETD2;UVRAG;TXLNG;CDK13;RAB11FIP4;PLK4;CCP110;CUL7;CCDC8;ATF5
prerank,long-chain fatty acid metabolic process (GO:0001676),0.35752421307586396,0.9591414749505688,0.5453551912568306,0.8602316713009863,1.0,22/64,29.29%,MGLL;PLA2G4A;CYP1B1;ELOVL5;DAGLA;FADS1;ACAD9;ACSL3;PNPLA3;HACL1;ACSL6;SLC27A2;ACSBG1;DAGLB;ABCD1;ACOT8;ELOVL1;FAAH;ALOXE3;SLC27A3;SCP2;CPT2
prerank,regulation of endocytosis (GO:0030100),0.35866466801332886,0.959110818029556,0.5477272727272727,0.8598587454990546,1.0,18/61,22.64%,STON2;LRP1;GPC3;ARFGAP1;LRPAP1;LRSAM1;STON1;ABL1;DAB2;RAB4B;HIP1;CD151;RAB5B;RUFY2;ZFYVE16;RAB4A;TSC2;RUBCN
prerank,regulation of lipid metabolic process (GO:0019216),0.34121502419427935,0.95907955120468,0.5509554140127388,0.8594758539053643,1.0,15/88,17.33%,ID2;TNFAIP8L3;CHD9;NCOR2;RXRA;PLPP1;RORA;CARM1;SREBF1;NR1D2;ACACA;CREBBP;SIN3B;LSS;NFYA
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.4627821626994506,0.9590091562395519,0.5523415977961432,0.8591978623961598,1.0,5/12,22.30%,B3GNT7;B3GNT9;B4GAT1;B3GNT6;B3GNT2
prerank,regulation of oxidative phosphorylation (GO:0002082),0.43969310018485996,0.9588460579284902,0.5456989247311828,0.859119750129295,1.0,7/16,25.17%,ACTN3;VCP;SHMT2;MLXIPL;COX7A2L;ABCD1;PINK1
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.45789780496001053,0.9585687604597546,0.5449515905947441,0.8588454798993677,1.0,1/12,0.82%,EFNA5
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.45789780496001053,0.9585687604597546,0.5449515905947441,0.8588454798993677,1.0,1/12,0.82%,EFNA5
prerank,early endosome to late endosome transport (GO:0045022),0.41273532799423457,0.9585501481262981,0.5471698113207547,0.8584522270237208,1.0,3/20,8.31%,ANKRD27;RILP;EEA1
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.33843353044797614,0.9584872600888453,0.5560253699788583,0.8581517458327609,1.0,28/87,27.79%,FHL1;FBXL7;PSMD7;PSMA8;DACT1;DLG1;PSMA4;PSMD12;CUL1;PSMA6;PSMD11;PSMC5;PSMD1;PSMD14;PSMC4;RBL2;PSMA3;PSMD4;PSMB1;USP47;PSMA5;GPNMB;PSMA7;CCL2;PSMC1;ZFP36L1;PSMA1;KANK2
prerank,long-chain fatty acid transport (GO:0015909),-0.2876080858812742,-0.9579838094103987,0.4827586206896552,0.7720344733569832,1.0,8/30,10.21%,APOE;ACSL1;PRKAA2;PRKAG2;CPT1A;SLC27A4;MFSD2A;MID1IP1
prerank,regulation of erythrocyte differentiation (GO:0045646),0.38283128240690945,0.9579530532473579,0.5423122765196663,0.8589088451820608,1.0,5/35,6.12%,HOXA5;LDB1;ACVR1B;STAT3;PRKDC
prerank,negative regulation of T cell differentiation (GO:0045581),0.46310778777595646,0.9575944978597585,0.5517730496453901,0.8592986601430828,1.0,5/10,35.48%,BMP4;LAG3;GLI3;ZC3H8;IRF1
prerank,tRNA 5'-leader removal (GO:0001682),0.44968087287927455,0.9572803905749099,0.5261044176706827,0.8595319645059332,1.0,6/13,30.67%,SSB;RPP40;RPP14;RPP21;POP5;PRORP
prerank,positive regulation of lamellipodium assembly (GO:0010592),-0.3005460117804158,-0.9572180815353913,0.5108695652173914,0.7723446796632999,1.0,3/24,2.63%,AUTS2;OCLN;PIK3R1
prerank,integrin-mediated signaling pathway (GO:0007229),0.3481337404685522,0.957076854051315,0.5574650912996778,0.8595616254433857,1.0,12/73,12.40%,ITGA11;COL3A1;ADAM9;PLPP3;COL16A1;ILK;PRAM1;ADAM10;ITGAV;ABL1;NRP1;RCC2
prerank,glycerophospholipid catabolic process (GO:0046475),0.39412118383817896,0.9568983746118419,0.543451652386781,0.8595181714335247,1.0,7/27,16.77%,PLA2G4F;PLA2G4A;SMPD4;PLA2G5;ENPP6;GDPD3;PLA2G15
prerank,leukotriene biosynthetic process (GO:0019370),0.4453589018085008,0.9567633199338933,0.5378378378378378,0.8593687929448406,1.0,2/14,8.09%,PLA2G4A;PLA2G5
prerank,vacuolar acidification (GO:0007035),0.417377504678376,0.9566666000174148,0.5398230088495575,0.8591552995932441,1.0,8/21,30.10%,TCIRG1;ATP6V0A1;ATP6V0D1;CLN3;SLC11A1;ATP6V0E1;CLN5;ATP6V1H
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),-0.31944147348514773,-0.9564717666399338,0.5172413793103449,0.7709901563119488,1.0,4/21,5.57%,EYA1;BCL2;BCL2L1;EYA4
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.31944147348514773,-0.9564717666399338,0.5172413793103449,0.7709901563119488,1.0,4/21,5.57%,EYA1;BCL2;BCL2L1;EYA4
prerank,membrane raft organization (GO:0031579),0.43934110378065605,0.9564285643530319,0.5366492146596858,0.8592647453564817,1.0,4/15,17.93%,ANXA2;S100A10;NPC1;CLN3
prerank,response to cadmium ion (GO:0046686),0.39604870095929107,0.9563062673627357,0.5384615384615384,0.8590828558685728,1.0,8/26,25.74%,EGFR;MAPK8;CHUK;SUMO1;AKT1;MAPK9;FOS;DAXX
prerank,regulation of mRNA polyadenylation (GO:1900363),0.42854070540767497,0.9562388095286788,0.5244565217391305,0.8587871882045702,1.0,8/17,28.16%,NCBP1;CPSF7;NCBP2;CPSF6;RNF20;ZC3H14;CDK9;HSF1
prerank,regulation of chondrocyte differentiation (GO:0032330),0.4044957074480263,0.9560624512492107,0.5487053020961775,0.8587319516398351,1.0,4/24,7.95%,PKDCC;WNT9A;MBOAT2;SOX9
prerank,gene expression (GO:0010467),0.320322189050194,0.9557385820300578,0.6352705410821643,0.8589639561966037,1.0,108/348,27.03%,SRSF6;RPSA;RRBP1;NUP93;DDX17;HNRNPH1;SRSF1;SRSF5;SEC13;TOPORS;RBM39;BAZ2A;DUSP11;RAE1;M1AP;SRSF2;CASC3;NOX4;SEH1L;ABCF1;HNRNPA2B1;TASP1;SMG6;SRSF11;SYMPK;GSPT1;HARS2;LMF1;HNRNPL;SMG1;NXF1;MRPS18B;ZC3H11A;U2AF1;SRRM1;RBM6;NFKBIB;NUP37;CHTOP;RBM5;PABPN1;MRPS14;HSPD1;XAB2;AGO2;EIF4G1;MRPL35;MEF2A;RBM4;RANBP2;U2AF2;MMS19;HNRNPK;CLP1;NUP88;CPSF4;STUB1;YTHDC1;SARNP;MRPS17;POLR2F;FYTTD1;THOC2;TFIP11;SRSF3;YARS2;RPS27A;NCBP1;E2F1;NCBP2;SYNCRIP;GOLPH3;SRSF7;NUP210;POM121;GLE1;SARS1;ASMT;HNRNPH3;RPL7A;DARS1;DHX8;NUP62;MED20;POLR2B;SRSF4;NDC1;MRPS21;NUP35;UPF1;MRPS18A;GALNT2;PABPC4;RPS9;HNRNPU;MRPL37;RBM3;UPF3B;DDX39B;DDX20;MRPL13;NUP85;POLR2H;TPR;NUP160;DRG1;EIF4E;SRBD1
prerank,telomere organization (GO:0032200),0.36646133230037337,0.9552027521509671,0.5674418604651162,0.8597313543360485,1.0,15/43,27.98%,PARP3;PRKDC;ERCC4;WRN;TERT;ATM;RAD50;DCLRE1B;PARP1;HUS1;XRCC6;H3-3A;POLD1;RTEL1;ATR
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.4621664301178382,0.9548681560224593,0.5380281690140845,0.8600107649378289,1.0,5/11,29.40%,NRP1;SIRT2;HGF;BCAR1;RAC1
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.44590963397701067,0.9547741333193972,0.5276595744680851,0.8597752881672078,1.0,3/12,22.07%,STARD3NL;FDXR;STARD3
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.38503281946614787,0.9545457302709438,0.5419126328217237,0.8598394430421932,1.0,14/31,34.16%,NT5C3B;DIS3L2;PATL1;LSM2;EXOSC4;CNOT8;DIS3;DCP1A;EDC4;LSM5;EXOSC2;EXOSC3;DCPS;CNOT6
prerank,regulation of mitochondrial membrane permeability (GO:0046902),-0.33417049520758957,-0.9543399812838258,0.5413223140495868,0.7746711018081078,1.0,2/18,1.61%,BCL2;BCL2L1
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.3717287433194292,0.9543239319378118,0.5336374002280502,0.8598886982434393,1.0,10/40,16.85%,VEGFA;SFRP4;ANXA2;RAB21;CBL;PICK1;HNRNPK;DAB2;ARRB1;HIP1
prerank,regulation of supramolecular fiber organization (GO:1902903),-0.3086054180003325,-0.9542841821249216,0.5046728971962616,0.7732157901663664,1.0,7/22,14.18%,AEBP1;APOE;MAP2;CAMSAP1;PRUNE1;GPX1;EFEMP2
prerank,cardiac muscle cell differentiation (GO:0055007),0.41203561365335123,0.9539568277880345,0.5604534005037783,0.8602415882612894,1.0,5/21,16.78%,VEGFA;ACVR1;ALPK3;AKAP13;KDM6B
prerank,regulation of melanin biosynthetic process (GO:0048021),-0.3948541278896581,-0.9538758336029165,0.5157232704402516,0.7725864770354682,1.0,2/10,2.49%,ZEB2;RAPGEF2
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.3252336981011299,0.9538670701252945,0.5918367346938775,0.8600039202509416,1.0,58/166,28.63%,ESR1;RARB;NCOR2;HDAC9;RXRA;WWTR1;NR2F1;RXRB;E2F3;POLR3H;MED27;RORA;RARA;ESRRB;GTF2F1;MAZ;TAF15;NR1D2;TAF6;NRBP1;HDAC1;ERCC3;CRCP;TAF13;ERCC2;VDR;NRBF2;POLR2F;CREBBP;MED26;NR3C1;TFB2M;POLR1G;TAF9B;CAVIN1;GTF3C1;TEAD2;NR3C2;POLR2B;NR2C2;NR2F6;TBP;POLR1C;TAF1C;KAT2B;TAF1;NR5A1;NCOR1;MED23;GTF2H4;POLR2H;TAF10;UBTF;CDK9;TAF1D;TAF3;NR1D1;POLR2I
prerank,macroautophagy (GO:0016236),0.33268508411834247,0.9538238824127339,0.5907692307692308,0.8596582201042012,1.0,44/118,29.16%,CSNK2A1;CSNK2A2;TCIRG1;VCP;LIX1L;TOMM40;NBR1;WIPI2;PGAM5;PIP4K2B;ATG3;STAM2;UBQLN1;CHMP3;SQSTM1;VIPAS39;PLEKHM1;VPS41;TOMM70;YOD1;PRKAG1;CLN3;RB1CC1;VTA1;PRKAB1;CHMP4B;CHMP4A;LAMP2;ATG16L1;MVB12A;MFN1;ACBD5;UVRAG;ILRUN;CHMP2A;PINK1;VTI1B;AMBRA1;ATG13;VPS16;VPS37B;ULK1;STX17;ZFYVE1
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.39190893832084234,-0.9537690269147083,0.49842271293375395,0.7712530314076309,1.0,2/10,2.13%,VTN;PRKCB
prerank,negative regulation of endopeptidase activity (GO:0010951),0.36201907402326944,0.9534945048429149,0.5489749430523918,0.8599198231132464,1.0,9/47,18.60%,SERPINH1;TIMP2;TIMP3;SERPINF1;SERPINE2;SERPINB9;CRB2;SERPING1;AKT1
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.3997043865091384,0.9534627172519294,0.5578562728380024,0.8595469676842,1.0,6/25,17.97%,EXT1;B3GNT7;B3GNT9;B4GAT1;B3GNT6;EXT2
prerank,oligodendrocyte differentiation (GO:0048709),-0.30428299417723276,-0.9533931188416086,0.5416666666666666,0.7705705293416341,1.0,4/19,8.83%,SOX13;SOX6;SLC8A3;EIF2B3
prerank,positive regulation of interleukin-12 production (GO:0032735),-0.28123459334148043,-0.9531850609203188,0.532051282051282,0.7694668825228549,1.0,4/31,13.66%,PLCB1;SYK;CD40;LGALS9
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.3326675362273493,0.9531587935282502,0.5755395683453237,0.8597956116627598,1.0,40/128,24.42%,FBXL7;CSNK1D;PPP1R12B;DYNC1H1;SFI1;DNM2;ODF2;ALMS1;DCTN2;CDC25B;FOXM1;CKAP5;LCMT1;CHEK2;FBXL12;KHDRBS1;CUL1;AKAP9;SDCCAG8;CEP164;CSNK1E;YWHAE;CEP41;PCM1;ARPP19;CEP63;HAUS5;CDC25A;CCDC57;CDK2;DYNC1I2;DCTN1;OPTN;PRKACA;ACTR1A;CDK5RAP2;NEDD1;CNTRL;PLK4;CCP110
prerank,stabilization of membrane potential (GO:0030322),0.42091654248064525,0.9523878329429363,0.5577689243027888,0.8610812201228858,1.0,1/16,0.40%,KCNK5
prerank,RNA modification (GO:0009451),0.35830286776838566,0.9523848961242902,0.5667420814479638,0.8606487395870273,1.0,23/54,34.74%,SSB;ANKRD16;ELP5;TRMT1;PUS3;ALKBH1;TRUB1;CTU2;TRMT6;TSR3;METTL1;TRMT61A;NSUN6;DTWD1;NSUN3;MEPCE;RBM15;NOP10;THUMPD1;PUS7L;PUS7;MRM2;AARS1
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.3272688913657832,0.9523697323669735,0.5831622176591376,0.8602421584065805,1.0,28/138,15.91%,ESR1;RARB;NCOR2;HDAC9;RXRA;WWTR1;NR2F1;RXRB;E2F3;MED27;RORA;RARA;ESRRB;GTF2F1;MAZ;TAF15;NR1D2;TAF6;NRBP1;HDAC1;ERCC3;TAF13;ERCC2;VDR;NRBF2;POLR2F;CREBBP;MED26
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.33059672293886816,0.952353162558416,0.586888657648283,0.8598395538449596,1.0,35/114,26.53%,CARD14;PSMD7;PSMA8;TNFRSF1B;ILK;TNFSF15;TXNDC17;PSMA4;LTBR;CHUK;COMMD7;PSMD12;CD27;PSMA6;TRAF3;PSMD11;FOXO3;PSMC5;PSMD1;PSMD14;PSMC4;MAP3K14;NFKBIA;PSMA3;TNFSF18;PSMD4;BIRC3;PSMB1;PSMA5;PSMA7;TP53;TRADD;RIPK1;PSMC1;CDIP1
prerank,regulation of stem cell population maintenance (GO:2000036),-0.3310827194700657,-0.9521903327010809,0.5201612903225806,0.7701976513813916,1.0,3/18,6.94%,PTN;ELAVL1;CNOT1
prerank,regulation of neurotransmitter receptor activity (GO:0099601),-0.24796765130092124,-0.952148010828944,0.6219512195121951,0.7687098518291675,1.0,17/57,14.79%,ACTN2;APP;GRIA1;CACNG7;GRIN2B;CACNG8;GRIA4;OPRM1;GRIN2A;CACNG3;GRIA3;SHISA6;CACNG4;RELN;DLGAP1;GRIN1;DLGAP2
prerank,cellular response to amino acid stimulus (GO:0071230),0.38527676589480875,0.9517893546535241,0.5566265060240964,0.8606474411121403,1.0,9/33,18.84%,IPO5;SESN3;LAMTOR1;CAPN2;CASTOR2;SESN2;KLHL22;NSMF;UBR2
prerank,positive regulation of brown fat cell differentiation (GO:0090336),0.4489995056621211,0.951626076778546,0.5160390516039052,0.8605566847473024,1.0,2/13,8.57%,SIX1;TFE3
prerank,dendritic spine organization (GO:0097061),0.3973515393948065,0.9512888331095992,0.5358910891089109,0.8608400073476913,1.0,8/26,13.31%,CTNND2;EPHB2;ARC;EPHB3;DLG4;ARF1;SHANK1;PICK1
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.3250235577723403,0.951250268406345,0.6135216952573158,0.8604770239928041,1.0,13/190,4.52%,THBS1;SLIT2;ESR1;PDE11A;CIT;CCN3;NPRL3;TWIST1;PHLPP2;PKHD1;PDE3A;UBE2B;XDH
prerank,regulation of myelination (GO:0031641),0.402113624382935,0.9511186000718224,0.5464414957780458,0.8603382688958249,1.0,7/25,16.17%,LGI4;HES5;TNFRSF1B;TMEM98;NCMAP;SIRT2;NKX6-2
prerank,positive regulation of phosphatase activity (GO:0010922),-0.3144729879048779,-0.9509106859999681,0.5238095238095238,0.7700548501010632,1.0,8/21,20.80%,ITGA1;PDGFRB;CD300A;PLEK;BMP2;PTPA;PPP1R15B;PPP1R15A
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.4713432777331041,0.9504953325444345,0.564327485380117,0.861265617719631,1.0,1/10,0.80%,VEGFA
prerank,positive regulation of cellular respiration (GO:1901857),0.46760649391484543,0.9503954741781147,0.5477178423236515,0.861033803472766,1.0,5/11,25.17%,VCP;IFNLR1;IL4;ISCU;PINK1
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.3695912834253019,0.949974369418022,0.5501193317422435,0.8615082595287921,1.0,6/38,13.35%,HJURP;IPO4;CENPC;CENPT;CABIN1;RBBP7
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.44385653228078104,0.9498784500712454,0.5503448275862068,0.8612932747472856,1.0,7/14,36.16%,ETNK1;ETNPPL;CHKB;PCYT2;SELENOI;PISD;CEPT1
prerank,metallo-sulfur cluster assembly (GO:0031163),0.41297853161481685,0.949389328979823,0.5601023017902813,0.8619407899497604,1.0,7/22,23.82%,FXN;NFS1;ISCA2;GLRX5;MMS19;ISCU;NUBP2
prerank,regulation of sequestering of calcium ion (GO:0051282),0.44886503013768564,0.9491677533020283,0.5550964187327824,0.8619854201991102,1.0,2/12,7.17%,UBASH3B;ANK2
prerank,purine-containing compound catabolic process (GO:0072523),-0.3480757849590085,-0.9490817303646808,0.5195729537366548,0.772882444047598,1.0,4/13,12.82%,NT5C2;DPYD;GDA;GPX1
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.47533936762657425,0.9489976752809499,0.5399408284023669,0.8619131611859198,1.0,4/10,13.33%,PLPP1;GAP43;PICK1;F2R
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.42925731410453427,0.9489943095480939,0.5467914438502673,0.8614901149396758,1.0,3/16,7.63%,PARP3;PRKDC;KMT5C
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.3438071017430847,0.9489317845584254,0.5560439560439561,0.8612034241825257,1.0,34/69,35.36%,INTS14;INTS3;INTS4;GTF2F1;CCNT2;INTS13;TAF6;TAF13;SNAPC4;POLR2F;RPRD1A;NCBP1;NCBP2;POLR2B;TBP;ICE1;POLR2H;INTS9;SRRT;CDK9;POLR2I;INTS7;POLR2L;INTS6;GTF2A2;RPAP2;SNAPC1;POLR2K;RPRD2;ZC3H8;INTS10;POU2F1;SNAPC3;GTF2E2
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),0.4509782511412715,0.9489092471024709,0.5724043715846995,0.8608139928382111,1.0,5/13,22.30%,B3GNT7;B3GNT9;B4GAT1;B3GNT6;B3GNT2
prerank,positive regulation of protein localization to cell surface (GO:2000010),0.4538396277419345,0.9487831254798318,0.5566298342541437,0.8606531228955518,1.0,3/13,15.19%,TM9SF4;RIC3;STX4
prerank,porphyrin-containing compound catabolic process (GO:0006787),0.4453794214745468,0.9487683641980147,0.5486486486486486,0.8598164894827525,1.0,2/14,4.36%,ABCC1;HMOX2
prerank,heme catabolic process (GO:0042167),0.4453794214745468,0.9487683641980147,0.5486486486486486,0.8598164894827525,1.0,2/14,4.36%,ABCC1;HMOX2
prerank,organelle fusion (GO:0048284),0.4032683274377705,0.9486225241618623,0.5578947368421052,0.8596987050082655,1.0,11/22,30.35%,MIEF2;SPG7;EEA1;STX4;VPS11;MFN1;AFG3L2;FIS1;USP30;VPS18;MIEF1
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.3906990844717666,-0.9485914079832775,0.5326797385620915,0.7724147643375869,1.0,4/10,15.19%,PARP14;INPP5F;SH2B3;SOCS3
prerank,negative regulation of blood pressure (GO:0045776),-0.3572164066701566,-0.9483483207114111,0.49382716049382713,0.7714671630495465,1.0,3/13,11.52%,NOS3;BMPR2;NOS1
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.365939125495288,0.9478287855752403,0.5488636363636363,0.8610288968810458,1.0,7/43,13.19%,EGFR;PTPN3;SOCS4;RNF115;CBL;PTPN2;STAM2
prerank,neutrophil chemotaxis (GO:0030593),0.3525616648789148,0.9478074088246489,0.5778275475923852,0.8606437523634839,1.0,6/53,8.83%,CCL13;CCL15;TGFB2;GBF1;EDN3;FCER1G
prerank,DNA replication initiation (GO:0006270),0.3730664124752335,0.9477216482402676,0.5568445475638051,0.8604034344681933,1.0,12/37,25.52%,POLE2;MCM2;CDC6;CDC45;MCM4;ORC2;CDT1;DBF4;CDK2;TOPBP1;MCM7;PRIM1
prerank,TOR signaling (GO:0031929),0.3987930863988105,0.94767106181942,0.5319949811794228,0.8600919301906931,1.0,11/26,25.17%,NPRL3;MEAK7;TIPRL;SYAP1;SMG1;FLCN;AKT1;MAPKAP1;RPTOR;RPS6KB1;PINK1
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.350994355760074,-0.9475500283462148,0.46825396825396826,0.7718178080719618,1.0,4/15,12.62%,SAMHD1;USP18;NLRC5;CACTIN
prerank,muscle tissue development (GO:0060537),-0.35592000585765093,-0.9474851634103855,0.5161290322580645,0.770393334304776,1.0,3/13,3.23%,ENG;PGM5;PTCH1
prerank,negative regulation of JNK cascade (GO:0046329),0.38447609453646275,0.9471623072539856,0.5715976331360947,0.8607661563203458,1.0,15/31,25.17%,PDCD4;DACT1;ITCH;PER1;MEN1;ZMYND11;AIDA;DNAJA1;DUSP19;GPS2;TAOK3;CYLD;MAPK8IP1;NCOR1;PINK1
prerank,regulation of aerobic respiration (GO:1903715),0.4338085097602232,0.9468218887209573,0.5472703062583223,0.8610789013944465,1.0,8/15,27.88%,ACTN3;VCP;IDE;SHMT2;COX7A2L;ABCD1;PINK1;NOP53
prerank,negative regulation of protein kinase activity (GO:0006469),0.3335206421975233,0.9467884357733694,0.5927889713679746,0.8607288534777137,1.0,21/88,20.12%,LRP6;SRCIN1;UBASH3B;LRP5;WWTR1;DVL1;TRIM27;CDK5RAP3;AKT1S1;PAK2;ABL1;PDPK1;DEPTOR;CHP1;GSKIP;CAMK2N1;NF1;CDKN1C;AKT1;RTRAF;DUSP19
prerank,membrane organization (GO:0061024),0.3200383542071477,0.9467843704744416,0.6218655967903711,0.8603048605137771,1.0,68/227,26.05%,EGFR;STON2;NUP93;CTTN;IGF2R;TLCD2;AP2A1;STX11;DNM2;ANK2;FCHO2;CBL;HUWE1;SYNJ1;SPAST;NPC1;LPCAT3;SNX9;AP3D1;USO1;TMEM43;CHP1;REPS1;GAPVD1;AP2A2;STAM2;PICK1;LRP2;OCRL;CHMP3;DMPK;CLTC;REEP3;DAB2;SNAP23;MITD1;ARRB1;TLCD1;HIP1;SPTBN1;RPS27A;UBC;CLN3;NAPA;TMEM170A;TMEM33;CHMP4B;CHMP4A;COX18;SYNJ2;PDCD6IP;CLTA;ARPC1A;MTCH1;PRKCI;REPS2;LDLR;VAMP4;SNX3;NEMP1;DVL2;CHMP2A;SCARB2;PLEKHA3;ACTR2;VAMP2;VTI1B;RAB5A
prerank,lysine metabolic process (GO:0006553),0.44976818943115043,0.9467691666783647,0.5584045584045584,0.8594782117431229,1.0,4/12,23.15%,HYKK;PHYKPL;CRYM;GCDH
prerank,lysine catabolic process (GO:0006554),0.44976818943115043,0.9467691666783647,0.5584045584045584,0.8594782117431229,1.0,4/12,23.15%,HYKK;PHYKPL;CRYM;GCDH
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.30498649209582196,-0.9465465731734529,0.5159574468085106,0.7710437929878803,1.0,6/25,12.10%,INSR;SMAD3;KLF2;ASS1;EDN1;DDAH2
prerank,positive regulation of hydrolase activity (GO:0051345),0.32748924665694956,0.9464301692439325,0.5930824008138352,0.8597832996907475,1.0,28/137,17.05%,SGSM2;SRGAP2;ASAP3;ARAP1;NTRK1;CCL13;CCL15;CALM2;BCAS3;SNX18;RAB3GAP1;S100A10;RIC1;RHOA;MAPK8;WRN;RGP1;ZC3H15;RIPK3;SNX9;MAPK12;EVI5L;F2R;NDEL1;NF1;CALM3;ERBB2;FLCN
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.4379727677059214,0.9461997397411231,0.5417218543046357,0.8598776621621609,1.0,3/15,11.26%,ADAM9;TNFRSF1B;SNX9
prerank,cell proliferation in forebrain (GO:0021846),0.4687366619139941,0.9458122133803745,0.5323033707865169,0.8602899047679032,1.0,2/10,14.74%,DOCK7;PCM1
prerank,monocarboxylic acid metabolic process (GO:0032787),0.3322137882226539,0.9456551448900682,0.5881753312945973,0.8602012375689667,1.0,18/117,15.62%,ME1;SLC5A6;SLC16A1;AGXT2;LDHC;ACSF3;CPT1C;ACSF2;ACOT11;GLO1;AKR1C1;NPC1;DLAT;ACSL3;SCPEP1;HACL1;GLYAT;CKB
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.40810940096966025,0.9452555273894497,0.5469973890339426,0.8606364168493076,1.0,3/20,8.06%,HOXA5;LDB1;HOXA9
prerank,striated muscle cell differentiation (GO:0051146),0.4313787620680213,0.9452343254674831,0.5445026178010471,0.860254167478531,1.0,5/16,16.78%,SDC1;SKI;MYEF2;AKAP13;KDM6B
prerank,regulation of double-strand break repair (GO:2000779),0.3677440596537458,0.9451955005643531,0.5771495877502945,0.8599017855396467,1.0,17/39,29.86%,TWIST1;OTUB1;SLF2;FOXM1;UBR5;SPIDR;SPIRE2;OTUB2;RAD51;SLF1;SETD2;ACTR2;WAS;RTEL1;DDX11;TIMELESS;TRIP12
prerank,positive regulation of immune effector process (GO:0002699),0.387942798398221,0.9448315416334909,0.5334957369062119,0.8603059925367915,1.0,2/27,8.09%,LBP;PLA2G5
prerank,brain development (GO:0007420),0.3223490517540826,0.9446331850759897,0.601842374616172,0.8603263745092391,1.0,31/136,20.58%,SLC23A1;ZFHX3;PBX3;NFIB;ADGRL2;HES5;PITPNM1;RAB3GAP1;AMIGO3;TGFBR2;PBX1;MEIS3;TBC1D23;CDK5RAP3;ZIC1;SYNJ1;POU6F1;PHF8;PAFAH1B2;ABCB6;CXCR4;NF1;NIPBL;PHGDH;IER3IP1;CHD8;PAFAH1B3;AFF2;SETD1A;SYNJ2;BPTF
prerank,defense response to Gram-negative bacterium (GO:0050829),0.3637735982735447,0.9444984415599887,0.559953434225844,0.8601835641842263,1.0,9/42,23.03%,LBP;RNASE7;RNASE3;RNASE6;DEFB1;IL6;DMBT1;OPTN;SLC11A1
prerank,regulation of mitotic spindle assembly (GO:1901673),0.4161266059932974,0.9442419020337188,0.5479274611398963,0.8602802953137393,1.0,8/19,26.95%,EML3;CHMP3;CHMP4B;PDCD6IP;HNRNPU;CHMP2A;TPR;DRG1
prerank,epithelium development (GO:0060429),0.3306569079129795,0.9439509701282477,0.611228813559322,0.8604925816140326,1.0,16/107,14.14%,SIX1;PKD1;VEGFA;ANXA7;MEOX2;HES5;ANXA4;DACT1;DVL1;SOX9;AKR1C1;FGFR2;EHF;SMO;DHRS9;BDH2
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.376522609139711,-0.9438334134443248,0.5317725752508361,0.7760516272728823,1.0,5/11,15.05%,CACNB2;CACNA2D1;SESTD1;NOS1;CACNB1
prerank,positive regulation of response to stimulus (GO:0048584),0.36659639589484083,0.9436706464808596,0.5439429928741093,0.8606907051541374,1.0,5/40,7.97%,PRKCD;TGFB2;MAVS;ILK;SELENON
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.40071521416331185,0.9435737558097272,0.5484293193717278,0.8604807677404853,1.0,12/22,36.10%,ATF4;PHF8;ERBB2;EIF2AK3;WDR75;SMARCA4;UBTF;DDX11;PWP1;NCL;LYAR;UTP15
prerank,axonogenesis (GO:0007409),0.32161734442467044,0.9434979387868337,0.6526104417670683,0.8602118068530519,1.0,26/237,8.42%,SLIT3;SLIT2;SLIT1;EMB;EFNA5;MAP1B;ULK2;GRB10;GAB2;GLI2;PDLIM7;EPHB2;DOCK7;SHC1;SEMA3E;NTN4;PRKCA;EPHB3;EPHB6;RAB8A;SEMA4B;LLGL1;PALLD;B4GALT5;CYFIP1;S100B
prerank,mesoderm development (GO:0007498),0.4154879134128133,0.9433189860098764,0.5687583444592791,0.8601540562800529,1.0,3/18,8.19%,VEGFA;FOXC2;IKZF3
prerank,receptor metabolic process (GO:0043112),0.3491961714123779,0.9430191795556738,0.5584562996594779,0.8603559319172471,1.0,16/53,23.01%,LRP1;NEDD4;RAMP2;DNM2;CD9;SNX1;FCER1G;RAMP1;RAB11B;CLTC;PHETA2;ARFGEF2;GRK4;ACKR3;MVB12A;UVRAG
prerank,regulation of potassium ion transport (GO:0043266),0.3882817231969725,0.9430055913446321,0.5743405275779376,0.8599537386960028,1.0,7/31,10.56%,FHL1;DRD1;KCNE5;KCNIP2;ANK2;DLG1;VIP
prerank,neurotransmitter uptake (GO:0001504),0.44576251078535784,0.942924156556168,0.5504087193460491,0.8597084259840547,1.0,1/12,0.11%,SLC38A1
prerank,tetrahydrofolate metabolic process (GO:0046653),0.46240171203638913,0.9429213350299154,0.5508982035928144,0.8592846111303821,1.0,5/10,18.96%,MTHFD2;MTHFD1;SHMT2;SHMT1;MTHFR
prerank,cholesterol transport (GO:0030301),0.35729042047383774,0.9428493131262095,0.5559322033898305,0.8590110908907954,1.0,16/45,28.00%,CEL;LIMA1;SOAT1;TSKU;AKR1C1;NPC1;ABCA1;OSBP;CLU;STARD5;STARD3;LDLR;NPC2;OSBPL5;SOAT2;SERAC1
prerank,cellular lipid catabolic process (GO:0044242),0.3852858366538469,0.9425464505301643,0.5692503176620076,0.8592155129751734,1.0,9/27,26.68%,CYP1B1;CEL;SIRT2;PLA2G15;ACBD5;ABHD12;ACOT8;ANGPTL3;FAAH
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.4550081905195169,0.9425056057014556,0.5401146131805158,0.8588813178899235,1.0,4/11,26.09%,YBX3;RIPK3;BIRC3;RIPK1
prerank,spindle assembly (GO:0051225),0.3425821897173699,0.9423179350516054,0.570964247020585,0.8588754961941538,1.0,20/67,25.54%,CSNK1D;GOLGA8B;MISP;TUBGCP3;NEK7;SMC3;RHOA;RCC1;CHEK2;MAPRE3;CEP63;HAUS5;STAG1;CCDC61;ARHGEF10;SMC1A;WRAP73;NEK6;NCOR1;SPICE1
prerank,cellular metal ion homeostasis (GO:0006875),0.3325418875336661,0.9421128048997901,0.5935550935550935,0.8588592792689388,1.0,17/102,13.84%,KCNJ2;ATP1B1;SLC12A2;SLC24A3;CCL13;PKHD1;CCL15;SLC10A7;SLC9A1;ANK2;EDN3;CHERP;STIM1;CSRP3;TMEM165;LETM1;DMPK
prerank,negative regulation of developmental growth (GO:0048640),0.3845712082536943,0.941880453762696,0.5611246943765281,0.8589232749574048,1.0,3/30,3.88%,FGF13;ULK2;PTPRS
prerank,positive regulation of chondrocyte differentiation (GO:0032332),-0.3918306402980043,-0.9416985588433394,0.5131578947368421,0.7794152184306429,1.0,3/10,3.68%,SOX5;ZBTB16;SOX6
prerank,cranial nerve development (GO:0021545),-0.37646819056275055,-0.9412522892104118,0.5382059800664452,0.7789329863715536,1.0,8/11,33.97%,CHD7;SALL1;ERBB3;TFAP2A;POU4F1;TIFAB;PAX2;ISL1
prerank,negative regulation of response to wounding (GO:1903035),0.41133051807844795,0.941157780965493,0.5542483660130719,0.8600831785942303,1.0,5/19,19.58%,FGF2;PTPRS;GIT1;CD109;CRK
prerank,regulation of fatty acid oxidation (GO:0046320),-0.34247722661180036,-0.940935793827767,0.5434782608695652,0.7781419710524546,1.0,3/16,6.25%,PPARA;PRKAG2;PPARGC1A
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.33057334472626365,0.9404427097655201,0.6173733195449845,0.8611697294765641,1.0,29/109,21.26%,GAB2;VAV2;PSMD7;SHC1;PSMA8;FCER1G;NFATC1;PSMA4;PAK2;MAPK8;CHUK;TAB2;PDPK1;PSMD12;CUL1;PIK3CB;PSMA6;NFATC3;PSMD11;PSMC5;SOS1;PSMD1;PSMD14;PSMC4;MAPK9;PSMA3;PSMD4;MAP2K7;PSMB1
prerank,transcription by RNA polymerase II (GO:0006366),0.3153677870991154,0.940422681728211,0.6533066132264529,0.8607900834944299,1.0,107/305,28.37%,ESR1;PRRX1;NFIX;RARB;DDX5;DEAF1;NCOR2;HDAC9;ELOF1;RXRA;WWTR1;ATF4;INTS14;NR2F1;TCFL5;NFX1;RXRB;INTS3;E2F3;MED27;RORA;RARA;SYMPK;ESRRB;INTS4;CDK12;HSF2BP;GTF2F1;CCNT2;INTS13;MAZ;PABPN1;TAF15;NR1D2;TAF6;NRBP1;HDAC1;TRIP11;ERCC3;TAF13;ERCC2;CLP1;TFDP1;MBD1;SNAPC4;CPSF4;VDR;NRBF2;POLR2F;AFF4;CREBBP;MED26;PARP1;PCF11;RPRD1A;MLLT3;NCBP1;SSRP1;NFYA;NR3C1;ELP4;CPSF7;NCBP2;CBFB;TAF9B;TEAD2;CSTF2;CEBPD;CSTF2T;NR3C2;ABT1;MED20;PAF1;NFIC;SNRPB;POLR2B;NR2C2;NR2F6;TBP;SETD2;TFCP2;ICE1;MNT;TAF1C;KAT2B;NELFB;CDK13;TAF1;NR5A1;EAF1;NCOR1;CTDP1;RTF1;MED23;GTF2H4;RNMT;POLR2H;NELFA;INTS9;TAF10;SRRT;SETX;CDK9;TAF5L;TAF3;NFE2L3;NR1D1
prerank,regulation of T cell proliferation (GO:0042129),0.3512889108015215,0.9403718117348688,0.594535519125683,0.8604715825393038,1.0,13/61,23.31%,SPN;GLMN;CD3E;TNFRSF1B;ANXA1;RIPK3;CD80;VTCN1;IL6;TNFSF18;IL4;DLG5;GPNMB
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),0.39026946010383357,0.940300717614117,0.5494367959949937,0.8602161112037999,1.0,7/25,13.93%,ATP1B1;DMD;STK39;COA8;ANK2;AKAP9;WNK1
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.3227973621424146,0.9400083058393405,0.6382978723404256,0.8603991850171532,1.0,42/172,18.10%,FGF2;PLEKHA4;PLA2G4A;PEMT;PIK3C2B;CSNK2A1;CSNK2A2;PITPNM1;LPCAT1;GPD1;TAMM41;LPCAT4;PLA2G5;ETNK1;DGKQ;PGS1;STARD7;PIP4K2B;GPAT4;SYNJ1;LPCAT3;ARF1;FAR1;PCTP;INPP4A;ETNPPL;PIK3CB;OCRL;PI4K2A;PLA2G12A;CDIPT;PNPLA3;CHKB;PIP5K1A;HDHD5;INPP5E;PI4KB;PTDSS1;VAC14;AGPAT5;CLN3;CDS1
prerank,positive regulation of T cell migration (GO:2000406),0.4019138112501556,0.9399905792864167,0.574002574002574,0.8600117895444802,1.0,5/20,13.93%,SPN;ADAM10;STK39;RHOA;WNK1
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.3826779211816937,0.939779167596282,0.5621156211562116,0.8600384753387369,1.0,5/28,13.86%,MAP1B;STMND1;ABL1;MAPRE3;ARL2
prerank,regulation of small molecule metabolic process (GO:0062012),-0.2939565064525522,-0.9397241067332811,0.563953488372093,0.7793966960566696,1.0,5/28,7.31%,APOE;PDK1;PPARA;FMO5;ADIPOR1
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.3785404278681562,0.9396865863442526,0.5776699029126213,0.8598058997157958,1.0,10/29,26.09%,CHUK;TANK;TRAF3;RPS27A;UBC;IKBKE;IRF3;BIRC3;TBK1;RIPK1
prerank,negative regulation of MAPK cascade (GO:0043409),0.3319778975703321,0.939613185486817,0.6063492063492063,0.8595400567014694,1.0,19/87,17.05%,PRKCD;EMILIN1;TIMP3;EPHB2;SPRED2;SMAD4;IRAK3;CDK5RAP3;DLG1;BMP4;FOXM1;PAQR3;PIK3CB;PTPN2;EZR;PPEF2;CAMK2N1;NF1;FLCN
prerank,retinoid metabolic process (GO:0001523),0.34238709539236356,0.9389928246427849,0.5829694323144105,0.8604861652546321,1.0,5/71,3.13%,GPC6;LRP1;GPC3;CYP1B1;SDC1
prerank,negative regulation of MAP kinase activity (GO:0043407),0.36257196146800363,0.9385959880400688,0.5755478662053056,0.8609303695965816,1.0,12/44,20.12%,PRKCD;PDCD4;IRAK3;CDK5RAP3;BMP4;PAQR3;PIK3CB;NF1;AIDA;DNAJA1;UCHL1;DUSP19
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),0.41653485500831855,0.9382446102162473,0.546448087431694,0.8612324774558414,1.0,5/16,18.60%,NPR3;TERT;PIK3CB;S100A1;AKT1
prerank,peptide catabolic process (GO:0043171),0.3943794938882866,0.9377981069876856,0.5877862595419847,0.8617432305736522,1.0,9/23,23.43%,ECE1;CPQ;XPNPEP1;LNPEP;IDE;NPEPPS;LVRN;CHAC2;DPEP1
prerank,positive regulation of neuron death (GO:1901216),-0.2546054717402218,-0.9374573905637611,0.5909090909090909,0.7831381882284956,1.0,11/46,15.04%,EFNB2;WNT5A;PICALM;EPHA7;GRIN2B;NUPR1;EGR1;SARM1;C1QA;TYROBP;SNCA
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.44016048154003656,0.9374515526522841,0.5610795454545454,0.861648328161539,1.0,4/12,13.64%,SLC9A1;CHERP;STIMATE;PTBP1
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),0.44016048154003656,0.9374515526522841,0.5610795454545454,0.861648328161539,1.0,4/12,13.64%,SLC9A1;CHERP;STIMATE;PTBP1
prerank,stem cell differentiation (GO:0048863),0.36576732616725394,0.9373413704714679,0.5530660377358491,0.861449748196888,1.0,8/39,17.53%,LRP6;TGFB2;PUM1;FGFR2;HOXB4;PSMD11;MLLT3;UFL1
prerank,heart looping (GO:0001947),0.3663350592599681,0.9371432554664768,0.5692488262910798,0.8614515541289854,1.0,8/39,15.71%,MICAL2;TGFBR2;TBX21;CCDC39;SRF;SMO;BBS5;NPHP3
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),-0.28969591957428203,-0.9359543583577711,0.594059405940594,0.785210943702917,1.0,5/27,8.00%,IL1RAPL1;CCDC88A;CTNNA2;NTNG1;HOMER1
prerank,regulation of DNA binding (GO:0051101),0.3581238304277784,0.9357238127460186,0.576036866359447,0.8640261169182584,1.0,11/44,19.69%,HJURP;HMGB1;SKI;MAPK8;SMO;SIRT2;MDFI;SUMO1;E2F1;CDT1;NFKBIA
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.4140790171215168,0.9356939640065678,0.5575916230366492,0.8636663729376927,1.0,3/19,8.65%,RIC3;CHRNB2;CHRNA5
prerank,small GTPase mediated signal transduction (GO:0007264),0.3298568719212033,0.935690422867261,0.6037151702786377,0.8632491686789219,1.0,20/103,16.28%,NTN1;PLCE1;FGF2;TIAM1;MRAS;TIAM2;SHC1;TRIM28;BCR;USP50;RRAD;ARFIP2;RAB38;SHOC2;CHP1;SETDB1;NUCB1;G3BP2;SOS1;NF1
prerank,negative regulation of translation (GO:0017148),0.3301667283646686,0.9355312558656844,0.5942492012779552,0.8631634117987436,1.0,31/87,29.55%,IGFBP5;SAMD4A;FTO;PUM1;ILF3;METTL16;AGO2;RBM4;CNOT8;CNOT10;EPRS1;SYNCRIP;DAPK3;CNOT9;SHMT1;EIF2AK4;CALR;UNK;EIF2AK3;FXR2;YBX1;ROCK1;RBM24;METTL14;MRPL13;TPR;RIDA;YTHDF1;FXR1;LARP1;CAPRIN1
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",0.44543653593162685,0.9354808260210156,0.5633001422475107,0.86241584640863,1.0,4/11,16.13%,AGO1;AGO2;RBM4;EIF6
prerank,miRNA mediated inhibition of translation (GO:0035278),0.44543653593162685,0.9354808260210156,0.5633001422475107,0.86241584640863,1.0,4/11,16.13%,AGO1;AGO2;RBM4;EIF6
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.3887467762441281,0.9351721333622481,0.5760197775030902,0.8626416162917041,1.0,13/26,31.88%,NOL3;ATF4;NFE2L2;AKT1;LRRK2;PYCR1;VNN1;PINK1;HTRA2;NME5;PRKN;GPR37;GPR37L1
prerank,negative regulation of phosphatase activity (GO:0010923),0.3934104482093706,0.9350841602277421,0.5577639751552795,0.8624009040728277,1.0,10/25,24.09%,TGFB2;TIPRL;ZCCHC9;URI1;CHP1;PPP1R35;PPP1R36;CRY2;FKBP1B;BOD1L1
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.37547982632130905,0.9350689377833391,0.5627198124267292,0.862009967916093,1.0,7/33,11.53%,GAS6;TCF7L2;PKHD1;RAMP2;NFE2L2;PAK4;PDPK1
prerank,embryonic heart tube morphogenesis (GO:0003143),0.35980320856792647,0.9350320718901894,0.5977011494252874,0.861667263938164,1.0,9/43,15.71%,MICAL2;ACVR1;TGFBR2;TBX21;CCDC39;SRF;SMO;BBS5;NPHP3
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.45537302515168765,0.9349980963893822,0.563338301043219,0.861315622280578,1.0,3/10,13.93%,ADAM10;STK39;WNK1
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.43444305702396124,0.9349621926278856,0.5523415977961432,0.8609682263335362,1.0,4/13,15.41%,NFAT5;RHOA;IRAK1;IL6
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.41341984496593176,0.934768389627142,0.5706594885598923,0.8609600172454104,1.0,2/17,1.03%,CACNA1C;ATP1B1
prerank,cellular response to chemokine (GO:1990869),0.3564439355414293,0.9344613469927059,0.5796766743648961,0.8612100920134739,1.0,5/46,8.97%,SLC12A2;CCL13;CCL15;STK39;RHOA
prerank,negative regulation of cation channel activity (GO:2001258),0.3828064904756263,0.9342913769749603,0.5632754342431762,0.8611555008490088,1.0,7/26,23.30%,EPHB2;CALM2;UBQLN1;CALM3;DRD2;CBARP;FKBP1B
prerank,tryptophan catabolic process (GO:0006569),0.45290889314729355,0.9339708567600906,0.556998556998557,0.8614144865357244,1.0,3/11,20.11%,IDO2;AFMID;KYAT1
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.3803475753774015,0.9337859033800336,0.5673076923076923,0.8613890450433989,1.0,2/30,1.47%,PRKCD;SRCIN1
prerank,central nervous system neuron development (GO:0021954),-0.3459702030618552,-0.9327378143385474,0.5124555160142349,0.7912986144472067,1.0,2/15,2.49%,MAP2;RAPGEF2
prerank,B cell mediated immunity (GO:0019724),0.46918994529960883,0.9325110152685927,0.5841584158415841,0.8636466205487532,1.0,2/10,12.13%,FCER1G;CD27
prerank,diacylglycerol metabolic process (GO:0046339),0.3948487939359422,0.9323998288008488,0.5614702154626109,0.8634533759759613,1.0,4/23,9.20%,PLCE1;DAGLA;DGKQ;PGS1
prerank,cellular response to cytokine stimulus (GO:0071345),0.3136034672012587,0.9323790088919442,0.732,0.8630805397882483,1.0,87/416,20.07%,PID1;VEGFA;LBP;GAS6;F3;COL1A2;FGF2;SLC12A2;PTGIS;YBX3;GRB10;GHR;MUC1;GAB2;DPYSL3;CNTFR;TWIST1;SLC26A6;SDC1;CCL13;SHC1;STAT5A;NFAT5;CCL15;STAT3;IL5;SHPK;SMPD4;TNFRSF1B;TXLNA;NFE2L2;IL12RB2;STK39;IRAK3;IFNLR1;RORA;SOX9;SOCS6;CBL;SBNO2;GBP6;SOCS2;RHOA;ANXA1;PTPN18;MAPK8;CHUK;CTF1;IRAK1;IL20RB;PIK3CB;CASP1;PTPN2;TANK;CD80;GSDME;WNK1;CLCF1;STX4;CXCR4;FOXO3;SOS1;IL6;HGF;STX1A;OSMR;RPS27A;UBC;EPRS1;PRLR;HMOX1;TRIM6;SYNCRIP;DAPK3;ACOD1;USP10;ERBIN;AKT1;SHMT1;BIRC5;PTPN23;PLP2;MMP2;CRK;PTAFR;ASAH1;UBE2G2
prerank,negative regulation of ATPase activity (GO:0032780),-0.31783342269553655,-0.932332646793609,0.5469387755102041,0.790689453676863,1.0,5/16,20.95%,IFIT1;SIRT1;VCPKMT;PXK;PPIF
prerank,clathrin-dependent endocytosis (GO:0072583),-0.2920721986381888,-0.9321086747535091,0.572139303482587,0.789680583925544,1.0,4/26,5.02%,DNAJC6;SGIP1;PICALM;PIP5K1C
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.35068451170929316,0.9321001948976799,0.588500563697858,0.8632335443681906,1.0,12/52,19.06%,SAMD4A;NT5C3B;PATL1;LSM2;EXOSC4;CNOT8;RC3H2;TUT7;CNOT10;DIS3;CNOT9;TNKS1BP1
prerank,regulation of cellular component organization (GO:0051128),0.322547726013351,0.9320957738073705,0.6361767728674204,0.8628223438389756,1.0,48/135,26.77%,PLCE1;STON2;NEDD4;ARFGAP1;HJURP;CAMK2D;SNCAIP;DCUN1D5;LAMTOR1;ANKRA2;IRAK3;TMC8;PAK4;SOCS2;STON1;ITCH;ABL1;URI1;SETD5;NCLN;MARK4;RAB4B;MLLT3;HIP1;SLC2A10;SSRP1;RAB5B;HCFC1;RUFY2;ZFYVE16;SETD1A;SLITRK2;SGK3;MAD2L2;RAB4A;RPTOR;TSC2;CAMSAP3;HNRNPU;ROCK1;IL17RB;PINK1;PTPN11;TAOK2;RAB5A;LAMTOR2;SGK1;ATF5
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.23327525439949207,-0.9317824178947349,0.7023809523809523,0.7888694269962524,1.0,21/69,24.08%,COX8A;COX6C;NDUFC2;COX4I1;CYC1;UQCRC2;UQCR11;COX10;NDUFA13;NDUFB2;UQCRB;NDUFB7;NDUFAF1;COX5B;UQCRC1;NDUFS1;NDUFA8;NDUFB11;UQCRQ;NDUFS6;NDUFA4
prerank,regulation of TORC1 signaling (GO:1903432),0.37489795413144134,0.9317507017448378,0.5757575757575758,0.8631087504806685,1.0,11/33,18.75%,SESN3;SEH1L;CLEC16A;CASTOR2;DGKQ;ATM;TELO2;SESN2;KLHL22;FLCN;KPTN
prerank,Golgi to plasma membrane transport (GO:0006893),0.35589546752339385,0.9313198434016157,0.5831435079726651,0.8635515170429188,1.0,21/47,28.13%,KIF13A;EXOC4;RAB34;GOPC;GGA2;LLGL1;GOLGA4;NSF;STEAP2;SPTBN1;GGA1;GOLPH3;BLZF1;ARFGEF2;OPTN;VAMP4;VAMP2;VPS35L;GCC2;OSBPL5;GGA3
prerank,membrane lipid metabolic process (GO:0006643),-0.30176227332656735,-0.9303898834814519,0.5159817351598174,0.7905337064065147,1.0,5/22,9.40%,ST3GAL6;CERK;SERINC1;GAL3ST1;SPHK1
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.3654848436578165,0.9302752679546186,0.5870588235294117,0.8652788255233733,1.0,6/38,15.19%,THBS1;TMC8;MADD;TNFRSF10B;BMP5;STX4
prerank,negative regulation of cellular senescence (GO:2000773),-0.3492196344651381,-0.9301490032809226,0.5186440677966102,0.7895192613989902,1.0,3/13,2.82%,CDK6;SLC30A10;AKT3
prerank,prostanoid biosynthetic process (GO:0046457),0.42760126351623584,0.9298635949664498,0.5694444444444444,0.8657046069567755,1.0,2/15,1.81%,PTGIS;PLA2G4A
prerank,regulation of cell adhesion (GO:0030155),0.32272300075828353,0.92971935453934,0.6436663233779608,0.8655614753673121,1.0,16/129,10.85%,PLXNA4;ZFHX3;VEGFA;EFNA5;P4HB;TGFBI;SPN;EPHB2;PKHD1;PRKCA;EPHB3;ADAM10;TFE3;ITGAV;ABL1;ATM
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.32634402641023513,-0.929698746475223,0.5690376569037657,0.7889922608430606,1.0,6/16,18.79%,AUTS2;BCOR;PIH1D1;CTR9;BRCA1;KDM1A
prerank,protein deacylation (GO:0035601),0.39430748951180433,0.9296821060062537,0.5792141951837769,0.8652137472977393,1.0,5/23,16.15%,HDAC4;SIRT5;HDAC1;SIRT2;HDAC6
prerank,prostaglandin biosynthetic process (GO:0001516),0.41162345997880984,0.9294699989425435,0.5543624161073826,0.8652495043188213,1.0,3/18,6.96%,PTGIS;PLA2G4A;PTGES2
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.43379158636685766,0.9287952929552474,0.5744089012517385,0.8662223252236145,1.0,4/14,18.74%,AGR2;HSPA5;UFL1;TMEM33
prerank,transcription by RNA polymerase III (GO:0006383),0.38316912266290243,0.9286098714977757,0.57,0.86617829767987,1.0,16/27,35.50%,POLR3H;CRCP;POLR3GL;SNAPC4;GTF3C4;POLR3K;GTF3C1;GTF3A;TBP;ICE1;POLR2L;SNAPC1;POLR2K;ZC3H8;SNAPC3;BRF1
prerank,steroid hormone biosynthetic process (GO:0120178),0.3758712875824311,0.9285322626756122,0.5621156211562116,0.8659319058338542,1.0,4/29,16.57%,CYP19A1;STARD3NL;FDXR;HSD17B8
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.41707003903488277,0.9284332537137878,0.5615696887686062,0.8657074798653221,1.0,9/18,33.91%,FXN;EDN3;ABL1;GDNF;RFK;ABL2;PDP2;ATP7A;PDP1
prerank,iron-sulfur cluster assembly (GO:0016226),0.3983647778486784,0.927724380672274,0.592071611253197,0.8667669989218356,1.0,7/24,23.82%,FXN;NFS1;ISCA2;GLRX5;MMS19;ISCU;NUBP2
prerank,positive regulation of response to biotic stimulus (GO:0002833),-0.2607074038516266,-0.9276048994271834,0.5827338129496403,0.7924158244043753,1.0,6/38,8.72%,BMP6;SASH1;LY86;CD180;GBP5;DDX60
prerank,positive regulation of activated T cell proliferation (GO:0042104),-0.311278541781412,-0.9274388350665004,0.5702127659574469,0.7912646477404921,1.0,8/18,28.40%,IGFBP2;IGF1;PYCARD;RPS3;AGER;FADD;IL18;IL27RA
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.43584864407792706,0.9271922314996504,0.5800807537012113,0.8674685398339941,1.0,2/13,7.50%,TWIST1;YJU2
prerank,protein neddylation (GO:0045116),0.4312742831510867,0.9271784656051575,0.5619946091644205,0.8670802521523902,1.0,4/13,22.49%,DCUN1D5;DCUN1D2;RNF7;UBA3
prerank,response to cAMP (GO:0051591),0.3623751913698022,0.9266654910329315,0.5971394517282479,0.8677091610981669,1.0,6/37,12.87%,IGFBP5;HCN4;SLC26A6;DGKQ;AKAP9;EZR
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),0.44389776406330667,0.9265005344229086,0.5849335302806499,0.8676428899382749,1.0,3/11,6.22%,IRS1;GHR;GIGYF1
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.39171282495334037,0.9264174336887897,0.5744125326370757,0.8674038450912652,1.0,1/21,0.44%,FOXP1
prerank,JNK cascade (GO:0007254),0.36502562338384326,0.9263238414711435,0.5717619603267211,0.8671746547333654,1.0,16/40,28.07%,MAP3K5;GPS1;MAPK8;MAP3K12;TAB2;IRAK1;MAP3K10;RPS27A;UBC;MAPK9;MAP2K7;GPS2;RIPK2;MAP3K11;UBE2V1;MAP2K4
prerank,mitochondrial translational termination (GO:0070126),0.3342509025154115,0.9262890957843603,0.6021621621621621,0.8668273644599259,1.0,42/88,37.99%,MRPS2;MRPL33;DAP3;MRPL19;MRPS35;MRPS28;MTRF1L;MRPS18B;MRPL39;MRPS14;MRPL35;MRPS17;MRPL45;PTCD3;MRPL12;MRPL47;MRPS26;MRPS24;MRPS21;MRPS18A;MRPL37;MRPL17;MRPL13;MRPL30;MRPL4;MRPL11;MRPL24;MRPL28;MRPS10;CHCHD1;MRPL15;MRPS31;MRPS33;MRPL50;MRPL41;AURKAIP1;MRPL14;MRPL32;MRPL38;MRPL57;MRPL46;MRPL2
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),-0.3677708078524705,-0.9262098172622966,0.5357142857142857,0.7926716593470432,1.0,4/10,10.21%,LPGAT1;NR1H3;SLC45A3;MID1IP1
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.4265362269506431,0.9261971386899055,0.6075268817204301,0.8666222286949563,1.0,2/16,2.55%,PDCD4;CHID1
prerank,determination of heart left/right asymmetry (GO:0061371),0.35611099862629514,0.9258824864673333,0.600459242250287,0.8668406243247683,1.0,8/42,15.71%,MICAL2;TGFBR2;TBX21;CCDC39;SRF;SMO;BBS5;NPHP3
prerank,positive regulation of innate immune response (GO:0045089),0.38025214620079656,0.9258442129556989,0.5831325301204819,0.8665050420827627,1.0,3/30,8.09%,LBP;MAVS;PLA2G5
prerank,positive regulation of developmental process (GO:0051094),0.3179643084810685,0.9257932034100173,0.6629554655870445,0.8661981055217249,1.0,31/164,13.27%,BMP1;VEGFA;FOXD1;ACVR1B;PHLDB1;LMNA;COBL;TLE6;AGR2;ACVR1;DVL1;MIEF2;MCU;FGFR1;EDN3;KMT5C;DLG4;SOX9;B4GALT5;PA2G4;ESRRB;TRPM4;TMEM119;BMP4;BMPR1A;NEUROD2;SHANK1;FOXO6;SRF;AGO2;NLGN1
prerank,regulation of macrophage cytokine production (GO:0010935),0.42933074523232256,0.9255328687067903,0.5898161244695899,0.8663501745959961,1.0,3/13,6.84%,TGFB3;TGFB2;IRAK3
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),0.40817773649457545,0.925216622123363,0.5908529048207664,0.8665668426680189,1.0,1/20,0.39%,PSTPIP1
prerank,cellular calcium ion homeostasis (GO:0006874),0.3207926017151669,0.9250332573656461,0.6581371545547595,0.8665488945345363,1.0,36/133,24.51%,SLC35G1;ATP1B1;SLC24A3;CCL13;CAMK2D;PKHD1;CCL15;PACS2;ADCY8;SLC10A7;MCU;ANK2;EDN3;CHERP;STIM1;CSRP3;TMEM165;MICU2;YWHAE;LETM1;DMPK;MICU1;CALB2;CALCA;KCTD17;CLN3;CALR;PRKACA;ATP2B4;ANXA6;STOML2;AFG3L2;FKBP1B;SLC8B1;STIM2;HERPUD1
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.3684735086379389,0.9249535364542913,0.5726708074534161,0.8662856477228683,1.0,9/36,19.92%,FHIT;CCAR2;GIPC1;OGT;USP7;TLK2;N4BP1;RYBP;UCHL5
prerank,mitochondrial translational elongation (GO:0070125),0.333634730456103,0.9246882426233026,0.5973884657236126,0.8664287629787181,1.0,42/88,37.99%,MRPS2;MRPL33;DAP3;MRPL19;MRPS35;MRPS28;MRPS18B;MRPL39;MRPS14;MRPL35;MRPS17;MRPL45;TUFM;PTCD3;MRPL12;MRPL47;MRPS26;MRPS24;MRPS21;MRPS18A;MRPL37;MRPL17;MRPL13;MRPL30;MRPL4;MRPL11;MRPL24;MRPL28;MRPS10;CHCHD1;MRPL15;MRPS31;MRPS33;MRPL50;MRPL41;AURKAIP1;MRPL14;MRPL32;MRPL38;MRPL57;MRPL46;MRPL2
prerank,glycogen biosynthetic process (GO:0005978),0.44204663137141376,0.9246826333526608,0.5726027397260274,0.8656098545870495,1.0,1/12,2.99%,PPP1R3C
prerank,glucan biosynthetic process (GO:0009250),0.44204663137141376,0.9246826333526608,0.5726027397260274,0.8656098545870495,1.0,1/12,2.99%,PPP1R3C
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.41372106617837734,0.9239424651461065,0.5797665369649806,0.8667233863916243,1.0,5/16,19.45%,IGFBP5;PHIP;BMP5;IGFBP6;ZFAND2B
prerank,neuropeptide signaling pathway (GO:0007218),-0.2455572811989751,-0.9239409891409714,0.6836734693877551,0.7964230493268932,1.0,15/58,23.79%,SORCS1;RAPGEF2;GLRA2;SORT1;OPRM1;CYSLTR1;NMU;NTS;GLRA1;NXPH2;PNOC;NMUR2;CYSLTR2;NXPH4;KISS1R
prerank,mesenchymal to epithelial transition (GO:0060231),0.4550254901649149,0.9239274368188356,0.5692307692307692,0.8663407112926282,1.0,2/10,10.16%,FZD7;BMP4
prerank,neuron cell-cell adhesion (GO:0007158),-0.35358055823419865,-0.9237058669305882,0.5543478260869565,0.7954887849354859,1.0,6/14,14.67%,NRXN1;ASTN2;NCAM2;CNTN4;NRXN3;ASTN1
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.3859247707104786,0.9235190755118046,0.597799511002445,0.8667557799232078,1.0,7/27,22.21%,IRAK3;TAB2;IRAK1;HSPD1;RPS27A;UBC;TLR1
prerank,actin filament organization (GO:0007015),0.32093288004144277,0.9234830801353652,0.6447638603696099,0.8664183429486141,1.0,20/151,9.07%,RHOBTB1;GSN;RND3;PPP1R9B;DPYSL3;VILL;PLS1;COBL;ARHGAP17;CORO6;FAT1;TLE6;MYO1E;CDC42EP2;MCU;ABI1;DLG1;ELMO3;RHOA;GAS2
prerank,regulation of monocyte differentiation (GO:0045655),0.42742866408314595,0.9234677860682692,0.5672043010752689,0.8660368394025207,1.0,1/14,0.44%,FOXP1
prerank,cellular response to catecholamine stimulus (GO:0071870),0.3891617589228297,0.9233750675072887,0.5777496839443742,0.8658179051553613,1.0,9/23,21.50%,DRD1;ATF4;SLC9A1;ABL1;SIRT2;LRRK2;GNB1;PRKACA;ATP2B4
prerank,heterochromatin assembly (GO:0031507),0.3980047641622707,0.9233026969791903,0.579088471849866,0.8655495879745797,1.0,6/20,20.97%,BAZ2A;EZH1;HDAC1;SIRT2;HMGA1;SUV39H1
prerank,regulation of actomyosin structure organization (GO:0110020),0.4339304274846705,0.9232408562522952,0.5708446866485014,0.8652510232648506,1.0,3/13,6.52%,ASAP3;ALMS1;SLC9A1
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.3761770214325312,0.9231654590834864,0.5865504358655044,0.8649984768250181,1.0,11/31,21.07%,SRCIN1;ARC;SIPA1L1;TANC2;NLGN1;ARHGAP44;EFNA1;NGEF;CDK5;LRRK2;ABI2
prerank,hexose metabolic process (GO:0019318),0.35665890742383594,0.9228193353868615,0.570267131242741,0.8652789983377657,1.0,11/39,21.37%,FUOM;SORD;GAA;PMM2;ADPGK;AKR1A1;HECTD4;SLC37A4;SLC35A2;GDPGP1;FPGT
prerank,negative regulation of gene expression (GO:0010629),0.30847099401539396,0.922689653697383,0.7171514543630892,0.8650861713135702,1.0,57/302,18.27%,ESR1;FOXP1;ID2;IGFBP5;VEGFA;FGF2;SLC24A3;EMILIN1;NCOR2;ANXA7;SAMD4A;HDAC9;TGFB2;CD3E;XDH;PHF1;ADAM10;RPS6KA4;TRIM27;ILF3;DGKQ;ZC3H12D;WWP2;RUNX1;BMP4;TERT;AGO1;DIS3L2;BMPR1A;METTL16;HDAC1;KDM4A;CIDEA;SMO;PTRH2;AGO2;ERP29;SETDB1;RBBP7;LSM2;PTBP1;RBM4;ZNF148;VDR;N4BP1;CNOT8;ZC3H10;CNOT10;RBL2;FLCN;SLC2A10;EPRS1;TRIM6;SYNCRIP;DAPK3;CITED2;CNOT9
prerank,positive regulation of interleukin-1 beta production (GO:0032731),-0.24998553314019054,-0.9226191857750249,0.6212121212121212,0.7963277822306991,1.0,15/45,20.47%,WNT5A;APP;AIM2;GBP5;HSPB1;EGR1;LPL;TRIM16;LGALS9;TYROBP;NOD2;PYCARD;MYD88;P2RX7;AGER
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.42195758730306954,0.9225646879581452,0.582109479305741,0.8649292062014787,1.0,5/15,15.94%,CAMK2D;PRKCA;SLC9A1;MEF2A;PARP1
prerank,nucleoside phosphate catabolic process (GO:1901292),0.4275859075060463,0.9224567799248603,0.5790229885057471,0.8647314989011531,1.0,4/13,9.86%,ENTPD2;ENTPD6;DCTPP1;SMPDL3A
prerank,fatty acid biosynthetic process (GO:0006633),0.3412751384810805,0.9222801125586952,0.6061269146608315,0.8646874879206334,1.0,9/63,13.54%,ABCD3;ACSF3;ELOVL5;SCD5;LIAS;FADS1;OLAH;CBR4;ACACA
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.35076611917393974,0.9217300639278921,0.616800920598389,0.8653874183035746,1.0,10/46,12.27%,SRGAP2;SRCIN1;TMEFF2;NTN4;EPHB3;ILK;RHOA;ITGAV;NRP1;PARVA
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.44263134387631436,0.9216388796939903,0.5798898071625345,0.8651456181808632,1.0,6/12,26.50%,HEXIM1;LARP7;NELFB;HNRNPU;RECQL5;NELFA
prerank,cellular protein metabolic process (GO:0044267),0.3072475920665845,0.9213709497901482,0.737,0.865281339117897,1.0,94/396,24.11%,PLOD2;ST8SIA2;IGFBP5;CHRDL1;FSTL1;PCSK5;RPSA;RRBP1;GAS6;GPC3;P4HB;DMP1;TGM5;PAPPA;GGCX;HM13;PRKCSH;PRKDC;SPG7;ADAM10;CKAP4;LOX;QSOX1;ABCF1;MBTPS1;NAGPA;GSPT1;HARS2;AKT2;CST3;WWP2;CALU;MRPS18B;BMP4;ABL1;RCN1;RIPK3;LCMT1;FDXR;FBXO22;ATG3;CHEK2;MRPS14;CCDC59;AGO2;EIF4G1;MRPL35;SPCS2;NUCB1;MIA3;UBE2L6;PSEN2;MRPS17;IL6;VCAN;IDE;YARS2;LIPT1;RPS27A;PCMT1;NTAQ1;ARAF;GNMT;MEN1;NAPSA;IGFBP6;DMBT1;SARS1;FBXW2;MMP2;APLP2;SEC11A;UBE2G2;ASMT;RPL7A;DARS1;PENK;STOML2;LOXL2;CSNK1G3;STK38;UBA3;MRPS21;CDKL3;B4GALT7;AFG3L2;MAN2B1;MRPS18A;PHKA2;PABPC4;FBXO11;RPS9;PHEX;VGF
prerank,proteasome assembly (GO:0043248),0.4459926779234593,0.9211351948115325,0.5864106351550961,0.8653671238973847,1.0,5/11,30.30%,PSMD11;OTUD6B;PSMD4;PSMG2;ADRM1
prerank,apoptotic process (GO:0006915),0.315067648993344,0.9206496360536155,0.6787512588116817,0.8659492411472857,1.0,43/203,19.82%,PLAGL1;PRKCD;EFNA5;CIT;PDCD4;PRKCE;MAGI3;FAP;RELT;TGFBR2;IAPP;DAP;MCM2;RAF1;PAK4;OGT;YARS1;CSRNP1;ATN1;AIFM1;TNFRSF10B;ERCC3;HSPD1;CASP1;LIG4;ERCC2;MAP3K10;DMPK;RHOB;CXCR4;ING4;PARP1;PLSCR3;HIP1;BNIP1;DAPK3;BID;AKT1;IRF3;RFK;CDK5;NFKBIA;TRAIP
prerank,regulation of NMDA receptor activity (GO:2000310),-0.28012396948049306,-0.9204736206826786,0.5903614457831325,0.7999069179283976,1.0,11/32,14.50%,ACTN2;APP;GRIA1;SLC6A9;GRIN2B;GRIA4;OPRM1;GRIN2A;GRIA3;RELN;GRIN1
prerank,rRNA methylation (GO:0031167),0.3952915087831184,0.9203480569009517,0.5841836734693877,0.8661730079201371,1.0,14/22,40.59%,EMG1;METTL16;TFB2M;FBL;BUD23;TRMT112;NSUN3;METTL15;MRM2;ZCCHC4;NSUN5;DIMT1;NSUN4;MTERF4
prerank,negative regulation of receptor binding (GO:1900121),0.45429550490906867,0.9202367280987318,0.5863509749303621,0.8659996185062103,1.0,2/10,8.49%,PTPRF;NOG
prerank,amyloid precursor protein catabolic process (GO:0042987),0.42789399595759914,0.9198904233066068,0.5724137931034483,0.8663239953621827,1.0,4/14,17.93%,ADAM10;BACE1;PSEN2;CLN3
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.3697914344190829,0.9198778013856724,0.5980629539951574,0.8659377445665261,1.0,10/30,26.09%,CHUK;TANK;TRAF3;RPS27A;UBC;IKBKE;IRF3;BIRC3;TBK1;RIPK1
prerank,positive regulation of monocyte chemotaxis (GO:0090026),-0.32223922733615906,-0.919582851201206,0.5676855895196506,0.8003742505214083,1.0,7/17,22.75%,CXCL12;ANO6;SERPINE1;CREB3;PLA2G7;CCR2;CXCL10
prerank,regulation of glycogen biosynthetic process (GO:0005979),0.39061449639559725,0.9192642924773838,0.599502487562189,0.8667490410956532,1.0,4/24,10.16%,IRS1;PPP1R3C;AKT2;PPP1R3F
prerank,manganese ion transport (GO:0006828),0.4199808004100357,0.9190731220252998,0.5768707482993197,0.8667440182189317,1.0,1/14,0.56%,SLC39A14
prerank,base-excision repair (GO:0006284),0.3497112725478392,0.9190617000611783,0.5937859608745685,0.8663533912712794,1.0,23/48,33.68%,MPG;HUWE1;ERCC5;OGG1;WRN;TDG;SMUG1;PARP1;POLB;APEX2;USP47;PARG;POLD1;POLG;XPA;PNKP;ADPRS;MBD4;XRCC1;ERCC6;POLQ;RPA3;PRMT6
prerank,isotype switching (GO:0045190),0.45500292785961094,0.9188763302422139,0.592032967032967,0.866308411618841,1.0,6/10,37.98%,HSPD1;LIG4;EXOSC3;MSH2;RNF8;RNF168
prerank,cellular macromolecule biosynthetic process (GO:0034645),0.3095195709396904,0.9187947957862842,0.7185929648241206,0.8660599937004769,1.0,76/306,23.76%,ST3GAL4;EXT1;RPSA;RRBP1;HELB;TOPORS;BAZ2A;POLE2;EIF4G2;RMI2;ABCF1;MCM2;B4GALT5;GSPT1;ST3GAL2;HARS2;CDC6;RBBP8;RAD1;ING5;WRN;MRPS18B;TERT;ATM;NFKBIB;MRPS14;GAL3ST4;RAD50;EEF1G;XAB2;AGO2;EIF4G1;INHBA;CDC45;MRPL35;MEF2A;MMS19;MRPS17;POLR2F;ING4;EEF2K;ATRIP;YARS2;B3GNT6;MCM4;EEF1B2;RPS27A;HUS1;E2F1;REV1;TUFM;ORC2;EXT2;GOLPH3;DBF4;EEFSEC;SARS1;CDK2;ASMT;RPL7A;DARS1;KAT7;TBRG1;MED20;GTPBP2;POLR2B;TOP1;MRPS21;TOPBP1;UPF1;PTMS;TOP1MT;DONSON;MRPS18A;PABPC4;RPS9
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.39750198076236226,0.9187622783342316,0.6004932182490752,0.8657221513388914,1.0,6/23,17.46%,GHR;CYP1B1;HES5;F2R;IL6;PRLR
prerank,regulation of mast cell degranulation (GO:0043304),-0.34199074463873685,-0.9186130590830535,0.55859375,0.8011159653025326,1.0,5/14,13.66%,LYN;CD300A;SYK;CD84;LGALS9
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.3969744394361134,0.9186052676852289,0.5967540574282147,0.8656199900139924,1.0,3/22,4.16%,GHR;CYP1B1;HES5
prerank,response to cytokine (GO:0034097),0.3221954185011885,0.9183786089612467,0.6653019447287615,0.8656876452333236,1.0,23/141,12.71%,PID1;COL3A1;ADAM9;AFF3;TIMP2;DPYSL3;TIMP3;NFAT5;HDAC4;STAT3;PRKCA;ADAM10;IRAK3;IFNLR1;CXCL16;RHOA;ANXA1;PTPN18;MAPK8;IRAK1;SRF;CASP1;PTPN2
prerank,outer dynein arm assembly (GO:0036158),0.4322355118752404,0.9183321423477298,0.5855978260869565,0.8653815572649256,1.0,3/14,12.51%,DNAH8;ODAD2;DNAAF4
prerank,homeostasis of number of cells (GO:0048872),0.446116458152375,0.9182137898944144,0.5899581589958159,0.86521941299235,1.0,4/12,13.33%,CCN3;UBAP2L;LPCAT3;F2R
prerank,male meiosis I (GO:0007141),0.4225699651075274,0.9179567055129343,0.5872170439414115,0.8653460086202485,1.0,3/16,18.67%,FOXJ3;HSF2BP;BRDT
prerank,vasoconstriction (GO:0042310),-0.3626277504135647,-0.9178101129135077,0.5527156549520766,0.8015001509025457,1.0,6/11,16.91%,SLC8A1;EDNRB;EDN1;ACTA2;PIK3C2A;HTR2B
prerank,response to hydroxyurea (GO:0072710),0.4508331614248223,0.9175742012308167,0.6014492753623188,0.8657303499582196,1.0,6/11,31.91%,DDI2;SPIDR;KAT7;DDX11;TIMELESS;BLM
prerank,histone H2A ubiquitination (GO:0033522),0.4075376747383875,0.9173757990930768,0.5750962772785623,0.8657272437091987,1.0,5/17,18.84%,UBE2B;RNF2;RING1;RYBP;UBR2
prerank,defense response to tumor cell (GO:0002357),-0.3763223955358904,-0.9169710430939306,0.565625,0.801938658389941,1.0,2/10,9.28%,RBMS3;ABI3
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.4239678549094381,0.9169603140289764,0.5824175824175825,0.8661303185686369,1.0,3/14,13.03%,RARA;ANXA1;CD80
prerank,protein homotetramerization (GO:0051289),0.3438659994916942,0.9164176060337441,0.6218961625282167,0.866796623942339,1.0,12/49,19.77%,KCNJ2;CRYZ;TRPM4;CBR4;ACACA;PKD2L1;ACOT13;SHMT2;GNMT;SHMT1;TK1;APPL2
prerank,actin filament network formation (GO:0051639),0.45957892920239024,0.9159450978293543,0.5933908045977011,0.8673406578513758,1.0,3/11,12.38%,PLS1;COBL;SPIRE2
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.33438738472787133,0.9158155921923319,0.628696604600219,0.8671842291796582,1.0,11/67,12.61%,PGF;VEGFA;VAV2;SULF1;ABI1;CYFIP1;RHOA;PAK2;ITGAV;NRP1;PIK3CB
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",-0.2920288414538814,-0.9157581693416992,0.5849056603773585,0.8031455083002011,1.0,6/23,17.58%,CECR2;KPNA1;H1-0;KPNB1;DNASE1L1;FOXL2
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),-0.3690193816498048,-0.9154806804028819,0.5294117647058824,0.8022586763609197,1.0,5/10,16.88%,PRKAA2;PRKAA1;MYOCD;SIRT1;KLF15
prerank,negative regulation of developmental process (GO:0051093),0.3349539154233242,0.914996167858234,0.6171617161716172,0.868391061720274,1.0,13/69,12.41%,GAS6;NFIB;GRIN3A;PARP3;PTPRS;SOX9;HUWE1;CST3;BMP4;FOXM1;ANP32B;NEUROD2;HEY1
prerank,DNA replication checkpoint signaling (GO:0000076),0.4163329784836238,0.9148244047766698,0.5945241199478487,0.868330902860467,1.0,7/16,30.65%,CDC6;CDC45;HUS1;CDT1;TOPBP1;TIMELESS;RAD17
prerank,positive regulation of DNA recombination (GO:0045911),0.3734562841915643,0.9148178189900723,0.591358024691358,0.8679370219830398,1.0,13/27,29.56%,FUS;KMT5C;WDR48;ERCC2;MMS19;PARP1;MAD2L2;ACTR2;SHLD3;WAS;SHLD1;HMCES;TIMELESS
prerank,establishment of spindle orientation (GO:0051294),0.3746539595214822,0.9145821568036596,0.6104868913857678,0.8680130178549804,1.0,7/28,22.78%,PKHD1;MISP;LLGL1;ZW10;NDEL1;DCTN1;CDK5RAP2
prerank,positive regulation of dendritic spine development (GO:0060999),-0.30263135922299417,-0.9145387616964182,0.5517241379310345,0.8028500937410061,1.0,5/20,13.83%,APOE;SHANK3;CUX2;RELN;LRP8
prerank,defense response to fungus (GO:0050832),0.4055977552605803,0.9143685452788203,0.5782122905027933,0.8680205633056629,1.0,1/17,4.32%,RNASE7
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.3891039618573661,0.9135242603539808,0.5966277561608301,0.8692948640831087,1.0,5/21,7.17%,CACNA1C;CAMK2D;CALM2;DMD;ANK2
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),0.4436794467883065,0.9133882964113106,0.5910987482614742,0.8691530061476853,1.0,2/11,6.35%,LMNA;SMAD4
prerank,regulation of biosynthetic process (GO:0009889),-0.361204415219732,-0.9132283848463679,0.5333333333333333,0.8042430758701475,1.0,3/11,15.04%,SLC25A33;MID1IP1;SNCA
prerank,regulation of protein secretion (GO:0050708),0.3195122260103413,0.9131531928105275,0.6656346749226006,0.8692189365714278,1.0,25/119,18.14%,CACNA1C;KCNB1;ADAM9;SLC12A2;UNC13B;TGFB3;APBB3;TGFB2;P3H1;PRKCA;DISP1;LLGL1;CACNA2D2;ERP29;EZR;STXBP5;GLP1R;PICK1;IL6;STX1A;APBB1;SLC2A2;SYTL4;GOLPH3;IER3IP1
prerank,epidermis development (GO:0008544),0.3424218972105193,0.9124404758588746,0.6328828828828829,0.870180017595446,1.0,9/56,15.76%,KRTDAP;TGM5;PLOD1;FGFR2;CRABP2;HDAC1;ALDH3A2;EMP1;GRHL1
prerank,positive regulation of T cell cytokine production (GO:0002726),-0.30191608275886916,-0.9124302578458948,0.5663716814159292,0.8045197643349148,1.0,5/20,16.28%,IL1R1;B2M;RSAD2;PRKCZ;CD55
prerank,regulation of microtubule-based process (GO:0032886),0.36213592951053897,0.9123314343574914,0.6200241254523522,0.8700225252827032,1.0,10/36,26.77%,EFNA5;PHLDB1;MARK4;HDAC6;ERBB2;CAMSAP3;CYLD;TAOK1;ROCK1;ATF5
prerank,T cell proliferation (GO:0042098),-0.3395963228633636,-0.9121261200625025,0.5622775800711743,0.8037245429830797,1.0,1/13,0.47%,CADM1
prerank,pigment granule transport (GO:0051904),0.4085710140940322,0.9119363803487494,0.6239782016348774,0.8699992769378118,1.0,7/18,30.60%,BBS5;RAB11B;BLOC1S3;MLPH;BBS7;MYO5A;RAB27B
prerank,melanosome transport (GO:0032402),0.4085710140940322,0.9119363803487494,0.6239782016348774,0.8699992769378118,1.0,7/18,30.60%,BBS5;RAB11B;BLOC1S3;MLPH;BBS7;MYO5A;RAB27B
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.35274361683233835,0.9116012421542652,0.588098016336056,0.8702484986843719,1.0,4/39,6.22%,VEGFA;FXYD5;RDX;JAG1
prerank,cardiac left ventricle morphogenesis (GO:0003214),-0.3286192955787547,-0.9110076138222941,0.5769230769230769,0.8047263803268492,1.0,6/13,21.44%,NOTCH1;RYR2;RBPJ;HEY2;FOXF1;NPY5R
prerank,regulation of synapse maturation (GO:0090128),-0.3735777443414104,-0.9109940131896328,0.5501618122977346,0.8032307672967571,1.0,4/10,13.53%,NRXN1;ARHGEF15;YWHAZ;RELN
prerank,protein K63-linked deubiquitination (GO:0070536),0.365976574871079,0.9109216948655483,0.5933014354066986,0.8711942633044095,1.0,12/31,23.72%,USP50;OTUB2;USP7;USP33;USP13;PSMD14;OTUD5;SHMT2;YOD1;ZRANB1;BRCC3;CYLD
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.35490613950606564,0.9107552456569747,0.5868544600938967,0.8711121838877998,1.0,4/39,7.98%,TCF7L2;MCU;AACS;CAPN10
prerank,regulation of Golgi organization (GO:1903358),0.40592729536455147,0.9107350596125469,0.5867549668874172,0.8707487487351532,1.0,7/17,33.72%,STX5;AKAP9;ARMH3;CAMSAP3;MYO5A;EHD3;STX18
prerank,axonal transport of mitochondrion (GO:0019896),0.43976468296134785,0.9106596712310957,0.6028571428571429,0.8704750726666143,1.0,4/11,21.84%,SYBU;SPAST;ACTR10;NEFL
prerank,negative regulation of interleukin-8 production (GO:0032717),0.4058822184239386,0.9105380339636912,0.578042328042328,0.8702975473893301,1.0,4/17,14.98%,ANXA4;ANXA1;MAPKBP1;ARRB1
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.33986935126455486,0.910404305466297,0.5997782705099778,0.8701425217123397,1.0,9/51,12.22%,MYOC;TGFB3;SORBS3;S100A10;PFN2;RHOA;ABL1;NRP1;TGFBR1
prerank,Fc receptor signaling pathway (GO:0038093),0.3200396313247508,0.9103672641373708,0.660455486542443,0.869808584643197,1.0,29/110,21.26%,GAB2;VAV2;PSMD7;SHC1;PSMA8;FCER1G;NFATC1;PSMA4;PAK2;MAPK8;CHUK;TAB2;PDPK1;PSMD12;CUL1;PIK3CB;PSMA6;NFATC3;PSMD11;PSMC5;SOS1;PSMD1;PSMD14;PSMC4;MAPK9;PSMA3;PSMD4;MAP2K7;PSMB1
prerank,eosinophil chemotaxis (GO:0048245),0.41882855236547895,0.9099662750832782,0.5936199722607489,0.8698046939799846,1.0,1/14,3.24%,CCL13
prerank,eosinophil migration (GO:0072677),0.41882855236547895,0.9099662750832782,0.5936199722607489,0.8698046939799846,1.0,1/14,3.24%,CCL13
prerank,cellular response to thyroid hormone stimulus (GO:0097067),0.4351236117814907,0.9095184599567624,0.5926449787835927,0.8703082847094378,1.0,4/12,20.84%,RDX;BRD8;CTSB;KLF9
prerank,T cell differentiation in thymus (GO:0033077),0.42070021213519815,0.909403868180643,0.5947075208913649,0.8701308676794284,1.0,5/14,30.97%,RIPK3;LIG4;GLI3;ZFP36L1;PTPRC
prerank,epithelial cell development (GO:0002064),0.39110901994307173,0.9092913229558717,0.5873655913978495,0.8699447994630961,1.0,2/20,3.91%,LRTOMT;PKHD1
prerank,positive regulation of transferase activity (GO:0051347),0.31494503506991695,0.9091123886271089,0.6853932584269663,0.8698799517268004,1.0,23/142,12.75%,EGFR;DDR2;NTRK3;NTRK1;EPHB2;MAPK15;TOPORS;EPHB3;DCUN1D5;EPHB6;NEK7;FGFR1;HNRNPA2B1;ROR1;FGFR2;MUSK;NVL;LMO4;AXIN1;DDR1;PABPN1;RAD50;DCUN1D2
prerank,sulfur compound catabolic process (GO:0044273),0.3504723662770261,0.908838752346722,0.610917537746806,0.8700335052363855,1.0,12/38,25.24%,BGN;ARSB;CSPG4;MPST;ACAT1;HEXA;VCAN;GLB1;CHAC2;DPEP1;GNS;FITM2
prerank,ether lipid metabolic process (GO:0046485),0.4153592140226421,0.9088344882224542,0.6146540027137042,0.8696373783154777,1.0,6/14,28.06%,PEX7;FAR1;AGMO;AGPS;NCEH1;TMEM86B
prerank,membrane depolarization (GO:0051899),0.3688620887636564,0.9084752367817852,0.6063829787234043,0.8699594846145418,1.0,4/32,10.41%,CACNA1G;SCN11A;CHRNB2;ABL1
prerank,cytoplasmic microtubule organization (GO:0031122),0.34067473216822464,0.9084235068193472,0.6362612612612613,0.8696563440566778,1.0,16/54,22.95%,LIMK2;DYNC1H1;CLIP4;TUBGCP3;DLG1;RHOA;SPAST;CHP1;EZR;PCM1;KATNA1;SLAIN2;DCTN1;CLIP2;CRIPT;CAMSAP3
prerank,regulation of lipid storage (GO:0010883),0.38514621430145124,0.9084127849004833,0.6092964824120602,0.8692771371190561,1.0,7/22,19.69%,FTO;ITGAV;PTPN2;IL6;MEST;IKBKE;NFKBIA
prerank,regulation of phospholipid metabolic process (GO:1903725),-0.36885811245473205,-0.9083537438481761,0.5566343042071198,0.8076700674631333,1.0,4/10,17.94%,MTMR3;MFSD2A;DNAJC19;PHB2
prerank,toll-like receptor signaling pathway (GO:0002224),0.32654325571129383,0.908285025920824,0.6321961620469083,0.8691077920131693,1.0,17/84,22.21%,LBP;SCARA3;HMGB1;IRAK3;CHUK;TAB2;IRAK1;HSPD1;TRAF3;S100A1;COLEC12;RPS27A;UBC;CTSB;BIRC3;CTSK;TLR1
prerank,protein localization to mitochondrion (GO:0070585),0.4426467337108757,0.9081253524755311,0.6128093158660844,0.8690232012487694,1.0,6/11,26.53%,AKT1;DNAJA1;COX18;LRRK2;PINK1;RALA
prerank,positive regulation of protein secretion (GO:0050714),0.3328137605896249,0.9078506249833846,0.6203501094091903,0.8691456952978648,1.0,9/69,7.98%,ADAM9;TCF7L2;UNC13B;TGFB3;APBB3;TGFB2;MCU;AACS;CAPN10
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.31404347010260225,0.9077457533197799,0.6752312435765673,0.8689544768151228,1.0,32/124,21.26%,TCF7L2;SFRP4;TIAM1;PRICKLE1;PSMD7;PDE6A;AP2A1;PSMA8;DVL1;FZD7;FZD5;RHOA;NFATC1;PSMA4;AGO1;PSMD12;PSMA6;AGO2;AP2A2;CLTC;GNAO1;PSMD11;PSMC5;PSMD1;PSMD14;PSMC4;SMURF2;PSMA3;PLCB2;GNB1;PSMD4;PSMB1
prerank,monocarboxylic acid catabolic process (GO:0072329),0.39015845650692527,0.9076903526665752,0.6002621231979031,0.8686752615964032,1.0,2/21,2.79%,AGXT2;CEL
prerank,retinal metabolic process (GO:0042574),0.42898357545609306,0.9071680915851144,0.6002728512960437,0.8692900902283728,1.0,2/12,9.00%,CYP1B1;AKR1C1
prerank,positive regulation of cellular protein localization (GO:1903829),0.33484429056913256,0.9067240255940505,0.6334792122538293,0.8697738273333349,1.0,17/69,21.72%,GNL3;WWTR1;TM9SF4;LIMK2;RIC3;MEAK7;CDK5RAP3;TRAPPC12;SESN2;MARK4;STX4;ORMDL3;CDT1;AKT1;KAT7;NUP62;EIF2AK3
prerank,negative regulation of neuron death (GO:1901215),0.3236521655557395,0.9065669610066618,0.6455696202531646,0.8696951564575229,1.0,21/93,20.63%,SIX1;NTRK1;TGFB3;SIX4;ATF4;TNFRSF1B;NRBP2;SOD1;EIF4G1;LIG4;F2R;NDNF;CLCF1;CLN3;GDNF;AKT1;CDK5;CHMP4B;CHMP4A;NFATC4;LRRK2
prerank,calcium import into the mitochondrion (GO:0036444),0.4455768893412363,0.9057215782846105,0.5838150289017341,0.8709542298725307,1.0,4/10,23.05%,MCU;MICU2;MICU1;AFG3L2
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.33238861924507307,0.9054983109819184,0.6469321851453176,0.8709777959908874,1.0,11/71,13.42%,PRKCD;PRKCE;VAV2;ARPC1B;ABI1;CYFIP1;FCER1G;WIPF1;ABL1;PIK3CB;MYH2
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.3312072803554434,-0.9050504280469148,0.6150627615062761,0.8136651845080997,1.0,5/15,15.22%,DGKD;HIP1R;AAK1;TNK2;BMP2K
prerank,negative regulation of cilium assembly (GO:1902018),0.42628977311780186,0.9050034106276349,0.5962059620596206,0.8715270769219402,1.0,7/12,30.16%,LIMK2;CDK10;EVI5L;CCP110;TESK1;YAP1;TCHP
prerank,regulation of T cell chemotaxis (GO:0010819),0.4284424517073705,0.90472692733229,0.6020260492040521,0.8717040484648384,1.0,3/11,13.93%,ADAM10;STK39;WNK1
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),-0.2898298624959064,-0.9046649063711343,0.5989304812834224,0.8130185391548241,1.0,6/26,12.10%,INSR;SMAD3;KLF2;ASS1;EDN1;DDAH2
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.42067454360770906,0.9046163838413475,0.5812080536912752,0.8715198034981815,1.0,6/15,22.65%,ATL2;REEP3;TMEM170A;TMEM33;ATL1;RAB18
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.3284123199121074,0.9043937862530189,0.6289104638619202,0.8715614551302511,1.0,11/67,11.32%,EGFR;PKDCC;DDR2;GHR;NTRK1;EPHB2;ABI1;FGFR1;FGFR2;ABL1;DDR1
prerank,negative regulation of interleukin-6 production (GO:0032715),0.3700346022912844,0.9043149323958597,0.6141636141636142,0.87130851759714,1.0,2/27,6.84%,GAS6;IRAK3
prerank,retrograde axonal transport (GO:0008090),0.40876565261196507,0.9040150947346418,0.5897097625329816,0.8714792931785895,1.0,5/16,21.84%,DLG2;DYNC1H1;SOD1;ACTR10;NEFL
prerank,response to nitric oxide (GO:0071731),-0.34849792331754903,-0.9039503873820888,0.6043956043956044,0.8130513648166198,1.0,4/13,18.03%,GUCY1B1;KCNC2;FOXO1;MT3
prerank,nucleocytoplasmic transport (GO:0006913),0.3518025420621643,0.9038575099126046,0.639269406392694,0.8713744545862709,1.0,12/40,25.80%,XPO1;SNUPN;GEMIN7;SMN1;NCBP1;NCBP2;GEMIN2;RITA1;SNRPB;HNRNPA1;DDX20;NUTF2
prerank,response to interferon-alpha (GO:0035455),0.408911256955119,0.9037624302901142,0.6075129533678757,0.8711701343793246,1.0,1/16,1.02%,GAS6
prerank,epithelial cell migration (GO:0010631),0.3516490820401243,0.9037501709560668,0.6139315230224321,0.870793999128102,1.0,9/37,11.54%,FSTL1;CYP1B1;FAP;FAT2;GIPC1;RHOA;PKN2;ABL1;NRP1
prerank,"phototransduction, visible light (GO:0007603)",0.42037596329993127,0.9036274214349617,0.5922865013774105,0.8706336868545838,1.0,4/14,20.78%,PDE6A;GNA11;SAG;GNB1
prerank,regulation of Notch signaling pathway (GO:0008593),0.3274075416794743,0.9029103129030874,0.6379498364231189,0.8715866181321833,1.0,10/76,9.29%,EGFR;CCN3;ZMIZ1;STAT3;TGFB2;MMP14;JAG1;POGLUT1;LLGL1;WWP2
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.40908231024653574,0.9024884858730502,0.5989445910290238,0.8719908562972065,1.0,3/15,12.77%,PABPC1;TENT4B;AGO2
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.32930709700961697,0.9024033104183441,0.6634408602150538,0.871754673485026,1.0,30/72,33.35%,CHD1L;HORMAD1;PNRC2;ERCC5;ERCC4;RNASE6;OGG1;CUL4A;RAD50;ERCC3;ERCC2;PARP1;RPS27A;UBC;DCP1A;POLD1;FBH1;GTF2H4;XPA;DNASE1L2;DDB1;EDC4;DXO;RNASE1;RBX1;IHO1;ERCC1;CUL4B;POLK;RPA3
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),-0.35892756433543616,-0.9023065635179383,0.5563636363636364,0.8151752426032222,1.0,9/11,41.98%,PRKCQ;NFKBIZ;MALT1;IL12RB1;CARD9;IL23A;IL12B;IL23R;CLEC6A
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.3976523798948731,0.9019515802062452,0.5920529801324503,0.8722243620587283,1.0,3/18,7.72%,VEGFA;ADCY8;RPS6KA4
prerank,organophosphate biosynthetic process (GO:0090407),0.3594874384487615,0.9019167147551469,0.6451612903225806,0.8718972632915855,1.0,12/37,26.42%,FGF2;LPCAT1;TKT;NFS1;FADS1;IP6K1;PIP5K1A;AGPAT5;MBOAT1;PPIP5K1;FITM2;PCYT2
prerank,regulation of protein processing (GO:0070613),0.38492831271445993,0.9016930571427746,0.6102150537634409,0.8719202252491584,1.0,5/21,20.63%,GAS1;RUNX1;SERPINE2;CLN3;LRRK2
prerank,regulation of Rho protein signal transduction (GO:0035023),0.32998252995545235,0.9013005398373118,0.653551912568306,0.8723101333359542,1.0,14/72,14.98%,MYOC;COL3A1;ARHGEF28;EPS8L1;BCR;RAF1;GPR20;ABL1;ABCA1;NRP1;SCAI;F2R;AKAP13;ARRB1
prerank,regulation of ruffle assembly (GO:1900027),0.38101738263582513,0.900928522210708,0.6055979643765903,0.8726096979665524,1.0,7/23,14.82%,RDX;EPS8L1;FAM98A;PFN2;NLGN1;NDEL1;PLEKHM1
prerank,regulation of interleukin-1 beta production (GO:0032651),0.32905686748583796,0.9006597654556064,0.6467991169977925,0.8727446208860743,1.0,9/66,15.41%,FOXP1;STAT3;CARD16;USP50;FZD5;GIT1;CASP1;F2R;IL6
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.42779208500431426,0.8999018932272079,0.6134228187919463,0.8738254732265263,1.0,4/13,15.00%,DKK3;SOD1;BMP5;CYP27B1
prerank,myelin assembly (GO:0032288),0.45103342375359456,0.8998523517437483,0.5960170697012802,0.8735222598651601,1.0,3/10,12.65%,PMP22;CD9;NCMAP
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.3516177616367895,0.899843844308688,0.6191037735849056,0.8731386197278427,1.0,7/38,18.68%,ESR1;RORA;MAPKBP1;TANK;PER1;USP10;ZMYND11
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),-0.3057996867009235,-0.8995357326682014,0.6264591439688716,0.819552720593093,1.0,4/18,8.94%,PPARA;PAG1;DUSP3;ASS1
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.31112010370191173,0.8994900892318156,0.7167689161554193,0.8734357558529666,1.0,17/159,7.27%,PCDHB16;PKD1;CDH11;GPC6;EMB;HMCN1;PTPRS;PTPRF;TGFB2;NECTIN3;LRFN4;CRB1;ACVR1;AMIGO3;FAT2;TGFBR2;PALLD
prerank,SNARE complex assembly (GO:0035493),-0.37276328746237075,-0.8992442713367511,0.558282208588957,0.8186736357836093,1.0,1/10,1.42%,STXBP6
prerank,protein kinase B signaling (GO:0043491),0.37929175764997825,0.8990891476718232,0.6071887034659821,0.8738027736089289,1.0,7/23,27.54%,GAS6;SIRT2;AKT1;TSC2;CCL2;ZFP36L1;SETX
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.21532141950885728,-0.8989254848341002,0.7333333333333333,0.8179228884615415,1.0,47/110,22.86%,RPS14;RPS15;RPL8;RPS25;RPS8;RPS20;RPL4;SMG7;RPS27;RPS10;RPL24;CTIF;RPS29;RPS7;RPL26;RPS16;RPL35;RPS24;RPL36;GSPT2;RPL18A;RPS12;RPL11;RPS11;RPL12;SMG8;UBA52;RPL18;RPS15A;EIF4A3;RPS28;RPL21;RPL7;RPL10;RPL15;RPS18;RPS19;RPS3;RPL38;RPS5;RPL28;RPL35A;RPS4X;RPL17;RPL23;RPL9;RPL31
prerank,"synaptic transmission, glutamatergic (GO:0035249)",0.4019350427432604,0.8989188978056133,0.6099110546378653,0.8737473669610446,1.0,2/18,2.64%,GRIK4;UNC13B
prerank,regulation of cellular senescence (GO:2000772),-0.2834473183960549,-0.8988783508447231,0.6120218579234973,0.8165134745549844,1.0,6/28,9.28%,CDK6;B2M;SLC30A10;AKT3;NUAK1;ABI3
prerank,protein acetylation (GO:0006473),0.3612947971230712,0.8986789775983627,0.6159600997506235,0.8737921375067729,1.0,6/30,15.58%,NAA60;NAA40;ING5;NAA16;ING4;CREBBP
prerank,positive regulation of cation channel activity (GO:2001259),0.3517833154390653,0.8984665353835781,0.625,0.8738004741454491,1.0,8/40,16.30%,EPHB2;ARC;CALM2;KCNIP2;ANK2;P2RY6;STAC3;CALM3
prerank,signal transduction by p53 class mediator (GO:0072331),0.3649537996066144,0.8979967955475149,0.6115023474178404,0.8742989774420569,1.0,5/30,13.07%,DDX5;FHIT;MDM4;NDRG1;SESN2
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.38761951392050836,0.8978091950977184,0.6104417670682731,0.8742448093734324,1.0,4/19,10.07%,VEGFA;PTPRU;DENND6A;FOXA1
prerank,pancreas development (GO:0031016),0.43446417560587786,0.8975546736712288,0.6100278551532033,0.8743542362437396,1.0,3/12,15.71%,TCF7L2;CCDC39;NPHP3
prerank,steroid metabolic process (GO:0008202),0.32607548046399404,0.8973430803131748,0.6405579399141631,0.8743623022254653,1.0,13/72,17.46%,CYP19A1;CYP1B1;AKR1C1;NPC1;DHRS4;FDXR;DHRS9;LRP2;PIAS4;VDR;CYP27B1;LSS;PRLR
prerank,response to interleukin-1 (GO:0070555),0.3272854708558347,0.8973032602225822,0.6666666666666666,0.874047197798635,1.0,10/73,12.93%,PTGIS;CCL13;HDAC4;CCL15;PRKCA;IRAK3;SOX9;ANXA1;IRAK1;TANK
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.3497636658060501,0.8970308395331771,0.6358447488584474,0.8741688145422651,1.0,19/43,31.92%,INTS3;CDK5RAP3;CDC6;ATM;RINT1;FOXN3;HUS1;BRCC3;TOPBP1;TAOK3;DONSON;TAOK1;TAOK2;NOP53;PABIR1;TRIM39;RAD17;BLM;CHFR
prerank,negative regulation of protein transport (GO:0051224),0.37665916665815774,0.8959150457547502,0.6320400500625782,0.8759318774692592,1.0,8/25,26.70%,PKDCC;WWP2;ERP29;DRD2;SNX3;CSK;HMGCR;NDFIP1
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),-0.328988680717466,-0.895892339919824,0.5708955223880597,0.8216129853141344,1.0,12/14,43.60%,IL17D;PAEP;CD84;RASGRP1;IL18;ISL1;CARD9;IL23A;IL12B;IL23R;IL17F;IL1B
prerank,regulation of cartilage development (GO:0061035),0.39643616523925407,0.8957890870341777,0.625,0.8757538284680051,1.0,6/18,15.17%,BMP1;MBOAT2;SOX9;BMP4;KAT2A;SCIN
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.3274281174658205,0.8957367445124497,0.6602357984994641,0.8754590521628466,1.0,11/73,13.42%,PRKCD;PRKCE;VAV2;ARPC1B;ABI1;CYFIP1;FCER1G;WIPF1;ABL1;PIK3CB;MYH2
prerank,regulation of RNA export from nucleus (GO:0046831),0.4388369194834607,0.8955032800304418,0.6495726495726496,0.8755109748778966,1.0,5/11,26.43%,KHDRBS1;NCBP2;CPSF6;SETD2;TPR
prerank,positive regulation of nuclear division (GO:0051785),-0.28192958230801857,-0.8944392731912828,0.6304347826086957,0.8233113601251917,1.0,3/25,4.83%,INSR;TGFA;PDGFRB
prerank,monocyte differentiation (GO:0030224),0.44057675822631076,0.894392998050301,0.6159420289855072,0.8772186325301624,1.0,2/10,10.16%,VEGFA;BMP4
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.4033224902594678,0.8943088695734964,0.6395806028833552,0.8769928169233948,1.0,2/17,2.85%,PDCD4;TGFB3
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.41836492726940055,0.8939685449770777,0.607190412782956,0.8772330098547393,1.0,6/13,22.86%,UBA5;SAE1;UBA3;SENP6;DESI2;DESI1
prerank,glycolipid metabolic process (GO:0006664),0.33883097629824527,0.8938152734117348,0.6538024971623155,0.8771113595400181,1.0,10/47,19.83%,ST3GAL4;PIGW;SMPD4;ARSA;ST3GAL2;GALC;HEXA;SUMF2;GLB1;ASAH1
prerank,regulation of response to biotic stimulus (GO:0002831),0.3684003897155617,0.8937949696092716,0.6306196840826246,0.8767562242424483,1.0,8/28,25.96%,FOXP1;TRAF3;N4BP1;APPL2;APPL1;BIRC3;XIAP;TKFC
prerank,positive regulation of type I interferon production (GO:0032481),0.32610969918901295,0.8934263719907224,0.6889848812095032,0.8770323282645164,1.0,38/73,35.64%,MAVS;PRKDC;POLR3H;CHUK;IRAK1;HSPD1;CRCP;POLR3GL;POLR2F;CREBBP;TOMM70;NFKB2;IRF3;POLR3K;XRCC6;SETD2;POLR1C;TBK1;PTPN11;CGAS;POLR2H;DDX41;RIPK2;POLR3E;RNF135;POLR2L;CTNNB1;HSP90AA1;NFKB1;POLR2K;RIOK3;POLR3F;IFIH1;RELA;DHX9;IRF1;MRE11;G3BP1
prerank,zinc ion homeostasis (GO:0055069),0.368522816004467,0.8934125728634376,0.6071428571428571,0.876663104207052,1.0,5/28,10.01%,SLC39A14;SLC39A7;TMC8;SLC30A5;SLC39A13
prerank,regulation of tau-protein kinase activity (GO:1902947),-0.3698133150458255,-0.8929448813368117,0.589171974522293,0.8250868498426983,1.0,2/10,11.44%,RB1;EGR1
prerank,cyclic purine nucleotide metabolic process (GO:0052652),-0.3045450471388584,-0.8928904969111383,0.6575342465753424,0.823674625059981,1.0,5/21,9.15%,ADCY5;GUCY1B1;ADCY1;ADCY4;NPR1
prerank,regulation of centrosome duplication (GO:0010824),0.36774041708138167,0.8924873494506309,0.6099033816425121,0.8779989064721582,1.0,9/29,25.54%,PKHD1;ALMS1;CHMP3;XRCC3;CHMP4B;PDCD6IP;TMEM67;CHMP2A;SPICE1
prerank,positive regulation of telomere capping (GO:1904355),0.3946709928013975,0.8922852181004773,0.630012936610608,0.8779732505327174,1.0,6/17,27.63%,MAPK15;NEK7;TNKS2;MAP2K7;PNKP;RTEL1
prerank,macromolecule catabolic process (GO:0009057),0.3674761292106235,0.8918001432265066,0.6309067688378033,0.8784619901691705,1.0,7/26,23.87%,NEDD4;LRSAM1;UCHL3;IDE;MVB12A;UVRAG;USE1
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.4368032396092908,0.891765809857631,0.6144756277695717,0.8781378479262384,1.0,4/10,28.16%,NCBP1;NCBP2;PAF1;HSF1
prerank,regulation of keratinocyte proliferation (GO:0010837),0.3832246317876151,0.8917506021092568,0.6248431618569636,0.877765804959951,1.0,3/22,14.99%,SRSF6;FGFR2;VDR
prerank,blood circulation (GO:0008015),0.34054400481283237,0.8915447943761039,0.6602052451539339,0.8777578580755718,1.0,5/49,3.95%,ELN;SGCD;GCLC;HCN4;MEOX2
prerank,glycerolipid metabolic process (GO:0046486),-0.3585833068217814,-0.891179286437481,0.5980707395498392,0.8259875250117227,1.0,5/11,14.25%,DGKB;DGKG;GAL3ST1;DGKZ;DGKA
prerank,positive regulation of protein depolymerization (GO:1901881),-0.3527062214286142,-0.8910788841260348,0.5941558441558441,0.8247041359400855,1.0,4/11,16.93%,SEMA5A;NES;PLEK;TRPV4
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.28436141494387773,-0.8908429871712833,0.6178010471204188,0.8236700825567879,1.0,5/23,7.63%,ACSL1;ELOVL7;HACD1;FAR2;HSD17B12
prerank,negative regulation of JUN kinase activity (GO:0043508),0.4445422613028648,0.890410177202093,0.6224066390041494,0.8795139033149247,1.0,5/10,24.26%,PDCD4;AIDA;DNAJA1;DUSP19;MAPK8IP1
prerank,regulation of fibroblast proliferation (GO:0048145),0.3399213559718706,0.8903460537863715,0.6373117033603708,0.8792330514089484,1.0,8/45,17.11%,GAS6;DDR2;MORC3;SKI;MED25;LIG4;NF1;E2F1
prerank,regulation of dendritic spine development (GO:0060998),0.3946314785425269,0.8899622381984768,0.610236220472441,0.8795472613564244,1.0,6/19,13.27%,GRIN3A;PTPRS;TANC2;SHANK1;FOXO6;NLGN1
prerank,regulation of myoblast fusion (GO:1901739),0.4367203750906444,0.8899052891882884,0.6194563662374821,0.8792554124008067,1.0,2/11,7.24%,EHD1;EHD2
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.30572594989565083,0.8896460921249698,0.7350859453993933,0.8793514741238776,1.0,35/161,16.70%,LRP6;TCF7L2;SFRP4;PRICKLE1;DKK3;PSMD7;TLE2;WWTR1;PTPRU;PSMA8;TLE6;DACT1;DVL1;SOX9;DACT3;NOG;TLE3;PSMA4;TPBG;AXIN1;PSMD12;HDAC1;INVS;PSMA6;LIMD1;DAB2;FUZ;PSMD11;LATS2;PSMC5;PSMD1;NPHP3;PSMD14;MLLT3;PSMC4
prerank,negative regulation of cell adhesion (GO:0007162),0.3246983718936298,0.889339327895272,0.6605005440696409,0.8795332056223084,1.0,9/72,6.70%,PLXNA4;TGFBI;SPN;MUC1;CYP1B1;EPHB2;JAG1;ADAM10;FZD7
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.3584931611823382,0.8890663845580188,0.6266829865361077,0.8796788711810305,1.0,4/30,6.35%,FSTL1;SFRP4;DKK3;SMAD4
prerank,negative regulation of transposition (GO:0010529),0.39785061460150883,0.8889767353553657,0.6094364351245085,0.8794579146587902,1.0,6/16,34.25%,TEX15;TUT7;UBR2;MOV10;SIRT7;DDX4
prerank,regulation of centriole replication (GO:0046599),0.4002535685451232,0.8887689425327995,0.6058981233243967,0.8794631401928551,1.0,8/17,29.02%,ALMS1;KAT2A;NUP62;CDK5RAP2;KAT2B;PLK4;SPICE1;STIL
prerank,positive chemotaxis (GO:0050918),0.39988276950362184,0.8882518650194383,0.6208277703604806,0.8799994534158259,1.0,1/17,0.80%,VEGFA
prerank,embryonic heart tube development (GO:0035050),-0.3264224906999661,-0.8880912775246077,0.5958188153310104,0.8281826803661347,1.0,4/14,11.33%,RYR2;SOX17;TBX2;SOX18
prerank,protein autophosphorylation (GO:0046777),0.3065210259426137,0.887998842379184,0.7410805300713558,0.8800801397441183,1.0,40/157,18.60%,EGFR;DDR2;ULK2;NTRK1;ACVR1B;MAPK15;CAMK2D;TNK1;EPHB3;STK39;FGFR1;CDK12;PAK2;FGFR2;SMG1;ABL1;MUSK;RIPK3;ATM;MAP3K12;IRAK1;DDR1;CHEK2;PDPK1;UHMK1;STK25;SRMS;MAP3K10;MAP3K3;EEF2K;CAMK4;ERBB2;STK16;MKNK2;SIK2;VRK2;DAPK3;CAD;CLK2;AKT1
prerank,placenta development (GO:0001890),0.42102770470048184,0.8879909619331811,0.6096551724137931,0.8796986474148126,1.0,4/12,26.57%,SOD1;PLAC1;CUL7;E2F8
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.313225756477983,0.8879325343759428,0.7025052192066806,0.8794020889454127,1.0,16/107,11.64%,SLC39A14;ATP1B1;SLC24A3;CCL13;PKHD1;CCL15;SLC39A7;SLC10A7;ANK2;EDN3;CHERP;STIM1;SLC30A5;SLC39A13;CSRP3;TMEM165
prerank,positive regulation of B cell proliferation (GO:0030890),-0.2680933101137951,-0.8875202133952118,0.6612903225806451,0.8279340905975946,1.0,11/29,21.36%,BCL2;TFRC;NFATC2;CD38;VAV3;CD74;CD40;CD320;IRS2;IL7;TNFSF13B
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.32231815247654316,0.8874675172450577,0.6858407079646017,0.8798623095704826,1.0,16/70,17.55%,SRGAP2;SRCIN1;TMEFF2;PKHD1;ATF4;NTN4;EPHB3;ILK;RHOA;ITGAV;NRP1;PARVA;SIPA1L3;MICALL2;TBCD;EFNA1
prerank,telomere maintenance via telomere trimming (GO:0090737),0.44699722618268833,0.887389031215324,0.6338235294117647,0.8788149538163669,1.0,6/10,32.63%,WRN;XRCC3;SLX4;SMARCAL1;BLM;ERCC1
prerank,t-circle formation (GO:0090656),0.44699722618268833,0.887389031215324,0.6338235294117647,0.8788149538163669,1.0,6/10,32.63%,WRN;XRCC3;SLX4;SMARCAL1;BLM;ERCC1
prerank,formation of extrachromosomal circular DNA (GO:0001325),0.44699722618268833,0.887389031215324,0.6338235294117647,0.8788149538163669,1.0,6/10,32.63%,WRN;XRCC3;SLX4;SMARCAL1;BLM;ERCC1
prerank,ATP transport (GO:0015867),-0.3640585837680965,-0.8870550086385736,0.5609756097560976,0.8274467672241548,1.0,3/10,27.96%,SLC25A24;CD47;SLC17A9
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.3107294126694422,-0.8869131407636003,0.6450381679389313,0.8262691691494548,1.0,6/18,14.35%,VCAM1;JAM2;SLC39A8;CX3CR1;ITGA4;GCNT1
prerank,hexose biosynthetic process (GO:0019319),0.3438931502309222,0.8866592300967178,0.6706021251475797,0.879763615178417,1.0,7/42,17.39%,SLC39A14;ATF4;SORD;CRTC2;PGK1;SLC37A4;ENO2
prerank,ribonucleoprotein complex biogenesis (GO:0022613),0.3356009851373084,0.8866268765741256,0.6659217877094972,0.8794312198373857,1.0,15/57,21.84%,XPO1;LTV1;RRS1;EMG1;CUL4A;RIOK1;NVL;MRTO4;BYSL;BOP1;METTL17;NOC2L;GTF3A;WDR12;PAK1IP1
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.3729332299801456,0.8864275306269832,0.6317135549872123,0.8793909215136945,1.0,1/21,0.80%,VEGFA
prerank,negative regulation of response to external stimulus (GO:0032102),0.3095578622418208,0.8857327224513892,0.696652719665272,0.8802970252112817,1.0,14/105,10.34%,PRKCD;FGF2;PTGIS;CCN3;DRD1;PTPRS;CARD16;TRAFD1;IRAK3;RORA;SHARPIN;ITCH;MAPKBP1;LPCAT3
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.42711819018238434,0.8856360784459522,0.6371308016877637,0.8796948804520858,1.0,3/11,23.30%,CALM2;CALM3;FKBP1B
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.42711819018238434,0.8856360784459522,0.6371308016877637,0.8796948804520858,1.0,3/11,23.30%,CALM2;CALM3;FKBP1B
prerank,positive regulation of cellular component organization (GO:0051130),0.3144044186038504,0.885625919683849,0.7028154327424401,0.8793200546774358,1.0,31/107,22.78%,TRABD2B;VEGFA;LRP1;MPP7;GPC3;TGFB3;TGFB2;VCP;CDC42EP2;SLF2;PLEKHM2;RUNX1;SPIDR;NEUROD2;TMED9;TGFBR1;ADD1;DAB2;ANAPC2;SUMO1;CD151;CDT1;BID;CDC20;PTPN23;DCTN1;CLU;LMAN1;SLF1;ICE1;CAMK1
prerank,inositol phosphate biosynthetic process (GO:0032958),0.4248774364360088,0.8853992920359379,0.6267409470752089,0.8793333176884014,1.0,2/11,11.09%,FGF2;IP6K1
prerank,genitalia development (GO:0048806),0.4330437846414398,0.8853285097803354,0.6336088154269972,0.8790880325573781,1.0,1/12,0.48%,PKD1
prerank,"transcription, DNA-templated (GO:0006351)",0.30002583530799043,0.8852212229845732,0.7454545454545455,0.8788941163448895,1.0,82/207,29.92%,NFIX;DDX5;DEAF1;TOPORS;BAZ2A;TCEA2;ATF4;TCFL5;NFX1;POLR3H;HSF2BP;GTF2F1;CCNT2;NFKBIB;TAF15;TAF6;TRIP11;ERCC3;CRCP;XAB2;TAF13;ERCC2;MEF2A;POLR3GL;MMS19;TFDP1;MBD1;POLR2F;FOXO3;AFF4;PARP1;MLLT3;SMN1;NCBP1;E2F1;SSRP1;NFYA;NCBP2;TFB2M;CBFB;TAF9B;GTF3C4;POLR3K;GTF3C1;TWNK;CEBPD;MRPL12;GTF3A;ABT1;MED20;PAF1;NFIC;POLR2B;TBP;POLR1C;MNT;TAF1C;NELFB;TAF1;EAF1;TP53;CTDP1;RTF1;GTF2H4;RNMT;POLR2H;NELFA;DRG1;TAF10;UBTF;SETX;CDK9;HSF1;TAF5L;TAF3;NFE2L3;POLR2I;PRMT5;MLLT1;PWP1;POLR2L;TTF2
prerank,protein polyglutamylation (GO:0018095),0.4285819666798589,0.8851965518709732,0.6294706723891274,0.8785434328151981,1.0,3/11,14.53%,TTLL2;TPGS1;CEP41
prerank,synapse organization (GO:0050808),0.3114298806517046,0.8849079347861731,0.7394871794871795,0.8787192204977904,1.0,13/125,5.66%,PCDHB16;GPC6;CTNND2;NEDD4;FARP1;DRD1;UNC13B;PTPRS;PTPRF;SEMA3E;LRFN4;PPFIA1;DVL1
prerank,regulation of transforming growth factor beta production (GO:0071634),-0.305910009886776,-0.8848573115301316,0.6216216216216216,0.8292533489649719,1.0,6/18,13.66%,LTBP1;SMAD3;CD200;FN1;CD34;LGALS9
prerank,lipid modification (GO:0030258),0.3472446896038202,0.8846681647004271,0.6442873969375736,0.8787358305338867,1.0,6/37,10.34%,PLPP3;PLPP5;PLPP1;MBOAT2;DGKQ;LPCAT3
prerank,negative regulation of fat cell differentiation (GO:0045599),0.349854895088377,0.8845409873694385,0.6522248243559718,0.878578823285237,1.0,9/34,17.31%,ZFPM2;WWTR1;RORA;SIRT2;IL6;TRIO;FLCN;E2F1;ANKRD26
prerank,regulation of viral transcription (GO:0046782),0.3460012881887603,0.8841354471770516,0.6548463356973995,0.8789243359723649,1.0,17/39,29.76%,MDFIC;TRIM27;UBP1;GTF2F1;MID2;HEXIM1;POLR2F;TRIM13;LARP7;POLR2B;NELFB;CTDP1;POLR2H;NELFA;CDK9;POLR2I;POLR2L
prerank,regulation of RIG-I signaling pathway (GO:0039535),0.3853064018849536,0.8837204460223117,0.603494623655914,0.879313014796326,1.0,8/18,29.31%,PUM1;GPATCH3;NPLOC4;BIRC3;SEC14L1;C1QBP;NOP53;PUM2
prerank,regulation of protein ubiquitination (GO:0031396),0.31312494503430793,0.8834471781013941,0.7153209109730849,0.8794246638625228,1.0,40/108,30.77%,PRR7;PRICKLE1;NXN;HUWE1;CDK5RAP3;OGT;AXIN1;SMAD7;TGFBR1;CHP1;PHF23;UBQLN1;SQSTM1;U2AF2;ARRB1;STUB1;N4BP1;MINAR1;UFL1;AKT1;MYCBP2;DNAJA1;LRRK2;BIRC3;DERL1;USP4;GTPBP4;CAMLG;XIAP;PINK1;RCHY1;DAXX;NDFIP1;SVBP;RIPK2;PER2;SPOPL;PRMT3;HSP90AA1;PRKN
prerank,ESCRT III complex disassembly (GO:1904903),0.44135504758972244,0.8827760685899008,0.6096491228070176,0.8798576524913507,1.0,6/10,40.03%,IST1;VTA1;CHMP2A;VPS4B;CHMP1B;VPS4A
prerank,ESCRT complex disassembly (GO:1904896),0.44135504758972244,0.8827760685899008,0.6096491228070176,0.8798576524913507,1.0,6/10,40.03%,IST1;VTA1;CHMP2A;VPS4B;CHMP1B;VPS4A
prerank,regulation of tissue remodeling (GO:0034103),0.38475808366138087,0.8823901425662541,0.6396276595744681,0.8801850055733949,1.0,3/18,9.48%,DDR2;CST3;RUNX1
prerank,regulation of rRNA processing (GO:2000232),0.3967234469664993,0.8820949739290017,0.6275303643724697,0.8803279389993052,1.0,12/16,39.88%,RIOK1;USP36;KAT2B;BUD23;WDR75;RIOK2;TRMT112;SIRT7;UTP15;DIMT1;YTHDF2;WDR43
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.30515650636340896,0.8819328142087315,0.7213114754098361,0.8802433403215374,1.0,57/119,32.93%,FGF2;PLEKHA4;TTC7A;PIK3C2B;PIGW;PITPNM1;SOCS4;SOCS7;SOCS6;SOCS2;PIGF;PIP4K2B;SYNJ1;SMG1;IP6K1;ARF1;INPP4A;PIK3CB;PIGL;OCRL;PI4K2A;PGAP2;TTC7B;CDIPT;PIP5K1A;INPP5E;PI4KB;VAC14;CDS1;SYNJ2;MTMR1;RAB4A;DPM3;MTM1;PIGV;TMEM150A;PLEKHA3;PIGQ;SOCS1;RAB5A;PI4KA;PIGB;PIP4K2C;SACM1L;PIK3C2G;FIG4;RUFY1;PIGN;PIKFYVE;SBF1;PIGC;MTMR2;PLEKHA1;MTMR9;MTMR12;PIGO;PIK3CA
prerank,negative regulation of neuron projection development (GO:0010977),-0.2367738839390881,-0.8818346515645206,0.7241379310344828,0.8340096943262185,1.0,20/56,19.63%,EFNB2;LPAR1;APOE;EPHA4;PTPRO;PTPN9;ARHGDIA;DCC;PRAG1;BAG5;MCF2;SPOCK1;MAG;TRPV4;DENND5A;MT3;LRP4;RTN4R;THY1;BCL11A
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),-0.32121896035383257,-0.8816939263418616,0.605072463768116,0.8328338811073017,1.0,6/14,18.46%,ADK;GMPS;IMPDH1;ADSS1;LHPP;PPAT
prerank,cognition (GO:0050890),0.34459320910663277,0.8815003466162181,0.6542491268917345,0.88062801971498,1.0,9/42,16.35%,ST3GAL4;DOP1B;SOBP;CHRNB2;CYFIP1;SETD5;SLC1A4;NF1;NIPBL
prerank,positive regulation of glucose transmembrane transport (GO:0010828),0.36932571868428293,0.8811504883996305,0.6317073170731707,0.8808726766889429,1.0,5/26,8.69%,IRS1;RHOQ;C2CD5;CAPN10;AKT2
prerank,gluconeogenesis (GO:0006094),0.3442149944368985,0.881144837477073,0.6730769230769231,0.8804919191272488,1.0,12/39,29.71%,SLC39A14;ATF4;CRTC2;PGK1;SLC37A4;ENO2;PFKFB1;SLC25A11;SLC25A12;PER2;MDH2;GAPDHS
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.31869012735231234,0.8810501484717764,0.6695371367061357,0.8802594478885318,1.0,24/72,26.09%,GAS6;ELF1;TAX1BP1;IRAK3;RUNX1;SHARPIN;CHUK;ABCE1;MADD;IRAK1;PTPN2;OTULIN;SUMO1;VRK2;CBFB;JAK1;BIRC3;CYLD;SPPL2A;PTPN11;TRADD;IFNGR2;SOCS1;RIPK1
prerank,aggrephagy (GO:0035973),0.36399627958778585,0.8808726018779277,0.6288532675709001,0.8801847781975817,1.0,10/27,22.58%,DYNC1H1;DYNC1LI2;UBQLN1;SQSTM1;IFT88;HDAC6;RPS27A;UBC;DYNC1I2;ACBD5
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.31766612660882204,0.8805919460562386,0.67170626349892,0.8802919697394814,1.0,16/75,18.60%,LRP6;PRKCD;LRP5;IPO5;IRAK3;CDK5RAP3;BMP4;ABL1;PAQR3;PIK3CB;HEXIM1;LATS2;NF1;CDKN1C;MEN1;AKT1
prerank,negative regulation of wound healing (GO:0061045),0.3623660833715613,0.8802848606647582,0.6335403726708074,0.8804586091698497,1.0,2/28,1.24%,FGF2;SLC12A2
prerank,tRNA wobble base modification (GO:0002097),0.4068308686452801,0.8790102362479731,0.627939142461964,0.8823753204962032,1.0,6/14,24.84%,ALKBH1;CTU2;ELP4;ALKBH8;ELP3;MTO1
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.4233266218157563,0.8789612913675935,0.6298882681564246,0.8820724651854619,1.0,3/11,18.89%,HMGB1;RUNX1;CBFB
prerank,telomere maintenance via telomerase (GO:0007004),0.3552662284841222,0.8789360242760118,0.6372549019607843,0.8817355200928851,1.0,11/28,30.89%,PPP6R3;TERT;TELO2;RAD50;TNKS1BP1;CDK2;ANKRD28;DKC1;RTEL1;HSP90AA1;NOP10
prerank,regulation of exosomal secretion (GO:1903541),0.3779562917159682,0.8788570222168065,0.6344647519582245,0.881478562373141,1.0,5/19,24.90%,SDC1;ATP9A;CHMP3;PDCD6IP;CHMP2A
prerank,CENP-A containing chromatin organization (GO:0061641),0.3569867324237855,0.8781293480574831,0.6385093167701863,0.8820171041713365,1.0,4/29,13.35%,HJURP;CENPC;CENPT;RBBP7
prerank,CENP-A containing nucleosome assembly (GO:0034080),0.3569867324237855,0.8781293480574831,0.6385093167701863,0.8820171041713365,1.0,4/29,13.35%,HJURP;CENPC;CENPT;RBBP7
prerank,response to ethanol (GO:0045471),0.40896163243538664,0.8776907650543981,0.6313617606602476,0.8824366157266363,1.0,4/14,17.07%,GRIN3A;CHRNB2;SOD1;ADCY7
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),-0.34166728846788263,-0.8776629176805726,0.6410256410256411,0.840039247584264,1.0,2/12,3.72%,SEMA6A;ADAMTS12
prerank,regulation of cell-substrate adhesion (GO:0010810),0.34300231987773944,0.8771999741014819,0.6537102473498233,0.8829313527602891,1.0,10/42,16.30%,VIT;PKHD1;AGR2;FZD7;RHOA;PIK3CB;ARL2;NDNF;NF1;TBCD
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.4038615921060901,0.8770520466878122,0.6462395543175488,0.8828088630925762,1.0,3/14,13.93%,ADAM10;STK39;WNK1
prerank,chloride transmembrane transport (GO:1902476),0.3328051855762567,0.8768197605501556,0.6815578465063001,0.8828340244658616,1.0,5/48,7.19%,SLC12A7;SLC12A2;SLC4A8;GABRA3;SLC12A4
prerank,dendritic cell differentiation (GO:0097028),0.37410493566324343,0.87663319872757,0.6364779874213836,0.8827959586438148,1.0,2/22,6.49%,GAS6;TGFBR2
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.41275629076355386,0.8762230078526353,0.6241519674355496,0.883144009922506,1.0,6/13,26.50%,HEXIM1;LARP7;NELFB;HNRNPU;RECQL5;NELFA
prerank,negative regulation of cell population proliferation (GO:0008285),0.2963650552823512,0.8761890553805944,0.841,0.8828199141171468,1.0,75/351,18.09%,ZBTB7C;WNT9A;IGFBP5;SFRP4;CCN3;NTRK1;SMAD6;CYP1B1;GLMN;FAP;TGFB3;P3H3;SLURP1;LMNA;PTPRU;TGFB2;MORC3;P3H1;CLMN;NOX4;TMEM115;PLPP1;ABI1;PRKRA;E2F3;IFNLR1;CDK10;SKI;RAF1;MDM4;P3H2;SOX9;TES;CHERP;NOG;DDAH1;CDC6;ING5;BMP4;VIP;DIS3L2;RBM5;NELL1;TGFB1I1;PBRM1;MED25;TENM1;PTPN2;INHBA;CGRRF1;F2R;GSDME;FRK;BMP5;TMEM127;FUZ;TFDP1;SIRT2;VDR;CYP27B1;SCIN;ING4;CAMK2N1;IL6;PPP2R5C;NF1;MINAR1;FLCN;MAGED1;E2F1;HMOX1;CDKN1C;MEN1;HMGA1;KLF10
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.3069103712634444,0.8758936138607674,0.7324380165289256,0.8829664484368155,1.0,22/121,15.41%,VEGFA;EFNA5;GAS6;SRCIN1;GHR;STAT3;HES5;CSPG4;IL5;ACVR1;NOX4;DLG4;DGKQ;PAK2;ANGPT4;ABL1;CTF1;NRP1;CD80;CLCF1;IL6;HGF
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.4207472535191599,0.87556355111372,0.6338797814207651,0.8831693761042543,1.0,4/12,22.62%,CDC6;CHEK2;HUS1;TOPBP1
prerank,protein catabolic process (GO:0030163),0.32427250445444084,0.8755042479493014,0.6734234234234234,0.8828877397920067,1.0,26/59,31.78%,VCP;PSMA8;LRSAM1;SOCS6;DDI2;UCHL3;CHEK2;NGLY1;ATE1;FBXO17;IDE;UBE2G2;LAMP2;USE1;ADAMTS9;OGA;RIPK1;HTRA2;DDB1;CLN5;MANBA;NR1D1;STT3B;HSP90AA1;PRKN;RAB12
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.31816574900649114,0.8754614046009171,0.6842684268426843,0.8825796463334157,1.0,14/69,16.37%,IRS1;PLCE1;NTRK1;GAB2;PIK3C2B;FGFR1;OGT;RHOA;PIK3CB;EZR;SIRT2;PI4KB;NF1;ERBB2
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.31943067885392906,0.8754587537182018,0.655592469545958,0.882195684135683,1.0,21/61,27.64%,NCOR2;PSMD7;PSMA8;SIRT5;PSMA4;PSMD12;PSMA6;PSMD11;PSMC5;PSMD1;PSMD14;PSMC4;AZIN1;PSMA3;PSMD4;PSMB1;PSMA5;PSMA7;PSMC1;PSMA1;PANK2
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.361509406756116,0.8750682021746752,0.6472019464720195,0.88252980992007,1.0,10/29,20.15%,ACSF3;ELOVL5;SCD5;CBR4;PPT2;ACACA;ACSL3;HSD17B8;ACSL6;ACSBG1
prerank,cellular response to virus (GO:0098586),0.3529022170459179,0.8750405651489167,0.6478696741854637,0.8821960458799261,1.0,8/30,19.40%,GBF1;LGALS8;CHUK;ARF1;GSDME;IL6;TOMM70;IRF3
prerank,ganglioside metabolic process (GO:0001573),0.3821786770265211,0.8749461290218518,0.6457800511508951,0.8819796909587854,1.0,2/20,4.53%,ST8SIA2;ST6GALNAC5
prerank,androgen metabolic process (GO:0008209),0.38624562433895626,0.8748865596954226,0.6276315789473684,0.8816962560294079,1.0,2/18,13.40%,CYP19A1;DHRS9
prerank,intraciliary retrograde transport (GO:0035721),0.4138192651686998,0.8748145969728115,0.6234817813765182,0.8814388295648338,1.0,7/12,31.93%,DYNLT2B;DYNC2I1;IFT43;DYNC2H1;IFT140;DYNC2I2;WDR35
prerank,regulation of defense response (GO:0031347),0.3180360289158091,0.8743194363295888,0.6912242686890574,0.8819205063929254,1.0,18/76,21.86%,MGLL;FOXP1;SHPK;BRD4;SBNO2;ANXA1;NR1D2;PSMA6;CASP1;TRAF3;PTGES;N4BP1;UFL1;APPL2;APPL1;BIRC3;DAGLB;AREL1
prerank,transition metal ion homeostasis (GO:0055076),0.3583264577170643,0.8743138232099084,0.6574185765983113,0.8815441130843251,1.0,8/28,17.75%,SLC39A14;NEO1;HMOX2;TMC8;CYBRD1;BDH2;IREB2;HMOX1
prerank,response to thyroid hormone (GO:0097066),0.4124746364672153,0.8739379155467605,0.6433566433566433,0.8818134029639879,1.0,4/13,20.84%,RDX;BRD8;CTSB;KLF9
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.3307207233139504,0.8736335505103047,0.674712643678161,0.8819621604572634,1.0,10/46,17.05%,EMILIN1;TIMP3;EPHB2;SPRED2;SMAD4;DLG1;PTPN2;EZR;CAMK2N1;FLCN
prerank,catecholamine biosynthetic process (GO:0042423),-0.348454598222923,-0.8733887718722773,0.6027397260273972,0.8475534119537924,1.0,3/11,15.04%,MOXD1;GCH1;SNCA
prerank,neuromuscular process (GO:0050905),0.39376536862395606,0.8732123669389575,0.6223684210526316,0.8823177314875444,1.0,6/16,20.59%,PRRT2;SHANK1;UBA5;CLN3;MYCBP2;DCTN1
prerank,anterograde trans-synaptic signaling (GO:0098916),0.2963615736955811,0.8729251865319364,0.78125,0.8824556879175468,1.0,20/224,8.74%,PCDHB16;LRP6;GRIK4;SLC12A7;DLG2;EXOC4;UNC13B;CEL;CAMKK1;PMP22;KCNN1;SLC6A2;GABRA3;KCNIP2;CHRNB2;SLC12A4;GIPC1;DLG4;CHRNA5;DLG1
prerank,mitochondrial translation (GO:0032543),0.31006957270825175,0.8729099865512921,0.7162592986184909,0.8820951166076355,1.0,29/104,28.80%,MRPS2;MRPL33;DAP3;MRPL19;MRPS35;MRPS28;NOA1;MTRF1L;MRPS18B;MRPL39;MRPS14;MRPL35;MRPS17;MRPL45;TUFM;PTCD3;MRPL12;MRPL47;MRPS26;MRPS24;MRPS21;MRPS18A;MRPL37;MRPL17;MRPL13;MRPL30;MRPL4;NDUFA7;MRPL11
prerank,microtubule bundle formation (GO:0001578),0.33762948911053026,0.8728435273955787,0.6710059171597633,0.8818388484804408,1.0,11/42,22.93%,NAV1;CFAP206;SPAST;CCDC66;CHP1;MARK4;LRGUK;TTLL3;CDK5RAP2;CAPN6;SPAG16
prerank,regulation of amyloid fibril formation (GO:1905906),-0.3128959342476644,-0.8724455358099303,0.6477272727272727,0.8479707821595708,1.0,2/15,2.33%,APOE;APP
prerank,sensory perception (GO:0007600),0.3332392061883731,0.8722362618732614,0.6854838709677419,0.8825065552989322,1.0,2/45,1.98%,GNAS;PROK2
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.3260139992921866,0.8718167152752524,0.6641053787047201,0.8828863296608639,1.0,18/57,25.42%,PRKDC;CDK5RAP3;ATM;CHEK2;SDE2;RINT1;FOXN3;HUS1;ATF2;CDK2;BRCC3;TOPBP1;TAOK3;DONSON;TAOK1;RPS27L;TP53;TAOK2
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.3241705498191181,0.8717332210647313,0.680968096809681,0.8826413496458642,1.0,28/67,30.11%,RDX;TBC1D2B;MAPK15;DYNLT2B;IFT20;GAP43;TBC1D24;ATG3;SDCCAG8;TBC1D9B;TBC1D10A;IFT88;TBC1D17;EVI5;TBC1D22B;ATP8B1;FXR2;RABGAP1;CYLD;TBC1D20;RAB5A;TWF1;WAS;FXR1;IFT140;RAC1;TBC1D19;MYO10
prerank,endothelial tube morphogenesis (GO:0061154),0.426889095747924,0.871659406672389,0.6414285714285715,0.8823766028272662,1.0,6/10,30.26%,RHOA;BMP4;RHOB;PRKD2;CCM2;CTNNB1
prerank,triglyceride biosynthetic process (GO:0019432),-0.30030454648060256,-0.8711782522183378,0.6131687242798354,0.849111473103685,1.0,6/18,17.76%,LPGAT1;GK;MOGAT3;LPIN2;DGAT2;DGAT1
prerank,modified amino acid transport (GO:0072337),0.4063155425853887,0.8710718103159579,0.6412005457025921,0.8830060120108858,1.0,2/15,6.01%,SLC5A6;SLC25A32
prerank,neuron projection organization (GO:0106027),-0.314154082421711,-0.8708741175282393,0.6448979591836734,0.8481927016340616,1.0,2/15,2.33%,INSR;APP
prerank,regulation of cellular component movement (GO:0051270),0.33145548537822395,0.8704898479473264,0.67561260210035,0.883649195260811,1.0,10/49,12.22%,EGFR;VEGFA;ARAP1;PKHD1;CD9;RAF1;RHOA;PKN2;ABL1;TGFBR1
prerank,vesicle organization (GO:0016050),0.33011107395843436,0.8699559703813732,0.6678240740740741,0.8842063656192769,1.0,12/46,21.28%,DNAJC13;LAMTOR1;USP50;LAPTM4B;WASHC4;SQSTM1;PI4K2A;VPS11;ZFYVE16;PHETA2;ARFGEF2;SNX11
prerank,activation of GTPase activity (GO:0090630),0.31212079264590264,0.8694615080908655,0.7124735729386892,0.884683271752941,1.0,26/89,22.94%,SGSM2;TIAM1;NTRK3;TIAM2;TBC1D8B;TBC1D2B;DOCK7;SIPA1L1;BCAS3;BCR;EVI5L;TBC1D9B;TBC1D25;SIPA1L3;TBCK;TBC1D10A;PIP5K1A;TBC1D17;NGEF;EVI5;RASGRF1;TBC1D22B;ARHGEF10;RAP1GAP2;SIPA1L2;RABGAP1
prerank,glycosphingolipid biosynthetic process (GO:0006688),0.39322471037847756,0.8689585006167624,0.6420079260237781,0.885197470054467,1.0,2/16,4.53%,ST8SIA2;ST6GALNAC5
prerank,secondary alcohol metabolic process (GO:1902652),0.3403340094805233,0.8688518461847211,0.6753246753246753,0.8850059499977684,1.0,19/42,33.34%,SOAT1;RXRA;TSKU;NSDHL;ABCA1;EBP;IDH3B;IL4;STARD3;APOF;ANGPTL3;OSBPL5;SOAT2;SQLE;OSBPL1A;IDH2;IDH3G;GBA2;IDH1
prerank,regulation of cation channel activity (GO:2001257),0.30709179861074315,0.8687664960336912,0.7121848739495799,0.8847591686190253,1.0,13/89,8.74%,FGF13;DLG2;AHNAK;CAMK2D;CALM2;DMD;CNIH2;KCNE5;SLMAP;ANK2;DLG4;SELENON;DLG1
prerank,autonomic nervous system development (GO:0048483),0.38720976707090654,0.8686544934344104,0.636849132176235,0.8845805567489003,1.0,5/17,23.59%,NTRK1;NRP1;NF1;GDNF;SOX8
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.3440128891474375,0.8681233745310087,0.6757719714964371,0.8851224637380845,1.0,10/37,22.56%,PDCD4;CHID1;STAT3;IL6;PER1;ADCY7;APPL2;APPL1;IL17RA;ABCD1
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.3600452709027138,0.8680607439116106,0.6600741656365884,0.8848534642957827,1.0,11/28,28.16%,PARP3;PRKDC;KMT5C;TFIP11;MAD2L2;ACTR2;SHLD3;WAS;PNKP;SHLD1;HSF1
prerank,organelle transport along microtubule (GO:0072384),0.35130839513366136,0.8676685528007387,0.6609124537607891,0.8851669743857535,1.0,9/31,23.07%,COPG1;RHOT2;ARHGAP21;RHOT1;TMEM201;NDEL1;CLN3;RAB1A;PEX14
prerank,dicarboxylic acid catabolic process (GO:0043649),0.40384565250873744,0.8676506523078937,0.6456375838926175,0.8848126346208831,1.0,3/13,7.40%,ACSF3;PM20D2;QPRT
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.3873729725022442,0.8671819021533936,0.6481958762886598,0.8852679873429492,1.0,4/18,16.33%,BRD4;CDC25B;RCC2;CDC25A
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.3703708151154382,0.8668990543227261,0.6691635455680399,0.8853853443663731,1.0,6/24,19.58%,TGFB2;ATF4;BACE1;FOXO3;NF1;CDK5
prerank,regulation of lamellipodium morphogenesis (GO:2000392),-0.3407093867639841,-0.8668935788840658,0.6360424028268551,0.8549935385378694,1.0,5/11,27.68%,ENPP2;CORO1C;CD44;CORO1B;SRC
prerank,regulation of response to cytokine stimulus (GO:0060759),0.38452829914475795,0.8668592619411907,0.6353240152477764,0.8850706386725361,1.0,4/19,11.00%,ELF1;MAVS;RUNX1;IRAK1
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.3717737160171081,0.8667427073614169,0.6409921671018277,0.8848976854046248,1.0,5/20,16.25%,AGO1;AGO2;LIMD1;EIF6;CNOT8
prerank,Notch signaling pathway (GO:0007219),0.3245502366758106,0.8665845868211818,0.6835164835164835,0.8848098194172773,1.0,14/59,15.58%,ZNF423;HES5;GMDS;DTX3;JAG1;ADAM10;PBX1;HEYL;NLE1;ITCH;HEY1;DTX2;PSEN2;CREBBP
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),0.4028022531112206,0.8665033637340077,0.6483050847457628,0.8845698963711702,1.0,2/14,5.50%,ENTPD2;ENTPD6
prerank,acetylcholine receptor signaling pathway (GO:0095500),-0.2932005686162902,-0.866435273950248,0.6593886462882096,0.8544100791718573,1.0,1/20,0.16%,PLCB1
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.3138467376265606,-0.8660619309935402,0.6156462585034014,0.8537356106491496,1.0,3/14,8.93%,TFRC;RIF1;NECTIN2
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.3706300167334148,0.8658525353857605,0.6649937264742786,0.8853554496425362,1.0,6/22,15.94%,CAMK2D;PRKCA;SMAD4;SLC9A1;MEF2A;PARP1
prerank,toll-like receptor 9 signaling pathway (GO:0034162),-0.32410198982647753,-0.8658042581444256,0.608540925266904,0.8527579667299262,1.0,10/13,38.19%,UNC93B1;MYD88;PIK3R4;TLR7;PIK3AP1;IRAK2;TNIP2;TRAF6;IRAK4;PIK3C3
prerank,positive regulation of response to external stimulus (GO:0032103),0.3002047937808684,0.8657578402691033,0.7497435897435898,0.8851477932245485,1.0,7/128,6.25%,THBS1;IL33;PDCD4;ABCC1;PRKCA;LRSAM1;PUM1
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.40127000943363533,0.8656694398245084,0.6408450704225352,0.8849067434317271,1.0,8/13,33.23%,ALG13;ALG1;ALG3;ALG14;ALG12;ALG9;SRD5A3;ALG8
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),-0.23585379487730077,-0.8653659231803429,0.7426470588235294,0.852115585938053,1.0,12/49,13.20%,SGMS1;BCL2;BCL2L1;DNM1L;DAPK2;DDX3X;NUPR1;BOK;CAV1;BCL2L11;STYXL1;NDUFA13
prerank,alcohol catabolic process (GO:0046164),-0.3530128939093434,-0.8649322618479127,0.6038961038961039,0.8515021929202161,1.0,5/10,20.63%,APOE;CYP27A1;SCARF1;MT3;CYP46A1
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.2980427019267306,-0.8647450761543831,0.6379310344827587,0.8503719401551869,1.0,4/18,7.63%,ACSL1;ELOVL7;HACD1;HSD17B12
prerank,positive regulation of signaling (GO:0023056),0.3407335057644331,0.8646826035321175,0.6578631452581032,0.8862000974868118,1.0,8/37,13.03%,ECE1;CLSTN2;ANXA2;ILK;EDN3;DLG4;NSF;CD80
prerank,positive regulation of viral process (GO:0048524),0.3152370500861142,0.8637608505583865,0.6924778761061947,0.8874820169729131,1.0,25/60,31.68%,MDFIC;PABPC1;TMEM39A;PKN2;GTF2F1;KPNA2;SRPK1;POLR2F;POLR2B;NELFB;STAU1;TBC1D20;PPID;CTDP1;POLR2H;NELFA;DDB1;CDK9;KPNA6;HACD3;POLR2I;LARP1;POLR2L;PPIH;POLR2K
prerank,response to amino acid (GO:0043200),0.34965136814034414,0.8634131596762376,0.6622436670687576,0.8876731415996064,1.0,10/31,27.26%,IPO5;MEAK7;LAMTOR1;CAPN2;SESN2;NSMF;GLRB;RPTOR;LAMTOR2;LAMTOR3
prerank,interstrand cross-link repair (GO:0036297),0.32566605556037115,0.8632630360577247,0.6751662971175166,0.8875525883442242,1.0,14/53,20.53%,VCP;FAAP20;ERCC4;WDR48;DCLRE1B;FANCE;ATRIP;FAAP24;RPS27A;UBC;RAD51;USP1;XRCC3;FANCG
prerank,response to ATP (GO:0033198),-0.29275274113658006,-0.8632333018831067,0.642570281124498,0.8519835235255651,1.0,5/18,19.33%,TRPC3;ABCC9;CIB2;P2RY1;P2RX7
prerank,regulation of protein localization to nucleus (GO:1900180),0.33311404975592085,0.8631263646172892,0.6861397479954181,0.8874076578712454,1.0,18/43,29.63%,WWTR1;LIMK2;CDK5RAP3;BMP4;NVL;SESN2;LATS2;BYSL;ORMDL3;FLCN;AKT1;KAT7;EIF2AK3;ILRUN;TPR;LIF;TESK1;YAP1
prerank,heterocycle biosynthetic process (GO:0018130),0.4025944885588435,0.8628416758461462,0.6347708894878706,0.8875294500338857,1.0,4/14,22.75%,LIAS;NFS1;NOXRED1;PYCR1
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.3407864997165862,0.8626379419303302,0.6867612293144209,0.8874957961046577,1.0,16/36,25.72%,DACT1;DLG1;ITCH;FOXM1;EZR;PER1;MEN1;ZMYND11;AIDA;DUSP19;GPS2;TAOK3;CYLD;NCOR1;PINK1;QARS1
prerank,regulation of store-operated calcium entry (GO:2001256),0.4322647159370149,0.8623418448743122,0.6456582633053222,0.8876191615791833,1.0,5/10,23.86%,EFHB;STIM1;SARAF;HOMER2;SLC8B1
prerank,central nervous system neuron differentiation (GO:0021953),0.34440664098248336,0.8622276887644743,0.6698679471788715,0.887440151204858,1.0,1/33,0.33%,LRP6
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.3927525714830537,0.8621461674321046,0.6648275862068965,0.8868122807286155,1.0,5/15,23.53%,BLOC1S2;AP3D1;BLOC1S3;SNAPIN;AP3B1
prerank,anterograde synaptic vesicle transport (GO:0048490),0.3927525714830537,0.8621461674321046,0.6648275862068965,0.8868122807286155,1.0,5/15,23.53%,BLOC1S2;AP3D1;BLOC1S3;SNAPIN;AP3B1
prerank,positive regulation of calcium-mediated signaling (GO:0050850),-0.33545818721502096,-0.8618833637026609,0.6227106227106227,0.8533095673673393,1.0,1/11,1.21%,CDH13
prerank,chromatin remodeling at centromere (GO:0031055),0.347238728474155,0.8617667270889174,0.6474201474201474,0.8871031540145792,1.0,4/31,13.35%,HJURP;CENPC;CENPT;RBBP7
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),-0.32734833573946465,-0.8617476914542448,0.6389891696750902,0.851998218251204,1.0,9/12,43.60%,PRKCQ;CCR2;IL12RB1;CARD9;IL23A;IL12B;IL23R;CLEC6A;IL1B
prerank,low-density lipoprotein particle remodeling (GO:0034374),-0.33531802771166885,-0.8616772620653568,0.6391752577319587,0.8506297031678095,1.0,2/11,8.02%,ABCG1;AGTR1
prerank,positive regulation of MAPK cascade (GO:0043410),0.29383549158134814,0.8614242698055041,0.8226452905811623,0.8873359957679645,1.0,22/245,8.09%,BMPER;EGFR;VEGFA;TNFAIP8L3;GAS6;FGF2;FSHR;NTRK3;NTRK1;CCL13;SHC1;CCL15;TGFB2;MID1;PRKCA;LAMTOR1;HMGB1;FGFR1;EDN3;IAPP;ROR1;PLA2G5
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.3019183116771865,0.8613935357905456,0.7365145228215768,0.8870150213907279,1.0,18/108,13.33%,F3;GSN;PRR7;MAP3K5;CRADD;XDH;VCP;TNFSF15;HMGB1;DAP;ANP32B;AIFM1;BCAP31;TNFRSF10B;HSPD1;CASP1;PDCD2;F2R
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.31629819921223307,0.8613376108951366,0.7103004291845494,0.8867366592163002,1.0,10/70,13.42%,PRKCD;PRKCE;VAV2;ARPC1B;ABI1;CYFIP1;WIPF1;ABL1;PIK3CB;MYH2
prerank,cell cycle checkpoint signaling (GO:0000075),-0.3327413484341123,-0.8613355505362814,0.6533333333333333,0.8498280396470757,1.0,4/12,11.71%,PRCC;ZWILCH;NABP2;PLK2
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.3443140159635392,0.8613155307631226,0.6662636033857315,0.8863922778053236,1.0,5/33,14.71%,EGFR;RDX;ANXA1;EIF4G1;TFDP1
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.3211777547237522,0.86123913743453,0.7096774193548387,0.8861392026172348,1.0,21/54,30.26%,PRR7;NXN;OGT;SMAD7;CHP1;SQSTM1;U2AF2;ARRB1;N4BP1;MINAR1;UFL1;AKT1;DNAJA1;USP4;GTPBP4;CAMLG;SVBP;PER2;SPOPL;PRMT3;CTNNB1
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.3720891611750005,0.8609502967216937,0.6556962025316456,0.8862532244090215,1.0,4/21,12.19%,KCNE5;ANK2;SNTA1;AKAP9
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.3396527947994643,0.8609085667845563,0.6742514970059881,0.885936813952778,1.0,3/31,8.74%,FHL1;DACT1;DLG1
prerank,negative regulation of lymphocyte activation (GO:0051250),-0.28231453011388824,-0.8608590843861063,0.7155172413793104,0.8493193903115249,1.0,9/21,25.47%,PAG1;DUSP3;TNFAIP3;PTPN22;SOX11;SAMSN1;LST1;LAX1;IL4I1
prerank,mitochondrial transcription (GO:0006390),0.4191560549082777,0.860120788757116,0.6476462196861626,0.8869367309465258,1.0,4/10,20.70%,FOXO3;TFB2M;TWNK;MRPL12
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.37726060532070443,0.8594561515175351,0.6438172043010753,0.8876610927095815,1.0,6/18,17.38%,MDFIC;CHP1;RAB23;LATS2;FLCN;SUFU
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.3874763856126962,0.8591073703179447,0.655217965653897,0.887876599767746,1.0,6/17,25.42%,TGFB2;MID1;STK25;TAOK3;TAOK1;TAOK2
prerank,regulation of isotype switching (GO:0045191),0.3990657970926032,0.8586839765260651,0.6438172043010753,0.8882283040362606,1.0,7/14,28.69%,PARP3;KMT5C;MAD2L2;IL4;SHLD3;SHLD1;HMCES
prerank,positive regulation of GTPase activity (GO:0043547),0.293370987977752,0.8584765054689256,0.7848484848484848,0.8882073763361765,1.0,38/188,17.93%,SGSM2;SRGAP2;ASAP3;TIAM1;ARAP1;NTRK3;NTRK1;TIAM2;TBC1D8B;TBC1D2B;DOCK7;CCL13;SIPA1L1;CCL15;BCAS3;SNX18;RAB3GAP1;S100A10;RIC1;BCR;RGP1;ZC3H15;SNX9;EVI5L;TBC1D9B;F2R;TBC1D25;NDEL1;SIPA1L3;TBCK;TBC1D10A;PIP5K1A;TBC1D17;NF1;ERBB2;FLCN;NGEF;SNX13
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.41245570627741013,0.8581614815957502,0.6431593794076164,0.888373404781567,1.0,2/12,7.95%,MUC13;SOX9
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.36522518953775035,0.8579095754007925,0.6533166458072591,0.8884111722581234,1.0,4/21,16.49%,SHPK;TKT;DERA;PGD
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.42185538538789846,0.8575448811830589,0.6606875934230194,0.8882697160396004,1.0,10/10,57.84%,CEP250;TULP1;RPE65;GRM6;CACNA2D4;CNGB1;CACNA1F;GNAT2;REEP6;GNAT1
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.42185538538789846,0.8575448811830589,0.6606875934230194,0.8882697160396004,1.0,10/10,57.84%,CEP250;TULP1;RPE65;GRM6;CACNA2D4;CNGB1;CACNA1F;GNAT2;REEP6;GNAT1
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.3296461814650555,0.8573710736462009,0.689419795221843,0.888174847364248,1.0,10/46,17.61%,PLA2G4A;LPCAT1;GPD1;LPCAT4;PLA2G5;DGKQ;GPAT4;PLA2G12A;PNPLA3;AGPAT5
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.3932095763112028,0.8573018971154525,0.6814516129032258,0.8879249628851322,1.0,4/17,11.54%,NTRK3;BCAS3;ABL1;NRP1
prerank,sister chromatid segregation (GO:0000819),0.3432958100797415,0.8563204303924363,0.6752136752136753,0.8892323924165195,1.0,5/31,15.07%,TUBG2;SMC4;MIS12;ZW10;KLHL22
prerank,positive regulation of protein polymerization (GO:0032273),0.3171606984306843,0.8562148491984662,0.7123893805309734,0.8890293971336353,1.0,23/65,30.86%,CTTN;PRKCE;CDC42EP2;PFN2;SNX9;AKAP9;TENM1;CDC42EP5;ARL2;SLAIN2;DCTN1;CDK5RAP2;BAIAP2L1;PINK1;NCK1;MET;DRG1;FES;TOGARAM1;RAC1;VASP;HSP90AA1;CARMIL1
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.36534477226523565,0.8554328380591882,0.699238578680203,0.8896305508419352,1.0,13/23,27.35%,PPP3CC;MAPK8;YWHAE;TFDP1;YWHAQ;E2F1;BID;SFN;BAD;TP53;YWHAB;NMT1;BBC3
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.36534477226523565,0.8554328380591882,0.699238578680203,0.8896305508419352,1.0,13/23,27.35%,PPP3CC;MAPK8;YWHAE;TFDP1;YWHAQ;E2F1;BID;SFN;BAD;TP53;YWHAB;NMT1;BBC3
prerank,negative regulation of lipid catabolic process (GO:0050995),-0.294546308496981,-0.855396065413016,0.6781609195402298,0.8590151881197502,1.0,6/17,23.47%,ADRA2A;PRKAA1;MFSD2A;BSCL2;ALK;APOC1
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),-0.32458325721932246,-0.8551010280782746,0.6689895470383276,0.8580891627945878,1.0,3/12,9.68%,LYN;ELF2;CD300A
prerank,positive regulation of glycogen metabolic process (GO:0070875),0.40071120679460454,0.8550504618723653,0.6295302013422819,0.889918660383741,1.0,1/13,0.40%,IRS1
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.3705897656943662,0.8548506277494212,0.6697490092470277,0.8898776254149878,1.0,4/21,8.97%,EFNA5;LDB1;SLC9A1;RHOA
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.36315660982829384,0.8534114533489804,0.6735218508997429,0.8920125456356011,1.0,1/22,0.59%,ID2
prerank,neutrophil migration (GO:1990266),0.31447943891484637,0.8532837969523586,0.7163355408388521,0.8918512362225647,1.0,6/58,8.83%,CCL13;CCL15;TGFB2;GBF1;EDN3;FCER1G
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.24569105723649265,-0.8526799279449392,0.7483443708609272,0.86156494223049,1.0,18/36,22.61%,PARP14;WNT5A;TRIM44;NLRC5;CSF1;CASP4;EDN1;CD74;AGPAT2;AXL;HSPA1A;TXK;AGPAT1;HSPA1B;IL7;ZBP1;PARP9;CD300LF
prerank,negative regulation of cell aging (GO:0090344),-0.3085449831826563,-0.8525440588760171,0.6844106463878327,0.8602988649530282,1.0,3/16,2.82%,CDK6;SLC30A10;AKT3
prerank,plasma membrane organization (GO:0007009),0.3143154413893578,0.852420634298431,0.7092511013215859,0.8929311834420003,1.0,18/61,22.56%,AHNAK2;TLCD2;ANK2;EHD2;NSF;STX2;SNX9;STX4;CXCR4;PLSCR3;TLCD1;SPTBN1;SYTL4;CLN3;CHMP4A;ANXA6;PLSCR4;ABCD1
prerank,negative regulation of complement activation (GO:0045916),-0.3465194188308238,-0.8523136527958309,0.6237288135593221,0.8592289751808102,1.0,4/10,23.17%,A2M;CR2;CD55;SUSD4
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.358315508376836,0.852165623146001,0.6679586563307494,0.8929951457115078,1.0,12/24,32.18%,PHF1;TRIM27;RBBP7;MPHOSPH8;TASOR;DNMT1;H3-3A;DNMT3A;SUZ12;SPI1;MTF2;CREBZF
prerank,negative regulation of GTPase activity (GO:0034260),0.35737528496556537,0.8521468881693308,0.6599496221662469,0.8926500678919111,1.0,8/22,20.63%,RDX;KLRK1;BCAS3;RCC2;ARL2;WNK1;TMED2;LRRK2
prerank,pore complex assembly (GO:0046931),0.3701629556550067,0.8521232481911517,0.658311345646438,0.8923171195336845,1.0,8/19,27.61%,NUP93;ADAM10;TMEM170A;NDC1;BAD;AFDN;TPR;AHCTF1
prerank,protein localization to lysosome (GO:0061462),0.3476976430010573,0.8520920059283461,0.6924004825090471,0.8920022014373375,1.0,7/28,28.13%,NEDD4;NAGPA;KPTN;ZFYVE16;SCARB2;GCC2;GGA3
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.28586918567534814,0.8519066788805214,0.918,0.891939303958838,1.0,63/509,13.42%,THBS1;MYOC;ESR1;EGFR;IRS1;VEGFA;TNFAIP8L3;GAS6;F3;FGF2;TCF7L2;PDCD4;NEDD4;FSHR;NTRK3;NTRK1;FGF17;GAB2;SEC13;SHC1;NFAT5;TGFB2;CARD16;MAVS;BRD4;ILK;LAMTOR1;PUM1;SEH1L;HMGB1;FGFR1;IAPP;ROR1;TRIM27;SOX9;CBL;S100B;CDK5RAP3;AKT2;RHOA;SHARPIN;ITGAV;FGFR2;LTBR;ALPK1;CHUK;TAB2;IRAK1;MAZ;PDPK1;BCAP31;C1QTNF4;NEUROD2;TNFRSF10B;CD27;MID2;TGFBR1;PIK3CB;CASP1;CD80;NLGN1;F2R;LRP2
prerank,lipid droplet organization (GO:0034389),0.3649965451657459,0.8518107023772667,0.6541353383458647,0.8917223464224174,1.0,10/22,30.18%,RAB3GAP1;FAF2;CIDEA;PNPLA3;CDS1;RAB18;FITM2;PPID;ZFYVE1;SQLE
prerank,mesenchymal cell differentiation (GO:0048762),0.3211060667071341,0.8517944096981507,0.7028248587570621,0.8913709383711599,1.0,10/51,9.72%,LRP6;DDX5;DDX17;TGFB2;TRIM28;FGFR1;HEYL;SOX9;NOG;FGFR2
prerank,negative regulation of immune system process (GO:0002683),0.392225013212894,0.8506168777367462,0.6720430107526881,0.8929882790888105,1.0,2/16,7.95%,COL3A1;SOX9
prerank,regulation of inflammatory response (GO:0050727),0.28985828122975804,0.8503682879153334,0.8111111111111111,0.8930309165934176,1.0,25/190,15.41%,MGLL;FOXP1;PRKCD;IL33;PDCD4;PTGIS;CCN3;ABCC1;SHPK;TNFRSF1B;BRD4;RORA;DAGLA;SBNO2;ANXA1;SHARPIN;LPCAT3;NR1D2;PSMA6;CASP1;PTPN2;SETD4;PTGES;CCN4;IL6
prerank,mesenchyme development (GO:0060485),0.39081311430028776,0.850299709028295,0.6581081081081082,0.8927717130945575,1.0,4/15,12.22%,CRELD1;FGFR2;BMP4;TGFBR1
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.35656603017787647,0.8501412013016669,0.6844106463878327,0.8926500843030292,1.0,10/22,31.72%,ERI3;RRS1;RPP40;WDR12;ABT1;KRI1;ERI1;EXOSC2;NOP14;EXOSC3
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),-0.2535327546754642,-0.8500248930093329,0.7553956834532374,0.8622843841783416,1.0,9/34,18.90%,WNT5A;RBP4;SLC7A5;LACC1;GPI;NOD2;PTPN22;PHB2;XBP1
prerank,phosphatidic acid metabolic process (GO:0046473),0.32611155719599155,0.8497210109349813,0.7105561861520999,0.8929648798099697,1.0,10/48,17.61%,PLA2G4A;LPCAT1;GPD1;LPCAT4;PLA2G5;DGKQ;GPAT4;PLA2G12A;PNPLA3;AGPAT5
prerank,cellular response to hydroxyurea (GO:0072711),0.42467688350443245,0.8490244816879995,0.6720116618075802,0.8937732224811777,1.0,7/10,39.04%,DDI2;SPIDR;DDX11;TIMELESS;BLM;RTF2;ATRX
prerank,multivesicular body assembly (GO:0036258),0.34256721044325805,0.8488252509136859,0.6742514970059881,0.8937493731306674,1.0,12/30,32.25%,STAM2;CHMP3;IST1;VTA1;CHMP4B;CHMP4A;PDCD6IP;MVB12A;CHMP2A;VPS37B;CHMP4C;VPS37C
prerank,regulation of MAP kinase activity (GO:0043405),0.302277132897451,0.8486480382585274,0.7513227513227513,0.8936649734327342,1.0,15/92,13.19%,EGFR;PRKCD;VEGFA;FGF2;IRAK3;FGFR1;EDN3;CDK5RAP3;CDK12;BMP4;PAQR3;IRAK1;TENM1;PIK3CB;PPEF2
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.3319283684008422,0.8486126391843258,0.6971098265895954,0.8933519194551697,1.0,5/38,7.71%,GAS6;SRCIN1;SHC1;NOX4;DLG4
prerank,cellular response to chemical stress (GO:0062197),0.3021805662064946,0.8483733846194679,0.7486800422386484,0.8933602182762754,1.0,40/96,30.79%,VKORC1L1;ATF4;LRRC8D;SLC4A11;NOX4;NFE2L2;STX2;ABL1;ATM;SOD1;LONP1;SESN2;SRXN1;PRDX3;SIRT2;STX4;FOXO3;TXNRD2;CAT;GSR;PARP1;VRK2;PRDX2;LRRK2;EIF2S1;PYCR1;PRDX1;GPX7;PYROXD1;SELENOS;PINK1;HTRA2;AIF1;SETX;RAD52;NOX1;PRDX5;PRDX6;KEAP1;ADNP2
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),-0.3356945139571362,-0.8483168919171843,0.6138613861386139,0.8641338035293857,1.0,5/10,19.31%,APC;CDC42;RACGAP1;ECT2;KNSTRN
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.3533465466539598,0.8483089111292482,0.6842105263157895,0.8930929262598057,1.0,4/24,7.97%,CAMK2D;CALM2;DMD;SELENON
prerank,oogenesis (GO:0048477),-0.3053891498841229,-0.8482917637559113,0.6441947565543071,0.8626829730375493,1.0,7/15,22.26%,PTN;FMN2;MEI4;NANOS3;MDK;NANOS1;TRIP13
prerank,regulation of histone methylation (GO:0031060),0.39506194856836896,0.847705566058405,0.6525885558583107,0.893697194527177,1.0,5/13,21.58%,NSD1;NNMT;CHTOP;MTHFR;PAF1
prerank,positive regulation of cellular senescence (GO:2000774),-0.3599597661200774,-0.8474914912650033,0.6372549019607843,0.8627331905046834,1.0,3/10,13.74%,B2M;ABI3;SIRT1
prerank,cellular component assembly (GO:0022607),0.2884364599951352,0.8472762955760254,0.8544176706827309,0.8940524663678207,1.0,61/253,23.46%,RHOJ;GAS6;CHAF1B;GSN;RHOQ;DPYSL3;PLS1;LIMA1;TLCD2;CFAP206;HES5;CD3E;M1AP;HORMAD1;DVL1;ILK;GPAA1;SPG7;QSOX1;LLGL1;DLG4;MDM4;SOX9;CYFIP1;RHOA;CDAN1;ST13;WIPF1;MYO9A;SNX9;SHANK1;PARVA;ZW10;EZR;STK25;NLGN1;ADD1;SCIN;CREBBP;KPNA3;LRGUK;TLCD1;SPTBN1;TTLL3;EPRS1;NOC2L;CALD1;TEAD2;CAPZA1;DARS1;TEX11;GPM6B;GORASP2;SPAG17;KMT2A;REPS2;SPAG16;AFG3L2;PEX14;BAIAP2L1;NIFK
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.3317919392668948,0.846635717161773,0.7053254437869823,0.8947430942119337,1.0,3/33,8.74%,FHL1;DACT1;DLG1
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),-0.31985631549998,-0.8464260703096644,0.6743295019157088,0.8632655015077133,1.0,5/13,20.57%,ELOVL7;HACD1;TECRL;ELOVL6;HACD4
prerank,heart contraction (GO:0060047),0.3264816231850563,0.8463328507375019,0.711764705882353,0.8948623498198274,1.0,7/41,12.09%,SGCD;ATP1B1;GAA;DMD;KCNE5;CSRP3;SOD1
prerank,regulation of pH (GO:0006885),0.41999470172638104,0.8462932740295243,0.6753424657534246,0.8945476168846594,1.0,2/11,10.51%,SLC9A1;SLC26A4
prerank,establishment of skin barrier (GO:0061436),-0.31036643310302225,-0.8462145543526479,0.6533864541832669,0.8606916321107544,1.0,3/15,12.68%,LSR;CLDN1;ALOX12
prerank,regulation of water loss via skin (GO:0033561),-0.31036643310302225,-0.8462145543526479,0.6533864541832669,0.8606916321107544,1.0,3/15,12.68%,LSR;CLDN1;ALOX12
prerank,negative regulation of cell activation (GO:0050866),0.39691345486325474,0.8461161292373004,0.6726027397260274,0.8944753531374773,1.0,2/14,2.99%,EMILIN1;C1QTNF1
prerank,sterol transport (GO:0015918),0.37265141705963306,0.8458530300298702,0.6645161290322581,0.8945472393266933,1.0,6/19,27.59%,NPC1;OSBP;STARD3;LDLR;NPC2;OSBPL5
prerank,neuron projection fasciculation (GO:0106030),0.4106371980397051,0.845832378845656,0.6619915848527349,0.8942045633438824,1.0,2/10,5.48%,EPHB2;EPHB3
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.29219784973214546,0.8452024224059964,0.7922606924643585,0.8948661881253388,1.0,26/149,17.81%,SLCO3A1;CARD14;NTRK1;RAB7B;STAT3;CARD16;ERC1;IRAK3;ROR1;RPS6KA4;TRIM27;CHUK;RIPK3;NFKBIB;TAB2;RNF25;IRAK1;MID2;PSMA6;PRDX3;IL6;NFKB2;RPS27A;UBC;TRIM13;TRIM6
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),0.4020203646328608,0.8442829025892816,0.657496561210454,0.8960292645535083,1.0,1/12,0.40%,IRS1
prerank,antigen receptor-mediated signaling pathway (GO:0050851),-0.19868355526106501,-0.8439649419698674,1.0,0.863546264163296,1.0,29/163,11.83%,PDE4D;BCL2;TEC;PRKCB;PIK3R1;INPP5D;RFTN1;PSMC6;FYB1;PAG1;TNFRSF21;BMX;PAK3;NFATC2;CD38;SKP1;THEMIS;EIF2B3;PSME3;PAK1;VAV3;ZC3H12A;PDE4B;PSME1;SPPL3;SYK;PRKCQ;PIK3CD;SH2B2
prerank,protein mono-ADP-ribosylation (GO:0140289),-0.3297350281740781,-0.8437506472474456,0.6895306859205776,0.8624701157815474,1.0,3/11,6.69%,PARP14;PARP16;PARP11
prerank,organophosphate catabolic process (GO:0046434),-0.3368030954280318,-0.8430683941268117,0.6518771331058021,0.8623453742388522,1.0,2/11,9.08%,ENPP2;PLBD2
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.28429906659717474,-0.8429510171344903,0.7098214285714286,0.8611158259597579,1.0,9/20,21.90%,PRKAA2;RPS6KA5;PPARGC1A;PRKAA1;NOS1;BRCA1;MAPK3;SOX4;GLYR1
prerank,negative regulation of immune response (GO:0050777),0.29265792227484516,0.8429396532243564,0.8226950354609929,0.897831574891501,1.0,27/154,18.22%,COL3A1;FSHR;GPR27;DRD1;TRAFD1;ADCY2;RAMP2;ADCY8;IRAK3;IAPP;ADCY9;TRIM27;GPR20;ITCH;MAPKBP1;VIP;RAMP1;GLP1R;PCBP2;MC4R;PTGDR;SIRT2;IL6;CREB1;ADCY7;CALCA;ACOD1
prerank,erythrocyte differentiation (GO:0030218),0.3241856212331031,0.8424337778485106,0.6931949250288351,0.898280185616767,1.0,11/44,21.06%,ID2;VEGFA;FLVCR1;CDK5RAP3;PTPN2;INHBA;UBA5;ACIN1;UFL1;HIPK2;SLC25A38
prerank,mRNA destabilization (GO:0061157),0.3290620392355926,0.8423564864628559,0.6768867924528302,0.8980260770163895,1.0,18/38,32.59%,FTO;PUM1;ZC3H12D;DIS3L2;METTL16;RC3H2;TUT7;UPF1;ROCK1;RBM24;METTL14;ZFP36L1;RIDA;YTHDF1;KHSRP;PLEKHN1;MOV10;DCPS
prerank,aspartate family amino acid metabolic process (GO:0009066),-0.29715724782279396,-0.8422556179626639,0.6694214876033058,0.8610604229623615,1.0,6/18,16.25%,SLC25A13;ASPG;ASS1;SMS;MSRA;FOLH1
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.3358544553416326,0.8419927996822805,0.6956521739130435,0.8982520476105699,1.0,18/37,33.09%,IFT20;IFT80;TRIP11;IFT46;PCM1;IFT88;DYNC2I1;TNPO1;IFT43;IFT27;DYNC2H1;KIF17;IFT140;DYNC2I2;KIFAP3;IFT52;WDR35;DYNLL2
prerank,hydrogen peroxide metabolic process (GO:0042743),0.3675322994667227,0.8417079882165266,0.6772486772486772,0.8983571822330275,1.0,9/19,31.40%,SOD1;PRDX3;CAT;PRDX2;PRDX1;PXDN;NOX1;PRDX5;CYBA
prerank,positive regulation of stem cell differentiation (GO:2000738),0.38501201172826904,0.8416714889936863,0.680327868852459,0.8980370108436277,1.0,4/16,13.18%,LTBP3;TGFB2;SOX9;HOXB4
prerank,negative regulation of cellular metabolic process (GO:0031324),0.3307011809015622,0.8415772749870941,0.6855491329479769,0.8978147118342916,1.0,12/37,25.17%,LRPAP1;SIRT5;DLG4;ITGAV;SIRT2;WDR54;AATF;TRAT1;ATXN2;OPTN;NCOR1;PINK1
prerank,positive regulation of developmental growth (GO:0048639),0.3233272822583923,0.8415454496683982,0.7303754266211604,0.8974916985756509,1.0,5/49,7.81%,NTN1;GHR;ACTN3;AGR2;GOLGA4
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.3537793778262026,0.841537172047112,0.6977040816326531,0.8971268613230757,1.0,3/21,9.48%,FOXP1;ELF1;RUNX1
prerank,positive regulation of keratinocyte differentiation (GO:0045618),-0.34496000133090104,-0.8414178418749474,0.6601307189542484,0.8612831354142517,1.0,3/10,13.34%,PRKCH;NME2;TRIM16
prerank,rRNA pseudouridine synthesis (GO:0031118),0.42371768756534395,0.8412713696152894,0.6772334293948127,0.8971910031833014,1.0,4/10,30.89%,RPUSD1;TSR3;DKC1;NOP10
prerank,ruffle organization (GO:0031529),0.3851433716130145,0.8411505402351491,0.6742934051144011,0.8970123187328003,1.0,4/16,15.63%,LIMA1;CYFIP1;ARFIP2;PIP5K1A
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.40135110355977105,0.8402470229084131,0.6821917808219178,0.8980754463524824,1.0,7/12,32.31%,UBE2C;CDC20;RAB1A;GOLGA2;BTRC;UBE2S;GORASP1
prerank,cholesterol efflux (GO:0033344),0.3639199090425965,0.8402290111300394,0.6662371134020618,0.8977296970707759,1.0,4/20,11.15%,SOAT1;TSKU;NPC1;ABCA1
prerank,response to UV-B (GO:0010224),-0.3225360954174513,-0.8402160916925009,0.6677966101694915,0.8622080955807307,1.0,12/12,67.78%,CRIP1;HYAL2;MME;STK11;CDKN1A;IL12A;IL12B;HYAL1;MFAP4;HYAL3;RELA;MSH2
prerank,axonal fasciculation (GO:0007413),0.39177940574148684,0.8400229145055302,0.663923182441701,0.8976882584776811,1.0,2/12,5.48%,EPHB2;EPHB3
prerank,regulation of catabolic process (GO:0009894),-0.2789533557837941,-0.8399974083302411,0.6504065040650406,0.8611876194446008,1.0,3/18,8.15%,NEDD4L;FAF1;HPGD
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.3058355854362437,0.8397699900858797,0.7416934619506966,0.8977395614486001,1.0,10/69,14.85%,SIX1;NTRK1;TGFB3;SIX4;NRBP2;SOD1;LIG4;F2R;NDNF;CLCF1
prerank,regulation of interferon-gamma production (GO:0032649),0.3053817721653194,0.8396622140505373,0.7378114842903575,0.8975435671901207,1.0,10/71,12.95%,GAS6;IL12RB2;HMGB1;TRIM27;RARA;FZD5;CRTAM;RIPK3;HSPD1;INHBA
prerank,response to chemokine (GO:1990868),0.3879727279608334,0.8395494162893685,0.6708860759493671,0.8973568743042756,1.0,4/13,13.93%,SLC12A2;STK39;RHOA;WNK1
prerank,epithelial cell morphogenesis (GO:0003382),0.37752276126345496,0.8394576489873853,0.6908602150537635,0.8971263245141782,1.0,2/17,3.91%,COL15A1;PKHD1
prerank,regulation of cell communication by electrical coupling (GO:0010649),-0.31233606412389286,-0.8393815176513779,0.6872852233676976,0.8608593434808743,1.0,2/13,1.30%,PDE4D;SLC8A1
prerank,cellular response to ionizing radiation (GO:0071479),0.3241300641522505,0.8393110613729713,0.713963963963964,0.8970101011710835,1.0,22/47,31.91%,RAD1;WRN;SWI5;SPIDR;ATM;TANK;LIG4;RHOB;TLK2;NIPBL;HUS1;RAD51;TNKS1BP1;XRCC6;TP53;ATR;HSF1;GRB2;INTS7;YAP1;RHNO1;BLM
prerank,positive regulation of TORC1 signaling (GO:1904263),0.3898823878120524,0.8387866335608183,0.6940700808625337,0.8974859846783535,1.0,5/16,17.05%,SEH1L;CLEC16A;TELO2;KLHL22;FLCN
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.39860221077176683,0.8381902488863963,0.6842837273991655,0.8981008093943909,1.0,2/12,2.64%,SYT8;UNC13B
prerank,positive regulation of glial cell differentiation (GO:0045687),0.37929551158277675,0.8376571071668214,0.6930171277997365,0.8985841357873291,1.0,5/17,15.21%,ID2;TNFRSF1B;SERPINE2;CLCF1;CXCR4
prerank,regulation of dephosphorylation (GO:0035303),-0.3019434459174748,-0.8372748480779156,0.7052238805970149,0.8634027830446798,1.0,3/15,6.82%,PPP1R16B;MTMR3;SMG7
prerank,endothelial cell differentiation (GO:0045446),0.4032589532985984,0.8371723079428773,0.6634214186369958,0.8989829487318118,1.0,2/12,6.22%,FSTL1;JAG1
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.39533915070152315,0.8369389374909982,0.6787709497206704,0.8990181990070696,1.0,8/13,40.26%,LCMT1;XRCC3;CDK5RAP2;TPR;DYNC1LI1;PCID2;NDC80;DUSP1
prerank,tetrapyrrole metabolic process (GO:0033013),0.36817701010920395,0.8369089031739162,0.6810126582278481,0.8986986186966941,1.0,4/18,14.35%,ABCC1;MTRR;MMAB;ABCB6
prerank,positive regulation of proteolysis (GO:0045862),0.3179275387563584,0.8366436099492564,0.7335526315789473,0.8987521661777602,1.0,17/55,25.29%,ADAM9;TNFRSF1B;OGT;WDR48;SNX9;MAPK12;TANK;STUB1;TBC1D10A;PERP;IST1;SH3D19;RCN3;CYFIP2;BAD;PINK1;HDAC2
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.30425918303857535,0.8363771634185373,0.7467248908296943,0.8988218020948306,1.0,25/73,26.09%,F3;CRADD;XDH;VCP;TNFSF15;DAP;ANP32B;AIFM1;TNFRSF10B;HSPD1;CASP1;PDCD2;F2R;HIP1;BID;MUL1;SENP1;EIF2AK3;MTCH1;DIABLO;BAD;BCL2L13;RPS27L;TRADD;RIPK1
prerank,regulation of p38MAPK cascade (GO:1900744),0.33261439628122313,0.8340887941879255,0.7111913357400722,0.9021575367153816,1.0,7/35,15.46%,VEGFA;GADD45G;XDH;DLG1;ULK4;EZR;PER1
prerank,positive regulation of viral transcription (GO:0050434),0.3485479181028236,0.8340113978543464,0.6988564167725541,0.9019066239900292,1.0,12/25,31.68%,MDFIC;GTF2F1;POLR2F;POLR2B;NELFB;CTDP1;POLR2H;NELFA;CDK9;POLR2I;POLR2L;POLR2K
prerank,negative regulation of viral life cycle (GO:1903901),0.38336507071002723,0.8335429841993014,0.678237650200267,0.9022760537147707,1.0,3/15,13.81%,GSN;MID2;TRIM26
prerank,male gonad development (GO:0008584),0.339277365099668,0.8334013611115101,0.7204301075268817,0.9021268918012179,1.0,6/34,13.42%,FSHR;TGFB2;SIX4;SOX9;INHBA;LRP2
prerank,amyloid-beta metabolic process (GO:0050435),0.3812071430871361,0.8332221025021115,0.6975476839237057,0.902046791830562,1.0,4/16,16.29%,BACE2;BACE1;PSEN2;IDE
prerank,multivesicular body organization (GO:0036257),0.33528085935626345,0.8330526606409291,0.7063778580024067,0.9019477767800359,1.0,12/31,32.25%,STAM2;CHMP3;IST1;VTA1;CHMP4B;CHMP4A;PDCD6IP;MVB12A;CHMP2A;VPS37B;CHMP4C;VPS37C
prerank,phosphatidylinositol metabolic process (GO:0046488),0.2915976282477228,0.8330059452596508,0.7703549060542797,0.9016537473024785,1.0,24/109,16.21%,FGF2;PLA2G4F;PLEKHA4;PLA2G4A;PIK3C2B;PIGW;PITPNM1;PLA2G5;PIP4K2B;MTMR11;SYNJ1;INPP5B;ARF1;INPP4A;MTMR10;PIK3CB;PIP4P2;OCRL;PI4K2A;PLA2G12A;CDIPT;PIP5K1A;INPP5E;PI4KB
prerank,cobalamin metabolic process (GO:0009235),0.3702713134081148,0.8320084969945049,0.6893453145057766,0.9028846285018578,1.0,3/17,9.59%,ABCC1;MTRR;MMAB
prerank,cellular response to nutrient levels (GO:0031669),0.31000558729950317,0.8317424772712602,0.7532894736842105,0.9029102642881361,1.0,20/62,29.39%,KCNB1;WIPI2;CLEC16A;WRN;SREBF1;FADS1;EIF4G1;USP33;VPS41;FLCN;KLF10;LRRK2;LAMP2;RPTOR;STK24;EHMT2;TFEB;ULK1;ZFYVE1;SREBF2
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.2944302177169629,0.8315533714980501,0.750816104461371,0.9028300064318578,1.0,35/84,36.31%,IGFBP5;SAMD4A;ILF3;RBM4;CNOT8;CNOT10;ORMDL3;EPRS1;SYNCRIP;DAPK3;CNOT9;SHMT1;CALR;CLU;ORMDL1;EIF2AK3;FXR2;YBX1;ROCK1;MRPL13;RIDA;FXR1;GGA3;LARP1;CAPRIN1;DAPK1;PRNP;NCL;PCIF1;PUS7;DHFR;RTN3;MALSU1;PAIP2;BIN1
prerank,cellular protein-containing complex assembly (GO:0034622),0.2846985374227397,0.8312889254629204,0.8,0.9028877628637756,1.0,50/159,25.60%,NUP93;TIAM1;TBCE;CD3E;DNAJB14;DMD;DNAAF3;SMAD4;FCHO2;CENPC;CCDC39;CENPT;SNX9;AXIN1;AIFM1;MIS12;HSPD1;LONP1;CHMP3;ARL2;CLTC;PTGES3L;PSMD11;TBCD;VBP1;HIP1;HIGD1A;PRLR;TMEM170A;CHMP4B;CHMP4A;OTUD6B;DLGAP5;CLU;PSMD4;CLTA;TTC12;POGZ;NDC1;COX7A2L;UVRAG;EIF4B;PSMG2;TCP1;VAMP4;PXN;CHMP2A;DNAJB12;NCK1;VAMP2
prerank,regulation of regulated secretory pathway (GO:1903305),-0.24687400028537274,-0.8307726077581401,0.7891566265060241,0.8741596453569289,1.0,14/34,19.89%,RIMS2;RIMS1;SYN1;DTNBP1;SYT13;SYT3;SYT10;PREPL;SYT2;SYT11;SYT12;RAB15;SYT7;SYT15
prerank,negative regulation of nuclear division (GO:0051784),0.40794370814542624,0.8304789267213136,0.7029702970297029,0.9038078067485403,1.0,2/11,10.16%,TOM1L1;BMP4
prerank,RNA destabilization (GO:0050779),0.36611399218162,0.8304697324115994,0.6948717948717948,0.9034499636246621,1.0,10/18,28.65%,FTO;PUM1;METTL16;ROCK1;RBM24;METTL14;RIDA;YTHDF1;ZC3H18;DXO
prerank,negative regulation of glycolytic process (GO:0045820),0.40386589478549345,0.8302847615432135,0.7088791848617176,0.9029933365173496,1.0,3/10,11.35%,HDAC4;ACTN3;GIT1
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.40386589478549345,0.8302847615432135,0.7088791848617176,0.9029933365173496,1.0,3/10,11.35%,HDAC4;ACTN3;GIT1
prerank,synapse assembly (GO:0007416),0.3058153998826982,0.8302654707680575,0.7556512378902045,0.9026477763063389,1.0,6/67,5.66%,PCDHB16;FGF13;FARP1;DRD1;LGI2;DVL1
prerank,regulation of cell-cell adhesion (GO:0022407),0.32251963982013115,0.8301738377553874,0.7286549707602339,0.9024286065173244,1.0,7/39,11.86%,EFNA5;PKHD1;ADA;EPHB3;JAG1;FUT4;SMAD7
prerank,toxin transport (GO:1901998),0.4110197335748873,0.8296095860248733,0.6711111111111111,0.9029827779965783,1.0,4/10,30.07%,ADAM10;SLC22A3;ANTXR1;RAB40B
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.3367052808362398,0.8293989292416084,0.7182254196642686,0.9029553224069676,1.0,5/31,13.14%,SPN;GLMN;ATM;CD80;VTCN1
prerank,T cell mediated immunity (GO:0002456),0.3921697591224493,0.8289302309969094,0.7008196721311475,0.9032987675210753,1.0,3/13,9.97%,GNL1;JAG1;CRTAM
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.40042396631040184,0.8287982703996352,0.6880108991825613,0.9031239806418776,1.0,6/11,31.91%,DONSON;FBH1;ZRANB3;TIMELESS;SMARCAL1;BLM
prerank,positive regulation of glucose import (GO:0046326),0.3572047997748312,0.8286365486221098,0.6945500633713562,0.903014925486663,1.0,4/21,8.69%,IRS1;RHOQ;CAPN10;AKT2
prerank,defense response to protozoan (GO:0042832),-0.3185625971284725,-0.8281399572607216,0.6823104693140795,0.8773490226033047,1.0,5/12,18.23%,GBP4;GBP7;CD40;BATF;MYD88
prerank,error-free translesion synthesis (GO:0070987),0.3548419698650288,0.827968962555959,0.6924050632911393,0.903660735149146,1.0,7/22,25.67%,VCP;RPS27A;UBC;REV1;NPLOC4;RCHY1;POLD1
prerank,nucleic acid-templated transcription (GO:0097659),0.3235384079274232,0.8278967516613701,0.6997635933806147,0.9033950857374988,1.0,18/42,31.68%,TOPORS;BAZ2A;TERT;NFKBIB;XAB2;MEF2A;MMS19;POLR2F;E2F1;MED20;POLR2B;POLR2H;DRG1;POLR2I;PWP1;POLR2L;TAF1B;POLR2K
prerank,negative regulation of platelet activation (GO:0010544),0.3755773858447767,0.8274501937934297,0.6826265389876881,0.9037126720526385,1.0,3/16,6.13%,PRKCD;C1QTNF1;CD9
prerank,cellular response to increased oxygen levels (GO:0036295),-0.3289563370745222,-0.8272982412588744,0.6724137931034483,0.8774541668631777,1.0,3/11,15.88%,FAS;CAV1;FOXO1
prerank,regulation of protein localization to cell surface (GO:2000008),0.33041254901613676,0.8270406757955957,0.7116060961313013,0.9040136279572795,1.0,7/33,15.19%,TM9SF4;RIC3;GOPC;GBF1;RAB11FIP5;RAB11B;STX4
prerank,positive regulation of interleukin-1 production (GO:0032732),-0.2215703873412671,-0.8269305441209335,0.8245614035087719,0.87667915414902,1.0,16/51,20.47%,WNT5A;APP;AIM2;GBP5;HSPB1;EGR1;LPL;TRIM16;LGALS9;TYROBP;S100A13;NOD2;PYCARD;MYD88;P2RX7;AGER
prerank,positive regulation of DNA binding (GO:0043388),0.3361198442529075,0.826624871148344,0.7104945717732207,0.9042644287132839,1.0,5/31,17.81%,TWIST1;HMGB1;SKI;SIRT2;TRIM6
prerank,gonad development (GO:0008406),0.32520163539400965,0.8265207428649933,0.7219003476245655,0.904063985421238,1.0,7/41,13.42%,FSHR;CYP19A1;TGFB2;SIX4;SOX9;INHBA;LRP2
prerank,mitochondrial RNA metabolic process (GO:0000959),0.38015567831767494,0.8265141218967523,0.6797829036635007,0.9037042926232436,1.0,4/14,20.70%,FOXO3;TFB2M;TWNK;MRPL12
prerank,regulation of neurogenesis (GO:0050767),0.31004490642833626,0.8258611461215105,0.7458563535911602,0.9043855612558043,1.0,10/55,15.41%,DOCK7;HES5;SERPINF1;BHLHE40;HEYL;HEY1;LIG4;LRP2;PCM1;IL6
prerank,7-methylguanosine RNA capping (GO:0009452),0.33629860324342054,0.8256978752420489,0.7102342786683107,0.9038999064089012,1.0,15/31,32.89%,GTF2F1;ERCC3;ERCC2;POLR2F;NCBP1;NCBP2;RAMAC;POLR2B;GTF2H4;RNMT;POLR2H;POLR2I;POLR2L;POLR2K;CCNH
prerank,7-methylguanosine mRNA capping (GO:0006370),0.33629860324342054,0.8256978752420489,0.7102342786683107,0.9038999064089012,1.0,15/31,32.89%,GTF2F1;ERCC3;ERCC2;POLR2F;NCBP1;NCBP2;RAMAC;POLR2B;GTF2H4;RNMT;POLR2H;POLR2I;POLR2L;POLR2K;CCNH
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),-0.31564126725486685,-0.8256964845143324,0.6798418972332015,0.877403091264291,1.0,3/13,4.10%,SHANK3;APP;ADCY1
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.3335943523056812,0.8252799514784945,0.725181598062954,0.9041742159127092,1.0,6/32,16.30%,DRD1;CALM2;P2RY6;PDPK1;F2R;CALM3
prerank,regulation of neuroblast proliferation (GO:1902692),0.37504803329860603,0.8248094175863186,0.7152406417112299,0.9045274375149527,1.0,1/15,0.80%,VEGFA
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.30625645485610314,0.8246609673145627,0.750561797752809,0.9044053401281571,1.0,19/56,27.57%,CIT;SNX18;RHOA;SPAST;SNX9;SPIRE2;MITD1;RHOB;SPTBN1;IST1;TTC19;CHMP4B;RTKN;PDCD6IP;JTB;ROCK1;CUL7;SON;EFHC1
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.3045350892972087,0.8246115318589513,0.7502750275027503,0.9041186779249043,1.0,7/65,8.14%,EGFR;ARAP1;PTPN3;MVB12B;AGR2;RNF115;CBL
prerank,blood vessel diameter maintenance (GO:0097746),0.32991231711619284,0.824455213024565,0.7275985663082437,0.903987068775762,1.0,4/34,7.38%,GCLC;ECE1;EDNRA;EDN3
prerank,positive regulation of hormone secretion (GO:0046887),0.36620513765306717,0.8243352245688376,0.713903743315508,0.9038050675655382,1.0,2/17,7.38%,CYP19A1;EDN3
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.2913385599261704,0.8238272123692016,0.7804370447450573,0.9042627483541904,1.0,16/104,16.33%,LRP6;LRP5;CALM2;CDK5RAP3;CDC6;RHOA;CDK12;SYAP1;ABL1;CCNT2;TELO2;CCNE2;PPEF2;CCNG2;CALM3;CDC25A
prerank,positive regulation of collagen metabolic process (GO:0010714),0.3673113224105443,0.823746338231594,0.6887052341597796,0.9040177103385404,1.0,4/17,13.33%,TGFB3;RUNX1;BMP4;F2R
prerank,negative regulation of ion transport (GO:0043271),-0.260739740046174,-0.8237108923668522,0.7630331753554502,0.879474282467425,1.0,9/24,16.92%,ACTN2;WNK2;ADRA2A;PACSIN3;NOS1;WNK4;SNCA;CASQ2;SYT11
prerank,regulation of muscle contraction (GO:0006937),0.34380280358871546,0.8234456824940722,0.7084917617237009,0.904109258655979,1.0,3/26,5.26%,PLCE1;PPP1R12B;TNNT3
prerank,regulation of striated muscle contraction (GO:0006942),0.34514437170525103,0.8232940133698969,0.716624685138539,0.9039864595541294,1.0,7/27,11.86%,HCN4;CALM2;TNNT3;DMD;ANK2;TNNI3K;SMAD7
prerank,positive regulation of cilium assembly (GO:0045724),0.3653346739055147,0.8223493456826666,0.7217847769028871,0.9051265213724888,1.0,8/18,30.05%,MARK4;FUZ;KCTD17;WRAP73;CCP110;ARHGAP35;TAPT1;SEPTIN9
prerank,protein prenylation (GO:0018342),0.4119275962508807,0.8220571090654397,0.6866295264623955,0.9051947565629889,1.0,7/10,42.53%,RABGGTB;PTAR1;FNTB;RABGGTA;CHM;FNTA;PGGT1B
prerank,negative regulation of centrosome duplication (GO:0010826),0.40387647527473614,0.821992308479743,0.7008547008547008,0.9049226294222896,1.0,4/11,24.62%,KAT2A;CDK5RAP2;KAT2B;TMEM67
prerank,protein auto-ADP-ribosylation (GO:0070213),0.3955933537143814,0.8215814680509705,0.6915887850467289,0.9051841142545592,1.0,5/12,24.60%,PARP3;TNKS2;PARP1;PARP12;PARP8
prerank,regulation of response to external stimulus (GO:0032101),0.2865862040974794,0.8212815650163466,0.7913669064748201,0.9053094556598933,1.0,34/121,26.13%,MGLL;FOXP1;EPHB2;SHPK;PDE6A;BRD4;SBNO2;ANXA1;NR1D2;PSMA6;CASP1;TRAF3;F2R;GUCY2D;PTGES;CXCR4;N4BP1;UFL1;SAG;APPL2;APPL1;GRK4;BIRC3;DAGLB;AREL1;USP14;CYLD;BST1;METAP2;XIAP;STK24;NMT1;TKFC;CYRIB
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),0.38956656788688787,0.8212279133096276,0.7035460992907802,0.9050327462148928,1.0,2/12,6.05%,ATP1B1;DMD
prerank,cellular zinc ion homeostasis (GO:0006882),0.3417758086426474,0.8210505869335654,0.6959798994974874,0.9049322200991735,1.0,4/26,10.01%,SLC39A14;SLC39A7;SLC30A5;SLC39A13
prerank,replication fork processing (GO:0031297),0.32155268814973625,0.8208723670641569,0.7344300822561692,0.9048293439239499,1.0,15/38,33.71%,TONSL;WRN;RAD51;TRAIP;PRIMPOL;BOD1L1;FBH1;ZRANB3;RTEL1;CDK9;ATR;DDX11;SMARCAL1;BLM;MMS22L
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.37018828708318957,0.8206529228538006,0.6969292389853138,0.9047937987863776,1.0,4/15,20.32%,STAT3;IL6;APPL1;IL17RA
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.3505146816409631,0.8205757006436694,0.7133676092544987,0.9045517621339947,1.0,2/22,3.37%,LBP;RAB7B
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.37149283489056184,0.8202653329234522,0.6851595006934813,0.9046624830410431,1.0,4/16,13.33%,TGFB3;RUNX1;BMP4;F2R
prerank,regulation of JNK cascade (GO:0046328),0.29209093364492844,0.8199246346307688,0.7985309548793285,0.9048240955986735,1.0,15/101,13.74%,RASSF2;EGFR;SH3RF3;GADD45G;MAP3K5;DACT1;HMGB1;FZD7;ITCH;LTBR;AXIN1;ULK4;CD27;TRAF3;MAP3K10
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.36577761580732016,0.8196237135192858,0.7031847133757961,0.9049212697469036,1.0,6/18,20.63%,SLC4A8;RAB3GAP1;RIMS4;NLGN1;SNAPIN;LRRK2
prerank,regulation of cholesterol metabolic process (GO:0090181),0.35530956321459695,0.819207377419399,0.711864406779661,0.9051849312053295,1.0,4/20,10.34%,MBTPS1;DGKQ;SREBF1;LPCAT3
prerank,centromere complex assembly (GO:0034508),0.32312045755999536,0.8191616277786704,0.7214885954381752,0.904885436328229,1.0,5/36,13.35%,HJURP;CENPC;CENPT;MIS12;RBBP7
prerank,phosphate-containing compound metabolic process (GO:0006796),0.27822046665862676,0.8170554823145089,0.8555555555555555,0.9077528210468025,1.0,28/198,14.16%,ALPL;PLCE1;TNFAIP8L3;PLA2G4F;PLA2G4A;PLPP3;EPHB2;NADK;GFPT1;STAT3;LIMK2;SHPK;PLPP1;LPCAT4;GFPT2;PLA2G5;LGALS13;PAK2;PIP4K2B;SYNJ1;PPA2;INPP5B;IP6K1;INPP4A;PIK3CB;DUSP18;OCRL;LIMD1
prerank,muscle cell development (GO:0055001),0.3342045581803858,0.8169425778054238,0.705237515225335,0.907559132496272,1.0,6/30,9.84%,VEGFA;SDC1;RAMP2;DMD;ANK2;ALPK3
prerank,mitotic cytokinesis (GO:0000281),0.3130299223093546,0.8168841611025253,0.7424242424242424,0.907294561067258,1.0,16/47,27.57%,CIT;SNX18;SPAST;SNX9;MITD1;RHOB;SPTBN1;TTC19;CHMP4B;RTKN;PDCD6IP;JTB;ROCK1;CUL7;SON;EFHC1
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.39006970971260396,0.8166957000591649,0.703125,0.9072279036004703,1.0,2/11,4.72%,RDX;PRKCA
prerank,positive regulation of endocytosis (GO:0045807),0.3138194207621265,0.8165285982800446,0.7551487414187643,0.9071080634283631,1.0,13/45,21.35%,LRP1;GPC3;RAB21;CBL;NLGN1;HNRNPK;DAB2;HIP1;CD151;CLN3;APPL2;CLU;IL4
prerank,extracellular transport (GO:0006858),0.39022739815552093,0.8164095708560292,0.7121621621621622,0.9069338955039875,1.0,3/12,12.51%,WWP2;ROPN1L;DNAAF4
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),-0.32743092392001044,-0.8163429971777111,0.7057057057057057,0.8908834837905248,1.0,5/10,20.84%,SIRT1;SNCA;KLF15;BRCA1;TAF7
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.2744981943224195,-0.8161871182034617,0.7465437788018433,0.8896852237848096,1.0,7/20,21.85%,RB1;LAMTOR5;NIBAN2;H1-0;IGF1;TGFB1;EP300
prerank,regulation of cytoplasmic translation (GO:2000765),0.3804727740764142,0.8155992436703471,0.7100840336134454,0.9077753818264317,1.0,1/14,1.82%,YBX3
prerank,divalent inorganic cation homeostasis (GO:0072507),-0.2641893576493065,-0.8152877953721264,0.7401960784313726,0.8897521455163506,1.0,10/25,18.03%,TMTC2;SLC8A1;CAV1;JPH2;GRIN1;SNCA;ANK3;ATP13A2;CIB2;MT3
prerank,negative regulation of viral process (GO:0048525),0.3025224686933114,0.8151827072732347,0.7408637873754153,0.9080341158632447,1.0,16/57,21.42%,TRIM28;MAVS;TRIM27;ILF3;UBP1;MID2;CHMP3;TRIM26;SRPK1;HEXIM1;N4BP1;TRIM13;TRIM6;LARP7;SHFL;TRIM8
prerank,cAMP biosynthetic process (GO:0006171),0.39996048534067397,0.8151017552669348,0.7153179190751445,0.9077776432989711,1.0,3/10,7.80%,ADCY2;ADCY8;ADCY9
prerank,peripheral nervous system development (GO:0007422),0.3376753805468924,0.8151000879263166,0.7182044887780549,0.907415521332841,1.0,8/23,23.59%,PMP22;ALDH3A2;NF1;GFRA3;SCN8A;GDNF;GPC1;SOX8
prerank,regulation of adenylate cyclase activity (GO:0045761),0.34788063614640574,0.8150972510682706,0.7371069182389937,0.9070524840503509,1.0,5/22,16.55%,CACNA1C;STIM1;CAP1;NF1;PALM
prerank,cyclooxygenase pathway (GO:0019371),0.4068195744795853,0.8148954194617843,0.7036474164133738,0.9069990081714332,1.0,3/10,14.30%,PTGIS;PTGES2;PTGES
prerank,mitochondrion organization (GO:0007005),0.27676501759737365,0.8143853725083845,0.8390688259109311,0.9073990410839666,1.0,59/165,31.36%,PID1;VPS13C;DNM2;MIEF2;SPG7;TOMM40;SIRT5;RHOT2;TIMM9;RHOT1;TERT;RAB38;NRF1;AIFM1;BCAP31;HSPD1;LONP1;MEF2A;MTFR1;SUPV3L1;PRDX3;TOMM70;PARP1;BCS1L;HIGD1A;POLG2;TFB2M;HCFC1;BID;CLUH;TWNK;FANCG;NIPSNAP2;LRRK2;MUL1;STOML2;MFN1;COX7A2L;MTM1;AFG3L2;VPS13D;PINK1;TIMM22;TIMM17B;AFG1L;RAB5IF;FMC1;FIS1;ATP23;USP30;ATAD3A;GABPA;MIEF1;PRKN;MPV17;MTFR1L;SSBP1;PPRC1;ATP7A
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.3413494997426404,0.8140833734682207,0.7123115577889447,0.9074684339858664,1.0,3/23,8.14%,SRCIN1;SOCS4;CBL
prerank,regulation of endopeptidase activity (GO:0052548),0.29722366762148467,0.8135598781563016,0.7582781456953642,0.9078996895906677,1.0,12/59,21.08%,SERPINH1;TIMP2;TIMP3;SERPINF1;SERPINE2;HDAC1;SERPINB9;CRB2;SERPING1;AKT1;PSMA3;BIRC3
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.3513191171166641,0.8126984210767155,0.7234848484848485,0.9087742824461262,1.0,4/21,16.33%,BRD4;CDC25B;RCC2;CDC25A
prerank,regulation of interferon-alpha production (GO:0032647),0.34186903221382,0.8126205939459222,0.7173100871731009,0.9085388063381252,1.0,8/23,27.69%,PTPRS;MAVS;CHUK;HSPD1;IRF3;SETD2;TBK1;RIPK2
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.3232468981156856,0.8114901251359027,0.7426900584795322,0.9099047141532416,1.0,13/37,23.28%,SPRED2;CALM2;DGKQ;AXIN1;SMAD7;EIF4G1;PPEF2;SIRT2;CALM3;TRIM6;TNKS1BP1;RPTOR;S1PR2
prerank,rRNA transcription (GO:0009303),0.3665786104015297,0.8112394182281055,0.7335958005249343,0.9099095975038777,1.0,10/17,35.50%,POLR1G;GTF3C4;CAVIN1;GTF3C1;GTF3A;NIFK;TAF1B;SIRT7;TCOF1;BRF1
prerank,fatty acid metabolic process (GO:0006631),0.28221592080375524,0.8109558942863015,0.8144329896907216,0.9099934501786832,1.0,33/115,29.29%,ABCD3;CEL;ACSF3;CPT1C;ACSF2;ACOT11;SLC27A6;ADIPOR2;CBR4;ACAD9;ACACA;ACSL3;PNPLA3;HACL1;CRAT;HSD17B8;PLA2G15;ACSL6;SLC27A2;ACSBG1;PEX2;ACBD5;MCAT;ACOT8;ANGPTL3;FA2H;FAAH;PON3;ALOXE3;SLC27A3;PER2;ACLY;CPT2
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.34002030598615673,0.8108880709519547,0.7371069182389937,0.90973902907947,1.0,3/23,11.86%,ID2;FGFR2;SMAD7
prerank,L-serine metabolic process (GO:0006563),0.40259104845516014,0.8104449879865702,0.6987270155586988,0.910040385859885,1.0,5/10,18.76%,SRR;PHGDH;SHMT2;PSAT1;SHMT1
prerank,regulation of dendrite morphogenesis (GO:0048814),0.3258007121264466,0.8100434355538276,0.72,0.9103082680884724,1.0,5/32,7.06%,NEDD4;CUX1;FBXW8;LZTS1;CHRNB2
prerank,regulation of JUN kinase activity (GO:0043506),0.3251756996508204,0.8098594569859909,0.7652694610778443,0.9102197247617544,1.0,10/33,24.76%,PDCD4;MAP3K5;PPEF2;MAP3K10;AIDA;DNAJA1;DUSP19;TAOK3;MAPK8IP1;DVL2
prerank,granulocyte differentiation (GO:0030851),-0.2822097579035745,-0.8093474709908061,0.7510204081632653,0.8988357997190337,1.0,3/18,4.54%,LEF1;CBFA2T3;DEK
prerank,positive regulation of chemokine production (GO:0032722),0.311789757957751,0.8089615459375085,0.7485714285714286,0.9112106592536137,1.0,4/44,6.52%,IL33;TWIST1;MAVS;HMGB1
prerank,histone H2B ubiquitination (GO:0033523),-0.3266585714372927,-0.8089451675913756,0.6942675159235668,0.8981191681675416,1.0,4/10,15.98%,RNF40;UBE2E1;LEO1;CTR9
prerank,negative regulation of defense response (GO:0031348),0.28905284078628596,0.8088534974812774,0.7963752665245203,0.9110150478600473,1.0,12/77,13.30%,PRKCD;PTGIS;CCN3;TRAFD1;IRAK3;RORA;SHARPIN;ITCH;MAPKBP1;LPCAT3;PTPN2;PCBP2
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.30467060883653585,0.8086598846864581,0.746119733924612,0.9109243292203175,1.0,4/49,4.16%,VEGFA;GHR;STAT3;HES5
prerank,lymphocyte proliferation (GO:0046651),0.34772944717420273,0.8085666424425296,0.718397997496871,0.9107094086147745,1.0,1/22,1.37%,ELF4
prerank,neurotrophin signaling pathway (GO:0038179),0.34389904444697206,0.8082022199818537,0.7347715736040609,0.9108889040175621,1.0,2/21,4.76%,NTRK1;KIDINS220
prerank,cardiac ventricle morphogenesis (GO:0003208),0.3110026171497317,0.8078607925733885,0.7497103128621089,0.9110275296672449,1.0,9/41,12.41%,TGFB2;JAG1;TGFBR2;HEYL;FGFR2;BMP4;BMPR1A;SMAD7;HEY1
prerank,cardiac ventricle development (GO:0003231),-0.268284820413466,-0.8068681633224706,0.788546255506608,0.900441013998237,1.0,9/20,21.43%,ENG;NOTCH1;PDE2A;SALL1;HEY2;STRA6;DLL4;SCN5A;GJA5
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.35826463178135703,0.8068659064379445,0.6962676962676962,0.9121370977985616,1.0,5/18,22.08%,CCDC39;ROPN1L;DNAAF4;NPHP3;SPAG17
prerank,positive regulation of acute inflammatory response (GO:0002675),0.3743012072264461,0.8067594674003298,0.7090163934426229,0.9119248288919954,1.0,2/14,16.81%,IL6;OSMR
prerank,positive regulation of triglyceride metabolic process (GO:0090208),-0.27603857296257484,-0.8067347186497161,0.7479674796747967,0.8991490352213191,1.0,4/16,11.38%,NR1H3;ABHD5;MFSD2A;SCARB1
prerank,regulation of immunoglobulin production (GO:0002637),0.34374579225659674,0.8067017067705419,0.728380024360536,0.9116345648583906,1.0,5/23,21.35%,EPHB2;CLCF1;STX4;IL6;IL4
prerank,cellular response to interferon-gamma (GO:0071346),0.2839037665859099,0.8056709526187805,0.8135593220338984,0.9127840210084014,1.0,17/88,21.42%,PRKCD;SLC26A6;CCL13;CAMK2D;CCL15;MID1;GBP6;CASP1;TRIM26;EPRS1;SYNCRIP;DAPK3;ACOD1;IRF3;PTAFR;JAK1;TRIM8
prerank,chemokine-mediated signaling pathway (GO:0070098),0.31049268608669944,0.8053067993874197,0.75,0.9129542896802318,1.0,3/42,6.72%,CCL13;CCL15;STK39
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.3754733940122088,0.8045279761242051,0.6939058171745153,0.9137382367176646,1.0,2/12,4.94%,CAMK2D;CALM2
prerank,regulation of calcium ion import (GO:0090279),-0.2634766249358534,-0.8044996272285024,0.8108108108108109,0.9016005132792486,1.0,4/21,12.04%,CXCL12;PDGFRB;PLPP4;SLC30A1
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.34400349665059,0.8037562527150742,0.7406015037593985,0.9145370872121867,1.0,6/24,14.52%,GAS6;RAMP2;NFE2L2;PAK4;PDPK1;NDNF
prerank,rRNA 3'-end processing (GO:0031125),0.39651310080864005,0.8036461102137564,0.7422096317280453,0.9143390957195522,1.0,1/10,2.58%,ERI3
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.39867309768911313,0.8035816773600166,0.7271468144044322,0.914068853941266,1.0,5/10,31.16%,CDT1;DBF4;STOML2;E2F8;SSBP1
prerank,basement membrane organization (GO:0071711),0.3691429701401965,0.8030289292886551,0.7043596730245232,0.9144900085341425,1.0,3/14,10.12%,NTN4;RAMP2;FLRT2
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.3801569273940725,0.8029586944952966,0.7024456521739131,0.9142266797785327,1.0,6/13,32.79%,PGM3;RENBP;CHST5;OGA;NAGK;CHST7
prerank,negative regulation of TORC1 signaling (GO:1904262),0.37513882545072486,0.8021075570889163,0.7345013477088949,0.9151226926374993,1.0,5/13,18.75%,SESN3;CASTOR2;ATM;SESN2;KPTN
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.34908863455485584,0.8019557443158546,0.7393548387096774,0.9149848411314502,1.0,9/20,30.85%,FKBP5;PPIL3;NKTR;FKBP1B;FKBP4;PPIG;PPID;PPIC;PPIH
prerank,necroptotic process (GO:0070266),0.36279824062346544,0.8016521030711081,0.7273936170212766,0.9150495974792662,1.0,7/16,32.03%,PGAM5;TRPM7;RIPK3;CYLD;RIPK1;ITPK1;IPMK
prerank,regulation of chromosome organization (GO:0033044),0.3354025292224696,0.8011752281126082,0.7155612244897959,0.9153857803916414,1.0,6/22,22.68%,RMI2;SMG6;SMG1;LIG4;CDT1;UPF1
prerank,Ras protein signal transduction (GO:0007265),0.2791606472838542,0.8010014037124095,0.8489795918367347,0.9152777441469638,1.0,22/137,15.40%,NTN1;PLCE1;COL1A2;FGF2;TIAM1;MRAS;GDI1;SHC1;TRIM28;EPS8L1;CDC42EP2;USP50;CYFIP1;RHOA;SHOC2;CDC42EP5;SETDB1;FARP2;ARHGEF1;G3BP2;RHOB;SOS1
prerank,regulation of interleukin-2 production (GO:0032663),0.3053483224404675,0.8006403268743418,0.7528735632183908,0.9154422459025381,1.0,10/43,21.92%,GLMN;TBX21;TRIM27;ANXA1;RUNX1;EZR;CD80;SPTBN1;HOMER2;STOML2
prerank,development of primary male sexual characteristics (GO:0046546),0.3275087828623018,0.8004443381133775,0.7560096153846154,0.9153552835291618,1.0,7/34,16.65%,FSHR;TGFB2;SIX4;SOX9;INHBA;LRP2;LHFPL2
prerank,positive regulation of ion transport (GO:0043270),0.30392382267552137,0.8003764899585306,0.7694954128440367,0.9151039389497175,1.0,9/48,15.43%,FHL1;DRD1;CRACR2A;CHRNB2;ANK2;DLG1;PRSS8;F2R;RAB3B
prerank,regulation of blood circulation (GO:1903522),0.32143959542915557,0.8002700677186763,0.7651245551601423,0.9148908203305076,1.0,6/34,13.84%,ECE1;CAMK2D;KCNE5;KCNIP2;S100A1;DMPK
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.3433588979120344,0.8000730993772049,0.7577319587628866,0.9148188302114455,1.0,13/20,36.18%,CAMK2D;PACS2;BCAP31;THADA;KCTD17;HERPUD1;CCDC47;FIS1;TMCO1;RAP1GDS1;SELENOK;WFS1;BAK1
prerank,positive regulation of inflammatory response (GO:0050729),0.2845845686537126,0.7995186961226296,0.8151260504201681,0.9152495592548622,1.0,4/86,3.92%,LBP;IL33;PDCD4;ABCC1
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.37116842652624377,0.7994659847006762,0.7375328083989501,0.9149606732576114,1.0,3/15,6.89%,TGFB2;CELF4;FGFR1
prerank,MAPK cascade (GO:0000165),0.26916121616237954,0.7983043700418619,0.9134808853118712,0.9162788657145391,1.0,66/295,21.26%,EGFR;IRS1;FGF2;FGF13;DLG2;FGF17;MRAS;PTPN3;PPP1CC;PSMD7;SHC1;MAP3K5;IL5;PSMA8;FGFR1;RAF1;DLG4;PDE6D;SOX9;DLG1;PSMA4;ITGAV;FGFR2;MAPK8;CHUK;PAQR3;SHOC2;PABPN1;MAPK12;PSMD12;CUL1;PIK3CB;PSMA6;YWHAE;MEF2A;ARL2;MAP3K3;PSMD11;PSMC5;SOS1;HGF;PSMD1;IL17RD;PSMD14;NF1;ERBB2;GFRA3;PSMC4;SPTBN1;RPS27A;UBC;FGF5;ARAF;WDR83;MEN1;GDNF;PEBP1;FGF18;PSMA3;RASGRF1;JAK1;LRRK2;FGFR3;PSMD4;MAP2K7;PSMB1
prerank,translation (GO:0006412),0.2703515998042316,0.7980195560220715,0.8797979797979798,0.9163337355769726,1.0,60/208,29.19%,RPSA;RRBP1;VARS1;MRPS2;MRPS28;WARS2;ABCF1;GSPT1;HARS2;NOA1;PPA2;MRPS18B;YARS1;ZC3H15;ABCE1;MRPS14;DARS2;EEF1G;AGO2;EIF4G1;MRPL35;ETF1;MRPS17;EEF2K;YARS2;EEF1B2;RPS27A;PPA1;EPRS1;TUFM;EEFSEC;SARS2;SARS1;DRG2;PTCD3;ASMT;RPL7A;DARS1;MRPL47;GTPBP2;MRPS24;MRPS21;MRPS18A;PABPC4;RPS9;MRPL37;TMA7;CARS1;QARS1;MRPL13;TRMT112;DRG1;SRBD1;RPL41;RPL30;WARS1;NDUFA7;MRPL11;IGHMBP2;TNIP1
prerank,RNA polyadenylation (GO:0043631),0.3315374498862842,0.797876459190642,0.7490864799025578,0.9158105320127808,1.0,7/26,21.58%,PABPC1;TENT4B;SYMPK;CLP1;PCF11;TENT2;PAF1
prerank,mRNA polyadenylation (GO:0006378),0.3315374498862842,0.797876459190642,0.7490864799025578,0.9158105320127808,1.0,7/26,21.58%,PABPC1;TENT4B;SYMPK;CLP1;PCF11;TENT2;PAF1
prerank,exit from mitosis (GO:0010458),0.37365557663623183,0.7978311695945111,0.710267229254571,0.9155148877588104,1.0,8/12,32.76%,SPAST;UBE2C;PPP2R2D;CHMP4B;CHMP2A;CTDP1;UBE2S;SIRT7
prerank,activation of protein kinase A activity (GO:0034199),0.35756981609294336,0.7977567867736697,0.7127371273712737,0.9152624996725072,1.0,4/16,7.80%,PRRC1;ADCY2;ADCY8;ADCY9
prerank,regulation of epidermal cell differentiation (GO:0045604),0.34064800527504363,0.7971216624807982,0.7407407407407407,0.9158120292297841,1.0,8/21,24.46%,SFRP4;RUNX1;BMP4;MAFG;CBFB;CTSK;SFN;ROCK1
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.3368588765040871,0.7970144191085485,0.7443890274314214,0.9156188817109661,1.0,4/24,11.54%,VEGFA;SEMA3E;SEMA4B;NRP1
prerank,fibrinolysis (GO:0042730),-0.30586883032913326,-0.7963540295893092,0.7567567567567568,0.9140653492837536,1.0,2/13,10.71%,PLAT;SERPINE1
prerank,regulation of presynapse organization (GO:0099174),0.3534909296123717,0.7960466981827782,0.7254901960784313,0.9163171564800952,1.0,2/18,5.02%,GPC6;LRFN4
prerank,regulation of presynapse assembly (GO:1905606),0.3534909296123717,0.7960466981827782,0.7254901960784313,0.9163171564800952,1.0,2/18,5.02%,GPC6;LRFN4
prerank,purine-containing compound salvage (GO:0043101),0.38197962355389703,0.7960043528449613,0.723463687150838,0.9160157091414631,1.0,3/12,13.26%,ADA;AMPD3;DGUOK
prerank,regulation of peptidase activity (GO:0052547),0.3569201698082397,0.7956459072859332,0.7539473684210526,0.9161811154899877,1.0,7/19,27.41%,CST3;MAPK12;HDAC1;RCN3;PSMA3;PINK1;SVBP
prerank,regulation of receptor-mediated endocytosis (GO:0048259),0.3170767821454833,0.795611905098457,0.7678571428571429,0.9158720870268356,1.0,11/35,21.35%,LRPAP1;RAB21;RSPO1;CBL;ARF1;PIK3CB;SNAP91;HNRNPK;HIP1;CLU;IL4
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.321735655847165,0.7954967133874324,0.768772348033373,0.9156880283776454,1.0,3/33,9.48%,ID2;PRKCA;RUNX1
prerank,positive regulation of cell cycle phase transition (GO:1901989),-0.29209814731055916,-0.7948849288660683,0.7300380228136882,0.9149720773079109,1.0,9/15,34.49%,KLHL18;STXBP4;PHB2;CUL3;CRNN;DYRK3;ATAD5;CDC73;NPM1
prerank,positive regulation of protein ubiquitination (GO:0031398),0.28885623881071015,0.7948689211213521,0.8074074074074075,0.9162360529059151,1.0,28/80,34.62%,PRICKLE1;TOPORS;DCUN1D5;HUWE1;CDK5RAP3;AXIN1;SMAD7;DCUN1D2;PHF23;UBQLN1;STUB1;MYCBP2;LRRK2;BIRC3;DERL1;XIAP;PINK1;RCHY1;NDFIP1;RIPK2;RBX1;HDAC3;MTA1;UBE2N;PTTG1IP;ARRDC4;PEF1;FAM107A
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.30313125197251795,-0.7946104256648211,0.759581881533101,0.9139462794517884,1.0,7/12,20.34%,BCL2;RPL26;CD74;SIRT1;CD44;KDM1A;TAF9
prerank,positive regulation of autophagy (GO:0010508),0.2901477106887935,0.7945836072297203,0.8407643312101911,0.9162780565374223,1.0,37/81,31.67%,SESN3;HMGB1;TRIM27;MID2;PIK3CB;SESN2;PAFAH1B2;TRIM65;FOXO3;ORMDL3;FLCN;TRIM13;UFL1;TRIM6;ATF6;EIF2AK4;LRRK2;OPTN;IL4;TRIM8;RUFY4;TSC2;NPRL2;ROCK1;TBK1;BAD;PINK1;GPSM1;PLEKHF1;TFEB;ULK1;LARP1;IRGM;PRKN;MTDH;DAPK1;PIM2
prerank,membrane fusion (GO:0061025),0.317218182747738,0.794052657792079,0.7503059975520195,0.9167016245767194,1.0,8/33,17.96%,STX11;DNM2;HUWE1;NSF;USO1;CHP1;SNAP23;NAPA
prerank,negative regulation of mitochondrion organization (GO:0010823),0.31518029385096424,0.7938755432482789,0.75,0.916600418424724,1.0,11/33,22.69%,NOL3;FXN;IAPP;HUWE1;HGF;SLC35F6;FLCN;AKT1;CLU;MUL1;TRIAP1
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.32174693068621585,0.7937794852638408,0.7478890229191797,0.9163838423496684,1.0,2/32,2.96%,DDX5;FHIT
prerank,histone ubiquitination (GO:0016574),0.33956628985796294,0.7934022699245256,0.7103174603174603,0.9165831268383412,1.0,12/21,36.97%,UBE2B;HUWE1;UBR2;PAF1;RNF20;USP22;UBE2A;UBE2N;WAC;DTX3L;ATXN7L3;RNF8
prerank,glycerophospholipid metabolic process (GO:0006650),0.28864937685625935,0.7932928927583018,0.8155650319829424,0.9163726133383094,1.0,20/75,23.22%,PLA2G4F;PLA2G4A;PIGW;SMPD4;PIGF;SYNJ1;FAR1;ABHD6;PIGL;ENPP6;PNPLA3;PIP5K1A;GDPD3;HDHD5;PLA2G15;CLN3;PLCB2;PIGX;ABHD12;PIGV
prerank,ribosome biogenesis (GO:0042254),0.27029855383615814,0.7932604223927195,0.8844221105527639,0.9160563649839666,1.0,68/187,33.16%,XPO1;C1D;LTV1;RRS1;RRP7A;LAS1L;EMG1;CUL4A;WDR3;ABCE1;RIOK1;NVL;ESF1;WDR55;DHX29;RRP12;NOLC1;UTP14A;DCAF13;EXOSC4;MRTO4;NOC4L;BYSL;EIF6;DIS3;BOP1;METTL17;NOC2L;MTREX;NOB1;RPL7A;NOP56;EIF2A;FBL;GTF3A;WDR36;WDR12;DDX49;PAK1IP1;SBDS;RPS9;WDR46;WDR75;TBL3;RIOK2;UTP11;SENP3;NOP58;FCF1;DKC1;POP5;NOP53;RPL41;RPL30;PIH1D2;RPF2;EXOSC2;NOP14;UTP3;EXOSC3;RRP1B;RPL36A;RPL37A;RPL27;UTP4;HEATR3;CUL4B;MPHOSPH6
prerank,regulation of cell division (GO:0051302),0.2856563424245475,0.7930707762322059,0.806941431670282,0.9159857999758847,1.0,18/72,24.42%,KIF13A;CALM2;TLE6;ESRRB;FGFR2;GIT1;CSPP1;SIRT2;CALM3;MLLT3;FLCN;BIRC6;SFN;SETD2;UVRAG;RAB11FIP4;PLK4;CCP110
prerank,cilium-dependent cell motility (GO:0060285),0.3381409783583269,0.7927573004738367,0.7410604192355117,0.9160614746515591,1.0,4/22,19.04%,DNAH8;CCDC39;DNAH2;TEKT2
prerank,cellular respiration (GO:0045333),0.3068638088799092,0.7924504401400657,0.7593896713615024,0.9161515851451122,1.0,8/41,14.04%,ETFRF1;COQ10B;ETFDH;ETFB;ETFA;NDUFS7;MTFR1;SURF1
prerank,carbohydrate derivative transport (GO:1901264),0.3527095588327054,0.7924242774155773,0.7432065217391305,0.9158327864535412,1.0,2/18,5.76%,LBP;SLC10A7
prerank,regulation of hormone secretion (GO:0046883),0.3635144356670441,0.7922895944328784,0.7424657534246575,0.9156610329830638,1.0,5/15,27.56%,EDN3;ANXA1;NMB;VAMP2;LIF
prerank,positive regulation of leukocyte migration (GO:0002687),0.3288834557774478,0.7922556084616662,0.7645631067961165,0.9153481543973817,1.0,6/27,21.35%,VEGFA;EDN3;MIA3;IL6;TNFSF18;IL4
prerank,Golgi to lysosome transport (GO:0090160),-0.31777383944377946,-0.7922534074421302,0.7029702970297029,0.916355846796144,1.0,2/11,6.42%,ANKFY1;SORT1
prerank,protein monoubiquitination (GO:0006513),0.31253870798453515,0.7916815718978883,0.755868544600939,0.91581586068625,1.0,10/36,26.33%,TOPORS;UBE2B;UBE2R2;HUWE1;KLHL22;PAF1;KLHL12;RNF20;UBE2W;RNF126
prerank,synaptic vesicle exocytosis (GO:0016079),0.30985697351546565,0.7912221798637963,0.7749120750293084,0.9161232840279899,1.0,16/40,28.75%,SYT8;UNC13B;STX11;PRRT2;STX2;SNAP23;STX4;STX1A;SNAPIN;CDK5;STX1B;VAMP2;STX19;SNPH;PCLO;RAB3A
prerank,embryonic digit morphogenesis (GO:0042733),0.3469007252972667,0.7912039035514047,0.7321428571428571,0.9157910497343523,1.0,5/18,15.58%,ECE1;TWIST1;NOG;HDAC1;CREBBP
prerank,calcium ion homeostasis (GO:0055074),0.2797854629520823,0.7903609842524462,0.8436516264428122,0.9166100447653858,1.0,13/95,11.64%,ATP1B1;SLC24A3;CCL13;PKHD1;CCL15;SLC10A7;ANK2;EDN3;SELENON;CHERP;STIM1;CSRP3;TMEM165
prerank,retina homeostasis (GO:0001895),-0.25989507911749044,-0.789278776957296,0.7983193277310925,0.9196814204665583,1.0,7/23,19.08%,B2M;WHRN;ATP1B2;HSPB1;CDH3;ACTB;POTEF
prerank,modulation by symbiont of host process (GO:0044003),-0.315598624834378,-0.7881212741076986,0.7310344827586207,0.9201143409016447,1.0,3/10,14.57%,B2M;MRC1;UBA52
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.3368764973126686,0.7880935229392293,0.7339449541284404,0.9194275540346062,1.0,8/21,23.86%,MCU;BCAP31;MICU2;LETM1;MICU1;ANXA6;AFG3L2;SLC8B1
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.3385938747520257,0.7879451547984262,0.748378728923476,0.9192778982602302,1.0,8/19,33.98%,ZNF76;TENM1;CHD8;RPTOR;ICE1;PRDX5;POLR3F;ZC3H8
prerank,regulation of neuron migration (GO:2001222),0.3282274294177826,0.7879042174287342,0.7614906832298136,0.9189921687683964,1.0,9/26,21.89%,COL3A1;SRGAP2;ULK4;NSMF;NIPBL;KIF20B;TNN;IGSF10;SHTN1
prerank,maintenance of protein location in nucleus (GO:0051457),0.3432811389905419,0.7877336844122007,0.7556390977443609,0.9188857085270766,1.0,2/20,4.39%,TOPORS;MORC3
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.37709457951680664,0.787499818943624,0.7156593406593407,0.918847958442599,1.0,6/12,29.26%,ELOVL5;FADS1;ABCD1;ACOT8;ELOVL1;SCP2
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),0.386493833395005,0.7873382978945758,0.7205240174672489,0.918704608985415,1.0,6/10,28.32%,CCT6A;CCT4;CCT8;TCP1;DKC1;CCT5
prerank,positive regulation of interferon-gamma production (GO:0032729),-0.21494906650431367,-0.787326168280832,0.9279279279279279,0.919901404795554,1.0,20/48,29.52%,IL1R1;PDE4D;SLC7A5;PDE4B;LGALS9;PTPN22;PYCARD;TXK;ISG15;CCR2;CD276;TLR7;RASGRP1;FADD;TLR3;ZFPM1;SLAMF6;IL18;CD14;TLR8
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.2798140140691836,-0.7872077222691111,0.7674418604651163,0.9185999560954782,1.0,2/16,8.90%,CLDN5;CLDN1
prerank,positive regulation of interleukin-2 production (GO:0032743),0.331928936878768,0.786730426126806,0.7601977750309024,0.9192081443035407,1.0,5/25,16.87%,GLMN;ANXA1;RUNX1;CD80;SPTBN1
prerank,positive regulation of transporter activity (GO:0032411),0.3671829348331691,0.7865872861403893,0.7375,0.9190608714928302,1.0,2/13,6.72%,RXRA;STK39
prerank,regulation of cholesterol efflux (GO:0010874),0.3188299358841666,0.7864707378187199,0.7750906892382105,0.9188708884257981,1.0,3/30,6.20%,LRP1;RXRA;LAMTOR1
prerank,cellular response to superoxide (GO:0071451),-0.32048966952811103,-0.7863214278594244,0.75,0.9185352700304951,1.0,2/10,4.76%,NOS3;SOD3
prerank,regulation of T cell activation (GO:0050863),0.3019986361226235,0.7863150039240709,0.7757437070938215,0.9187343692464051,1.0,7/42,13.14%,TNFRSF1B;TBX21;CRTAM;ABL1;HSPD1;KAT2A;VTCN1
prerank,actin nucleation (GO:0045010),0.3410419218691663,0.7861223951870235,0.7369758576874206,0.9186578647582261,1.0,6/21,25.24%,ARPC1B;TRIM27;SPIRE2;SCIN;ARPC1A;ACTR2
prerank,positive regulation of protein deacetylation (GO:0090312),0.36822824120497355,0.7860332444408271,0.738191632928475,0.9184126528759318,1.0,4/14,24.81%,NNMT;NIPBL;AKAP8;SAP30BP
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.27481685448345916,0.7855739850879184,0.8708677685950413,0.9186768453784699,1.0,15/110,14.03%,GNAS;FSHR;DRD1;ADGRL2;ADCY2;RAMP2;ADCY8;IAPP;ADCY9;VIP;RAMP1;ABCA1;GLP1R;MC4R;GPR12
prerank,lipid catabolic process (GO:0016042),-0.2714330609460181,-0.7853445970666328,0.7760617760617761,0.9185733386050818,1.0,8/18,26.62%,PLA1A;PLAAT3;LPL;LIPE;MT3;LIPH;LIPC;HSD17B14
prerank,regulation of calcium-mediated signaling (GO:0050848),0.33174839292710295,0.7850552308527622,0.7772455089820359,0.9190628406586288,1.0,1/25,0.49%,CMKLR1
prerank,cellular response to glucose starvation (GO:0042149),0.3090704711226636,0.7847959665996128,0.7828638497652582,0.9190748850060267,1.0,12/41,22.27%,SESN3;ATF4;IMPACT;HSPA5;SESN2;PICK1;FOXO3;PRKAG1;SIK2;KPTN;EIF2AK3;HNRNPA1
prerank,cardiocyte differentiation (GO:0035051),0.39528030997925223,0.7847776028321221,0.7402597402597403,0.9187433104055599,1.0,3/10,16.78%,TGFB2;AKAP13;KDM6B
prerank,positive regulation of cholesterol efflux (GO:0010875),0.33678760722221013,0.7846461772112217,0.7480916030534351,0.9185536530705166,1.0,2/21,3.85%,LRP1;RXRA
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.3321788951083999,0.7843605808193591,0.760759493670886,0.9185907104313442,1.0,9/24,26.58%,PKD1;DNAAF4;PSMD14;EFNA1;UCHL5;PRKACA;USP14;PINK1;TMF1
prerank,negative regulation of cell communication (GO:0010648),0.3390383122583493,0.7842871085011528,0.754863813229572,0.9183306786647741,1.0,3/21,13.39%,UBASH3B;ACVR1;SRMS
prerank,Notch signaling involved in heart development (GO:0061314),0.3808888104566181,0.7836401821001029,0.7475728155339806,0.9188686463314654,1.0,3/11,12.41%,JAG1;HEYL;HEY1
prerank,postsynaptic membrane organization (GO:0001941),0.34756653698733103,0.7836041961855695,0.7396373056994818,0.9185579451479471,1.0,5/17,13.27%,CEL;DLG4;NRXN2;MUSK;NLGN1
prerank,regulation of exocytosis (GO:0017157),0.2972968825155073,0.7828814361623303,0.7820069204152249,0.9192030925087031,1.0,11/46,17.41%,RAB2B;RAB21;RAB8A;ANXA1;NSF;RAB3D;STXBP5;CHMP3;STX4;RAB3B;SYTL4
prerank,regulation of protein localization (GO:0032880),0.2934479393613338,0.7825545962175552,0.7959866220735786,0.9192866782584587,1.0,15/58,22.78%,DVL1;TRIM27;DLG1;PLEKHM2;MAPK8;SLC26A4;VIP;CSNK1E;PARP1;SUMO1;UFL1;TRIM6;TRIM46;TMEM231;CAMK1
prerank,negative regulation of interleukin-17 production (GO:0032700),-0.3184785337685162,-0.7823366509868798,0.7035830618892508,0.9217947842914274,1.0,10/10,68.18%,NCKAP1L;IL12A;TLR4;FOXP3;IL12B;VSIR;TNFSF4;IFNG;DDIT3;PRNP
prerank,cochlea morphogenesis (GO:0090103),-0.3202058550105279,-0.7813978902878363,0.7142857142857143,0.9217138933852139,1.0,2/10,5.32%,TBX18;TBX1
prerank,regulation of cytokine production involved in immune response (GO:0002718),-0.26196574588352295,-0.7813452802681132,0.7892376681614349,0.9203179680955027,1.0,4/22,10.46%,WNT5A;SLC7A5;LACC1;TRIL
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.3177191437796552,0.7811731466932997,0.7690447400241838,0.9208518495304161,1.0,13/32,31.91%,CDK5RAP3;ATM;RINT1;FOXN3;BRCC3;TOPBP1;TAOK3;DONSON;TAOK1;TAOK2;NOP53;TRIM39;BLM
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.29921603973664923,0.7811450641433356,0.7889390519187359,0.9205362187201417,1.0,12/45,20.77%,ZC3H7A;PUM1;MATR3;CYFIP1;METTL16;NOLC1;YTHDC1;FOXO3;PER1;ZC3H10;ATXN2;EIF2A
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.31819166396489196,0.7810806548702593,0.7496977025392987,0.9202757516932514,1.0,9/30,24.86%,TENT4B;ERCC4;TEN1;HNRNPC;XRN1;MEN1;HNRNPA1;HNRNPU;TP53
prerank,synaptonemal complex assembly (GO:0007130),0.36597110271261574,0.7802230650767923,0.7556440903054449,0.9207354772943787,1.0,4/15,29.25%,HORMAD1;TEX11;P3H4;SYCP2
prerank,synaptonemal complex organization (GO:0070193),0.36597110271261574,0.7802230650767923,0.7556440903054449,0.9207354772943787,1.0,4/15,29.25%,HORMAD1;TEX11;P3H4;SYCP2
prerank,dendrite self-avoidance (GO:0070593),0.3605391309460447,0.7800860923626611,0.7447089947089947,0.9205718122836283,1.0,5/16,20.99%,EMB;PALLD;IGSF9;TNN;DSCAM
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),-0.3048966157028902,-0.7796393912410461,0.7561837455830389,0.9215561275542691,1.0,5/12,18.46%,GMPS;IMPDH1;ADSS1;LHPP;PPAT
prerank,chemical synaptic transmission (GO:0007268),0.26313138479350473,0.7790456508988584,0.9247743229689067,0.9216343263585627,1.0,24/284,8.74%,PCDHB16;LRP6;GRIK4;SLC12A7;DLG2;EXOC4;UNC13B;CEL;CAMKK1;PMP22;KCNN1;ERC1;SLC6A2;GABRA3;RIC3;DVL1;KCNIP2;CHRNB2;SLC12A4;GIPC1;DLG4;TBC1D24;CHRNA5;DLG1
prerank,cellular response to UV-A (GO:0071492),0.38101829650952135,0.7789603799976159,0.7564841498559077,0.9213947827349498,1.0,4/11,28.54%,MMP2;OPN3;PPID;TIMP1
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.2843977017133855,0.7788427470762284,0.8194444444444444,0.9211947818763849,1.0,22/70,26.09%,ACVR1B;TGFB2;CRADD;BAG3;TNFRSF1B;BLOC1S2;ITGAV;BCL2L2;PDPK1;TNFRSF10B;CD27;INHBA;DEDD;BID;APPL1;FGFR3;IL4;DIABLO;BAD;TRADD;DAXX;RIPK1
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.33768570993442637,0.778612426441126,0.7522697795071336,0.9211600197657993,1.0,6/20,12.41%,PDCD4;TGFB2;HEYL;BMP4;TGFBR1;HEY1
prerank,establishment of mitotic spindle localization (GO:0040001),0.31667709635366803,0.7785663796953401,0.7713226205191595,0.9208607888653879,1.0,6/28,22.78%,PKHD1;MISP;ZW10;NDEL1;DCTN1;CDK5RAP2
prerank,cGMP biosynthetic process (GO:0006182),-0.31708826354788444,-0.778346909353036,0.7269503546099291,0.9221380019814518,1.0,2/10,9.15%,GUCY1B1;NPR1
prerank,positive regulation of transmembrane transport (GO:0034764),0.36598413253957385,0.7780876958823059,0.7422402159244265,0.9211456901260358,1.0,2/13,4.52%,SLC26A6;C2CD5
prerank,glycosphingolipid metabolic process (GO:0006687),-0.21901894162990887,-0.7779807022688969,0.9396551724137931,0.9212333364289084,1.0,13/42,19.29%,ST6GALNAC3;ST8SIA1;CERK;GLTP;SUMF1;ST8SIA3;SMPD3;GM2A;B3GALNT1;GLA;B4GALT6;NEU1;A4GALT
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.3455196887989839,0.7777156817472071,0.752,0.921292446861375,1.0,3/16,9.97%,KLRK1;RAET1E;CRTAM
prerank,sphingoid biosynthetic process (GO:0046520),0.37697109119627653,0.7773874115874816,0.739803094233474,0.921026262772126,1.0,1/11,1.78%,ACER3
prerank,sphingosine biosynthetic process (GO:0046512),0.37697109119627653,0.7773874115874816,0.739803094233474,0.921026262772126,1.0,1/11,1.78%,ACER3
prerank,response to ionizing radiation (GO:0010212),0.2866825749161652,0.7772847493995831,0.8315217391304348,0.9208134744805876,1.0,17/70,19.06%,COP1;INTS3;ANXA1;RAD1;SWI5;SPIDR;ATM;TANK;LIG4;RHOB;AEN;HUS1;TRIM13;MEN1;CLK2;RAD51;TNKS1BP1
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.33216547133301,0.7769205870985211,0.7728459530026109,0.9209655184972102,1.0,6/22,17.88%,IPO5;HEXIM1;CAMK2N1;LATS2;CDKN1C;MEN1
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.27992935611267294,-0.7760824591253451,0.7619047619047619,0.9227441185347453,1.0,1/14,0.38%,AUTS2
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.3066198266314855,0.7760450304956593,0.7789473684210526,0.9217872850229593,1.0,6/34,12.03%,LRP5;ANAPC5;CDC16;EDN3;PHIP;ANAPC4
prerank,protein autoprocessing (GO:0016540),0.34968596664392504,0.7756799280082581,0.7697547683923706,0.921932687345725,1.0,7/17,36.54%,FXN;CASP1;AFG3L2;HTRA2;PIDD1;MYRF;CTSL
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.2762436838790089,0.7756586693599268,0.8457502623294858,0.9216061464576688,1.0,13/101,13.20%,EGFR;PKD1;VEGFA;FGF2;CALM2;FGFR1;EDN3;RHOA;SYAP1;IRAK1;TELO2;TENM1;MAPRE3
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.2963622470947478,0.7752709270345912,0.8050171037628279,0.9217949076315366,1.0,16/48,26.53%,TOPORS;TNFRSF1B;PRKDC;ABL1;BCL2L2;ATM;CHEK2;AEN;E2F1;IKBKE;HIPK2;SFN;RPS27L;TP53;HTRA2;CDIP1
prerank,nucleotide catabolic process (GO:0009166),0.34516513077039435,0.7752624990691591,0.7636363636363637,0.9214502419434089,1.0,3/16,13.98%,XDH;VCP;DERA
prerank,establishment of protein localization to membrane (GO:0090150),0.28748942952513734,0.7752498156079686,0.8277356446370531,0.9211162032631448,1.0,15/66,22.80%,EGFR;NECTIN3;RABGEF1;RAB3GAP1;NPC1;ATG3;RAB11B;ZDHHC4;BID;RAB3GAP2;COX18;ZDHHC20;GORASP2;PRKCI;ZDHHC9
prerank,prostaglandin metabolic process (GO:0006693),0.32496883980200514,0.7743639932416874,0.7754077791718946,0.9219333329900019,1.0,2/26,1.81%,PTGIS;PLA2G4A
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.3102464051726412,0.7730670110392028,0.7818181818181819,0.9233081968215043,1.0,7/33,18.60%,IRS1;PIK3C2B;PIK3CB;SIRT2;NF1;ERBB2;AKT1
prerank,homologous chromosome segregation (GO:0045143),-0.26552768398544735,-0.7728793662739571,0.7920353982300885,0.9261991912605859,1.0,14/20,40.33%,FMN2;MEI4;FANCD2;PRDM9;SGO1;MAJIN;MEIOB;TERB1;PTTG1;RNF212B;MEIKIN;ANKRD31;TERB2;ZCWPW1
prerank,myoblast fusion (GO:0007520),0.3690881120956976,0.7724571416371198,0.7643835616438356,0.9237654327297047,1.0,2/12,6.13%,PTGFRN;CD9
prerank,transport along microtubule (GO:0010970),0.36626186815857525,0.7719414157844184,0.7551867219917012,0.9241138734472449,1.0,3/13,8.00%,BAG3;COPG1;ARHGAP21
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.251375239733527,-0.7714545497002446,0.8324022346368715,0.9268693969809607,1.0,10/24,20.34%,BCL2;BCL2L1;CXCL12;CD74;SIRT1;TPT1;CD44;KDM1A;CDKN2D;TAF9
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.34561720182324246,0.7714405330522954,0.7523809523809524,0.9244402131693573,1.0,9/16,36.12%,ZC3H12D;UPF1;RBM24;ZFP36L1;KHSRP;PLEKHN1;MOV10;TARDBP;RC3H1
prerank,positive regulation of telomerase activity (GO:0051973),0.3068901489551752,0.7692076975732889,0.7901840490797546,0.9271311058740181,1.0,10/33,30.61%,MAPK15;NEK7;NVL;CCT4;MAP2K7;TCP1;PNKP;DKC1;CTNNB1;HSP90AA1
prerank,sphingolipid biosynthetic process (GO:0030148),0.2845963245059103,0.7691330872073603,0.8209277238403452,0.926870041046209,1.0,7/71,6.23%,ACER3;PLPP3;ST6GALNAC5;KDSR;SMPD4;ELOVL5;PLPP1
prerank,negative regulation of histone modification (GO:0031057),0.3469849448770652,0.7688737639349883,0.7715877437325905,0.9268689675427666,1.0,3/14,19.13%,TWIST1;THAP7;NOC2L
prerank,ketone body metabolic process (GO:1902224),0.3779853761591992,0.7688305830019394,0.7296511627906976,0.9265753112143001,1.0,4/10,14.14%,AACS;HMGCL;ACAT1;BDH2
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.3398811560311662,0.7677833660672785,0.7811671087533156,0.9276043104001933,1.0,3/17,9.97%,KLRK1;RAET1E;CRTAM
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.37318863270111013,0.7676860461032206,0.7562776957163959,0.927387795712796,1.0,6/11,28.32%,CCT6A;CCT4;CCT8;TCP1;DKC1;CCT5
prerank,mitochondrial protein processing (GO:0034982),0.36127407411278695,0.7674165064719428,0.7539118065433855,0.9274025708448084,1.0,6/11,28.30%,SPG7;PMPCA;STOML2;AFG3L2;PMPCB;ATP23
prerank,N-acetylneuraminate metabolic process (GO:0006054),0.37981339803278935,0.7671051496873228,0.745985401459854,0.9274505580215167,1.0,3/10,16.71%,GNPDA1;NANP;RENBP
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.34832140522950533,0.7663737712213174,0.7493297587131368,0.9280791222231471,1.0,10/16,22.68%,IRAK3;GSPT1;CLEC16A;TBC1D25;ETF1;HDAC6;CLN3;GLE1;SHFL;UPF1
prerank,regulation of cellular component size (GO:0032535),0.30979328075486556,0.7661145435501482,0.7870257037943696,0.9280566025400546,1.0,3/30,4.56%,VAV2;RDX;PEX11A
prerank,acylglycerol metabolic process (GO:0006639),0.30108007274823556,0.7660164273809585,0.8032407407407407,0.9278349883492242,1.0,6/37,15.02%,MGLL;LMF1;DGKQ;PGS1;ABHD6;PNPLA3
prerank,pyrimidine-containing compound catabolic process (GO:0072529),0.34775463670984497,0.7659373315237624,0.7594594594594595,0.927597147667756,1.0,4/16,21.32%,DPYSL3;UPP2;TET2;NT5C
prerank,adipose tissue development (GO:0060612),0.37521481345304886,0.7657030429291923,0.749648382559775,0.9275531121582477,1.0,2/11,8.24%,LRP5;SH3PXD2B
prerank,regulation of cytokine production (GO:0001817),0.2659978169567592,0.7656650974031471,0.890608875128999,0.9272549808251589,1.0,19/126,16.18%,FOXP1;IL33;GLMN;HDAC9;TNFRSF1B;RPS6KA4;BTNL9;ANXA1;CRTAM;RIPK3;SOD1;CIDEA;KAT2A;TRAF3;VTCN1;CCN4;IL6;PER1;N4BP1
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.3474766581418219,0.7655356482228222,0.7926023778071334,0.9270740003302472,1.0,2/17,7.50%,TWIST1;YJU2
prerank,pinocytosis (GO:0006907),0.38619814499303184,0.7655297302076036,0.7758369723435226,0.9267275475278076,1.0,1/10,3.84%,RAB34
prerank,mitochondrial fusion (GO:0008053),0.33519280126150874,0.765494194537121,0.767379679144385,0.92641446812148,1.0,8/18,30.35%,MIEF2;SPG7;STOML2;MFN1;AFG3L2;FIS1;USP30;MIEF1
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.3471040912359842,0.7654076190505237,0.7560627674750356,0.9261841790087705,1.0,6/15,22.69%,NOL3;FXN;HGF;AKT1;CLU;TRIAP1
prerank,positive regulation of MAP kinase activity (GO:0043406),0.283280763671226,0.7652836943667778,0.8392857142857143,0.9260069239252313,1.0,6/66,7.38%,EGFR;VEGFA;FGF2;MAP3K5;FGFR1;EDN3
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.30727429688397834,0.7639958547747823,0.7713936430317848,0.9273568009973703,1.0,11/29,30.89%,PPP6R3;TERT;TELO2;RAD50;TNKS1BP1;CDK2;ANKRD28;DKC1;RTEL1;HSP90AA1;NOP10
prerank,stress-activated MAPK cascade (GO:0051403),0.2839319496393286,0.763860556426884,0.8273615635179153,0.9271803746938361,1.0,23/61,29.11%,MAP3K5;GPS1;MAPK8;CHUK;MAP3K12;TAB2;IRAK1;CUL1;MAP3K10;RPS27A;UBC;MAP2K3;MAPK9;MAP2K7;GPS2;TAOK2;ZFP36L1;RIPK2;MAP3K11;UBE2V1;MAP2K4;CCM2;BTRC
prerank,pyrimidine nucleoside catabolic process (GO:0046135),-0.3184683812449106,-0.7635622154119978,0.7371794871794872,0.9370309641714826,1.0,2/10,5.48%,UPB1;DPYD
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.3440159252228343,0.763182698679646,0.7830188679245284,0.9276976789241747,1.0,3/17,14.80%,DRD1;ADCY9;AKAP13
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.3188354878583235,0.7625231079992087,0.7818411097099621,0.9282157290176809,1.0,2/26,6.52%,LBP;HMGB1
prerank,C-terminal protein amino acid modification (GO:0018410),-0.3028350112264554,-0.7620152755535736,0.78125,0.9378768882652517,1.0,3/11,16.54%,AGBL4;FOLH1;TTL
prerank,respiratory chain complex IV assembly (GO:0008535),0.32701458072071704,0.7616465459467687,0.7695262483994878,0.9290138773661927,1.0,10/21,33.03%,COA8;SURF1;BCS1L;COA6;FASTKD3;COX18;COX15;COA5;COX16;TIMM21
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.33847414848537755,0.7615084710360956,0.7593085106382979,0.928836330912972,1.0,3/17,12.87%,UBASH3A;PTPN2;EZR
prerank,positive regulation of protein processing (GO:0010954),0.3292307964996914,0.7596027182343377,0.7835325365205843,0.9309553860292821,1.0,2/19,10.34%,GSN;LPCAT3
prerank,protein destabilization (GO:0031648),0.30573539431992613,0.7595065922811152,0.804583835946924,0.9307317426523621,1.0,12/32,31.83%,GSN;SERF1A;CREBBP;MUL1;PEX2;DERL1;GGA3;NR1D1;BTRC;IRGM;PRKN;PRNP
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.3091798217786643,0.7592590643020175,0.8033573141486811,0.9306981379782883,1.0,8/30,22.56%,ABCD3;ELOVL5;SLC27A6;ACSL6;SLC27A2;ACSBG1;PEX2;ABCD1
prerank,amino sugar metabolic process (GO:0006040),0.3761135614130935,0.7588799263157558,0.7594202898550725,0.9308293526084587,1.0,2/10,7.56%,GFPT1;GFPT2
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.3333828750459827,0.7585721715662223,0.7727272727272727,0.930865794569754,1.0,5/18,19.98%,COA8;SURF1;BCS1L;FASTKD3;COX18
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.37688116949950407,0.7585239696135272,0.7655571635311144,0.9305736281593784,1.0,5/10,25.96%,GPATCH3;NPLOC4;SEC14L1;C1QBP;TKFC
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.3470647325907611,0.7582536705957936,0.7676630434782609,0.930219942752977,1.0,2/15,12.77%,PABPC1;AGO2
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.3470647325907611,0.7582536705957936,0.7676630434782609,0.930219942752977,1.0,2/15,12.77%,PABPC1;AGO2
prerank,skeletal muscle contraction (GO:0003009),0.32975793997159575,0.7580491911726517,0.7708333333333334,0.9301472836934042,1.0,2/19,14.61%,TNNT3;STAC3
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.3570050753159266,0.757811494445432,0.7671957671957672,0.9300913105753584,1.0,3/13,11.15%,CD9;FCER1G;ABCA1
prerank,actin crosslink formation (GO:0051764),0.3600049978130416,0.7572714435641812,0.7746077032810271,0.9304370166913194,1.0,2/12,9.07%,DPYSL3;GAS2
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.3218634436686792,0.7568209882508424,0.7868852459016393,0.9306657550261558,1.0,8/23,31.52%,PDE6A;GUCY2D;SAG;GRK4;METAP2;NMT1;PDE6G;METAP1
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.378768433293209,0.7566607990511278,0.7771428571428571,0.9305220583342317,1.0,2/10,8.83%,LAPTM4B;TSKU
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.3317518782708095,0.7563287863145057,0.7907894736842105,0.9306090647744101,1.0,4/19,13.26%,ADA;TERT;AMPD3;DGUOK
prerank,regulation of postsynaptic membrane potential (GO:0060078),0.3006088697393171,0.7553470405094624,0.8195754716981132,0.9315142881775517,1.0,3/34,5.53%,MPP2;GABRA3;RAB3GAP1
prerank,modulation by host of symbiont process (GO:0051851),-0.22391108603350818,-0.7549133247102943,0.851063829787234,0.9463951938053666,1.0,13/31,31.39%,LEF1;NAPEPLD;CX3CR1;EP300;NUCKS1;HMGA2;POU2F3;AQP1;HPN;JUN;SAP30;CCL5;CCL4
prerank,regulation of embryonic development (GO:0045995),0.30559420273343385,0.7541576220337539,0.8086854460093896,0.9326926174211055,1.0,9/34,16.35%,PHLDB1;TLE6;POGLUT1;EHMT1;B4GALT5;TDG;NPHP3;CRB2;NIPBL
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.28615756300889533,0.753981351872229,0.8125,0.9325653367824625,1.0,3/45,4.19%,PRKCD;CAMK2D;MID1
prerank,positive regulation of myelination (GO:0031643),0.37712497842923914,0.7537537137652869,0.7905308464849354,0.9325169108332296,1.0,2/11,12.65%,TNFRSF1B;NCMAP
prerank,fatty acid elongation (GO:0030497),-0.2827117400424247,-0.7534455567067517,0.8111111111111111,0.9469493815860565,1.0,2/13,4.75%,ELOVL7;HACD1
prerank,positive regulation of nervous system process (GO:0031646),0.335683516073035,0.753411570764453,0.7867001254705144,0.9325981040102087,1.0,3/18,12.65%,UNC13B;TNFRSF1B;NCMAP
prerank,sterol metabolic process (GO:0016125),0.27968173640122057,0.752711748658901,0.8409343715239155,0.9331416413851288,1.0,8/60,11.15%,CYP19A1;CYP1B1;SOAT1;RXRA;TSKU;NSDHL;FDXR;ABCA1
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.3047966604622271,0.7520668994945267,0.7863961813842482,0.9336256728301756,1.0,2/29,6.52%,GAS6;HMGB1
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.3043972279113555,0.7517958751078776,0.7939464493597206,0.9336213200873349,1.0,3/35,4.16%,GHR;CYP1B1;HES5
prerank,negative regulation of interferon-beta production (GO:0032688),0.37413659349151995,0.7517588720093049,0.7763347763347763,0.933315693446173,1.0,1/10,3.88%,PTPRS
prerank,hexose transmembrane transport (GO:0008645),0.3234054377743767,0.7516199027411996,0.7870967741935484,0.9331242202386638,1.0,5/21,17.24%,SLC5A2;SLC2A9;SLC50A1;SLC2A10;SLC2A2
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),0.353047824418245,0.7513262054724553,0.7826704545454546,0.9331531352766709,1.0,4/13,17.38%,MDFIC;CHP1;RAB23;SUFU
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.34147706140742806,0.7513246169603858,0.8010899182561307,0.9328036967022683,1.0,1/15,2.05%,NTRK1
prerank,negative regulation of signaling (GO:0023057),0.31096649861731246,0.7500027722776611,0.7913043478260869,0.9341250148955748,1.0,5/25,20.96%,UBASH3B;ACVR1;SRMS;TRAT1;OPTN
prerank,protein palmitoylation (GO:0018345),-0.22291068595371183,-0.749563640031714,0.8982035928143712,0.9507072630923996,1.0,13/30,27.78%,ZDHHC14;GLUL;ZDHHC18;ZDHHC3;ZDHHC2;ZDHHC23;ZDHHC12;ZDHHC21;ZDHHC7;GOLGA7B;ZDHHC6;ZDHHC24;ZDHHC22
prerank,mitochondrion distribution (GO:0048311),-0.29687571820338904,-0.7494610573207372,0.8045602605863192,0.9493316937711329,1.0,4/12,13.84%,DNM1L;TRAK2;ARMC1;TRAK1
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.23860510818663894,-0.7489350594974125,0.8854625550660793,0.9485474961170052,1.0,9/24,20.29%,BCL2L1;NR1H3;AQP11;UBXN1;OPA1;HSPA1A;RACK1;XBP1;CREB3
prerank,copper ion homeostasis (GO:0055070),0.33452110794416134,0.7489313061732804,0.7900262467191601,0.935128110450343,1.0,8/17,33.84%,ARF1;ABCB6;ANKRD9;XIAP;SLC31A2;ATP7A;PRNP;MT2A
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.20495557092790773,-0.7488607670875459,0.9361702127659575,0.9471511597516545,1.0,15/57,17.98%,UACA;DDX3X;GRIN2B;PDCD5;AIM2;GRIN2A;SOX7;SYK;NDUFA13;ACVR1C;SIRT1;GRIN1;GPER1;FOXL2;PYCARD
prerank,regulation of DNA recombination (GO:0000018),0.3034715000563087,0.7481137563586465,0.8171779141104294,0.9358418631640072,1.0,12/32,32.24%,SPIDR;KPNA2;RAD50;SMARCAD1;RAD51;IL4;SETD2;ZRANB3;RTEL1;IL7R;BLM;MSH2
prerank,regulation of complement activation (GO:0030449),0.29146738590163207,0.7477455048434988,0.8121353558926487,0.9359679894490801,1.0,7/40,20.76%,CFH;C9;SERPING1;C8B;C8G;CPB2;CLU
prerank,regulation of transposition (GO:0010528),0.35132393308028714,0.7473191560402946,0.7770177838577291,0.936165645434247,1.0,2/13,18.84%,TEX15;UBR2
prerank,long-term synaptic potentiation (GO:0060291),0.3281454868311181,0.7471231343103989,0.8012987012987013,0.9360445254065966,1.0,2/21,3.16%,MPP2;ARC
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.2922016781182694,0.746371355947201,0.8152562574493445,0.9366230900535203,1.0,11/38,22.45%,PHLPP2;PKHD1;XDH;PIK3CB;PPP2R5C;FLCN;AKT1;MUL1;BANK1;DRD2;TSC2
prerank,cellular response to interleukin-1 (GO:0071347),0.2569105699035792,0.7454305050560913,0.913491246138002,0.9374166014475529,1.0,31/143,21.26%,PTGIS;CCL13;PSMD7;CCL15;PSMA8;IRAK3;RPS6KA4;SOX9;PSMA4;CHUK;TAB2;IRAK1;PSMD12;CUL1;PSMA6;TANK;SQSTM1;MAP3K3;PSMD11;PSMC5;PSMD1;PSMD14;PSMC4;RPS27A;UBC;ACOD1;USP10;NFKBIA;PSMA3;PSMD4;PSMB1
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),-0.2877822179411731,-0.7440461266653402,0.797153024911032,0.9521012701486048,1.0,9/12,40.79%,IL17D;PAEP;RASGRP1;IL18;ISL1;CARD9;IL23A;IL12B;IL23R
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.34375407265342023,0.7439952814569196,0.7826666666666666,0.9388617830604596,1.0,2/15,7.94%,ARPC1B;TRIM27
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.31076603077791937,0.7439748751023595,0.7977941176470589,0.9385350954045698,1.0,11/27,29.11%,MAP3K5;MAPK8;CHUK;CUL1;RPS27A;UBC;KAT7;MAP2K7;TAOK2;CCM2;BTRC
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.33738952262119365,0.7435862634043067,0.7888446215139442,0.9386602564743799,1.0,5/16,15.94%,CAMK2D;PRKCA;SLC9A1;MEF2A;PARP1
prerank,rRNA catabolic process (GO:0016075),0.3356161450842673,0.7428279389557662,0.7861885790172642,0.9392681759436293,1.0,4/16,17.21%,ERN2;XRN1;EXOSC4;DIS3
prerank,negative regulation of inflammatory response (GO:0050728),0.253929710497808,0.7422912368493852,0.9396378269617707,0.9395750456401166,1.0,28/182,17.39%,PRKCD;FSHR;PTGIS;GPR27;CCN3;DRD1;ADCY2;RAMP2;ADCY8;TNFRSF1B;IAPP;RORA;ADCY9;GPR20;SHARPIN;LPCAT3;VIP;RAMP1;GIT1;PTPN2;GLP1R;MC4R;PTGDR;IL6;CREB1;OTULIN;ADCY7;CALCA
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.31719621811640064,0.7420629054537546,0.8109919571045576,0.9395109414150021,1.0,2/19,11.35%,CARD16;GIT1
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.2739762240387539,0.7419511295961967,0.8537117903930131,0.9393120175497948,1.0,25/62,30.77%,YBX3;NOL3;CCAR2;NFE2L2;SYVN1;HYOU1;BCL2L2;URI1;AKT1;NOC2L;DNAJA1;CREB3L1;LRRK2;CLU;ACKR3;VNN1;SELENOS;HERPUD1;PINK1;HTRA2;PLAUR;SNAI2;NME5;SNAI1;PRKN
prerank,pyrimidine nucleoside metabolic process (GO:0006213),-0.27463489511471656,-0.7416253089182869,0.8307692307692308,0.9537213428923783,1.0,4/14,14.66%,UPB1;DPYD;ERH;UMPS
prerank,protein targeting (GO:0006605),0.25754647281371157,0.7412809178229748,0.8920863309352518,0.9397776184320328,1.0,36/118,30.12%,LTBP2;SEC61A1;RABGEF1;TOMM40;GIPC1;TIMM9;PEX16;PEX1;ATG3;BCAP31;NLGN1;SPCS2;HPS4;HACL1;TOMM70;ZDHHC4;PEX6;ZFAND2B;ZDHHC20;LAMP2;PRKCI;ZDHHC9;TIMM22;TIMM17B;TAOK2;KATNB1;LONP2;KIF13B;PARD3;VPS37B;FIS1;SRPRA;SPCS1;PIKFYVE;ZFAND2A;SRP14
prerank,regulation of immune effector process (GO:0002697),0.28819986242927814,0.74108183047823,0.8329439252336449,0.9396631128203033,1.0,7/41,20.76%,CFH;C9;SERPING1;C8B;C8G;CPB2;CLU
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.2838624678300846,0.7409227548261661,0.8260869565217391,0.9395039116661877,1.0,7/47,12.93%,EGFR;TGFB2;MID1;NBR1;FOXM1;ULK4;STK25
prerank,regulation of apoptotic signaling pathway (GO:2001233),0.29408788978258443,0.7408600517352651,0.8343409915356711,0.9392284420501644,1.0,8/36,12.22%,CSNK2A1;CSNK2A2;CRADD;ING5;MADD;MAZ;DEPTOR;TGFBR1
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.28222612633146243,0.7406482585929461,0.8371824480369515,0.9391467117099564,1.0,13/46,28.26%,TOMM40;TIMM9;AIFM1;BCAP31;HSPD1;TOMM70;GRPEL1;AKT1;PINK1;TIMM22;TIMM17B;RALA;FIS1
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.26157198812673343,-0.7406419543525097,0.8264462809917356,0.9534523008235386,1.0,2/16,3.85%,BCL2L1;CXCL12
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.3397732264992891,0.7402341118895486,0.8077474892395983,0.939310689895587,1.0,5/13,21.72%,LPCAT3;MANF;USP19;CLU;EIF2AK3
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.30951809117565127,0.7395276950735256,0.8061349693251534,0.9398262980720421,1.0,5/25,15.34%,ACVR1B;STAT3;PRKDC;INHBA;FOXO3
prerank,postreplication repair (GO:0006301),0.2855727575260449,0.7392238096926678,0.838150289017341,0.9398468682513546,1.0,18/45,33.57%,UBE2B;VCP;FAAP20;UBE2L6;UBE2V2;RPS27A;UBC;REV1;USP10;PRIMPOL;POLD1;UBE2V1;UBE2A;MSH2;UBE2N;POLK;RPA3;PARP10
prerank,ceramide catabolic process (GO:0046514),0.34093107182761373,0.739045402067561,0.7852437417654808,0.9397076887149037,1.0,3/14,19.83%,ACER3;HEXA;ASAH1
prerank,epithelial cell-cell adhesion (GO:0090136),0.3578896079949975,0.7387540653370409,0.7959479015918958,0.9397085610254744,1.0,2/11,7.62%,CCN3;JUP
prerank,negative regulation of protein depolymerization (GO:1901880),0.30650197481890834,0.7375327871396573,0.788293897882939,0.940840134780393,1.0,2/24,3.07%,FGF13;LIMA1
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.3086348285434011,0.7371646831982943,0.8347613219094248,0.9409138541244126,1.0,9/26,27.81%,ITCH;ALPK1;TAB2;IRAK1;RPS27A;UBC;CYLD;RIPK2;UBE2V1
prerank,negative regulation of amyloid-beta formation (GO:1902430),-0.25438987839643185,-0.7362979041627501,0.8225806451612904,0.9575947906534629,1.0,1/17,1.41%,APOE
prerank,female gamete generation (GO:0007292),0.3021602356554612,0.7362042326379127,0.8123486682808717,0.9417240285086087,1.0,5/29,13.11%,FSHR;M1AP;HORMAD1;MARF1;KMT2D
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.3253082773560272,0.7361086334066005,0.8067114093959732,0.94148592263061,1.0,9/18,37.96%,ANXA1;NR3C1;KLF9;HNRNPU;ZFP36L1;SSTR2;FAM107A;PCK2;UBE2L3
prerank,cellular copper ion homeostasis (GO:0006878),0.3397360161667961,0.7359284722887041,0.8049113233287858,0.9413349272841208,1.0,7/14,33.84%,ARF1;ABCB6;ANKRD9;SLC31A2;ATP7A;PRNP;MT2A
prerank,positive regulation of microtubule polymerization (GO:0031116),0.3011555797430372,0.7357514260817881,0.8355663824604141,0.9412037269336889,1.0,13/28,29.40%,CKAP5;GIT1;AKAP9;ARL2;SLAIN2;DCTN1;CDK5RAP2;MET;DRG1;FES;TOGARAM1;MECP2;RAC1
prerank,cellular response to metal ion (GO:0071248),0.253989067793629,0.7355065359634303,0.893595041322314,0.9411416736724051,1.0,20/123,18.87%,EGFR;SLC12A2;DLG2;SYT8;CAMK2D;CLIC4;ADCY8;DLG4;MAPK8;CHUK;NEUROD2;NLGN1;ADD1;MEF2A;IQGAP1;SUMO1;ADCY7;HVCN1;AKT1;AOC1
prerank,regulation of intracellular protein transport (GO:0033157),0.2958041664839909,0.7353324787356277,0.8174123337363967,0.940997283114267,1.0,12/32,28.37%,BCAS3;BMP4;TENM1;UHMK1;NDEL1;PCM1;KIF20B;ICE1;VAMP2;TPR;GCC2;B3GAT3
prerank,glucose import (GO:0046323),0.34003063393994937,0.7343809043470961,0.7903225806451613,0.9418167502089172,1.0,3/13,17.19%,SLC5A2;RAB4B;SLC2A10
prerank,regulation of lymphocyte proliferation (GO:0050670),0.32748519738108406,0.7329562325682916,0.7966321243523317,0.943116934457705,1.0,2/16,8.19%,TNFRSF1B;IKZF3
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.27145795470280965,0.73273982133912,0.8694232861806311,0.9430487031382567,1.0,17/59,27.69%,ERC1;SHARPIN;CHUK;TAB2;TANK;RPS27A;UBC;NKIRAS1;AKT1;MAP3K14;NFKBIA;BIRC3;ROCK1;TBK1;TRADD;RIPK1;RIPK2
prerank,"base-excision repair, gap-filling (GO:0006287)",0.28919758327281403,0.7322949572778725,0.8272189349112427,0.9432143368372168,1.0,14/35,33.35%,MPG;OGG1;TDG;SMUG1;PARP1;POLB;PARG;POLD1;POLG;PNKP;ADPRS;MBD4;XRCC1;RPA3
prerank,mitochondrial membrane organization (GO:0007006),-0.21350469125631705,-0.7314720773917388,0.855,0.962230388855037,1.0,10/32,21.33%,BCL2;BCL2L1;CHCHD3;GHITM;OPA1;MTX2;MFN2;SAMM50;PPIF;BNIP3
prerank,positive regulation of cell development (GO:0010720),0.2948500675796171,0.7312492058273942,0.8317757009345794,0.9441069594192005,1.0,5/31,13.42%,PDE3A;SERPINF1;BMP4;LIG4;LRP2
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.25701337311480105,0.7301905666908526,0.9224489795918367,0.9450440933859124,1.0,18/117,17.39%,FSHR;GPR27;DRD1;ADCY2;RAMP2;ADCY8;IAPP;ADCY9;GPR20;VIP;RAMP1;GLP1R;MC4R;PTGDR;IL6;CREB1;ADCY7;CALCA
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.3551035322335287,0.7297915661199653,0.8025751072961373,0.9451688292072449,1.0,2/10,16.15%,AOC3;HDAC6
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.3090544615054309,0.7291089648104522,0.8318471337579618,0.9456327597397017,1.0,5/23,18.11%,INTS3;CDK5RAP3;ZW10;ZFYVE19;WEE2
prerank,programmed necrotic cell death (GO:0097300),0.3261051529973348,0.7290453535345025,0.8129117259552042,0.9453621749227894,1.0,3/18,10.71%,PGAM5;TRPM7;RIPK3
prerank,positive regulation of exosomal secretion (GO:1903543),0.32898523208873826,0.7288350498914633,0.7889039242219216,0.9452470740412224,1.0,1/15,3.13%,SDC1
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.28665131396169924,0.7283472151200036,0.8270858524788391,0.9454598812798531,1.0,7/32,16.30%,PRKCD;CALM2;SYMPK;CNEP1R1;PTBP1;NSMF;CALM3
prerank,excitatory postsynaptic potential (GO:0060079),0.3214835244598557,0.7275813397298582,0.8168831168831169,0.945983607607179,1.0,5/19,21.82%,MPP2;RAB3GAP1;AKT1;LRRK2;DRD2
prerank,dendritic cell migration (GO:0036336),0.32797522774513,0.7272372757258908,0.8170563961485557,0.9460172377564388,1.0,3/16,15.21%,HMGB1;TRPM4;CXCR4
prerank,negative regulation of cholesterol transport (GO:0032375),-0.2939994978659302,-0.72712424246495,0.8083067092651757,0.9662018510215399,1.0,10/10,70.62%,APOC1;SHH;ABCG5;APOA2;PLA2G10;ABCG8;APOC3;ABCA2;NFKB1;SREBF2
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.325872414031873,0.7269525837384239,0.8162162162162162,0.9460157712865682,1.0,6/16,34.57%,VTA1;CHMP4B;CHMP4A;TMEM50B;CHMP4C;TMEM50A
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.26900448621715084,0.726297804120817,0.854006586169045,0.9464298450254041,1.0,4/57,4.16%,VEGFA;GHR;STAT3;HES5
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.25571397778731836,0.7258966264972596,0.9295199182839632,0.9465429563537178,1.0,18/116,17.39%,FSHR;GPR27;DRD1;ADCY2;RAMP2;ADCY8;IAPP;ADCY9;GPR20;VIP;RAMP1;GLP1R;MC4R;PTGDR;IL6;CREB1;ADCY7;CALCA
prerank,positive regulation of type 2 immune response (GO:0002830),0.3444739949756971,0.7256589627528179,0.7994428969359332,0.9464738129695138,1.0,4/14,21.35%,RARA;IL6;DENND1B;IL4
prerank,positive regulation of secretion (GO:0051047),0.3562737291120388,0.7255172467843582,0.8033707865168539,0.9462937625188172,1.0,2/11,15.17%,ACSL3;SCIN
prerank,diol metabolic process (GO:0034311),0.31826268746280334,0.7247889133036192,0.8157894736842105,0.9468047740877225,1.0,2/19,6.23%,PLPP3;PLPP1
prerank,peptide hormone secretion (GO:0030072),0.30102043417957186,0.7246405462081125,0.8196125907990315,0.9466151570297895,1.0,6/26,23.89%,EDN3;ANXA1;VIP;IL6;RAB1A;FAM3B
prerank,positive regulation of T cell differentiation (GO:0045582),0.28878078581795485,0.7238551381963573,0.8331374853113983,0.9471779612169076,1.0,2/36,2.38%,ZMIZ1;GLI2
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.2875602753681469,0.723641858999104,0.8410438908659549,0.9470623321234024,1.0,10/35,16.57%,SCD5;AACS;HMGCL;CBR4;FAR1;PPT2;ACAT1;ACACA;BDH2;HSD17B8
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.29787882013897277,0.7229340809188834,0.8363858363858364,0.9475377201875329,1.0,9/28,25.74%,CRADD;BAG3;BLOC1S2;TNFRSF10B;DEDD;BID;DIABLO;TRADD;DAXX
prerank,positive regulation of interferon-alpha production (GO:0032727),0.31229516941123026,0.7227385765260458,0.8252933507170795,0.9473974000298623,1.0,7/19,27.69%,MAVS;CHUK;HSPD1;IRF3;SETD2;TBK1;RIPK2
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.3442038356197231,0.7222945509370595,0.8071135430916553,0.9475520639764342,1.0,4/12,18.60%,FUT4;WNK1;MIA3;AKT1
prerank,negative regulation of catalytic activity (GO:0043086),-0.23125190621225553,-0.722128115750059,0.8980582524271845,0.9706842176797575,1.0,8/24,18.44%,NOTCH1;NES;IFIT1;NOS1;SIRT1;CAMK2A;MT3;PPP1R12A
prerank,regulation of histone H3-K9 acetylation (GO:2000615),-0.2943337970144196,-0.7220387392294861,0.7795527156549521,0.9692754932115325,1.0,2/10,9.09%,RAPGEF3;PIH1D1
prerank,regulation of protein kinase A signaling (GO:0010738),0.3138578244564242,0.7216472818872582,0.813953488372093,0.9479308175028122,1.0,2/20,7.43%,FSHR;IAPP
prerank,regulation of cellular catabolic process (GO:0031329),0.2667220746512827,0.720586332127151,0.8783482142857143,0.9487479815940857,1.0,30/62,31.34%,MAPK15;OSBPL7;RAB8A;PIP4K2B;ABL1;ATM;USP33;WDR41;USP13;HDAC6;DAPK3;USP10;DCAF12;LRRK2;RPTOR;ABCD1;KAT8;SMCR8;ROCK1;SCARB2;LONP2;PIP4K2C;DRAM1;ABL2;CISD2;GPR137B;DRAM2;KEAP1;PRKN;DAPK1
prerank,positive regulation of exocytosis (GO:0045921),0.2854946113928287,0.7205240554637106,0.8380716934487021,0.9484638178145831,1.0,10/35,30.60%,SDC1;RAB2B;RAB3D;STXBP5;SYTL4;PDCD6IP;CHMP2A;RAB5A;RAB3A;RAB27B
prerank,aromatic amino acid family catabolic process (GO:0009074),0.32474164855533083,0.7198957821025018,0.8010752688172043,0.9488150173560964,1.0,4/15,26.62%,IDO2;GSTZ1;KYAT1;HGD
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.3595203841698132,0.7190453057027321,0.8328611898016998,0.9494338735415898,1.0,6/10,36.34%,YOD1;ERLEC1;UBE2G2;INSIG1;OS9;UBAC2
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),0.35308496571776493,0.7189190915489327,0.8046647230320699,0.9492293820909967,1.0,3/10,22.11%,CALM3;DRD2;CBARP
prerank,positive regulation of cytokine production (GO:0001819),0.24354359359791314,0.7185004697320261,0.982982982982983,0.9493408013053902,1.0,54/292,22.32%,FOXP1;LBP;F3;IL33;CYP1B1;GLMN;TWIST1;RAB7B;STAT3;ATF4;MAVS;SULF1;PRKDC;IL12RB2;HMGB1;POLR3H;RORA;TRIM27;RARA;FZD5;FCER1G;ANXA1;RUNX1;CRTAM;IRAK1;C1QTNF4;SOD1;HSPD1;CRCP;KAT2A;CD80;F2R;POLR3GL;SETD4;POLR2F;IL6;CREBBP;NFKB2;SPTBN1;HMOX1;TRIM6;IRF3;POLR3K;SULF2;XRCC6;APPL1;IL17RA;IL4;RAB1A;EIF2AK3;DRD2;STOML2;TLR1;POLR1C
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.28968613787748665,0.7184939706025871,0.8349514563106796,0.9489982849980337,1.0,7/29,20.61%,NTRK1;SHC1;ITGAV;SHOC2;LRRC59;ERBIN;RASGRF1
prerank,negative regulation of reproductive process (GO:2000242),0.3192192184061354,0.7184407309745199,0.8324538258575198,0.948715754253648,1.0,6/17,28.54%,SULF1;WEE2;CALR;WDR77;ARHGDIB;TIMP1
prerank,protein K48-linked ubiquitination (GO:0070936),0.26928109175401554,0.7182587453668187,0.8744444444444445,0.9485781324561028,1.0,8/54,11.08%,TOPORS;UBE2B;UBE2R2;RNF115;SYVN1;ITCH;UBR5;UBE2C
prerank,regulation of sodium ion transport (GO:0002028),0.2878743257390867,0.7178892043610063,0.8535714285714285,0.9486522747061691,1.0,7/34,15.46%,NEDD4;SLMAP;SNTA1;DLG1;PRSS8;WNK1;PER1
prerank,regulation of DNA damage checkpoint (GO:2000001),0.35375903886536825,0.7175784187896828,0.8214804063860668,0.9486439979864262,1.0,1/10,5.85%,CCAR2
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.24439178287407393,0.717391579539672,0.9708249496981891,0.9485153360486973,1.0,44/208,21.56%,ESR1;CARD16;MAVS;BRD4;RORA;ROR1;TRIM27;S100B;RHOA;SHARPIN;LTBR;ALPK1;MAPKBP1;CHUK;TAB2;IRAK1;PDPK1;TNFRSF10B;MID2;CASP1;TANK;TRAF3;F2R;SQSTM1;AKAP13;MAP3K3;PER1;ZDHHC13;TRAF3IP2;TRIM13;UFL1;HMOX1;TRIM6;IKBKE;USP10;MAP3K14;ZMYND11;CC2D1A;OPTN;BIRC3;NUP62;TRIM8;MIER1;MUL1
prerank,magnesium ion transport (GO:0015693),0.3424596789729726,0.716756484676156,0.8043478260869565,0.9488366985893049,1.0,7/12,28.45%,NIPA2;MRS2;CNNM4;MAGT1;MMGT1;NIPAL2;NIPAL1
prerank,ribosomal large subunit biogenesis (GO:0042273),0.26951087688313524,0.7166308256416647,0.8655555555555555,0.9486261517799248,1.0,25/54,36.73%,RRS1;LAS1L;NLE1;NVL;MRTO4;PPAN;EIF6;BOP1;NOC2L;RPL7A;GTF3A;WDR12;PAK1IP1;MAK16;RRP15;NOP53;RPF2;RSL1D1;HEATR3;RPLP0;MALSU1;RPL3;MDN1;LTO1;RPL10A
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.28792415362321483,-0.7153212182870414,0.8070739549839229,0.9756446325803696,1.0,4/10,16.28%,PRKCQ;ZBTB7B;LGALS9;CD55
prerank,positive regulation of cell killing (GO:0031343),0.33838473208071845,0.7150278216306392,0.8038674033149171,0.9500474816929506,1.0,7/13,32.30%,FZD7;MAPK8;DVL2;NOX1;RAC1;CYBA;NOXO1
prerank,neuromuscular process controlling balance (GO:0050885),-0.278718868761444,-0.7140536836049128,0.8220640569395018,0.9756516852980208,1.0,1/12,1.51%,NRXN1
prerank,mitotic sister chromatid cohesion (GO:0007064),0.3164509687815949,0.7131445154090129,0.828060522696011,0.9517622806904775,1.0,7/16,29.53%,NIPBL;HASPIN;POGZ;PDS5A;SMC1A;PDS5B;MAU2
prerank,positive regulation of ATPase activity (GO:0032781),0.2756436373762842,0.7130864536594737,0.8637951105937136,0.9514789385376957,1.0,4/41,11.14%,ATP1B1;TNNT3;PFN2;CHTOP
prerank,spliceosomal snRNP assembly (GO:0000387),0.2761686321256342,0.7121851414378677,0.865979381443299,0.9521287067388231,1.0,14/38,32.17%,SNUPN;LSM2;GEMIN7;SMN1;SRSF10;GEMIN2;SNRPB;WDR77;USP4;DDX20;PRMT5;SNRPF;SART3;TGS1
prerank,intestinal absorption (GO:0050892),0.3387369763384269,0.7119394309401036,0.8328690807799443,0.9520450900520671,1.0,1/13,3.08%,SLC26A6
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),-0.24702448417411926,-0.711580300814993,0.8728813559322034,0.976966628094785,1.0,3/18,12.11%,PIK3R1;BOK;BCL2L11
prerank,positive regulation of immunoglobulin production (GO:0002639),0.28904487258417155,0.7112250280689433,0.8628158844765343,0.9524537329513377,1.0,11/31,30.97%,EPHB2;KMT5C;CLCF1;STX4;IL6;MAD2L2;SHLD3;SHLD1;HMCES;SASH3;PTPRC
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),0.3354625970659755,0.7108962358280181,0.8138888888888889,0.9524743710188168,1.0,5/13,27.69%,TBC1D10A;PERP;CYFIP2;BAD;RIPK2
prerank,positive regulation of lymphocyte migration (GO:2000403),0.3411387318574875,0.7108314144739251,0.8118948824343015,0.9521952965765349,1.0,2/12,8.97%,SPN;RHOA
prerank,linoleic acid metabolic process (GO:0043651),-0.25527355949539177,-0.7105252349370127,0.8518518518518519,0.9766218212992194,1.0,2/17,5.86%,ACSL1;PNPLA8
prerank,regulation of humoral immune response (GO:0002920),0.272015682342815,0.7095682217690036,0.8677309007981756,0.9532117251938362,1.0,7/44,20.76%,CFH;C9;SERPING1;C8B;C8G;CPB2;CLU
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),0.2960270164916923,0.7094587871888913,0.8617683686176837,0.9529890564681381,1.0,2/26,2.76%,ACER3;CYP1B1
prerank,axon development (GO:0061564),0.256536661139423,0.7093665500260046,0.9055201698513801,0.9527385069524702,1.0,21/78,25.42%,MAP1B;EPHB2;DOCK7;EPHB3;RAB8A;GAP43;LLGL1;S100B;FGFR2;PLP1;APBB1;CDK5;SLITRK2;MAPK8IP3;ATL1;DRD2;SHTN1;AFG3L2;ARHGAP35;LMTK2;TAOK2
prerank,apical junction assembly (GO:0043297),0.26548586617977504,0.7093644050376877,0.8791574279379157,0.9523967600010568,1.0,14/53,22.25%,MPP7;RAMP2;DLG1;RHOA;PKN2;PAK2;CLDN11;ARL2;MICALL2;TBCD;WDR1;CLDN15;PDCD6IP;PRKCI
prerank,primary alcohol metabolic process (GO:0034308),0.2921135440110004,0.7089831338872508,0.8299492385786802,0.9524359342107133,1.0,5/25,18.49%,CYP1B1;ALDH3A2;DHRS9;GDPD3;DHRS3
prerank,somite development (GO:0061053),0.3420515381417212,0.7086238341583103,0.8111273792093704,0.952466712516301,1.0,3/11,16.67%,MEOX2;SMO;MTHFD1
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.2930232101156631,0.7083243031256103,0.8401486988847584,0.9524545557829982,1.0,7/25,21.28%,ARAP1;AGR2;CBL;HIP1;CNOT9;AKT1;NUP62
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.3269596308834884,0.7082797126586389,0.8222523744911805,0.9521479453417898,1.0,4/15,20.10%,SAT2;SMOX;SRM;ASMT
prerank,cellular response to arsenic-containing substance (GO:0071243),-0.2533714112021344,-0.7081169337307062,0.8661710037174721,0.9777899474515298,1.0,6/15,20.95%,CPEB2;DDX3X;ZC3H12A;ZFAND1;ATF3;PPIF
prerank,dephosphorylation (GO:0016311),0.24503359523212703,0.7080262184323534,0.9293756397134084,0.9520719546977171,1.0,15/147,9.69%,ALPL;PTPN3;PLPP3;PPP1CC;PLPP5;PTPRS;PTPRF;DUSP11;PTPRU;PPM1H;PLPP1;PPM1M;DAPP1;PTPN18;PPP3CC
prerank,retinol metabolic process (GO:0042572),0.3246663475698832,0.7079001590760735,0.811141304347826,0.9518503481975835,1.0,4/14,24.81%,CYP1B1;DHRS9;DHRS3;RDH10
prerank,regulation of DNA recombination at telomere (GO:0072695),-0.24214429503852813,-0.7077394029719353,0.9201680672268907,0.9752146532181131,1.0,6/19,16.79%,POLR2G;POLR2E;POLR2C;TERF2IP;POLR2D;POLR2A
prerank,negative regulation of DNA recombination at telomere (GO:0048239),-0.24214429503852813,-0.7077394029719353,0.9201680672268907,0.9752146532181131,1.0,6/19,16.79%,POLR2G;POLR2E;POLR2C;TERF2IP;POLR2D;POLR2A
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),0.25848531494372573,0.7072272287547751,0.9017278617710583,0.9522455104195172,1.0,22/75,26.04%,MAP1B;FARP1;DOCK7;DVL1;RAB8A;LLGL1;S100B;FGFR2;TMEM106B;MEF2A;TBCD;APBB1;CDK5;SLITRK2;UNK;ATL1;DRD2;SHTN1;AFG3L2;LMTK2;TAOK2;SDC2
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),-0.2058414620744119,-0.7069349673731139,0.94,0.9746243638040171,1.0,16/40,21.33%,BCL2L1;DNM1L;PDCD5;GHITM;FAM162A;BCL2L11;MFF;GPX1;IGF1;OPA1;GPER1;PYCARD;BIK;PRELID1;PPIF;BNIP3
prerank,ncRNA processing (GO:0034470),0.23914016063551324,0.7055289322727228,0.9527638190954774,0.9536956428166837,1.0,68/200,32.46%,C1D;RRP7A;SSB;INTS3;PRKRA;HNRNPA2B1;LAS1L;EMG1;INTS4;WDR3;AGO1;NVL;DGCR8;ESF1;WDR55;RRP12;AGO2;NOLC1;UTP14A;DCAF13;EXOSC4;MRTO4;NOC4L;BYSL;TUT7;DIS3;ADAT1;BOP1;SARS1;MTREX;NOB1;ZCCHC8;RPL7A;NOP56;FBL;WDR36;WDR12;DDX49;SBDS;RPS9;WDR46;WDR75;RPP21;TBL3;UTP11;SENP3;PUS10;NOP58;INTS9;FCF1;DKC1;POP5;SRRT;NOP53;RPL41;RPL30;PIH1D2;INTS7;INTS6;EXOSC2;NOP14;UTP3;EXOSC3;RRP1B;RPL36A;RPL37A;RPL27;UTP4
prerank,neuron projection extension (GO:1990138),0.2836963921430219,0.7054182224224823,0.8588098016336057,0.9534693335317925,1.0,9/32,20.19%,MAP1B;ULK2;CYFIP1;IMPACT;NRP1;IQGAP1;CDK5;EIF2AK4;TNN
prerank,response to axon injury (GO:0048678),0.31249466459220726,0.7047238983812474,0.8348623853211009,0.95387653613915,1.0,3/18,12.09%,DPYSL3;GAP43;SOD1
prerank,glutamate metabolic process (GO:0006536),0.3063421548209324,0.7044411875048786,0.8169934640522876,0.9538323558744697,1.0,1/19,1.59%,GCLC
prerank,lipid droplet formation (GO:0140042),-0.29255001279831205,-0.7038724970522442,0.8162544169611308,0.9764347668635258,1.0,2/10,13.26%,CDS2;BSCL2
prerank,regulation of lamellipodium organization (GO:1902743),-0.2635610246107484,-0.7037173766434734,0.8444444444444444,0.9751004415927832,1.0,14/14,73.67%,CDC42;CAPZB;CD44;CARMIL2;VIL1;PDPN;EPHA2;FER;DMTN;TWF2;CARMIL1;RAC1;WAS;TWF1
prerank,glycolytic process (GO:0006096),-0.21623431353698586,-0.7034853037093242,0.8932584269662921,0.973867094715649,1.0,5/28,10.94%,HK2;PGAM4;PGAM1;GPI;ALDOC
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.2848727058845354,0.7031811890974516,0.8640192539109507,0.9548270718203596,1.0,5/28,11.98%,MAP3K5;ATF4;ERN2;AIFM1;TNFRSF10B
prerank,indolalkylamine catabolic process (GO:0046218),0.34558823347843703,0.7024989844116185,0.7997097242380261,0.9551938430102462,1.0,2/10,20.11%,IDO2;KYAT1
prerank,protein ADP-ribosylation (GO:0006471),0.2915344062746641,0.7023937702699531,0.8640192539109507,0.9549532743628888,1.0,6/28,15.94%,PARP3;SIRT5;ARF4;TNKS2;SIRT2;PARP1
prerank,pyrimidine nucleobase metabolic process (GO:0006206),0.33365903985616097,0.7023578868849448,0.810320781032078,0.9546426356862524,1.0,1/12,2.56%,DPYSL3
prerank,regulation of nuclear division (GO:0051783),0.3026742320923437,0.7018990638537156,0.8346153846153846,0.954778148743958,1.0,8/20,29.12%,RCC1;DAPK3;KIF20B;CUL9;CDK13;CUL7;CCDC8;PRMT5
prerank,"wound healing, spreading of cells (GO:0044319)",0.29406053881285227,0.7015351594107269,0.8417085427135679,0.9548108060943711,1.0,4/24,17.02%,TMEFF2;RHOA;DDR1;CD151
prerank,telomere maintenance in response to DNA damage (GO:0043247),-0.2960073736269281,-0.7009515652512277,0.827922077922078,0.9750607135487096,1.0,3/10,13.02%,RIF1;DCLRE1C;TERF2IP
prerank,replicative senescence (GO:0090399),0.3358675328958147,0.7007863921627031,0.8186968838526912,0.9552539594696544,1.0,3/12,11.37%,TERT;ATM;CHEK2
prerank,regulation of interleukin-10 production (GO:0032653),-0.189375690658814,-0.6994311832819844,0.9423076923076923,0.9751498024256083,1.0,13/44,20.55%,TNFRSF21;CD274;SYK;CD34;LGALS9;PRKCZ;TYROBP;NOD2;CD47;PYCARD;DLL1;AGER;ISG15
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.3228089808078556,0.6994094531941326,0.8319783197831978,0.9563931574678912,1.0,6/15,32.79%,GNPDA1;RENBP;CHST5;OGA;NAGK;CHST7
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),0.2367747926605284,0.6993943125855059,0.9645390070921985,0.9560641268753889,1.0,36/168,23.76%,RPSA;DDX5;SAMD4A;PABPC1;CASC3;TENT4B;THRAP3;SMG6;PNRC2;GSPT1;SMG1;AGO1;DIS3L2;ATM;PATL1;EIF4G1;ETF1;XRN1;EXOSC4;MRTO4;CNOT8;RC3H2;TUT7;CNOT10;RPS27A;NCBP1;NCBP2;CNOT9;TNKS1BP1;RPL7A;PYM1;TENT2;UPF1;DCP1A;UPF3A;RPS9
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.30688205086751297,0.6993373890152035,0.848404255319149,0.9557873613226749,1.0,8/18,30.77%,NOL3;NFE2L2;AKT1;VNN1;PINK1;HTRA2;NME5;PRKN
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.24759719168158653,0.6990666436855386,0.9278897136797455,0.955718828823621,1.0,24/94,21.26%,PSMD7;PSMA8;IRAK3;RPS6KA4;PSMA4;CHUK;TAB2;IRAK1;PSMD12;CUL1;PSMA6;SQSTM1;MAP3K3;PSMD11;PSMC5;PSMD1;PSMD14;PSMC4;RPS27A;UBC;NFKBIA;PSMA3;PSMD4;PSMB1
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.29715518317181244,0.6979143779983437,0.8553459119496856,0.9565720752642195,1.0,5/20,23.47%,HSPD1;LONP1;PTGES3L;CLU;PSMG2
prerank,positive regulation of mitochondrion organization (GO:0010822),-0.18710077724546784,-0.6970792880908913,0.9693877551020408,0.9762076978508123,1.0,9/57,12.29%,KDR;DNM1L;HIP1R;PDCD5;PPARGC1A;BOK;FAM162A;BCL2L11;MFF
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.30339279312234596,0.6956654488395317,0.8344370860927153,0.9585886313312668,1.0,5/20,17.88%,IPO5;HEXIM1;LATS2;CDKN1C;MEN1
prerank,positive regulation of peptidase activity (GO:0010952),0.30360826830922216,0.695574364501212,0.8403693931398417,0.9583405768179295,1.0,5/20,25.17%,VCP;MAPK12;TANK;RCN3;PINK1
prerank,regulation of keratinocyte differentiation (GO:0045616),0.28939523933544087,0.6955415737177802,0.8557089084065245,0.9580274243443954,1.0,6/24,21.51%,SRSF6;RUNX1;VDR;CYP27B1;CBFB;CTSK
prerank,neuron apoptotic process (GO:0051402),0.30557326038233823,0.6954431525856122,0.861003861003861,0.9577837170783867,1.0,6/19,22.24%,CIT;ATN1;LIG4;BID;CDK5;DIABLO
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.2815601457282191,0.6953367506459545,0.8494492044063647,0.9575520784031193,1.0,5/27,15.41%,NFAT5;RHOA;IRAK1;HSPD1;IL6
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),-0.25358079832292535,-0.6951254888502986,0.8623481781376519,0.9767441778391361,1.0,11/15,40.79%,SYK;CD55;CCR2;SHH;IL12A;IL23A;PNP;EBI3;IHH;IL12B;IL23R
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.28550384876924256,0.6939839039308734,0.8754578754578755,0.9586189714945413,1.0,6/26,21.19%,IRAK3;LRRC14;APPL2;APPL1;BIRC3;GPS2
prerank,sarcomere organization (GO:0045214),0.28976073674103,0.6935031456687142,0.8578431372549019,0.9587649716406955,1.0,5/27,20.47%,SIX4;TNNT3;CSRP3;WDR1;CSRP2
prerank,nuclear membrane disassembly (GO:0051081),0.3204041623855067,0.693127533168795,0.8310055865921788,0.9587881076078757,1.0,4/14,24.70%,PRKCA;CNEP1R1;DCTN1;NEK6
prerank,regulation of secretion (GO:0051046),-0.26137248520759676,-0.6922682042494468,0.8735632183908046,0.9780238498204648,1.0,7/13,30.75%,MYO6;OAS2;ERBB3;KCNQ1;NRG1;OPRK1;GPLD1
prerank,positive regulation of establishment of protein localization (GO:1904951),0.3063911479496085,0.692132883649553,0.8628495339547271,0.9594694241060351,1.0,8/18,28.32%,CHP1;CCT6A;CCT4;CCT8;TCP1;PTP4A3;DKC1;CCT5
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.26147278548559233,-0.6914323705813495,0.8892857142857142,0.9773520174539565,1.0,13/13,73.88%,NECTIN2;FADD;IL12A;IL12RB1;IL23A;IL12B;IL23R;XCL1;PVR;SLC22A13;MR1;STX7;CYRIB
prerank,neuron maturation (GO:0042551),0.3067571960809183,0.6913954590043916,0.8517555266579974,0.9598880011639682,1.0,4/18,13.76%,LGI4;B4GALT5;PICK1;FARP2
prerank,positive regulation of T cell proliferation (GO:0042102),-0.17819830752240912,-0.6912876596962987,0.978021978021978,0.9760111729379632,1.0,6/55,10.68%,IGFBP2;TFRC;VCAM1;SLC7A1;CD274;SYK
prerank,regulation of systemic arterial blood pressure (GO:0003073),-0.2450343967752423,-0.6912793328974474,0.8658536585365854,0.9745467601441872,1.0,3/16,9.22%,KLK2;ACE;BMPR2
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.32199737720719895,0.6909802809139316,0.8434547908232118,0.9599617722475757,1.0,1/14,1.82%,YBX3
prerank,regulation of ERAD pathway (GO:1904292),0.33174869657437417,0.6897145549089819,0.8345120226308345,0.9608856575160291,1.0,7/11,37.77%,USP13;USP19;HERPUD1;RNFT1;TMEM259;USP25;RNF185
prerank,positive regulation of vasoconstriction (GO:0045907),0.32494300526249636,0.6892085282333968,0.8732394366197183,0.9610578377578508,1.0,2/13,13.33%,TRPM4;F2R
prerank,positive regulation of interleukin-10 production (GO:0032733),0.28008295523477755,0.6891582901667688,0.8568047337278106,0.9607697330472542,1.0,4/30,15.41%,STAT3;HMGB1;HSPD1;IL6
prerank,protein localization to condensed chromosome (GO:1903083),0.3301604738000109,0.6890433542305981,0.8583690987124464,0.960546830949236,1.0,3/12,16.87%,MIS12;ZW10;IK
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.2572284572165369,0.6889827705560884,0.915273132664437,0.9602583989778629,1.0,16/59,29.26%,ABCD3;ACSF3;OSBPL7;CBR4;OSBP;ACACA;SRR;HSD17B8;SLC27A2;HSD3B7;MCAT;ACOT8;HOGA1;PER2;ACLY;SCP2
prerank,negative regulation of dephosphorylation (GO:0035305),0.3030055025857702,0.6876293383350571,0.8375634517766497,0.9612860153682619,1.0,7/18,20.46%,PPP1R8;ZCCHC9;URI1;CHP1;ARPP19;PPP1R35;PPP1R36
prerank,innate immune response (GO:0045087),0.23396515586099054,0.6866590092564474,0.9728915662650602,0.9619208299899689,1.0,40/217,23.72%,LBP;COLEC11;TNK1;RNASE7;TRIM28;MAVS;HMGB1;IFNLR1;CXCL16;RNASE3;TRIM27;S100B;FCER1G;RNASE6;ALPK1;CHUK;IRAK1;MID2;DEFB1;SRMS;TRIM26;FRK;SRPK1;COLEC12;CYP27B1;OTULIN;TRIM13;SHMT2;TRIM6;DMBT1;CAPZA1;SHFL;IL4;TRIM8;TRIM43;CD300LB;SETD2;SLC11A1;VNN1;CYLD
prerank,glycoprotein catabolic process (GO:0006516),0.30292146376698353,0.685899008926975,0.8430079155672823,0.9623414778657101,1.0,7/17,29.17%,EDEM2;NGLY1;FBXO17;ADAMTS9;OGA;MANBA;STT3B
prerank,ribosomal large subunit assembly (GO:0000027),0.29015034397746664,0.6855762050359946,0.8597402597402597,0.9623134068166592,1.0,4/24,17.60%,RRS1;NLE1;PPAN;BOP1
prerank,serine family amino acid biosynthetic process (GO:0009070),0.32333894667453045,0.6855521565007464,0.8442280945757997,0.9619940431079427,1.0,5/12,20.54%,SRR;PHGDH;MTHFD1;PSAT1;SEPHS2
prerank,rRNA processing (GO:0006364),0.23433503504102665,0.6854048846923607,0.958502024291498,0.9617977675335925,1.0,62/172,32.71%,C1D;PRKDC;RRP7A;LAS1L;EMG1;SRFBP1;WDR3;RIOK1;NVL;ESF1;WDR55;RRP12;NOLC1;UTP14A;DCAF13;EXOSC4;MRTO4;NOC4L;BYSL;EIF6;DIS3;BOP1;MTREX;NOB1;RPL7A;TSR3;NOP56;FBL;WDR36;WDR12;DDX49;SBDS;RPS9;WDR46;WDR75;TBL3;RIOK2;UTP11;MAK16;SENP3;NOP58;RRP15;FCF1;DKC1;POP5;NOP53;RPL41;RPL30;ERI1;PIH1D2;EXOSC2;NOP14;UTP3;THUMPD1;EXOSC3;RIOK3;RRP1B;RPL36A;RPL37A;RPL27;UTP4;RSL1D1
prerank,regulation of interferon-beta production (GO:0032648),0.2629548679219853,0.6852880945649618,0.9060710194730813,0.9615665426350936,1.0,19/46,35.48%,PTPRS;MAVS;TRAF3;TOMM70;IRF3;RNF216;TBK1;PTPN11;YY1;PPM1B;RIPK2;RNF135;HSP90AA1;LILRB1;RIOK3;POLR3F;IFIH1;DHX9;IRF1
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),-0.22817550767307831,-0.6851345072098507,0.9049773755656109,0.9790002467754708,1.0,6/22,20.80%,ROCK2;PPP4R4;STYXL1;PTPA;PPP1R11;PPP1R15A
prerank,negative regulation of cell cycle (GO:0045786),0.24769710430152936,0.6836799541756649,0.9237472766884531,0.9628241274949649,1.0,14/73,18.46%,PDCD4;PTPN3;GAS1;IPO5;BMP4;TAF6;INHBA;HEXIM1;RHOB;CAMK2N1;LATS2;CDKN1C;MEN1;HECA
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.2835254441213372,0.6813189027706205,0.8591022443890274,0.9647942746224674,1.0,4/25,13.33%,DRD1;ANK2;PDPK1;F2R
prerank,negative regulation of viral genome replication (GO:0045071),0.2649471789550664,0.6812402463406075,0.8982456140350877,0.9645243114748473,1.0,10/40,22.29%,MAVS;ILF3;RESF1;SETDB1;SRPK1;N4BP1;TRIM6;MPHOSPH8;SHFL;TASOR
prerank,diol biosynthetic process (GO:0034312),0.310873807018966,0.6801638532597424,0.8392857142857143,0.9652306499307161,1.0,1/15,1.78%,ACER3
prerank,histone monoubiquitination (GO:0010390),-0.2115885016542972,-0.6797498260764775,0.9386792452830188,0.9826480766974949,1.0,6/24,15.98%,BCOR;SKP1;RNF40;UBE2E1;LEO1;CTR9
prerank,vesicle transport along microtubule (GO:0047496),0.2907561802194116,0.6794078087528433,0.8617683686176837,0.9656255267519519,1.0,5/23,21.53%,KIF13A;DYNC1H1;NDEL1;CLN3;RAB1A
prerank,snRNA 3'-end processing (GO:0034472),0.30348464547716336,0.6791912380455728,0.8716931216931217,0.9654888262871615,1.0,7/19,31.72%,INTS14;EXOSC4;TOE1;INTS7;INTS6;EXOSC2;EXOSC3
prerank,regulation of lipid catabolic process (GO:0050994),-0.2297266399564598,-0.6790594756815582,0.9094488188976378,0.9818367030472346,1.0,6/19,23.47%,ADRA2A;PRKAA1;BSCL2;TYSND1;ALK;APOC1
prerank,lipid homeostasis (GO:0055088),0.25235122767455254,0.6788438460231414,0.9243604004449388,0.9655115193165459,1.0,17/57,26.62%,ACOXL;TLCD2;ACOX3;ABCA1;NR1D2;PNPLA3;THADA;TLCD1;ORMDL3;MLXIPL;RCN3;ORMDL1;ABCD1;TM6SF2;FITM2;POLD1;ANGPTL3
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.2949251812329937,0.6788063374146325,0.8627450980392157,0.9651978666115271,1.0,2/19,3.67%,CUX1;FBXW8
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.2851974086877347,0.6786404458599781,0.9044665012406948,0.9650132825851321,1.0,5/25,21.03%,TWIST1;NSD1;HEY1;TRIM6;MAD2L2
prerank,calcium-ion regulated exocytosis (GO:0017156),0.281821315746386,0.6781392790750066,0.8836633663366337,0.9651570704638038,1.0,2/27,4.17%,SYT8;ARHGAP17
prerank,hematopoietic stem cell differentiation (GO:0060218),0.33240723969272545,0.6779464142378078,0.8497109826589595,0.9650025918458113,1.0,4/10,24.86%,HOXB4;MLLT3;UFL1;TP53
prerank,determination of left/right symmetry (GO:0007368),0.26616918665455536,0.6778508004428337,0.8837209302325582,0.9647551696802347,1.0,12/36,31.14%,ODAD2;CCDC39;DNAAF4;SMO;NPHP3;CITED2;LEFTY1;BBS7;PKD1L1;ENKUR;STIL;MEGF8
prerank,mitochondrial fission (GO:0000266),-0.24575475376408484,-0.6776434267612731,0.9087837837837838,0.9816016493507668,1.0,5/16,16.99%,DNM3;DNM1L;MFF;OPA1;MTFR2
prerank,macrophage migration (GO:1905517),-0.2614100069056438,-0.6774621862361823,0.8470588235294118,0.9802891228200162,1.0,13/13,73.89%,EDNRB;TAFA4;CCR2;CCL5;CCL3;EDN2;SAA1;CXCL17;LGALS3;P2RX4;P2RY12;CKLF;CCL2
prerank,negative regulation of neuron differentiation (GO:0045665),0.29186291374619566,0.6772099732057246,0.8673469387755102,0.9650410996751229,1.0,6/22,20.20%,HES5;SOX9;HEY1;NEPRO;EIF2AK4;CALR
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.3131507202257688,0.6763233665676319,0.8588709677419355,0.9655427275943609,1.0,2/13,12.77%,PABPC1;AGO2
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),-0.26511131704479207,-0.6762832291989821,0.8531468531468531,0.9798026339763161,1.0,4/12,13.52%,PIK3R1;BOK;BCL2L11;PTPN1
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.2860789427914262,0.676133768807792,0.8754623921085081,0.9653804965502266,1.0,8/24,27.81%,ITCH;TAB2;IRAK1;RPS27A;UBC;CYLD;RIPK2;UBE2V1
prerank,mismatch repair (GO:0006298),0.27623726924558234,0.676125988955676,0.8878048780487805,0.9650446434880752,1.0,9/27,33.35%,ABL1;TDG;PMS2;MSH4;SETD2;POLD1;MSH2;ERCC1;RPA3
prerank,protein-containing complex subunit organization (GO:0043933),0.24087679971085801,0.6758065275273278,0.9520833333333333,0.964989829253046,1.0,35/109,27.24%,HES5;CD3E;GPAA1;SPG7;SEH1L;LLGL1;DLG4;MDM4;SOX9;ST13;WIPF1;SNX9;SHANK1;ZW10;CREBBP;KPNA3;EPRS1;TEAD2;CAPZA1;DARS1;NDC1;KMT2A;REPS2;NUP35;AFG3L2;PEX14;NIFK;DET1;TP53;PPID;VAMP2;TPR;WAS;PPP2R1A;PARD3
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.2953295719031614,0.6753505663563361,0.868,0.9650997738093244,1.0,3/18,16.80%,MCMDC2;GINS4;MCM4
prerank,UV-damage excision repair (GO:0070914),-0.2642812303829253,-0.6749485129744124,0.8840579710144928,0.9795491295121653,1.0,12/12,73.60%,ACTR5;SIRT1;INO80;MC1R;DDB2;POLA1;XPC;POLD3;CUL4B;ERCC1;DDB1;XPA
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.3203280234664882,0.6746650562882505,0.8581460674157303,0.9654187561384845,1.0,2/12,12.10%,PRKCA;CNEP1R1
prerank,response to exogenous dsRNA (GO:0043330),0.302260422108907,0.6746269127178957,0.866754617414248,0.9651135861471086,1.0,6/18,25.92%,MAVS;IRAK3;COLEC12;MUL1;SLC3A2;CGAS
prerank,fatty acid transmembrane transport (GO:1902001),0.2966578834466959,0.673551510215982,0.8690012970168612,0.9658147324964702,1.0,1/19,0.95%,ABCD3
prerank,T cell activation involved in immune response (GO:0002286),0.32349295786080545,0.6726210240641505,0.84375,0.9663619077881547,1.0,4/12,23.03%,FCER1G;EIF2AK4;TNFSF18;SLC11A1
prerank,regulation of defense response to virus by host (GO:0050691),0.27205424298134406,0.6725972507691133,0.9062119366626066,0.9660411020815238,1.0,10/30,25.92%,MAVS;IFNLR1;TOMM70;TRAF3IP2;TRIM6;EIF2AK4;IL4;MUL1;RNF216;CGAS
prerank,negative regulation of phosphate metabolic process (GO:0045936),-0.22782519832529843,-0.6723088718140008,0.9386792452830188,0.9804988282223984,1.0,7/22,19.77%,BMP7;DYNLL1;PLEK;SIRT1;ANKLE2;CDKN2C;CDKN2D
prerank,response to gamma radiation (GO:0010332),0.2826150095893073,0.671623405853492,0.8638036809815951,0.9665927781410195,1.0,11/24,29.63%,WRN;ATM;LIG4;TLK2;TRIM13;MEN1;XRCC6;TP53;ATR;HSF1;YAP1
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.2308670819625428,0.669927500997855,0.9685279187817258,0.9677846233934727,1.0,16/152,14.45%,GNAS;FSHR;DRD1;ADGRL2;ADCY2;RAMP2;ADCY8;IAPP;ADCY9;VIP;RAMP1;ABCA1;GLP1R;MC4R;GPR12;GNAO1
prerank,cholesterol metabolic process (GO:0008203),0.24427871792293354,0.669812167389326,0.9442622950819672,0.9675420551938317,1.0,24/68,33.95%,CEL;SOAT1;RXRA;TSKU;NSDHL;ABCA1;LSS;EBP;IL4;STARD3;APOF;HMGCR;ANGPTL3;OSBPL5;SOAT2;ACAT2;ACLY;SQLE;INSIG1;OSBPL1A;GGPS1;GBA2;PLPP6;TM7SF2
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.3222019961082168,0.6697268259106658,0.8567375886524823,0.9672695156985502,1.0,11/11,67.80%,PKD2L1;RTP4;LPO;RTP2;PKD1L3;TAS1R3;PIGR;GNAT2;GNAT3;TAS1R2;RTP3
prerank,intracellular lipid transport (GO:0032365),0.2867801059928854,0.6695572027362462,0.8737113402061856,0.9670737424345441,1.0,1/21,0.95%,ABCD3
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.280033435042692,0.6694796246563038,0.8846153846153846,0.9667990817797576,1.0,5/25,20.52%,LRPAP1;DLG4;ITGAV;WDR54;ATXN2
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.27228771536211405,0.6694769649076902,0.8955582232893158,0.9664583707397326,1.0,13/31,27.35%,PPP3CC;MAPK8;YWHAE;TFDP1;YWHAQ;E2F1;BID;SFN;BAD;TP53;YWHAB;NMT1;BBC3
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.3209620948942935,0.6694735834385113,0.8733997155049786,0.9661175471263632,1.0,1/11,2.19%,MUC1
prerank,positive regulation of histone methylation (GO:0031062),0.2779292049688744,0.669457185864712,0.8834355828220859,0.9657879390988406,1.0,5/24,12.63%,PHF1;SMAD4;OGT;CHTOP;WDR5
prerank,interleukin-6-mediated signaling pathway (GO:0070102),0.29576860113583775,0.6684159418206389,0.8748335552596538,0.9663981049319407,1.0,3/18,8.14%,STAT3;SMAD4;CBL
prerank,positive regulation of mitochondrial fission (GO:0090141),0.2925876292048488,0.6678687425200188,0.873202614379085,0.9665295679253492,1.0,8/18,30.77%,MIEF2;MCU;MUL1;PINK1;RALA;FIS1;MIEF1;PRKN
prerank,regulation of gastrulation (GO:0010470),0.3157555036031272,0.6668756269388939,0.8739495798319328,0.9671107492348079,1.0,2/14,6.42%,PHLDB1;POGLUT1
prerank,regulation of response to oxidative stress (GO:1902882),-0.2719609480406503,-0.6667920094246806,0.8858131487889274,0.9838185133967362,1.0,1/11,1.65%,MCTP1
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.33159673177895044,0.6666685419560127,0.8438395415472779,0.9669640158809263,1.0,2/10,12.61%,XDH;PIK3CB
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.2791385478454837,0.6665754477328504,0.8986402966625463,0.9666990056679206,1.0,2/25,5.53%,MPP2;RAB3GAP1
prerank,negative regulation of biosynthetic process (GO:0009890),0.29852354731223607,0.665395592355875,0.8818897637795275,0.9674243431043769,1.0,2/16,6.89%,EMILIN1;COA8
prerank,cellular response to ATP (GO:0071318),-0.24215218483174286,-0.6649352337132136,0.8772563176895307,0.9839418173744714,1.0,14/14,75.81%,CIB2;P2RY1;P2RX7;P2RX3;P2RY2;PDXP;TRPV1;RYR3;P2RY4;HSP90B1;P2RX4;P2RY12;SSH1;TAF1
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.2855982367502327,0.6648021394131263,0.8878748370273793,0.9676187735471131,1.0,1/21,1.14%,FGF13
prerank,regulation of adaptive immune response (GO:0002819),0.29221049343200484,0.6641887658476655,0.8904458598726115,0.9678360116172819,1.0,4/18,20.14%,TRIM27;RIPK3;ADCY7;EIF2AK4
prerank,negative regulation of T cell activation (GO:0050868),0.2609947057773542,0.6638670728262563,0.9079102715466352,0.9677824404521702,1.0,4/35,13.14%,SPN;GLMN;CD80;VTCN1
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.23996286852912507,-0.663735684379377,0.9213483146067416,0.9834221286341975,1.0,5/14,20.71%,SYK;LGALS9;CD55;PTPN22;CCR2
prerank,ERK1 and ERK2 cascade (GO:0070371),-0.22218303200634187,-0.6631594828189701,0.9383259911894273,0.9824369075820661,1.0,6/21,18.22%,KDR;LGALS9;IGF1;HTR2B;MT3;MAPK3
prerank,regulation of dopamine secretion (GO:0014059),0.27653581032277974,0.6623482830448693,0.8925925925925926,0.9688153809099072,1.0,2/25,7.06%,SYT8;CHRNB2
prerank,protein acylation (GO:0043543),0.2590059143760595,0.6615686334689671,0.9040462427745665,0.9691857118024747,1.0,10/38,23.75%,ING5;ZDHHC16;KAT2A;HHAT;ING4;CREBBP;ZDHHC13;ZDHHC20;ZDHHC9;KAT2B
prerank,morphogenesis of a polarized epithelium (GO:0001738),-0.2534100331934347,-0.6608343529149867,0.8781362007168458,0.9827956494682992,1.0,4/12,23.67%,LAMA5;VANGL2;ACTB;ZDHHC7
prerank,regulation of stem cell proliferation (GO:0072091),-0.22828380538123044,-0.6606534381596771,0.9251968503937008,0.9814914152205142,1.0,4/17,18.79%,FBLN1;ACE;SOX11;KDM1A
prerank,phasic smooth muscle contraction (GO:0014821),0.32140870502443125,0.660114931588244,0.8462643678160919,0.9701240150351685,1.0,3/10,21.82%,EDN3;GDNF;DRD2
prerank,microtubule depolymerization (GO:0007019),0.29416483646421276,0.6600558393572467,0.8733681462140992,0.9698360858195227,1.0,4/17,21.10%,STMND1;CKAP5;KIF24;STMN2
prerank,arachidonic acid secretion (GO:0050482),0.3254525898244492,0.659591700543708,0.85383502170767,0.9695562730107714,1.0,2/10,9.20%,PLA2G5;ANXA1
prerank,arachidonate transport (GO:1903963),0.3254525898244492,0.659591700543708,0.85383502170767,0.9695562730107714,1.0,2/10,9.20%,PLA2G5;ANXA1
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),0.3253688885145537,0.6589961467425525,0.8526912181303116,0.9697384234887706,1.0,2/10,16.97%,KCNE5;SUMO1
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),-0.26203930932958863,-0.6582583550128883,0.882943143812709,0.9819114054490262,1.0,5/11,24.51%,AKAP6;LRRC38;NOS1AP;LRRC55;TREM2
prerank,receptor recycling (GO:0001881),0.3265027545707056,0.6579498491793522,0.8807069219440353,0.9702909768313956,1.0,4/10,25.05%,RAB11B;PHETA2;ARFGEF2;LMTK2
prerank,meiosis I (GO:0007127),0.2820898636722144,0.6566463449101511,0.911504424778761,0.971086205529443,1.0,3/23,18.67%,FOXJ3;HSF2BP;BRDT
prerank,response to interferon-gamma (GO:0034341),0.24008145772801723,0.6561275872894988,0.9341252699784017,0.9712050343361046,1.0,11/67,18.22%,SLC26A6;CCL13;CCL15;CXCL16;GBP6;CASP1;CYP27B1;EPRS1;SYNCRIP;DAPK3;ACOD1
prerank,negative regulation of histone acetylation (GO:0035067),-0.2564483077950302,-0.6559507182922723,0.8975155279503105,0.9821743936372653,1.0,6/11,27.76%,SIRT1;SNCA;BRCA1;TAF7;SIN3A;SET
prerank,cellular response to interferon-beta (GO:0035458),-0.2515649925742994,-0.6552067103556337,0.9139784946236559,0.9812886349769914,1.0,3/14,13.20%,STAT1;AIM2;NDUFA13
prerank,mitochondrial transport (GO:0006839),0.2452366055445185,0.6546792615183066,0.9340159271899886,0.9721280344516688,1.0,16/53,28.26%,FLVCR1;SPG7;TOMM40;TIMM9;BCAP31;TOMM70;TMEM14C;BCS1L;COX18;STARD3;ABCB10;BAD;TIMM22;TIMM17B;SLC25A5;FIS1
prerank,cellular response to dsRNA (GO:0071359),0.29968108389962944,0.6542572685892148,0.8787465940054496,0.9721547013645204,1.0,7/15,34.83%,MAVS;COLEC12;MUL1;CGAS;RIOK3;IFIH1;DHX9
prerank,regulation of histone acetylation (GO:0035065),0.26151602123875695,0.6538260865111176,0.9097472924187726,0.972161327543031,1.0,9/33,22.78%,TADA2A;RPS6KA4;SETD5;ARRB1;FLCN;THAP7;NOC2L;KMT2A;CAMK1
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.266132168773802,0.6535516536754343,0.9033457249070632,0.972047859401611,1.0,8/30,23.29%,UGGT2;FUT8;UGGT1;STT3A;LMAN1;DPM3;MGAT5;MAGT1
prerank,synaptic vesicle cycle (GO:0099504),-0.20175745650559015,-0.653448815163068,0.9757575757575757,0.9811805187789095,1.0,10/30,21.51%,RIMS1;PIP5K1C;SYNDIG1;SYT10;SNCA;SNAP25;SLC32A1;SYT7;SLC18A2;CPLX2
prerank,protein lipidation (GO:0006497),0.24597402607487368,0.6533681210942441,0.9478357380688124,0.9718681289782622,1.0,14/59,27.07%,PIGW;WIPI2;PIGF;ZDHHC16;PIGL;HHAT;PGAP2;ZDHHC13;ZDHHC20;DPM3;ZDHHC9;PIGV;PIGQ;PIGB
prerank,positive regulation of lipid storage (GO:0010884),0.28405675482183845,0.6533339627770215,0.8881748071979434,0.9715502730950561,1.0,4/21,18.25%,EHD1;CIDEA;PLIN3;IKBKE
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.27044638337838955,0.6529720355800371,0.8995098039215687,0.9715174652446897,1.0,12/26,29.40%,AKAP9;ARL2;SLAIN2;DCTN1;STMN2;CDK5RAP2;KATNB1;MET;DRG1;FES;TOGARAM1;RAC1
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),-0.21397594207532822,-0.6527125349349185,0.9434782608695652,0.9802988268718398,1.0,9/21,25.47%,BCL2L1;BOK;BCL2L11;OPA1;HSPA1A;XBP1;CREB3;TXNDC12;PMAIP1
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.2695501417200832,0.6523127571492704,0.9196102314250914,0.9717585352340666,1.0,12/28,33.38%,ITCH;TAB2;IRAK1;OTULIN;RPS27A;UBC;CYLD;RIPK2;UBE2V1;IRGM;UBE2N;RELA
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.25398827896576953,0.6522576318433773,0.9218009478672986,0.9714690942561897,1.0,8/42,18.34%,VCP;FAAP20;WRN;UBE2L6;RPS27A;UBC;REV1;USP10
prerank,positive regulation of phagocytosis (GO:0050766),0.24415898772803202,0.6519290967498121,0.9324324324324325,0.9714030613659501,1.0,7/47,20.20%,GAS6;PLA2G5;FCER1G;LMAN2;APPL2;TUB;CALR
prerank,negative regulation of establishment of protein localization (GO:1904950),0.3226694519840863,0.6503543925047525,0.8781204111600588,0.9723861559522669,1.0,4/10,26.70%,WWP2;DNAJA1;SNX3;NDFIP1
prerank,negative regulation of interleukin-2 production (GO:0032703),0.2754462285436057,0.6500136496365939,0.8941176470588236,0.9723433082823478,1.0,3/18,12.87%,TBX21;TRIM27;EZR
prerank,histone H2A monoubiquitination (GO:0035518),0.2908817300901321,0.6499749188823201,0.8949468085106383,0.9720393667258079,1.0,4/17,18.07%,RNF2;RING1;PCGF2;RYBP
prerank,organic hydroxy compound biosynthetic process (GO:1901617),-0.17939919381433497,-0.6486416686298578,0.9924242424242424,0.981931185560901,1.0,7/44,14.57%,CYP7B1;PRKAG2;CYP27A1;INSIG2;OSBPL9;ALOX12;MSMO1
prerank,regulation of cellular amide metabolic process (GO:0034248),0.2576323358740316,0.6485788829128587,0.9085439229843562,0.9728518492393318,1.0,15/32,34.24%,PRKCD;CYFIP1;NOLC1;FOXO3;ATXN2;EIF2A;ROCK1;RBM3;EIF4E;PUM3;METAP1;TMED10;PCIF1;SAMD8;TCOF1
prerank,amide biosynthetic process (GO:0043604),0.24699228245750893,0.6485345183145818,0.9249422632794457,0.9725451441709839,1.0,4/47,8.64%,PCSK5;SMPD4;DMD;NANP
prerank,sensory perception of pain (GO:0019233),0.28005688323840694,0.6478794978619895,0.9012658227848102,0.9727593042518116,1.0,3/21,14.30%,PROK2;CHRNB2;PTGES
prerank,positive regulation of translational initiation (GO:0045948),0.2875614183231737,0.6459827739914763,0.8860927152317881,0.9739702086975277,1.0,6/18,28.88%,CDC123;KHDRBS1;UHMK1;RPS6KB1;YTHDF1;LARP1
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),-0.2564667118557533,-0.6455816433360089,0.9227799227799228,0.9827827153636268,1.0,3/11,11.38%,NR1H3;MFSD2A;SCARB1
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),0.317373315844862,0.6452397519918299,0.8969359331476323,0.9742322898807395,1.0,3/11,25.18%,TIMM9;TOMM70;TIMM22
prerank,peptidyl-asparagine modification (GO:0018196),0.26056931597688165,0.6427799603686521,0.9248768472906403,0.9759011590146234,1.0,8/31,23.29%,UGGT2;FUT8;UGGT1;STT3A;LMAN1;DPM3;MGAT5;MAGT1
prerank,zymogen activation (GO:0031638),0.24919544925952083,0.642688788802202,0.9451728247914184,0.9756288417002285,1.0,5/39,17.58%,PRSS12;MMP14;TBC1D10A;PGK1;PERP
prerank,negative regulation of amyloid fibril formation (GO:1905907),0.30392114212621224,0.6423009205084999,0.8866571018651362,0.9756111747796633,1.0,5/12,22.64%,IAPP;VBP1;CLU;PFDN4;LDLR
prerank,B cell differentiation (GO:0030183),0.24511574992283625,0.6421642735868663,0.9291338582677166,0.9753796250625842,1.0,9/46,21.35%,HDAC9;HDAC4;SYVN1;PTPN2;CLCF1;TCF3;GPS2;TPD52;IL4
prerank,rRNA metabolic process (GO:0016072),0.22046305843916952,0.64196130239048,0.9806517311608961,0.9752071859112829,1.0,54/160,32.46%,C1D;ERN2;RRP7A;LAS1L;EMG1;WDR3;NVL;ESF1;WDR55;RRP12;NOLC1;UTP14A;DCAF13;XRN1;EXOSC4;MRTO4;NOC4L;BYSL;DIS3;BOP1;MTREX;NOB1;RPL7A;NOP56;FBL;WDR36;WDR12;DDX49;SBDS;NIFK;RPS9;WDR46;WDR75;TBL3;UTP11;SENP3;NOP58;FCF1;DKC1;POP5;NOP53;RPL41;RPL30;DEDD2;PIH1D2;EXOSC2;NOP14;UTP3;EXOSC3;RRP1B;RPL36A;RPL37A;RPL27;UTP4
prerank,Rac protein signal transduction (GO:0016601),0.2868226773787911,0.6412520698679494,0.8935897435897436,0.9754449243741444,1.0,3/18,13.76%,TIAM1;CYFIP1;FARP2
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.29195510316655565,0.6411928368689828,0.8977719528178244,0.9751547673083578,1.0,3/15,18.45%,CHEK2;HUS1;ATF2
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.2568447164763413,0.6409893840395374,0.9250302297460702,0.9749850261394779,1.0,7/36,14.45%,TCF7L2;PDE6A;FZD5;NFATC1;AGO1;AGO2;GNAO1
prerank,acetyl-CoA metabolic process (GO:0006084),0.29359756394689496,0.6404725592391707,0.8890392422192152,0.9750749042657892,1.0,5/15,29.06%,ACAT1;ACACA;HMGCS2;PPCS;ACLY
prerank,organelle fission (GO:0048285),0.2709769589110623,0.6397764775036677,0.9064102564102564,0.9752925098646402,1.0,10/24,31.04%,PEX11A;DNM2;MTFR1;SEC16B;MUL1;ACOT8;FIS1;MIEF1;PRKN;MTFR1L
prerank,carnitine metabolic process (GO:0009437),0.30338252633159946,0.6394137960916146,0.8868194842406877,0.9752478590874117,1.0,3/12,18.76%,CPT1C;CRAT;SHMT1
prerank,cellular response to exogenous dsRNA (GO:0071360),0.30943131264718193,0.6392901355340973,0.8981348637015782,0.9750163852081797,1.0,4/12,25.92%,MAVS;COLEC12;MUL1;CGAS
prerank,regulation of gene expression by genetic imprinting (GO:0006349),-0.26330655284961085,-0.6388742553653903,0.9042553191489362,0.9859241197198066,1.0,10/10,73.69%,ZFP57;PCGF5;CTCFL;DNMT3L;PRMT7;KDM1B;PCGF3;MECP2;IGF2;DNMT3A
prerank,"synaptic transmission, GABAergic (GO:0051932)",0.31465755530930845,0.6382894787782687,0.8815977175463623,0.9754814447205159,1.0,1/10,5.11%,GABRA3
prerank,bile acid metabolic process (GO:0008206),0.26331492218497227,0.6376712840181855,0.9188861985472155,0.9756266283909887,1.0,10/27,32.80%,OSBPL7;AKR1C1;NPC1;OSBP;SLC27A2;HSD3B7;ACOT8;SCP2;OSBPL1A;GBA2
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.2628280752355369,0.6371131344248463,0.9201520912547528,0.9757133148670256,1.0,6/26,18.60%,EYA2;FGFR1;TERT;INHBA;GDNF;AKT1
prerank,cell junction maintenance (GO:0034331),-0.23707711263084894,-0.6369594730262124,0.9063670411985019,0.9857600959956669,1.0,7/14,29.22%,CLDN1;CBLN2;CSF1R;CBLN1;MYADM;PARD6A;NLGN2
prerank,regulation of innate immune response (GO:0045088),-0.16490215649926213,-0.6361196105447197,1.0,0.9848649592368236,1.0,12/57,16.42%,IFNAR2;SAMHD1;USP18;GBP5;RNASEL;TRIM21;CACTIN;DHX58;PTPN1;LRP8;TNFAIP3;PTPN22
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.24674523417987607,0.6360731473888849,0.9344262295081968,0.976185638621434,1.0,15/44,28.98%,PABPC1;FTO;PUM1;METTL16;AGO2;CNOT8;UPF1;ROCK1;RBM24;METTL14;ZFP36L1;RIDA;TNRC6A;YTHDF1;KHSRP
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.24249924038958187,0.6341044340109697,0.9410404624277456,0.9773693632468813,1.0,8/45,18.46%,PTPN3;GAS1;TOM1L1;BMP4;ZW10;CDKN1C;WEE2;HECA
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.2618734845786255,0.6335240535701384,0.917910447761194,0.9774633399592302,1.0,3/23,9.97%,KLRK1;RAET1E;CRTAM
prerank,macrophage chemotaxis (GO:0048246),-0.26136078332914886,-0.6330067697455638,0.912621359223301,0.9855520654488407,1.0,10/10,73.89%,EDNRB;TAFA4;CCL5;CCL3;EDN2;SAA1;CXCL17;LGALS3;CKLF;CCL2
prerank,detection of visible light (GO:0009584),-0.22616362510821988,-0.6328303426694634,0.942652329749104,0.9842402870721266,1.0,2/16,11.87%,ABCA4;RP1
prerank,bile acid biosynthetic process (GO:0006699),-0.1971690042264108,-0.6328012883618369,0.9587628865979382,0.9828316011068656,1.0,3/24,10.49%,CYP7B1;CYP27A1;OSBPL9
prerank,regulation of mitochondrial fission (GO:0090140),0.26413948267394316,0.6320547352467908,0.9247448979591837,0.9782368988029422,1.0,10/24,30.77%,MIEF2;MCU;LRRK2;MUL1;PINK1;CYRIB;RALA;FIS1;MIEF1;PRKN
prerank,heterochromatin organization (GO:0070828),-0.23512195728355595,-0.6304963499091545,0.9461279461279462,0.9828948119923374,1.0,1/14,0.66%,MECOM
prerank,transcription preinitiation complex assembly (GO:0070897),0.2957207963830634,0.6304131363593309,0.8967921896792189,0.9791507992323415,1.0,5/12,30.96%,BDP1;TBP;TAF1;GTF2A2;TAF1B
prerank,aerobic respiration (GO:0009060),-0.20866028424729766,-0.6287088234822019,0.9393939393939394,0.9826492753380268,1.0,7/20,21.25%,ME3;UQCRC2;SLC25A14;UQCRB;MTFR2;UQCRC1;ATP5F1D
prerank,cellular amino acid catabolic process (GO:0009063),0.22315920830200753,0.6282809254428761,0.9597030752916225,0.9804036527391315,1.0,23/87,26.62%,HYKK;MTRR;DDAH1;IDO2;HMGCL;AUH;ACAT1;HNMT;CARNMT1;GCSH;GSTZ1;SHMT2;BCKDK;SHMT1;DAO;PHYKPL;KYAT1;BCAT1;CRYM;GCDH;BCKDHB;HIBCH;HGD
prerank,apoptotic nuclear changes (GO:0030262),0.2623210289800165,0.6282193586929408,0.9337579617834395,0.9801094709323825,1.0,5/24,18.22%,ERN2;HMGB1;CDK5RAP3;ACIN1;DFFB
prerank,ceramide metabolic process (GO:0006672),0.23823583519465585,0.6272882514249052,0.9548022598870056,0.9804765192177122,1.0,4/49,6.23%,ACER3;PLPP3;SMPD4;PLPP1
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.21627808937184875,0.6264501630085008,0.9949341438703141,0.9807594571888125,1.0,43/158,28.01%,CARD16;MAVS;BRD4;ROR1;TRIM27;S100B;RHOA;SHARPIN;LTBR;ALPK1;CHUK;TAB2;IRAK1;TNFRSF10B;MID2;CASP1;F2R;AKAP13;MAP3K3;ZDHHC13;TRAF3IP2;TRIM13;HMOX1;TRIM6;IKBKE;MAP3K14;CC2D1A;BIRC3;NUP62;TRIM8;MIER1;MUL1;TBK1;NEK6;TMEM106A;PINK1;TFG;TRADD;RIPK1;NDFIP1;RIPK2;UBE2V1;CANT1
prerank,stem cell development (GO:0048864),0.2807507622647833,0.6264489193692054,0.908,0.9804193880288996,1.0,8/16,34.47%,NOLC1;KLHL12;SOX8;TAPT1;SNAI2;PTPRC;TCOF1;PEF1
prerank,second-messenger-mediated signaling (GO:0019932),0.22743285151626952,0.6259471269916869,0.9637526652452025,0.9804431390414282,1.0,16/82,21.72%,PLCE1;PPP1R9B;MCU;EDN3;DDAH1;ACKR4;TRPM4;RCAN1;PDPK1;NDNF;CXCR4;NMUR1;RCAN3;LRRK2;ACKR3;EIF2AK3
prerank,presynapse organization (GO:0099172),0.3088486490531463,0.6257972999748148,0.8913963328631875,0.9802031066119818,1.0,2/10,13.27%,DVL1;NLGN1
prerank,cellular response to nitrogen compound (GO:1901699),0.2749878247033623,0.6243196946342244,0.9053177691309987,0.9809528891155981,1.0,10/20,31.91%,DDI2;SPIDR;AOC1;ATP2B4;DAXX;HSF1;DDX11;TIMELESS;RIOK3;BLM
prerank,positive regulation of viral genome replication (GO:0045070),0.2537004280453795,0.6241894480436262,0.9244114002478315,0.9807180350750223,1.0,4/29,14.30%,PABPC1;TMEM39A;PKN2;SRPK1
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.25963714343233874,0.6239515052154381,0.9122807017543859,0.9805559598229259,1.0,3/23,11.35%,HDAC4;ACTN3;GIT1
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.2748820875087237,0.6225599766959956,0.9125168236877523,0.981199066342075,1.0,4/17,16.87%,MIS12;ZW10;HASPIN;IK
prerank,mitotic spindle assembly (GO:0090307),0.23761511786175452,0.6211794091676943,0.945823927765237,0.9818451834810137,1.0,15/42,32.84%,MISP;SMC3;RHOA;CHEK2;STAG1;CCDC61;ARHGEF10;SMC1A;WRAP73;SPICE1;GOLGA2;TOGARAM1;BCCIP;KIF2A;PIBF1
prerank,positive regulation of defense response (GO:0031349),0.22167488020202888,0.6207771165683781,0.9760166840458812,0.9817796077770256,1.0,4/89,5.56%,IL33;PDCD4;ABCC1;LRSAM1
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",0.28762824702220247,0.6204826184125811,0.9130434782608695,0.9816439787996077,1.0,2/14,14.06%,TERT;TNKS2
prerank,thyroid hormone generation (GO:0006590),0.306180944442691,0.6203327837147113,0.9075757575757576,0.9814145507807436,1.0,1/10,5.63%,CPQ
prerank,T cell receptor signaling pathway (GO:0050852),0.21483036288070712,0.6200429465467843,0.9826175869120655,0.9812712048813217,1.0,42/138,29.15%,PSMD7;CD3E;PSMA8;PRAM1;BTNL9;PSMA4;PAK2;CHUK;TAB2;PDPK1;PSMD12;KHDRBS1;CUL1;PIK3CB;PSMA6;VTCN1;WNK1;PSMD11;PSMC5;PSMD1;PSMD14;RC3H2;PSMC4;DENND1B;TRAT1;PSMA3;PSMD4;PSMB1;STOML2;PSMA5;PSMA7;NFKBID;CSK;NCK1;MOG;PSMC1;WAS;PSMA1;RIPK2;PRKD2;BTRC;BCAR1
prerank,leukocyte tethering or rolling (GO:0050901),0.27583340196579714,0.6196060247897627,0.9165526675786594,0.9812276501528053,1.0,1/17,2.06%,SPN
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.2838342220354369,0.6182085561580678,0.9059945504087193,0.9818617293136019,1.0,1/15,2.19%,MUC1
prerank,regulation of phagocytosis (GO:0050764),0.2305074253970334,0.6171195716124291,0.9672686230248307,0.9822650995474652,1.0,6/53,14.24%,GAS6;PLA2G5;FCER1G;ITGAV;PIP4P2;LMAN2
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.17330770784252048,-0.6158447172997769,0.9864864864864865,0.9890377017735746,1.0,37/38,72.76%,NDUFC2;NDUFA13;NDUFB2;NDUFB7;NDUFAF1;NDUFS1;NDUFA8;NDUFB11;NDUFS6;NDUFA4;NDUFA2;NDUFA12;NDUFC1;NDUFB4;NDUFV1;NDUFS5;NDUFA11;NDUFB8;NDUFS4;NDUFA5;NDUFA3;NDUFS2;NDUFB5;NDUFS8;NDUFS3;NDUFB10;NDUFB3;NDUFA10;NDUFAB1;NDUFA9;NDUFV3;NDUFA6;NDUFV2;NDUFB9;NDUFA7;NDUFA1;NDUFB6
prerank,regulation of microtubule nucleation (GO:0010968),0.3051572942708987,0.6150237185109205,0.902046783625731,0.9833653145669583,1.0,3/10,20.59%,CKAP5;GIT1;DCTN1
prerank,positive regulation of isotype switching (GO:0045830),0.2777642689435665,0.6139166612284034,0.9206349206349206,0.983790279325235,1.0,7/15,28.69%,KMT5C;CLCF1;MAD2L2;IL4;SHLD3;SHLD1;HMCES
prerank,cellular response to gamma radiation (GO:0071480),0.2735913045519194,0.6134050738976867,0.9114583333333334,0.9838148035337004,1.0,8/17,29.63%,WRN;ATM;TLK2;XRCC6;TP53;ATR;HSF1;YAP1
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),-0.22304518047013927,-0.613366455233915,0.9330543933054394,0.9890495829917968,1.0,6/16,20.74%,GMPS;IMPDH1;ADSS1;LHPP;PPAT;AMPD2
prerank,protein targeting to mitochondrion (GO:0006626),0.23055683228639381,0.6130785908214617,0.963963963963964,0.9836916308450429,1.0,8/52,16.90%,TOMM40;TIMM9;AIFM1;BCAP31;HSPD1;TOMM70;PMPCA;GRPEL1
prerank,negative regulation of T cell mediated immunity (GO:0002710),-0.23893730166258442,-0.6126863245373733,0.9146757679180887,0.9879977235483159,1.0,2/11,12.09%,AHR;CEACAM1
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.2882083304194156,0.612229620756694,0.9192886456908345,0.9839198934479763,1.0,8/13,37.28%,IL6;MGAT5;HES1;PTPRC;IL7R;JAK3;CRLF2;JAK2
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.24806130796143028,0.6117243797049635,0.9443127962085308,0.9839147632299776,1.0,3/30,7.50%,TWIST1;CCAR2;YJU2
prerank,regulation of mitotic nuclear division (GO:0007088),0.22868578096666436,0.6111194848433668,0.9650900900900901,0.9839729117361313,1.0,16/55,26.87%,LRP5;TOM1L1;EDN3;BMP4;RCC1;LCMT1;PHIP;DAPK3;KIF20B;NUP62;CUL9;CDK5RAP2;CDK13;CUL7;CCDC8;IGF2
prerank,myelin maintenance (GO:0043217),0.30324828117335095,0.6108189457615073,0.907185628742515,0.9838350721337437,1.0,4/10,22.56%,SOD1;CXCR4;CLU;ABCD1
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.2947796269166759,0.6108109632239371,0.9029957203994294,0.9835011030306031,1.0,6/11,33.32%,SMARCA4;NOP53;DDX11;PWP1;SIRT7;NCL
prerank,tryptophan metabolic process (GO:0006568),0.29623212805534,0.6101563998290558,0.9129172714078374,0.9835878469658936,1.0,2/11,20.11%,IDO2;KYAT1
prerank,steroid biosynthetic process (GO:0006694),0.2252224754618437,0.6099843106788957,0.9498327759197325,0.9833668322699136,1.0,16/56,30.91%,CYP19A1;OSBPL7;FDXR;OSBP;LSS;PRLR;EBP;SLC27A2;SC5D;HSD3B7;ACOT8;HMGCR;SCP2;SQLE;INSIG1;OSBPL1A
prerank,intracellular sterol transport (GO:0032366),0.27784215431535175,0.6092586649105638,0.8987854251012146,0.9835211920489915,1.0,3/13,13.32%,NPC1;ABCA1;OSBP
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.24737545896371765,0.6082976696672379,0.9440993788819876,0.9838285032134075,1.0,5/27,17.39%,DRD1;GPR20;F2R;GPR157;CALCA
prerank,positive regulation of signaling receptor activity (GO:2000273),0.24288216542704627,0.6076292138584568,0.9644128113879004,0.9839215337085502,1.0,5/36,16.15%,EPHB2;ARC;NRP1;HDAC1;HDAC6
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.23093317636786323,0.6069490509827402,0.9608062709966405,0.9840395351331159,1.0,8/50,17.76%,CDK5RAP3;CDC6;CCNT2;CCNE2;CCNG2;CAMK2N1;CDC25A;CDKN1C
prerank,response to muramyl dipeptide (GO:0032495),-0.22637667573691567,-0.6061506355941387,0.9285714285714286,0.9901426518784888,1.0,4/12,16.42%,ARHGEF2;VIM;NOD2;PTPN22
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),0.28341110822972093,0.6057244884048634,0.9153952843273232,0.984510222293832,1.0,7/13,38.71%,LSM2;SRSF10;USP4;DDX20;SART3;CD2BP2;PRPF31
prerank,phosphate ion transmembrane transport (GO:0035435),0.29002803885251077,0.6053942619080007,0.9157458563535912,0.9843863322301272,1.0,5/12,31.39%,SLC25A3;SLC37A4;SLC37A3;SLC25A11;SLC20A2
prerank,negative regulation of translational initiation (GO:0045947),0.28277662786322305,0.6030880782753785,0.9069767441860465,0.9854800908349961,1.0,5/13,28.88%,AGO2;RBM4;EIF2AK4;TPR;LARP1
prerank,negative regulation of protein dephosphorylation (GO:0035308),0.2600173726309622,0.6026790048450499,0.93854033290653,0.9853902004490697,1.0,8/21,25.25%,PPP1R8;TIPRL;YWHAE;ARPP19;CRY2;FKBP1B;BOD1L1;YWHAB
prerank,microtubule-based transport (GO:0099111),0.2875864454369312,0.6022664088567857,0.9014844804318488,0.9853044799324341,1.0,4/12,22.08%,ROPN1L;DNAAF4;DYNC1I2;SPAG17
prerank,plasma membrane tubulation (GO:0097320),0.28032992905976484,0.6022166466120252,0.91027496382055,0.9849922568731508,1.0,3/13,19.68%,EHD2;SNX9;CHMP4A
prerank,regulation of protein localization to centrosome (GO:1904779),-0.2378779383234823,-0.6015738412138111,0.9540983606557377,0.9911918619879221,1.0,3/10,16.11%,APC;NSFL1C;CEP72
prerank,covalent chromatin modification (GO:0016569),0.27348314402174073,0.6005819553972818,0.9196185286103542,0.9856864236780083,1.0,3/14,17.53%,SETD5;HDAC1;UFL1
prerank,regulation of DNA-dependent DNA replication (GO:0090329),-0.23385752504866003,-0.6002310017531103,0.9354838709677419,0.990457463329978,1.0,6/12,28.13%,WDR18;METTL4;WRNIP1;TIPIN;GMNN;TICRR
prerank,nucleoside catabolic process (GO:0009164),0.2942014534630751,0.6000208729593227,0.9310344827586207,0.9857002127335862,1.0,3/11,21.32%,UPP2;DERA;NT5C
prerank,primary miRNA processing (GO:0031053),0.2917709075553236,0.5995930706471895,0.9034965034965035,0.9856237343934992,1.0,2/10,11.42%,HNRNPA2B1;DGCR8
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.2451961070280585,0.5988652318699511,0.9455006337135615,0.9857383573865477,1.0,2/25,4.13%,CSNK2A1;CSNK2A2
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.27140408018872686,0.5982533121534441,0.9249329758713136,0.9857794467218516,1.0,6/15,34.62%,ANXA1;NR3C1;HNRNPU;ZFP36L1;SSTR2;FAM107A
prerank,B cell activation (GO:0042113),0.21915408438397466,0.598199399323,0.9716466739367503,0.9854714586293719,1.0,12/68,21.59%,EPHB2;HDAC9;HDAC4;CHRNB2;HSPD1;PTPN2;CLCF1;TCF3;GPS2;TPD52;IL4;BANK1
prerank,nuclear body organization (GO:0030575),0.27539135377468904,0.597793327479449,0.906721536351166,0.9853760435648519,1.0,4/12,19.33%,USP50;USPL1;HIPK2;AFF2
prerank,long-chain fatty acid biosynthetic process (GO:0042759),-0.19396937814554788,-0.5974876143221998,0.9768518518518519,0.9904585771094102,1.0,12/23,37.50%,HPGD;GSTM1;ALOX12;ELOVL6;ASAH2;ALOX5;CYP2E1;GSTM4;ACOT7;LTC4S;GSTP1;CYP1A1
prerank,positive regulation of histone modification (GO:0031058),0.2378440062478444,0.5972291875075562,0.9488703923900119,0.9853649953356262,1.0,8/33,24.81%,TADA2A;RPS6KA4;CHTOP;ARRB1;NIPBL;AKAP8;PAF1;SAP30BP
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.25452939832905574,0.5968069844976788,0.9423312883435583,0.9852887882002653,1.0,9/22,35.48%,RUNX1;KAT2A;LAG3;CBFB;SOCS1;BCL6;CD46;FANCA;IRF1
prerank,branched-chain amino acid metabolic process (GO:0009081),0.2583662077555992,0.5963580605512735,0.9414758269720102,0.9848907030702199,1.0,6/20,26.33%,AUH;ACAT1;BCKDK;BCAT1;BCKDHB;HIBCH
prerank,branched-chain amino acid catabolic process (GO:0009083),0.2583662077555992,0.5963580605512735,0.9414758269720102,0.9848907030702199,1.0,6/20,26.33%,AUH;ACAT1;BCKDK;BCAT1;BCKDHB;HIBCH
prerank,entry into host (GO:0044409),0.28012364958088876,0.5954246330445236,0.92904953145917,0.9851037650214814,1.0,6/13,30.26%,CBL;ITGAV;CXCR4;MET;GRB2;CTNNB1
prerank,purine nucleotide catabolic process (GO:0006195),0.2760943838969786,0.5940145088736578,0.9327846364883402,0.9856073159266111,1.0,1/13,4.52%,XDH
prerank,positive regulation of interleukin-13 production (GO:0032736),0.2952754106414881,0.5935164494746319,0.9110787172011662,0.9855607886324625,1.0,3/10,27.90%,RARA;IL4;SPHK2
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.2594357785822038,0.5934340442404353,0.9341935483870968,0.9852749300638366,1.0,10/19,35.16%,AEN;HIPK2;RPS27L;TP53;CDIP1;SNW1;MSH2;DYRK2;BCL3;PHLDA3
prerank,regulation of AMPA receptor activity (GO:2000311),0.24797026752904772,0.591838390481879,0.9508599508599509,0.9858425786058925,1.0,5/25,17.85%,ARC;CNIH2;SHANK1;NLGN1;SHISA8
prerank,glutamine family amino acid metabolic process (GO:0009064),0.2344444701922405,0.591426212940841,0.9473684210526315,0.9857541672404078,1.0,12/33,31.06%,GCLC;DDAH1;CAD;RIMKLB;KYAT1;GCLM;PYCR1;RIMKLA;FPGS;NIT2;DGLUCY;ALDH18A1
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.18839606319188473,-0.590326701368181,0.9854368932038835,0.9925603506143966,1.0,6/26,15.64%,CDK6;TMEM178A;MAFB;CEACAM1;HOXA7;C1QC
prerank,adrenergic receptor signaling pathway (GO:0071875),0.2553414622761365,0.5900930469730219,0.9504563233376793,0.986176026235877,1.0,3/20,14.80%,DRD1;ADCY9;AKAP13
prerank,endochondral bone morphogenesis (GO:0060350),0.28697996066390186,0.5900481193653271,0.9196675900277008,0.9858672257937644,1.0,3/11,20.71%,TMEM119;BMP4;FGFR3
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.263886779147598,0.5888995707545699,0.9340369393139841,0.9861861068358508,1.0,5/17,27.29%,KCNE5;SUMO1;RNF207;VAMP2;KCNRG
prerank,carbohydrate derivative catabolic process (GO:1901136),0.2601563307555214,0.5884444708588292,0.9369973190348525,0.9861272609045226,1.0,7/18,29.17%,DERA;NGLY1;FBXO17;ADAMTS9;OGA;MANBA;STT3B
prerank,alpha-amino acid metabolic process (GO:1901605),0.2236397736494597,0.5871502773082606,0.9646924829157175,0.9864910137828213,1.0,13/45,25.62%,NOX4;MTRR;DDAH1;SRR;MTHFD1;GNMT;MTHFR;RIMKLB;KYAT1;PYCR1;DPEP1;RIMKLA;SLC25A12
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.2829167512804133,0.5853386670063564,0.9166666666666666,0.9871485800942238,1.0,2/11,14.55%,SCARA3;COLEC12
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.2498337019919445,0.5843423184832757,0.9571984435797666,0.9873634005553089,1.0,5/22,22.11%,AHNAK;DMD;STAC3;DRD2;CBARP
prerank,erythrocyte development (GO:0048821),-0.2384509163946774,-0.5823346501560762,0.9539473684210527,0.9949635753536201,1.0,10/10,76.18%,SH2B3;NCKAP1L;ALAS2;ALAS1;GATA1;DMTN;LYAR;MED1;ZBTB7A;ABCB10
prerank,negative regulation of histone methylation (GO:0031061),0.28745910381971695,0.581948559324681,0.9386861313868613,0.9882754009962187,1.0,2/10,12.63%,PHF1;WDR5
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.26814519310485685,0.5809440560148859,0.9430122116689281,0.9884496654447246,1.0,1/14,6.25%,PUM1
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",-0.15210641093718355,-0.5785803776024778,1.0,0.9950773271012708,1.0,6/53,11.28%,CALCRL;HTR2C;HTR4;OPRM1;CNR1;CHRM3
prerank,cellular response to inorganic substance (GO:0071241),0.24997673112491695,0.5782895293489961,0.959792477302205,0.9894559653905542,1.0,9/21,31.91%,DDI2;SPIDR;AOC1;CDK2;DPEP1;DDX11;TIMELESS;MTR;BLM
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.2502399867438454,0.577858160806942,0.9486521181001284,0.9893503865825716,1.0,5/21,16.36%,SIRT5;COA8;SIRT2;HDAC6;AATF
prerank,plasma membrane repair (GO:0001778),0.26963490155111014,0.5777476251574152,0.9515235457063712,0.9890690053922749,1.0,1/13,2.92%,AHNAK2
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",0.26450165605106546,0.5729628262933024,0.9493333333333334,0.9910794994674637,1.0,5/15,24.93%,NLGN1;CLN3;USP46;DRD2;SYN3
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.23049383001726031,0.5718580588047989,0.9733009708737864,0.9912687727873467,1.0,3/29,9.97%,KLRK1;RAET1E;CRTAM
prerank,regulation of response to interferon-gamma (GO:0060330),0.26182357293852476,0.5715981820232396,0.938288920056101,0.9910611648578315,1.0,5/14,26.03%,PTPN2;SUMO1;JAK1;IFNGR2;SOCS1
prerank,establishment of melanosome localization (GO:0032401),0.2514424844246165,0.5705737001127117,0.9384203480589023,0.9912181670384538,1.0,7/19,30.60%,BBS5;RAB11B;BLOC1S3;MLPH;BBS7;MYO5A;RAB27B
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.2604095752868483,0.5695092022350219,0.9307589880159787,0.9914207330003505,1.0,3/15,21.03%,ABL1;SMAD7;MAD2L2
prerank,determination of bilateral symmetry (GO:0009855),0.23679535346571698,0.5693403288522044,0.95125,0.9911628952578092,1.0,6/24,24.67%,ODAD2;DNAAF4;NPHP3;CITED2;LEFTY1;BBS7
prerank,maturation of LSU-rRNA (GO:0000470),0.23578719908254178,0.568537699307657,0.9702602230483272,0.9912074649815997,1.0,11/26,32.81%,LAS1L;EIF6;BOP1;RPL7A;WDR12;NIFK;MAK16;RRP15;RPF2;RSL1D1;DDX18
prerank,regulation of viral genome replication (GO:0045069),0.21418880115541367,0.5677949124774364,0.9840728100113766,0.9912090844151217,1.0,16/56,29.19%,PABPC1;TMEM39A;MAVS;ILF3;PKN2;SRPK1;N4BP1;TRIM6;SHFL;STAU1;PPID;BANF1;DDB1;HACD3;LARP1;TNIP1
prerank,protein import into mitochondrial matrix (GO:0030150),0.2534236557716077,0.5677289458176269,0.9548472775564409,0.9909039444617039,1.0,7/18,35.20%,TOMM40;TOMM70;GRPEL1;TIMM17B;GRPEL2;TIMM21;TIMM23
prerank,regulation of steroid metabolic process (GO:0019218),0.24421129995453586,0.5667511977713191,0.9597989949748744,0.9910093470823543,1.0,5/23,19.83%,LAMTOR1;RORA;DGKQ;STUB1;ASAH1
prerank,canonical glycolysis (GO:0061621),-0.18001023868807317,-0.5665889554359541,0.9899497487437185,0.9971293191032857,1.0,4/24,10.94%,HK2;PGAM1;GPI;ALDOC
prerank,glucose catabolic process to pyruvate (GO:0061718),-0.18001023868807317,-0.5665889554359541,0.9899497487437185,0.9971293191032857,1.0,4/24,10.94%,HK2;PGAM1;GPI;ALDOC
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.26573223369283894,0.5653920785865975,0.9485396383866481,0.9912848344962328,1.0,1/13,4.11%,STAT3
prerank,sphingolipid metabolic process (GO:0006665),0.20007654058167534,0.564939397052764,0.9958202716823407,0.9911804515062699,1.0,8/108,6.75%,ACER3;PLPP3;PDXDC1;KDSR;SMPD4;ELOVL5;PLPP1;ARSA
prerank,pyroptosis (GO:0070269),0.2586818103286529,0.5646788285709485,0.9357429718875502,0.9909715502473613,1.0,2/15,13.83%,CASP1;GSDME
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.22470199753917547,0.5639573497625273,0.9641148325358851,0.9909577316625938,1.0,9/35,24.09%,CALM2;PPP6R1;TIPRL;PPP6R3;CALM3;PPP6R2;CRY2;FKBP1B;BOD1L1
prerank,insulin secretion (GO:0030073),0.25036594076709257,0.5626603215154709,0.9588859416445623,0.9912281444173349,1.0,3/19,13.72%,ANXA1;RAB11FIP5;RAB11B
prerank,regulation of osteoclast differentiation (GO:0045670),0.22319386038991365,0.5623550965007161,0.9644549763033176,0.9910282015894228,1.0,1/33,1.84%,UBASH3B
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.23034247533706093,0.5621757335967619,0.9689054726368159,0.9907744851520901,1.0,4/28,15.39%,OSBPL7;CDK5RAP3;AXIN1;PSMC5
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.23826391583411488,0.5619673357083026,0.9539641943734015,0.9905377805175627,1.0,3/22,12.87%,UBASH3A;PTPN2;EZR
prerank,negative regulation of DNA binding (GO:0043392),0.22776674371766292,0.5608142872099016,0.9623329283110571,0.9907288455477227,1.0,8/28,24.31%,HEY1;SMO;MDFI;SUMO1;E2F1;NFKBIA;MAD2L2;ILRUN
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.2543266218314803,0.5594868527792171,0.9418918918918919,0.9909847432013767,1.0,4/16,29.01%,SOX9;APPL2;NCOR1;WDTC1
prerank,phosphate ion transport (GO:0006817),0.2506674635193055,0.5590273728510999,0.9556714471968709,0.9908504950394907,1.0,5/16,31.39%,SLC25A3;SLC37A4;SLC37A3;SLC25A11;SLC20A2
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.24095708151836642,0.5574292409819601,0.9602053915275995,0.9912097785290233,1.0,5/20,26.14%,ADA;RPGRIP1L;GPRASP1;YWHAB;MET
prerank,ganglion development (GO:0061548),-0.2237332463061451,-0.5561869780915689,0.9583333333333334,0.9995237991039692,1.0,2/11,15.12%,NRP2;UNC5C
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.2781362727552069,0.5561064095973199,0.9552023121387283,0.9914484435336742,1.0,4/10,31.38%,IRAK3;TLE5;PTPRC;MAP2K5
prerank,melanosome localization (GO:0032400),0.23740245346041627,0.5558739698027071,0.9547803617571059,0.991217704284298,1.0,7/21,30.60%,BBS5;RAB11B;BLOC1S3;MLPH;BBS7;MYO5A;RAB27B
prerank,inorganic ion transmembrane transport (GO:0098660),0.2625555584370859,0.5551492116728622,0.9424964936886395,0.9912031819886076,1.0,2/12,15.82%,TRPM4;PKD2L1
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.2645952629888472,0.5543945417230425,0.9400855920114123,0.9911859821921476,1.0,6/13,35.99%,HSPA5;UFL1;NCK1;ATF6B;WFS1;DNAJB9
prerank,positive regulation of cell aging (GO:0090343),0.2689991040572023,0.5536888845606379,0.9539748953974896,0.9911365575946928,1.0,4/11,25.92%,LMNA;HMGA1;ARG2;CGAS
prerank,alpha-amino acid catabolic process (GO:1901606),0.22341186657155734,0.5535036046503121,0.9719853836784409,0.9908770288909308,1.0,6/29,20.11%,MTRR;IDO2;ACAT1;GSTZ1;DAO;KYAT1
prerank,glycerol metabolic process (GO:0006071),-0.2274157620247327,-0.5531842175610926,0.9504950495049505,0.9991111636070057,1.0,5/10,29.41%,GK;GK5;TPI1;GOT1;COQ3
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.22862426678343917,0.5519989199530914,0.9651741293532339,0.9911274051663467,1.0,7/25,29.71%,FOXK1;ADPGK;PGK1;ENO2;PFKP;PFKL;GAPDHS
prerank,sterol biosynthetic process (GO:0016126),-0.16337822577744343,-0.5514186080409793,0.9940119760479041,0.998260945266483,1.0,10/33,24.23%,PRKAG2;INSIG2;FDFT1;HMGCS1;MSMO1;FDPS;DHCR24;HSD17B7;PMVK;ARV1
prerank,negative regulation of hormone secretion (GO:0046888),0.2709074366984027,0.5488131684703584,0.9559659090909091,0.9920441667097278,1.0,3/10,32.27%,RAB11FIP5;LIF;RAB11FIP3
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.27650380829347854,0.5476156374541303,0.9613733905579399,0.9921873435280856,1.0,2/10,18.60%,MIA3;AKT1
prerank,positive regulation of B cell activation (GO:0050871),0.20687867439854965,0.5463753874906894,0.9876543209876543,0.9923166797409001,1.0,7/50,15.41%,EPHB2;MMP14;CHRNB2;KMT5C;CD27;CLCF1;IL6
prerank,cholesterol biosynthetic process (GO:0006695),0.2171683449091198,0.546037377212032,0.9672727272727273,0.9921158363881057,1.0,12/31,33.95%,NSDHL;LSS;EBP;SC5D;HMGCR;ACAT2;ACLY;SQLE;INSIG1;GGPS1;PLPP6;TM7SF2
prerank,2-oxoglutarate metabolic process (GO:0006103),-0.20855044258898864,-0.5443552940331252,0.9825783972125436,0.999155705839237,1.0,13/13,79.17%,ADHFE1;D2HGDH;GOT1;AADAT;GPT2;GOT2;OGDH;TAT;DLST;IDH1;IDH2;L2HGDH;PHYH
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.20031327860047196,0.5435276994446483,0.9945533769063181,0.9927503007008481,1.0,7/63,15.41%,EPHB2;CD3E;CHRNB2;ANXA1;CD80;CLCF1;IL6
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.24472838434688485,0.5414761522156628,0.9614325068870524,0.9931780443688234,1.0,7/15,30.89%,CCT6A;CCT4;CCT8;TCP1;DKC1;CCT5;NOP10
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.2588456088916784,0.5409640420749552,0.9634831460674157,0.9930306795022954,1.0,4/11,27.38%,NCBP1;NCBP2;PAF1;ZFP36L1
prerank,superoxide anion generation (GO:0042554),0.25678086656638494,0.5394496243752148,0.943884892086331,0.9932542283024455,1.0,1/13,5.96%,NOX4
prerank,mitochondrial genome maintenance (GO:0000002),0.2622130362888613,0.5368278857619287,0.9492753623188406,0.9938740791160042,1.0,3/11,15.94%,LONP1;MEF2A;PARP1
prerank,positive regulation of chromatin organization (GO:1905269),-0.21487758945386065,-0.5364349960625701,0.9692307692307692,1.0,1.0,12/12,78.53%,TAL1;TERF2IP;SIN3A;TERF1;ACD;TINF2;ATRX;TERF2;UBE2N;DAXX;H3-3A;MIER1
prerank,positive regulation of JUN kinase activity (GO:0043507),0.22424780694160557,0.5358166407437337,0.9649561952440551,0.9938734512169138,1.0,6/23,27.71%,MAP3K5;MAP3K10;DUSP19;TAOK3;DVL2;MAP3K11
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.18808571243149078,0.5341840126731985,0.9937106918238994,0.9941108699018484,1.0,39/87,38.68%,ECSIT;COA8;AIFM1;ACAD9;NDUFS7;SURF1;BCS1L;TTC19;FASTKD3;COX18;NDUFAF4;UQCC3;SDHAF1;NDUFB6;DMAC2;NDUFA1;NDUFA7;SDHAF2;COA5;NDUFB9;SDHAF4;NDUFV2;NDUFA6;COX16;TIMM21;SDHAF3;NDUFAF5;NDUFV3;NDUFA9;UQCC1;NDUFAB1;UQCRFS1;NUBPL;NDUFA10;COX20;COX14;NDUFB3;NDUFB10;NDUFS3
prerank,aspartate family amino acid catabolic process (GO:0009068),0.233573904912257,0.533626064861047,0.9790301441677588,0.9939654447970165,1.0,4/19,23.15%,HYKK;PHYKPL;CRYM;GCDH
prerank,sensory perception of taste (GO:0050909),0.26732362540798393,0.5329660096347468,0.9608391608391609,0.993862549046297,1.0,10/10,73.28%,PKD2L1;ASIC2;PKD1L3;TAS1R3;GNAT3;TAS1R2;ASIC1;TAS1R1;ASIC3;CD36
prerank,sensory perception of smell (GO:0007608),-0.21825371916389427,-0.5327778767692376,0.9764309764309764,0.9996709344493357,1.0,11/11,78.20%,SYT10;SLC24A4;ADCY3;BEST2;OMP;BBS4;GFY;OBP2B;MKKS;UBR3;DRD2
prerank,tyrosine metabolic process (GO:0006570),-0.21506344864652424,-0.5323573866364142,0.9743589743589743,0.9983870287142927,1.0,4/11,25.47%,FAH;THAP4;TYR;IL4I1
prerank,modulation by host of viral genome replication (GO:0044827),-0.20145646305480572,-0.5323324329135339,0.978021978021978,0.9969865077698022,1.0,13/13,79.88%,ZC3H12A;IFI27;NUCKS1;FMR1;FBXL2;CCL8;CCNK;YTHDC2;PPIB;VAPA;PRKN;TBC1D20;EIF2AK4
prerank,positive regulation of T cell activation (GO:0050870),0.19766588798445928,0.5312682009813894,0.9911894273127754,0.9940860392776153,1.0,6/62,15.41%,ZMIZ1;CD3E;ANXA1;HSPD1;CD80;IL6
prerank,negative regulation of phagocytosis (GO:0050765),0.23801253972275918,0.5287193869002973,0.9725130890052356,0.9945808306776448,1.0,4/17,24.44%,HMGB1;PIP4P2;APPL1;SNX3
prerank,positive regulation of defense response to virus by host (GO:0002230),0.22124392292267422,0.527103671061163,0.9784537389100126,0.9947435181288543,1.0,9/24,30.83%,MAVS;TOMM70;TRAF3IP2;TRIM6;EIF2AK4;IL4;CGAS;HSP90AA1;LILRB1
prerank,cellular biogenic amine metabolic process (GO:0006576),0.2505168669237,0.5250650066518234,0.9657064471879286,0.9950132032059019,1.0,3/12,22.51%,HNMT;SRM;SLC22A3
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.2259154138656064,0.5239283927737715,0.9711417816813049,0.995020201916074,1.0,8/21,32.31%,UBE2C;CDC20;MAD2L2;RAB1A;GOLGA2;BTRC;UBE2S;GORASP1
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.22178740969914762,0.5217007792567342,0.9837092731829574,0.9953239591122826,1.0,5/23,25.18%,TIMM9;TOMM70;COX18;BAD;TIMM22
prerank,peptide biosynthetic process (GO:0043043),0.17762124020463205,0.5175793524908839,1.0,0.9961661756762757,1.0,12/153,13.22%,PCSK5;RPSA;RRBP1;DMD;ABCF1;GSPT1;HARS2;MRPS18B;MRPS14;AGO2;EIF4G1;MRPL35
prerank,microtubule anchoring (GO:0034453),0.24783420999493405,0.5148884130501122,0.9696969696969697,0.9965633158313225,1.0,5/12,31.31%,PCM1;CAMSAP3;PEX14;GCC2;BCCIP
prerank,negative regulation of cell division (GO:0051782),0.2499533604172247,0.5133319990273361,0.9732016925246827,0.9966490680813236,1.0,4/11,31.91%,ZFYVE19;E2F8;CHMP4C;BLM
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.20381644337943083,0.5129978563386421,0.9879227053140096,0.9964080929475865,1.0,5/33,18.57%,UBASH3A;PTPN2;EZR;KCNN4;TRAT1
prerank,negative regulation by host of viral transcription (GO:0043922),0.24569993722536088,0.5129640216850921,0.975254730713246,0.9960827253157141,1.0,12/12,75.45%,HDAC1;TARDBP;TFAP4;REST;INPP5K;PSMC3;CCL3;CCL4;CCL5;JUN;POU2F3;HMGA2
prerank,negative regulation of innate immune response (GO:0045824),0.20280275380172552,0.5128485357178694,0.9882075471698113,0.9957788720710166,1.0,6/34,21.56%,TRAFD1;IRAK3;PTPN2;SERPING1;ACOD1;MUL1
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.21109994398988924,0.5127717849309771,0.9783393501805054,0.9954665719158566,1.0,4/27,16.77%,ETNK1;ETNPPL;CHKB;PLA2G15
prerank,inner mitochondrial membrane organization (GO:0007007),0.19443748285427764,0.5121955124274078,0.990990990990991,0.9953021335515151,1.0,6/47,15.87%,SPG7;TIMM9;MICOS10;LETM1;ATP5MC3;TOMM70
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.18917847179443148,0.5119821717158713,0.9966777408637874,0.9947037310558406,1.0,25/56,40.38%,ECSIT;ACAD9;NDUFS7;BCS1L;NDUFAF4;NDUFB6;DMAC2;NDUFA1;NDUFA7;NDUFB9;NDUFV2;NDUFA6;TIMM21;NDUFAF5;NDUFV3;NDUFA9;NDUFAB1;NUBPL;NDUFA10;NDUFB3;NDUFB10;NDUFS3;TMEM126A;NDUFS8;NDUFB5
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.18917847179443148,0.5119821717158713,0.9966777408637874,0.9947037310558406,1.0,25/56,40.38%,ECSIT;ACAD9;NDUFS7;BCS1L;NDUFAF4;NDUFB6;DMAC2;NDUFA1;NDUFA7;NDUFB9;NDUFV2;NDUFA6;TIMM21;NDUFAF5;NDUFV3;NDUFA9;NDUFAB1;NUBPL;NDUFA10;NDUFB3;NDUFB10;NDUFS3;TMEM126A;NDUFS8;NDUFB5
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.23870541934168982,0.5111234725875499,0.9581005586592178,0.9945991781693025,1.0,5/14,30.97%,TNFRSF1B;IL4;LDLR;NR1D1;PTPRC
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.238277908977434,0.5091670501077177,0.9735376044568245,0.9947929309540539,1.0,4/13,28.67%,HEY1;MAD2L2;TAF1;PER2
prerank,T cell homeostasis (GO:0043029),0.24946586261592915,0.5090750358403989,0.9639769452449568,0.9944792571869475,1.0,5/10,33.98%,RIPK3;AKT1;JAK3;PPP2R3C;ZC3H8
prerank,B cell activation involved in immune response (GO:0002312),0.23825071210227006,0.5061044779107897,0.967741935483871,0.9948946241668296,1.0,6/13,37.98%,LIG4;EXOSC3;GPR183;MSH2;RNF8;RNF168
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.21656833586774646,0.5054997884930676,0.9754838709677419,0.9947128418888759,1.0,3/20,12.67%,AK3;ATIC;AMPD3
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.24378798068900984,0.5038559033939661,0.9720670391061452,0.9947805965170379,1.0,3/11,25.29%,IL4;TMEM106A;HDAC2
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.23625300889541517,0.5032216233081439,0.9677871148459384,0.9945860418940105,1.0,5/14,24.51%,SYVN1;CREB3L1;LRRK2;SELENOS;HERPUD1
prerank,regulation of activated T cell proliferation (GO:0046006),0.20278224124582905,0.5020642643762531,0.9869668246445498,0.9945348029414326,1.0,3/30,10.71%,HMGB1;CRTAM;RIPK3
prerank,cristae formation (GO:0042407),0.20521961683867868,0.5017870464837294,0.985239852398524,0.9942682266796349,1.0,12/27,38.50%,SPG7;LETM1;ATP5MC3;UQCC3;AFG3L2;ATP5MC2;DNAJC11;ATP5MF;ATP5PD;ATP5F1E;ATP5F1C;IMMT
prerank,positive regulation of behavior (GO:0048520),0.2505204012653894,0.4997055329563785,0.9794238683127572,0.9944185152853975,1.0,2/10,13.27%,AGRP;NLGN1
prerank,mesenchymal cell development (GO:0014031),0.2200596494752447,0.49950141066540643,0.9787234042553191,0.994136922726574,1.0,8/18,34.47%,HEYL;NOLC1;KLHL12;SOX8;TAPT1;SNAI2;TCOF1;PEF1
prerank,regulation of phosphate metabolic process (GO:0019220),0.22444765851324622,0.4992640985911268,0.988296488946684,0.9938555167764705,1.0,4/16,25.12%,SMG6;SIRT2;IL4;MCM7
prerank,regulation of microglial cell activation (GO:1903978),-0.1790805840047215,-0.4980953524639823,0.9962825278810409,1.0,1.0,5/15,24.51%,SPHK1;CX3CL1;SYT11;GRN;TREM2
prerank,negative regulation by host of viral process (GO:0044793),-0.2014185287471755,-0.497026651746328,0.9834437086092715,1.0,1.0,10/10,79.88%,ZC3H12A;CRP;CCL8;PTX3;CCNK;LTF;PSMC3;VAPA;PRKN;EIF2AK4
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.24133342266513114,0.4948488053123486,0.9688385269121813,0.9945081011484491,1.0,4/11,33.56%,ARRB1;SAG;ADM;GRK2
prerank,positive regulation of lymphocyte activation (GO:0051251),0.20047366081162799,0.49240972161661384,0.9914320685434517,0.994713353512189,1.0,6/28,26.13%,PRKDC;HSPD1;IL6;XRCC6;CCL2;CYRIB
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.22590181905625473,0.4914841817050955,0.9832041343669251,0.9945715841703956,1.0,2/16,8.69%,RORA;FOXK1
prerank,aromatic amino acid family metabolic process (GO:0009072),-0.20116746171227717,-0.47981014296142876,0.9930555555555556,1.0,1.0,10/10,79.90%,THAP4;IL4I1;KYNU;QDPR;PCBD1;IYD;PAH;ATP7A;ASRGL1;KYAT1
prerank,positive regulation of interferon-beta production (GO:0032728),0.19289207166371627,0.47832586851621156,0.992797118847539,0.9967587951561991,1.0,13/33,35.48%,MAVS;TOMM70;IRF3;TBK1;PTPN11;RIPK2;RNF135;HSP90AA1;RIOK3;POLR3F;IFIH1;DHX9;IRF1
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.21518520439342326,0.4772488855637694,0.9843971631205674,0.9966303224533096,1.0,5/16,31.85%,RIPK3;CYRIB;LILRB1;PTPRC;STX7
prerank,carbohydrate catabolic process (GO:0016052),0.18459372136363553,0.47550843489136274,0.9929245283018868,0.9965888179071468,1.0,11/38,30.53%,MAN2C1;DERA;PGK1;ENO2;MAN2B1;ENO4;PFKFB1;MANBA;PFKL;GAPDHS;LDHA
prerank,secondary alcohol biosynthetic process (GO:1902653),0.18931707645322549,0.4716339553399739,0.9877750611246944,0.9968571107236135,1.0,11/30,33.95%,NSDHL;LSS;EBP;HMGCR;ACAT2;ACLY;SQLE;INSIG1;GGPS1;PLPP6;TM7SF2
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),-0.16026124089424768,-0.47141334876465657,0.9956140350877193,1.0,1.0,18/18,84.00%,HIP1R;BOK;HSPA1A;TMEM14A;BAX;ZNF205;CHCHD10;TMEM102;GSK3B;FZD9;ACAA2;GSK3A;BAK1;MPV17L;SLC25A5;MUL1;BID;SLC35F6
prerank,regulation of neutrophil migration (GO:1902622),0.2258501037178195,0.4624919061843493,0.9885714285714285,0.9978904814238969,1.0,3/10,29.40%,MPP1;BST1;RAC1
prerank,positive regulation of immune response (GO:0050778),-0.11852259538747925,-0.4599069514087367,1.0,1.0,1.0,22/64,32.64%,GBP5;CD74;RSAD2;LGALS9;SIRT1;NOD2;PYCARD;ITGAM;XBP1;POLR3B;POLR3D;HRG;GRN;FADD;NMI;IL15;TLR8;CCL5;CD226;MYB;IL12RB1;POLR3C
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.16173663904550337,-0.4572381739964994,0.9957446808510638,1.0,1.0,3/17,13.48%,ATP5ME;ATP5MC1;ATP5F1B
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),-0.16888498242089403,-0.455124320935861,0.99644128113879,1.0,1.0,14/14,83.13%,NECTIN2;IKBKG;RPS3;CARD11;CD226;TESPA1;LCK;BCL10;RAB29;CD81;RELA;PRKD2;TRAT1;KCNN4
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.16277650601084093,-0.45488809109239114,1.0,0.9986750215045795,1.0,3/16,13.48%,ATP5ME;ATP5MC1;ATP5F1B
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.19952699940398064,0.45342481363197723,0.9895968790637191,0.9987753172954231,1.0,7/18,33.45%,TCTA;IL4;GPR137B;LILRB3;LILRB1;FBN1;FSTL3
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.2002587614295846,0.45251220567254935,0.9918256130790191,0.9985701797339986,1.0,7/18,30.89%,CCT6A;CCT4;CCT8;TCP1;DKC1;CCT5;NOP10
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.22264051033660762,0.44840565643198554,0.9884726224783862,0.9984013216411338,1.0,1/10,13.93%,WNK1
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.22264051033660762,0.44840565643198554,0.9884726224783862,0.9984013216411338,1.0,1/10,13.93%,WNK1
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.22037667746228431,0.443009763417756,0.9928057553956835,0.998686283306018,1.0,1/10,9.97%,CRTAM
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.20905193271426464,0.43951628807550913,0.9862258953168044,0.9987209796475547,1.0,7/12,38.67%,YTHDC1;CDYL;HNRNPU;RBM15;RLIM;SMCHD1;PCGF3
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.18381382545266012,0.4359328688755361,0.9935979513444302,0.9987349025448995,1.0,4/24,17.14%,LIG4;RPS27A;UBC;POLB
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.19559544161096226,0.43591680663628923,0.9934123847167325,0.998406709424237,1.0,2/16,14.38%,ERCC4;MSH4
prerank,regulation of B cell activation (GO:0050864),0.18053042987577034,0.4338652243805802,0.99265605875153,0.9982712894188707,1.0,4/25,21.59%,IKZF3;IL6;IL4;BANK1
prerank,regulation of triglyceride biosynthetic process (GO:0010866),0.19806445334393996,0.43313010775324456,0.9933949801849405,0.9980073006287231,1.0,4/15,25.24%,SREBF1;CNEP1R1;LDLR;FITM2
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.18065081501522845,0.42844672862372374,0.9936467598475223,0.9980770310823348,1.0,2/22,12.58%,FZD5;HSPD1
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.2120346426880133,0.4248725797078088,0.9942279942279942,0.9980273496301083,1.0,4/10,37.01%,ATP5MC3;ATP5MC2;ATP5PD;ATP5F1C
prerank,spermatid development (GO:0007286),-0.12583549257962773,-0.42070725226965056,1.0,0.9991242148313589,1.0,6/32,23.99%,JAM2;NECTIN2;CEP57;TDRD5;SYCP3;ACRBP
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.1934038197205311,0.41736184975248164,0.995945945945946,0.9982252298597032,1.0,7/14,38.91%,BOP1;WDR12;NIFK;RPF2;DDX18;PES1;RPL7L1
prerank,negative regulation of synaptic transmission (GO:0050805),0.1695165871491396,0.3941302720149655,0.9974424552429667,0.9991945693807952,1.0,8/23,33.65%,ARF1;PICK1;LRRK2;DRD2;PRRT1;ATAD1;MTMR2;STXBP1
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.15643081028788453,0.381533417527957,0.9987995198079231,0.9993380604016634,1.0,1/29,5.25%,HORMAD1
prerank,DNA catabolic process (GO:0006308),0.18662179673553644,0.3751228649510354,0.9985955056179775,0.9991954210591477,1.0,3/11,26.63%,DFFB;FBH1;DNASE1L2
